--
-- PostgreSQL database dump
--
-- Dumped from database version 9.5.3
-- Dumped by pg_dump version 9.5.3

SET statement_timeout = 0;
SET lock_timeout = 0;
SET client_encoding = 'UTF8';
SET standard_conforming_strings = on;
SET check_function_bodies = false;
SET client_min_messages = warning;
SET row_security = off;

--
-- Name: plpgsql; Type: EXTENSION; Schema: -; Owner: -
--

CREATE EXTENSION IF NOT EXISTS plpgsql WITH SCHEMA pg_catalog;


--
-- Name: EXTENSION plpgsql; Type: COMMENT; Schema: -; Owner: -
--

COMMENT ON EXTENSION plpgsql IS 'PL/pgSQL procedural language';


SET search_path = public, pg_catalog;

SET default_tablespace = '';

SET default_with_oids = false;

--
-- Name: drugs; Type: TABLE; Schema: public; Owner: -
--

CREATE TABLE drugs (
    id integer NOT NULL,
    drug_name character varying,
    compound_name character varying,
    pub_chem_id integer,
    molecular_formula character varying,
    molecular_weight numeric,
    cas character varying,
    log_p numeric,
    h_bond_donor_count integer,
    h_bond_acceptor_count integer,
    rotatable_bond_count integer,
    polar_surface_area numeric,
    heavy_atom_count integer,
    formal_charge integer,
    complexity numeric,
    defined_stereocenter_count integer,
    undefined_stereocenter_count integer,
    melting_point_range character varying,
    ld_50 numeric,
    smiles text,
    iupac_name text
);


--
-- Name: drugs_id_seq; Type: SEQUENCE; Schema: public; Owner: -
--

CREATE SEQUENCE drugs_id_seq
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


--
-- Name: drugs_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: -
--

ALTER SEQUENCE drugs_id_seq OWNED BY drugs.id;


--
-- Name: id; Type: DEFAULT; Schema: public; Owner: -
--

ALTER TABLE ONLY drugs ALTER COLUMN id SET DEFAULT nextval('drugs_id_seq'::regclass);


--
-- Data for Name: drugs; Type: TABLE DATA; Schema: public; Owner: -
--

COPY drugs (id, drug_name, compound_name, pub_chem_id, molecular_formula, molecular_weight, cas, log_p, h_bond_donor_count, h_bond_acceptor_count, rotatable_bond_count, polar_surface_area, heavy_atom_count, formal_charge, complexity, defined_stereocenter_count, undefined_stereocenter_count, melting_point_range, ld_50, smiles, iupac_name) FROM stdin;
1	A-HYDROCORT	HYDROCORTISONE SODIUM SUCCINATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2	A-METHAPRED	METHYLPREDNISOLONE SODIUM SUCCINATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3	A-N STANNOUS AGGREGATED ALBUMIN	TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1910	CODEINE, ASPIRIN, APAP FORMULA NO. 3	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
5	A.P.L.	GONADOTROPIN, CHORIONIC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
70	ACETAZOLAMIDE	ACETAZOLAMIDE	1986	C4H6N4O3S2	222.237	\N	-0.3	2	7	2	152	13	0	297	0	0	\N	\N	CC(=O)NC1=NN=C(S1)S(=O)(=O)N	N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
8	ABACAVIR AND LAMIVUDINE	ABACAVIR;LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
11	ABACAVIR SULFATE AND LAMIVUDINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
13	ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
63	ACETASOL	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
16	ABACAVIR SULFATE; LAMIVUDINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
17	ABACAVIR SULFATE; LAMIVUDINE	ABACAVIR SULFATE;LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
18	ABACAVIR; LAMIVUDINE	ABACAVIR;LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
78	ACETOHEXAMIDE	ACETOHEXAMIDE	1989	C15H20N2O4S	324.395	\N	2.4	2	4	4	101	22	0	498	0	0	\N	\N	CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2	1-(4-acetylphenyl)sulfonyl-3-cyclohexyl-urea
43	ACETADOTE	ACETYLCYSTEINE	12035	C5H9NO3S	163.191	\N	0.4	3	4	3	67.4	10	0	148	1	0	\N	\N	CC(=O)NC(CS)C(=O)O	(2R)-2-acetamido-3-sulfanyl-propanoic acid
90	ACITRETIN	ACITRETIN	5284513	C21H26O3	326.436	\N	6.1	1	3	6	46.5	24	0	539	0	0	\N	\N	CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC	(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid
20	ABILIFY	ARIPIPRAZOLE	60795	C23H27Cl2N3O2	448.388	\N	4.6	1	4	7	44.8	30	0	559	0	0	\N	\N	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
52	ACETAMINOPHEN, ASPIRIN AND CAFFEINE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
27	ABSTRAL	FENTANYL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
29	ACANYA	BENZOYL PEROXIDE	7187	C14H10O4	242.23	\N	3.5	0	4	5	52.6	18	0	258	0	0	\N	\N	C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2	benzoyl benzenecarboperoxoate
33	ACCRETROPIN	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
53	ACETAMINOPHEN, ASPIRIN AND CAFFEINE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
66	ACETATED RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
46	ACETAMINOPHEN AND CODEINE PHOSPHATE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
25	ABREVA	DOCOSANOL	12620	C22H46O	326.609	\N	10.5	1	1	20	20.2	23	0	190	0	0	\N	\N	CCCCCCCCCCCCCCCCCCCCCCO	docosan-1-ol
48	ACETAMINOPHEN AND HYDROCODONE BITARTRATE	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
50	ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE	PENTAZOCINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
37	ACCURETIC	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
80	ACHES-N-PAIN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
24	ABRAXANE	PACLITAXEL	36314	C47H51NO14	853.918	\N	2.5	4	14	14	221	62	0	1790	11	0	\N	\N	CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	\N
59	ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE	DIHYDROCODEINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
67	ACETATED RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
62	ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE	DIHYDROCODEINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
65	ACETASOL HC	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
35	ACCUPRIL	QUINAPRIL HYDROCHLORIDE	54891	C25H31ClN2O5	474.982	\N	\N	3	6	10	95.9	33	0	648	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O.Cl	(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
77	ACETIC ACID W/ HYDROCORTISONE	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
81	ACHROMYCIN	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
68	ACETATED RINGER'S IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
69	ACETATED RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
36	ACCURBRON	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
93	ACTAHIST	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
32	ACCOLATE	ZAFIRLUKAST	5717	C31H33N3O6S	575.68	\N	5.5	2	6	9	124	41	0	1010	0	0	\N	\N	CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC	cyclopentyl N-[3-[[2-methoxy-4-(o-tolylsulfonylcarbamoyl)phenyl]methyl]-1-methyl-indol-5-yl]carbamate
94	ACTEMRA	TOCILIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
95	ACTH	CORTICOTROPIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
96	ACTHAR	CORTICOTROPIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
98	ACTHREL	CORTICORELIN OVINE TRIFLUTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
101	ACTICORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1913	CODEINE, ASPIRIN, APAP FORMULA NO. 4	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
109	ACTIMMUNE	INTERFERON GAMMA-1B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
142	ADAPALENE AND BENZOYL PEROXIDE	BENZOYL PEROXIDE	7187	C14H10O4	242.23	\N	3.5	0	4	5	52.6	18	0	258	0	0	\N	\N	C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2	benzoyl benzenecarboperoxoate
112	ACTIQ	FENTANYL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
118	ACTONEL WITH CALCIUM (COPACKAGED)	CALCIUM CARBONATE	10112	CCaO3	100.086	\N	\N	0	3	0	63.2	5	0	18.8	0	0	\N	\N	C(=O)([O-])[O-].[Ca+2]	calcium;carbonate
114	ACTIVASE	ALTEPLASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
136	ACZONE	DAPSONE	2955	C12H12N2O2S	248.3	\N	1	2	4	2	94.6	17	0	306	0	0	\N	\N	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	4-(4-aminophenyl)sulfonylaniline
125	ACTRON	KETOPROFEN	3825	C16H14O3	254.285	\N	3.1	1	3	4	54.4	19	0	331	0	1	\N	\N	CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O	2-(3-benzoylphenyl)propanoic acid
144	ADASUVE	LOXAPINE	3964	C18H18ClN3O	327.812	\N	3.1	0	3	1	28.1	23	0	450	0	0	\N	\N	CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine
111	ACTINEX	MASOPROCOL	71398	C18H22O4	302.37	\N	4.3	4	4	5	80.9	22	0	303	2	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)C(C)CC2=CC(=C(C=C2)O)O	4-[(2S,3R)-4-(3,4-dihydroxyphenyl)-2,3-dimethyl-butyl]benzene-1,2-diol
138	ADALAT	NIFEDIPINE	4485	C17H18N2O6	346.339	\N	2.2	1	7	5	110	25	0	608	0	0	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
205	ADIPEX-P	PHENTERMINE HYDROCHLORIDE	70969	C10H16ClN	185.695	\N	\N	2	1	2	26	12	0	112	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)N.Cl	2-methyl-1-phenyl-propan-2-amine;hydrochloride
201	ADEMPAS	RIOCIGUAT	11304743	C20H19FN8O2	422.424	\N	1.6	2	9	5	138	31	0	618	0	0	\N	\N	CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC	methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methyl-carbamate
107	ACTIFED W/ CODEINE	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
129	ACUTECT	TECHNETIUM TC-99M APCITIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
135	ACYLANID	ACETYLDIGITOXIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
137	ADAGEN	PEGADEMASE BOVINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
143	ADAPALENE; BENZOYL PEROXIDE	ADAPALENE;BENZOYL PEROXIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
145	ADCETRIS	BRENTUXIMAB VEDOTIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
147	ADDERALL 10	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
148	ADDERALL 10	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
149	ADDERALL 10	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
150	ADDERALL 10	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
151	ADDERALL 12.5	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
152	ADDERALL 12.5	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
153	ADDERALL 12.5	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
154	ADDERALL 12.5	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
155	ADDERALL 15	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
156	ADDERALL 15	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
157	ADDERALL 15	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
158	ADDERALL 15	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
159	ADDERALL 20	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
160	ADDERALL 20	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
161	ADDERALL 20	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
162	ADDERALL 20	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
163	ADDERALL 30	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
164	ADDERALL 30	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
165	ADDERALL 30	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
166	ADDERALL 30	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
167	ADDERALL 5	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
168	ADDERALL 5	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
169	ADDERALL 5	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
170	ADDERALL 5	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
171	ADDERALL 7.5	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
172	ADDERALL 7.5	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
173	ADDERALL 7.5	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
174	ADDERALL 7.5	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
175	ADDERALL XR 10	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
176	ADDERALL XR 10	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
177	ADDERALL XR 10	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
178	ADDERALL XR 10	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
179	ADDERALL XR 15	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
180	ADDERALL XR 15	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
181	ADDERALL XR 15	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
182	ADDERALL XR 15	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
183	ADDERALL XR 20	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
184	ADDERALL XR 20	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
185	ADDERALL XR 20	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
186	ADDERALL XR 20	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
187	ADDERALL XR 25	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
188	ADDERALL XR 25	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
189	ADDERALL XR 25	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
190	ADDERALL XR 25	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
191	ADDERALL XR 30	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
192	ADDERALL XR 30	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
193	ADDERALL XR 30	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
194	ADDERALL XR 30	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
195	ADDERALL XR 5	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
196	ADDERALL XR 5	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
197	ADDERALL XR 5	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
198	ADDERALL XR 5	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
207	ADPHEN	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1923	CODRIX	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
294	ALCOHOL 10% AND DEXTROSE 5%	ALCOHOL	702	C2H6O	46.069	\N	-0.1	1	1	0	20.2	3	0	2.8	0	0	\N	\N	CCO	ethanol
239	ADZENYS XR-ODT	AMPHETAMINE	3007	C9H13N	135.21	\N	1.8	1	1	2	26	10	0	84.7	0	1	\N	\N	CC(CC1=CC=CC=C1)N	1-phenylpropan-2-amine
260	AGRYLIN	ANAGRELIDE HYDROCHLORIDE	42786	C10H8Cl3N3O	292.544	\N	\N	2	1	0	44.7	17	0	360	0	0	\N	\N	C1C2=C(C=CC(=C2Cl)Cl)NC3=NC(=O)CN31.Cl	6,7-dichloro-5,10-dihydro-3H-imidazo[2,1-b]quinazolin-2-one;hydrochloride
266	AKINETON	BIPERIDEN LACTATE	197083	C24H35NO4	401.547	\N	\N	3	5	6	81	29	0	481	0	5	\N	\N	CC(C(=O)O)O.C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O	1-(5-bicyclo[2.2.1]hept-2-enyl)-1-phenyl-3-(1-piperidyl)propan-1-ol;2-hydroxypropanoic acid
263	AK-PENTOLATE	CYCLOPENTOLATE HYDROCHLORIDE	22162	C17H26ClNO3	327.849	\N	\N	2	4	7	49.8	22	0	331	0	1	\N	\N	CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O.Cl	2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenyl-acetate;hydrochloride
237	ADVIL PM	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
268	AKOVAZ	EPHEDRINE SULFATE	5359318	C20H32N2O6S	428.544	\N	\N	6	8	6	148	29	0	202	4	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1R,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
252	AFINITOR	EVEROLIMUS	6442177	C53H83NO14	958.24	\N	5.9	3	14	9	205	68	0	1810	15	0	\N	\N	CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC	\N
261	AK-FLUOR 10%	FLUORESCEIN SODIUM	9885981	C20H10Na2O5	376.275	\N	\N	0	5	0	81.6	27	0	522	0	0	\N	\N	C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)[O-])OC5=C3C=CC(=C5)[O-].[Na+].[Na+]	disodium;3-oxospiro[isobenzofuran-1,9'-xanthene]-3',6'-diolate
303	ALDACTAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
222	ADVIL	IBUPROFEN SODIUM	5338317	C13H17NaO2	228.267	\N	\N	0	2	4	40.1	16	0	208	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)[O-].[Na+]	sodium;2-(4-isobutylphenyl)propanoate
221	ADVIL	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
306	ALDARA	IMIQUIMOD	57469	C14H16N4	240.31	\N	2.6	1	3	2	56.7	18	0	294	0	0	\N	\N	CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N	1-isobutylimidazo[4,5-c]quinolin-4-amine
245	AEROLONE	ISOPROTERENOL HYDROCHLORIDE	5807	C11H18ClNO3	247.719	\N	\N	5	4	4	72.7	16	0	187	0	1	\N	\N	CC(C)NCC(C1=CC(=C(C=C1)O)O)O.Cl	4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol;hydrochloride
264	AKBETA	LEVOBUNOLOL HYDROCHLORIDE	5284409	C17H26ClNO3	327.849	\N	\N	3	4	6	58.6	22	0	350	1	0	\N	\N	CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O.Cl	5-[(2S)-3-(tert-butylamino)-2-hydroxy-propoxy]tetralin-1-one;hydrochloride
312	ALDOMET	METHYLDOPATE HYDROCHLORIDE	17276	C12H18ClNO4	275.729	\N	\N	4	5	5	92.8	18	0	271	1	0	\N	\N	CCOC(=O)C(C)(CC1=CC(=C(C=C1)O)O)N.Cl	ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoate;hydrochloride
283	ALBALON	NAPHAZOLINE HYDROCHLORIDE	11079	C14H15ClN2	246.738	\N	\N	2	1	2	24.4	17	0	272	0	0	\N	\N	C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl	2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride
235	ADVIL PM	DIPHENHYDRAMINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
251	AFEDITAB CR	NIFEDIPINE	4485	C17H18N2O6	346.339	\N	2.2	1	7	5	110	25	0	608	0	0	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
225	ADVIL ALLERGY AND CONGESTION RELIEF	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
292	ALCAINE	PROPARACAINE HYDROCHLORIDE	517321	C16H27ClN2O3	330.853	\N	\N	2	5	10	64.8	22	0	295	0	0	\N	\N	CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N.Cl	2-(diethylamino)ethyl 3-amino-4-propoxy-benzoate;hydrochloride
255	AFRINOL	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
304	ALDACTAZIDE	SPIRONOLACTONE	5833	C24H32O4S	416.576	\N	2.9	0	5	2	85.7	29	0	818	7	0	\N	\N	CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C	S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxo-spiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-tetrahydrofuran]-7-yl] ethanethioate
241	AEROLATE	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
257	AGGRASTAT	TIROFIBAN HYDROCHLORIDE	64781	C22H37ClN2O5S	477.057	\N	\N	4	7	14	113	31	0	579	1	0	\N	\N	CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O.Cl	(2S)-2-(butylsulfonylamino)-3-[4-[4-(4-piperidyl)butoxy]phenyl]propanoic acid;hydrochloride
247	AEROSEB-HC	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
254	AFREZZA	INSULIN RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
278	ALA-CORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
279	ALA-SCALP	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
281	ALAVERT	LORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
282	ALAWAY	KETOTIFEN FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
289	ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE	IPRATROPIUM BROMIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
291	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	IPRATROPIUM BROMIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
295	ALCOHOL 10% AND DEXTROSE 5%	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
297	ALCOHOL 5% AND DEXTROSE 5%	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
299	ALCOHOL 5% IN D5-W	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
302	ALCOHOL 5% IN DEXTROSE 5% IN WATER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
321	ALDURAZYME	LARONIDASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1270	BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
409	AMCINONIDE	AMCINONIDE	443958	C28H35FO7	502.579	\N	3.6	1	8	4	99.1	36	0	1090	8	0	\N	\N	CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CCC5=CC(=O)C=CC54C)F)O)C)OC6(O2)CCCC6	\N
422	AMILORIDE HYDROCHLORIDE	AMILORIDE HYDROCHLORIDE	16230	C6H9Cl2N7O	266.086	\N	\N	5	5	1	159	16	0	279	0	0	\N	\N	C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.Cl	3,5-diamino-6-chloro-N-(diaminomethylene)pyrazine-2-carboxamide;hydrochloride
415	AMICAR	AMINOCAPROIC ACID	564	C6H13NO2	131.175	\N	-3	2	3	5	63.3	9	0	83.1	0	0	\N	\N	C(CCC(=O)O)CCN	6-aminohexanoic acid
410	AMELUZ	AMINOLEVULINIC ACID HYDROCHLORIDE	123608	C5H10ClNO3	167.589	\N	\N	3	4	4	80.4	10	0	121	0	0	\N	\N	C(CC(=O)O)C(=O)CN.Cl	5-amino-4-oxo-pentanoic acid;hydrochloride
377	ALPHATREX	BETAMETHASONE DIPROPIONATE	21800	C28H37FO7	504.595	\N	3.6	1	8	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
402	AMBENYL	BROMODIPHENHYDRAMINE HYDROCHLORIDE	15736	C17H21BrClNO	370.715	\N	\N	1	2	6	13.7	21	0	258	0	1	\N	\N	C[NH+](C)CCOC(C1=CC=CC=C1)C2=CC=C(C=C2)Br.[Cl-]	2-[(4-bromophenyl)-phenyl-methoxy]ethyl-dimethyl-ammonium;chloride
391	ALVESCO	CICLESONIDE	6918155	C32H44O7	540.697	\N	5.3	1	7	6	99.1	39	0	1100	9	0	\N	\N	CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6	\N
362	ALORA	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
416	AMIDATE	ETOMIDATE	36339	C14H16N2O2	244.294	\N	3	0	3	5	44.1	18	0	277	0	1	\N	\N	CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2	ethyl 3-(1-phenylethyl)imidazole-4-carboxylate
333	ALFERON N INJECTION	INTERFERON ALFA-N3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
343	ALLEGRA	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
372	ALPHADROL	FLUPREDNISOLONE	5876	C21H27FO5	378.44	\N	1.4	3	6	2	94.8	27	0	760	8	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)CO)O)CC(C4=CC(=O)C=CC34C)F)O	(6S,8S,9S,10R,11S,13S,14S,17R)-6-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
427	AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER	GLYCINE	750	C2H5NO2	75.067	\N	-3.2	2	3	1	63.3	5	0	42.9	0	0	\N	\N	C(C(=O)O)N	2-aminoacetic acid
325	ALESSE	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
366	ALPHACAINE	LIDOCAINE	3676	C14H22N2O	234.343	\N	2.3	1	2	5	32.3	17	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
342	ALLAY	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
387	ALTOPREV	LOVASTATIN	53232	C24H36O5	404.547	\N	4.3	1	5	7	72.8	29	0	666	8	0	\N	\N	CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C	[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate
338	ALKERAN	MELPHALAN	460612	C13H18Cl2N2O2	305.199	\N	-0.5	2	4	8	66.6	19	0	265	1	0	\N	\N	C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl	(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid
359	ALOCRIL	NEDOCROMIL SODIUM	50295	C19H15NNa2O7	415.309	\N	\N	0	8	3	127	29	0	742	0	0	\N	\N	CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)[O-])C(=O)C=C(N2CC)C(=O)[O-].[Na+].[Na+]	disodium;9-ethyl-4,6-dioxo-10-propyl-pyrano[3,2-g]quinoline-2,8-dicarboxylate
353	ALLI	ORLISTAT	3034010	C29H53NO5	495.745	\N	10	1	5	23	81.7	35	0	579	4	0	\N	\N	CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O	[(1S)-1-[[(2S,3S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-formamido-4-methyl-pentanoate
335	ALIMTA	PEMETREXED	446556	C20H21N5O6	427.417	\N	0.2	6	6	9	187	31	0	748	1	0	\N	\N	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid
384	ALTACE	RAMIPRIL	5362129	C23H32N2O5	416.518	\N	1.4	2	6	10	95.9	30	0	619	5	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O	(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid
383	ALTABAX	RETAPAMULIN	6918462	C30H47NO4S	517.769	\N	6.1	1	6	6	92.1	36	0	895	10	0	\N	\N	CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CC5CCC(C4)N5C)C	\N
371	ALPHADERM	UREA	1176	CH4N2O	60.056	\N	-1.4	2	1	0	69.1	4	0	29	0	0	\N	\N	C(=O)(N)N	urea
365	ALPHA CHYMAR	CHYMOTRYPSIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
370	ALPHADERM	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
373	ALPHAGAN	BRIMONIDINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
374	ALPHAGAN P	BRIMONIDINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
378	ALPHAZINE	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
388	ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE	ALUMINUM HYDROXIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
389	ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE	MAGNESIUM TRISILICATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
404	AMBIEN	ZOLPIDEM TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
405	AMBIEN CR	ZOLPIDEM TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
408	AMCILL	AMPICILLIN/AMPICILLIN TRIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
412	AMERGE	NARATRIPTAN HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
413	AMERSCAN MDP KIT	TECHNETIUM TC-99M MEDRONATE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
414	AMEVIVE	ALEFACEPT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
425	AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
426	AMINO ACIDS	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1286	BUTALBITAL; ACETAMINOPHEN; CAFFEINE; CODEINE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1361	CAPITAL AND CODEINE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1891	CO-GESIC	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
431	AMINOHIPPURATE SODIUM	AMINOHIPPURATE SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3373	EXCEDRIN (MIGRAINE)	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
3438	FEMCET	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
512	AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
443	AMINOSYN 3.5% M	MAGNESIUM ACETATE	8896	C4H6MgO4	142.393	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Mg+2]	magnesium;diacetate
437	AMINOSOL 5%	PROTEIN HYDROLYSATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
438	AMINOSYN 10%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
439	AMINOSYN 10% (PH6)	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
440	AMINOSYN 3.5%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
441	AMINOSYN 3.5% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
442	AMINOSYN 3.5% M	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
447	AMINOSYN 3.5% M	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
451	AMINOSYN 3.5% M IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
466	AMINOSYN 7% W/ ELECTROLYTES	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
472	AMINOSYN 8.5% W/ ELECTROLYTES	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
444	AMINOSYN 3.5% M	PHOSPHORIC ACID	1004	H3O4P	97.994	\N	-2.1	3	4	0	77.8	5	0	49.8	0	0	\N	\N	OP(=O)(O)O	phosphoric acid
456	AMINOSYN 3.5% W/ DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
457	AMINOSYN 3.5% W/ DEXTROSE 25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
458	AMINOSYN 3.5% W/ DEXTROSE 5% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
459	AMINOSYN 3.5% W/ DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
460	AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
461	AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
462	AMINOSYN 5%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
463	AMINOSYN 7%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
464	AMINOSYN 7% (PH6)	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
465	AMINOSYN 7% W/ ELECTROLYTES	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
453	AMINOSYN 3.5% M IN PLASTIC CONTAINER	PHOSPHORIC ACID	1004	H3O4P	97.994	\N	-2.1	3	4	0	77.8	5	0	49.8	0	0	\N	\N	OP(=O)(O)O	phosphoric acid
469	AMINOSYN 8.5%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
470	AMINOSYN 8.5% (PH6)	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
471	AMINOSYN 8.5% W/ ELECTROLYTES	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
445	AMINOSYN 3.5% M	POTASSIUM ACETATE	517044	C2H3KO2	98.142	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[K+]	potassium;acetate
475	AMINOSYN II 10%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
476	AMINOSYN II 10% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
477	AMINOSYN II 10% W/ ELECTROLYTES	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
449	AMINOSYN 3.5% M	POTASSIUM ACETATE	517044	C2H3KO2	98.142	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[K+]	potassium;acetate
479	AMINOSYN II 10% W/ ELECTROLYTES	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
491	AMINOSYN II 3.5% M	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
482	AMINOSYN II 15% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
483	AMINOSYN II 3.5%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
484	AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
485	AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
486	AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
487	AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
488	AMINOSYN II 3.5% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
489	AMINOSYN II 3.5% M	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
467	AMINOSYN 7% W/ ELECTROLYTES	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
473	AMINOSYN 8.5% W/ ELECTROLYTES	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
493	AMINOSYN II 3.5% M	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
494	AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
495	AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
446	AMINOSYN 3.5% M	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
450	AMINOSYN 3.5% M	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
499	AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
500	AMINOSYN II 3.5% M IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
504	AMINOSYN II 3.5% M IN PLASTIC CONTAINER	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
505	AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
506	AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
511	AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
513	AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
518	AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
519	AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
520	AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
521	AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
522	AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
523	AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
524	AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
525	AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3498	FIORICET	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
529	AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
530	AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
531	AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3501	FIORICET W/ CODEINE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
537	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4003	HY-PHEN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
539	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4065	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
544	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
545	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4246	INFANTS' FEVERALL	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
533	AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER	POTASSIUM ACETATE	517044	C2H3KO2	98.142	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[K+]	potassium;acetate
550	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
515	AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
552	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
527	AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
516	AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
535	AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
542	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
557	AMINOSYN II 5%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
558	AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
559	AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
560	AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
517	AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
562	AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
528	AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
536	AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
543	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
549	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
567	AMINOSYN II 7%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
568	AMINOSYN II 7% W/ ELECTROLYTES	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
573	AMINOSYN II 8.5%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
574	AMINOSYN II 8.5% W/ ELECTROLYTES	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
579	AMINOSYN-HBC 7%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
580	AMINOSYN-HBC 7% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
581	AMINOSYN-HF 8%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
582	AMINOSYN-PF 10%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
583	AMINOSYN-PF 7%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
584	AMINOSYN-RF 5.2%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4295	INJECTAPAP	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
611	AMLODIPINE MALEATE; BENAZEPRIL HYDROCHLORIDE	AMLODIPINE MALEATE	6435922	C24H29ClN2O9	524.951	\N	\N	4	11	12	175	36	0	766	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C(=CC(=O)O)C(=O)O	O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate;maleic acid
595	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE	2162	C20H25ClN2O5	408.879	\N	3	2	7	10	99.9	28	0	647	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN	O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
613	AMMONIA N 13	AMMONIA N-13	119432	H3N	16.03	\N	-0.7	1	1	0	1	1	0	0	0	0	\N	\N	N	azane
614	AMMONIUM CHLORIDE	AMMONIUM CHLORIDE	25517	ClH4N	53.489	\N	\N	1	1	0	1	2	0	0	0	0	\N	\N	[NH4+].[Cl-]	ammonium;chloride
618	AMMONIUM LACTATE	AMMONIUM LACTATE	62358	C3H9NO3	107.109	\N	\N	2	3	0	61.4	7	0	53.5	0	1	\N	\N	CC(C(=O)[O-])O.[NH4+]	ammonium;2-hydroxypropanoate
591	AMJEVITA	ADALIMUMAB-ATTO	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
624	AMOXAPINE	AMOXAPINE	2170	C17H16ClN3O	313.785	\N	2.6	1	3	1	36.9	22	0	424	0	0	\N	\N	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	8-chloro-6-piperazin-1-yl-benzo[b][1,4]benzoxazepine
594	AMLODIPINE AND OLMESARTAN MEDOXOMIL	OLMESARTAN MEDOXOMIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
596	AMLODIPINE AND OLMESARTAN MEDOXOMIL	OLMESARTAN MEDOXOMIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
635	AMPICILLIN AND SULBACTAM	AMPICILLIN SODIUM	23663979	C16H18N3NaO4S	371.387	\N	\N	2	6	4	141	25	0	568	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C.[Na+]	sodium;(2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
652	ANAGRELIDE HYDROCHLORIDE	ANAGRELIDE HYDROCHLORIDE	42786	C10H8Cl3N3O	292.544	\N	\N	2	1	0	44.7	17	0	360	0	0	\N	\N	C1C2=C(C=CC(=C2Cl)Cl)NC3=NC(=O)CN31.Cl	6,7-dichloro-5,10-dihydro-3H-imidazo[2,1-b]quinazolin-2-one;hydrochloride
656	ANCEF	CEFAZOLIN SODIUM	23675322	C14H13N8NaO4S3	476.48	\N	\N	1	12	7	238	30	0	746	2	0	\N	\N	CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
632	AMPHICOL	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
627	AMOXICILLIN AND CLAVULANATE POTASSIUM	CLAVULANATE POTASSIUM	23665591	C8H8KNO5	237.252	\N	\N	1	5	2	89.9	15	0	329	2	0	\N	\N	C1C2N(C1=O)C(C(=CCO)O2)C(=O)[O-].[K+]	potassium;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
641	AMRIX	CYCLOBENZAPRINE HYDROCHLORIDE	22576	C20H22ClN	311.853	\N	\N	1	1	3	3.2	22	0	365	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31.Cl	3-(dibenzo[1,2-a:1',2'-e][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
603	AMLODIPINE BESYLATE AND VALSARTAN	VALSARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
622	AMNESTROGEN	ESTROGENS, ESTERIFIED	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
644	AMTURNIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
606	AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE	VALSARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
679	ANGIO-CONRAY	IOTHALAMATE SODIUM	23667529	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	426	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)C(=O)NC)I.[Na+]	sodium;3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoate
623	AMOSENE	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
653	ANAPROX	NAPROXEN SODIUM	23681059	C14H13NaO3	252.245	\N	\N	0	3	3	49.4	18	0	282	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+]	sodium;(2S)-2-(6-methoxy-2-naphthyl)propanoate
610	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	OLMESARTAN MEDOXOMIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
619	AMMONUL	SODIUM BENZOATE	517055	C7H5NaO2	144.105	\N	\N	0	2	1	40.1	10	0	108	0	0	\N	\N	C1=CC=C(C=C1)C(=O)[O-].[Na+]	sodium;benzoate
578	AMINOSYN II 8.5% W/ ELECTROLYTES	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
636	AMPICILLIN AND SULBACTAM	SULBACTAM SODIUM	23663973	C8H10NNaO5S	255.22	\N	\N	0	5	1	103	16	0	452	2	0	\N	\N	CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)[O-])C.[Na+]	sodium;(2S,5R)-3,3-dimethyl-4,4,7-trioxo-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
630	AMPHADASE	HYALURONIDASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
631	AMPHETAMINE SULFATE	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
638	AMPICILLIN TRIHYDRATE	AMPICILLIN/AMPICILLIN TRIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
642	AMTURNIDE	ALISKIREN HEMIFUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
648	AN-MAA	TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
649	AN-SULFUR COLLOID	TECHNETIUM TC-99M SULFUR COLLOID KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
670	ANEXSIA	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
672	ANEXSIA 5/325	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
674	ANEXSIA 7.5/325	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
676	ANEXSIA 7.5/650	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
773	ARISTADA	ARIPIPRAZOLE LAUROXIL	49831411	C36H51Cl2N3O4	660.721	\N	10	0	6	20	62.3	45	0	858	0	0	\N	\N	CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=C1C=C(C=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	[7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-2-oxo-3,4-dihydroquinolin-1-yl]methyl dodecanoate
781	ARMODAFINIL	ARMODAFINIL	9690109	C15H15NO2S	273.35	\N	1.7	1	3	5	79.4	19	0	302	1	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	2-[(R)-benzhydrylsulfinyl]acetamide
740	AQUATAG	BENZTHIAZIDE	2343	C15H14ClN3O4S3	431.924	\N	1.7	2	7	5	161	26	0	739	0	0	\N	\N	C1=CC=C(C=C1)CSCC2=NS(=O)(=O)C3=CC(=C(C=C3N2)Cl)S(=O)(=O)N	3-(benzylsulfanylmethyl)-6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
689	ANOQUAN	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
742	ARALEN	CHLOROQUINE PHOSPHATE	64927	C18H32ClN3O8P2	515.865	\N	\N	7	11	8	184	32	0	359	0	1	\N	\N	CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O	N4-(7-chloro-4-quinolyl)-N1,N1-diethyl-pentane-1,4-diamine;phosphoric acid
681	ANGIOVIST 282	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
683	ANGIOVIST 292	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
696	ANTABUSE	DISULFIRAM	3117	C10H20N2S4	296.524	\N	3.9	0	4	7	121	16	0	201	0	0	\N	\N	CCN(CC)C(=S)SSC(=S)N(CC)CC	diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate
692	ANORO ELLIPTA	VILANTEROL TRIFENATATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
694	ANSOLYSEN	PENTOLINIUM TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
734	APTIOM	ESLICARBAZEPINE ACETATE	179344	C17H16N2O3	296.326	\N	2	1	3	2	72.6	22	0	440	1	0	\N	\N	CC(=O)OC1CC2=CC=CC=C2N(C3=CC=CC=C13)C(=O)N	[(5S)-11-carbamoyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl] acetate
747	ARANELLE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
698	ANTARA (MICRONIZED)	FENOFIBRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
699	ANTEPAR	PIPERAZINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
693	ANSAID	FLURBIPROFEN	3394	C15H13FO2	244.265	\N	4.2	1	3	3	37.3	18	0	286	0	1	\N	\N	CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O	2-(3-fluoro-4-phenyl-phenyl)propanoic acid
714	ANTIZOL	FOMEPIZOLE	3406	C4H6N2	82.106	\N	1.4	1	1	0	28.7	6	0	44.8	0	0	\N	\N	CC1=CNN=C1	4-methyl-1H-pyrazole
728	APRESAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
752	ARAVA	LEFLUNOMIDE	3899	C12H9F3N2O2	270.211	\N	2.5	1	6	2	55.1	19	0	327	0	0	\N	\N	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide
769	ARIDOL	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
732	APRISO	MESALAMINE	4075	C7H7NO3	153.137	\N	1.3	3	4	1	83.6	11	0	160	0	0	\N	\N	C1=CC(=C(C=C1N)C(=O)O)O	5-amino-2-hydroxy-benzoic acid
784	ARRANON	NELARABINE	3011155	C11H15N5O5	297.271	\N	-0.7	4	9	3	149	21	0	377	4	0	\N	\N	COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N	(2R,3S,4S,5R)-2-(2-amino-6-methoxy-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
715	ANTRENYL	OXYPHENONIUM BROMIDE	5748	C21H34BrNO3	428.411	\N	\N	1	4	9	46.5	26	0	409	0	1	\N	\N	CC[N+](C)(CC)CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.[Br-]	2-(2-cyclohexyl-2-hydroxy-2-phenyl-acetyl)oxyethyl-diethyl-methyl-ammonium;bromide
736	AQUAMEPHYTON	PHYTONADIONE	5284607	C31H46O2	450.707	\N	10.9	0	2	14	34.1	33	0	696	2	0	\N	\N	CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C	2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
737	AQUAPHYLLIN	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
711	ANTHIM	OBILTOXAXIMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
703	ANTHELIOS 20	TITANIUM DIOXIDE	26042	O2Ti	79.865	\N	\N	0	2	0	34.1	3	0	18.3	0	0	\N	\N	O=[Ti]=O	dioxotitanium
776	ARISTOCORT	TRIAMCINOLONE DIACETATE	6216	C25H31FO8	478.513	\N	1.9	2	9	6	127	34	0	1020	8	0	\N	\N	CC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)OC(=O)C)O	[2-[(8S,9R,10S,11S,13S,14S,16R,17S)-16-acetoxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
786	ARTANE	TRIHEXYPHENIDYL HYDROCHLORIDE	66007	C20H32ClNO	337.932	\N	\N	2	2	5	23.5	23	0	314	0	1	\N	\N	C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O.Cl	1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol;hydrochloride
717	ANUSOL HC	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
738	AQUASOL A	VITAMIN A	445354	C20H30O	286.459	\N	5.7	1	1	5	20.2	21	0	496	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
720	APIDRA	INSULIN GLULISINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
721	APIDRA SOLOSTAR	INSULIN GLULISINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
723	APOGEN	GENTAMICIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
746	ARAMINE	METARAMINOL BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
751	ARANESP	DARBEPOETIN ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
753	ARCALYST	RILONACEPT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
762	ARFORMOTEROL TARTRATE	ARFORMOTEROL TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
785	ARSENIC TRIOXIDE	ARSENIC TRIOXIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
789	ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE	ARTICAINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
790	ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
804	ASPIRIN	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
823	ATENOLOL	ATENOLOL	2249	C14H22N2O3	266.341	\N	0.2	3	4	8	84.6	19	0	263	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide
832	ATOMOXETINE	ATOMOXETINE	54841	C17H21NO	255.361	\N	3.7	1	2	6	21.3	19	0	237	1	0	\N	\N	CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2	(3R)-N-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine
796	ASELLACRIN 10	SOMATROPIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
797	ASELLACRIN 2	SOMATROPIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
848	ATROPINE AND DEMEROL	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
830	ATNAA	ATROPINE	174174	C17H23NO3	289.375	\N	1.8	1	4	5	49.8	21	0	353	2	1	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3	[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenyl-propanoate
809	ASTELIN	AZELASTINE HYDROCHLORIDE	54360	C22H25Cl2N3O	418.362	\N	\N	1	3	3	35.9	28	0	558	0	1	\N	\N	CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl.Cl	4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;hydrochloride
856	AUGMENTIN '125'	CLAVULANATE POTASSIUM	23665591	C8H8KNO5	237.252	\N	\N	1	5	2	89.9	15	0	329	2	0	\N	\N	C1C2N(C1=O)C(C(=CCO)O2)C(=O)[O-].[K+]	potassium;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
807	ASPIRIN; DIPYRIDAMOLE	ASPIRIN;DIPYRIDAMOLE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
806	ASPIRIN AND DIPYRIDAMOLE	DIPYRIDAMOLE	3108	C24H40N8O4	504.636	\N	0.7	4	12	12	145	36	0	561	0	0	\N	\N	C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO	2-[[2-[bis(2-hydroxyethyl)amino]-4,8-bis(1-piperidyl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol
842	ATRIPLA	EFAVIRENZ	64139	C14H9ClF3NO2	315.676	\N	4	1	5	1	38.3	21	0	519	1	0	\N	\N	C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
812	ATACAND	CANDESARTAN CILEXETIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
813	ATACAND HCT	CANDESARTAN CILEXETIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
843	ATRIPLA	EMTRICITABINE	60877	C8H10FN3O3S	247.244	\N	-0.6	2	5	2	113	16	0	374	2	0	\N	\N	C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F	4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
881	AVANDARYL	GLIMEPIRIDE	3476	C24H34N4O5S	490.619	\N	3.9	3	5	7	133	34	0	895	0	0	\N	\N	CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C	4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide
801	ASHLYNA	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
829	ATIVAN	LORAZEPAM	3958	C15H10Cl2N2O2	321.157	\N	2.4	2	3	1	61.7	21	0	443	0	1	\N	\N	C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl	7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one
879	AVANDAMET	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
896	AVINZA	MORPHINE SULFATE	5288826	C17H19NO3	285.343	\N	0.8	2	4	0	52.9	21	0	494	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
791	ARZERRA	OFATUMUMAB	6918251	C12H10N4O2	242.238	\N	-0.3	1	6	0	67.6	18	0	608	0	0	\N	\N	C1COCC2=C1N=CC3=NC(=C4C=CON4)N=C23	\N
821	ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE	ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
831	ATNAA	PRALIDOXIME CHLORIDE	5359226	C7H9ClN2O	172.612	\N	\N	1	3	1	34.3	11	0	216	0	0	\N	\N	CN1C=CC=CC1=C[NH+]=O.[Cl-]	[(E)-(1-methyl-2-pyridylidene)methyl]-oxo-ammonium;chloride
825	ATENOLOL AND CHLORTHALIDONE	CHLORTHALIDONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
880	AVANDAMET	ROSIGLITAZONE MALEATE	5281055	C22H23N3O7S	473.5	\N	\N	3	10	9	171	33	0	588	0	1	\N	\N	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O	maleic acid;5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione
886	AVC	SULFANILAMIDE	5333	C6H8N2O2S	172.202	\N	-0.6	2	4	1	94.6	11	0	211	0	0	\N	\N	C1=CC(=CC=C1N)S(=O)(=O)N	4-aminobenzenesulfonamide
808	ASTAGRAF XL	TACROLIMUS	445643	C44H69NO12	804.031	\N	2.7	3	12	7	178	57	0	1480	14	0	\N	\N	CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC	\N
794	ASBRON	THEOPHYLLINE SODIUM GLYCINATE	23663537	C9H12N5NaO4	277.216	\N	\N	2	6	1	135	19	0	314	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(C(=O)[O-])N.[Na+]	sodium;2-aminoacetate;1,3-dimethyl-7H-purine-2,6-dione
827	ATHROMBIN	WARFARIN SODIUM	16204922	C19H15NaO4	330.315	\N	\N	0	4	4	66.4	24	0	508	0	1	\N	\N	CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)[O-].[Na+]	sodium;2-oxo-3-(3-oxo-1-phenyl-butyl)chromen-4-olate
844	ATRIPLA	TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
845	ATROMID-S	CLOFIBRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
852	ATROVENT	IPRATROPIUM BROMIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
853	ATROVENT HFA	IPRATROPIUM BROMIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
871	AUREOMYCIN	CHLORTETRACYCLINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
872	AURYXIA	FERRIC CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
878	AVALIDE	IRBESARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
884	AVAPRO	IRBESARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
885	AVASTIN	BEVACIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
890	AVENTYL	NORTRIPTYLINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
891	AVENTYL HYDROCHLORIDE	NORTRIPTYLINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5082	LORCET-HD	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
899	AVONEX	INTERFERON BETA-1A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
915	AZASAN	AZATHIOPRINE	2265	C9H7N7O2S	277.262	\N	0.1	1	7	2	143	19	0	354	0	0	\N	\N	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	6-(3-methyl-5-nitro-imidazol-4-yl)sulfanyl-7H-purine
922	AZELAIC ACID	AZELAIC ACID	2266	C9H16O4	188.223	\N	1.6	2	4	8	74.6	13	0	147	0	0	\N	\N	C(CCCC(=O)O)CCCC(=O)O	nonanedioic acid
958	BACLOFEN	BACLOFEN	2284	C10H12ClNO2	213.661	\N	-1	2	3	4	63.3	14	0	191	0	1	\N	\N	C1=CC(=CC=C1C(CC(=O)O)CN)Cl	4-amino-3-(4-chlorophenyl)butanoic acid
934	AZOPT	BRINZOLAMIDE	68844	C12H21N3O5S3	383.496	\N	-0.3	2	9	7	164	23	0	598	1	0	\N	\N	CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC	(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide
972	BALANCED SALT	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
997	BAYCOL	CERIVASTATIN SODIUM	23663992	C26H33FNNaO5	481.54	\N	\N	2	7	11	103	34	0	626	2	0	\N	\N	CC(C)C1=C(C(=C(C(=N1)C(C)C)C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)COC.[Na+]	sodium;(E,3R,5S)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl]-3,5-dihydroxy-hept-6-enoate
910	AYUNA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
908	AXUMIN	FLUCICLOVINE F-18	450601	C5H8FNO2	132.125	\N	-2.6	2	4	1	63.3	9	0	142	0	0	\N	\N	C1C(CC1(C(=O)O)N)F	1-amino-3-fluoranyl-cyclobutanecarboxylic acid
973	BALANCED SALT	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1001	BC	MAGNESIUM SULFATE	24083	MgO4S	120.361	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Mg+2]	magnesium;sulfate
903	AXID	NIZATIDINE	3033637	C12H21N5O2S2	331.453	\N	1.6	2	8	9	140	21	0	349	0	0	\N	\N	CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C	(E)-N1'-[2-[[2-[(dimethylamino)methyl]thiazol-4-yl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine
904	AXID AR	NIZATIDINE	3033637	C12H21N5O2S2	331.453	\N	1.6	2	8	9	140	21	0	349	0	0	\N	\N	CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C	(E)-N1'-[2-[[2-[(dimethylamino)methyl]thiazol-4-yl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine
961	BACTOCILL	OXACILLIN SODIUM	23667631	C19H18N3NaO5S	423.419	\N	\N	1	7	4	141	29	0	687	3	0	\N	\N	CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+]	sodium;(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-isoxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
929	AZO GANTANOL	PHENAZOPYRIDINE HYDROCHLORIDE	8691	C11H12ClN5	249.702	\N	\N	3	5	2	89.6	17	0	237	0	0	\N	\N	C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N.Cl	3-phenylazopyridine-2,6-diamine;hydrochloride
933	AZOLID	PHENYLBUTAZONE	4781	C19H20N2O2	308.381	\N	3.2	0	2	5	40.6	23	0	389	0	0	\N	\N	CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3	4-butyl-1,2-diphenyl-pyrazolidine-3,5-dione
921	AZDONE	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
974	BALANCED SALT	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
1000	BC	POTASSIUM SULFATE	24507	K2O4S	174.253	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[K+].[K+]	dipotassium;sulfate
925	AZILECT	RASAGILINE MESYLATE	3052775	C13H17NO3S	267.343	\N	\N	2	4	2	74.8	18	0	305	1	0	\N	\N	CS(=O)(=O)O.C#CCNC1CCC2=CC=CC=C12	methanesulfonic acid;(1R)-N-prop-2-ynylindan-1-amine
991	BANZEL	RUFINAMIDE	129228	C10H8F2N4O	238.198	\N	0.7	1	5	3	73.8	17	0	282	0	0	\N	\N	C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F	1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide
959	BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
999	BC	SODIUM SULFATE	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
938	AZULFIDINE	SULFASALAZINE	5353980	C18H14N4O5S	398.393	\N	2.3	3	9	6	146	28	0	804	0	0	\N	\N	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O	(3E)-6-oxo-3-[[4-(2-pyridylsulfamoyl)phenyl]hydrazono]cyclohexa-1,4-diene-1-carboxylic acid
936	AZOR	OLMESARTAN MEDOXOMIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
932	AZO GANTRISIN	SULFISOXAZOLE	5344	C11H13N3O3S	267.303	\N	1	2	6	3	107	18	0	374	0	0	\N	\N	CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide
964	BACTRIM	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
940	BACI-RX	BACITRACIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
941	BACIGUENT	BACITRACIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
942	BACIIM	BACITRACIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
943	BACITRACIN	BACITRACIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
944	BACITRACIN ZINC AND POLYMYXIN B SULFATE	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
946	BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
949	BACITRACIN ZINC-POLYMYXIN B SULFATE	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
951	BACITRACIN-NEOMYCIN-POLYMYXIN	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
954	BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE	BACITRACIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
955	BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
977	BALANCED SALT	SODIUM CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
978	BALNEOL-HC	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
989	BANCAP HC	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
994	BAROS	TARTARIC ACID	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1004	BECONASE AQ	BECLOMETHASONE DIPROPIONATE MONOHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5354	MEDIGESIC PLUS	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1038	BENZACLIN	BENZOYL PEROXIDE	7187	C14H10O4	242.23	\N	3.5	0	4	5	52.6	18	0	258	0	0	\N	\N	C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2	benzoyl benzenecarboperoxoate
1044	BENZPHETAMINE HYDROCHLORIDE	BENZPHETAMINE HYDROCHLORIDE	11558159	C17H22ClN	275.82	\N	\N	1	1	5	3.2	19	0	214	1	0	\N	\N	CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2.Cl	(2S)-N-benzyl-N-methyl-1-phenyl-propan-2-amine;hydrochloride
1047	BENZYL BENZOATE	BENZYL BENZOATE	2345	C14H12O2	212.248	\N	4	0	2	4	26.3	16	0	213	0	0	\N	\N	C1=CC=C(C=C1)COC(=O)C2=CC=CC=C2	benzyl benzoate
1084	BETAXOLOL HYDROCHLORIDE	BETAXOLOL HYDROCHLORIDE	107952	C18H30ClNO3	343.892	\N	\N	3	4	11	50.7	23	0	286	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl	1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol;hydrochloride
1086	BETHANECHOL CHLORIDE	BETHANECHOL CHLORIDE	11548	C7H17ClN2O2	196.675	\N	\N	1	3	4	52.3	12	0	140	0	1	\N	\N	CC(C[N+](C)(C)C)OC(=O)N.[Cl-]	2-carbamoyloxypropyl(trimethyl)ammonium;chloride
1095	BEXAROTENE	BEXAROTENE	82146	C24H28O2	348.486	\N	7.6	1	2	3	37.3	26	0	551	0	0	\N	\N	CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C	4-[1-(1,1,4,4,7-pentamethyltetralin-6-yl)vinyl]benzoic acid
1111	BICNU	CARMUSTINE	2578	C5H9Cl2N3O2	214.046	\N	1.5	1	3	4	61.8	12	0	156	0	0	\N	\N	C(CCl)NC(=O)N(CCCl)N=O	1,3-bis(2-chloroethyl)-1-nitroso-urea
1053	BEROCCA PN	DEXPANTHENOL	131204	C9H19NO4	205.254	\N	-0.9	4	4	6	89.8	14	0	182	1	0	\N	\N	CC(C)(CO)C(C(=O)NCCCO)O	(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butanamide
1033	BENTYL	DICYCLOMINE HYDROCHLORIDE	441344	C19H36ClNO2	345.952	\N	\N	1	3	8	29.5	23	0	326	0	0	\N	\N	CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2.Cl	2-(diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate;hydrochloride
1009	BELDIN	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
1021	BENDECTIN	DOXYLAMINE SUCCINATE	11224	C21H28N2O5	388.464	\N	\N	2	7	9	100	28	0	369	0	1	\N	\N	CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O	N,N-dimethyl-2-[1-phenyl-1-(2-pyridyl)ethoxy]ethanamine;succinic acid
1099	BEYAZ	DROSPIRENONE	68873	C24H30O3	366.501	\N	3.5	0	3	0	43.4	27	0	828	10	0	\N	\N	CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C	\N
1026	BENICAR	OLMESARTAN MEDOXOMIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1100	BEYAZ	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
1028	BENICAR HCT	OLMESARTAN MEDOXOMIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1029	BENLYSTA	BELIMUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1112	BIDIL	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
1064	BETA-2	ISOETHARINE HYDROCHLORIDE	5791	C13H22ClNO3	275.773	\N	\N	5	4	5	72.7	18	0	223	0	2	\N	\N	CCC(C(C1=CC(=C(C=C1)O)O)O)NC(C)C.Cl	4-[1-hydroxy-2-(isopropylamino)butyl]benzene-1,2-diol;hydrochloride
1024	BENDOPA	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
1030	BENOQUIN	MONOBENZONE	7638	C13H12O2	200.237	\N	3.4	1	2	3	29.5	15	0	167	0	0	\N	\N	C1=CC=C(C=C1)COC2=CC=C(C=C2)O	4-benzyloxyphenol
1056	BEROCCA PN	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
1080	BETAPEN-VK	PENICILLIN V POTASSIUM	23676814	C16H17KN2O5S	388.479	\N	\N	1	6	5	124	25	0	553	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
1068	BETADINE	POVIDONE-IODINE	410087	C6H9I2NO	364.953	\N	\N	0	1	1	20.3	10	0	120	0	0	\N	\N	C=CN1CCCC1=O.II	molecular iodine;1-vinylpyrrolidin-2-one
1081	BETAPRONE	PROPIOLACTONE	2365	C3H4O2	72.063	\N	-0.2	0	2	0	26.3	5	0	57.9	0	0	\N	\N	C1COC1=O	oxetan-2-one
1042	BENZEDRINE	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1022	BENDECTIN	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
1032	BENSULFOID	SULFUR	402	H2S	34.08088	\N	0.5	1	1	0	1	1	0	0	0	0	\N	\N	S	hydrogen sulfide
1059	BEROCCA PN	THIAMINE HYDROCHLORIDE	6202	C12H18Cl2N4OS	337.263	\N	\N	3	6	4	104	20	0	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-]	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol;chloride;hydrochloride
1096	BEXTRA	VALDECOXIB	119607	C16H14N2O3S	314.359	\N	2.6	1	5	3	94.6	22	0	462	0	0	\N	\N	CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N	4-(5-methyl-3-phenyl-isoxazol-4-yl)benzenesulfonamide
1065	BETA-HC	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1066	BETA-VAL	BETAMETHASONE VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1067	BETADERM	BETAMETHASONE VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1076	BETAMETHASONE VALERATE	BETAMETHASONE VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1082	BETASERON	INTERFERON BETA-1B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1083	BETATREX	BETAMETHASONE VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1093	BEVESPI AEROSPHERE	FORMOTEROL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1097	BEXXAR	TOSITUMOMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1098	BEXXAR	IODINE I 131 TOSITUMOMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1107	BICILLIN C-R	PENICILLIN G PROCAINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1109	BICILLIN C-R 900/300	PENICILLIN G PROCAINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1113	BIDIL	ISOSORBIDE DINITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5939	NEOPAP	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1165	BRETYLIUM TOSYLATE	BRETYLIUM TOSYLATE	6100	C18H24BrNO3S	414.358	\N	\N	0	3	3	65.6	24	0	349	0	0	\N	\N	CC[N+](C)(C)CC1=CC=CC=C1Br.CC1=CC=C(C=C1)S(=O)(=O)[O-]	(2-bromophenyl)methyl-ethyl-dimethyl-ammonium;4-methylbenzenesulfonate
1190	BRIVIACT	BRIVARACETAM	9837243	C11H20N2O2	212.293	\N	1	1	2	5	63.4	15	0	253	2	0	\N	\N	CCCC1CC(=O)N(C1)C(CC)C(=O)N	(2S)-2-[(4R)-2-oxo-4-propyl-pyrrolidin-1-yl]butanamide
1119	BIO-TROPIN	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1196	BROMDAY	BROMFENAC SODIUM	23693301	C15H11BrNNaO3	356.151	\N	\N	1	4	4	83.2	21	0	372	0	0	\N	\N	C1=CC(=C(C(=C1)CC(=O)[O-])N)C(=O)C2=CC=C(C=C2)Br.[Na+]	sodium;2-[2-amino-3-(4-bromobenzoyl)phenyl]acetate
1201	BROMOCRIPTINE MESYLATE	BROMOCRIPTINE MESYLATE	31100	C33H44BrN5O8S	750.706	\N	\N	4	9	5	181	48	0	1320	6	0	\N	\N	CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O.CS(=O)(=O)O	\N
1191	BROMANATE DM	BROMPHENIRAMINE MALEATE	5281067	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
1120	BIOSCRUB	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
1208	BROMPHERIL	DEXBROMPHENIRAMINE MALEATE	6433334	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	1	0	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
1192	BROMANATE DM	DEXTROMETHORPHAN HYDROBROMIDE	5464025	C18H26BrNO	352.316	\N	\N	1	2	1	12.5	21	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br	\N
1127	BISOPROLOL FUMARATE	BISOPROLOL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1128	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	BISOPROLOL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1169	BREVIBLOC	ESMOLOL HYDROCHLORIDE	104769	C16H26ClNO4	331.837	\N	\N	3	5	10	67.8	22	0	288	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O.Cl	methyl 3-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]propanoate;hydrochloride
1140	BLISOVI 24 FE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
1161	BREO ELLIPTA	FLUTICASONE FUROATE	9854489	C27H29F3O6S	538.578	\N	4.8	1	10	6	119	37	0	1080	9	0	\N	\N	CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
1148	BONIVA	IBANDRONATE SODIUM	23670359	C9H22NNaO7P2	341.212	\N	\N	4	8	9	141	20	0	377	0	1	\N	\N	CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+]	sodium;hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphono-propyl]phosphinate
1173	BREVICON 21-DAY	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
1116	BILTRICIDE	PRAZIQUANTEL	4891	C19H24N2O2	312.413	\N	2.7	0	2	1	40.6	23	0	472	0	1	\N	\N	C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2	2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one
1193	BROMANATE DM	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
1209	BROMPHERIL	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
1211	BRONCHO SALINE	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1139	BLINCYTO	BLINATUMOMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1133	BLEPH-10	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
1163	BRETHAIRE	TERBUTALINE SULFATE	657301	C12H21NO7S	323.36	\N	\N	6	8	4	156	21	0	286	0	1	\N	\N	CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.OS(=O)(=O)O	5-[2-(tert-butylamino)-1-hydroxy-ethyl]benzene-1,3-diol;sulfuric acid
1182	BRILINTA	TICAGRELOR	9871419	C23H28F2N6O4S	522.572	\N	2	4	12	10	164	36	0	736	6	0	\N	\N	CCCSC1=NC2=C(C(=N1)NC3CC3C4=CC(=C(C=C4)F)F)N=NN2C5CC(C(C5O)O)OCCO	(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyl-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
1160	BREATHTEK UBT FOR H-PYLORI	UREA C-13	636363	CH4N2O	61.048	\N	-1.4	2	1	0	69.1	4	0	29	0	0	\N	\N	C(=O)(N)N	diaminomethanone
1149	BONTRIL	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1150	BONTRIL PDM	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1153	BORTEZOMIB	BORTEZOMIB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1154	BOSULIF	BOSUTINIB MONOHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1155	BOTOX	OnabotulinumtoxinA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1156	BOTOX COSMETIC	OnabotulinumtoxinA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1157	BRANCHAMIN 4%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1158	BRANCHAMIN 4% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1162	BREO ELLIPTA	VILANTEROL TRIFENATATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1183	BRIMONIDINE TARTRATE	BRIMONIDINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1184	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	BRIMONIDINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1186	BRISDELLE	PAROXETINE MESYLATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1188	BRISTAGEN	GENTAMICIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1189	BRISTAMYCIN	ERYTHROMYCIN STEARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1212	BRONITIN MIST	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1236	BUDESONIDE	BUDESONIDE	5281004	C25H34O6	430.541	\N	2.5	2	6	4	93.1	31	0	862	8	1	\N	\N	CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C	\N
1217	BROVANA	ARFORMOTEROL TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1218	BRYREL	PIPERAZINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1224	BSS	SODIUM CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1226	BSS PLUS	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1239	BUNAVAIL	BUPRENORPHINE HYDROCHLORIDE	3033050	C29H42ClNO4	504.108	\N	\N	3	5	5	62.2	35	0	869	7	0	\N	\N	CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O.Cl	\N
1300	BUTRANS	BUPRENORPHINE	644073	C29H41NO4	467.65	\N	5	2	5	5	62.2	34	0	869	7	0	\N	\N	CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	\N
1255	BUPROPION HYDROBROMIDE	BUPROPION HYDROBROMIDE	11984562	C13H19BrClNO	320.655	\N	\N	2	2	4	29.1	17	0	247	0	1	\N	\N	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Br	2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrobromide
1257	BUSPAR	BUSPIRONE HYDROCHLORIDE	36431	C21H32ClN5O2	421.97	\N	\N	1	6	6	69.6	29	0	529	0	0	\N	\N	C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4.Cl	8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;hydrochloride
1261	BUTABARB	BUTABARBITAL SODIUM	23690439	C10H15N2NaO3	234.231	\N	\N	1	3	3	81.6	16	0	330	0	2	\N	\N	CCC(C)C1(C(=O)NC(=NC1=O)[O-])CC.[Na+]	sodium;5-ethyl-4,6-dioxo-5-sec-butyl-1H-pyrimidin-2-olate
1234	BUCET	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
1266	BUTALBITAL AND ACETAMINOPHEN	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
1308	CABAZITAXEL	CABAZITAXEL	9854073	C45H57NO14	835.944	\N	2.7	3	14	15	202	60	0	1690	11	0	\N	\N	CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC	\N
1241	BUPHENYL	SODIUM PHENYLBUTYRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1309	CABAZITAXEL INJECTION	CABAZITAXEL	9854073	C45H57NO14	835.944	\N	2.7	3	14	15	202	60	0	1690	11	0	\N	\N	CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC	\N
1310	CABERGOLINE	CABERGOLINE	54746	C26H37N5O2	451.615	\N	3.4	2	4	8	71.7	33	0	713	3	0	\N	\N	CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C	(6aR,9R,10aR)-7-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
1269	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
1246	BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1219	BSS	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1225	BSS PLUS	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1273	BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
1250	BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1213	BRONKAID MIST	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
1244	BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
1227	BSS PLUS	GLUTATHIONE DISULFIDE	65359	C20H32N6O12S2	612.626	\N	-9.1	10	16	21	368	40	0	879	4	0	\N	\N	C(CC(=O)NC(CSSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)C(=O)NCC(=O)O)C(C(=O)O)N	(2S)-2-amino-5-[[(1R)-1-[[[(2R)-2-[[(4S)-4-amino-4-carboxy-butanoyl]amino]-3-(carboxymethylamino)-3-oxo-propyl]disulfanyl]methyl]-2-(carboxymethylamino)-2-oxo-ethyl]amino]-5-oxo-pentanoic acid
1216	BRONKOSOL	ISOETHARINE HYDROCHLORIDE	5791	C13H22ClNO3	275.773	\N	\N	5	4	5	72.7	18	0	223	0	2	\N	\N	CCC(C(C1=CC(=C(C=C1)O)O)O)NC(C)C.Cl	4-[1-hydroxy-2-(isopropylamino)butyl]benzene-1,2-diol;hydrochloride
1220	BSS	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1304	BYSTOLIC	NEBIVOLOL HYDROCHLORIDE	9933004	C22H26ClF2NO4	441.9	\N	\N	4	7	6	71	30	0	483	0	4	\N	\N	C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O.Cl	1-(6-fluorochroman-2-yl)-2-[[2-(6-fluorochroman-2-yl)-2-hydroxy-ethyl]amino]ethanol;hydrochloride
1221	BSS	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
1222	BSS	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
1223	BSS	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1214	BRONKODYL	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
1297	BUTOCONAZOLE NITRATE	BUTOCONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1298	BUTORPHANOL TARTRATE	BUTORPHANOL TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1299	BUTORPHANOL TARTRATE PRESERVATIVE FREE	BUTORPHANOL TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1306	BYVALSON	VALSARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1314	CAFCIT	CAFFEINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1316	CAFERGOT	ERGOTAMINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1317	CAFFEINE CITRATE	CAFFEINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6050	NORCET	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1329	CALCIUM ACETATE	CALCIUM ACETATE	6116	C4H6CaO4	158.166	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Ca+2]	calcium;diacetate
1320	CALCIBIND	CELLULOSE SODIUM PHOSPHATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1322	CALCIMAR	CALCITONIN SALMON	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1323	CALCIPARINE	HEPARIN CALCIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1359	CAPECITABINE	CAPECITABINE	60953	C15H22FN3O6	359.354	\N	0.6	3	7	7	121	25	0	582	4	0	\N	\N	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O	pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl]-5-fluoro-2-oxo-pyrimidin-4-yl]carbamate
1382	CARBACHOL	CARBACHOL	5831	C6H15ClN2O2	182.648	\N	\N	1	3	4	52.3	11	0	117	0	0	\N	\N	C[N+](C)(C)CCOC(=O)N.[Cl-]	2-carbamoyloxyethyl(trimethyl)ammonium;chloride
1326	CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE	CALCIPOTRIENE HYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1327	CALCITONIN-SALMON	CALCITONIN SALMON	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1385	CARBASTAT	CARBACHOL	5831	C6H15ClN2O2	182.648	\N	\N	1	3	4	52.3	11	0	117	0	0	\N	\N	C[N+](C)(C)CCOC(=O)N.[Cl-]	2-carbamoyloxyethyl(trimethyl)ammonium;chloride
1384	CARBAMAZEPINE	CARBAMAZEPINE	2554	C15H12N2O	236.274	\N	2.5	1	1	0	46.3	18	0	326	0	0	\N	\N	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	benzo[b][1]benzazepine-11-carboxamide
1395	CARBINOXAMINE MALEATE	CARBINOXAMINE MALEATE	5282409	C20H23ClN2O5	406.863	\N	\N	2	7	8	100	28	0	386	0	1	\N	\N	CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	2-[(4-chlorophenyl)-(2-pyridyl)methoxy]-N,N-dimethyl-ethanamine;maleic acid
1399	CARBON DIOXIDE, USP	CARBON DIOXIDE	280	CO2	44.009	\N	0.9	0	2	0	34.1	3	0	18.3	0	0	\N	\N	C(=O)=O	carbon dioxide
1383	CARBAGLU	CARGLUMIC ACID	121396	C6H10N2O5	190.155	\N	-2.4	4	5	5	130	13	0	227	1	0	\N	\N	C(CC(=O)O)C(C(=O)O)NC(=O)N	(2S)-2-ureidopentanedioic acid
1335	CALMURID HC	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1366	CAPITROL	CHLOROXINE	2722	C9H5Cl2NO	214.045	\N	3.5	1	2	0	33.1	13	0	191	0	0	\N	\N	C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1	5,7-dichloroquinolin-8-ol
1342	CAMBIA	DICLOFENAC POTASSIUM	23667642	C14H10Cl2KNO2	334.237	\N	\N	1	3	4	52.2	20	0	310	0	0	\N	\N	C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[K+]	potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate
1421	CARDURA	DOXAZOSIN MESYLATE	62978	C24H29N5O8S	547.583	\N	\N	2	12	4	175	38	0	770	0	1	\N	\N	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC.CS(=O)(=O)O	[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone;methanesulfonic acid
1391	CARBIDOPA, LEVODOPA AND ENTACAPONE	ENTACAPONE	5281081	C14H15N3O5	305.29	\N	2.1	2	6	4	130	22	0	500	0	0	\N	\N	CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N	(E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide
1341	CAM-METRAZINE	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1360	CAPEX	FLUOCINOLONE ACETONIDE	6215	C24H30F2O6	452.495	\N	2.5	2	8	2	93.1	32	0	960	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C	\N
1345	CAMPATH	ALEMTUZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1334	CALDOLOR	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
1350	CANDESARTAN CILEXETIL	CANDESARTAN CILEXETIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1351	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE	CANDESARTAN CILEXETIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1357	CAP-PROFEN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
1353	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	CANDESARTAN CILEXETIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1347	CAMPTOSAR	IRINOTECAN HYDROCHLORIDE	74990	C33H39ClN4O6	623.147	\N	\N	2	8	5	113	44	0	1200	1	0	\N	\N	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7.Cl	\N
1389	CARBIDOPA AND LEVODOPA	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
1411	CARDIOPLEGIC IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1358	CAPASTAT SULFATE	CAPREOMYCIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1396	CARBOCAINE	MEPIVACAINE HYDROCHLORIDE	66070	C15H23ClN2O	282.812	\N	\N	2	2	2	32.3	19	0	282	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl	N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide;hydrochloride
1348	CANASA	MESALAMINE	4075	C7H7NO3	153.137	\N	1.3	3	4	1	83.6	11	0	160	0	0	\N	\N	C1=CC(=C(C=C1N)C(=O)O)O	5-amino-2-hydroxy-benzoic acid
1343	CAMILA	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
1365	CAPITAL SOLEIL 15	OCTOCRYLENE	22571	C24H27NO2	361.485	\N	7.1	0	3	10	50.1	27	0	510	0	1	\N	\N	CCCCC(CC)COC(=O)C(=C(C1=CC=CC=C1)C2=CC=CC=C2)C#N	2-ethylhexyl 2-cyano-3,3-diphenyl-prop-2-enoate
1412	CARDIOPLEGIC IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
1407	CARDIOGEN-82	RUBIDIUM CHLORIDE RB-82	71357	ClRb	117.368	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[Rb+]	rubidium-82(1+);chloride
1413	CARDIOPLEGIC IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1336	CALMURID HC	UREA	1176	CH4N2O	60.056	\N	-1.4	2	1	0	69.1	4	0	29	0	0	\N	\N	C(=O)(N)N	urea
1381	CARAFATE	SUCRALFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1409	CARDIOLITE	TECHNETIUM TC-99M SESTAMIBI KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1415	CARDIOTEC	TECHNETIUM TC-99M TEBOROXIME KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1433	CARNEXIV	CARBAMAZEPINE	2554	C15H12N2O	236.274	\N	2.5	1	1	0	46.3	18	0	326	0	0	\N	\N	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	benzo[b][1]benzazepine-11-carboxamide
1439	CARVEDILOL	CARVEDILOL	2585	C24H26N2O4	406.482	\N	4.2	3	5	10	75.7	30	0	508	0	1	\N	\N	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
1460	CEFAZOLIN AND DEXTROSE	CEFAZOLIN SODIUM	23675322	C14H13N8NaO4S3	476.48	\N	\N	1	12	7	238	30	0	746	2	0	\N	\N	CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1467	CEFIXIME	CEFIXIME	5362065	C16H15N5O7S2	453.444	\N	-0.7	4	12	8	238	30	0	861	2	0	\N	\N	C=CC1=C(N2C(C(C2=O)NC(=O)C(=NOCC(=O)O)C3=CSC(=N3)N)SC1)C(=O)O	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
1472	CEFOBID	CEFOPERAZONE SODIUM	23663974	C25H26N9NaO8S2	667.648	\N	\N	3	13	9	274	45	0	1250	3	0	\N	\N	CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1474	CEFOTAN	CEFOTETAN DISODIUM	53024	C17H15N7Na2O8S4	619.568	\N	\N	2	15	7	327	38	0	1080	2	0	\N	\N	CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)[O-])S4)OC)SC2)C(=O)[O-].[Na+].[Na+]	disodium;(6R,7S)-7-[[4-(2-amino-1-carboxylato-2-oxo-ethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1431	CARMOL HC	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1482	CEFOXITIN	CEFOXITIN SODIUM	23667300	C16H16N3NaO7S2	449.428	\N	\N	2	9	8	205	29	0	750	2	0	\N	\N	COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3.[Na+]	sodium;(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1486	CEFPODOXIME PROXETIL	CEFPODOXIME PROXETIL	6526396	C21H27N5O9S2	557.593	\N	0.6	2	14	13	235	37	0	976	2	1	\N	\N	CC(C)OC(=O)OC(C)OC(=O)C1=C(CSC2N1C(=O)C2NC(=O)C(=NOC)C3=CSC(=N3)N)COC	1-isopropoxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1436	CARTEOLOL HYDROCHLORIDE	CARTEOLOL HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1468	CEFIZOX	CEFTIZOXIME SODIUM	23663938	C13H12N5NaO5S2	405.379	\N	\N	2	10	5	204	26	0	675	2	0	\N	\N	CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=CCS3)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1438	CARTROL	CARTEOLOL HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1492	CEFTRIAXONE	CEFTRIAXONE SODIUM	23679441	C18H17N8NaO7S3	576.553	\N	\N	3	13	8	291	37	0	1120	2	0	\N	\N	CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1496	CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER	CEFUROXIME SODIUM	23670318	C16H15N4NaO8S	446.366	\N	\N	2	10	8	202	30	0	804	2	0	\N	\N	CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1501	CELEBREX	CELECOXIB	2662	C17H14F3N3O2S	381.373	\N	3.4	1	7	3	86.4	26	0	577	0	0	\N	\N	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
1459	CEFADYL	CEPHAPIRIN SODIUM	23675312	C17H16N3NaO6S2	445.44	\N	\N	1	9	8	179	29	0	713	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(4-pyridylsulfanyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1443	CATAPRES	CLONIDINE HYDROCHLORIDE	20179	C9H10Cl3N3	266.55	\N	\N	3	1	2	36.4	15	0	222	0	0	\N	\N	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl	N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine;hydrochloride
1447	CATARASE	CHYMOTRYPSIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1448	CATHFLO ACTIVASE	ALTEPLASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1442	CATAFLAM	DICLOFENAC POTASSIUM	23667642	C14H10Cl2KNO2	334.237	\N	\N	1	3	4	52.2	20	0	310	0	0	\N	\N	C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[K+]	potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate
1525	CEREBYX	FOSPHENYTOIN SODIUM	56338	C16H13N2Na2O6P	406.241	\N	\N	1	6	4	122	27	0	536	0	0	\N	\N	C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)([O-])[O-])C3=CC=CC=C3.[Na+].[Na+]	disodium;(2,5-dioxo-4,4-diphenyl-imidazolidin-1-yl)methyl phosphate
1510	CELONTIN	METHSUXIMIDE	6476	C12H13NO2	203.241	\N	1.2	0	2	1	37.4	15	0	294	0	1	\N	\N	CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2	1,3-dimethyl-3-phenyl-pyrrolidine-2,5-dione
1452	CEA-SCAN	ARCITUMOMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1508	CELLCEPT	MYCOPHENOLATE MOFETIL	5281078	C23H31NO7	433.501	\N	3.2	1	8	10	94.5	31	0	646	0	0	\N	\N	CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)OCCN3CCOCC3)OC	2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate
1432	CARMOL HC	UREA	1176	CH4N2O	60.056	\N	-1.4	2	1	0	69.1	4	0	29	0	0	\N	\N	C(=O)(N)N	urea
1455	CEDAX	CEFTIBUTEN DIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1458	CEFADROXIL	CEFADROXIL/CEFADROXIL HEMIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1511	CENESTIN	ESTROGENS, CONJUGATED SYNTHETIC A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1524	CERDELGA	ELIGLUSTAT TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1526	CEREDASE	ALGLUCERASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1527	CERETEC	TECHNETIUM TC-99M EXAMETAZIME KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1528	CEREZYME	IMIGLUCERASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6052	NORCO	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1530	CERUMENEX	TROLAMINE POLYPEPTIDE OLEATE CONDENSATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1533	CETACORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1546	CEVIMELINE	CEVIMELINE HYDROCHLORIDE	83898	C10H17NOS	199.312	\N	1.5	0	3	0	37.8	13	0	215	2	0	\N	\N	CC1OC2(CN3CCC2CC3)CS1	(2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine]
1547	CEVIMELINE HYDROCHLORIDE	CEVIMELINE HYDROCHLORIDE	83898	C10H17NOS	199.312	\N	1.5	0	3	0	37.8	13	0	215	2	0	\N	\N	CC1OC2(CN3CCC2CC3)CS1	(2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine]
1581	CHLORAMPHENICOL	CHLORAMPHENICOL SODIUM SUCCINATE	656833	C15H15Cl2N2NaO8	445.181	\N	\N	2	8	9	162	28	0	541	2	0	\N	\N	C1=CC(=CC=C1C(C(COC(=O)CCC(=O)[O-])NC(=O)C(Cl)Cl)O)[N+](=O)[O-].[Na+]	sodium;4-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxo-butanoate
1580	CHLORAMPHENICOL	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
1595	CHLORDIAZACHEL	CHLORDIAZEPOXIDE HYDROCHLORIDE	9916	C16H15Cl2N3O	336.216	\N	\N	2	3	1	48.2	22	0	580	0	0	\N	\N	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O.Cl	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine;hydrochloride
1598	CHLORDIAZEPOXIDE HYDROCHLORIDE	CHLORDIAZEPOXIDE HYDROCHLORIDE	9916	C16H15Cl2N3O	336.216	\N	\N	2	3	1	48.2	22	0	580	0	0	\N	\N	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O.Cl	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine;hydrochloride
1600	CHLORMERODRIN HG 197	CHLORMERODRIN HG-197	91667977	C5H11ClHgN2O2	363.572	\N	\N	2	3	4	64.4	11	0	110	0	1	\N	\N	COC(CNC(=O)N)C[Hg+].[Cl-]	(2-methoxy-3-ureido-propyl)mercury-197(1+);chloride
1609	CHLOROPROCAINE HYDROCHLORIDE	CHLOROPROCAINE HYDROCHLORIDE	441348	C13H20Cl2N2O2	307.215	\N	\N	2	4	7	55.6	19	0	259	0	0	\N	\N	CCN(CC)CCOC(=O)C1=C(C=C(C=C1)N)Cl.Cl	2-(diethylamino)ethyl 4-amino-2-chloro-benzoate;hydrochloride
1548	CHANTIX	VARENICLINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1614	CHLOROQUINE PHOSPHATE	CHLOROQUINE PHOSPHATE	64927	C18H32ClN3O8P2	515.865	\N	\N	7	11	8	184	32	0	359	0	1	\N	\N	CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O	N4-(7-chloro-4-quinolyl)-N1,N1-diethyl-pentane-1,4-diamine;phosphoric acid
1618	CHLOROTHIAZIDE SODIUM	CHLOROTHIAZIDE SODIUM	23675744	C7H5ClN3NaO4S2	317.694	\N	\N	1	7	1	124	18	0	538	0	0	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)[N-]C=N2.[Na+]	sodium;6-chloro-1,1-dioxo-1$l^{6},2,4-benzothiadiazin-2-ide-7-sulfonamide
1615	CHLOROTHIAZIDE	CHLOROTHIAZIDE	2720	C7H6ClN3O4S2	295.712	\N	-0.2	2	6	1	135	17	0	532	0	0	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2	6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1543	CETRAXAL	CIPROFLOXACIN HYDROCHLORIDE	62999	C17H19ClFN3O3	367.805	\N	\N	3	7	3	72.9	25	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.Cl	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid;hydrochloride
1531	CERVIDIL	DINOPROSTONE	5280360	C20H32O5	352.471	\N	2.8	3	5	12	94.8	25	0	469	4	0	\N	\N	CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O	(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]hept-5-enoic acid
1554	CHILDREN'S ADVIL	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
1556	CHILDREN'S ADVIL ALLERGY SINUS	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
1584	CHLORAPREP ONE-STEP	ISOPROPYL ALCOHOL	3776	C3H8O	60.096	\N	0.3	1	1	0	20.2	4	0	10.8	0	0	\N	\N	CC(C)O	propan-2-ol
1586	CHLORAPREP ONE-STEP FREPP	ISOPROPYL ALCOHOL	3776	C3H8O	60.096	\N	0.3	1	1	0	20.2	4	0	10.8	0	0	\N	\N	CC(C)O	propan-2-ol
1588	CHLORAPREP ONE-STEP SEPP	ISOPROPYL ALCOHOL	3776	C3H8O	60.096	\N	0.3	1	1	0	20.2	4	0	10.8	0	0	\N	\N	CC(C)O	propan-2-ol
1590	CHLORAPREP SINGLE SWABSTICK	ISOPROPYL ALCOHOL	3776	C3H8O	60.096	\N	0.3	1	1	0	20.2	4	0	10.8	0	0	\N	\N	CC(C)O	propan-2-ol
1576	CHIROCAINE	LEVOBUPIVACAINE HYDROCHLORIDE	117965	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	1	0	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	(2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
1532	CESAMET	NABILONE	5284592	C24H36O3	372.549	\N	6.4	1	3	6	46.5	27	0	524	2	0	\N	\N	CCCCCCC(C)(C)C1=CC2=C(C3CC(=O)CCC3C(O2)(C)C)C(=C1)O	(6aR,10aR)-3-(1,1-dimethylheptyl)-1-hydroxy-6,6-dimethyl-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-9-one
1565	CHILDREN'S CLARITIN	LORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1540	CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
1579	CHLOR-TRIMETON	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
1549	CHEMET	SUCCIMER	2724354	C4H6O4S2	182.208	\N	0.1	4	6	3	76.6	10	0	139	2	0	\N	\N	C(C(C(=O)O)S)(C(=O)O)S	(2S,3R)-2,3-bis(sulfanyl)butanedioic acid
1534	CETAMIDE	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
1575	CHIRHOSTIM	SECRETIN SYNTHETIC HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1605	CHLOROMYCETIN HYDROCORTISONE	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6304	OFIRMEV	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1624	CHLORPHENIRAMINE MALEATE	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
1627	CHLORPROPAMIDE	CHLORPROPAMIDE	2727	C10H13ClN2O3S	276.735	\N	2.3	2	3	4	83.6	17	0	345	0	0	\N	\N	CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl	1-(4-chlorophenyl)sulfonyl-3-propyl-urea
1646	CHROMIC CHLORIDE	CHROMIC CHLORIDE	6452300	Cl3Cr	158.346	\N	\N	0	3	0	0	4	0	0	0	0	\N	\N	[Cl-].[Cl-].[Cl-].[Cr+3]	chromic;trichloride
1628	CHLORTHALIDONE	CHLORTHALIDONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1654	CICLOPIROX	CICLOPIROX	2749	C12H17NO2	207.273	\N	2	1	2	1	40.5	15	0	325	0	0	\N	\N	CC1=CC(=O)N(C(=C1)C2CCCCC2)O	6-cyclohexyl-1-hydroxy-4-methyl-pyridin-2-one
1659	CIMETIDINE	CIMETIDINE	2756	C10H16N6S	252.34	\N	0.4	3	4	7	114	17	0	296	0	0	\N	\N	CC1=C(N=CN1)CSCCNC(=NC)NC#N	1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine
1666	CINOBAC	CINOXACIN	2762	C12H10N2O5	262.221	\N	2.1	1	7	2	88.4	19	0	449	0	0	\N	\N	CCN1C2=CC3=C(C=C2C(=O)C(=N1)C(=O)O)OCO3	1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid
1670	CIPRO	CIPROFLOXACIN	2764	C17H18FN3O3	331.347	\N	-1.1	2	7	3	72.9	24	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
1674	CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER	CIPROFLOXACIN	2764	C17H18FN3O3	331.347	\N	-1.1	2	7	3	72.9	24	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
1689	CISATRACURIUM BESYLATE	CISATRACURIUM BESYLATE	62886	C65H82N2O18S2	1243.487	\N	\N	0	18	26	258	87	0	1560	4	0	\N	\N	C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]	benzenesulfonate;5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
1692	CITALOPRAM HYDROBROMIDE	CITALOPRAM HYDROBROMIDE	77995	C20H22BrFN2O	405.311	\N	\N	1	4	5	36.3	25	0	466	0	1	\N	\N	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.Br	1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile;hydrobromide
1700	CLADRIBINE	CLADRIBINE	20279	C10H12ClN5O3	285.688	\N	0.8	3	7	2	119	19	0	338	3	0	\N	\N	C1C(C(OC1N2C=NC3=C2N=C(N=C3N)Cl)CO)O	(2R,3S,5R)-5-(6-amino-2-chloro-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
1632	CHOLEBRINE	IOCETAMIC ACID	27648	C12H13I3N2O3	613.96	\N	2.6	2	4	4	83.6	20	0	383	0	1	\N	\N	CC(CN(C1=C(C=C(C(=C1I)N)I)I)C(=O)C)C(=O)O	3-(N-acetyl-3-amino-2,4,6-triiodo-anilino)-2-methyl-propanoic acid
1704	CLARAVIS	ISOTRETINOIN	5282379	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
1633	CHOLEDYL	OXTRIPHYLLINE	656652	C12H21N5O3	283.332	\N	\N	1	4	2	91.6	20	0	415	0	0	\N	\N	CN1C(=C2C(=NC=N2)N(C1=O)C)[O-].C[N+](C)(C)CCO	1,3-dimethyl-2-oxo-purin-6-olate;2-hydroxyethyl(trimethyl)ammonium
1720	CLENZ-LYTE	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
1644	CHORIONIC GONADOTROPIN	GONADOTROPIN, CHORIONIC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1645	CHROMALBIN	ALBUMIN CHROMATED CR-51 SERUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1707	CLARINEX D 24 HOUR	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
1709	CLARINEX-D 12 HOUR	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
1663	CIN-QUIN	QUINIDINE SULFATE	441074	C20H24N2O2	324.424	\N	2.9	1	4	4	45.6	24	0	457	4	0	\N	\N	COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O	(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol
1722	CLENZ-LYTE	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
1669	CINTICHEM TECHNETIUM 99M HEDSPA	TECHNETIUM TC-99M ETIDRONATE KIT	123827	C2H8O7P2Tc	304.933	\N	\N	5	7	2	135	12	0	211	0	0	\N	\N	CC(O)(P(=O)(O)O)P(=O)(O)O.[Tc]	(1-hydroxy-1-phosphono-ethyl)phosphonic acid;technetium-99
1653	CIBACALCIN	CALCITONIN HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1662	CIMZIA	CERTOLIZUMAB PEGOL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1668	CINQAIR	RESLIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1673	CIPRO HC	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1687	CIS-MDP	TECHNETIUM TC-99M MEDRONATE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1688	CIS-PYRO	TECHNETIUM TC-99M PYROPHOSPHATE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1691	CISPLATIN	CISPLATIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1694	CITANEST FORTE	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2980	DURAPREP	IODINE POVACRYLEX	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1696	CITANEST FORTE DENTAL	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1705	CLARINEX	DESLORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1706	CLARINEX D 24 HOUR	DESLORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1708	CLARINEX-D 12 HOUR	DESLORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1711	CLARITIN	LORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1712	CLARITIN HIVES RELIEF	LORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1713	CLARITIN HIVES RELIEF REDITAB	LORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1714	CLARITIN REDITABS	LORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1715	CLARITIN-D	LORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1717	CLARITIN-D 24 HOUR	LORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1719	CLEMASTINE FUMARATE	CLEMASTINE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1725	CLEOCIN	CLINDAMYCIN HYDROCHLORIDE	16051951	C18H34Cl2N2O5S	461.439	\N	\N	5	7	7	128	28	0	502	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl.Cl	(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide;hydrochloride
1727	CLEOCIN	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
1733	CLIMARA	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
2981	DURAPREP	ISOPROPYL ALCOHOL	3776	C3H8O	60.096	\N	0.3	1	1	0	20.2	4	0	10.8	0	0	\N	\N	CC(C)O	propan-2-ol
1735	CLIMARA PRO	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
1777	CLINIMIX E 2.75/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1784	CLINIMIX E 2.75/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1778	CLINIMIX E 2.75/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
1779	CLINIMIX E 2.75/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
1786	CLINIMIX E 2.75/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
1723	CLENZ-LYTE	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1780	CLINIMIX E 2.75/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1724	CLENZ-LYTE	SODIUM SULFATE	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
1744	CLINDAMYCIN PHOSPHATE AND TRETINOIN	TRETINOIN	444795	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
1750	CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1751	CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1752	CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1753	CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1754	CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1755	CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1756	CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1757	CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1758	CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1759	CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1760	CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1761	CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1762	CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1763	CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1764	CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1765	CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1766	CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1767	CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1768	CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1769	CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1770	CLINIMIX 5/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1771	CLINIMIX 5/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1772	CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1773	CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1774	CLINIMIX E 2.75/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1776	CLINIMIX E 2.75/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1781	CLINIMIX E 2.75/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1783	CLINIMIX E 2.75/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1788	CLINIMIX E 2.75/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1790	CLINIMIX E 2.75/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1795	CLINIMIX E 4.25/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6580	OXYCET	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1797	CLINIMIX E 4.25/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1802	CLINIMIX E 4.25/20 SULFITE FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6582	OXYCODONE 2.5/APAP 500	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1804	CLINIMIX E 4.25/20 SULFITE FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1809	CLINIMIX E 4.25/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6584	OXYCODONE 5/APAP 500	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1811	CLINIMIX E 4.25/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1816	CLINIMIX E 4.25/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6586	OXYCODONE AND ACETAMINOPHEN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1818	CLINIMIX E 4.25/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1823	CLINIMIX E 5/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6597	OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1825	CLINIMIX E 5/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6638	PAPA-DEINE #3	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1799	CLINIMIX E 4.25/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
1806	CLINIMIX E 4.25/20 SULFITE FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
1813	CLINIMIX E 4.25/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
1830	CLINIMIX E 5/15 SULFITE FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1793	CLINIMIX E 2.75/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
1832	CLINIMIX E 5/15 SULFITE FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1800	CLINIMIX E 4.25/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
1807	CLINIMIX E 4.25/20 SULFITE FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
1814	CLINIMIX E 4.25/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
1821	CLINIMIX E 4.25/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
1837	CLINIMIX E 5/20 SULFITE FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1794	CLINIMIX E 2.75/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1839	CLINIMIX E 5/20 SULFITE FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1801	CLINIMIX E 4.25/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1808	CLINIMIX E 4.25/20 SULFITE FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1815	CLINIMIX E 4.25/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1822	CLINIMIX E 4.25/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1844	CLINIMIX E 5/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1846	CLINIMIX E 5/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1852	CLINIMIX E 5/35 SULFITE FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1862	CLISTIN	CARBINOXAMINE MALEATE	5282409	C20H23ClN2O5	406.863	\N	\N	2	7	8	100	28	0	386	0	1	\N	\N	CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	2-[(4-chlorophenyl)-(2-pyridyl)methoxy]-N,N-dimethyl-ethanamine;maleic acid
1851	CLINIMIX E 5/35 SULFITE FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1853	CLINIMIX E 5/35 SULFITE FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1916	CODEPREX	CHLORPHENIRAMINE POLISTIREX	2725	C16H19ClN2	274.792	\N	3.4	0	2	5	16.1	19	0	249	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine
1867	CLOFARABINE	CLOFARABINE	119182	C10H11ClFN5O3	303.678	\N	0.9	3	8	2	119	20	0	370	4	0	\N	\N	C1=NC2=C(N1C3C(C(C(O3)CO)O)F)N=C(N=C2N)Cl	(2R,3R,4S,5R)-5-(6-amino-2-chloro-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol
1875	CLONIDINE HYDROCHLORIDE	CLONIDINE HYDROCHLORIDE	20179	C9H10Cl3N3	266.55	\N	\N	3	1	2	36.4	15	0	222	0	0	\N	\N	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl	N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine;hydrochloride
1874	CLONIDINE	CLONIDINE	2803	C9H9Cl2N3	230.092	\N	1.6	2	1	2	36.4	14	0	222	0	0	\N	\N	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl	N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
1858	CLINISOL 15% SULFITE FREE IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1859	CLINOLIPID 20%	OLIVE OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1860	CLINOLIPID 20%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1884	CLOTRIMAZOLE	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
1889	CLOZAPINE	CLOZAPINE	2818	C18H19ClN4	326.828	\N	3.2	1	4	1	30.9	23	0	584	0	0	\N	\N	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine
1917	CODEPREX	CODEINE POLISTIREX	5284371	C18H21NO3	299.37	\N	1.1	1	4	1	41.9	22	0	509	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol
1906	CODEINE SULFATE	CODEINE SULFATE	5284371	C18H21NO3	299.37	\N	1.1	1	4	1	41.9	22	0	509	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol
1866	CLODERM	CLOCORTOLONE PIVALATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1868	CLOFIBRATE	CLOFIBRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1870	CLOMID	CLOMIPHENE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1871	CLOMIPHENE CITRATE	CLOMIPHENE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1938	COLESTID	COLESTIPOL HYDROCHLORIDE	62816	C11H28ClN5O	281.829	\N	\N	5	6	11	101	18	0	117	0	1	\N	\N	C1C(O1)CCl.C(CNCCNCCNCCN)N	N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine;2-(chloromethyl)oxirane
1945	COLONAID	DIPHENOXYLATE HYDROCHLORIDE	6432394	C30H33ClN2O2	489.056	\N	\N	1	4	9	53.3	35	0	666	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.Cl	ethyl 1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylate;hydrochloride
1876	CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONE	CHLORTHALIDONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1900	COARTEM	LUMEFANTRINE	6437380	C30H32Cl3NO	528.942	\N	8.7	1	2	10	23.5	35	0	671	0	1	\N	\N	CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)C(=CC4=CC=C(C=C4)Cl)C2=CC(=C1)Cl)O	2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylene]fluoren-4-yl]ethanol
1921	CODOXY	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
1903	CODAMINE	PHENYLPROPANOLAMINE HYDROCHLORIDE	9065	C9H14ClNO	187.667	\N	\N	3	2	2	46.2	12	0	110	0	2	\N	\N	CC(C(C1=CC=CC=C1)O)N.Cl	2-amino-1-phenyl-propan-1-ol;hydrochloride
1893	CO-LAV	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
1894	CO-LAV	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
1882	CLORPRES	CHLORTHALIDONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1928	COL-PROBENECID	PROBENECID	4911	C13H19NO4S	285.358	\N	3.2	1	5	7	83.1	19	0	374	0	0	\N	\N	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O	4-(dipropylsulfamoyl)benzoic acid
1931	COLBENEMID	PROBENECID	4911	C13H19NO4S	285.358	\N	3.2	1	5	7	83.1	19	0	374	0	0	\N	\N	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O	4-(dipropylsulfamoyl)benzoic acid
1849	CLINIMIX E 5/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
1895	CO-LAV	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
1896	CO-LAV	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1940	COLGATE TOTAL	SODIUM FLUORIDE	5235	FNa	41.988	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[F-].[Na+]	sodium;fluoride
1892	CO-GESIC	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1897	CO-LAV	SODIUM SULFATE ANHYDROUS	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
1899	COARTEM	ARTEMETHER	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1926	COGNEX	TACRINE HYDROCHLORIDE	2723754	C13H15ClN2	234.727	\N	\N	2	2	0	38.9	16	0	229	0	0	\N	\N	C1CCC2=NC3=CC=CC=C3C(=C2C1)N.Cl	1,2,3,4-tetrahydroacridin-9-amine;hydrochloride
1902	CODAMINE	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1943	COLOCORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6640	PAPA-DEINE #4	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1952	COLY-MYCIN S	COLISTIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1953	COLY-MYCIN S	COLISTIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1954	COLY-MYCIN S	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1995	COMPOUND 65	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
1991	COMPLERA	EMTRICITABINE	60877	C8H10FN3O3S	247.244	\N	-0.6	2	5	2	113	16	0	374	2	0	\N	\N	C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F	4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
1974	COMBIPATCH	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
1984	COMBUNOX	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
2004	CONRAY 325	IOTHALAMATE SODIUM	23667529	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	426	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)C(=O)NC)I.[Na+]	sodium;3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoate
2024	CORLANOR	IVABRADINE HYDROCHLORIDE	3045381	C27H37ClN2O5	505.052	\N	\N	1	6	10	60.5	35	0	663	1	0	\N	\N	CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC.Cl	3-[3-[[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methyl-amino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one;hydrochloride
2023	CORGARD	NADOLOL	39147	C17H27NO4	309.406	\N	0.7	4	5	6	82	22	0	344	2	1	\N	\N	CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O	(2R,3S)-5-[3-(tert-butylamino)-2-hydroxy-propoxy]tetralin-2,3-diol
1987	COMMIT	NICOTINE POLACRILEX	89594	C10H14N2	162.236	\N	1.2	0	2	1	16.1	12	0	147	1	0	\N	\N	CN1CCCC1C2=CN=CC=C2	3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
1975	COMBIPATCH	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
1957	COLYTE	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
1947	COLOVAGE	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
1958	COLYTE	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
1972	COMBIGAN	BRIMONIDINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1963	COLYTE WITH FLAVOR PACKS	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
1976	COMBIPRES	CHLORTHALIDONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2032	CORTALONE	PREDNISOLONE	5755	C21H28O5	360.45	\N	1.6	3	5	2	94.8	26	0	724	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
1990	COMPAZINE	PROCHLORPERAZINE MALEATE	4917	C20H24ClN3S	373.943	\N	4.9	0	4	4	35	25	0	429	0	0	\N	\N	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine
1979	COMBIVENT	IPRATROPIUM BROMIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2027	CORPHED	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
1981	COMBIVENT RESPIMAT	IPRATROPIUM BROMIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1982	COMBIVIR	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1948	COLOVAGE	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
1949	COLOVAGE	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1960	COLYTE	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1950	COLOVAGE	SODIUM SULFATE ANHYDROUS	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
1956	COLY-MYCIN S	THONZONIUM BROMIDE	11102	C32H55BrN4O	591.723	\N	\N	0	5	22	38.2	38	0	515	0	0	\N	\N	CCCCCCCCCCCCCCCC[N+](C)(C)CCN(CC1=CC=C(C=C1)OC)C2=NC=CC=N2.[Br-]	hexadecyl-[2-[(4-methoxyphenyl)methyl-pyrimidin-2-yl-amino]ethyl]-dimethyl-ammonium;bromide
2011	CONZIP	TRAMADOL HYDROCHLORIDE	63013	C16H26ClNO2	299.839	\N	\N	2	3	4	32.7	20	0	282	2	0	\N	\N	CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O.Cl	(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol;hydrochloride
1993	COMPLERA	TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2014	COR-OTICIN	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2030	CORSYM	PHENYLPROPANOLAMINE POLISTIREX	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2031	CORT-DOME	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2034	CORTEF	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2035	CORTEF	HYDROCORTISONE CYPIONATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2036	CORTEF ACETATE	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2037	CORTENEMA	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2038	CORTICOTROPIN	CORTICOTROPIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2039	CORTIFOAM	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2040	CORTISONE ACETATE	CORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2041	CORTISPORIN	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2042	CORTISPORIN	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2045	CORTISPORIN	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2048	CORTISPORIN	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2051	CORTONE	CORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2052	CORTRIL	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2053	CORTRIL	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2054	CORTROPHIN-ZINC	CORTICOTROPIN-ZINC HYDROXIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2055	CORTROSYN	COSYNTROPIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2056	CORVERT	IBUTILIDE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2084	CROTAN	CROTAMITON	688020	C13H17NO	203.285	\N	2.8	0	1	3	20.3	15	0	235	0	0	\N	\N	CCN(C1=CC=CC=C1C)C(=O)C=CC	(E)-N-ethyl-N-(o-tolyl)but-2-enamide
2059	COSENTYX	SECUKINUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2091	CUPRIC CHLORIDE IN PLASTIC CONTAINER	CUPRIC CHLORIDE	24014	Cl2Cu	134.446	\N	\N	0	0	0	0	3	0	2.8	0	0	\N	\N	Cl[Cu]Cl	dichlorocopper
2092	CUPRIC SULFATE	CUPRIC SULFATE	24462	CuO4S	159.602	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Cu+2]	copper;sulfate
2121	CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	2907	C7H15Cl2N2O2P	261.083	\N	0.6	1	4	5	41.6	14	0	212	0	1	\N	\N	C1CNP(=O)(OC1)N(CCCl)CCCl	N,N-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine
2130	CYPROHEPTADINE HYDROCHLORIDE	CYPROHEPTADINE HYDROCHLORIDE	13770	C21H22ClN	323.864	\N	\N	1	1	0	3.2	23	0	423	0	0	\N	\N	CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1.Cl	4-(dibenzo[1,2-a:1',2'-e][7]annulen-11-ylidene)-1-methyl-piperidine;hydrochloride
2065	COSYNTROPIN	COSYNTROPIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2066	COTAZYM	PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2067	COTELLIC	COBIMETINIB FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2134	CYSTARAN	CYSTEAMINE HYDROCHLORIDE	9082	C2H8ClNS	113.603	\N	\N	3	2	1	27	5	0	10	0	0	\N	\N	C(CS)N.Cl	2-aminoethanethiol;hydrochloride
2151	DACARBAZINE	DACARBAZINE	5353562	C6H10N6O	182.187	\N	-0.3	2	4	3	95.4	13	0	302	0	0	\N	\N	CN(C)NN=C1C(=NC=N1)C(=O)N	(5E)-5-(dimethylaminohydrazono)imidazole-4-carboxamide
2159	DALVANCE	DALBAVANCIN HYDROCHLORIDE	16134627	C88H100Cl2N10O28	1816.71	\N	3.8	21	30	22	573	128	0	3740	18	0	\N	\N	CC(C)CCCCCCCCC(=O)NC1C(C(C(OC1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)C(C6C(=O)NC(C7=CC(=CC(=C7C8=C(C=CC(=C8)C(C(=O)N6)NC(=O)C4NC(=O)C9C1=CC(=CC(=C1Cl)O)OC1=C(C=CC(=C1)C(C(=O)NC(CC1=CC=C(O3)C=C1)C(=O)N9)NC)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)C(=O)NCCCN(C)C)O)Cl)C(=O)O)O)O	\N
2164	DAPIPRAZOLE HYDROCHLORIDE	DAPIPRAZOLE HYDROCHLORIDE	6917787	C19H28ClN5	361.918	\N	\N	1	4	4	37.2	25	0	395	0	0	\N	\N	CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4.Cl	3-[2-[4-(o-tolyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;hydrochloride
2074	COZAAR	LOSARTAN POTASSIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2075	CREON	PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2076	CRESCORMON	SOMATROPIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2152	DACOGEN	DECITABINE	451668	C8H12N4O4	228.208	\N	-1.2	3	4	2	121	16	0	356	3	0	\N	\N	C1C(C(OC1N2C=NC(=NC2=O)N)CO)O	4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one
2156	DALGAN	DEZOCINE	3033053	C16H23NO	245.366	\N	3.7	2	2	0	46.2	18	0	306	3	0	\N	\N	CC12CCCCCC(C1N)CC3=C2C=C(C=C3)O	\N
2167	DARANIDE	DICHLORPHENAMIDE	3038	C6H6Cl2N2O4S2	305.144	\N	0.3	2	6	2	137	16	0	452	0	0	\N	\N	C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N	4,5-dichlorobenzene-1,3-disulfonamide
2127	CYMBALTA	DULOXETINE HYDROCHLORIDE	60834	C18H20ClNOS	333.874	\N	\N	2	3	6	49.5	22	0	312	1	0	\N	\N	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl	(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine;hydrochloride
2158	DALMANE	FLURAZEPAM HYDROCHLORIDE	3393	C21H23ClFN3O	387.883	\N	3	0	4	6	35.9	27	0	540	0	0	\N	\N	CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F	7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one
2096	CUTIVATE	FLUTICASONE PROPIONATE	444036	C25H31F3O5S	500.573	\N	4	1	9	6	106	34	0	984	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
2140	CYSVIEW KIT	HEXAMINOLEVULINATE HYDROCHLORIDE	6433082	C11H22ClNO3	251.751	\N	\N	2	4	10	69.4	16	0	192	0	0	\N	\N	CCCCCCOC(=O)CCC(=O)CN.Cl	hexyl 5-amino-4-oxo-pentanoate;hydrochloride
2136	CYSTO-CONRAY	IOTHALAMATE MEGLUMINE	656642	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	555	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)C(=O)NC)I.CNCC(C(C(C(CO)O)O)O)O	3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
2087	CRYSTODIGIN	DIGITOXIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2143	CYTOMEL	LIOTHYRONINE SODIUM	23666110	C15H11I3NNaO4	672.959	\N	\N	2	5	5	95.6	24	0	408	1	0	\N	\N	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.[Na+]	sodium;(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoate
2145	CYTOTEC	MISOPROSTOL	5282381	C22H38O5	382.541	\N	3.7	2	5	14	83.8	27	0	487	3	1	\N	\N	CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O	methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyl-oct-1-enyl]-5-oxo-cyclopentyl]heptanoate
2094	CUROSURF	PORACTANT ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2086	CRYSELLE	NORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
2093	CUPRIMINE	PENICILLAMINE	5852	C5H11NO2S	149.208	\N	-1.8	3	4	2	64.3	9	0	124	1	0	\N	\N	CC(C)(C(C(=O)O)N)S	(2S)-2-amino-3-methyl-3-sulfanyl-butanoic acid
2068	COTRIM	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
2062	COSOPT	TIMOLOL MALEATE	5281056	C17H28N4O7S	432.492	\N	\N	4	12	9	183	29	0	429	1	0	\N	\N	CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O	(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;maleic acid
2100	CYANOCOBALAMIN CO 57 SCHILLING TEST KIT	CYANOCOBALAMIN CO-57	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2125	CYKLOKAPRON	TRANEXAMIC ACID	5526	C8H15NO2	157.213	\N	-2	2	3	2	63.3	11	0	139	0	0	\N	\N	C1CC(CCC1CN)C(=O)O	4-(aminomethyl)cyclohexanecarboxylic acid
2072	COUMADIN	WARFARIN SODIUM	16204922	C19H15NaO4	330.315	\N	\N	0	4	4	66.4	24	0	508	0	1	\N	\N	CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)[O-].[Na+]	sodium;2-oxo-3-(3-oxo-1-phenyl-butyl)chromen-4-olate
2131	CYRAMZA	RAMUCIRUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2133	CYSTAGON	CYSTEAMINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6775	PERCOCET	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2237	DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2173	DARUNAVIR ETHANOLATE	DARUNAVIR ETHANOLATE	23725083	C29H43N3O8S	593.736	\N	\N	4	10	12	169	41	0	856	5	0	\N	\N	CCO.CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N	[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate;ethanol
2221	DECITABINE	DECITABINE	451668	C8H12N4O4	228.208	\N	-1.2	3	4	2	121	16	0	356	3	0	\N	\N	C1C(C(OC1N2C=NC(=NC2=O)N)CO)O	4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one
2222	DECLOMYCIN	DEMECLOCYCLINE HYDROCHLORIDE	54686764	C21H22Cl2N2O8	501.313	\N	\N	7	9	2	182	33	0	961	5	0	\N	\N	CN(C)C1C2CC3C(C4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O.Cl	(4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride
2213	DECADERM	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2233	DELCOBESE	DEXTROAMPHETAMINE ADIPATE	49800024	C15H23NO4	281.352	\N	\N	3	5	7	101	20	0	198	1	0	\N	\N	CC(CC1=CC=CC=C1)N.C(CCC(=O)O)CC(=O)O	adipic acid;(2S)-1-phenylpropan-2-amine
2196	DASETTA 1/35	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2212	DECABID	INDECAINIDE HYDROCHLORIDE	52194	C20H25ClN2O	344.883	\N	\N	3	2	6	55.1	24	0	398	0	0	\N	\N	CC(C)NCCCC1(C2=CC=CC=C2C3=CC=CC=C31)C(=O)N.Cl	9-[3-(isopropylamino)propyl]fluorene-9-carboxamide;hydrochloride
2169	DARBID	ISOPROPAMIDE IODIDE	6284	C23H33IN2O	480.434	\N	\N	1	2	8	43.1	27	0	419	0	0	\N	\N	CC(C)[N+](C)(CCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)N)C(C)C.[I-]	(4-amino-4-oxo-3,3-diphenyl-butyl)-diisopropyl-methyl-ammonium;iodide
2239	DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2230	DELAXIN	METHOCARBAMOL	4107	C11H15NO5	241.243	\N	0.6	2	5	7	91	17	0	236	0	1	\N	\N	COC1=CC=CC=C1OCC(COC(=O)N)O	[2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate
2207	DAYTRANA	METHYLPHENIDATE	4158	C14H19NO2	233.311	\N	0.2	1	3	4	38.3	17	0	249	0	2	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	methyl 2-phenyl-2-(2-piperidyl)acetate
2236	DELFEN	NONOXYNOL-9	72385	C33H60O10	616.833	\N	4.6	1	10	35	103	43	0	520	0	0	\N	\N	CCCCCCCCCC1=CC=C(C=C1)OCCOCCOCCOCCOCCOCCOCCOCCOCCO	2-[2-[2-[2-[2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol
2204	DAYPRO ALTA	OXAPROZIN POTASSIUM	23694685	C18H14KNO3	331.412	\N	\N	0	4	5	66.2	23	0	367	0	0	\N	\N	C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)[O-])C3=CC=CC=C3.[K+]	potassium;3-(4,5-diphenyloxazol-2-yl)propanoate
2225	DEFINITY	PERFLUTREN	6432	C3F8	188.02	\N	3.1	0	8	0	0	11	0	120	0	0	\N	\N	C(C(F)(F)F)(C(F)(F)F)(F)F	1,1,1,2,2,3,3,3-octafluoropropane
2194	DARZALEX	DARATUMUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2177	DARVOCET A500	PROPOXYPHENE NAPSYLATE	28332	C32H37NO5S	547.71	\N	\N	1	6	10	92.3	39	0	688	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C.C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)O	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate;naphthalene-2-sulfonic acid
2240	DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2245	DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2241	DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2246	DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2229	DELATESTRYL	TESTOSTERONE ENANTHATE	9416	C26H40O3	400.603	\N	6.3	0	3	7	43.4	29	0	679	6	0	\N	\N	CCCCCCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C	[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate
2202	DAUNOXOME	DAUNORUBICIN CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2227	DEL-VI-A	VITAMIN A PALMITATE	5280531	C36H60O2	524.874	\N	13.6	0	2	21	26.3	38	0	803	0	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C	[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
2226	DEFITELIO	DEFIBROTIDE SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2231	DELCOBESE	AMPHETAMINE ADIPATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2232	DELCOBESE	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2234	DELCOBESE	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2235	DELESTROGEN	ESTRADIOL VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2238	DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2243	DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2248	DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2253	DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2258	DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2263	DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2346	DEPOCYT	CYTARABINE	6253	C9H13N3O5	243.219	\N	-2.1	4	5	2	129	17	0	383	4	0	\N	\N	C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O	4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one
2310	DELTALIN	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
2320	DEMULEN 1/35-21	ETHYNODIOL DIACETATE	9270	C24H32O4	384.516	\N	3.9	0	4	5	52.6	28	0	758	7	0	\N	\N	CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C	[(3S,8R,9S,10R,13S,14S,17R)-17-acetoxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
2268	DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2348	DERMA-SMOOTHE/FS	FLUOCINOLONE ACETONIDE	6215	C24H30F2O6	452.495	\N	2.5	2	8	2	93.1	32	0	960	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C	\N
2328	DENDRID	IDOXURIDINE	5905	C9H11IN2O5	354.1	\N	-1	3	5	2	99.1	17	0	386	3	0	\N	\N	C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-iodo-pyrimidine-2,4-dione
2329	DENTIPATCH	LIDOCAINE	3676	C14H22N2O	234.343	\N	2.3	1	2	5	32.3	17	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
2273	DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2341	DEPO-PROVERA	MEDROXYPROGESTERONE ACETATE	6279	C24H34O4	386.532	\N	4.1	0	4	3	60.4	28	0	767	7	0	\N	\N	CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
2342	DEPO-SUBQ PROVERA 104	MEDROXYPROGESTERONE ACETATE	6279	C24H34O4	386.532	\N	4.1	0	4	3	60.4	28	0	767	7	0	\N	\N	CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
2315	DEMEROL	MEPERIDINE HYDROCHLORIDE	5750	C15H22ClNO2	283.796	\N	\N	1	3	4	29.5	19	0	276	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2.Cl	ethyl 1-methyl-4-phenyl-piperidine-4-carboxylate;hydrochloride
2278	DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2312	DELZICOL	MESALAMINE	4075	C7H7NO3	153.137	\N	1.3	3	4	1	83.6	11	0	160	0	0	\N	\N	C1=CC(=C(C=C1N)C(=O)O)O	5-amino-2-hydroxy-benzoic acid
2318	DEMSER	METYROSINE	441350	C10H13NO3	195.218	\N	-1.6	3	4	3	83.6	14	0	211	1	0	\N	\N	CC(CC1=CC=C(C=C1)O)(C(=O)O)N	(2S)-2-amino-3-(4-hydroxyphenyl)-2-methyl-propanoic acid
2335	DEPEN	PENICILLAMINE	5852	C5H11NO2S	149.208	\N	-1.8	3	4	2	64.3	9	0	124	1	0	\N	\N	CC(C)(C(C(=O)O)N)S	(2S)-2-amino-3-methyl-3-sulfanyl-butanoic acid
2283	DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2317	DEMI-REGROTON	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
2266	DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2271	DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2276	DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2288	DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2337	DEPINAR	TANNIC ACID	16129778	C76H52O46	1701.206	\N	6.2	25	46	31	778	122	0	3570	5	0	\N	\N	C1=C(C=C(C(=C1O)O)O)C(=O)OC2=CC(=CC(=C2O)O)C(=O)OCC3C(C(C(C(O3)OC(=O)C4=CC(=C(C(=C4)OC(=O)C5=CC(=C(C(=C5)O)O)O)O)O)OC(=O)C6=CC(=C(C(=C6)OC(=O)C7=CC(=C(C(=C7)O)O)O)O)O)OC(=O)C8=CC(=C(C(=C8)OC(=O)C9=CC(=C(C(=C9)O)O)O)O)O)OC(=O)C1=CC(=C(C(=C1)OC(=O)C1=CC(=C(C(=C1)O)O)O)O)O	\N
2344	DEPO-TESTADIOL	TESTOSTERONE CYPIONATE	441404	C27H40O3	412.614	\N	6.4	0	3	5	43.4	30	0	732	6	0	\N	\N	CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=CC(=O)CCC35C	[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
2345	DEPO-TESTOSTERONE	TESTOSTERONE CYPIONATE	441404	C27H40O3	412.614	\N	6.4	0	3	5	43.4	30	0	732	6	0	\N	\N	CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=CC(=O)CCC35C	[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
2313	DEMADEX	TORSEMIDE	41781	C16H20N4O3S	348.421	\N	2.7	3	5	5	109	24	0	518	0	0	\N	\N	CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C	1-isopropyl-3-[[4-(3-methylanilino)-3-pyridyl]sulfonyl]urea
2293	DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2338	DEPINAR	ZINC ACETATE	11192	C4H6O4Zn	183.468	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Zn+2]	zinc;diacetate
2298	DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2303	DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2316	DEMI-REGROTON	CHLORTHALIDONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2349	DERMABET	BETAMETHASONE VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2350	DERMACORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6823	PHENAPHEN W/ CODEINE NO. 2	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
6827	PHENAPHEN W/ CODEINE NO. 4	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2355	DESCOVY	TENOFOVIR ALAFENAMIDE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2372	DESONATE	DESONIDE	5311066	C24H32O6	416.514	\N	2.7	2	6	2	93.1	30	0	873	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C	\N
2373	DESONIDE	DESONIDE	5311066	C24H32O6	416.514	\N	2.7	2	6	2	93.1	30	0	873	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C	\N
2358	DESLORATADINE	DESLORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2359	DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR	DESLORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2377	DESVENLAFAXINE	DESVENLAFAXINE	125017	C16H25NO2	263.381	\N	2.6	2	3	4	43.7	19	0	266	0	1	\N	\N	CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O	4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol
2384	DEXACIDIN	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2399	DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE	DEXBROMPHENIRAMINE MALEATE	6433334	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	1	0	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
2401	DEXCHLORPHENIRAMINE MALEATE	DEXCHLORPHENIRAMINE MALEATE	5281070	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	1	0	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
2407	DEXMEDETOMIDINE HYDROCHLORIDE	DEXMEDETOMIDINE HYDROCHLORIDE	6918081	C13H17ClN2	236.743	\N	\N	2	1	2	28.7	16	0	205	1	0	\N	\N	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.Cl	5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole;hydrochloride
2413	DEXRAZOXANE HYDROCHLORIDE	DEXRAZOXANE HYDROCHLORIDE	6918223	C11H17ClN4O4	304.731	\N	\N	3	6	3	98.8	20	0	404	1	0	\N	\N	CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2.Cl	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione;hydrochloride
2365	DESOGEN	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2353	DERMOTIC	FLUOCINOLONE ACETONIDE	6215	C24H30F2O6	452.495	\N	2.5	2	8	2	93.1	32	0	960	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C	\N
2403	DEXFERRUM	IRON DEXTRAN	105075	FeH2O4S	153.917	\N	\N	2	4	0	83	6	0	81.3	0	0	\N	\N	OS(=O)(=O)O.[Fe]	iron;sulfuric acid
2484	DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2360	DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
2427	DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2378	DESVENLAFAXINE	DESVENLAFAXINE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2379	DESVENLAFAXINE SUCCINATE	DESVENLAFAXINE SUCCINATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2381	DETROL	TOLTERODINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2382	DETROL LA	TOLTERODINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2380	DESYREL	TRAZODONE HYDROCHLORIDE	62935	C19H23Cl2N5O	408.327	\N	\N	1	4	5	42.4	27	0	611	0	0	\N	\N	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl.Cl	2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride
2395	DEXAMPEX	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2402	DEXEDRINE	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2414	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2415	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2416	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2417	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2418	DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE	AMPHETAMINE ASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2419	DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2420	DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE	DEXTROAMPHETAMINE SACCHARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2421	DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2422	DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; DEXTROAMPHETAMINE SULFATE; AMPHETAMINE SULFATE	DEXTROAMPHETAMINE SACCHARATE;AMPHETAMINE ASPARTATE MONOHYDRATE;DEXTROAMPHETAMINE SULFATE;AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2423	DEXTROAMPHETAMINE SULFATE	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2424	DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE	DEXTROMETHORPHAN HYDROBROMIDE;QUINIDINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2426	DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2428	DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2430	DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2432	DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2434	DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2436	DEXTROSE 10% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2437	DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2439	DEXTROSE 2.5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2441	DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2443	DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2445	DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6829	PHENAPHEN-650 W/ CODEINE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
6894	PHRENILIN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2448	DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6896	PHRENILIN FORTE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2452	DEXTROSE 2.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2453	DEXTROSE 20% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2454	DEXTROSE 25%	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2455	DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6898	PHRENILIN WITH CAFFEINE AND CODEINE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2457	DEXTROSE 30% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2458	DEXTROSE 38.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7716	PROPACET 100	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2460	DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7733	PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2464	DEXTROSE 40% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2465	DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7738	PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
7771	PROVAL #3	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2471	DEXTROSE 5% AND ELECTROLYTE NO. 75 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8089	ROXICET	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2449	DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2468	DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, MONOBASIC	516951	H2KO4P	136.084	\N	\N	2	4	0	80.6	6	0	61.9	0	0	\N	\N	OP(=O)(O)[O-].[K+]	potassium;dihydrogen phosphate
2477	DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2438	DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2440	DEXTROSE 2.5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2481	DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2442	DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2483	DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2771	DICOPAC KIT	CYANOCOBALAMIN CO-58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2485	DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2451	DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2487	DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2463	DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2470	DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2490	DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2493	DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2495	DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2497	DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2499	DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2501	DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2503	DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2505	DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2508	DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8091	ROXICET 5/500	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2513	DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8094	ROXILOX	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2517	DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8184	SEDAPAP	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2519	DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8619	SYNALGOS-DC-A	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2522	DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2524	DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2526	DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2528	DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2530	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.075%	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8662	TALACEN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2533	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8692	TAVIST ALLERGY/SINUS/HEADACHE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2536	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8762	TENCON	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2539	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9000	TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
9154	TREZIX	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2542	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9189	TRIAD	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
9201	TRIAPRIN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2545	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K)	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9342	TYLENOL	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
9343	TYLENOL W/ CODEINE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2548	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9345	TYLENOL W/ CODEINE NO. 1	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2511	DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2551	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K)	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2515	DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2516	DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2554	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2557	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2560	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2563	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K)	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2566	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2569	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2572	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2575	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.30% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9347	TYLENOL W/ CODEINE NO. 2	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2578	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9349	TYLENOL W/ CODEINE NO. 3	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2581	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9351	TYLENOL W/ CODEINE NO. 4	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2584	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9353	TYLOX	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2587	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9355	TYLOX	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2590	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9358	TYLOX-325	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2593	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9379	ULTRACET	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2596	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.075%	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9586	VICODIN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
9588	VICODIN ES	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2599	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9590	VICODIN HP	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
9733	WYGESIC	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2602	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9744	XARTEMIS XR	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
9934	ZYDONE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2605	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2630	DIABETA	GLYBURIDE	3488	C23H28ClN3O5S	494.003	\N	4.8	3	5	8	122	33	0	746	0	0	\N	\N	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide
2573	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2608	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2636	DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
2574	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2611	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2614	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2617	DEXTROSE 50%	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2618	DEXTROSE 50% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2619	DEXTROSE 60%	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2620	DEXTROSE 60% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2621	DEXTROSE 7.7% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2622	DEXTROSE 70% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2623	DEXTROSTAT	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2626	DHC PLUS	DIHYDROCODEINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2629	DI-METREX	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2634	DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2639	DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9938	ZYFREL	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2644	DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
71	ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	13290219	C4H5N4NaO3S2	244.219	\N	\N	2	7	2	127	14	0	302	0	0	\N	\N	CC(=O)NC1=NN=C(S1)S(=O)(=O)[NH-].[Na+]	sodium;(5-acetamido-1,3,4-thiadiazol-2-yl)sulfonylazanide
2649	DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5873	NEO-CORT-DOME	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
2654	DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
79	ACETYLCYSTEINE	ACETYLCYSTEINE	12035	C5H9NO3S	163.191	\N	0.4	3	4	3	67.4	10	0	148	1	0	\N	\N	CC(=O)NC(CS)C(=O)O	(2R)-2-acetamido-3-sulfanyl-propanoic acid
2659	DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
131	ACYCLOVIR	ACYCLOVIR	2022	C8H11N5O3	225.208	\N	-1.6	3	4	4	115	16	0	308	0	0	\N	\N	C1=NC2=C(N1COCCO)NC(=NC2=O)N	2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one
2664	DIALYTE W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7543	PRISMASOL BGK 4/0 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
2641	DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
2669	DIALYTE W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2651	DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
2666	DIALYTE W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
2676	DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2671	DIALYTE W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
2642	DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2646	DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2681	DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2652	DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2656	DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2661	DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2686	DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2647	DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2657	DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2662	DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2691	DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2679	DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2684	DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2689	DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2696	DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2701	DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2706	DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2711	DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9548	VENTOLIN HFA	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
2716	DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2756	DIATRIZOATE-60	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
2721	DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2752	DIASTAT	DIAZEPAM	3016	C16H13ClN2O	284.743	\N	3	0	2	1	32.7	20	0	403	0	0	\N	\N	CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
2759	DIAZOXIDE	DIAZOXIDE	3019	C8H7ClN2O2S	230.666	\N	1.2	1	3	0	66.9	14	0	360	0	0	\N	\N	CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl	7-chloro-3-methyl-4H-1$l^{6},2,4-benzothiadiazine 1,1-dioxide
2775	DICYCLOMINE HYDROCHLORIDE	DICYCLOMINE HYDROCHLORIDE	441344	C19H36ClNO2	345.952	\N	\N	1	3	8	29.5	23	0	326	0	0	\N	\N	CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2.Cl	2-(diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate;hydrochloride
2726	DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2777	DIDANOSINE	DIDANOSINE	50599	C10H12N4O3	236.231	\N	-1.2	2	4	2	88.7	17	0	348	2	0	\N	\N	C1CC(OC1CO)N2C=NC3=C2NC=NC3=O	9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purin-6-one
2782	DIETHYLSTILBESTROL	DIETHYLSTILBESTROL	448537	C18H20O2	268.356	\N	5.1	2	2	4	40.5	20	0	286	0	0	\N	\N	CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O	4-[(E)-1-ethyl-2-(4-hydroxyphenyl)but-1-enyl]phenol
2790	DIFLUNISAL	DIFLUNISAL	3059	C13H8F2O3	250.201	\N	4.4	2	5	2	57.5	18	0	311	0	0	\N	\N	C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O	5-(2,4-difluorophenyl)-2-hydroxy-benzoic acid
2731	DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2807	DIMENHYDRINATE	DIMENHYDRINATE	10660	C24H28ClN5O3	469.97	\N	\N	1	5	6	81.8	33	0	509	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2	2-benzhydryloxy-N,N-dimethyl-ethanamine;8-chloro-1,3-dimethyl-7H-purine-2,6-dione
2760	DIBENIL	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
2802	DILOR	DYPHYLLINE	3182	C10H14N4O4	254.246	\N	-1.8	2	5	3	98.9	18	0	364	0	1	\N	\N	CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O	7-(2,3-dihydroxypropyl)-1,3-dimethyl-purine-2,6-dione
2786	DIFLUCAN	FLUCONAZOLE	3365	C13H12F2N6O	306.277	\N	0.4	1	7	5	81.6	22	0	358	0	0	\N	\N	C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O	2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol
2736	DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2800	DILAUDID	HYDROMORPHONE HYDROCHLORIDE	5284570	C17H19NO3	285.343	\N	1.8	1	4	0	49.8	21	0	494	4	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(=O)CC4	(4R,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
2717	DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2767	DICLOFENAC SODIUM AND MISOPROSTOL	MISOPROSTOL	5282381	C22H38O5	382.541	\N	3.7	2	5	14	83.8	27	0	487	3	1	\N	\N	CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O	methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyl-oct-1-enyl]-5-oxo-cyclopentyl]heptanoate
2761	DIBENZYLINE	PHENOXYBENZAMINE HYDROCHLORIDE	5284441	C18H23Cl2NO	340.288	\N	\N	1	2	8	12.5	22	0	262	0	1	\N	\N	CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2.Cl	N-benzyl-N-(2-chloroethyl)-1-phenoxy-propan-2-amine;hydrochloride
2741	DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2796	DILANTIN	PHENYTOIN SODIUM	657302	C15H11N2NaO2	274.255	\N	\N	1	3	2	47.2	20	0	356	0	0	\N	\N	C1=CC=C(C=C1)C2(C(=O)[N-]C(=O)N2)C3=CC=CC=C3.[Na+]	sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione
2795	DILANTIN	PHENYTOIN	1775	C15H12N2O2	252.273	\N	2.5	2	2	2	58.2	19	0	350	0	0	\N	\N	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	5,5-diphenylimidazolidine-2,4-dione
2763	DICLEGIS	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
2718	DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2746	DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2683	DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2688	DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2693	DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2719	DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2751	DIASONE SODIUM	SULFOXONE SODIUM	8954	C14H14N2Na2O6S3	448.434	\N	\N	2	10	6	185	27	0	509	0	0	\N	\N	C1=CC(=CC=C1NCS(=O)[O-])S(=O)(=O)C2=CC=C(C=C2)NCS(=O)[O-].[Na+].[Na+]	disodium;[4-[4-(sulfinatomethylamino)phenyl]sulfonylanilino]methanesulfinate
2774	DICURIN PROCAINE	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
2770	DICOPAC KIT	CYANOCOBALAMIN CO-57	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2799	DILATRATE-SR	ISOSORBIDE DINITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9549	VENTOLIN ROTACAPS	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
2855	DIURIL	CHLOROTHIAZIDE SODIUM	23675744	C7H5ClN3NaO4S2	317.694	\N	\N	1	7	1	124	18	0	538	0	0	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)[N-]C=N2.[Na+]	sodium;6-chloro-1,1-dioxo-1$l^{6},2,4-benzothiadiazin-2-ide-7-sulfonamide
2816	DIOVAN	VALSARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2834	DISCASE	CHYMOPAPAIN	9001	C6H4Na2O8S2	314.19	\N	\N	2	8	0	172	18	0	413	0	0	\N	\N	C1=C(C=C(C(=C1S(=O)(=O)[O-])O)O)S(=O)(=O)[O-].[Na+].[Na+]	disodium;4,5-dihydroxybenzene-1,3-disulfonate
2818	DIOVAN HCT	VALSARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2810	DIMETANE-DX	DEXTROMETHORPHAN HYDROBROMIDE	5464025	C18H26BrNO	352.316	\N	\N	1	2	1	12.5	21	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br	\N
2860	DIZAC	DIAZEPAM	3016	C16H13ClN2O	284.743	\N	3	0	2	1	32.7	20	0	403	0	0	\N	\N	CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
2813	DIMETHYL SULFOXIDE	DIMETHYL SULFOXIDE	679	C2H6OS	78.129	\N	-0.6	0	2	0	36.3	4	0	29	0	0	\N	\N	CS(=O)C	methylsulfinylmethane
2824	DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE	DIPHENOXYLATE HYDROCHLORIDE	6432394	C30H33ClN2O2	489.056	\N	\N	1	4	9	53.3	35	0	666	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.Cl	ethyl 1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylate;hydrochloride
2828	DIPIVEFRIN HYDROCHLORIDE	DIPIVEFRIN HYDROCHLORIDE	71486	C19H30ClNO5	387.901	\N	\N	3	6	9	84.9	26	0	463	0	1	\N	\N	CC(C)(C)C(=O)OC1=C(C=C(C=C1)C(CNC)O)OC(=O)C(C)(C)C.Cl	[2-(2,2-dimethylpropanoyloxy)-4-[1-hydroxy-2-(methylamino)ethyl]phenyl] 2,2-dimethylpropanoate;hydrochloride
2843	DISULFIRAM	DISULFIRAM	3117	C10H20N2S4	296.524	\N	3.9	0	4	7	121	16	0	201	0	0	\N	\N	CCN(CC)C(=S)SSC(=S)N(CC)CC	diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate
2866	DOCEFREZ	DOCETAXEL	148124	C43H53NO14	807.89	\N	1.6	5	14	13	224	58	0	1660	11	0	\N	\N	CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	\N
2867	DOCETAXEL	DOCETAXEL	148124	C43H53NO14	807.89	\N	1.6	5	14	13	224	58	0	1660	11	0	\N	\N	CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	\N
2877	DONEPEZIL HYDROCHLORIDE	DONEPEZIL HYDROCHLORIDE	5741	C24H30ClNO3	415.958	\N	\N	1	4	6	38.8	29	0	510	0	1	\N	\N	COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC.Cl	2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-one;hydrochloride
2886	DORIBAX	DORIPENEM	73303	C15H24N4O6S2	420.499	\N	-3.4	5	10	7	196	27	0	780	6	0	\N	\N	CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O	(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
2891	DORZOLAMIDE HYDROCHLORIDE	DORZOLAMIDE HYDROCHLORIDE	6918132	C10H17ClN2O4S3	360.886	\N	\N	3	7	3	151	20	0	534	2	0	\N	\N	CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.Cl	(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride
2899	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	62978	C24H29N5O8S	547.583	\N	\N	2	12	4	175	38	0	770	0	1	\N	\N	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC.CS(=O)(=O)O	[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone;methanesulfonic acid
2889	DORYX	DOXYCYCLINE HYCLATE	54686183	C46H58Cl2N4O18	1025.88	\N	\N	16	20	4	385	70	0	958	12	0	\N	\N	CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
2909	DOXYCHEL	DOXYCYCLINE	54671203	C22H24N2O8	444.44	\N	-0.7	6	9	2	182	32	0	956	6	0	\N	\N	CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
2859	DIVIGEL	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
2897	DOW-ISONIAZID	ISONIAZID	3767	C6H7N3O	137.142	\N	-0.7	2	3	1	68	10	0	120	0	0	\N	\N	C1=CN=CC=C1C(=O)NN	pyridine-4-carbohydrazide
2888	DORMATE	MEBUTAMATE	6151	C10H20N2O4	232.28	\N	1.4	2	4	8	105	16	0	237	0	1	\N	\N	CCC(C)C(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2,3-dimethyl-pentyl] carbamate
2835	DISIPAL	ORPHENADRINE HYDROCHLORIDE	9568	C18H24ClNO	305.846	\N	\N	1	2	6	12.5	21	0	260	0	1	\N	\N	CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C.Cl	N,N-dimethyl-2-[o-tolyl(phenyl)methoxy]ethanamine;hydrochloride
2827	DIPHENYLAN SODIUM	PHENYTOIN SODIUM	657302	C15H11N2NaO2	274.255	\N	\N	1	3	2	47.2	20	0	356	0	0	\N	\N	C1=CC=C(C=C1)C2(C(=O)[N-]C(=O)N2)C3=CC=CC=C3.[Na+]	sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione
2844	DITATE-DS	ESTRADIOL VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2814	DIONOSIL AQUEOUS	PROPYLIODONE	4949	C10H11I2NO3	447.011	\N	2.4	0	4	5	46.6	16	0	341	0	0	\N	\N	CCCOC(=O)CN1C=C(C(=O)C(=C1)I)I	propyl 2-(3,5-diiodo-4-oxo-1-pyridyl)acetate
2811	DIMETANE-DX	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
2845	DITATE-DS	TESTOSTERONE ENANTHATE	9416	C26H40O3	400.603	\N	6.3	0	3	7	43.4	29	0	679	6	0	\N	\N	CCCCCCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C	[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate
2865	DOCA	DESOXYCORTICOSTERONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2895	DOTAREM	GADOTERATE MEGLUMINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7238	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
7256	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2965	DURACLON	CLONIDINE HYDROCHLORIDE	20179	C9H10Cl3N3	266.55	\N	\N	3	1	2	36.4	15	0	222	0	0	\N	\N	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl	N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine;hydrochloride
3000	DYLOJECT	DICLOFENAC SODIUM	5018304	C14H10Cl2NNaO2	318.129	\N	\N	1	3	4	52.2	20	0	310	0	0	\N	\N	C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+]	sodium;2-[2-(2,6-dichloroanilino)phenyl]acetate
2994	DV	DIENESTROL	667476	C18H18O2	266.34	\N	5.4	2	2	3	40.5	20	0	318	0	0	\N	\N	CC=C(C1=CC=C(C=C1)O)C(=CC)C2=CC=C(C=C2)O	4-[(E,1E)-1-ethylidene-2-(4-hydroxyphenyl)but-2-enyl]phenol
2930	DRONABINOL	DRONABINOL	16078	C21H30O2	314.469	\N	7	1	2	4	29.5	23	0	439	2	0	\N	\N	CCCCCC1=CC2=C(C3C=C(CCC3C(O2)(C)C)C)C(=C1)O	(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol
2933	DROSPIRENONE AND ETHINYL ESTRADIOL	DROSPIRENONE	68873	C24H30O3	366.501	\N	3.5	0	3	0	43.4	27	0	828	10	0	\N	\N	CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C	\N
2951	DULOXETINE HYDROCHLORIDE	DULOXETINE HYDROCHLORIDE	60834	C18H20ClNOS	333.874	\N	\N	2	3	6	49.5	22	0	312	1	0	\N	\N	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl	(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine;hydrochloride
2922	DRICORT	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2999	DYCLONE	DYCLONINE HYDROCHLORIDE	68304	C18H28ClNO2	325.877	\N	\N	1	3	8	29.5	22	0	292	0	0	\N	\N	CCCCOC1=CC=C(C=C1)C(=O)CCN2CCCCC2.Cl	1-(4-butoxyphenyl)-3-(1-piperidyl)propan-1-one;hydrochloride
2934	DROSPIRENONE AND ETHINYL ESTRADIOL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2975	DURANEST	ETIDOCAINE HYDROCHLORIDE	37497	C17H28N2O	276.424	\N	3.7	1	2	7	32.3	20	0	283	0	1	\N	\N	CCCN(CC)C(CC)C(=O)NC1=C(C=CC=C1C)C	N-(2,6-dimethylphenyl)-2-[ethyl(propyl)amino]butanamide
2947	DUEXIS	FAMOTIDINE	5702160	C8H15N7O2S3	337.435	\N	-0.6	4	8	7	238	20	0	469	0	0	\N	\N	C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N	3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N'-sulfamoyl-propanamidine
2968	DURAGESIC-100	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
2945	DUETACT	GLIMEPIRIDE	3476	C24H34N4O5S	490.619	\N	3.9	3	5	7	133	34	0	895	0	0	\N	\N	CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C	4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide
2917	DRALSERP	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
2938	DROXIA	HYDROXYUREA	3657	CH4N2O2	76.055	\N	-1.8	3	2	0	75.4	5	0	42.9	0	0	\N	\N	C(=O)(N)NO	hydroxyurea
2948	DUEXIS	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
2961	DUOPA	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
2955	DUOCAINE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
2973	DURAMORPH PF	MORPHINE SULFATE	5288826	C17H19NO3	285.343	\N	0.8	2	4	0	52.9	21	0	494	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
3023	E-Z-EM PREP LYTE	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
2957	DUODOTE	PRALIDOXIME CHLORIDE	5359226	C7H9ClN2O	172.612	\N	\N	1	3	1	34.3	11	0	216	0	0	\N	\N	CN1C=CC=CC1=C[NH+]=O.[Cl-]	[(E)-(1-methyl-2-pyridylidene)methyl]-oxo-ammonium;chloride
2944	DUAVEE	ESTROGENS, CONJUGATED	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2925	DRIXORAL	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
2949	DULERA	FORMOTEROL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2992	DUTREBIS	RALTEGRAVIR POTASSIUM	23668479	C20H20FKN6O5	482.514	\N	\N	2	9	6	153	33	0	843	0	0	\N	\N	CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)[O-])C(=O)NCC3=CC=C(C=C3)F.[K+]	potassium;4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[1-methyl-1-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]ethyl]-6-oxo-pyrimidin-5-olate
2920	DRAXIMAGE MDP-10	TECHNETIUM TC-99M MEDRONATE	157443	CH6O6P2Tc	274.907	\N	\N	4	6	2	115	10	0	152	0	0	\N	\N	C(P(=O)(O)O)P(=O)(O)O.[Tc]	phosphonomethylphosphonic acid;technetium-99
2953	DUO-MEDIHALER	PHENYLEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2979	DURAPHYL	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
2959	DUONEB	IPRATROPIUM BROMIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2964	DURACILLIN A.S.	PENICILLIN G PROCAINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2967	DURADYNE DHC	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2974	DURANEST	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2983	DUREZOL	DIFLUPREDNATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2984	DURICEF	CEFADROXIL/CEFADROXIL HEMIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2991	DUTREBIS	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3011	DYSPORT	abobotulinumtoxinA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3028	E-Z-HD	BARIUM SULFATE	24414	BaO4S	233.383	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Ba+2]	barium(2+);sulfate
3088	ELIPHOS	CALCIUM ACETATE	6116	C4H6CaO4	158.166	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Ca+2]	calcium;diacetate
3097	ELLIOTTS B SOLUTION	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
3114	EMBOLEX	DIHYDROERGOTAMINE MESYLATE	71171	C34H41N5O8S	679.789	\N	\N	4	9	4	181	48	0	1260	7	0	\N	\N	CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O	\N
3033	ECONAZOLE NITRATE	ECONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3047	EFAVIRENZ	EFAVIRENZ	64139	C14H9ClF3NO2	315.676	\N	4	1	5	1	38.3	21	0	519	1	0	\N	\N	C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
3080	ELETRIPTAN HYDROBROMIDE	ELETRIPTAN HYDROBROMIDE	656631	C22H27BrN2O2S	463.434	\N	\N	2	3	6	61.6	28	0	582	1	0	\N	\N	CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4.Br	5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole;hydrobromide
3036	ECOZA	ECONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3037	EDARBI	AZILSARTAN KAMEDOXOMIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3038	EDARBYCLOR	AZILSARTAN KAMEDOXOMIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3039	EDARBYCLOR	CHLORTHALIDONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3055	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	EMTRICITABINE	60877	C8H10FN3O3S	247.244	\N	-0.6	2	5	2	113	16	0	374	2	0	\N	\N	C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F	4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
3121	EMGEL	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3043	EDLUAR	ZOLPIDEM TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3041	EDECRIN	ETHACRYNIC ACID	3278	C13H12Cl2O4	303.135	\N	3.8	1	4	6	63.6	19	0	370	0	0	\N	\N	CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl	2-[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid
3083	ELIFEMME	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3099	ELLIOTTS B SOLUTION	MAGNESIUM SULFATE	24083	MgO4S	120.361	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Mg+2]	magnesium;sulfate
3049	EFAVIRENZ EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	EFAVIRENZ EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3050	EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE	EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3032	EC-NAPROSYN	NAPROXEN	156391	C14H14O3	230.263	\N	3.3	1	3	3	46.5	17	0	277	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O	(2S)-2-(6-methoxy-2-naphthyl)propanoic acid
3052	EFAVIRENZ/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3053	EFAVIRENZ/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE	TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3081	ELIDEL	PIMECROLIMUS	6509979	C43H68ClNO11	810.463	\N	3.8	2	11	6	158	56	0	1440	14	0	\N	\N	CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C	\N
3056	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3057	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	EFAVIRENZ;EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3123	EMLA	PRILOCAINE	4906	C13H20N2O	220.316	\N	2.1	2	2	5	41.1	16	0	218	0	1	\N	\N	CCCNC(C)C(=O)NC1=CC=CC=C1C	N-(o-tolyl)-2-(propylamino)propanamide
3059	EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3060	EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3061	EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3046	EDURANT	RILPIVIRINE HYDROCHLORIDE	11711114	C22H19ClN6	402.886	\N	\N	3	6	5	97.4	29	0	607	0	0	\N	\N	CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N.Cl	4-[[4-[4-[(E)-2-cyanovinyl]-2,6-dimethyl-anilino]pyrimidin-2-yl]amino]benzonitrile;hydrochloride
3025	E-Z-EM PREP LYTE	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
3026	E-Z-EM PREP LYTE	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
3027	E-Z-EM PREP LYTE	SODIUM SULFATE ANHYDROUS	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
3095	ELLA	ULIPRISTAL ACETATE	130904	C30H37NO4	475.629	\N	3.5	0	5	5	63.7	35	0	984	5	0	\N	\N	CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C	[(8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate
3070	ELAPRASE	IDURSULFASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3072	ELASE-CHLOROMYCETIN	DESOXYRIBONUCLEASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3073	ELASE-CHLOROMYCETIN	FIBRINOLYSIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3075	ELDECORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3077	ELELYSO	TALIGLUCERASE ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3090	ELITEK	RASBURICASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3098	ELLIOTTS B SOLUTION	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3103	ELLIOTTS B SOLUTION	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3104	ELMIRON	PENTOSAN POLYSULFATE SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3106	ELOXATIN	OXALIPLATIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3107	ELSPAR	ASPARAGINASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3109	EMADINE	EMEDASTINE DIFUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3115	EMBOLEX	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3221	EQUAGESIC	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
3126	EMPLICITI	ELOTUZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3183	ENTOCORT EC	BUDESONIDE	5281004	C25H34O6	430.541	\N	2.5	2	6	4	93.1	31	0	862	8	1	\N	\N	CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C	\N
3146	ENDOSOL EXTRA	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
3209	EPITOL	CARBAMAZEPINE	2554	C15H12N2O	236.274	\N	2.5	1	1	0	46.3	18	0	326	0	0	\N	\N	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	benzo[b][1]benzazepine-11-carboxamide
3138	ENABLEX	DARIFENACIN HYDROBROMIDE	444030	C28H31BrN2O2	507.472	\N	\N	2	3	7	55.6	33	0	607	1	0	\N	\N	C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br	2-[(3S)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenyl-acetamide;hydrobromide
3161	ENLON	EDROPHONIUM CHLORIDE	8307	C10H16ClNO	201.694	\N	\N	1	2	2	20.2	13	0	145	0	0	\N	\N	CC[N+](C)(C)C1=CC(=CC=C1)O.[Cl-]	ethyl-(3-hydroxyphenyl)-dimethyl-ammonium;chloride
3134	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3135	EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE;NEVIRAPINE	EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE;NEVIRAPINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3139	ENALAPRIL MALEATE	ENALAPRIL MALEATE	5388961	C24H32N2O9	492.525	\N	\N	4	10	12	171	35	0	638	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O	(2S)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid;maleic acid
3142	ENALAPRILAT	ENALAPRILAT	5462501	C18H24N2O5	348.399	\N	-0.7	3	6	8	107	25	0	490	3	0	\N	\N	CC(C(=O)N1CCCC1C(=O)O)NC(CCC2=CC=CC=C2)C(=O)O	(2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
3159	ENFLURANE	ENFLURANE	3226	C3H2ClF5O	184.49	\N	2.1	0	6	3	9.2	10	0	107	0	1	\N	\N	C(C(OC(F)F)(F)F)(F)Cl	2-chloro-1-(difluoromethoxy)-1,1,2-trifluoro-ethane
3181	ENTECAVIR	ENTECAVIR	153941	C12H15N5O3	277.284	\N	-0.8	4	4	2	126	20	0	480	3	0	\N	\N	C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N	2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylene-cyclopentyl]-3H-purin-6-one
3143	ENBREL	ETANERCEPT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3230	ERGOCALCIFEROL	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
3189	EOVIST	GADOXETATE DISODIUM	9961939	C23H28GdN3Na2O11	725.717	\N	\N	0	14	15	220	40	0	712	0	1	\N	\N	CCOC1=CC=C(C=C1)CC(CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Gd+3]	disodium;2-[[2-[bis(carboxylatomethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+)
3147	ENDOSOL EXTRA	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3225	EQUIPIN	HOMATROPINE METHYLBROMIDE	6646	C17H24BrNO3	370.287	\N	\N	1	4	4	46.5	22	0	374	0	3	\N	\N	C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-]	(8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenyl-acetate;bromide
3173	ENPRESSE-21	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3222	EQUAGESIC	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
3154	ENDURON	METHYCLOTHIAZIDE	4121	C9H11Cl2N3O4S2	360.224	\N	1.4	2	7	2	126	20	0	571	0	1	\N	\N	CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl	6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3165	ENOVID	NORETHYNODREL	6231	C20H26O2	298.426	\N	2.1	1	2	1	37.3	22	0	606	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3CCC(=O)C4	(8R,9S,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3150	ENDOSOL EXTRA	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
3184	ENTRESTO	SACUBITRIL	9811834	C24H29NO5	411.498	\N	3.7	2	5	12	92.7	30	0	550	2	0	\N	\N	CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O	4-[[(1S,3R)-4-ethoxy-3-methyl-4-oxo-1-[(4-phenylphenyl)methyl]butyl]amino]-4-oxo-butanoic acid
3152	ENDOSOL EXTRA	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
3160	ENJUVIA	ESTROGENS, CONJUGATED SYNTHETIC B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3188	ENVARSUS XR	TACROLIMUS	445643	C44H69NO12	804.031	\N	2.7	3	12	7	178	57	0	1480	14	0	\N	\N	CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC	\N
3185	ENTRESTO	VALSARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3186	ENTYVIO	VEDOLIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3196	EPICORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3201	EPIFOAM	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3210	EPIVIR	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3211	EPIVIR-HBV	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3213	EPOGEN/PROCRIT	EPOETIN ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3215	EPREX	EPOETIN ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3216	EPROSARTAN MESYLATE	EPROSARTAN MESYLATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3219	EPZICOM	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3220	EPZICOM	ABACAVIR;LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3228	ERELZI	ETANERCEPT-SZZS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3232	ERGOMAR	ERGOTAMINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3233	ERGOSTAT	ERGOTAMINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3235	ERGOTAMINE TARTRATE AND CAFFEINE	ERGOTAMINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3239	ERTACZO	SERTACONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3240	ERWINAZE	asparaginase Erwinia chrysanthemi	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9687	VOLMAX	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
3273	ESGIC	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
3332	ETHRANE	ENFLURANE	3226	C3H2ClF5O	184.49	\N	2.1	0	6	3	9.2	10	0	107	0	1	\N	\N	C(C(OC(F)F)(F)F)(F)Cl	2-chloro-1-(difluoromethoxy)-1,1,2-trifluoro-ethane
3268	ESCITALOPRAM	ESCITALOPRAM OXALATE	146571	C22H23FN2O5	414.433	\N	\N	2	8	6	111	30	0	537	1	0	\N	\N	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O	(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile;oxalic acid
3269	ESCITALOPRAM OXALATE	ESCITALOPRAM OXALATE	146571	C22H23FN2O5	414.433	\N	\N	2	8	6	111	30	0	537	1	0	\N	\N	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O	(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile;oxalic acid
3282	ESMOLOL HYDROCHLORIDE	ESMOLOL HYDROCHLORIDE	104769	C16H26ClNO4	331.837	\N	\N	3	5	10	67.8	22	0	288	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O.Cl	methyl 3-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]propanoate;hydrochloride
3284	ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER	ESMOLOL HYDROCHLORIDE	104769	C16H26ClNO4	331.837	\N	\N	3	5	10	67.8	22	0	288	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O.Cl	methyl 3-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]propanoate;hydrochloride
3286	ESOMEPRAZOLE SODIUM	ESOMEPRAZOLE SODIUM	10959536	C17H18N3NaO3S	367.399	\N	\N	0	7	5	81.5	25	0	459	0	1	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Na+]	sodium;5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-ide
3249	ERYPAR	ERYTHROMYCIN STEARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3290	ESTAZOLAM	ESTAZOLAM	3261	C16H11ClN4	294.742	\N	1.7	0	3	1	43.1	21	0	407	0	0	\N	\N	C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4	8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
3291	ESTERIFIED ESTROGENS	ESTROGENS, ESTERIFIED	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3310	ESTRATAB	ESTROGENS, ESTERIFIED	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3254	ERYTHROCIN STEARATE	ERYTHROMYCIN STEARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3315	ESTROPIPATE	ESTROPIPATE	5284555	C22H32N2O5S	436.567	\N	\N	3	7	2	113	30	0	650	4	0	\N	\N	CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1	[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine
3323	ETHACRYNIC ACID	ETHACRYNIC ACID	3278	C13H12Cl2O4	303.135	\N	3.8	1	4	6	63.6	19	0	370	0	0	\N	\N	CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl	2-[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid
3331	ETHOSUXIMIDE	ETHOSUXIMIDE	3291	C7H11NO2	141.17	\N	0.4	1	2	1	46.2	10	0	188	0	1	\N	\N	CCC1(CC(=O)NC1=O)C	3-ethyl-3-methyl-pyrrolidine-2,5-dione
3325	ETHAMIDE	ETHOXZOLAMIDE	3295	C9H10N2O3S2	258.31	\N	2	1	6	3	119	16	0	341	0	0	\N	\N	CCOC1=CC2=C(C=C1)N=C(S2)S(=O)(=O)N	6-ethoxy-1,3-benzothiazole-2-sulfonamide
3336	ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL	ETHYNODIOL DIACETATE	9270	C24H32O4	384.516	\N	3.9	0	4	5	52.6	28	0	758	7	0	\N	\N	CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C	[(3S,8R,9S,10R,13S,14S,17R)-17-acetoxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
3340	ETOMIDATE	ETOMIDATE	36339	C14H16N2O2	244.294	\N	3	0	3	5	44.1	18	0	277	0	1	\N	\N	CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2	ethyl 3-(1-phenylethyl)imidazole-4-carboxylate
3278	ESIMIL	GUANETHIDINE MONOSULFATE	86471	C10H24N4O4S	296.386	\N	\N	4	6	3	151	19	0	248	0	0	\N	\N	C1CCCN(CCC1)CCN=C(N)N.OS(=O)(=O)O	2-[2-(azocan-1-yl)ethyl]guanidine;sulfuric acid
3280	ESKALITH	LITHIUM CARBONATE	11125	CLi2O3	73.888	\N	\N	0	3	0	63.2	6	0	18.8	0	0	\N	\N	[Li+].[Li+].C(=O)([O-])[O-]	dilithium;carbonate
3264	ERYTHROMYCIN STEARATE	ERYTHROMYCIN STEARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3330	ETHMOZINE	MORICIZINE HYDROCHLORIDE	34632	C22H26ClN3O4S	463.977	\N	\N	2	6	6	96.4	31	0	601	0	0	\N	\N	CCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4.Cl	ethyl N-[10-(3-morpholinopropanoyl)phenothiazin-2-yl]carbamate;hydrochloride
3344	ETRAFON 2-10	PERPHENAZINE	4748	C21H26ClN3OS	403.969	\N	4.2	1	5	6	55.2	27	0	463	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
3267	ESBRIET	PIRFENIDONE	40632	C12H11NO	185.226	\N	1.9	0	1	1	20.3	14	0	285	0	0	\N	\N	CC1=CN(C(=O)C=C1)C2=CC=CC=C2	5-methyl-1-phenyl-pyridin-2-one
3301	ESTRADIOL VALERATE	ESTRADIOL VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3303	ESTRADIOL VALERATE AND DIENOGEST	ESTRADIOL VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3304	ESTRADIOL VALERATE; ESTRADIOL VALERATE; DIENOGEST	ESTRADIOL VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3305	ESTRADIOL VALERATE; ESTRADIOL VALERATE; DIENOGEST	ESTRADIOL VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3307	ESTRADURIN	POLYESTRADIOL PHOSPHATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3309	ESTRASORB	ESTRADIOL HEMIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3326	ETHAMOLIN	ETHANOLAMINE OLEATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3333	ETHRIL 250	ERYTHROMYCIN STEARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3334	ETHRIL 500	ERYTHROMYCIN STEARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3387	EXNA	BENZTHIAZIDE	2343	C15H14ClN3O4S3	431.924	\N	1.7	2	7	5	161	26	0	739	0	0	\N	\N	C1=CC=C(C=C1)CSCC2=NS(=O)(=O)C3=CC(=C(C=C3N2)Cl)S(=O)(=O)N	3-(benzylsulfanylmethyl)-6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3375	EXCEDRIN (MIGRAINE)	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
3389	EXOSURF NEONATAL	CETYL ALCOHOL	2682	C16H34O	242.447	\N	7.3	1	1	14	20.2	17	0	123	0	0	\N	\N	CCCCCCCCCCCCCCCCO	hexadecan-1-ol
3431	FAZACLO ODT	CLOZAPINE	2818	C18H19ClN4	326.828	\N	3.2	1	4	1	30.9	23	0	584	0	0	\N	\N	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine
3352	EURAX	CROTAMITON	688020	C13H17NO	203.285	\N	2.8	0	1	3	20.3	15	0	235	0	0	\N	\N	CCN(C1=CC=CC=C1C)C(=O)C=CC	(E)-N-ethyl-N-(o-tolyl)but-2-enamide
3448	FEMRING	ESTRADIOL ACETATE	9818306	C20H26O3	314.425	\N	2.8	1	3	2	46.5	23	0	476	5	0	\N	\N	CC(=O)OC1=CC2=C(C=C1)C3CCC4(C(C3CC2)CCC4O)C	[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate
3410	FALMINA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3379	EXEMESTANE	EXEMESTANE	60198	C20H24O2	296.41	\N	3.1	0	2	0	34.1	22	0	653	5	0	\N	\N	CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C	(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione
3412	FAMCICLOVIR	FAMCICLOVIR	3324	C14H19N5O4	321.337	\N	0	1	8	9	122	23	0	404	0	0	\N	\N	CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C	[2-(acetoxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate
3413	FAMOTIDINE	FAMOTIDINE	5702160	C8H15N7O2S3	337.435	\N	-0.6	4	8	7	238	20	0	469	0	0	\N	\N	C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N	3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N'-sulfamoyl-propanamidine
3432	FEBUXOSTAT	FEBUXOSTAT	134018	C16H16N2O3S	316.375	\N	3.9	1	6	5	111	22	0	448	0	0	\N	\N	CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O	2-(3-cyano-4-isobutoxy-phenyl)-4-methyl-thiazole-5-carboxylic acid
3433	FELBAMATE	FELBAMATE	3331	C11H14N2O4	238.243	\N	0.6	2	4	7	105	17	0	246	0	0	\N	\N	C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N	(3-carbamoyloxy-2-phenyl-propyl) carbamate
3457	FENOPROFEN CALCIUM	FENOPROFEN CALCIUM	64747	C30H30CaO8	558.64	\N	\N	2	8	6	101	39	0	265	0	2	\N	\N	CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].O.O.[Ca+2]	calcium;2-(3-phenoxyphenyl)propanoate;dihydrate
3383	EXFORGE HCT	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3421	FANAPT	ILOPERIDONE	71360	C24H27FN2O4	426.488	\N	4.1	0	7	8	64.8	31	0	586	0	0	\N	\N	CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC	1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]propoxy]-3-methoxy-phenyl]ethanone
3363	EVEKEO	AMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3367	EVOMELA	MELPHALAN HYDROCHLORIDE	9927978	C13H19Cl3N2O2	341.657	\N	\N	3	4	8	66.6	20	0	265	1	0	\N	\N	C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl.Cl	(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid;hydrochloride
3442	FEMCON FE	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3346	ETRAFON 2-25	PERPHENAZINE	4748	C21H26ClN3OS	403.969	\N	4.2	1	5	6	55.2	27	0	463	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
3428	FASTIN	PHENTERMINE HYDROCHLORIDE	70969	C10H16ClN	185.695	\N	\N	2	1	2	26	12	0	112	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)N.Cl	2-methyl-1-phenyl-propan-2-amine;hydrochloride
3377	EXELON	RIVASTIGMINE	77991	C14H22N2O2	250.342	\N	2.3	0	3	5	32.8	18	0	269	1	0	\N	\N	CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C	[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methyl-carbamate
3393	EXSEL	SELENIUM SULFIDE	24011	SSe	111.031	\N	\N	0	1	0	32.1	2	0	2	0	0	\N	\N	S=[Se]	\N
3423	FANSIDAR	SULFADOXINE	17134	C12H14N4O4S	310.328	\N	0.7	2	8	5	125	21	0	420	0	0	\N	\N	COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide
3376	EXELDERM	SULCONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3378	EXELON	RIVASTIGMINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3381	EXFORGE	VALSARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3384	EXFORGE HCT	VALSARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3388	EXONDYS 51	ETEPLIRSEN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3391	EXOSURF NEONATAL	TYLOXAPOL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3394	EXTAVIA	INTERFERON BETA-1B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3398	EXTRANEAL	ICODEXTRIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3399	EXUBERA	INSULIN RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3400	EYLEA	AFLIBERCEPT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3404	EZETIMIBE; SIMVASTATIN	EZETIMIBE;SIMVASTATIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3406	FABRAZYME	AGALSIDASE BETA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3419	FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE	MAGNESIUM HYDROXIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3424	FARESTON	TOREMIFENE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3449	FEMSTAT	BUTOCONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3450	FEMSTAT 3	BUTOCONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3452	FENOFIBRATE	FENOFIBRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3453	FENOFIBRATE (MICRONIZED)	FENOFIBRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3454	FENOFIBRIC ACID	CHOLINE FENOFIBRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3455	FENOGLIDE	FENOFIBRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3459	FENTANYL	FENTANYL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3460	FENTANYL CITRATE	FENTANYL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9698	VOSPIRE ER	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
3462	FENTANYL CITRATE AND DROPERIDOL	FENTANYL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3463	FENTANYL CITRATE PRESERVATIVE FREE	FENTANYL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3500	FIORICET	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
3524	FLEXERIL	CYCLOBENZAPRINE HYDROCHLORIDE	22576	C20H22ClN	311.853	\N	\N	1	1	3	3.2	22	0	365	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31.Cl	3-(dibenzo[1,2-a:1',2'-e][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
3523	FLECTOR	DICLOFENAC EPOLAMINE	114753	C20H24Cl2N2O3	411.323	\N	\N	3	5	6	72.8	27	0	363	0	0	\N	\N	C1CCN(C1)CCO.C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl	2-[2-(2,6-dichloroanilino)phenyl]acetic acid;2-pyrrolidin-1-ylethanol
3495	FIBRICOR	FENOFIBRIC ACID	64929	C17H15ClO4	318.753	\N	3.9	1	4	5	63.6	22	0	405	0	0	\N	\N	CC(C)(C(=O)O)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid
3474	FERIDEX I.V.	FERUMOXIDES	6432052	Fe3O4	231.531	\N	\N	0	4	0	4	7	0	0	0	0	\N	\N	[O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3]	diferric;ferrous;oxygen(2-)
3486	FEXOFENADINE HCL; PSEUDOEPHEDRINE HCL	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
3497	FINASTERIDE	FINASTERIDE	57363	C23H36N2O2	372.553	\N	3	2	2	2	58.2	27	0	678	7	0	\N	\N	CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C	(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
3520	FLAVOXATE HYDROCHLORIDE	FLAVOXATE HYDROCHLORIDE	441345	C24H26ClNO4	427.925	\N	\N	1	5	6	55.8	30	0	631	0	0	\N	\N	CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4.Cl	2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenyl-chromene-8-carboxylate;hydrochloride
3472	FENTORA	FENTANYL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3473	FERAHEME	FERUMOXYTOL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3475	FERNDEX	DEXTROAMPHETAMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3522	FLECAINIDE ACETATE	FLECAINIDE ACETATE	41022	C19H24F6N2O5	474.4	\N	\N	3	12	7	96.9	32	0	531	0	1	\N	\N	CC(=O)O.C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F	acetic acid;N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide
3552	FLUCYTOSINE	FLUCYTOSINE	3366	C4H4FN3O	129.094	\N	-0.9	2	3	0	67.5	9	0	208	0	0	\N	\N	C1=NC(=O)NC(=C1F)N	6-amino-5-fluoro-1H-pyrimidin-2-one
3553	FLUDARA	FLUDARABINE PHOSPHATE	30751	C10H13FN5O7P	365.214	\N	-3.1	5	12	4	186	24	0	514	4	0	\N	\N	C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(N=C2N)F	[(2R,3S,4S,5R)-5-(6-amino-2-fluoro-purin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate
3479	FERRISELTZ	FERRIC AMMONIUM CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3481	FERROUS CITRATE FE 59	FERROUS CITRATE, FE-59	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3482	FERROUS FUMARATE	FERROUS FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3555	FLUDEOXYGLUCOSE F18	FLUDEOXYGLUCOSE F-18	450503	C6H11FO5	181.15	\N	-1.6	4	6	1	90.2	12	0	155	5	0	\N	\N	C(C1C(C(C(C(O1)O)F)O)O)O	(2S,3R,4S,5S,6R)-3-fluoranyl-6-(hydroxymethyl)tetrahydropyran-2,4,5-triol
3484	FESOTERODINE FUMARATE	FESOTERODINE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3560	FLUNISOLIDE	FLUNISOLIDE	82153	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	910	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C	\N
3563	FLUOCINONIDE	FLUOCINONIDE	9642	C26H32F2O7	494.532	\N	3.2	1	9	4	99.1	35	0	1070	9	0	\N	\N	CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C	\N
3521	FLAXEDIL	GALLAMINE TRIETHIODIDE	6172	C30H60I3N3O3	891.541	\N	\N	0	6	21	27.7	39	0	489	0	0	\N	\N	CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-]	2-[2,3-bis[2-(triethylammonio)ethoxy]phenoxy]ethyl-triethyl-ammonium;triiodide
3541	FLOWTUSS	GUAIFENESIN	3516	C10H14O4	198.218	\N	1.4	2	4	5	58.9	14	0	151	0	1	\N	\N	COC1=CC=CC=C1OCC(CO)O	3-(2-methoxyphenoxy)propane-1,2-diol
3535	FLOROPRYL	ISOFLUROPHATE	5936	C6H14FO3P	184.147	\N	1.2	0	4	4	35.5	11	0	144	0	0	\N	\N	CC(C)OP(=O)(OC(C)C)F	2-[fluoro(isopropoxy)phosphoryl]oxypropane
3485	FETZIMA	LEVOMILNACIPRAN HYDROCHLORIDE	6917778	C15H23ClN2O	282.812	\N	\N	2	2	5	46.3	19	0	295	2	0	\N	\N	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2.Cl	(1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenyl-cyclopropanecarboxamide;hydrochloride
3514	FLAGYL	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
3543	FLOXIN	OFLOXACIN	4583	C18H20FN3O4	361.373	\N	-0.4	1	8	2	73.3	26	0	634	0	1	\N	\N	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	\N
3526	FLO-PRED	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
3558	FLUMADINE	RIMANTADINE HYDROCHLORIDE	15165	C12H22ClN	215.765	\N	\N	2	1	1	26	14	0	180	0	1	\N	\N	CC(C12CC3CC(C1)CC(C3)C2)N.Cl	1-(1-adamantyl)ethanamine;hydrochloride
3480	FERRLECIT	SODIUM FERRIC GLUCONATE COMPLEX	23693558	C6H11FeNaO7+3	273.982	\N	\N	5	7	5	141	15	3	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+].[Fe+3]	ferric;sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
3525	FLEXICORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3532	FLORINEF	FLUDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3542	FLOWTUSS	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3556	FLUDROCORTISONE ACETATE	FLUDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3589	FLUXID	FAMOTIDINE	5702160	C8H15N7O2S3	337.435	\N	-0.6	4	8	7	238	20	0	469	0	0	\N	\N	C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N	3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N'-sulfamoyl-propanamidine
3609	FOLVRON	FERROUS SULFATE	24393	FeO4S	151.901	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Fe+2]	ferrous;sulfate
3564	FLUOCINONIDE EMULSIFIED BASE	FLUOCINONIDE	9642	C26H32F2O7	494.532	\N	3.2	1	9	4	99.1	35	0	1070	9	0	\N	\N	CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C	\N
3569	FLUOROPLEX	FLUOROURACIL	3385	C4H3FN2O2	130.078	\N	-0.9	2	3	0	58.2	9	0	199	0	0	\N	\N	C1=C(C(=O)NC(=O)N1)F	5-fluoro-1H-pyrimidine-2,4-dione
3570	FLUOROURACIL	FLUOROURACIL	3385	C4H3FN2O2	130.078	\N	-0.9	2	3	0	58.2	9	0	199	0	0	\N	\N	C1=C(C(=O)NC(=O)N1)F	5-fluoro-1H-pyrimidine-2,4-dione
3573	FLUOXETINE	FLUOXETINE HYDROCHLORIDE	62857	C17H19ClF3NO	345.79	\N	\N	2	5	6	21.3	23	0	308	0	1	\N	\N	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl	N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride
3578	FLUPHENAZINE HCL	FLUPHENAZINE HYDROCHLORIDE	67356	C22H28Cl2F3N3OS	510.441	\N	\N	3	8	6	55.2	32	0	544	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO.Cl.Cl	2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride
3580	FLURANDRENOLIDE	FLURANDRENOLIDE	15209	C24H33FO6	436.52	\N	1.4	2	7	2	93.1	31	0	868	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)CCC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C	\N
3582	FLURBIPROFEN	FLURBIPROFEN	3394	C15H13FO2	244.265	\N	4.2	1	3	3	37.3	18	0	286	0	1	\N	\N	CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O	2-(3-fluoro-4-phenyl-phenyl)propanoic acid
3587	FLUVASTATIN SODIUM	FLUVASTATIN SODIUM	23663976	C24H25FNNaO4	433.455	\N	\N	2	5	8	85.5	31	0	596	2	0	\N	\N	CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+]	sodium;(E,3R,5S)-7-[3-(4-fluorophenyl)-1-isopropyl-indol-2-yl]-3,5-dihydroxy-hept-6-enoate
3611	FOMEPIZOLE	FOMEPIZOLE	3406	C4H6N2	82.106	\N	1.4	1	1	0	28.7	6	0	44.8	0	0	\N	\N	CC1=CNN=C1	4-methyl-1H-pyrazole
3631	FOSCARNET SODIUM	FOSCARNET SODIUM	44561	CNa3O5P	191.949	\N	\N	0	5	0	103	10	0	103	0	0	\N	\N	C(=O)([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+]	trisodium;phosphonatoformate
3632	FOSCAVIR	FOSCARNET SODIUM	44561	CNa3O5P	191.949	\N	\N	0	5	0	103	10	0	103	0	0	\N	\N	C(=O)([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+]	trisodium;phosphonatoformate
3636	FOSPHENYTOIN SODIUM	FOSPHENYTOIN SODIUM	56338	C16H13N2Na2O6P	406.241	\N	\N	1	6	4	122	27	0	536	0	0	\N	\N	C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)([O-])[O-])C3=CC=CC=C3.[Na+].[Na+]	disodium;(2,5-dioxo-4,4-diphenyl-imidazolidin-1-yl)methyl phosphate
3571	FLUOTHANE	HALOTHANE	3562	C2HBrClF3	197.379	\N	2.3	0	3	0	0	7	0	60.4	0	1	\N	\N	C(C(F)(F)F)(Cl)Br	2-bromo-2-chloro-1,1,1-trifluoro-ethane
3635	FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3615	FORANE	ISOFLURANE	3763	C3H2ClF5O	184.49	\N	2.1	0	6	2	9.2	10	0	102	0	1	\N	\N	C(C(F)(F)F)(OC(F)F)Cl	2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane
3619	FORTAMET	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
3594	FOAMCOAT	ALUMINUM HYDROXIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3595	FOAMCOAT	MAGNESIUM TRISILICATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3596	FOAMICON	ALUMINUM HYDROXIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3597	FOAMICON	MAGNESIUM TRISILICATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3668	FURADANTIN	NITROFURANTOIN	6604200	C8H6N4O5	238.159	\N	-0.5	1	6	2	121	17	0	390	0	0	\N	\N	C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]	1-[(E)-(5-nitro-2-furyl)methyleneamino]imidazolidine-2,4-dione
3667	FURACIN	NITROFURAZONE	5447130	C6H6N4O4	198.138	\N	0.2	2	5	2	126	14	0	261	0	0	\N	\N	C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N	[(E)-(5-nitro-2-furyl)methyleneamino]urea
3654	FREAMINE III 8.5% W/ ELECTROLYTES	POTASSIUM ACETATE	517044	C2H3KO2	98.142	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[K+]	potassium;acetate
3647	FREAMINE III 3% W/ ELECTROLYTES	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
3648	FREAMINE III 3% W/ ELECTROLYTES	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
3649	FREAMINE III 3% W/ ELECTROLYTES	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
3604	FOLLISTIM	FOLLITROPIN ALFA/BETA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3605	FOLLISTIM AQ	FOLLITROPIN ALFA/BETA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3606	FOLLUTEIN	GONADOTROPIN, CHORIONIC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3568	FLUORINE F-18	SODIUM FLUORIDE F-18	23690531	FNa	40.991	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[F-].[Na+]	sodium;fluorine-18(1-)
3585	FLUTEX	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
3613	FORADIL	FORMOTEROL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3614	FORADIL CERTIHALER	FORMOTEROL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3618	FORMOTEROL FUMARATE	FORMOTEROL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3622	FORTEO	TERIPARATIDE RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3640	FREAMINE 8.5%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3641	FREAMINE HBC 6.9%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3642	FREAMINE II 8.5%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3643	FREAMINE III 10%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3644	FREAMINE III 3% W/ ELECTROLYTES	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3650	FREAMINE III 8.5%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3651	FREAMINE III 8.5% W/ ELECTROLYTES	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3657	FROVA	FROVATRIPTAN SUCCINATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3658	FROVATRIPTAN SUCCINATE	FROVATRIPTAN SUCCINATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3664	FULYZAQ	CROFELEMER	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3673	FUZEON	ENFUVIRTIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
286	ALBUTEROL	ALBUTEROL	2083	C13H21NO3	239.315	\N	0.3	4	4	5	72.7	17	0	227	0	1	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol
3774	GLUCAMIDE	CHLORPROPAMIDE	2727	C10H13ClN2O3S	276.735	\N	2.3	2	3	4	83.6	17	0	345	0	0	\N	\N	CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl	1-(4-chlorophenyl)sulfonyl-3-propyl-urea
3736	GENVOYA	ELVITEGRAVIR	5277135	C23H23ClFNO5	447.887	\N	5.3	2	7	7	87.1	31	0	702	1	0	\N	\N	CC(C)C(CO)N1C=C(C(=O)C2=CC(=C(C=C21)OC)CC3=C(C(=CC=C3)Cl)F)C(=O)O	6-[(3-chloro-2-fluoro-phenyl)methyl]-1-[(1S)-1-(hydroxymethyl)-2-methyl-propyl]-7-methoxy-4-oxo-quinoline-3-carboxylic acid
3760	GILENYA	FINGOLIMOD	107970	C19H33NO2	307.478	\N	4.2	3	3	12	66.5	22	0	258	0	0	\N	\N	CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N	2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
3671	FUROXONE	FURAZOLIDONE	5323714	C8H7N3O5	225.16	\N	-0.1	0	6	2	101	16	0	326	0	0	\N	\N	C1COC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]	3-[(E)-(5-nitro-2-furyl)methyleneamino]oxazolidin-2-one
3682	GALLIUM CITRATE GA 67	GALLIUM CITRATE GA-67	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3670	FUROSEMIDE	FUROSEMIDE	3440	C12H11ClN2O5S	330.739	\N	2	3	7	5	131	21	0	481	0	0	\N	\N	C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl	4-chloro-2-(2-furylmethylamino)-5-sulfamoyl-benzoic acid
3677	GABAPENTIN	GABAPENTIN	3446	C9H17NO2	171.24	\N	-1.1	2	3	3	63.3	12	0	162	0	0	\N	\N	C1CCC(CC1)(CC(=O)O)CN	2-[1-(aminomethyl)cyclohexyl]acetic acid
3681	GALANTAMINE HYDROBROMIDE	GALANTAMINE HYDROBROMIDE	121587	C17H22BrNO3	368.271	\N	\N	2	4	1	41.9	22	0	440	3	0	\N	\N	CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O.Br	\N
3686	GANCICLOVIR	GANCICLOVIR	3454	C9H13N5O4	255.234	\N	-1.7	4	5	5	135	18	0	346	0	0	\N	\N	C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N	2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-3H-purin-6-one
3711	GEMCITABINE	GEMCITABINE	60750	C9H11F2N3O4	263.201	\N	-1.5	3	6	2	108	18	0	426	3	0	\N	\N	C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F	4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one
3690	GANITE	GALLIUM NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3718	GENAPAX	GENTIAN VIOLET	11057	C25H30ClN3	407.986	\N	\N	0	3	4	9.5	29	0	542	0	0	\N	\N	CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-]	[4-[bis[4-(dimethylamino)phenyl]methylene]cyclohexa-2,5-dien-1-ylidene]-dimethyl-ammonium;chloride
3767	GLIPIZIDE	GLIPIZIDE	3478	C21H27N5O4S	445.538	\N	1.9	3	6	7	139	31	0	697	0	0	\N	\N	CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide
3685	GAMOPHEN	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
3672	FUSILEV	LEVOLEUCOVORIN CALCIUM	149436	C20H23N7O7	473.446	\N	-1.2	7	9	9	216	34	0	911	2	0	\N	\N	C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid
3697	GARAMYCIN	GENTAMICIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3715	GEMONIL	METHARBITAL	4099	C9H14N2O3	198.222	\N	1.2	1	3	2	66.5	14	0	294	0	0	\N	\N	CCC1(C(=O)NC(=O)N(C1=O)C)CC	5,5-diethyl-1-methyl-hexahydropyrimidine-2,4,6-trione
3720	GENCEPT 10/11-21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3701	GASTROMARK	FERUMOXSIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3709	GELNIQUE	OXYBUTYNIN CHLORIDE	91505	C22H32ClNO3	393.952	\N	\N	2	4	8	49.8	27	0	490	0	1	\N	\N	CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl	4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenyl-acetate;hydrochloride
3691	GANTANOL	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
3695	GANTRISIN	SULFISOXAZOLE DIOLAMINE	5344	C11H13N3O3S	267.303	\N	1	2	6	3	107	18	0	374	0	0	\N	\N	CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide
3678	GABITRIL	TIAGABINE HYDROCHLORIDE	91274	C20H26ClNO2S2	412.003	\N	\N	2	5	6	97	26	0	474	1	0	\N	\N	CC1=C(SC=C1)C(=CCCN2CCCC(C2)C(=O)O)C3=C(C=CS3)C.Cl	(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-enyl]piperidine-3-carboxylic acid;hydrochloride
3706	GAVISCON	ALUMINUM HYDROXIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3707	GAVISCON	MAGNESIUM TRISILICATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3708	GAZYVA	OBINUTUZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3726	GENOPTIC	GENTAMICIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3727	GENOTROPIN	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3728	GENOTROPIN PRESERVATIVE FREE	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3729	GENTACIDIN	GENTAMICIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3730	GENTAFAIR	GENTAMICIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3731	GENTAK	GENTAMICIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3732	GENTAMICIN	GENTAMICIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3733	GENTAMICIN SULFATE	GENTAMICIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3734	GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	GENTAMICIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3738	GENVOYA	TENOFOVIR ALAFENAMIDE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3770	GLOFIL-125	IOTHALAMATE SODIUM I-125	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3771	GLUCAGEN	GLUCAGON HYDROCHLORIDE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3772	GLUCAGON	GLUCAGON HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3773	GLUCAGON	GLUCAGON RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3777	GLUCOSCAN	TECHNETIUM TC-99M GLUCEPTATE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
296	ALCOHOL 5% AND DEXTROSE 5%	ALCOHOL	702	C2H6O	46.069	\N	-0.1	1	1	0	20.2	3	0	2.8	0	0	\N	\N	CCO	ethanol
3847	GYNOREST	DYDROGESTERONE	9051	C21H28O2	312.453	\N	3.8	0	2	1	34.1	23	0	628	6	0	\N	\N	CC(=O)C1CCC2C1(CCC3C2C=CC4=CC(=O)CCC34C)C	(8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
3846	GYNODIOL	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3783	GLUTETHIMIDE	GLUTETHIMIDE	3487	C13H15NO2	217.268	\N	1.9	1	2	2	46.2	16	0	294	0	1	\N	\N	CCC1(CCC(=O)NC1=O)C2=CC=CC=C2	3-ethyl-3-phenyl-piperidine-2,6-dione
3788	GLYCINE 1.5% IN PLASTIC CONTAINER	GLYCINE	750	C2H5NO2	75.067	\N	-3.2	2	3	1	63.3	5	0	42.9	0	0	\N	\N	C(C(=O)O)N	2-aminoacetic acid
3795	GLYCOPYRROLATE	GLYCOPYRROLATE	11693	C19H28BrNO3	398.341	\N	\N	1	4	5	46.5	24	0	424	0	2	\N	\N	C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-]	(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenyl-acetate;bromide
3821	GRIFULVIN V	GRISEOFULVIN, MICROCRYSTALLINE	441140	C17H17ClO6	352.767	\N	2.2	0	6	3	71.1	24	0	575	2	0	\N	\N	CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
3825	GRISACTIN ULTRA	GRISEOFULVIN, ULTRAMICROCRYSTALLINE	441140	C17H17ClO6	352.767	\N	2.2	0	6	3	71.1	24	0	575	2	0	\N	\N	CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
3796	GLYCORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3829	GUAIFENESIN	GUAIFENESIN	3516	C10H14O4	198.218	\N	1.4	2	4	5	58.9	14	0	151	0	1	\N	\N	COC1=CC=CC=C1OCC(CO)O	3-(2-methoxyphenoxy)propane-1,2-diol
3834	GUANABENZ ACETATE	GUANABENZ ACETATE	5702062	C10H12Cl2N4O2	291.132	\N	\N	3	4	2	114	18	0	259	0	0	\N	\N	CC(=O)O.C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl	acetic acid;2-[(E)-(2,6-dichlorophenyl)methyleneamino]guanidine
3835	GUANETHIDINE MONOSULFATE	GUANETHIDINE MONOSULFATE	86471	C10H24N4O4S	296.386	\N	\N	4	6	3	151	19	0	248	0	0	\N	\N	C1CCCN(CCC1)CCN=C(N)N.OS(=O)(=O)O	2-[2-(azocan-1-yl)ethyl]guanidine;sulfuric acid
3837	GUANIDINE HYDROCHLORIDE	GUANIDINE HYDROCHLORIDE	5742	CH6ClN3	95.53	\N	\N	4	1	0	75.9	5	0	26.3	0	0	\N	\N	C(=N)(N)N.Cl	guanidine;hydrochloride
3861	HALFAN	HALOFANTRINE HYDROCHLORIDE	37392	C26H31Cl3F3NO	536.885	\N	\N	2	5	10	23.5	34	0	584	0	1	\N	\N	CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O.Cl	3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthryl]propan-1-ol;hydrochloride
3856	HALDOL	HALOPERIDOL	3559	C21H23ClFNO2	375.868	\N	3.2	1	4	6	40.5	26	0	451	0	0	\N	\N	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one
3877	HALOTHANE	HALOTHANE	3562	C2HBrClF3	197.379	\N	2.3	0	3	0	0	7	0	60.4	0	1	\N	\N	C(C(F)(F)F)(Cl)Br	2-bromo-2-chloro-1,1,1-trifluoro-ethane
3797	GLYDO	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
3799	GLYSET	MIGLITOL	441314	C8H17NO5	207.226	\N	-2.6	5	6	3	104	14	0	179	4	0	\N	\N	C1C(C(C(C(N1CCO)CO)O)O)O	(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol
3853	HABITROL	NICOTINE	89594	C10H14N2	162.236	\N	1.2	0	2	1	16.1	12	0	147	1	0	\N	\N	CN1CCCC1C2=CN=CC=C2	3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
3789	GLYCOLAX	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
3812	GONAL-F	FOLLITROPIN ALFA/BETA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3813	GONAL-F RFF	FOLLITROPIN ALFA/BETA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3814	GONAL-F RFF REDI-JECT	FOLLITROPIN ALFA/BETA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3791	GLYCOPREP	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
3803	GO-EVAC	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
3833	GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
3792	GLYCOPREP	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
3793	GLYCOPREP	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
3820	GRANIX	TBO-FILGRASTIM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3805	GO-EVAC	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
3794	GLYCOPREP	SODIUM SULFATE ANHYDROUS	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
3880	HARVONI	SOFOSBUVIR	45375808	C22H29FN3O9P	529.458	\N	1	3	11	11	153	36	0	913	6	0	\N	\N	CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3	isopropyl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydrofuran-2-yl]methoxy-phenoxy-phosphoryl]amino]propanoate
3839	GYNAZOLE-1	BUTOCONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3848	H-CORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3849	H.P. ACTHAR GEL	CORTICOTROPIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3850	H.P. ACTHAR GEL	REPOSITORY CORTICOTROPIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3881	HC #1	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3882	HC #4	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3883	HC (HYDROCORTISONE)	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3884	HEAD & SHOULDERS CONDITIONER	PYRITHIONE ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
354	ALLOPURINOL	ALLOPURINOL	2094	C5H4N4O	136.114	\N	-0.5	2	2	0	65.8	10	0	275	0	0	\N	\N	C1=C2C(=NC=NC2=O)NN1	1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one
3893	HELIUM, USP	HELIUM	23987	He	4.003	\N	\N	0	0	0	0	1	0	0	0	0	\N	\N	[He]	helium
3963	HOMAPIN-10	HOMATROPINE METHYLBROMIDE	6646	C17H24BrNO3	370.287	\N	\N	1	4	4	46.5	22	0	374	0	3	\N	\N	C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-]	(8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenyl-acetate;bromide
3936	HERPLEX	IDOXURIDINE	5905	C9H11IN2O5	354.1	\N	-1	3	5	2	99.1	17	0	386	3	0	\N	\N	C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-iodo-pyrimidine-2,4-dione
3896	HEMSOL-HC	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3897	HEPARIN LOCK FLUSH	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3898	HEPARIN SODIUM	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3899	HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3900	HEPARIN SODIUM 1,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3901	HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3902	HEPARIN SODIUM 10,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3903	HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5%	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3904	HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3905	HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45%	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3906	HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3907	HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5%	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3908	HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3909	HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3910	HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.9%	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3911	HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3912	HEPARIN SODIUM 2,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3913	HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3914	HEPARIN SODIUM 20,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3915	HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3916	HEPARIN SODIUM 25,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3917	HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5%	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3918	HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3919	HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3920	HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9%	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3921	HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3922	HEPARIN SODIUM 5,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3923	HEPARIN SODIUM 5,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3924	HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45%	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3925	HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9%	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3926	HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3927	HEPARIN SODIUM IN PLASTIC CONTAINER	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3928	HEPARIN SODIUM PRESERVATIVE FREE	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3929	HEPATAMINE 8%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3930	HEPATASOL 8%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3931	HEPATOLITE	TECHNETIUM TC-99M DISOFENIN KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3934	HER STYLE	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3888	HEDULIN	PHENINDIONE	4760	C15H10O2	222.243	\N	2.9	0	2	1	34.1	17	0	304	0	0	\N	\N	C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O	2-phenylindane-1,3-dione
3935	HERCEPTIN	TRASTUZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3961	HIWOLFIA	RAUWOLFIA SERPENTINA ROOT	441975	C21H24N2O3	352.434	\N	2.7	1	4	2	54.6	26	0	606	4	0	\N	\N	CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45	\N
3938	HETRAZAN	DIETHYLCARBAMAZINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3950	HICON	SODIUM IODIDE I-131	71368	INa	153.896	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[I-]	sodium;iodine-131(1-)
3889	HELICOSOL	UREA C-13	636363	CH4N2O	61.048	\N	-1.4	2	1	0	69.1	4	0	29	0	0	\N	\N	C(=O)(N)N	diaminomethanone
3947	HI-COR	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3951	HIPPURAN I 131	IODOHIPPURATE SODIUM I-131	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3952	HIPPUTOPE	IODOHIPPURATE SODIUM I-131	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3953	HIPREX	METHENAMINE HIPPURATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3959	HISTAMINE PHOSPHATE	HISTAMINE PHOSPHATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3966	HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3968	HUMALOG	INSULIN LISPRO RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3969	HUMALOG KWIKPEN	INSULIN LISPRO RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3970	HUMALOG MIX 50/50	INSULIN LISPRO PROTAMINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3971	HUMALOG MIX 50/50	INSULIN LISPRO RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3972	HUMALOG MIX 50/50 KWIKPEN	INSULIN LISPRO PROTAMINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3973	HUMALOG MIX 50/50 KWIKPEN	INSULIN LISPRO RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3974	HUMALOG MIX 50/50 PEN	INSULIN LISPRO PROTAMINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3975	HUMALOG MIX 50/50 PEN	INSULIN LISPRO RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3976	HUMALOG MIX 75/25	INSULIN LISPRO PROTAMINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3977	HUMALOG MIX 75/25	INSULIN LISPRO RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3978	HUMALOG MIX 75/25 KWIKPEN	INSULIN LISPRO PROTAMINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3979	HUMALOG MIX 75/25 KWIKPEN	INSULIN LISPRO RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3980	HUMALOG MIX 75/25 PEN	INSULIN LISPRO PROTAMINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3981	HUMALOG MIX 75/25 PEN	INSULIN LISPRO RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3982	HUMALOG PEN	INSULIN LISPRO RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3984	HUMATROPE	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3985	HUMEGON	MENOTROPINS (FSH;LH)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3986	HUMIRA	ADALIMUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
379	ALPRAZOLAM	ALPRAZOLAM	2118	C17H13ClN4	308.769	\N	2.1	0	3	1	43.1	22	0	434	0	0	\N	\N	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4	8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
3988	HUMULIN 50/50	INSULIN RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3989	HUMULIN 50/50	INSULIN SUSP ISOPHANE RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3990	HUMULIN 70/30	INSULIN RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3991	HUMULIN 70/30	INSULIN SUSP ISOPHANE RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3992	HUMULIN 70/30 PEN	INSULIN RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3993	HUMULIN 70/30 PEN	INSULIN SUSP ISOPHANE RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3994	HUMULIN BR	INSULIN RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3995	HUMULIN L	INSULIN ZINC SUSP RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3996	HUMULIN N	INSULIN SUSP ISOPHANE RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3997	HUMULIN R	INSULIN HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3998	HUMULIN R	INSULIN RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3999	HUMULIN R KWIKPEN	INSULIN HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4000	HUMULIN R PEN	INSULIN RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4001	HUMULIN U	INSULIN ZINC SUSP EXTENDED RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4002	HY-PAM ""25""	HYDROXYZINE PAMOATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4004	HY-PHEN	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
432	AMINOPHYLLIN	AMINOPHYLLINE	9433	C16H24N10O4	420.434	\N	\N	4	8	1	191	30	0	273	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N	1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine
4007	HYCODAN	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4009	HYCOFENIX	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4011	HYDASE	HYALURONIDASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7273	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4008	HYCOFENIX	GUAIFENESIN	3516	C10H14O4	198.218	\N	1.4	2	4	5	58.9	14	0	151	0	1	\N	\N	COC1=CC=CC=C1OCC(CO)O	3-(2-methoxyphenoxy)propane-1,2-diol
4016	HYDRA-ZIDE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4017	HYDRA-ZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4042	HYDREA	HYDROXYUREA	3657	CH4N2O2	76.055	\N	-1.8	3	2	0	75.4	5	0	42.9	0	0	\N	\N	C(=O)(N)NO	hydroxyurea
3983	HUMATIN	PAROMOMYCIN SULFATE	441375	C23H47N5O18S	713.706	\N	\N	15	23	9	430	47	0	952	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O	(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-6-hydroxy-cyclohexoxy]-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl]oxy-tetrahydropyran-3,4-diol;sulfuric acid
4013	HYDELTRASOL	PREDNISOLONE SODIUM PHOSPHATE	441409	C21H27Na2O8P	484.392	\N	\N	2	8	3	147	32	0	878	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]	disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
4012	HYDELTRA-TBA	PREDNISOLONE TEBUTATE	93055	C27H38O6	458.595	\N	4.1	2	6	6	101	33	0	925	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COC(=O)CC(C)(C)C)O)CCC4=CC(=O)C=CC34C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] 3,3-dimethylbutanoate
4010	HYCOFENIX	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
4031	HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE AND RESERPINE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
4005	HYCAMTIN	TOPOTECAN HYDROCHLORIDE	60699	C23H24ClN3O5	457.911	\N	\N	3	7	3	103	32	0	867	1	0	\N	\N	CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O.Cl	\N
4048	HYDRO-RX	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4063	HYDROCHLOROTHIAZIDE; IRBESARTAN	IRBESARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4064	HYDROCODONE BITARTRATE	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4066	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4068	HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7298	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4070	HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4071	HYDROCODONE BITARTRATE AND IBUPROFEN	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4073	HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4129	HYPAQUE	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
4076	HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4130	HYPAQUE	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
4139	HYPERSTAT	DIAZOXIDE	3019	C8H7ClN2O2S	230.666	\N	1.2	1	3	0	66.9	14	0	360	0	0	\N	\N	CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl	7-chloro-3-methyl-4H-1$l^{6},2,4-benzothiadiazine 1,1-dioxide
4079	HYDROCODONE BITARTRATE,CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4158	IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
4108	HYDROPANE	HOMATROPINE METHYLBROMIDE	6646	C17H24BrNO3	370.287	\N	\N	1	4	4	46.5	22	0	374	0	3	\N	\N	C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-]	(8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenyl-acetate;bromide
4099	HYDRODIURIL	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4085	HYDROCORTISONE	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4086	HYDROCORTISONE ACETATE	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4087	HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROCHLORIDE 1%	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4082	HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX	HYDROCODONE POLISTIREX	5284569	C18H21NO3	299.37	\N	2.2	0	4	1	38.8	22	0	509	4	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)CC4	(4R,4aR,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
4090	HYDROCORTISONE AND ACETIC ACID	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4091	HYDROCORTISONE BUTYRATE	HYDROCORTISONE BUTYRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4092	HYDROCORTISONE IN ABSORBASE	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4093	HYDROCORTISONE SODIUM PHOSPHATE	HYDROCORTISONE SODIUM PHOSPHATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4094	HYDROCORTISONE SODIUM SUCCINATE	HYDROCORTISONE SODIUM SUCCINATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4095	HYDROCORTISONE VALERATE	HYDROCORTISONE VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4096	HYDROCORTONE	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4097	HYDROCORTONE	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4098	HYDROCORTONE	HYDROCORTISONE SODIUM PHOSPHATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4100	HYDROFLUMETHIAZIDE	HYDROFLUMETHIAZIDE	3647	C8H8F3N3O4S2	331.284	\N	0.4	3	10	1	135	20	0	578	0	0	\N	\N	C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1	1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4119	HYDROXYCHLOROQUINE SULFATE	HYDROXYCHLOROQUINE SULFATE	12947	C18H28ClN3O5S	433.948	\N	\N	4	8	9	131	28	0	413	0	1	\N	\N	CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO.OS(=O)(=O)O	2-[4-[(7-chloro-4-quinolyl)amino]pentyl-ethyl-amino]ethanol;sulfuric acid
4122	HYDROXYUREA	HYDROXYUREA	3657	CH4N2O2	76.055	\N	-1.8	3	2	0	75.4	5	0	42.9	0	0	\N	\N	C(=O)(N)NO	hydroxyurea
4123	HYDROXYZINE	HYDROXYZINE HYDROCHLORIDE	3658	C21H27ClN2O2	374.909	\N	3.7	1	4	8	35.9	26	0	376	0	1	\N	\N	C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol
4072	HYDROCODONE BITARTRATE AND IBUPROFEN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4147	HYZYD	ISONIAZID	3767	C6H7N3O	137.142	\N	-0.7	2	3	1	68	10	0	120	0	0	\N	\N	C1=CN=CC=C1C(=O)NN	pyridine-4-carbohydrazide
4109	HYDROPANE	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4149	IBRANCE	PALBOCICLIB	5330286	C24H29N7O2	447.543	\N	1.8	2	8	5	103	33	0	775	0	0	\N	\N	CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C	6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-yl-2-pyridyl)amino]pyrido[2,3-d]pyrimidin-7-one
4074	HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
4105	HYDROMOX	QUINETHAZONE	6307	C10H12ClN3O3S	289.734	\N	1.2	3	5	2	110	18	0	436	0	1	\N	\N	CCC1NC2=CC(=C(C=C2C(=O)N1)S(=O)(=O)N)Cl	7-chloro-2-ethyl-4-oxo-2,3-dihydro-1H-quinazoline-6-sulfonamide
4141	HYSERPIN	RAUWOLFIA SERPENTINA ROOT	441975	C21H24N2O3	352.434	\N	2.7	1	4	2	54.6	26	0	606	4	0	\N	\N	CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45	\N
4144	HYTRIN	TERAZOSIN HYDROCHLORIDE	44383	C19H26ClN5O4	423.898	\N	\N	2	8	4	103	29	0	544	0	1	\N	\N	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.Cl	[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-tetrahydrofuran-2-yl-methanone;hydrochloride
4125	HYDROXYZINE PAMOATE	HYDROXYZINE PAMOATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4126	HYGROTON	CHLORTHALIDONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4127	HYLENEX RECOMBINANT	HYALURONIDASE RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4140	HYPROTIGEN 5%	PROTEIN HYDROLYSATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4142	HYSINGLA	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4143	HYTONE	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4146	HYZAAR	LOSARTAN POTASSIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4150	IBRIN	FIBRINOGEN, I-125	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4156	IBUPROFEN AND DIPHENHYDRAMINE CITRATE	DIPHENHYDRAMINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4216	IMURAN	AZATHIOPRINE	2265	C9H7N7O2S	277.262	\N	0.1	1	7	2	143	19	0	354	0	0	\N	\N	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	6-(3-methyl-5-nitro-imidazol-4-yl)sulfanyl-7H-purine
4176	IDKIT:HP	CITRIC ACID	311	C6H8O7	192.123	\N	-1.7	4	7	5	132	13	0	227	0	0	\N	\N	C(C(=O)O)C(CC(=O)O)(C(=O)O)O	citric acid
4259	INFUVITE ADULT	DEXPANTHENOL	131204	C9H19NO4	205.254	\N	-0.9	4	4	6	89.8	14	0	182	1	0	\N	\N	CC(C)(CO)C(C(=O)NCCCO)O	(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butanamide
4194	ILUVIEN	FLUOCINOLONE ACETONIDE	6215	C24H30F2O6	452.495	\N	2.5	2	8	2	93.1	32	0	960	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C	\N
4164	IBUPROFEN LYSINE	IBUPROFEN LYSINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4199	IMBRUVICA	IBRUTINIB	24821094	C25H24N6O2	440.507	\N	3.6	1	6	5	99.2	33	0	678	1	0	\N	\N	C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N	1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidyl]prop-2-en-1-one
4165	IBUPROFEN SODIUM	IBUPROFEN SODIUM	5338317	C13H17NaO2	228.267	\N	\N	0	2	4	40.1	16	0	208	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)[O-].[Na+]	sodium;2-(4-isobutylphenyl)propanoate
4169	IBUTILIDE FUMARATE	IBUTILIDE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4172	IDAMYCIN	IDARUBICIN HYDROCHLORIDE	636362	C26H28ClNO9	533.958	\N	\N	6	10	3	177	37	0	912	6	0	\N	\N	CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl	(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
4178	IFEX	IFOSFAMIDE	3690	C7H15Cl2N2O2P	261.083	\N	0.9	1	4	5	41.6	14	0	218	0	1	\N	\N	C1CN(P(=O)(OC1)NCCCl)CCCl	N,3-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine
4179	IFEX/MESNEX KIT	IFOSFAMIDE	3690	C7H15Cl2N2O2P	261.083	\N	0.9	1	4	5	41.6	14	0	218	0	1	\N	\N	C1CN(P(=O)(OC1)NCCCl)CCCl	N,3-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine
4188	ILOPERIDONE	ILOPERIDONE	71360	C24H27FN2O4	426.488	\N	4.1	0	7	8	64.8	31	0	586	0	0	\N	\N	CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC	1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]propoxy]-3-methoxy-phenyl]ethanone
4205	IMIQUIMOD	IMIQUIMOD	57469	C14H16N4	240.31	\N	2.6	1	3	2	56.7	18	0	294	0	0	\N	\N	CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N	1-isobutylimidazo[4,5-c]quinolin-4-amine
4241	INDOCIN	INDOMETHACIN SODIUM	23675763	C19H15ClNNaO4	379.772	\N	\N	0	4	4	71.4	26	0	512	0	0	\N	\N	CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)[O-].[Na+]	sodium;2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetate
4239	INDO-LEMMON	INDOMETHACIN	3715	C19H16ClNO4	357.79	\N	4.3	1	4	4	68.5	25	0	506	0	0	\N	\N	CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O	2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetic acid
4184	ILARIS	CANAKINUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4185	ILETIN I	INSULIN PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4186	ILETIN II	INSULIN PURIFIED PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4248	INFED	IRON DEXTRAN	105075	FeH2O4S	153.917	\N	\N	2	4	0	83	6	0	81.3	0	0	\N	\N	OS(=O)(=O)O.[Fe]	iron;sulfuric acid
7557	PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
7564	PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
4214	IMPAVIDO	MILTEFOSINE	3599	C21H46NO4P	407.576	\N	6.7	0	4	20	58.6	27	0	363	0	0	\N	\N	CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C	hexadecyl 2-(trimethylammonio)ethyl phosphate
4187	ILEVRO	NEPAFENAC	151075	C15H14N2O2	254.289	\N	1.9	2	3	4	86.2	19	0	337	0	0	\N	\N	C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)N)N	2-(2-amino-3-benzoyl-phenyl)acetamide
4196	IMAGENT	PERFLEXANE	9639	C6F14	338.044	\N	5.1	0	14	3	0	20	0	319	0	0	\N	\N	C(C(C(C(F)(F)F)(F)F)(F)F)(C(C(F)(F)F)(F)F)(F)F	1,1,1,2,2,3,3,4,4,5,5,6,6,6-tetradecafluorohexane
4224	INDERAL	PROPRANOLOL HYDROCHLORIDE	62882	C16H22ClNO2	295.807	\N	\N	3	3	6	41.5	20	0	257	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl	1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol;hydrochloride
4163	IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
4200	IMDUR	ISOSORBIDE MONONITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4262	INFUVITE ADULT	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
4263	INFUVITE ADULT	RIBOFLAVIN 5'-PHOSPHATE SODIUM	23666409	C17H20N4NaO9P	478.33	\N	\N	5	10	7	204	32	0	856	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)[O-])O)O)O.[Na+]	sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentyl] hydrogen phosphate
4206	IMITREX	SUMATRIPTAN	5358	C14H21N3O2S	295.401	\N	0.9	2	4	6	73.6	20	0	405	0	0	\N	\N	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C	1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide
4204	IMIPRAMINE PAMOATE	IMIPRAMINE PAMOATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4177	IDKIT:HP	UREA C-13	636363	CH4N2O	61.048	\N	-1.4	2	1	0	69.1	4	0	29	0	0	\N	\N	C(=O)(N)N	diaminomethanone
4213	IMODIUM MULTI-SYMPTOM RELIEF	SIMETHICONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4221	INCRELEX	MECASERMIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4236	INDICLOR	INDIUM IN-111 CHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4237	INDIUM IN 111 CHLORIDE	INDIUM IN-111 CHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4247	INFASURF PRESERVATIVE FREE	CALFACTANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4249	INFERGEN	INTERFERON ALFACON-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4252	INFLECTRA	INFLIXIMAB-DYYB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3345	ETRAFON 2-25	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
4269	INFUVITE PEDIATRIC	CHOLECALCIFEROL	5280795	C27H44O	384.648	\N	7.9	1	1	6	20.2	28	0	610	5	0	\N	\N	CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-dimethylhexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
4343	INTAL	CROMOLYN SODIUM	27503	C23H14Na2O11	512.334	\N	\N	1	11	6	172	36	0	824	0	0	\N	\N	C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)[O-])O)C(=O)C=C(O2)C(=O)[O-].[Na+].[Na+]	disodium;5-[3-(2-carboxylato-4-oxo-chromen-5-yl)oxy-2-hydroxy-propoxy]-4-oxo-chromene-2-carboxylate
4271	INFUVITE PEDIATRIC	DEXPANTHENOL	131204	C9H19NO4	205.254	\N	-0.9	4	4	6	89.8	14	0	182	1	0	\N	\N	CC(C)(CO)C(C(=O)NCCCO)O	(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butanamide
4351	INTROPIN	DOPAMINE HYDROCHLORIDE	65340	C8H12ClNO2	189.639	\N	\N	4	3	2	66.5	12	0	119	0	0	\N	\N	C1=CC(=C(C=C1CCN)O)O.Cl	4-(2-aminoethyl)benzene-1,2-diol;hydrochloride
4352	INTROVALE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4354	INTUNIV	GUANFACINE HYDROCHLORIDE	71401	C9H10Cl3N3O	282.549	\N	\N	3	1	2	81.5	16	0	256	0	0	\N	\N	C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl.Cl	N-(diaminomethylene)-2-(2,6-dichlorophenyl)acetamide;hydrochloride
4293	INH	ISONIAZID	3767	C6H7N3O	137.142	\N	-0.7	2	3	1	68	10	0	120	0	0	\N	\N	C1=CN=CC=C1C(=O)NN	pyridine-4-carbohydrazide
7571	PRISMASOL BK 0/0 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
7578	PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
7585	PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
7592	PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
4273	INFUVITE PEDIATRIC	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
4303	INOMAX	NITRIC OXIDE	145068	NO	30.006	\N	0.2	0	1	0	18.1	2	0	2	0	0	\N	\N	[N]=O	nitric oxide
4274	INFUVITE PEDIATRIC	PYRIDOXINE	1054	C8H11NO3	169.18	\N	-0.8	3	4	2	73.6	12	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol
4307	INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4308	INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
4294	INJECTAFER	FERRIC CARBOXYMALTOSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4276	INFUVITE PEDIATRIC	THIAMINE	1130	C12H17N4OS+	265.355	\N	1	2	5	4	104	18	1	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol
4289	INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)	THIAMINE	1130	C12H17N4OS+	265.355	\N	1	2	5	4	104	18	1	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol
4277	INFUVITE PEDIATRIC	TOCOPHEROL ACETATE	86472	C31H52O3	472.754	\N	10.8	0	3	14	35.5	34	0	602	3	0	\N	\N	CC1=C2C(=C(C(=C1C)OC(=O)C)C)CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C	[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-yl] acetate
4265	INFUVITE ADULT	VITAMIN A PALMITATE	5280531	C36H60O2	524.874	\N	13.6	0	2	21	26.3	38	0	803	0	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C	[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
4301	INNOVAR	FENTANYL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4305	INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4310	INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4315	INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4320	INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4325	INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4329	INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4333	INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4337	INSTANT MICROSPHERES	TECHNETIUM TC-99M ALBUMIN MICROSPHERES KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4338	INSULATARD NPH HUMAN	INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4339	INSULIN	INSULIN PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4340	INSULIN INSULATARD NPH NORDISK	INSULIN SUSP ISOPHANE PURIFIED PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4341	INSULIN NORDISK MIXTARD (PORK)	INSULIN PURIFIED PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4342	INSULIN NORDISK MIXTARD (PORK)	INSULIN SUSP ISOPHANE PURIFIED PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4346	INTERMEZZO	ZOLPIDEM TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4347	INTRALIPID 10%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4348	INTRALIPID 20%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4349	INTRALIPID 30%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4355	INULIN AND SODIUM CHLORIDE	INULIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3347	ETRAFON-A	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
4358	INVAGESIC	ORPHENADRINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4436	ISOCLOR	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
4424	IRRIGATING SOLUTION G IN PLASTIC CONTAINER	CITRIC ACID	311	C6H8O7	192.123	\N	-1.7	4	7	5	132	13	0	227	0	0	\N	\N	C(C(=O)O)C(CC(=O)O)(C(=O)O)O	citric acid
4361	INVAGESIC FORTE	ORPHENADRINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4362	INVANZ	ERTAPENEM SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4395	IONSYS	FENTANYL HYDROCHLORIDE	83932	C22H29ClN2O	372.937	\N	\N	1	2	6	23.6	26	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3.Cl	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide;hydrochloride
4398	IOPAMIDOL	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
4422	IRINOTECAN HYDROCHLORIDE	IRINOTECAN HYDROCHLORIDE	74990	C33H39ClN4O6	623.147	\N	\N	2	8	5	113	44	0	1200	1	0	\N	\N	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7.Cl	\N
4423	IRON DEXTRAN	IRON DEXTRAN	105075	FeH2O4S	153.917	\N	\N	2	4	0	83	6	0	81.3	0	0	\N	\N	OS(=O)(=O)O.[Fe]	iron;sulfuric acid
4438	ISOETHARINE HYDROCHLORIDE	ISOETHARINE HYDROCHLORIDE	5791	C13H22ClNO3	275.773	\N	\N	5	4	5	72.7	18	0	223	0	2	\N	\N	CCC(C(C1=CC(=C(C=C1)O)O)O)NC(C)C.Cl	4-[1-hydroxy-2-(isopropylamino)butyl]benzene-1,2-diol;hydrochloride
4440	ISOETHARINE MESYLATE	ISOETHARINE MESYLATE	3762	C13H21NO3	239.315	\N	1.7	4	4	5	72.7	17	0	223	0	2	\N	\N	CCC(C(C1=CC(=C(C=C1)O)O)O)NC(C)C	4-[1-hydroxy-2-(isopropylamino)butyl]benzene-1,2-diol
4412	IQUIX	LEVOFLOXACIN	149096	C18H20FN3O4	361.373	\N	-0.4	1	8	2	73.3	26	0	634	1	0	\N	\N	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	\N
4373	IOBENGUANE SULFATE I 131	IOBENGUANE SULFATE I-131	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4374	IODOHIPPURATE SODIUM I 131	IODOHIPPURATE SODIUM I-131	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4378	IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4377	IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4384	IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4425	IRRIGATING SOLUTION G IN PLASTIC CONTAINER	MAGNESIUM OXIDE	14792	MgO	40.304	\N	\N	0	1	0	17.1	2	0	2	0	0	\N	\N	O=[Mg]	oxomagnesium
4366	INVERSINE	MECAMYLAMINE HYDROCHLORIDE	13221	C11H22ClN	203.754	\N	\N	2	1	1	12	13	0	197	0	3	\N	\N	CC1(C2CCC(C2)C1(C)NC)C.Cl	N,2,3,3-tetramethylnorbornan-2-amine;hydrochloride
4369	INVOKAMET	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
4363	INVEGA	PALIPERIDONE	115237	C23H27FN4O3	426.492	\N	2.2	1	7	4	82.2	31	0	764	0	1	\N	\N	CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
4379	IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4390	IONOSOL T AND DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4408	IOSAT	POTASSIUM IODIDE	4875	IK	166.003	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[K+].[I-]	potassium;iodide
4392	IONOSOL T AND DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM LACTATE	23671663	C3H5KO3	128.168	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[K+]	potassium;2-hydroxypropanoate
4380	IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
4437	ISOCLOR	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
4446	ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4381	IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4375	IODOTOPE	SODIUM IODIDE I-131	71368	INa	153.896	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[I-]	sodium;iodine-131(1-)
4382	IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
4383	IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM PHOSPHATE, MONOBASIC ANHYDROUS	23672064	H2NaO4P	119.976	\N	\N	2	4	0	80.6	6	0	61.9	0	0	\N	\N	OP(=O)(O)[O-].[Na+]	sodium;dihydrogen phosphate
4409	IPLEX	MECASERMIN RINFABATE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4410	IPRATROPIUM BROMIDE	IPRATROPIUM BROMIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4411	IPRIVASK	DESIRUDIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4413	IRBESARTAN	IRBESARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4415	IRBESARTAN AND HYDROCHLOROTHIAZIDE	IRBESARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4417	IRBESARTAN HYDROCHLOROTHIAZIDE	IRBESARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4418	IRBESARTAN; HYDROCHLOROTHIAZIDE	IRBESARTAN: HYDROCHLOROTHIAZIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4419	IRBESARTAN; HYDROCHLOROTHIAZIDE	IRBESARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4431	ISMO	ISOSORBIDE MONONITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4443	ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4448	ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3349	ETRAFON-FORTE	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
4454	ISOLYTE E IN PLASTIC CONTAINER	SODIUM CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4964	LIMBITROL	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
4456	ISOLYTE E W/ DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4461	ISOLYTE E W/ DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4462	ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4451	ISOLYTE E IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4467	ISOLYTE H W/ DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4458	ISOLYTE E W/ DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4472	ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4474	ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
4477	ISOLYTE M W/ DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4479	ISOLYTE M W/ DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
4482	ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4485	ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
4490	ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
4517	ISOLYTE S PH 7.4 IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, MONOBASIC	516951	H2KO4P	136.084	\N	\N	2	4	0	80.6	6	0	61.9	0	0	\N	\N	OP(=O)(O)[O-].[K+]	potassium;dihydrogen phosphate
4487	ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4452	ISOLYTE E IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4459	ISOLYTE E W/ DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4465	ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4470	ISOLYTE H W/ DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4493	ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4453	ISOLYTE E IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4460	ISOLYTE E W/ DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4466	ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4471	ISOLYTE H W/ DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4499	ISOLYTE R W/ DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4476	ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4481	ISOLYTE M W/ DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4509	ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM GLUCONATE	23672301	C6H11NaO7	218.137	\N	\N	5	7	5	141	14	0	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+]	sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
4504	ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4514	ISOLYTE S IN PLASTIC CONTAINER	SODIUM GLUCONATE	23672301	C6H11NaO7	218.137	\N	\N	5	7	5	141	14	0	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+]	sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
4520	ISOLYTE S PH 7.4 IN PLASTIC CONTAINER	SODIUM GLUCONATE	23672301	C6H11NaO7	218.137	\N	\N	5	7	5	141	14	0	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+]	sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
4521	ISOLYTE S PH 7.4 IN PLASTIC CONTAINER	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4522	ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7318	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4533	ISOPAQUE 440	MEGLUMINE METRIZOATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4558	IV PERSANTINE	DIPYRIDAMOLE	3108	C24H40N8O4	504.636	\N	0.7	4	12	12	145	36	0	561	0	0	\N	\N	C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO	2-[[2-[bis(2-hydroxyethyl)amino]-4,8-bis(1-piperidyl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol
4595	JUNIOR STRENGTH ADVIL	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4569	JANIMINE	IMIPRAMINE HYDROCHLORIDE	8228	C19H25ClN2	316.873	\N	\N	1	2	4	6.5	22	0	291	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine;hydrochloride
4542	ISORDIL	ISOSORBIDE DINITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4543	ISOSORBIDE DINITRATE	ISOSORBIDE DINITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4544	ISOSORBIDE MONONITRATE	ISOSORBIDE MONONITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4528	ISONIAZID	ISONIAZID	3767	C6H7N3O	137.142	\N	-0.7	2	3	1	68	10	0	120	0	0	\N	\N	C1=CN=CC=C1C(=O)NN	pyridine-4-carbohydrazide
4536	ISOPROTERENOL HYDROCHLORIDE	ISOPROTERENOL HYDROCHLORIDE	5807	C11H18ClNO3	247.719	\N	\N	5	4	4	72.7	16	0	187	0	1	\N	\N	CC(C)NCC(C1=CC(=C(C=C1)O)O)O.Cl	4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol;hydrochloride
4556	ISUPREL	ISOPROTERENOL HYDROCHLORIDE	5807	C11H18ClNO3	247.719	\N	\N	5	4	4	72.7	16	0	187	0	1	\N	\N	CC(C)NCC(C1=CC(=C(C=C1)O)O)O.Cl	4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol;hydrochloride
4623	KALYDECO	IVACAFTOR	16220172	C24H28N2O3	392.499	\N	5.6	3	4	4	78.4	29	0	671	0	0	\N	\N	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	N-(2,4-ditert-butyl-5-hydroxy-phenyl)-4-oxo-1H-quinoline-3-carboxamide
4564	JADELLE	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4600	JUXTAPID	LOMITAPIDE MESYLATE	11274333	C40H41F6N3O5S	789.834	\N	\N	3	12	10	124	55	0	1200	0	0	\N	\N	CS(=O)(=O)O.C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F	methanesulfonic acid;N-(2,2,2-trifluoroethyl)-9-[4-[4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]-1-piperidyl]butyl]fluorene-9-carboxamide
4530	ISOPAQUE 280	MEGLUMINE	8567	C7H17NO5	195.215	\N	-2.8	6	6	6	113	13	0	134	4	0	\N	\N	CNCC(C(C(C(CO)O)O)O)O	(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
4534	ISOPAQUE 440	METRIZOATE MAGNESIUM	10080104	C24H20I6MgN4O8	1278.176	\N	\N	2	8	4	179	43	0	443	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)N(C)C(=O)C)I.CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)N(C)C(=O)C)I.[Mg+2]	magnesium;3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodo-benzoate
4531	ISOPAQUE 280	METRIZOIC ACID	2528	C12H11I3N2O4	627.943	\N	1.9	2	4	3	86.7	21	0	448	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)N(C)C(=O)C)I	3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodo-benzoic acid
4578	JENCYCLA	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4538	ISOPTO CARPINE	PILOCARPINE HYDROCHLORIDE	5909	C11H17ClN2O2	244.719	\N	\N	1	3	3	44.1	16	0	245	2	0	\N	\N	CCC1C(COC1=O)CC2=CN=CN2C.Cl	(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one;hydrochloride
4694	KLOTRIX	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4540	ISOPTO CETAPRED	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
4616	KAINAIR	PROPARACAINE HYDROCHLORIDE	517321	C16H27ClN2O3	330.853	\N	\N	2	5	10	64.8	22	0	295	0	0	\N	\N	CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N.Cl	2-(diethylamino)ethyl 3-amino-4-propoxy-benzoate;hydrochloride
4525	ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4610	KABIVEN IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4526	ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4527	ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM GLUCONATE	23672301	C6H11NaO7	218.137	\N	\N	5	7	5	141	14	0	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+]	sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
4539	ISOPTO CETAMIDE	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
4554	ISTALOL	TIMOLOL MALEATE	5281056	C17H28N4O7S	432.492	\N	\N	4	12	9	183	29	0	429	1	0	\N	\N	CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O	(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;maleic acid
4577	JEANATOPE	ALBUMIN IODINATED I-125 SERUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4584	JETREA	OCRIPLASMIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4605	KABIVEN IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4607	KABIVEN IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4612	KABIVEN IN PLASTIC CONTAINER	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4613	KADCYLA	ADO-TRASTUZUMAB EMTANSINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4619	KALBITOR	ECALLANTIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4622	KALEXATE	SODIUM POLYSTYRENE SULFONATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4627	KANUMA	SEBELIPASE ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4966	LIMBITROL DS	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
4635	KAYEXALATE	SODIUM POLYSTYRENE SULFONATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4638	KEFLET	CEPHALEXIN	27447	C16H17N3O4S	347.389	\N	0.6	3	6	4	138	24	0	600	3	0	\N	\N	CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O	(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
4693	KLOROMIN	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
4633	KARIVA	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
4675	KEVEYIS	DICHLORPHENAMIDE	3038	C6H6Cl2N2O4S2	305.144	\N	0.3	2	6	2	137	16	0	452	0	0	\N	\N	C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N	4,5-dichlorobenzene-1,3-disulfonamide
4712	KYTRIL	GRANISETRON HYDROCHLORIDE	65264	C18H25ClN4O	348.875	\N	\N	2	3	2	50.2	24	0	442	0	2	\N	\N	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl	1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide;hydrochloride
4666	KETALAR	KETAMINE HYDROCHLORIDE	15851	C13H17Cl2NO	274.185	\N	\N	2	2	2	29.1	17	0	269	0	1	\N	\N	CNC1(CCCCC1=O)C2=CC=CC=C2Cl.Cl	2-(2-chlorophenyl)-2-(methylamino)cyclohexanone;hydrochloride
4671	KETOPROFEN	KETOPROFEN	3825	C16H14O3	254.285	\N	3.1	1	3	4	54.4	19	0	331	0	1	\N	\N	CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O	2-(3-benzoylphenyl)propanoic acid
4713	LABETALOL HYDROCHLORIDE	LABETALOL HYDROCHLORIDE	71412	C19H25ClN2O3	364.87	\N	\N	5	4	8	95.6	25	0	385	0	2	\N	\N	CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O.Cl	2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]ethyl]benzamide;hydrochloride
4659	KEPPRA	LEVETIRACETAM	5284583	C8H14N2O2	170.212	\N	-0.3	1	2	3	63.4	12	0	203	1	0	\N	\N	CCC(C(=O)N)N1CCCC1=O	(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
4660	KEPPRA XR	LEVETIRACETAM	5284583	C8H14N2O2	170.212	\N	-0.3	1	2	3	63.4	12	0	203	1	0	\N	\N	CCC(C(=O)N)N1CCCC1=O	(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
4707	KWELL	LINDANE	727	C6H6Cl6	290.814	\N	3.8	0	0	0	0	12	0	104	0	0	\N	\N	C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl	1,2,3,4,5,6-hexachlorocyclohexane
4699	KORLYM	MIFEPRISTONE	55245	C29H35NO2	429.604	\N	3.8	1	3	3	40.5	32	0	921	5	0	\N	\N	CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O	(8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
4689	KLOR-CON	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4648	KEMADRIN	PROCYCLIDINE HYDROCHLORIDE	207841	C19H30ClNO	323.905	\N	\N	2	2	5	23.5	22	0	301	0	1	\N	\N	C1CCC(CC1)C(CCN2CCCC2)(C3=CC=CC=C3)O.Cl	1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol;hydrochloride
4665	KESSO-GESIC	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
4695	KOGLUCOID	RAUWOLFIA SERPENTINA ROOT	441975	C21H24N2O3	352.434	\N	2.7	1	4	2	54.6	26	0	606	4	0	\N	\N	CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45	\N
4721	LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4722	LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
4738	LAMIVUDINE AND STAVUDINE	STAVUDINE	18283	C10H12N2O4	224.216	\N	-0.8	2	4	2	78.9	16	0	388	2	0	\N	\N	CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO	1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
4658	KEPIVANCE	PALIFERMIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4664	KERYDIN	TAVABOROLE	11499245	C7H6BFO2	151.931	\N	\N	1	3	0	29.5	11	0	155	0	0	\N	\N	B1(C2=C(CO1)C=C(C=C2)F)O	5-fluoro-1-hydroxy-3H-2,1-benzoxaborole
4662	KERLEDEX	CHLORTHALIDONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4732	LAMISIL	TERBINAFINE	1549008	C21H25N	291.438	\N	5.6	0	1	5	3.2	22	0	428	0	0	\N	\N	CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21	(E)-N,6,6-trimethyl-N-(1-naphthylmethyl)hept-2-en-4-yn-1-amine
4714	LABID	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
4651	KENACORT	TRIAMCINOLONE DIACETATE	6216	C25H31FO8	478.513	\N	1.9	2	9	6	127	34	0	1020	8	0	\N	\N	CC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)OC(=O)C)O	[2-[(8S,9R,10S,11S,13S,14S,16R,17S)-16-acetoxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
4673	KETOTIFEN FUMARATE	KETOTIFEN FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4676	KEYTRUDA	PEMBROLIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4680	KINERET	ANAKINRA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4682	KINLYTIC	UROKINASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4683	KIONEX	SODIUM POLYSTYRENE SULFONATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4703	KRYSTEXXA	PEGLOTICASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4710	KYNAMRO	MIPOMERSEN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4717	LACRISERT	HYDROXYPROPYL CELLULOSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4719	LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4736	LAMIVUDINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4737	LAMIVUDINE AND STAVUDINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4739	LAMIVUDINE AND ZIDOVUDINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4741	LAMIVUDINE, NEVIRAPINE, AND STAVUDINE	LAMIVUDINE, NEVIRAPINE, AND STAVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4742	LAMIVUDINE, NEVIRAPINE, AND STAVUDINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4745	LAMIVUDINE, ZIDOVUDINE TABS 150MG/300MG CO-PACKAGED WITH NEVIRAPINE TABS 200MG	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6810	PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
9204	TRIAVIL 2-10	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
4748	Lamivudine, Zidovudine, Nevirapine Tabs 150mg/300mg/200mg	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9206	TRIAVIL 2-25	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
4800	LANORINAL	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
4802	LANORINAL	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
4752	LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS	Nevirapine	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4753	LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS	Zidovudine	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4754	LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE FDC TABS	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4756	Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7340	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4816	LARIN 1.5/30	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4759	LAMIVUDINE/ZIDOVUDINE TABLETS CO-PACKAGED WITH NEVIRAPINE TABLETS	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4831	LASIX	FUROSEMIDE	3440	C12H11ClN2O5S	330.739	\N	2	3	7	5	131	21	0	481	0	0	\N	\N	C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl	4-chloro-2-(2-furylmethylamino)-5-sulfamoyl-benzoic acid
4798	LANIAZID	ISONIAZID	3767	C6H7N3O	137.142	\N	-0.7	2	3	1	68	10	0	120	0	0	\N	\N	C1=CN=CC=C1C(=O)NN	pyridine-4-carbohydrazide
4762	LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4833	LATANOPROST	LATANOPROST	5311221	C26H40O5	432.601	\N	4.3	3	5	14	87	31	0	526	5	0	\N	\N	CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O	isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenyl-pentyl]cyclopentyl]hept-5-enoate
4793	LANABIOTIC	LIDOCAINE	3676	C14H22N2O	234.343	\N	2.3	1	2	5	32.3	17	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
4765	LAMIVUDINE; STAVUDINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4767	LAMIVUDINE; STAVUDINE; NEVIRAPINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4835	LATUDA	LURASIDONE HYDROCHLORIDE	11237860	C28H37ClN4O2S	529.14	\N	\N	1	6	5	85	36	0	804	6	0	\N	\N	C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O.Cl	\N
4743	LAMIVUDINE, NEVIRAPINE, AND STAVUDINE	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
4770	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4771	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4772	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4773	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE	TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4836	LAX-LYTE WITH FLAVOR PACKS	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
4775	LAMIVUDINE; ZIDOVUDINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4814	LARGON	PROPIOMAZINE HYDROCHLORIDE	71802	C20H25ClN2OS	376.943	\N	\N	1	4	5	48.8	25	0	441	0	1	\N	\N	CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CC(C)N(C)C.Cl	1-[10-[2-(dimethylamino)propyl]phenothiazin-2-yl]propan-1-one;hydrochloride
4777	LAMIVUDINE; ZIDOVUDINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4766	LAMIVUDINE; STAVUDINE	STAVUDINE	18283	C10H12N2O4	224.216	\N	-0.8	2	4	2	78.9	16	0	388	2	0	\N	\N	CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO	1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
4780	LAMIVUDINE; ZIDOVUDINE; ABACAVIR	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4755	LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE FDC TABS	TENOFOVIR	464205	C9H14N5O4P	287.216	\N	-1.6	3	8	5	136	19	0	354	1	0	\N	\N	CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	[(1R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methylphosphonic acid
4783	LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4799	LANOPHYLLIN	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
4786	LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ	LAMIVUDINE;ZIDOVUDINE;EFAVIRENZ	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4787	LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4792	LANABIOTIC	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4796	LANABIOTIC	BACITRACIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4811	LANTUS	INSULIN GLARGINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4812	LANTUS SOLOSTAR	INSULIN GLARGINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4828	LARTRUVO	OLARATUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4841	LAZANDA	FENTANYL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7492	PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4844	LEMTRADA	ALEMTUZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4845	LENTARD	INSULIN ZINC SUSP PURIFIED BEEF/PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4846	LENTE	INSULIN ZINC SUSP PURIFIED PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4847	LENTE ILETIN II	INSULIN ZINC SUSP PURIFIED BEEF	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4848	LENTE ILETIN II (PORK)	INSULIN ZINC SUSP PURIFIED PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4849	LENTE INSULIN	INSULIN ZINC SUSP BEEF	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4924	LIBRELEASE	CHLORDIAZEPOXIDE	2712	C16H14ClN3O	299.758	\N	2.4	1	3	1	48.2	21	0	580	0	0	\N	\N	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine
4920	LEXXEL	FELODIPINE	3333	C18H19Cl2NO4	384.253	\N	3.9	1	5	6	64.6	25	0	614	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C	O5-ethyl O3-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
4927	LIDEX	FLUOCINONIDE	9642	C26H32F2O7	494.532	\N	3.2	1	9	4	99.1	35	0	1070	9	0	\N	\N	CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C	\N
4928	LIDEX-E	FLUOCINONIDE	9642	C26H32F2O7	494.532	\N	3.2	1	9	4	99.1	35	0	1070	9	0	\N	\N	CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C	\N
4855	LESCOL	FLUVASTATIN SODIUM	23663976	C24H25FNNaO4	433.455	\N	\N	2	5	8	85.5	31	0	596	2	0	\N	\N	CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+]	sodium;(E,3R,5S)-7-[3-(4-fluorophenyl)-1-isopropyl-indol-2-yl]-3,5-dihydroxy-hept-6-enoate
4840	LAXILOSE	LACTULOSE	11333	C12H22O11	342.297	\N	-4.3	8	11	5	190	23	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
4843	LEFLUNOMIDE	LEFLUNOMIDE	3899	C12H9F3N2O2	270.211	\N	2.5	1	6	2	55.1	19	0	327	0	0	\N	\N	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide
4862	LETROZOLE	LETROZOLE	3902	C17H11N5	285.31	\N	2.7	0	4	3	78.3	22	0	420	0	0	\N	\N	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile
4869	LEVALBUTEROL HYDROCHLORIDE	LEVALBUTEROL HYDROCHLORIDE	123601	C13H22ClNO3	275.773	\N	\N	5	4	5	72.7	18	0	227	1	0	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.Cl	4-[(1R)-2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;hydrochloride
4879	LEVETIRACETAM	LEVETIRACETAM	5284583	C8H14N2O2	170.212	\N	-0.3	1	2	3	63.4	12	0	203	1	0	\N	\N	CCC(C(=O)N)N1CCCC1=O	(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
4887	LEVOCARNITINE	LEVOCARNITINE	10917	C7H15NO3	161.201	\N	-0.2	1	3	3	60.4	11	0	134	1	0	\N	\N	C[N+](C)(C)CC(CC(=O)[O-])O	(3R)-3-hydroxy-4-(trimethylammonio)butanoate
4870	LEVAQUIN	LEVOFLOXACIN	149096	C18H20FN3O4	361.373	\N	-0.4	1	8	2	73.3	26	0	634	1	0	\N	\N	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	\N
4897	LEVOLEUCOVORIN CALCIUM	LEVOLEUCOVORIN CALCIUM	149436	C20H23N7O7	473.446	\N	-1.2	7	9	9	216	34	0	911	2	0	\N	\N	C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid
4866	LEUKINE	SARGRAMOSTIM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4906	LEVOPROME	LEVOMEPROMAZINE	72287	C19H24N2OS	328.474	\N	4.7	0	4	5	41	23	0	378	1	0	\N	\N	CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C	(2R)-3-(2-methoxyphenothiazin-10-yl)-N,N,2-trimethyl-propan-1-amine
4885	LEVO-T	LEVOTHYROXINE SODIUM	23666112	C15H10I4NNaO4	798.856	\N	\N	2	5	5	95.6	25	0	426	1	0	\N	\N	C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+]	sodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate
4932	LIDOCAINE HYDROCHLORIDE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4933	LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4929	LIDOCAINE	LIDOCAINE	3676	C14H22N2O	234.343	\N	2.3	1	2	5	32.3	17	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
4930	LIDOCAINE AND PRILOCAINE	LIDOCAINE	3676	C14H22N2O	234.343	\N	2.3	1	2	5	32.3	17	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
4921	LIALDA	MESALAMINE	4075	C7H7NO3	153.137	\N	1.3	3	4	1	83.6	11	0	160	0	0	\N	\N	C1=CC(=C(C=C1N)C(=O)O)O	5-amino-2-hydroxy-benzoic acid
4872	LEVATOL	PENBUTOLOL SULFATE	37464	C18H29NO2	291.435	\N	4.2	2	3	7	41.5	21	0	294	1	0	\N	\N	CC(C)(C)NCC(COC1=CC=CC=C1C2CCCC2)O	(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol
4837	LAX-LYTE WITH FLAVOR PACKS	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4838	LAX-LYTE WITH FLAVOR PACKS	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
4839	LAX-LYTE WITH FLAVOR PACKS	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4884	LEVO-DROMORAN	LEVORPHANOL TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4894	LEVOFLOXACIN; DEXTROSE	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4905	LEVOPHED	NOREPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4911	LEVORPHANOL TARTRATE	LEVORPHANOL TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5027	LOCHOLEST	CHOLESTYRAMINE	70695641	C21H30N+	296.478	\N	5.7	0	0	6	0	22	1	300	0	1	\N	\N	CCC1=CC=C(C=C1)C(C)CCC2=CC=C(C=C2)[N+](C)(C)C	[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethyl-ammonium
4943	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
5014	LO LOESTRIN FE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5032	LODINE	ETODOLAC	3308	C17H21NO3	287.359	\N	2.8	2	3	4	62.3	21	0	400	0	1	\N	\N	CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O	2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid
4994	LIPTRUZET	EZETIMIBE	150311	C24H21F2NO3	409.433	\N	4	2	5	6	60.8	30	0	567	3	0	\N	\N	C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O	(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxy-propyl]-4-(4-hydroxyphenyl)azetidin-2-one
4963	LILETTA	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4955	LIDODERM	LIDOCAINE	3676	C14H22N2O	234.343	\N	2.3	1	2	5	32.3	17	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
4975	LINZESS	LINACLOTIDE	16158208	C59H79N15O21S6	1526.725	\N	-6.8	19	28	13	726	101	0	3030	14	0	\N	\N	CC1C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)C(=O)NC(CSSCC(C(=O)N3)N)C(=O)NC(C(=O)N5CCCC5C(=O)N1)CC(=O)N)CC6=CC=C(C=C6)O)CCC(=O)O	\N
4968	LINCOCIN	LINCOMYCIN HYDROCHLORIDE	64710	C18H35ClN2O6S	442.996	\N	\N	6	8	7	148	28	0	499	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O.Cl	(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide;hydrochloride
4972	LINDANE	LINDANE	727	C6H6Cl6	290.814	\N	3.8	0	0	0	0	12	0	104	0	0	\N	\N	C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl	1,2,3,4,5,6-hexachlorocyclohexane
4973	LINEZOLID	LINEZOLID	441401	C16H20FN3O4	337.351	\N	0.7	1	6	4	71.1	24	0	472	1	0	\N	\N	CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F	N-[[(5S)-3-(3-fluoro-4-morpholino-phenyl)-2-oxo-oxazolidin-5-yl]methyl]acetamide
4977	LIOTHYRONINE SODIUM	LIOTHYRONINE SODIUM	23666110	C15H11I3NNaO4	672.959	\N	\N	2	5	5	95.6	24	0	408	1	0	\N	\N	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.[Na+]	sodium;(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoate
5001	LISINOPRIL	LISINOPRIL	5362119	C21H31N3O5	405.495	\N	-2.9	4	7	12	133	29	0	550	3	0	\N	\N	C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O	(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
5016	LO LOESTRIN FE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5024	LO/OVRAL	NORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4998	LIQUAMAR	PHENPROCOUMON	54680692	C18H16O3	280.323	\N	3.6	1	3	3	46.5	21	0	420	0	1	\N	\N	CCC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O	4-hydroxy-3-(1-phenylpropyl)chromen-2-one
4981	LIPO GANTRISIN	SULFISOXAZOLE ACETYL	6662	C13H15N3O4S	309.34	\N	1.3	1	6	3	115	21	0	482	0	0	\N	\N	CC1=C(ON=C1C)N(C(=O)C)S(=O)(=O)C2=CC=C(C=C2)N	N-(4-aminophenyl)sulfonyl-N-(3,4-dimethylisoxazol-5-yl)acetamide
4959	LIGNOSPAN FORTE	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4961	LIGNOSPAN STANDARD	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4978	LIPIDIL	FENOFIBRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4979	LIPIODOL	ETHIODIZED OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4982	LIPO-HEPIN	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4983	LIPOFEN	FENOFIBRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4984	LIPOSYN 10%	SAFFLOWER OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4985	LIPOSYN 20%	SAFFLOWER OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4986	LIPOSYN II 10%	SAFFLOWER OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4987	LIPOSYN II 10%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4988	LIPOSYN II 20%	SAFFLOWER OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4989	LIPOSYN II 20%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4990	LIPOSYN III 10%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4991	LIPOSYN III 20%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4992	LIPOSYN III 30%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4995	LIQUAEMIN LOCK FLUSH	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4996	LIQUAEMIN SODIUM	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4997	LIQUAEMIN SODIUM PRESERVATIVE FREE	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5006	LITHIUM CITRATE	LITHIUM CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5009	LITHONATE	LITHIUM CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5017	LO LOESTRIN FE	FERROUS FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5020	LO-BLISOVI FE	NORETHINDRONE ACETATE;ETHINYL ESTRADIOL;FERROUS FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5029	LOCOID	HYDROCORTISONE BUTYRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5030	LOCOID LIPOCREAM	HYDROCORTISONE BUTYRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5104	LOTRISONE	BETAMETHASONE DIPROPIONATE	21800	C28H37FO7	504.595	\N	3.6	1	8	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
7499	PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
7506	PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
7513	PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
5088	LORYNA	DROSPIRENONE	68873	C24H30O3	366.501	\N	3.5	0	3	0	43.4	27	0	828	10	0	\N	\N	CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C	\N
5126	LUFYLLIN	DYPHYLLINE	3182	C10H14N4O4	254.246	\N	-1.8	2	5	3	98.9	18	0	364	0	1	\N	\N	CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O	7-(2,3-dihydroxypropyl)-1,3-dimethyl-purine-2,6-dione
5041	LOESTRIN FE 1.5/30	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5144	LUVOX	FLUVOXAMINE MALEATE	9560989	C19H25F3N2O6	434.412	\N	\N	3	11	11	131	30	0	446	0	0	\N	\N	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O	maleic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
5141	LUSEDRA	FOSPROPOFOL DISODIUM	3038497	C13H19Na2O5P	332.243	\N	\N	0	5	5	81.6	21	0	285	0	0	\N	\N	CC(C)C1=C(C(=CC=C1)C(C)C)OCOP(=O)([O-])[O-].[Na+].[Na+]	disodium;(2,6-diisopropylphenoxy)methyl phosphate
5069	LOPRESSOR HCT	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5122	LOZOL	INDAPAMIDE	3702	C16H16ClN3O3S	365.832	\N	2.9	2	5	3	101	24	0	580	0	1	\N	\N	CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N	4-chloro-N-(2-methylindolin-1-yl)-3-sulfamoyl-benzamide
5094	LOSEASONIQUE	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
5062	LOPINAVIR; RITONAVIR	LOPINAVIR	92727	C37H48N4O5	628.814	\N	5.9	4	5	15	120	46	0	940	4	0	\N	\N	CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O	(2S)-N-[(1S,3S,4S)-1-benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-pentyl]-3-methyl-2-(2-oxohexahydropyrimidin-1-yl)butanamide
5095	LOTEMAX	LOTEPREDNOL ETABONATE	444025	C24H31ClO7	466.955	\N	3.9	1	7	7	99.1	32	0	882	7	0	\N	\N	CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl	chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate
5118	LOXAPINE SUCCINATE	LOXAPINE SUCCINATE	71399	C22H24ClN3O5	445.9	\N	\N	2	7	4	103	31	0	542	0	0	\N	\N	CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O	8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine;succinic acid
5140	LURASIDONE HYDROCHLORIDE	LURASIDONE HYDROCHLORIDE	11237860	C28H37ClN4O2S	529.14	\N	\N	1	6	5	85	36	0	804	6	0	\N	\N	C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O.Cl	\N
5059	LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE	SIMETHICONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5052	LONITEN	MINOXIDIL	4201	C9H15N5O	209.253	\N	1.2	3	3	1	88.9	15	0	329	0	0	\N	\N	C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O	3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine
5061	LOPINAVIR AND RITONAVIR	LOPINAVIR;RITONAVIR	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5113	LOW-OGESTREL-21	NORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
5064	LOPINAVIR; RITONAVIR	LOPINAVIR;RITONAVIR	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5065	LOPRESSIDONE	CHLORTHALIDONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5066	LOPRESSIDONE	METOPROLOL TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5067	LOPRESSOR	METOPROLOL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5068	LOPRESSOR	METOPROLOL TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5070	LOPRESSOR HCT	METOPROLOL TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5047	LOMAIRA	PHENTERMINE HYDROCHLORIDE	70969	C10H16ClN	185.695	\N	\N	2	1	2	26	12	0	112	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)N.Cl	2-methyl-1-phenyl-propan-2-amine;hydrochloride
5127	LUMASON	SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES	17358	F6S	146.05	\N	4.2	0	6	0	1	7	0	62.7	0	0	\N	\N	FS(F)(F)(F)(F)F	hexafluoro-$l^{6}-sulfane
5074	LORATADINE	LORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5075	LORATADINE AND PSEUDOEPHEDRINE SULFATE	LORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5107	LOTUSATE	TALBUTAL	8275	C11H16N2O3	224.26	\N	1.4	2	3	4	75.3	16	0	329	0	1	\N	\N	CCC(C)C1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-sec-butyl-hexahydropyrimidine-2,4,6-trione
5077	LORATADINE REDIDOSE	LORATADINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5083	LORCET-HD	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5085	LORFAN	LEVALLORPHAN TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5087	LORTAB	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5090	LOSARTAN POTASSIUM	LOSARTAN POTASSIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5092	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	LOSARTAN POTASSIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5124	LUCENTIS	RANIBIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5128	LUMENHANCE	MANGANESE CHLORIDE TETRAHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5130	LUMIZYME	ALGLUCOSIDASE ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5134	LUNGAGGREGATE REAGENT	TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5143	LUVERIS	LUTROPIN ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5146	LUXIQ	BETAMETHASONE VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5152	LYMPHOSEEK KIT	TECHNETIUM TC-99M TILMANOCEPT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7520	PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
5160	M-ZOLE 3 COMBINATION PACK	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5161	M-ZOLE 7 DUAL PACK	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7527	PRISMASOL BGK 2/0 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
7534	PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
5155	LYOPHILIZED CYTOXAN	CYCLOPHOSPHAMIDE	2907	C7H15Cl2N2O2P	261.083	\N	0.6	1	4	5	41.6	14	0	212	0	1	\N	\N	C1CNP(=O)(OC1)N(CCCl)CCCl	N,N-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine
5165	M.V.C. 9+3	DEXPANTHENOL	131204	C9H19NO4	205.254	\N	-0.9	4	4	6	89.8	14	0	182	1	0	\N	\N	CC(C)(CO)C(C(=O)NCCCO)O	(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butanamide
5166	M.V.C. 9+3	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
5153	LYNORAL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5167	M.V.C. 9+3	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
5179	M.V.I. ADULT	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
5151	LYMPHAZURIN	ISOSULFAN BLUE	50108	C27H31N2NaO6S2	566.663	\N	\N	0	7	7	137	38	0	1040	0	0	\N	\N	CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC)C=C2)C3=C(C=CC(=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+]	sodium;2-[[4-(diethylamino)phenyl]-(4-diethyliminiocyclohexa-2,5-dien-1-ylidene)methyl]benzene-1,4-disulfonate
5159	M-PREDROL	METHYLPREDNISOLONE ACETATE	5877	C24H32O6	416.514	\N	2.7	2	6	4	101	30	0	858	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)C)O	[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
5154	LYNPARZA	OLAPARIB	23725625	C24H23FN4O3	434.471	\N	1.9	1	5	4	82.1	32	0	790	0	0	\N	\N	C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F	4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluoro-phenyl]methyl]-2H-phthalazin-1-one
5207	M.V.I. PEDIATRIC	PHYTONADIONE	5284607	C31H46O2	450.707	\N	10.9	0	2	14	34.1	33	0	696	2	0	\N	\N	CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C	2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
5156	LYRICA	PREGABALIN	5486971	C8H17NO2	159.229	\N	-1.6	2	3	5	63.3	11	0	123	1	0	\N	\N	CC(C)CC(CC(=O)O)CN	(3S)-3-(aminomethyl)-5-methyl-hexanoic acid
5170	M.V.C. 9+3	RIBOFLAVIN 5'-PHOSPHATE SODIUM	23666409	C17H20N4NaO9P	478.33	\N	\N	5	10	7	204	32	0	856	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)[O-])O)O)O.[Na+]	sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentyl] hydrogen phosphate
5182	M.V.I. ADULT	RIBOFLAVIN 5'-PHOSPHATE SODIUM	23666409	C17H20N4NaO9P	478.33	\N	\N	5	10	7	204	32	0	856	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)[O-])O)O)O.[Na+]	sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentyl] hydrogen phosphate
5233	M.V.I.-12	RIBOFLAVIN	493570	C17H20N4O6	376.369	\N	-1.5	5	7	5	155	27	0	680	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O	7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione
5171	M.V.C. 9+3	THIAMINE HYDROCHLORIDE	6202	C12H18Cl2N4OS	337.263	\N	\N	3	6	4	104	20	0	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-]	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol;chloride;hydrochloride
5158	LYSTEDA	TRANEXAMIC ACID	5526	C8H15NO2	157.213	\N	-2	2	3	2	63.3	11	0	139	0	0	\N	\N	C1CC(CCC1CN)C(=O)O	4-(aminomethyl)cyclohexanecarboxylic acid
5172	M.V.C. 9+3	VITAMIN A	445354	C20H30O	286.459	\N	5.7	1	1	5	20.2	21	0	496	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
5173	M.V.C. 9+3	VITAMIN E	14985	C29H50O2	430.717	\N	10.7	1	2	12	29.5	31	0	503	3	0	\N	\N	CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O	(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
5185	M.V.I. ADULT	VITAMIN E	14985	C29H50O2	430.717	\N	10.7	1	2	12	29.5	31	0	503	3	0	\N	\N	CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O	(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
5186	M.V.I. ADULT	VITAMIN K	5280483	C31H46O2	450.707	\N	10.9	0	2	14	34.1	33	0	696	0	2	\N	\N	CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C	2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
5199	M.V.I. ADULT (PHARMACY BULK PACKAGE)	VITAMIN K	5280483	C31H46O2	450.707	\N	10.9	0	2	14	34.1	33	0	696	0	2	\N	\N	CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C	2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
5285	MANDOL	CEFAMANDOLE NAFATE	23665731	C19H17N6NaO6S2	512.491	\N	\N	1	11	9	210	34	0	844	3	0	\N	\N	CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(C4=CC=CC=C4)OC=O)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2R)-2-formyloxy-2-phenyl-acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
5300	MAOLATE	CHLORPHENESIN CARBAMATE	2724	C10H12ClNO4	245.659	\N	1.2	2	4	6	81.8	16	0	219	0	1	\N	\N	C1=CC(=CC=C1OCC(COC(=O)N)O)Cl	[3-(4-chlorophenoxy)-2-hydroxy-propyl] carbamate
5336	MD-60	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
5335	MD-50	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
5311	MARINOL	DRONABINOL	16078	C21H30O2	314.469	\N	7	1	2	4	29.5	23	0	439	2	0	\N	\N	CCCCCC1=CC2=C(C3C=C(CCC3C(O2)(C)C)C)C(=C1)O	(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol
5264	MACROTEC	TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5265	MACUGEN	PEGAPTANIB SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5322	MAXIBOLIN	ETHYLESTRENOL	13765	C20H32O	288.475	\N	5.1	1	1	1	20.2	21	0	453	6	0	\N	\N	CCC1(CCC2C1(CCC3C2CCC4=CCCCC34)C)O	(8R,9S,10R,13S,14S,17S)-17-ethyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol
5267	MAGNACORT	HYDROCORTAMATE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5268	MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE	MAGNESIUM HYDROXIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5314	MARPLAN	ISOCARBOXAZID	3759	C12H13N3O2	231.255	\N	1.5	2	4	4	67.2	17	0	254	0	0	\N	\N	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	N'-benzyl-5-methyl-isoxazole-3-carbohydrazide
5313	MARLISSA	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
5272	MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE	MAGNESIUM SULFATE ANHYDROUS	24083	MgO4S	120.361	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Mg+2]	magnesium;sulfate
5284	MALATHION	MALATHION	4004	C10H19O6PS2	330.35	\N	2.4	0	8	11	128	19	0	341	0	1	\N	\N	CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC	diethyl 2-dimethoxyphosphinothioylsulfanylbutanedioate
5286	MANGANESE CHLORIDE IN PLASTIC CONTAINER	MANGANESE CHLORIDE	10313134	Cl2Mn	125.838	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Mn+2]	manganous;dichloride
5288	MANNITOL 10%	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
5301	MAPROTILINE HYDROCHLORIDE	MAPROTILINE HYDROCHLORIDE	71478	C20H24ClN	313.869	\N	\N	2	1	4	12	22	0	339	0	0	\N	\N	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24.Cl	\N
5334	MAZANOR	MAZINDOL	4020	C16H13ClN2O	284.743	\N	2.2	1	2	1	35.8	20	0	419	0	1	\N	\N	C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O	5-(4-chlorophenyl)-2,3-dihydroimidazo[1,2-b]isoindol-5-ol
5346	MECAMYLAMINE HYDROCHLORIDE	MECAMYLAMINE HYDROCHLORIDE	13221	C11H22ClN	203.754	\N	\N	2	1	1	12	13	0	197	0	3	\N	\N	CC1(C2CCC(C2)C1(C)NC)C.Cl	N,2,3,3-tetramethylnorbornan-2-amine;hydrochloride
5349	MECLODIUM	MECLOFENAMATE SODIUM	4038	C14H10Cl2NNaO2	318.129	\N	\N	1	3	3	52.2	20	0	332	0	0	\N	\N	CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)[O-])Cl.[Na+]	sodium;2-(2,6-dichloro-3-methyl-anilino)benzoate
5352	MEDICAL AIR, USP	MEDICAL AIR	977	O2	31.998	\N	-1.1	0	2	0	34.1	2	0	0	0	0	\N	\N	O=O	molecular oxygen
5329	MAXOLON	METOCLOPRAMIDE HYDROCHLORIDE	23659	C14H23Cl2N3O2	336.257	\N	\N	3	4	7	67.6	21	0	300	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl.Cl	4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide;hydrochloride
5261	MACROBID	NITROFURANTOIN	6604200	C8H6N4O5	238.159	\N	-0.5	1	6	2	121	17	0	390	0	0	\N	\N	C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]	1-[(E)-(5-nitro-2-furyl)methyleneamino]imidazolidine-2,4-dione
5318	MAXAIR	PIRBUTEROL ACETATE	171674	C14H24N2O5	300.355	\N	\N	5	7	5	123	21	0	261	0	1	\N	\N	CC(=O)O.CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O	acetic acid;6-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)pyridin-3-ol
5316	MATULANE	PROCARBAZINE HYDROCHLORIDE	9703	C12H20ClN3O	257.762	\N	\N	4	3	5	53.2	17	0	210	0	0	\N	\N	CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl	N-isopropyl-4-[(2-methylhydrazino)methyl]benzamide;hydrochloride
5256	M.V.I.-12 LYOPHILIZED	PYRIDOXINE	1054	C8H11NO3	169.18	\N	-0.8	3	4	2	73.6	12	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol
5270	MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
5274	MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE	SODIUM SULFATE	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
5331	MAXZIDE	TRIAMTERENE	5546	C12H11N7	253.269	\N	1	3	7	1	130	19	0	307	0	0	\N	\N	C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N	6-phenylpteridine-2,4,7-triamine
5259	M.V.I.-12 LYOPHILIZED	VITAMIN A	445354	C20H30O	286.459	\N	5.7	1	1	5	20.2	21	0	496	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
5307	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5309	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5344	MDP-BRACCO	TECHNETIUM TC-99M MEDRONATE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5353	MEDICAL GAS, USP	MEDICAL GAS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5357	MEDIHALER ERGOTAMINE	ERGOTAMINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5358	MEDIHALER-EPI	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5356	MEDIGESIC PLUS	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
5392	MENRIUM 10-4	CHLORDIAZEPOXIDE	2712	C16H14ClN3O	299.758	\N	2.4	1	3	1	48.2	21	0	580	0	0	\N	\N	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine
5376	MELAMISA	DROSPIRENONE	68873	C24H30O3	366.501	\N	3.5	0	3	0	43.4	27	0	828	10	0	\N	\N	CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C	\N
5390	MENOSTAR	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
5377	MELAMISA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5360	MEDIPREN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
5365	MEFENAMIC ACID	MEFENAMIC ACID	4044	C15H15NO2	241.29	\N	5.1	2	3	3	49.3	18	0	292	0	0	\N	\N	CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C	2-(2,3-dimethylanilino)benzoic acid
5382	MELOXICAM	MELOXICAM	54677470	C14H13N3O4S2	351.395	\N	3	2	7	2	136	23	0	628	0	0	\N	\N	CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O	4-hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-1,1-dioxo-1$l^{6},2-benzothiazine-3-carboxamide
5383	MELPHALAN HYDROCHLORIDE	MELPHALAN HYDROCHLORIDE	9927978	C13H19Cl3N2O2	341.657	\N	\N	3	4	8	66.6	20	0	265	1	0	\N	\N	C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl.Cl	(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid;hydrochloride
5387	MENADIONE	MENADIONE	4055	C11H8O2	172.183	\N	2.2	0	2	0	34.1	13	0	289	0	0	\N	\N	CC1=CC(=O)C2=CC=CC=C2C1=O	2-methylnaphthalene-1,4-dione
5427	MESANTOIN	MEPHENYTOIN	4060	C12H14N2O2	218.256	\N	1.5	1	2	2	49.4	16	0	310	0	1	\N	\N	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2	5-ethyl-3-methyl-5-phenyl-imidazolidine-2,4-dione
5373	MEGATOPE	ALBUMIN IODINATED I-131 SERUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5410	MEPRIAM	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
5418	MERCAPTOPURINE	MERCAPTOPURINE	667490	C5H4N4S	152.175	\N	0	2	2	0	85.2	10	0	190	0	0	\N	\N	C1=NC2=C(N1)C(=S)N=CN2	3,7-dihydropurine-6-thione
5378	MELFIAT	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5379	MELFIAT-105	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5424	MERSALYL-THEOPHYLLINE	MERSALYL SODIUM	23690449	C13H17HgNNaO6	506.862	\N	\N	2	6	9	88.7	22	0	334	0	1	\N	\N	COC(CNC(=O)C1=CC=CC=C1OCC(=O)[O-])C[Hg].O.[Na+]	sodium;[3-[[2-(carboxylatomethoxy)benzoyl]amino]-2-methoxy-propyl]mercury;hydrate
5426	MESALAMINE	MESALAMINE	4075	C7H7NO3	153.137	\N	1.3	3	4	1	83.6	11	0	160	0	0	\N	\N	C1=CC(=C(C=C1N)C(=O)O)O	5-amino-2-hydroxy-benzoic acid
5444	METAXALONE	METAXALONE	15459	C12H15NO3	221.256	\N	2.2	1	3	3	47.6	16	0	247	0	1	\N	\N	CC1=CC(=CC(=C1)OCC2CNC(=O)O2)C	5-[(3,5-dimethylphenoxy)methyl]oxazolidin-2-one
5448	METHADONE HYDROCHLORIDE	METHADONE HYDROCHLORIDE	14184	C21H28ClNO	345.911	\N	\N	1	2	7	20.3	24	0	346	0	1	\N	\N	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2.Cl	6-(dimethylamino)-4,4-diphenyl-heptan-3-one;hydrochloride
5451	METHAMPEX	METHAMPHETAMINE HYDROCHLORIDE	10836	C10H15N	149.237	\N	2.1	1	1	3	12	11	0	95	1	0	\N	\N	CC(CC1=CC=CC=C1)NC	(2S)-N-methyl-1-phenyl-propan-2-amine
5453	METHAZOLAMIDE	METHAZOLAMIDE	4100	C5H8N4O3S2	236.264	\N	0.1	1	6	1	139	14	0	419	0	0	\N	\N	CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C	N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide
5389	MENOPUR	MENOTROPINS (FSH;LH)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5391	MENOTROPINS	MENOTROPINS (FSH;LH)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5457	METHIMAZOLE	METHIMAZOLE	1349907	C4H6N2S	114.166	\N	-0.3	1	1	0	47.4	7	0	119	0	0	\N	\N	CN1C=CNC1=S	3-methyl-1H-imidazole-2-thione
5431	METADATE CD	METHYLPHENIDATE HYDROCHLORIDE	9280	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	0	2	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl 2-phenyl-2-(2-piperidyl)acetate;hydrochloride
5361	MEDROL	METHYLPREDNISOLONE	6741	C22H30O5	374.477	\N	1.9	3	5	2	94.8	27	0	754	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O	(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
5401	MEPERGAN	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
5420	MERIDIA	SIBUTRAMINE HYDROCHLORIDE	64764	C17H27Cl2N	316.31	\N	\N	1	1	5	3.2	20	0	275	0	1	\N	\N	CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C.Cl	1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethyl-butan-1-amine;hydrochloride
5425	MERSALYL-THEOPHYLLINE	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
5435	METAHYDRIN	TRICHLORMETHIAZIDE	5560	C8H8Cl3N3O4S2	380.639	\N	0.6	3	7	2	135	20	0	571	0	1	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl	6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5419	MERETEK UBT KIT (W/ PRANACTIN)	UREA C-13	636363	CH4N2O	61.048	\N	-1.4	2	1	0	69.1	4	0	29	0	0	\N	\N	C(=O)(N)N	diaminomethanone
5438	METARAMINOL BITARTRATE	METARAMINOL BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5439	METASTRON	STRONTIUM CHLORIDE SR-89	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5455	METHENAMINE HIPPURATE	METHENAMINE HIPPURATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7541	PRISMASOL BGK 4/0 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
5554	MICRONASE	GLYBURIDE	3488	C23H28ClN3O5S	494.003	\N	4.8	3	5	8	122	33	0	746	0	0	\N	\N	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide
5540	MICRAININ	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
5520	MEXATE	METHOTREXATE SODIUM	126941	C20H22N8O5	454.447	\N	-1.8	5	12	9	211	33	0	704	1	0	\N	\N	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
5465	METHOXSALEN	METHOXSALEN	4114	C12H8O4	216.192	\N	1.9	0	4	1	48.7	16	0	325	0	0	\N	\N	COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2	9-methoxyfuro[3,2-g]chromen-7-one
5466	METHSCOPOLAMINE BROMIDE	METHSCOPOLAMINE BROMIDE	5459110	C18H24BrNO4	398.297	\N	\N	1	5	5	59.1	24	0	454	5	0	\N	\N	C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C.[Br-]	\N
5467	METHYCLOTHIAZIDE	METHYCLOTHIAZIDE	4121	C9H11Cl2N3O4S2	360.224	\N	1.4	2	7	2	126	20	0	571	0	1	\N	\N	CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl	6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5470	METHYLDOPA	METHYLDOPA	38853	C10H13NO4	211.217	\N	-1.9	4	5	3	104	15	0	246	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N	(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid
5477	METHYLERGONOVINE MALEATE	METHYLERGONOVINE MALEATE	5281072	C24H29N3O6	455.511	\N	\N	5	7	6	143	33	0	668	3	0	\N	\N	CCC(CO)NC(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C.C(=CC(=O)O)C(=O)O	(6aR,9R)-N-[(1S)-1-(hydroxymethyl)propyl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;maleic acid
5483	METHYLPREDNISOLONE ACETATE	METHYLPREDNISOLONE ACETATE	5877	C24H32O6	416.514	\N	2.7	2	6	4	101	30	0	858	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)C)O	[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
5491	METIPRANOLOL	METIPRANOLOL HYDROCHLORIDE	31477	C17H27NO4	309.406	\N	2.7	2	5	8	67.8	22	0	348	0	1	\N	\N	CC1=CC(=C(C(=C1OC(=O)C)C)C)OCC(CNC(C)C)O	[4-[2-hydroxy-3-(isopropylamino)propoxy]-2,3,6-trimethyl-phenyl] acetate
5496	METOCURINE IODIDE	METOCURINE IODIDE	24244	C40H48I2N2O6	906.641	\N	\N	0	8	4	55.4	50	0	1060	2	0	\N	\N	C[N+]1(CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)OC)O3)[N+](CCC6=CC(=C5OC)OC)(C)C)OC)C.[I-].[I-]	\N
5517	METUBINE IODIDE	METOCURINE IODIDE	24244	C40H48I2N2O6	906.641	\N	\N	0	8	4	55.4	50	0	1060	2	0	\N	\N	C[N+]1(CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)OC)O3)[N+](CCC6=CC(=C5OC)OC)(C)C)OC)C.[I-].[I-]	\N
5515	METRONIDAZOLE HYDROCHLORIDE	METRONIDAZOLE HYDROCHLORIDE	68592	C6H10ClN3O3	207.614	\N	\N	2	4	2	83.9	13	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-].Cl	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol;hydrochloride
5498	METOPIRONE	METYRAPONE	4174	C14H14N2O	226.279	\N	2	0	3	3	42.8	17	0	275	0	0	\N	\N	CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2	2-methyl-1,2-bis(3-pyridyl)propan-1-one
5523	MEXILETINE HYDROCHLORIDE	MEXILETINE HYDROCHLORIDE	21467	C11H18ClNO	215.721	\N	\N	2	2	3	35.2	14	0	139	0	1	\N	\N	CC1=C(C(=CC=C1)C)OCC(C)N.Cl	1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride
5524	MEXITIL	MEXILETINE HYDROCHLORIDE	21467	C11H18ClNO	215.721	\N	\N	2	2	3	35.2	14	0	139	0	1	\N	\N	CC1=C(C(=CC=C1)C)OCC(C)N.Cl	1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride
5528	MIBELAS 24 FE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5555	MICRONOR	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
5482	METHYLPREDNISOLONE	METHYLPREDNISOLONE SODIUM SUCCINATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5484	METHYLPREDNISOLONE SODIUM SUCCINATE	METHYLPREDNISOLONE SODIUM SUCCINATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5541	MICRO-K	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
5486	METI-DERM	PREDNISOLONE	5755	C21H28O5	360.45	\N	1.6	3	5	2	94.8	26	0	724	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
5490	METIMYD	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
5500	METOPROLOL TARTRATE	METOPROLOL TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5502	METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE	METOPROLOL TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5504	METRA	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5525	MEZLIN	MEZLOCILLIN SODIUM MONOHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5526	MIACALCIN	CALCITONIN SALMON	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5529	MICARDIS	TELMISARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5531	MICARDIS HCT	TELMISARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5532	MICONAZOLE 3	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5533	MICONAZOLE 3 COMBINATION PACK	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5534	MICONAZOLE 7	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5535	MICONAZOLE 7 COMBINATION PACK	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5536	MICONAZOLE NITRATE	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5537	MICONAZOLE NITRATE COMBINATION PACK	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5538	MICORT-HC	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5553	MICROLITE	TECHNETIUM TC-99M ALBUMIN COLLOID KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5566	MIGERGOT	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
5569	MIGRANAL	DIHYDROERGOTAMINE MESYLATE	71171	C34H41N5O8S	679.789	\N	\N	4	9	4	181	48	0	1260	7	0	\N	\N	CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O	\N
5639	MODURETIC 5-50	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5562	MIDOL	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
5613	MIRENA	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
5647	MONISTAT	MICONAZOLE	4189	C18H14Cl4N2O	416.123	\N	5.3	0	2	6	27	25	0	417	0	1	\N	\N	C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl	1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
5567	MIGERGOT	ERGOTAMINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5561	MIDODRINE HYDROCHLORIDE	MIDODRINE HYDROCHLORIDE	18340	C12H19ClN2O4	290.744	\N	\N	4	5	6	93.8	19	0	263	0	1	\N	\N	COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O.Cl	2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxy-ethyl]acetamide;hydrochloride
5568	MIGLITOL	MIGLITOL	441314	C8H17NO5	207.226	\N	-2.6	5	6	3	104	14	0	179	4	0	\N	\N	C1C(C(C(C(N1CCO)CO)O)O)O	(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol
5594	MINOCIN	MINOCYCLINE HYDROCHLORIDE	54685925	C23H28ClN3O7	493.941	\N	\N	6	9	3	165	34	0	971	4	0	\N	\N	CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl	(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride
5574	MILOPHENE	CLOMIPHENE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5575	MILPREM-200	ESTROGENS, CONJUGATED	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5596	MINODYL	MINOXIDIL	4201	C9H15N5O	209.253	\N	1.2	3	3	1	88.9	15	0	329	0	0	\N	\N	C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O	3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine
5577	MILPREM-400	ESTROGENS, CONJUGATED	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5616	MISOPROSTOL	MISOPROSTOL	5282381	C22H38O5	382.541	\N	3.7	2	5	14	83.8	27	0	487	3	1	\N	\N	CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O	methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyl-oct-1-enyl]-5-oxo-cyclopentyl]heptanoate
5619	MITOMYCIN	MITOMYCIN	5746	C15H18N4O5	334.332	\N	-0.4	3	8	4	147	24	0	757	4	0	\N	\N	CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N	\N
5631	MODAFINIL	MODAFINIL	4236	C15H15NO2S	273.35	\N	1.7	1	3	5	79.4	19	0	302	0	1	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	2-benzhydrylsulfinylacetamide
5640	MOEXIPRIL HYDROCHLORIDE	MOEXIPRIL HYDROCHLORIDE	54889	C27H35ClN2O7	535.034	\N	\N	3	8	12	114	37	0	742	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC.Cl	(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
5628	MOBAN	MOLINDONE HYDROCHLORIDE	9883259	C16H25ClN2O2	312.838	\N	\N	2	3	3	45.3	21	0	354	0	1	\N	\N	CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C.Cl	3-ethyl-2-methyl-5-(morpholinomethyl)-1,5,6,7-tetrahydroindol-4-one;hydrochloride
5630	MOCTANIN	MONOCTANOIN	3033877	C11H22O4	218.293	\N	2	2	4	10	66.8	15	0	159	0	1	\N	\N	CCCCCCCC(=O)OCC(CO)O	2,3-dihydroxypropyl octanoate
5590	MINITRAN	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
5573	MILONTIN	PHENSUXIMIDE	6839	C11H11NO2	189.214	\N	0.8	0	2	1	37.4	14	0	256	0	1	\N	\N	CN1C(=O)CC(C1=O)C2=CC=CC=C2	1-methyl-3-phenyl-pyrrolidine-2,5-dione
5606	MIRALAX	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
5608	MIRAPEX	PRAMIPEXOLE DIHYDROCHLORIDE	119569	C10H19Cl2N3S	284.243	\N	\N	4	4	3	79.2	16	0	188	1	0	\N	\N	CCCNC1CCC2=C(C1)SC(=N2)N.Cl.Cl	(6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride
5632	MODERIL	RESCINNAMINE	5280954	C35H42N2O9	634.726	\N	4.5	1	10	11	118	46	0	1080	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C=CC6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
5589	MINITEC	TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5601	MINTEZOL	THIABENDAZOLE	5430	C10H7N3S	201.247	\N	2.5	1	3	1	69.8	14	0	212	0	0	\N	\N	C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3	4-(1H-benzimidazol-2-yl)thiazole
5607	MIRALUMA	TECHNETIUM TC-99M SESTAMIBI KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5610	MIRCERA	METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5614	MIRTAZAPINE	MIRTAZAPINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5615	MIRVASO	BRIMONIDINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5626	MIXTARD HUMAN 70/30	INSULIN RECOMBINANT PURIFIED HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5627	MIXTARD HUMAN 70/30	INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5648	MONISTAT 1 COMBINATION PACK	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5649	MONISTAT 3	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5650	MONISTAT 3 COMBINATION PACK	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5651	MONISTAT 3 COMBINATION PACK (PREFILLED)	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5652	MONISTAT 5	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5653	MONISTAT 7	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5654	MONISTAT 7 COMBINATION PACK	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5655	MONISTAT DUAL- PAK	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5656	MONISTAT-DERM	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5660	MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5679	MOVIPREP	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
5767	MYOTONACHOL	BETHANECHOL CHLORIDE	11548	C7H17ClN2O2	196.675	\N	\N	1	3	4	52.3	12	0	140	0	1	\N	\N	CC(C[N+](C)(C)C)OC(=O)N.[Cl-]	2-carbamoyloxypropyl(trimethyl)ammonium;chloride
5663	MONOKET	ISOSORBIDE MONONITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7548	PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
7555	PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
5719	MVC PLUS	DEXPANTHENOL	131204	C9H19NO4	205.254	\N	-0.9	4	4	6	89.8	14	0	182	1	0	\N	\N	CC(C)(CO)C(C(=O)NCCCO)O	(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butanamide
5700	MUCINEX DM	DEXTROMETHORPHAN HYDROBROMIDE	5464025	C18H26BrNO	352.316	\N	\N	1	2	1	12.5	21	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br	\N
5668	MONUROL	FOSFOMYCIN TROMETHAMINE	54331	C7H18NO7P	259.195	\N	\N	5	7	4	161	16	0	190	2	0	\N	\N	CC1C(O1)P(=O)(O)[O-].C(C(CO)(CO)[NH3+])O	[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]ammonium;hydroxy-[(2R,3S)-3-methyloxiran-2-yl]phosphinate
5697	MUCINEX	GUAIFENESIN	3516	C10H14O4	198.218	\N	1.4	2	4	5	58.9	14	0	151	0	1	\N	\N	COC1=CC=CC=C1OCC(CO)O	3-(2-methoxyphenoxy)propane-1,2-diol
5698	MUCINEX D	GUAIFENESIN	3516	C10H14O4	198.218	\N	1.4	2	4	5	58.9	14	0	151	0	1	\N	\N	COC1=CC=CC=C1OCC(CO)O	3-(2-methoxyphenoxy)propane-1,2-diol
5666	MONOPRIL-HCT	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5704	MUCOMYST W/ ISOPROTERENOL	ISOPROTERENOL HYDROCHLORIDE	5807	C11H18ClNO3	247.719	\N	\N	5	4	4	72.7	16	0	187	0	1	\N	\N	CC(C)NCC(C1=CC(=C(C=C1)O)O)O.Cl	4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol;hydrochloride
5771	MYRBETRIQ	MIRABEGRON	9865528	C21H24N4O2S	396.509	\N	2.1	4	6	9	129	28	0	467	1	0	\N	\N	C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O	2-(2-aminothiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenyl-ethyl]amino]ethyl]phenyl]acetamide
5685	MOXAM	MOXALACTAM DISODIUM	441242	C20H18N6Na2O9S	564.437	\N	\N	2	13	7	237	38	0	947	2	1	\N	\N	CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C(C4=CC=C(C=C4)O)C(=O)[O-])OC)OC2)C(=O)[O-].[Na+].[Na+]	disodium;(6R,7R)-7-[[2-carboxylato-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
5747	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	6441022	C23H32ClNO7	469.959	\N	\N	2	8	10	94.5	32	0	646	0	0	\N	\N	CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)OCCN3CCOCC3)OC.Cl	2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate;hydrochloride
5722	MVC PLUS	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
5690	MOZOBIL	PLERIXAFOR	65015	C28H54N8	502.796	\N	0	6	8	4	78.7	36	0	456	0	0	\N	\N	C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3	1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane
5680	MOVIPREP	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
5681	MOVIPREP	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
5763	MYMETHAZINE FORTIS	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
5699	MUCINEX D	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
5743	MYCOBUTIN	RIFABUTIN	6323490	C46H62N4O11	847.019	\N	6.3	5	14	5	206	61	0	1870	9	0	\N	\N	CC1C=CC=C(C(=O)NC2=C3C(=NC4(N3)CCN(CC4)CC(C)C)C5=C6C(=C(C(=C5C2=O)O)C)OC(C6=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C	\N
5691	MPI DMSA KIDNEY REAGENT	TECHNETIUM TC-99M SUCCIMER KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5683	MOVIPREP	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
5693	MPI INDIUM DTPA IN 111	INDIUM IN-111 PENTETATE DISODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5694	MPI KRYPTON 81M GENERATOR	KRYPTON, KR-81M	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5725	MVC PLUS	THIAMINE HYDROCHLORIDE	6202	C12H18Cl2N4OS	337.263	\N	\N	3	6	4	104	20	0	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-]	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol;chloride;hydrochloride
5753	MYFED	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
5750	MYDRIACYL	TROPICAMIDE	5593	C17H20N2O2	284.359	\N	1.5	1	3	6	53.4	21	0	310	0	1	\N	\N	CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2	N-ethyl-3-hydroxy-2-phenyl-N-(4-pyridylmethyl)propanamide
5708	MULTIFUGE	PIPERAZINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5728	MYALEPT	METRELEPTIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5738	MYCITRACIN	BACITRACIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5762	MYLOTARG	GEMTUZUMAB OZOGAMICIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5764	MYOBLOC	Botulinum Toxin Type B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5766	MYOSCINT	IMCIROMAB PENTETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5768	MYOVIEW	TECHNETIUM TC-99M TETROFOSMIN KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5769	MYOVIEW 30ML	TECHNETIUM TC-99M TETROFOSMIN KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5770	MYOZYME	ALGLUCOSIDASE ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9208	TRIAVIL 4-10	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
5848	NATURAL ESTROGENIC SUBSTANCE-ESTRONE	ESTRONE	5870	C18H22O2	270.372	\N	3.1	1	2	0	37.3	20	0	418	4	0	\N	\N	CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one
5795	NALFON	FENOPROFEN CALCIUM	64747	C30H30CaO8	558.64	\N	\N	2	8	6	101	39	0	265	0	2	\N	\N	CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].O.O.[Ca+2]	calcium;2-(3-phenoxyphenyl)propanoate;dihydrate
5857	NAVSTEL	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
5839	NASONEX	MOMETASONE FUROATE	441336	C27H30Cl2O6	521.431	\N	3.9	1	6	5	93.8	35	0	1020	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C	[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
5790	NAFTIFINE HYDROCHLORIDE	NAFTIFINE HYDROCHLORIDE	5281098	C21H22ClN	323.864	\N	\N	1	1	5	3.2	23	0	342	0	0	\N	\N	CN(CC=CC1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32.Cl	(E)-N-methyl-N-(1-naphthylmethyl)-3-phenyl-prop-2-en-1-amine;hydrochloride
5793	NALBUPHINE	NALBUPHINE HYDROCHLORIDE	5360733	C21H28ClNO4	393.908	\N	\N	4	5	2	73.2	27	0	597	5	0	\N	\N	C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O.Cl	(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol;hydrochloride
5799	NALOXONE	NALOXONE HYDROCHLORIDE	5464092	C19H22ClNO4	363.838	\N	\N	3	5	2	70	25	0	594	4	0	\N	\N	C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.Cl	(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
5804	NALTREXONE HYDROCHLORIDE	NALTREXONE HYDROCHLORIDE	5485201	C20H24ClNO4	377.865	\N	\N	3	5	2	70	26	0	621	4	0	\N	\N	C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O.Cl	(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
5788	NAFAZAIR	NAPHAZOLINE HYDROCHLORIDE	11079	C14H15ClN2	246.738	\N	\N	2	1	2	24.4	17	0	272	0	0	\N	\N	C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl	2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride
5817	NAPRELAN	NAPROXEN SODIUM	23681059	C14H13NaO3	252.245	\N	\N	0	3	3	49.4	18	0	282	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+]	sodium;(2S)-2-(6-methoxy-2-naphthyl)propanoate
5822	NAPROXEN SODIUM	NAPROXEN SODIUM	23681059	C14H13NaO3	252.245	\N	\N	0	3	3	49.4	18	0	282	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+]	sodium;(2S)-2-(6-methoxy-2-naphthyl)propanoate
5818	NAPROSYN	NAPROXEN	156391	C14H14O3	230.263	\N	3.3	1	3	3	46.5	17	0	277	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O	(2S)-2-(6-methoxy-2-naphthyl)propanoic acid
5840	NATACYN	NATAMYCIN	5284447	C33H47NO13	665.733	\N	-1.3	7	14	3	231	47	0	1220	14	0	\N	\N	CC1CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC3C(O3)C=CC(=O)O1)O)O)O)C(=O)O)OC4C(C(C(C(O4)C)O)N)O	\N
5867	NEFAZODONE HYDROCHLORIDE	NEFAZODONE HYDROCHLORIDE	54911	C25H33Cl2N5O2	506.472	\N	\N	1	5	10	51.6	34	0	649	0	0	\N	\N	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl.Cl	2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one;hydrochloride
5858	NAVSTEL	OXIGLUTATIONE	65359	C20H32N6O12S2	612.626	\N	-9.1	10	16	21	368	40	0	879	4	0	\N	\N	C(CC(=O)NC(CSSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)C(=O)NCC(=O)O)C(C(=O)O)N	(2S)-2-amino-5-[[(1R)-1-[[[(2R)-2-[[(4S)-4-amino-4-carboxy-butanoyl]amino]-3-(carboxymethylamino)-3-oxo-propyl]disulfanyl]methyl]-2-(carboxymethylamino)-2-oxo-ethyl]amino]-5-oxo-pentanoic acid
5792	NAGLAZYME	GALSULFASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5869	NEMBUTAL	PENTOBARBITAL	4737	C11H18N2O3	226.276	\N	2.1	2	3	4	75.3	16	0	305	0	1	\N	\N	CCCC(C)C1(C(=O)NC(=O)NC1=O)CC	5-ethyl-5-(1-methylbutyl)hexahydropyrimidine-2,4,6-trione
5830	NARDIL	PHENELZINE SULFATE	61100	C8H14N2O4S	234.27	\N	\N	4	6	3	121	15	0	159	0	0	\N	\N	C1=CC=C(C=C1)CCNN.OS(=O)(=O)O	2-phenylethylhydrazine;sulfuric acid
5859	NAVSTEL	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
5772	MYSOLINE	PRIMIDONE	4909	C12H14N2O2	218.256	\N	0.9	2	2	2	58.2	16	0	279	0	0	\N	\N	CCC1(C(=O)NCNC1=O)C2=CC=CC=C2	5-ethyl-5-phenyl-hexahydropyrimidine-4,6-dione
5831	NAROPIN	ROPIVACAINE HYDROCHLORIDE	175804	C17H27ClN2O	310.866	\N	\N	2	2	4	32.3	21	0	308	1	0	\N	\N	CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	(2S)-N-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide;hydrochloride
5862	NAVSTEL	SODIUM PHOSPHATE	24243	Na3O4P	163.939	\N	\N	0	4	0	86.2	8	0	36.8	0	0	\N	\N	[O-]P(=O)([O-])[O-].[Na+].[Na+].[Na+]	trisodium;phosphate
5775	MYTREX A	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
5803	NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE	PENTAZOCINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5825	NAQUA	TRICHLORMETHIAZIDE	5560	C8H8Cl3N3O4S2	380.639	\N	0.6	3	7	2	135	20	0	571	0	1	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl	6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5828	NARATRIPTAN	NARATRIPTAN HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5842	NATAZIA	ESTRADIOL VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5845	NATPARA	PARATHYROID HORMONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5846	NATRECOR	NESIRITIDE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5847	NATROBA	SPINOSAD	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5854	NAVELBINE	VINORELBINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5856	NAVSTEL	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5872	NEO TECT KIT	TECHNETIUM TC-99M DEPREOTIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5874	NEO-CORT-DOME	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5876	NEO-CORT-DOME	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5878	NEO-CORTEF	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9210	TRIAVIL 4-25	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
9212	TRIAVIL 4-50	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
5910	NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
5958	NEOTHYLLINE	DYPHYLLINE	3182	C10H14N4O4	254.246	\N	-1.8	2	5	3	98.9	18	0	364	0	1	\N	\N	CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O	7-(2,3-dihydroxypropyl)-1,3-dimethyl-purine-2,6-dione
5962	NEPTAZANE	METHAZOLAMIDE	4100	C5H8N4O3S2	236.264	\N	0.1	1	6	1	139	14	0	419	0	0	\N	\N	CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C	N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide
5887	NEO-MEDROL ACETATE	METHYLPREDNISOLONE ACETATE	5877	C24H32O6	416.514	\N	2.7	2	6	4	101	30	0	858	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)C)O	[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
5957	NEOSTIGMINE METHYLSULFATE	NEOSTIGMINE METHYLSULFATE	5824	C13H22N2O6S	334.387	\N	\N	0	6	3	104	22	0	337	0	0	\N	\N	CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.COS(=O)(=O)[O-]	[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-ammonium;methyl sulfate
5889	NEO-POLYCIN	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5891	NEO-POLYCIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5881	NEO-DELTA-CORTEF	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
5884	NEO-HYDELTRASOL	PREDNISOLONE SODIUM PHOSPHATE	441409	C21H27Na2O8P	484.392	\N	\N	2	8	3	147	32	0	878	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]	disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
5938	NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
5959	NEOTRIZINE	TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)	60896	C33H36N12O6S3	792.909	\N	\N	6	18	9	319	54	0	1060	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-pyrimidin-2-yl-benzenesulfonamide
5901	NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5902	NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5907	NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5916	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5919	NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5920	NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5929	NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5934	NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5942	NEOPHAM 6.4%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5943	NEOPROFEN	IBUPROFEN LYSINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5946	NEOSCAN	GALLIUM CITRATE GA-67	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5947	NEOSPORIN	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5960	NEPHRAMINE 5.4%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5961	NEPHROFLOW	IODOHIPPURATE SODIUM I-123	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5967	NETSPOT	GALLIUM DOTATATE GA-68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5969	NEUMEGA	OPRELVEKIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5970	NEUPOGEN	FILGRASTIM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
592	AMLEXANOX	AMLEXANOX	2161	C16H14N2O4	298.298	\N	3.1	2	6	2	103	22	0	467	0	0	\N	\N	CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N	2-amino-7-isopropyl-5-oxo-chromeno[2,3-b]pyridine-3-carboxylic acid
5974	NEUROLITE	TECHNETIUM TC-99M BICISATE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7562	PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
5985	NEXPLANON	ETONOGESTREL	6917715	C22H28O2	324.464	\N	3.3	1	2	2	37.3	24	0	677	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
5972	NEURACEQ	FLORBETABEN F-18	11501341	C21H26FNO3	358.444	\N	4.2	1	5	12	39.7	26	0	364	0	0	\N	\N	CNC1=CC=C(C=C1)C=CC2=CC=C(C=C2)OCCOCCOCCF	4-[(E)-2-[4-[2-[2-(2-fluoranylethoxy)ethoxy]ethoxy]phenyl]vinyl]-N-methyl-aniline
5975	NEURONTIN	GABAPENTIN	3446	C9H17NO2	171.24	\N	-1.1	2	3	3	63.3	12	0	162	0	0	\N	\N	C1CCC(CC1)(CC(=O)O)CN	2-[1-(aminomethyl)cyclohexyl]acetic acid
6040	NIZORAL	KETOCONAZOLE	456201	C26H28Cl2N4O4	531.434	\N	4.3	0	6	7	69.1	36	0	735	2	0	\N	\N	CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl	1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
5973	NEURAMATE	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
6043	NOLUDAR	METHYPRYLON	4162	C10H17NO2	183.251	\N	0.8	1	2	2	46.2	13	0	231	0	1	\N	\N	CCC1(C(=O)C(CNC1=O)C)CC	3,3-diethyl-5-methyl-piperidine-2,4-dione
5987	NIACIN	NIACIN	938	C6H5NO2	123.111	\N	0.4	1	3	1	50.2	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)O	nicotinic acid
5988	NIACOR	NIACIN	938	C6H5NO2	123.111	\N	0.4	1	3	1	50.2	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)O	nicotinic acid
5992	NICLOCIDE	NICLOSAMIDE	4477	C13H8Cl2N2O4	327.117	\N	4	2	4	2	95.2	21	0	404	0	0	\N	\N	C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O	5-chloro-N-(2-chloro-4-nitro-phenyl)-2-hydroxy-benzamide
5995	NICORETTE	NICOTINE POLACRILEX	89594	C10H14N2	162.236	\N	1.2	0	2	1	16.1	12	0	147	1	0	\N	\N	CN1CCCC1C2=CN=CC=C2	3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
5993	NICODERM CQ	NICOTINE	89594	C10H14N2	162.236	\N	1.2	0	2	1	16.1	12	0	147	1	0	\N	\N	CN1CCCC1C2=CN=CC=C2	3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
6003	NILANDRON	NILUTAMIDE	4493	C12H10F3N3O4	317.224	\N	2	1	7	1	95.2	22	0	515	0	0	\N	\N	CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C	5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione
6014	NISOLDIPINE	NISOLDIPINE	4499	C20H24N2O6	388.42	\N	3.3	1	7	7	110	28	0	704	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	O5-isobutyl O3-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
6021	NITROFURANTOIN	NITROFURANTOIN	6604200	C8H6N4O5	238.159	\N	-0.5	1	6	2	121	17	0	390	0	0	\N	\N	C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]	1-[(E)-(5-nitro-2-furyl)methyleneamino]imidazolidine-2,4-dione
6026	NITROFURAZONE	NITROFURAZONE	5447130	C6H6N4O4	198.138	\N	0.2	2	5	2	126	14	0	261	0	0	\N	\N	C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N	[(E)-(5-nitro-2-furyl)methyleneamino]urea
6027	NITROGEN, NF	NITROGEN	947	N2	28.014	\N	0.1	0	2	0	47.6	2	0	8	0	0	\N	\N	N#N	molecular nitrogen
6037	NITROUS OXIDE, USP	NITROUS OXIDE	948	N2O	44.013	\N	0.5	0	2	0	54.5	3	0	29.3	0	0	\N	\N	N#[N+][O-]	nitrous oxide
6039	NIZATIDINE	NIZATIDINE	3033637	C12H21N5O2S2	331.453	\N	1.6	2	8	9	140	21	0	349	0	0	\N	\N	CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C	(E)-N1'-[2-[[2-[(dimethylamino)methyl]thiazol-4-yl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine
6072	NORETHINDRONE ACETATE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6045	NOR-QD	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
5968	NEULASTA	PEGFILGRASTIM	119525	C18H24FN3O6S	429.463	\N	\N	2	10	3	127	29	0	638	0	0	\N	\N	CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O.CS(=O)(=O)O	1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid;methanesulfonic acid
6015	NITHIODOTE	SODIUM NITRITE	23668193	NNaO2	68.995	\N	\N	0	3	0	52.5	4	0	13.5	0	0	\N	\N	N(=O)[O-].[Na+]	sodium;nitrite
6010	NINLARO	IXAZOMIB CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6012	NIPRIDE	SODIUM NITROPRUSSIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6035	NITROPRESS	SODIUM NITROPRUSSIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6042	NOGENIC HC	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6044	NOLVADEX	TAMOXIFEN CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6051	NORCET	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6053	NORCO	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6059	NORDITROPIN	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6060	NORDITROPIN FLEXPRO	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6061	NORDITROPIN NORDIFLEX	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6062	NOREPINEPHRINE BITARTRATE	NOREPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9215	TRIBENZOR	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
6079	NORETHINDRONE ACETATE ETHINYL ESTRADIOL; FERROUS FUMARATE	NORETHINDRONE ACETATE ETHINYL ESTRADIOL;FERROUS FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6080	NORETHINDRONE ACETATE; ETHINYL ESTRADIOL; ETHINYL ESTRADIOL; FERROUS FUMARATE	NORETHINDRONE ACETATE;ETHINYL ESTRADIOL;ETHINYL ESTRADIOL;FERROUS FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6169	NORTHERA	DROXIDOPA	92974	C9H11NO5	213.189	\N	-3.2	5	6	3	124	15	0	235	2	0	\N	\N	C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O	(2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxy-propanoic acid
6158	NORMOZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
6119	NORISODRINE AEROTROL	ISOPROTERENOL HYDROCHLORIDE	5807	C11H18ClNO3	247.719	\N	\N	5	4	4	72.7	16	0	187	0	1	\N	\N	CC(C)NCC(C1=CC(=C(C=C1)O)O)O.Cl	4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol;hydrochloride
6142	NORMODYNE	LABETALOL HYDROCHLORIDE	71412	C19H25ClN2O3	364.87	\N	\N	5	4	8	95.6	25	0	385	0	2	\N	\N	CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O.Cl	2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]ethyl]benzamide;hydrochloride
6159	NORMOZIDE	LABETALOL HYDROCHLORIDE	71412	C19H25ClN2O3	364.87	\N	\N	5	4	8	95.6	25	0	385	0	2	\N	\N	CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O.Cl	2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]ethyl]benzamide;hydrochloride
6163	NORPLANT	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6144	NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM ACETATE	8896	C4H6MgO4	142.393	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Mg+2]	magnesium;diacetate
6091	NORFLEX	ORPHENADRINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6136	NORMOCARB HF 25	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6089	NORETHINDRONE AND MESTRANOL	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6094	NORGESIC	ORPHENADRINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6120	NORITATE	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
6078	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6097	NORGESIC FORTE	ORPHENADRINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6082	NORETHINDRONE AND ETHINYL ESTRADIOL	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6160	NOROXIN	NORFLOXACIN	4539	C16H18FN3O3	319.336	\N	-1	2	7	3	72.9	23	0	519	0	0	\N	\N	CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O	1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
6099	NORGESTIMATE AND ETHINYL ESTRADIOL	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6100	NORGESTIMATE; ETHINYL ESTRADIOL	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6103	NORGESTREL AND ETHINYL ESTRADIOL	NORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6149	NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6150	NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
6137	NORMOCARB HF 25	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
6138	NORMOCARB HF 25	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6152	NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM GLUCONATE	23672301	C6H11NaO7	218.137	\N	\N	5	7	5	141	14	0	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+]	sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
6128	NORLESTRIN FE 1/50	FERROUS FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6131	NORLESTRIN FE 2.5/50	FERROUS FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6143	NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6147	NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6167	NORQUEST FE	FERROUS FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
597	AMLODIPINE BESYLATE	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
6242	NUTRESTORE	GLUTAMINE	5961	C5H10N2O3	146.146	\N	-3.1	3	4	4	106	10	0	146	1	0	\N	\N	C(CC(=O)N)C(C(=O)O)N	(2S)-2,5-diamino-5-oxo-pentanoic acid
6239	NUPRIN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
6253	NUVESSA	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
6260	NYMALIZE	NIMODIPINE	4497	C21H26N2O7	418.446	\N	3.1	1	8	9	120	30	0	736	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC	O5-isopropyl O3-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
6261	NYSERT	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
6237	NUMORPHAN	OXYMORPHONE HYDROCHLORIDE	5284604	C17H19NO4	301.342	\N	0.8	2	5	0	70	22	0	539	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O	(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6273	OBESTIN-30	PHENTERMINE HYDROCHLORIDE	70969	C10H16ClN	185.695	\N	\N	2	1	2	26	12	0	112	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)N.Cl	2-methyl-1-phenyl-propan-2-amine;hydrochloride
6229	NULYTELY	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
6180	NORTRIPTYLINE HYDROCHLORIDE	NORTRIPTYLINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6230	NULYTELY	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6183	NOVAFED	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
6184	NOVAMINE 11.4%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6185	NOVAMINE 15%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6186	NOVAMINE 15% SULFITE FREE IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6187	NOVAMINE 8.5%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6231	NULYTELY	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
6232	NULYTELY	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6190	NOVOLIN 70/30	INSULIN RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6191	NOVOLIN 70/30	INSULIN SUSP ISOPHANE RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6192	NOVOLIN 70/30	INSULIN RECOMBINANT PURIFIED HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6193	NOVOLIN 70/30	INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6194	NOVOLIN L	INSULIN ZINC SUSP RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6195	NOVOLIN L	INSULIN ZINC SUSP SEMISYNTHETIC PURIFIED HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6196	NOVOLIN N	INSULIN SUSP ISOPHANE RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6197	NOVOLIN N	INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6198	NOVOLIN R	INSULIN RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6199	NOVOLIN R	INSULIN RECOMBINANT PURIFIED HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6200	NOVOLOG	INSULIN ASPART RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6201	NOVOLOG FLEXPEN	INSULIN ASPART RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6202	NOVOLOG FLEXTOUCH	INSULIN ASPART RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6203	NOVOLOG INNOLET	INSULIN ASPART RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6204	NOVOLOG MIX 50/50	INSULIN ASPART PROTAMINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6205	NOVOLOG MIX 50/50	INSULIN ASPART RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6206	NOVOLOG MIX 70/30	INSULIN ASPART PROTAMINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6207	NOVOLOG MIX 70/30	INSULIN ASPART RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6208	NOVOLOG MIX 70/30 FLEXPEN	INSULIN ASPART PROTAMINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6209	NOVOLOG MIX 70/30 FLEXPEN	INSULIN ASPART RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6210	NOVOLOG MIX 70/30 PENFILL	INSULIN ASPART PROTAMINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6211	NOVOLOG MIX 70/30 PENFILL	INSULIN ASPART RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6212	NOVOLOG PENFILL	INSULIN ASPART RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6266	NYSTATIN AND TRIAMCINOLONE ACETONIDE	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
6216	NPH ILETIN I (BEEF-PORK)	INSULIN SUSP ISOPHANE BEEF/PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6217	NPH ILETIN II	INSULIN SUSP ISOPHANE PURIFIED BEEF	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6218	NPH ILETIN II (PORK)	INSULIN SUSP ISOPHANE PURIFIED PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6219	NPH INSULIN	INSULIN SUSP ISOPHANE BEEF	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6220	NPH PURIFIED PORK ISOPHANE INSULIN	INSULIN SUSP ISOPHANE PURIFIED PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6223	NUCALA	MEPOLIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6228	NULOJIX	BELATACEPT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6238	NUPLAZID	PIMAVANSERIN TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6241	NUTRACORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6243	NUTRILIPID 10%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6244	NUTRILIPID 20%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6245	NUTROPIN	SOMATROPIN [rDNA origin]	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6246	NUTROPIN	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6247	NUTROPIN AQ	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6248	NUTROPIN AQ NUSPIN	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6249	NUTROPIN AQ PEN	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6250	NUTROPIN DEPOT	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6275	OBREDON	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6345	OMNARIS	CICLESONIDE	6918155	C32H44O7	540.697	\N	5.3	1	7	6	99.1	39	0	1100	9	0	\N	\N	CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6	\N
6371	ONFI	CLOBAZAM	2789	C16H13ClN2O2	300.742	\N	2.1	0	2	1	40.6	21	0	423	0	0	\N	\N	CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione
6299	ODEFSEY	EMTRICITABINE	60877	C8H10FN3O3S	247.244	\N	-0.6	2	5	2	113	16	0	374	2	0	\N	\N	C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F	4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
6312	OGESTREL 0.5/50-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6306	OFORTA	FLUDARABINE PHOSPHATE	30751	C10H13FN5O7P	365.214	\N	-3.1	5	12	4	186	24	0	514	4	0	\N	\N	C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(N=C2N)F	[(2R,3S,4S,5R)-5-(6-amino-2-fluoro-purin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate
6274	OBREDON	GUAIFENESIN	3516	C10H14O4	198.218	\N	1.4	2	4	5	58.9	14	0	151	0	1	\N	\N	COC1=CC=CC=C1OCC(CO)O	3-(2-methoxyphenoxy)propane-1,2-diol
6347	OMNIPAQUE 140	IOHEXOL	3730	C19H26I3N3O9	821.142	\N	-3	8	9	12	200	34	0	653	0	3	\N	\N	CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I	5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
6373	ONIVYDE	IRINOTECAN HYDROCHLORIDE	74990	C33H39ClN4O6	623.147	\N	\N	2	8	5	113	44	0	1200	1	0	\N	\N	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7.Cl	\N
6284	OCTOCAINE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
6291	OCUFLOX	OFLOXACIN	4583	C18H20FN3O4	361.373	\N	-0.4	1	8	2	73.3	26	0	634	0	1	\N	\N	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	\N
6292	OCUMYCIN	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6305	OFLOXACIN	OFLOXACIN	4583	C18H20FN3O4	361.373	\N	-0.4	1	8	2	73.3	26	0	634	0	1	\N	\N	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	\N
6294	OCUPRESS	CARTEOLOL HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6316	OLANZAPINE	OLANZAPINE	4585	C17H20N4S	312.435	\N	2.8	1	5	1	56.2	22	0	543	0	0	\N	\N	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
6330	OLOPATADINE HYDROCHLORIDE	OLOPATADINE HYDROCHLORIDE	5282402	C21H24ClNO3	373.877	\N	\N	2	4	5	49.8	26	0	488	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O.Cl	2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid;hydrochloride
6342	OMEPRAZOLE MAGNESIUM	OMEPRAZOLE MAGNESIUM	4594	C17H19N3O3S	345.417	\N	2.2	1	6	5	96.3	24	0	453	0	1	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
6366	ONDANSETRON HYDROCHLORIDE	ONDANSETRON HYDROCHLORIDE	68647	C18H20ClN3O	329.828	\N	\N	1	2	2	39.8	23	0	440	0	1	\N	\N	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl	9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one;hydrochloride
6301	ODEFSEY	TENOFOVIR ALAFENAMIDE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6365	ONDANSETRON	ONDANSETRON	4595	C18H19N3O	293.37	\N	2.3	0	2	2	39.8	22	0	440	0	1	\N	\N	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
6276	OBY-TRIM	PHENTERMINE HYDROCHLORIDE	70969	C10H16ClN	185.695	\N	\N	2	1	2	26	12	0	112	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)N.Cl	2-methyl-1-phenyl-propan-2-amine;hydrochloride
6295	OCUSERT PILO-20	PILOCARPINE	5910	C11H16N2O2	208.261	\N	1.1	0	3	3	44.1	15	0	245	2	0	\N	\N	CCC1C(COC1=O)CC2=CN=CN2C	(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one
6278	OCL	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
6372	ONGLYZA	SAXAGLIPTIN HYDROCHLORIDE	49800073	C18H26ClN3O2	351.875	\N	\N	3	4	2	90.4	24	0	609	4	2	\N	\N	C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N.Cl	(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;hydrochloride
6280	OCL	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
6281	OCL	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6319	OLEPTRO	TRAZODONE HYDROCHLORIDE	62935	C19H23Cl2N5O	408.327	\N	\N	1	4	5	42.4	27	0	611	0	0	\N	\N	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl.Cl	2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride
6320	OLMESARTAN MEDOXOMIL	OLMESARTAN MEDOXOMIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6322	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	OLMESARTAN MEDOXOMIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6325	OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE	OLMESARTAN MEDOXOMIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6326	OLMESARTAN MEDOXOMIL; AMLODIPINE; HYDROCHLOROTHIAZIDE	OLMESARTAN MEDOXOMIL;AMLODIPINE;HYDROCHLOROTHIAZIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6327	OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE	OLMESARTAN MEDOXOMIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6329	OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE	OLMESARTAN MEDOXOMIL;HYDROCHLOROTHIAZIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6334	OMACOR	OMEGA-3ACID ETHYL ESTERS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6354	OMNIPEN (AMPICILLIN)	AMPICILLIN/AMPICILLIN TRIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6358	OMNITROPE	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6359	OMONTYS	PEGINESATIDE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6360	OMONTYS PRESERVATIVE FREE	PEGINESATIDE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6363	ONCASPAR	PEGASPARGASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6375	ONSOLIS	FENTANYL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6376	ONTAK	DENILEUKIN DIFTITOX	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7569	PRISMASOL BK 0/0 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
7576	PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
6473	ORTHO-CEPT	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
6457	ORSYTHIA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6384	OPDIVO	NIVOLUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6405	ORA-TESTRYL	FLUOXYMESTERONE	6446	C20H29FO3	336.447	\N	2.4	2	4	0	57.5	24	0	630	7	0	\N	\N	CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C)O)C)O)F	(8S,9R,10S,11S,13S,14S,17S)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
6393	OPTIMARK	GADOVERSETAMIDE	444013	C20H34GdN5O10	661.767	\N	\N	2	13	19	207	36	0	614	0	0	\N	\N	COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]	2-[bis[2-[carboxylatomethyl-[2-(2-methoxyethylamino)-2-oxo-ethyl]amino]ethyl]amino]acetate;gadolinium(3+)
6426	ORETIC	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
6389	OPHTHOCORT	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6437	ORGATRAX	HYDROXYZINE HYDROCHLORIDE	3658	C21H27ClN2O2	374.909	\N	3.7	1	4	8	35.9	26	0	376	0	1	\N	\N	C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol
6397	OPTIRAY 160	IOVERSOL	3741	C18H24I3N3O9	807.115	\N	-3	8	9	12	200	33	0	623	0	2	\N	\N	C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO	N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
6410	ORAGRAFIN CALCIUM	IPODATE CALCIUM	14381	C24H24CaI6N4O4	1233.985	\N	\N	0	6	8	112	39	0	333	0	0	\N	\N	CN(C)C=NC1=C(C=C(C(=C1I)CCC(=O)[O-])I)I.CN(C)C=NC1=C(C=C(C(=C1I)CCC(=O)[O-])I)I.[Ca+2]	calcium;3-[3-(dimethylaminomethyleneamino)-2,4,6-triiodo-phenyl]propanoate
6380	OPCICON ONE-STEP	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6480	ORTHO-NOVUM 1/50 21	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6433	ORETON	METHYLTESTOSTERONE	6010	C20H30O2	302.458	\N	3.4	1	2	0	37.3	22	0	550	6	0	\N	\N	CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
6422	ORAVIG	MICONAZOLE	4189	C18H14Cl4N2O	416.123	\N	5.3	0	2	6	27	25	0	417	0	1	\N	\N	C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl	1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
6435	ORFADIN	NITISINONE	115355	C14H10F3NO5	329.231	\N	2.3	0	8	2	97	23	0	524	0	0	\N	\N	C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-]	2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione
6460	ORTHO CYCLEN-21	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6378	OPANA	OXYMORPHONE HYDROCHLORIDE	5284604	C17H19NO4	301.342	\N	0.8	2	5	0	70	22	0	539	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O	(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6402	OPTISON	ALBUMIN HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6415	ORAP	PIMOZIDE	16362	C28H29F2N3O	461.557	\N	6.3	1	4	7	35.6	34	0	632	0	0	\N	\N	C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F	3-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidyl]-1H-benzimidazol-2-one
6406	ORABASE HCA	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6407	ORABLOC	ARTICAINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6408	ORABLOC	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6419	ORAQIX	PRILOCAINE	4906	C13H20N2O	220.316	\N	2.1	2	2	5	41.1	16	0	218	0	1	\N	\N	CCCNC(C)C(=O)NC1=CC=CC=C1C	N-(o-tolyl)-2-(propylamino)propanamide
6377	ONZETRA XSAIL	SUMATRIPTAN SUCCINATE	59772	C18H27N3O6S	413.489	\N	\N	4	8	9	148	28	0	498	0	0	\N	\N	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O	1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide;succinic acid
6438	ORINASE	TOLBUTAMIDE	5505	C12H18N2O3S	270.347	\N	2.3	2	3	5	83.6	18	0	354	0	0	\N	\N	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C	1-butyl-3-(p-tolylsulfonyl)urea
6424	ORENCIA	ABATACEPT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6436	ORGARAN	DANAPAROID SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6445	ORLEX HC	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6447	ORPHENADRINE CITRATE	ORPHENADRINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6450	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	ORPHENADRINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6453	ORPHENGESIC	ORPHENADRINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6456	ORPHENGESIC FORTE	ORPHENADRINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7583	PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
6554	OVULEN	ETHYNODIOL DIACETATE	9270	C24H32O4	384.516	\N	3.9	0	4	5	52.6	28	0	758	7	0	\N	\N	CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C	[(3S,8R,9S,10R,13S,14S,17R)-17-acetoxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
6541	OTOVEL	FLUOCINOLONE ACETONIDE	6215	C24H30F2O6	452.495	\N	2.5	2	8	2	93.1	32	0	960	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C	\N
6599	OXYCODONE HYDROCHLORIDE AND IBUPROFEN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
6569	OXILAN-300	IOXILAN	3743	C18H24I3N3O8	791.116	\N	-2.4	7	8	11	180	32	0	647	0	2	\N	\N	CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCCO)I	5-[acetyl(2,3-dihydroxypropyl)amino]-N3-(2,3-dihydroxypropyl)-N1-(2-hydroxyethyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
6547	OVIDE	MALATHION	4004	C10H19O6PS2	330.35	\N	2.4	0	8	11	128	19	0	341	0	1	\N	\N	CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC	diethyl 2-dimethoxyphosphinothioylsulfanylbutanedioate
6494	ORTHO-NOVUM 2-21	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6555	OVULEN	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6542	OTREXUP	METHOTREXATE	126941	C20H22N8O5	454.447	\N	-1.8	5	12	9	211	33	0	704	1	0	\N	\N	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
6572	OXSORALEN	METHOXSALEN	4114	C12H8O4	216.192	\N	1.9	0	4	1	48.7	16	0	325	0	0	\N	\N	COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2	9-methoxyfuro[3,2-g]chromen-7-one
6489	ORTHO-NOVUM 10-21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6550	OVRAL	NORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6552	OVRAL-28	NORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6504	ORTHOCLONE OKT3	MUROMONAB-CD3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6509	OSELTAMIVIR PHOSPHATE	OSELTAMIVIR PHOSPHATE	78000	C16H31N2O8P	410.404	\N	\N	5	9	8	168	27	0	468	3	0	\N	\N	CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC.OP(=O)(O)O	ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohexene-1-carboxylate;phosphoric acid
6564	OXAPROZIN	OXAPROZIN	4614	C18H15NO3	293.322	\N	4.2	1	4	5	63.3	22	0	361	0	0	\N	\N	C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3	3-(4,5-diphenyloxazol-2-yl)propanoic acid
6566	OXAZEPAM	OXAZEPAM	4616	C15H11ClN2O2	286.715	\N	2.2	2	3	1	61.7	20	0	407	0	1	\N	\N	C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O	7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
6578	OXYBUTYNIN	OXYBUTYNIN	4634	C22H31NO3	357.494	\N	4.2	1	4	8	49.8	26	0	490	0	1	\N	\N	CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O	4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenyl-acetate
6592	OXYCODONE AND ASPIRIN	OXYCODONE TEREPHTHALATE	5464088	C26H27NO8	481.501	\N	\N	3	9	3	134	35	0	722	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O.C1=CC(=CC=C1C(=O)O)C(=O)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;terephthalic acid
6577	OXY-KESSO-TETRA	OXYTETRACYCLINE HYDROCHLORIDE	54680782	C22H25ClN2O9	496.897	\N	\N	8	10	2	202	34	0	1000	6	0	\N	\N	CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O.Cl	(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
6520	OSMOPREP	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	24203	HNa2O4P	141.957	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[Na+].[Na+]	disodium;hydrogen phosphate
6526	OSTEOSCAN	TECHNETIUM TC-99M ETIDRONATE KIT	123827	C2H8O7P2Tc	304.933	\N	\N	5	7	2	135	12	0	211	0	0	\N	\N	CC(O)(P(=O)(O)O)P(=O)(O)O.[Tc]	(1-hydroxy-1-phosphono-ethyl)phosphonic acid;technetium-99
6521	OSMOPREP	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6525	OSTEOLITE	TECHNETIUM TC-99M MEDRONATE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6528	OTICAIR	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6532	OTOBIONE	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6535	OTOBIOTIC	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6537	OTOCORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6548	OVIDREL	CHORIOGONADOTROPIN ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6561	OXALIPLATIN	OXALIPLATIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6568	OXICONAZOLE NITRATE	OXICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6571	OXISTAT	OXICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6579	Oxybutynin Chloride	Oxybutynin Chloride	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6601	OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN	OXYCODONE HYDROCHLORIDE;ACETAMINOPHEN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6649	PARASAL	AMINOSALICYLIC ACID	4649	C7H7NO3	153.137	\N	1.3	3	4	1	83.6	11	0	160	0	0	\N	\N	C1=CC(=C(C=C1N)O)C(=O)O	4-amino-2-hydroxy-benzoic acid
7590	PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4529	ISOPAQUE 280	CALCIUM	5460341	Ca	40.078	\N	\N	0	0	0	0	1	0	0	0	0	\N	\N	[Ca]	calcium
6652	PARCOPA	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
6645	PARAFLEX	CHLORZOXAZONE	2733	C7H4ClNO2	169.564	\N	1.8	1	2	0	38.3	11	0	185	0	0	\N	\N	C1=CC2=C(C=C1Cl)NC(=O)O2	5-chloro-3H-1,3-benzoxazol-2-one
6647	PARAGARD T 380A	COPPER	23978	Cu	63.546	\N	\N	0	0	0	0	1	0	0	0	0	\N	\N	[Cu]	copper
6665	PARSIDOL	ETHOPROPAZINE HYDROCHLORIDE	122824	C19H25ClN2S	348.933	\N	\N	1	3	5	31.8	23	0	322	0	1	\N	\N	CCN(CC)C(C)CN1C2=CC=CC=C2SC3=CC=CC=C31.Cl	N,N-diethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
6604	OXYLONE	FLUOROMETHOLONE	9878	C22H29FO4	376.468	\N	2	2	5	1	74.6	27	0	787	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O	(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
6654	PAREDRINE	HYDROXYAMPHETAMINE HYDROBROMIDE	9377	C9H14BrNO	232.121	\N	\N	3	2	2	46.2	12	0	108	0	1	\N	\N	CC(CC1=CC=C(C=C1)O)N.Br	4-(2-aminopropyl)phenol;hydrobromide
6635	PANTOPAQUE	IOPHENDYLATE	7458	C19H29IO2	416.343	\N	7	0	2	12	26.3	22	0	285	0	1	\N	\N	CCOC(=O)CCCCCCCCC(C)C1=CC=C(C=C1)I	ethyl 10-(4-iodophenyl)undecanoate
2289	DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2294	DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6612	OXYTROL	OXYBUTYNIN	4634	C22H31NO3	357.494	\N	4.2	1	4	8	49.8	26	0	490	0	1	\N	\N	CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O	4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenyl-acetate
6603	OXYGEN, USP	OXYGEN	977	O2	31.998	\N	-1.1	0	2	0	34.1	2	0	0	0	0	\N	\N	O=O	molecular oxygen
6624	PAMELOR	NORTRIPTYLINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6606	OXYPHENBUTAZONE	OXYPHENBUTAZONE	4641	C19H20N2O3	324.38	\N	2.7	1	3	5	60.8	24	0	454	0	1	\N	\N	CCCCC1C(=O)N(N(C1=O)C2=CC=C(C=C2)O)C3=CC=CC=C3	4-butyl-1-(4-hydroxyphenyl)-2-phenyl-pyrazolidine-3,5-dione
6617	PACITAXEL	PACLITAXEL	36314	C47H51NO14	853.918	\N	2.5	4	14	14	221	62	0	1790	11	0	\N	\N	CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	\N
6628	PANCREAZE	PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6620	PALIPERIDONE	PALIPERIDONE	115237	C23H27FN4O3	426.492	\N	2.2	1	7	4	82.2	31	0	764	0	1	\N	\N	CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
6630	PANDEL	HYDROCORTISONE PROBUTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6631	PANHEPRIN	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6636	PANTOPRAZOLE SODIUM	PANTOPRAZOLE SODIUM	15008962	C16H14F2N3NaO4S	405.352	\N	\N	0	10	7	90.8	27	0	497	0	1	\N	\N	COC1=C(C(=NC=C1)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC(F)F)OC.[Na+]	sodium;5-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]benzimidazol-1-ide
6644	PARADIONE	PARAMETHADIONE	8280	C7H11NO3	157.169	\N	0.8	0	3	1	46.6	11	0	214	0	1	\N	\N	CCC1(C(=O)N(C(=O)O1)C)C	5-ethyl-3,5-dimethyl-oxazolidine-2,4-dione
6663	PAROXETINE	PAROXETINE HYDROCHLORIDE	62878	C19H21ClFNO3	365.829	\N	\N	2	5	4	39.7	25	0	402	2	0	\N	\N	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.Cl	(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrochloride
6662	PAROXETINE	PAROXETINE	43815	C19H20FNO3	329.371	\N	3.5	1	5	4	39.7	24	0	402	2	0	\N	\N	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
6667	PASKALIUM	POTASSIUM AMINOSALICYLATE	23690428	C7H6KNO3	191.227	\N	\N	2	4	1	86.4	12	0	165	0	0	\N	\N	C1=CC(=C(C=C1N)O)C(=O)[O-].[K+]	potassium;4-amino-2-hydroxy-benzoate
6693	PEG 3350 AND ELECTROLYTES	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6698	PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6643	PARACORT	PREDNISONE	5865	C21H26O5	358.434	\N	1.5	2	5	2	91.7	26	0	764	6	0	\N	\N	CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
6695	PEG 3350 AND ELECTROLYTES	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6696	PEG 3350 AND ELECTROLYTES	SODIUM SULFATE ANHYDROUS	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
6651	PARATHAR	TERIPARATIDE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6688	PEDIAZOLE	SULFISOXAZOLE ACETYL	6662	C13H15N3O4S	309.34	\N	1.3	1	6	3	115	21	0	482	0	0	\N	\N	CC1=C(ON=C1C)N(C(=O)C)S(=O)(=O)C2=CC=C(C=C2)N	N-(4-aminophenyl)sulfonyl-N-(3,4-dimethylisoxazol-5-yl)acetamide
6656	PAREMYD	TROPICAMIDE	5593	C17H20N2O2	284.359	\N	1.5	1	3	6	53.4	21	0	310	0	1	\N	\N	CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2	N-ethyl-3-hydroxy-2-phenyl-N-(4-pyridylmethyl)propanamide
6659	PARNATE	TRANYLCYPROMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6678	PBZ	TRIPELENNAMINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6689	PEDIOTIC	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6767	PEPCID COMPLETE	CALCIUM CARBONATE	10112	CCaO3	100.086	\N	\N	0	3	0	63.2	5	0	18.8	0	0	\N	\N	C(=O)([O-])[O-].[Ca+2]	calcium;carbonate
6745	PENNTUSS	CHLORPHENIRAMINE POLISTIREX	2725	C16H19ClN2	274.792	\N	3.4	0	2	5	16.1	19	0	249	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine
6760	PENTOLAIR	CYCLOPENTOLATE HYDROCHLORIDE	22162	C17H26ClNO3	327.849	\N	\N	2	4	7	49.8	22	0	331	0	1	\N	\N	CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O.Cl	2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenyl-acetate;hydrochloride
6734	PENETREX	ENOXACIN	3229	C15H17FN4O3	320.324	\N	-0.2	2	8	3	85.8	23	0	521	0	0	\N	\N	CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O	1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid
6795	PERIKABIVEN IN PLASTIC CONTAINER	MAGNESIUM SULFATE	24083	MgO4S	120.361	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Mg+2]	magnesium;sulfate
6751	PENTASA	MESALAMINE	4075	C7H7NO3	153.137	\N	1.3	3	4	1	83.6	11	0	160	0	0	\N	\N	C1=CC(=C(C=C1N)C(=O)O)O	5-amino-2-hydroxy-benzoic acid
6754	PENTHRANE	METHOXYFLURANE	4116	C3H4Cl2F2O	164.961	\N	2.2	0	3	2	9.2	8	0	75.7	0	0	\N	\N	COC(C(Cl)Cl)(F)F	2,2-dichloro-1,1-difluoro-1-methoxy-ethane
6726	PEMETREXED	PEMETREXED SODIUM	125891	C20H19N5Na2O6	471.381	\N	\N	4	6	7	193	33	0	737	1	0	\N	\N	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+]	disodium;(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate
6728	PEMOLINE	PEMOLINE	4723	C9H8N2O2	176.175	\N	0.9	1	2	1	64.7	13	0	244	0	1	\N	\N	C1=CC=C(C=C1)C2C(=O)N=C(O2)N	2-amino-5-phenyl-oxazol-4-one
6718	PEGASYS	PEGINTERFERON ALFA-2A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6719	PEGINTERFERON	PEGINTERFERON ALFA-2A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6739	PENICILLIN G SODIUM	PENICILLIN G SODIUM	23668834	C16H17N2NaO4S	356.372	\N	\N	1	5	4	115	24	0	536	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[Na+]	sodium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6721	PEGINTRON	PEGINTERFERON ALFA-2B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6722	PEGINTRON/REBETOL COMBO PACK	PEGINTERFERON ALFA-2B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6729	PEN-VEE K	PENICILLIN V POTASSIUM	23676814	C16H17KN2O5S	388.479	\N	\N	1	6	5	124	25	0	553	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6773	PEPTAVLON	PENTAGASTRIN	9853654	C37H49N7O9S	767.899	\N	1.5	8	10	22	276	54	0	1310	4	0	\N	\N	CC(C)(C)OC(=O)NCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N	(3S)-4-[[(1S)-2-amino-1-benzyl-2-oxo-ethyl]amino]-3-[[(2S)-2-[[(2S)-2-[3-(tert-butoxycarbonylamino)propanoylamino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-4-oxo-butanoic acid
6752	PENTETATE CALCIUM TRISODIUM	PENTETATE CALCIUM TRISODIUM	25513	C14H18CaN3Na3O10	497.356	\N	\N	0	13	11	210	31	0	454	0	0	\N	\N	C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Ca+2]	calcium;trisodium;2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate
6763	PENTOXIFYLLINE	PENTOXIFYLLINE	4740	C13H18N4O3	278.312	\N	0.3	0	4	5	75.5	20	0	426	0	0	\N	\N	CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C	3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione
6707	PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
6731	PENBRITIN	AMPICILLIN/AMPICILLIN TRIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6703	PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6733	PENECORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7393	PRED-G	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
6797	PERIKABIVEN IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
6704	PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
6738	PENICILLIN G PROCAINE	PENICILLIN G PROCAINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6714	PEG-LYTE	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
6715	PEG-LYTE	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6798	PERIKABIVEN IN PLASTIC CONTAINER	SODIUM GLYCEROPHOSPHATE	14754	C3H7Na2O6P	216.036	\N	\N	2	6	3	113	12	0	117	0	1	\N	\N	C(C(COP(=O)([O-])[O-])O)O.[Na+].[Na+]	disodium;2,3-dihydroxypropyl phosphate
6716	PEG-LYTE	SODIUM SULFATE ANHYDROUS	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
6762	PENTOTHAL	THIOPENTAL SODIUM	23665410	C11H17N2NaO2S	264.319	\N	\N	1	3	4	59.5	17	0	346	0	2	\N	\N	CCCC(C)C1(C(=O)NC(=NC1=O)[S-])CC.[Na+]	sodium;5-ethyl-5-(1-methylbutyl)-4,6-dioxo-1H-pyrimidine-2-thiolate
6769	PEPCID COMPLETE	MAGNESIUM HYDROXIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6774	PERCHLORACAP	POTASSIUM PERCHLORATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6785	PERCORTEN	DESOXYCORTICOSTERONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6786	PERCORTEN	DESOXYCORTICOSTERONE PIVALATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6787	PERFOROMIST	FORMOTEROL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6789	PERGONAL	MENOTROPINS (FSH;LH)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6792	PERIKABIVEN IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6794	PERIKABIVEN IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6799	PERIKABIVEN IN PLASTIC CONTAINER	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6900	PHRENILIN WITH CAFFEINE AND CODEINE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
6872	PHOSLO	CALCIUM ACETATE	6116	C4H6CaO4	158.166	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Ca+2]	calcium;diacetate
6882	PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
6813	PERTOFRANE	DESIPRAMINE HYDROCHLORIDE	65327	C18H23ClN2	302.846	\N	\N	2	2	4	15.3	21	0	267	0	0	\N	\N	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methyl-propan-1-amine;hydrochloride
6804	PERJETA	PERTUZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6859	PHERAZINE DM	DEXTROMETHORPHAN HYDROBROMIDE	5464025	C18H26BrNO	352.316	\N	\N	1	2	1	12.5	21	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br	\N
6812	PERSANTINE	DIPYRIDAMOLE	3108	C24H40N8O4	504.636	\N	0.7	4	12	12	145	36	0	561	0	0	\N	\N	C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO	2-[[2-[bis(2-hydroxyethyl)amino]-4,8-bis(1-piperidyl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol
6876	PHOSPHOLINE IODIDE	ECHOTHIOPHATE IODIDE	10547	C9H23INO3PS	383.225	\N	\N	0	5	8	60.8	16	0	208	0	0	\N	\N	CCOP(=O)(OCC)SCC[N+](C)(C)C.[I-]	2-diethoxyphosphorylsulfanylethyl(trimethyl)ammonium;iodide
6868	PHILITH	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6883	PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6814	PERTZYE	PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6815	PEXEVA	PAROXETINE MESYLATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6816	PFIZER-E	ERYTHROMYCIN STEARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2299	DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6806	PERMAX	PERGOLIDE MESYLATE	47812	C20H30N2O3S2	410.591	\N	\N	2	5	4	107	27	0	480	3	0	\N	\N	CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC.CS(=O)(=O)O	(6aR,9R,10aR)-9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline;methanesulfonic acid
6809	PERPHENAZINE	PERPHENAZINE	4748	C21H26ClN3OS	403.969	\N	4.2	1	5	6	55.2	27	0	463	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
6820	PFIZERPEN-A	AMPICILLIN/AMPICILLIN TRIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6821	PFIZERPEN-AS	PENICILLIN G PROCAINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6834	PHENELZINE SULFATE	PHENELZINE SULFATE	61100	C8H14N2O4S	234.27	\N	\N	4	6	3	121	15	0	159	0	0	\N	\N	C1=CC=C(C=C1)CCNN.OS(=O)(=O)O	2-phenylethylhydrazine;sulfuric acid
6846	PHENTERMINE RESIN 30	PHENTERMINE RESIN COMPLEX	4771	C10H15N	149.237	\N	1.9	1	1	2	26	11	0	112	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)N	2-methyl-1-phenyl-propan-2-amine
6850	PHENY-PAS-TEBAMIN	PHENYL AMINOSALICYLATE	8609	C13H11NO3	229.235	\N	3.2	2	4	3	72.6	17	0	263	0	0	\N	\N	C1=CC=C(C=C1)OC(=O)C2=C(C=C(C=C2)N)O	phenyl 4-amino-2-hydroxy-benzoate
6836	PHENERGAN VC	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
6855	PHENYTEK	PHENYTOIN SODIUM	657302	C15H11N2NaO2	274.255	\N	\N	1	3	2	47.2	20	0	356	0	0	\N	\N	C1=CC=C(C=C1)C2(C(=O)[N-]C(=O)N2)C3=CC=CC=C3.[Na+]	sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione
6831	PHENAZINE	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6832	PHENAZINE-35	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6833	PHENDIMETRAZINE TARTRATE	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6856	PHENYTEX	PHENYTOIN SODIUM	657302	C15H11N2NaO2	274.255	\N	\N	1	3	2	47.2	20	0	356	0	0	\N	\N	C1=CC=C(C=C1)C2(C(=O)[N-]C(=O)N2)C3=CC=CC=C3.[Na+]	sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione
6857	PHENYTOIN	PHENYTOIN	1775	C15H12N2O2	252.273	\N	2.5	2	2	2	58.2	19	0	350	0	0	\N	\N	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	5,5-diphenylimidazolidine-2,4-dione
6835	PHENERGAN	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
6880	PHOTREXA	RIBOFLAVIN 5'-PHOSPHATE SODIUM	23666409	C17H20N4NaO9P	478.33	\N	\N	5	10	7	204	32	0	856	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)[O-])O)O)O.[Na+]	sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentyl] hydrogen phosphate
6885	PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
6886	PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6892	PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6887	PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER	SODIUM PHOSPHATE	24243	Na3O4P	163.939	\N	\N	0	4	0	86.2	8	0	36.8	0	0	\N	\N	[O-]P(=O)([O-])[O-].[Na+].[Na+].[Na+]	trisodium;phosphate
6875	PHOSPHOCOL P32	CHROMIC PHOSPHATE P-32	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6877	PHOSPHOTEC	TECHNETIUM TC-99M PYROPHOSPHATE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6879	PHOTOFRIN	PORFIMER SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6946	PLACIDYL	ETHCHLORVYNOL	5281077	C7H9ClO	144.598	\N	1.5	1	1	3	20.2	9	0	154	0	1	\N	\N	CCC(C=CCl)(C#C)O	(E)-1-chloro-3-ethyl-pent-1-en-4-yn-3-ol
6949	PLAQUENIL	HYDROXYCHLOROQUINE SULFATE	12947	C18H28ClN3O5S	433.948	\N	\N	4	8	9	131	28	0	413	0	1	\N	\N	CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO.OS(=O)(=O)O	2-[4-[(7-chloro-4-quinolyl)amino]pentyl-ethyl-amino]ethanol;sulfuric acid
6919	PICATO	INGENOL MEBUTATE	6918670	C25H34O6	430.541	\N	2	3	6	4	104	31	0	926	8	0	\N	\N	CC=C(C)C(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)CO)O)O)C	\N
6903	PHYSIOLYTE IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2304	DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6931	PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
6920	PILOCARPINE HYDROCHLORIDE	PILOCARPINE HYDROCHLORIDE	5909	C11H17ClN2O2	244.719	\N	\N	1	3	3	44.1	16	0	245	2	0	\N	\N	CCC1C(COC1=O)CC2=CN=CN2C.Cl	(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one;hydrochloride
6925	PINDAC	PINACIDIL	4826	C13H19N5	245.33	\N	2.7	2	3	5	73.1	18	0	327	0	1	\N	\N	CC(C(C)(C)C)N=C(NC#N)NC1=CC=NC=C1	1-cyano-3-(4-pyridyl)-2-(1,2,2-trimethylpropyl)guanidine
6933	PIPERACILLIN	PIPERACILLIN SODIUM	23666879	C23H26N5NaO7S	539.539	\N	\N	2	8	6	185	37	0	989	4	0	\N	\N	CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+]	sodium;(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6942	PIROXICAM	PIROXICAM	54676228	C15H13N3O4S	331.346	\N	3.1	2	6	2	108	23	0	611	0	0	\N	\N	CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3	4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1$l^{6},2-benzothiazine-3-carboxamide
6963	PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM ACETATE	517044	C2H3KO2	98.142	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[K+]	potassium;acetate
6904	PHYSIOLYTE IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6905	PHYSIOLYTE IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
6910	PHYSIOSOL IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
6915	PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
6953	PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
6906	PHYSIOLYTE IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6911	PHYSIOSOL IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6936	PIPERAZINE CITRATE	PIPERAZINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6916	PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6954	PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6907	PHYSIOLYTE IN PLASTIC CONTAINER	SODIUM GLUCONATE	23672301	C6H11NaO7	218.137	\N	\N	5	7	5	141	14	0	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+]	sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
6912	PHYSIOSOL IN PLASTIC CONTAINER	SODIUM GLUCONATE	23672301	C6H11NaO7	218.137	\N	\N	5	7	5	141	14	0	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+]	sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
6917	PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER	SODIUM GLUCONATE	23672301	C6H11NaO7	218.137	\N	\N	5	7	5	141	14	0	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+]	sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
6979	PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
6985	PLASMA-LYTE R IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
6935	PIPERACILLIN AND TAZOBACTAM	TAZOBACTAM SODIUM	23663400	C10H11N4NaO5S	322.271	\N	\N	0	7	3	134	21	0	579	3	0	\N	\N	CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)[O-])CN3C=CN=N3.[Na+]	sodium;(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6950	PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6961	PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6962	PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM ACETATE TETRAHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6965	PLASMA-LYTE 56 IN PLASTIC CONTAINER	MAGNESIUM ACETATE TETRAHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6974	PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6986	PLATINOL	CISPLATIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6987	PLATINOL-AQ	CISPLATIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6989	PLEGINE	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6994	PLEGRIDY	PEGINTERFERON BETA-1A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7000	PMB 200	ESTROGENS, CONJUGATED	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7002	PMB 400	ESTROGENS, CONJUGATED	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
598	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
600	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
6990	PLEGISOL IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
6996	PLENDIL	FELODIPINE	3333	C18H19Cl2NO4	384.253	\N	3.9	1	5	6	64.6	25	0	614	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C	O5-ethyl O3-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
6998	PLIAGLIS	LIDOCAINE	3676	C14H22N2O	234.343	\N	2.3	1	2	5	32.3	17	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
6991	PLEGISOL IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7001	PMB 200	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
7004	PODOFILOX	PODOFILOX	10607	C22H22O8	414.41	\N	2	1	8	4	92.7	30	0	629	4	0	\N	\N	COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O	(5R,5aR,8aR,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,3]benzodioxol-8-one
7036	POMALYST	POMALIDOMIDE	134780	C13H11N3O4	273.248	\N	0.2	2	5	1	110	20	0	504	0	1	\N	\N	C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N	4-amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione
7014	POLYCILLIN	AMPICILLIN/AMPICILLIN TRIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7044	POTASSIUM ACETATE	POTASSIUM ACETATE	517044	C2H3KO2	98.142	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[K+]	potassium;acetate
7016	POLYCILLIN-PRB	AMPICILLIN/AMPICILLIN TRIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7045	POTASSIUM AMINOSALICYLATE	POTASSIUM AMINOSALICYLATE	23690428	C7H6KNO3	191.227	\N	\N	2	4	1	86.4	12	0	165	0	0	\N	\N	C1=CC(=C(C=C1N)O)C(=O)[O-].[K+]	potassium;4-amino-2-hydroxy-benzoate
6992	PLEGISOL IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7020	POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7012	POLY-PRED	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
7017	POLYCILLIN-PRB	PROBENECID	4911	C13H19NO4S	285.358	\N	3.2	1	5	7	83.1	19	0	374	0	0	\N	\N	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O	4-(dipropylsulfamoyl)benzoic acid
7021	POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
6993	PLEGISOL IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7022	POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7032	POLYSPORIN	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7025	POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7023	POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES	SODIUM SULFATE ANHYDROUS	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
6999	PLIAGLIS	TETRACAINE	5411	C15H24N2O2	264.369	\N	3.7	1	4	9	41.6	19	0	249	0	0	\N	\N	CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C	2-(dimethylamino)ethyl 4-(butylamino)benzoate
7035	POLYTRIM	TRIMETHOPRIM SULFATE	12254408	C14H20N4O7S	388.395	\N	\N	4	11	5	189	26	0	388	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N.OS(=O)(=O)O	sulfuric acid;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
7043	PORTRAZZA	NECITUMUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7047	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7050	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7053	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7056	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7059	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7062	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7065	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7068	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
602	AMLODIPINE BESYLATE AND VALSARTAN	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
7071	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
604	AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
607	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
7075	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
609	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
7078	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
643	AMTURNIDE	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
7081	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
935	AZOR	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
7084	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8430	STALEVO 200	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
7087	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7090	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7093	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7096	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7099	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7102	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7106	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7109	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7112	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7115	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7118	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7121	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7124	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1312	CADUET	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
7127	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3380	EXFORGE	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
7130	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
3382	EXFORGE HCT	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
7133	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5099	LOTREL	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
6181	NORVASC	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
6323	OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
7139	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7436	PRESTALIA	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
7142	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7392	PRED-G	GENTAMICIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7145	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7148	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7151	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7154	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7157	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7160	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7163	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7166	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7172	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7175	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7178	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7181	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7184	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8740	TEKAMLO	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
7187	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8747	TELMISARTAN AND AMLODIPINE	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
7190	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9335	TWYNSTA	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
7193	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
645	AMVAZ	AMLODIPINE MALEATE	6435922	C24H29ClN2O9	524.951	\N	\N	4	11	12	175	36	0	766	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C(=CC(=O)O)C(=O)O	O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate;maleic acid
7196	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
616	AMMONIUM CHLORIDE 2.14%	AMMONIUM CHLORIDE	25517	ClH4N	53.489	\N	\N	1	1	0	1	2	0	0	0	0	\N	\N	[NH4+].[Cl-]	ammonium;chloride
7199	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
617	AMMONIUM CHLORIDE IN PLASTIC CONTAINER	AMMONIUM CHLORIDE	25517	ClH4N	53.489	\N	\N	1	1	0	1	2	0	0	0	0	\N	\N	[NH4+].[Cl-]	ammonium;chloride
9735	WYMOX	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
626	AMOXICILLIN AND CLAVULANATE POTASSIUM	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7207	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
628	AMOXICILLIN PEDIATRIC	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7210	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7183	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7213	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7216	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7219	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7222	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7225	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7228	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7231	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7234	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7239	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7243	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
855	AUGMENTIN '125'	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7246	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
857	AUGMENTIN '200'	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7249	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
859	AUGMENTIN '250'	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7252	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
861	AUGMENTIN '400'	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
863	AUGMENTIN '500'	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
865	AUGMENTIN '875'	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7257	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7241	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7261	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7242	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
7264	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7260	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
7267	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7277	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
7270	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7274	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7278	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7281	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7284	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7287	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7290	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7292	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
867	AUGMENTIN ES-600	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7299	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7303	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
869	AUGMENTIN XR	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7306	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
2842	DISPERMOX	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7309	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4807	LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7312	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4827	LAROTID	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7315	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
5686	MOXATAG	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7297	POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7319	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7301	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7323	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7302	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
7326	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7322	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
7329	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7344	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
7332	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7335	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7341	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7345	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7348	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7351	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7354	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8433	STALEVO 50	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
7386	PRE-SATE	CHLORPHENTERMINE HYDROCHLORIDE	65477	C10H15Cl2N	220.137	\N	\N	2	1	2	26	13	0	137	0	0	\N	\N	CC(C)(CC1=CC=C(C=C1)Cl)N.Cl	1-(4-chlorophenyl)-2-methyl-propan-2-amine;hydrochloride
7358	POTASSIUM CITRATE	POTASSIUM CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7361	POVAN	PYRVINIUM PAMOATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7432	PREPOPIK	CITRIC ACID	311	C6H8O7	192.123	\N	-1.7	4	7	5	132	13	0	227	0	0	\N	\N	C(C(=O)O)C(CC(=O)O)(C(=O)O)O	citric acid
7387	PRECEDEX	DEXMEDETOMIDINE HYDROCHLORIDE	6918081	C13H17ClN2	236.743	\N	\N	2	1	2	28.7	16	0	205	1	0	\N	\N	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.Cl	5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole;hydrochloride
7366	PRALUENT	ALIROCUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7360	POTIGA	EZOGABINE	121892	C16H18FN3O2	303.337	\N	2.8	3	5	6	76.4	22	0	348	0	0	\N	\N	CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N	ethyl N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
7369	PRAMOSONE	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7367	PRAMINE	IMIPRAMINE HYDROCHLORIDE	8228	C19H25ClN2	316.873	\N	\N	1	2	4	6.5	22	0	291	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine;hydrochloride
7450	PREVANTICS MAXI SWABSTICK	ISOPROPYL ALCOHOL	3776	C3H8O	60.096	\N	0.3	1	1	0	20.2	4	0	10.8	0	0	\N	\N	CC(C)O	propan-2-ol
7439	PREVACID	LANSOPRAZOLE	3883	C16H14F3N3O2S	369.362	\N	2.8	1	8	5	87.1	25	0	480	0	1	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
7456	PREVEN EMERGENCY CONTRACEPTIVE KIT	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
7433	PREPOPIK	MAGNESIUM OXIDE	14792	MgO	40.304	\N	\N	0	1	0	17.1	2	0	2	0	0	\N	\N	O=[Mg]	oxomagnesium
7371	PRANDIMET	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
7443	PREVACID NAPRAPAC 250 (COPACKAGED)	NAPROXEN	156391	C14H14O3	230.263	\N	3.3	1	3	3	46.5	17	0	277	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O	(2S)-2-(6-methoxy-2-naphthyl)propanoic acid
7411	PREFEST	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
7380	PRAXBIND	IDARUCIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7418	PRELUDIN	PHENMETRAZINE HYDROCHLORIDE	92159	C11H16ClNO	213.705	\N	\N	2	2	1	21.3	14	0	154	0	2	\N	\N	CC1C(OCCN1)C2=CC=CC=C2.Cl	3-methyl-2-phenyl-morpholine;hydrochloride
7359	POTASSIUM IODIDE	POTASSIUM IODIDE	4875	IK	166.003	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[K+].[I-]	potassium;iodide
7362	POVIDONE IODINE	POVIDONE-IODINE	410087	C6H9I2NO	364.953	\N	\N	0	1	1	20.3	10	0	120	0	0	\N	\N	C=CN1CCCC1=O.II	molecular iodine;1-vinylpyrrolidin-2-one
7365	PRALIDOXIME CHLORIDE	PRALIDOXIME CHLORIDE	5359226	C7H9ClN2O	172.612	\N	\N	1	3	1	34.3	11	0	216	0	0	\N	\N	CN1C=CC=CC1=C[NH+]=O.[Cl-]	[(E)-(1-methyl-2-pyridylidene)methyl]-oxo-ammonium;chloride
7375	PRASUGREL	PRASUGREL	6918456	C20H20FNO3S	373.442	\N	3.6	0	6	6	74.8	26	0	555	0	1	\N	\N	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4	[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxo-ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate
7381	PRAZEPAM	PRAZEPAM	4890	C19H17ClN2O	324.808	\N	3.6	0	2	3	32.7	23	0	482	0	0	\N	\N	C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4	7-chloro-1-(cyclopropylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one
7403	PREDNISOLONE TEBUTATE	PREDNISOLONE TEBUTATE	93055	C27H38O6	458.595	\N	4.1	2	6	6	101	33	0	925	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COC(=O)CC(C)(C)C)O)CCC4=CC(=O)C=CC34C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] 3,3-dimethylbutanoate
7399	PREDNICEN-M	PREDNISONE	5865	C21H26O5	358.434	\N	1.5	2	5	2	91.7	26	0	764	6	0	\N	\N	CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
7414	PREGABALIN	PREGABALIN	5486971	C8H17NO2	159.229	\N	-1.6	2	3	5	63.3	11	0	123	1	0	\N	\N	CC(C)CC(CC(=O)O)CN	(3S)-3-(aminomethyl)-5-methyl-hexanoic acid
7356	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7397	PREDAMIDE	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
7415	PREGNYL	GONADOTROPIN, CHORIONIC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7419	PREMARIN	ESTROGENS, CONJUGATED	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7420	PREMASOL 10% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7421	PREMASOL 6% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7422	PREMPHASE (PREMARIN;CYCRIN 14/14)	ESTROGENS, CONJUGATED	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7424	PREMPHASE 14/14	ESTROGENS, CONJUGATED	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7426	PREMPRO	ESTROGENS, CONJUGATED	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7428	PREMPRO (PREMARIN;CYCRIN)	ESTROGENS, CONJUGATED	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7430	PREMPRO/PREMPHASE	CONJUGATED ESTROGENS/MEDROXYPROGESTERONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7477	PRIMATENE MIST	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
7494	PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
7461	PREVPAC	LANSOPRAZOLE	3883	C16H14F3N3O2S	369.362	\N	2.8	1	8	5	87.1	25	0	480	0	1	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
7488	PRINIVIL	LISINOPRIL	5362119	C21H31N3O5	405.495	\N	-2.9	4	7	12	133	29	0	550	3	0	\N	\N	C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O	(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
7468	PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7490	PRINZIDE	LISINOPRIL	5362119	C21H31N3O5	405.495	\N	-2.9	4	7	12	133	29	0	550	3	0	\N	\N	C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O	(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
7495	PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7482	PRINCIPEN	AMPICILLIN/AMPICILLIN TRIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7483	PRINCIPEN '125'	AMPICILLIN/AMPICILLIN TRIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7484	PRINCIPEN '250'	AMPICILLIN/AMPICILLIN TRIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7485	PRINCIPEN '500'	AMPICILLIN/AMPICILLIN TRIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7486	PRINCIPEN W/ PROBENECID	AMPICILLIN/AMPICILLIN TRIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7473	PRIMACOR	MILRINONE LACTATE	172293	C15H15N3O4	301.302	\N	\N	3	6	2	123	22	0	478	0	1	\N	\N	CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2.CC(C(=O)O)O	2-hydroxypropanoic acid;6-methyl-2-oxo-5-(4-pyridyl)-1H-pyridine-3-carbonitrile
7474	PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER	MILRINONE LACTATE	172293	C15H15N3O4	301.302	\N	\N	3	6	2	123	22	0	478	0	1	\N	\N	CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2.CC(C(=O)O)O	2-hydroxypropanoic acid;6-methyl-2-oxo-5-(4-pyridyl)-1H-pyridine-3-carbonitrile
7471	PRILOSEC	OMEPRAZOLE MAGNESIUM	4594	C17H19N3O3S	345.417	\N	2.2	1	6	5	96.3	24	0	453	0	1	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
7493	PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7470	PRILOSEC	OMEPRAZOLE	4594	C17H19N3O3S	345.417	\N	2.2	1	6	5	96.3	24	0	453	0	1	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
7467	PRILOCAINE HYDROCHLORIDE	PRILOCAINE HYDROCHLORIDE	92163	C13H21ClN2O	256.774	\N	\N	3	2	5	41.1	17	0	218	0	1	\N	\N	CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl	N-(o-tolyl)-2-(propylamino)propanamide;hydrochloride
7500	PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7469	PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE	PRILOCAINE HYDROCHLORIDE	92163	C13H21ClN2O	256.774	\N	\N	3	2	5	41.1	17	0	218	0	1	\N	\N	CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl	N-(o-tolyl)-2-(propylamino)propanamide;hydrochloride
7475	PRIMAQUINE	PRIMAQUINE PHOSPHATE	4908	C15H21N3O	259.353	\N	2.2	2	4	6	60.2	19	0	262	0	1	\N	\N	CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2	N4-(6-methoxy-8-quinolyl)pentane-1,4-diamine
7476	PRIMAQUINE PHOSPHATE	PRIMAQUINE PHOSPHATE	4908	C15H21N3O	259.353	\N	2.2	2	4	6	60.2	19	0	262	0	1	\N	\N	CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2	N4-(6-methoxy-8-quinolyl)pentane-1,4-diamine
7480	PRIMIDONE	PRIMIDONE	4909	C12H14N2O2	218.256	\N	0.9	2	2	2	58.2	16	0	279	0	0	\N	\N	CCC1(C(=O)NCNC1=O)C2=CC=CC=C2	5-ethyl-5-phenyl-hexahydropyrimidine-4,6-dione
7497	PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
7507	PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7498	PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7505	PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7512	PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7519	PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7491	PRISCOLINE	TOLAZOLINE HYDROCHLORIDE	6048	C10H13ClN2	196.678	\N	\N	2	1	2	24.4	13	0	169	0	0	\N	\N	C1CN=C(N1)CC2=CC=CC=C2.Cl	2-benzyl-4,5-dihydro-1H-imidazole;hydrochloride
7514	PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7481	PRIMSOL	TRIMETHOPRIM HYDROCHLORIDE	173769	C14H19ClN4O3	326.781	\N	\N	3	7	5	106	22	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N.Cl	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine;hydrochloride
7465	PRIALT	ZICONOTIDE ACETATE	16129690	C102H172N36O32S7	2639.138	\N	-14	42	46	40	1310	177	0	5480	0	22	\N	\N	CC1C(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CSSCC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)NC(C(=O)NCC(=O)NC(C(=O)N3)CO)C(C)O)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCN	\N
7521	PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7528	PRISMASOL BGK 2/0 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7535	PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7542	PRISMASOL BGK 4/0 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
6337	OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7549	PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7029	POLYMOX	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7619	PROCALAMINE	CALCIUM ACETATE	6116	C4H6CaO4	158.166	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Ca+2]	calcium;diacetate
7616	PROCAINE HYDROCHLORIDE W/ EPINEPHRINE	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
7556	PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7620	PROCALAMINE	GLYCERIN	753	C3H8O3	92.094	\N	-1.8	3	3	2	60.7	6	0	25.2	0	0	\N	\N	C(C(CO)O)O	glycerol
7550	PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
7621	PROCALAMINE	MAGNESIUM ACETATE	8896	C4H6MgO4	142.393	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Mg+2]	magnesium;diacetate
7551	PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7563	PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7558	PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7601	PROAMATINE	MIDODRINE HYDROCHLORIDE	18340	C12H19ClN2O4	290.744	\N	\N	4	5	6	93.8	19	0	263	0	1	\N	\N	COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O.Cl	2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxy-ethyl]acetamide;hydrochloride
7630	PROCARDIA	NIFEDIPINE	4485	C17H18N2O6	346.339	\N	2.2	1	7	5	110	25	0	608	0	0	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
7631	PROCARDIA XL	NIFEDIPINE	4485	C17H18N2O6	346.339	\N	2.2	1	7	5	110	25	0	608	0	0	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
7622	PROCALAMINE	PHOSPHORIC ACID	1004	H3O4P	97.994	\N	-2.1	3	4	0	77.8	5	0	49.8	0	0	\N	\N	OP(=O)(O)O	phosphoric acid
7570	PRISMASOL BK 0/0 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7602	PROBALAN	PROBENECID	4911	C13H19NO4S	285.358	\N	3.2	1	5	7	83.1	19	0	374	0	0	\N	\N	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O	4-(dipropylsulfamoyl)benzoic acid
7604	PROBAMPACIN	PROBENECID	4911	C13H19NO4S	285.358	\N	3.2	1	5	7	83.1	19	0	374	0	0	\N	\N	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O	4-(dipropylsulfamoyl)benzoic acid
7606	PROBEN-C	PROBENECID	4911	C13H19NO4S	285.358	\N	3.2	1	5	7	83.1	19	0	374	0	0	\N	\N	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O	4-(dipropylsulfamoyl)benzoic acid
7613	PROCAINAMIDE HCL	PROCAINAMIDE HYDROCHLORIDE	66068	C13H22ClN3O	271.789	\N	\N	3	3	6	58.4	18	0	221	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl	4-amino-N-[2-(diethylamino)ethyl]benzamide;hydrochloride
7615	PROCAINE HYDROCHLORIDE	PROCAINE HYDROCHLORIDE	5795	C13H21ClN2O2	272.773	\N	\N	2	4	7	55.6	18	0	222	0	0	\N	\N	CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.Cl	2-(diethylamino)ethyl 4-aminobenzoate;hydrochloride
7577	PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7617	PROCAINE HYDROCHLORIDE W/ EPINEPHRINE	PROCAINE HYDROCHLORIDE	5795	C13H21ClN2O2	272.773	\N	\N	2	4	7	55.6	18	0	222	0	0	\N	\N	CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.Cl	2-(diethylamino)ethyl 4-aminobenzoate;hydrochloride
7633	PROCHLORPERAZINE	PROCHLORPERAZINE EDISYLATE	91499	C22H30ClN3O6S3	564.127	\N	\N	2	10	7	161	35	0	668	0	0	\N	\N	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl.C(CS(=O)(=O)O)S(=O)(=O)O	2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine;ethane-1,2-disulfonic acid
7632	PROCHLORPERAZINE	PROCHLORPERAZINE	4917	C20H24ClN3S	373.943	\N	4.9	0	4	4	35	25	0	429	0	0	\N	\N	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine
7598	PRO-BANTHINE	PROPANTHELINE BROMIDE	9279	C23H30BrNO3	448.401	\N	\N	0	4	7	35.5	28	0	474	0	0	\N	\N	CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C.[Br-]	diisopropyl-methyl-[2-(9H-xanthene-9-carbonyloxy)ethyl]ammonium;bromide
7554	PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7561	PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7584	PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7568	PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7575	PRISMASOL BK 0/0 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7591	PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7597	PRISTIQ	DESVENLAFAXINE SUCCINATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7603	PROBAMPACIN	AMPICILLIN/AMPICILLIN TRIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7618	PROCALAMINE	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7638	PROCTOCORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7639	PROCTOFOAM HC	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7641	PROCYSBI	CYSTEAMINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7459	PREVPAC	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
9256	TRIMOX	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
7726	PROPOXYPHENE COMPOUND 65	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
8436	STALEVO 75	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
7647	PROGLYCEM	DIAZOXIDE	3019	C8H7ClN2O2S	230.666	\N	1.2	1	3	0	66.9	14	0	360	0	0	\N	\N	CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl	7-chloro-3-methyl-4H-1$l^{6},2,4-benzothiadiazine 1,1-dioxide
7654	PROLEUKIN	ALDESLEUKIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7655	PROLIA	DENOSUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7723	PROPINE	DIPIVEFRIN HYDROCHLORIDE	71486	C19H30ClNO5	387.901	\N	\N	3	6	9	84.9	26	0	463	0	1	\N	\N	CC(C)(C)C(=O)OC1=C(C=C(C=C1)C(CNC)O)OC(=O)C(C)(C)C.Cl	[2-(2,2-dimethylpropanoyloxy)-4-[1-hydroxy-2-(methylamino)ethyl]phenyl] 2,2-dimethylpropanoate;hydrochloride
7657	PROLIXIN DECANOATE	FLUPHENAZINE DECANOATE	3388	C32H44F3N3O2S	591.778	\N	9	0	9	16	61.3	41	0	765	0	0	\N	\N	CCCCCCCCCC(=O)OCCN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F	2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl decanoate
7659	PROLOID	THYROGLOBULIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7642	PROFEN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
7644	PROFERDEX	IRON DEXTRAN	105075	FeH2O4S	153.917	\N	\N	2	4	0	83	6	0	81.3	0	0	\N	\N	OS(=O)(=O)O.[Fe]	iron;sulfuric acid
7713	PROMPT PHENYTOIN SODIUM	PHENYTOIN SODIUM	657302	C15H11N2NaO2	274.255	\N	\N	1	3	2	47.2	20	0	356	0	0	\N	\N	C1=CC=C(C=C1)C2(C(=O)[N-]C(=O)N2)C3=CC=CC=C3.[Na+]	sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione
7640	PROCTOFOAM HC	PRAMOXINE HYDROCHLORIDE	73957	C17H28ClNO3	329.865	\N	\N	1	4	9	30.9	22	0	248	0	0	\N	\N	CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2.Cl	4-[3-(4-butoxyphenoxy)propyl]morpholine;hydrochloride
7714	PRONESTYL	PROCAINAMIDE HYDROCHLORIDE	66068	C13H22ClN3O	271.789	\N	\N	3	3	6	58.4	18	0	221	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl	4-amino-N-[2-(diethylamino)ethyl]benzamide;hydrochloride
7715	PRONESTYL-SR	PROCAINAMIDE HYDROCHLORIDE	66068	C13H22ClN3O	271.789	\N	\N	3	3	6	58.4	18	0	221	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl	4-amino-N-[2-(diethylamino)ethyl]benzamide;hydrochloride
7645	PROGESTASERT	PROGESTERONE	5994	C21H30O2	314.469	\N	3.9	0	2	1	34.1	23	0	589	6	0	\N	\N	CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C	(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
7663	PROMAZINE HYDROCHLORIDE	PROMAZINE HYDROCHLORIDE	5887	C17H21ClN2S	320.879	\N	\N	1	3	4	31.8	21	0	285	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31.Cl	N,N-dimethyl-3-phenothiazin-10-yl-propan-1-amine;hydrochloride
7718	PROPAFENONE HYDROCHLORIDE	PROPAFENONE HYDROCHLORIDE	36708	C21H28ClNO3	377.909	\N	\N	3	4	11	58.6	26	0	368	0	1	\N	\N	CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O.Cl	1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one;hydrochloride
7719	PROPANTHELINE BROMIDE	PROPANTHELINE BROMIDE	9279	C23H30BrNO3	448.401	\N	\N	0	4	7	35.5	28	0	474	0	0	\N	\N	CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C.[Br-]	diisopropyl-methyl-[2-(9H-xanthene-9-carbonyloxy)ethyl]ammonium;bromide
7720	PROPARACAINE HYDROCHLORIDE	PROPARACAINE HYDROCHLORIDE	517321	C16H27ClN2O3	330.853	\N	\N	2	5	10	64.8	22	0	295	0	0	\N	\N	CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N.Cl	2-(diethylamino)ethyl 3-amino-4-propoxy-benzoate;hydrochloride
7724	PROPOFOL	PROPOFOL	4943	C12H18O	178.275	\N	3.8	1	1	2	20.2	13	0	135	0	0	\N	\N	CC(C)C1=C(C(=CC=C1)C(C)C)O	2,6-diisopropylphenol
7722	PROPHENE 65	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
7717	PROPACET 100	PROPOXYPHENE NAPSYLATE	28332	C32H37NO5S	547.71	\N	\N	1	6	10	92.3	39	0	688	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C.C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)O	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate;naphthalene-2-sulfonic acid
7652	PROKLAR	SULFAMETHIZOLE	5328	C9H10N4O2S2	270.325	\N	0.5	2	7	3	135	17	0	349	0	0	\N	\N	CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide
7643	PROFENAL	SUPROFEN	5359	C14H12O3S	260.307	\N	3.3	1	4	4	82.6	18	0	321	0	1	\N	\N	CC(C1=CC=C(C=C1)C(=O)C2=CC=CS2)C(=O)O	2-[4-(thiophene-2-carbonyl)phenyl]propanoic acid
7648	PROGRAF	TACROLIMUS	445643	C44H69NO12	804.031	\N	2.7	3	12	7	178	57	0	1480	14	0	\N	\N	CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC	\N
7660	PROLOPRIM	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
7790	PULMICORT	BUDESONIDE	5281004	C25H34O6	430.541	\N	2.5	2	6	4	93.1	31	0	862	8	1	\N	\N	CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C	\N
7729	PROPOXYPHENE COMPOUND-65	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
7749	PROQUIN XR	CIPROFLOXACIN HYDROCHLORIDE	62999	C17H19ClFN3O3	367.805	\N	\N	3	7	3	72.9	25	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.Cl	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid;hydrochloride
7816	Q-PAM	DIAZEPAM	3016	C16H13ClN2O	284.743	\N	3	0	2	1	32.7	20	0	403	0	0	\N	\N	CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
7756	PROSTIN E2	DINOPROSTONE	5280360	C20H32O5	352.471	\N	2.8	3	5	12	94.8	25	0	469	4	0	\N	\N	CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O	(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]hept-5-enoic acid
7750	PROSCAR	FINASTERIDE	57363	C23H36N2O2	372.553	\N	3	2	2	2	58.2	27	0	678	7	0	\N	\N	CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C	(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
7825	QUARTETTE	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
7815	Q-GESIC	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
7797	PURINETHOL	MERCAPTOPURINE	667490	C5H4N4S	152.175	\N	0	2	2	0	85.2	10	0	190	0	0	\N	\N	C1=NC2=C(N1)C(=S)N=CN2	3,7-dihydropurine-6-thione
7768	PROTOSTAT	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
7778	PROVIGIL	MODAFINIL	4236	C15H15NO2S	273.35	\N	1.7	1	3	5	79.4	19	0	302	0	1	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	2-benzhydrylsulfinylacetamide
7820	QSYMIA	PHENTERMINE HYDROCHLORIDE	70969	C10H16ClN	185.695	\N	\N	2	1	2	26	12	0	112	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)N.Cl	2-methyl-1-phenyl-propan-2-amine;hydrochloride
7766	PROTOPAM CHLORIDE	PRALIDOXIME CHLORIDE	5359226	C7H9ClN2O	172.612	\N	\N	1	3	1	34.3	11	0	216	0	0	\N	\N	CN1C=CC=CC1=C[NH+]=O.[Cl-]	[(E)-(1-methyl-2-pyridylidene)methyl]-oxo-ammonium;chloride
7746	PROPULSID	CISAPRIDE MONOHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7747	PROPULSID QUICKSOLV	CISAPRIDE MONOHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7751	PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7739	PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN	PROPOXYPHENE NAPSYLATE	28332	C32H37NO5S	547.71	\N	\N	1	6	10	92.3	39	0	688	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C.C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)O	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate;naphthalene-2-sulfonic acid
7740	PROPRANOLOL HYDROCHLORIDE	PROPRANOLOL HYDROCHLORIDE	62882	C16H22ClNO2	295.807	\N	\N	3	3	6	41.5	20	0	257	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl	1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol;hydrochloride
7754	PROSTASCINT	CAPROMAB PENDETIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7748	PROPYLTHIOURACIL	PROPYLTHIOURACIL	657298	C7H10N2OS	170.23	\N	0.8	2	2	2	73.2	11	0	223	0	0	\N	\N	CCCC1=CC(=O)NC(=S)N1	6-propyl-2-thioxo-1H-pyrimidin-4-one
7759	PROTAMINE SULFATE	PROTAMINE SULFATE	1118	H2O4S	98.072	\N	-1.4	2	4	0	83	5	0	81.3	0	0	\N	\N	OS(=O)(=O)O	sulfuric acid
7769	PROTRIPTYLINE HYDROCHLORIDE	PROTRIPTYLINE HYDROCHLORIDE	6603149	C19H22ClN	299.842	\N	\N	2	1	4	12	21	0	296	0	0	\N	\N	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13.Cl	3-(11H-dibenzo[1,2-a:1',2'-e][7]annulen-11-yl)-N-methyl-propan-1-amine;hydrochloride
7760	PROTAMINE ZINC & ILETIN I (BEEF-PORK)	INSULIN SUSP PROTAMINE ZINC BEEF/PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7761	PROTAMINE ZINC AND ILETIN II	INSULIN SUSP PROTAMINE ZINC PURIFIED BEEF	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7762	PROTAMINE ZINC AND ILETIN II (PORK)	INSULIN SUSP PROTAMINE ZINC PURIFIED PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7763	PROTAMINE ZINC INSULIN	INSULIN SUSP PROTAMINE ZINC PURIFIED BEEF	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7782	PSEUDO-12	PSEUDOEPHEDRINE POLISTIREX	7028	C10H15NO	165.236	\N	0.9	2	2	3	32.3	12	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol
7795	PUR-WASH	PURIFIED WATER	962	H2O	18.015	\N	-0.5	1	1	0	1	1	0	0	0	0	\N	\N	O	water
7770	PROTROPIN	SOMATREM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7806	PYRAZINAMIDE	PYRAZINAMIDE	1046	C5H5N3O	123.115	\N	-0.6	1	3	1	68.9	9	0	115	0	0	\N	\N	C1=CN=C(C=N1)C(=O)N	pyrazine-2-carboxamide
7809	PYRIDOXINE HYDROCHLORIDE	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
7767	PROTOPIC	TACROLIMUS	445643	C44H69NO12	804.031	\N	2.7	3	12	7	178	57	0	1480	14	0	\N	\N	CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC	\N
7787	PSEUDOEPHEDRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
7812	PYTEST	UREA, C-14	11457650	CH4N2O	62.048	\N	-1.4	2	1	0	69.1	4	0	29	0	0	\N	\N	C(=O)(N)N	diaminomethanone
7793	PULMOLITE	TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7794	PULMOZYME	DORNASE ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7796	PURIFIED CORTROPHIN GEL	CORTICOTROPIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7799	PYLERA	BISMUTH SUBCITRATE POTASSIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7803	PYOCIDIN	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7811	PYROLITE	TECHNETIUM TC-99M PYRO/TRIMETA PHOSPHATES KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7819	QOLIANA	BRIMONIDINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7832	QUESTRAN	CHOLESTYRAMINE	70695641	C21H30N+	296.478	\N	5.7	0	0	6	0	22	1	300	0	1	\N	\N	CCC1=CC=C(C=C1)C(C)CCC2=CC=C(C=C2)[N+](C)(C)C	[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethyl-ammonium
7931	RENACIDIN	CITRIC ACID	311	C6H8O7	192.123	\N	-1.7	4	7	5	132	13	0	227	0	0	\N	\N	C(C(=O)O)C(CC(=O)O)(C(=O)O)O	citric acid
7899	RAZADYNE	GALANTAMINE HYDROBROMIDE	121587	C17H22BrNO3	368.271	\N	\N	2	4	1	41.9	22	0	440	3	0	\N	\N	CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O.Br	\N
7932	RENACIDIN	GLUCONOLACTONE	7027	C6H10O6	178.14	\N	-2	4	6	1	107	12	0	181	4	0	\N	\N	C(C1C(C(C(C(=O)O1)O)O)O)O	(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-one
7834	QUETIAPINE FUMARATE	QUETIAPINE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7854	QUIXIN	LEVOFLOXACIN	149096	C18H20FN3O4	361.373	\N	-0.4	1	8	2	73.3	26	0	634	1	0	\N	\N	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	\N
7828	QUASENSE	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
7838	QUILLICHEW ER	METHYLPHENIDATE HYDROCHLORIDE	9280	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	0	2	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl 2-phenyl-2-(2-piperidyl)acetate;hydrochloride
7922	RELAFEN	NABUMETONE	4409	C15H16O2	228.291	\N	3.1	0	2	4	26.3	17	0	262	0	0	\N	\N	CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC	4-(6-methoxy-2-naphthyl)butan-2-one
7910	REGITINE	PHENTOLAMINE MESYLATE	91430	C18H23N3O4S	377.459	\N	\N	3	6	4	111	26	0	456	0	0	\N	\N	CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O	3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methyl-anilino]phenol;methanesulfonic acid
7930	REMSED	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7913	REGONOL	PYRIDOSTIGMINE BROMIDE	7550	C9H13BrN2O2	261.119	\N	\N	0	3	2	33.4	14	0	183	0	0	\N	\N	C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-]	(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate;bromide
7840	QUINACT	QUINIDINE GLUCONATE	94328	C26H36N2O9	520.579	\N	\N	7	11	9	184	37	0	627	8	0	\N	\N	COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.C(C(C(C(C(C(=O)O)O)O)O)O)O	(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid
7849	QUINIDEX	QUINIDINE SULFATE	441074	C20H24N2O2	324.424	\N	2.9	1	4	4	45.6	24	0	457	4	0	\N	\N	COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O	(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol
7852	QUININE SULFATE	QUININE SULFATE	8549	C20H24N2O2	324.424	\N	2.9	1	4	4	45.6	24	0	457	3	1	\N	\N	COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O	(R)-(6-methoxy-4-quinolyl)-[(2S,5R)-5-vinylquinuclidin-2-yl]methanol
7867	RAMELTEON	RAMELTEON	208902	C16H21NO2	259.349	\N	2.7	1	2	4	38.3	19	0	331	1	0	\N	\N	CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3	N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e]benzofuran-8-yl]ethyl]propanamide
7871	RANITIDINE	RANITIDINE	3001055	C13H22N4O3S	314.404	\N	0.3	2	7	9	112	21	0	347	0	0	\N	\N	CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C	(E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furyl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine
7879	RASAGILINE MESYLATE	RASAGILINE MESYLATE	3052775	C13H17NO3S	267.343	\N	\N	2	4	2	74.8	18	0	305	1	0	\N	\N	CS(=O)(=O)O.C#CCNC1CCC2=CC=CC=C12	methanesulfonic acid;(1R)-N-prop-2-ynylindan-1-amine
7881	RAU-SED	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
7875	RAPAMUNE	SIROLIMUS	5284616	C51H79NO13	914.187	\N	6	3	13	6	195	65	0	1760	15	0	\N	\N	CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC	\N
7835	QUIBRON-T	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
7906	RECLAST	ZOLEDRONIC ACID	68740	C5H10N2O7P2	272.09	\N	-4.3	5	8	4	153	16	0	327	0	0	\N	\N	C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O	(1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid
7861	RADIO-IODINATED (I 125) SERUM ALBUMIN (HUMAN)	ALBUMIN IODINATED I-125 SERUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7862	RADIOGARDASE (PRUSSIAN BLUE)	FERRIC HEXACYANOFERRATE(II)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7863	RADIOIODINATED SERUM ALBUMIN (HUMAN) IHSA I 125	ALBUMIN IODINATED I-125 SERUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7864	RADIONUCLIDE-LABELED (125 I) FIBRINOGEN (HUMAN) SENSOR	FIBRINOGEN, I-125	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7878	RAPTIVA	EFALIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7884	RAUTENSIN	ALSEROXYLON	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7886	RAUWILOID	ALSEROXYLON	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7888	RAVICTI	GLYCEROL PHENYLBUTYRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7889	RAVOCAINE AND NOVOCAIN W/ LEVOPHED	NOREPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7896	RAXIBACUMAB	RAXIBACUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7901	RBC-SCAN	TECHNETIUM TC-99M RED BLOOD CELL KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7905	REBIF	INTERFERON BETA-1A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7909	REFLUDAN	LEPIRUDIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7914	REGRANEX	BECAPLERMIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7915	REGROTON	CHLORTHALIDONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7917	REGULAR ILETIN II	INSULIN PURIFIED BEEF	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7918	REGULAR ILETIN II (PORK)	INSULIN PURIFIED PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7919	REGULAR INSULIN	INSULIN PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7920	REGULAR PURIFIED PORK INSULIN	INSULIN PURIFIED PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7926	REMERON	MIRTAZAPINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7927	REMERON SOLTAB	MIRTAZAPINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7928	REMICADE	INFLIXIMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8009	RHINOCORT	BUDESONIDE	5281004	C25H34O6	430.541	\N	2.5	2	6	4	93.1	31	0	862	8	1	\N	\N	CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C	\N
7935	RENAMIN W/O ELECTROLYTES	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8035	RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
6648	PARAPLATIN	CARBOPLATIN	38904	C6H14N2O4Pt	373.272	\N	\N	4	6	0	76.6	13	0	169	0	0	\N	\N	C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]	ammonia;cyclobutane-1,1-dicarboxylic acid;platinum
7943	RENOCAL-76	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
8034	RIMSO-50	DIMETHYL SULFOXIDE	679	C2H6OS	78.129	\N	-0.6	0	2	0	36.3	4	0	29	0	0	\N	\N	CS(=O)C	methylsulfinylmethane
7998	REVERSOL	EDROPHONIUM CHLORIDE	8307	C10H16ClNO	201.694	\N	\N	1	2	2	20.2	13	0	145	0	0	\N	\N	CC[N+](C)(C)C1=CC(=CC=C1)O.[Cl-]	ethyl-(3-hydroxyphenyl)-dimethyl-ammonium;chloride
7974	RESERPINE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
7978	RESERPINE AND HYDROFLUMETHIAZIDE	HYDROFLUMETHIAZIDE	3647	C8H8F3N3O4S2	331.284	\N	0.4	3	10	1	135	20	0	578	0	0	\N	\N	C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1	1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
7965	REPREXAIN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
8019	RIFAMATE	ISONIAZID	3767	C6H7N3O	137.142	\N	-0.7	2	3	1	68	10	0	120	0	0	\N	\N	C1=CN=CC=C1C(=O)NN	pyridine-4-carbohydrazide
8022	RIFAMPIN AND ISONIAZID	ISONIAZID	3767	C6H7N3O	137.142	\N	-0.7	2	3	1	68	10	0	120	0	0	\N	\N	C1=CN=CC=C1C(=O)NN	pyridine-4-carbohydrazide
7950	RENOTEC	TECHNETIUM TC-99M FERPENTETATE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8001	REVLIMID	LENALIDOMIDE	216326	C13H13N3O3	259.265	\N	-0.5	2	4	1	92.5	19	0	437	0	1	\N	\N	C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N	3-(4-amino-1-oxo-isoindolin-2-yl)piperidine-2,6-dione
8038	RIOMET	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
8014	RID MOUSSE	PIPERONYL BUTOXIDE	5794	C19H30O5	338.444	\N	3.7	0	5	13	46.2	24	0	312	0	0	\N	\N	CCCCOCCOCCOCC1=CC2=C(C=C1CCC)OCO2	5-[2-(2-butoxyethoxy)ethoxymethyl]-6-propyl-1,3-benzodioxole
8036	RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7987	RESPORAL	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
7938	RENESE-R	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
8011	RIBASPHERE	RIBAVIRIN	37542	C8H12N4O5	244.207	\N	-1.8	4	7	3	144	17	0	304	4	0	\N	\N	C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide
7959	REOPRO	ABCIXIMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8012	RIBAVARIN	RIBAVIRIN	37542	C8H12N4O5	244.207	\N	-1.8	4	7	3	144	17	0	304	4	0	\N	\N	C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide
8018	RIFADIN	RIFAMPIN	5381226	C43H58N4O12	822.953	\N	4	6	15	5	217	59	0	1750	9	0	\N	\N	CC1C=CC=C(C(=O)NC2=C(C3=C(C(=C4C(=C3C(=O)C2=CNN5CCN(CC5)C)C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C	\N
8027	RILPIVIRINE	RILPIVIRINE	6451164	C22H18N6	366.428	\N	4.5	2	6	5	97.4	28	0	607	0	0	\N	\N	CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N	4-[[4-[4-[(E)-2-cyanovinyl]-2,6-dimethyl-anilino]pyrimidin-2-yl]amino]benzonitrile
7963	REPATHA	EVOLOCUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7964	REPREXAIN	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7966	REPRONEX	MENOTROPINS (FSH;LH)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8032	RIMANTADINE HYDROCHLORIDE	RIMANTADINE HYDROCHLORIDE	15165	C12H22ClN	215.765	\N	\N	2	1	1	26	14	0	180	0	1	\N	\N	CC(C12CC3CC(C1)CC(C3)C2)N.Cl	1-(1-adamantyl)ethanamine;hydrochloride
7967	REQUIP	ROPINIROLE HYDROCHLORIDE	68727	C16H25ClN2O	296.839	\N	\N	2	2	7	32.3	20	0	287	0	0	\N	\N	CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1.Cl	4-[2-(dipropylamino)ethyl]indolin-2-one;hydrochloride
7958	RENVELA	SEVELAMER CARBONATE	11593706	C7H14ClNO4	211.642	\N	\N	3	5	2	96.1	13	0	81.4	0	1	\N	\N	C=CCN.C1C(O1)CCl.C(=O)(O)O	carbonic acid;2-(chloromethyl)oxirane;prop-2-en-1-amine
8037	RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7989	RESTORIL	TEMAZEPAM	5391	C16H13ClN2O2	300.742	\N	2.2	1	3	1	52.9	21	0	434	0	1	\N	\N	CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3	7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
8008	REZULIN	TROGLITAZONE	5591	C24H27NO5S	441.542	\N	5.1	2	6	5	110	31	0	681	0	2	\N	\N	CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O	5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl)methoxy]phenyl]methyl]thiazolidine-2,4-dione
7990	RETAVASE	RETEPLASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
7997	REVATIO	SILDENAFIL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8006	REZIRA	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8119	RYTARY	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
5394	MENRIUM 5-2	CHLORDIAZEPOXIDE	2712	C16H14ClN3O	299.758	\N	2.4	1	3	1	48.2	21	0	580	0	0	\N	\N	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine
8128	SAFYRAL	DROSPIRENONE	68873	C24H30O3	366.501	\N	3.5	0	3	0	43.4	27	0	828	10	0	\N	\N	CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C	\N
8074	ROMAZICON	FLUMAZENIL	3373	C15H14FN3O3	303.293	\N	1	0	5	3	64.4	22	0	461	0	0	\N	\N	CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C	ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
8144	SANCUSO	GRANISETRON	5284566	C18H24N4O	312.417	\N	2.8	1	3	2	50.2	23	0	442	2	0	\N	\N	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C	1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide
8114	RUFEN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
8120	RYTARY	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
8050	RITUXAN	RITUXIMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8052	RIVASTIGMINE	RIVASTIGMINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8053	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8067	ROCEPHIN KIT	LIDOCAINE	3676	C14H22N2O	234.343	\N	2.3	1	2	5	32.3	17	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
8149	SANOREX	MAZINDOL	4020	C16H13ClN2O	284.743	\N	2.2	1	2	1	35.8	20	0	419	0	1	\N	\N	C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O	5-(4-chlorophenyl)-2,3-dihydroimidazo[1,2-b]isoindol-5-ol
8075	RONDOMYCIN	METHACYCLINE HYDROCHLORIDE	54685047	C22H23ClN2O8	478.882	\N	\N	7	9	2	182	33	0	998	5	0	\N	\N	CN(C)C1C2C(C3C(=C)C4=C(C(=CC=C4)O)C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O.Cl	(4S,4aR,5S,5aR,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8134	SALONPAS	METHYL SALICYLATE	4133	C8H8O3	152.149	\N	2.3	1	3	2	46.5	11	0	144	0	0	\N	\N	COC(=O)C1=CC=CC=C1O	methyl 2-hydroxybenzoate
8151	SANSERT	METHYSERGIDE MALEATE	5281073	C25H31N3O6	469.538	\N	\N	4	7	6	132	34	0	697	3	0	\N	\N	CCC(CO)NC(=O)C1CN(C2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C.C(=CC(=O)O)C(=O)O	(6aR,9R)-N-[(1S)-1-(hydroxymethyl)propyl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide;maleic acid
8090	ROXICET	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
8098	ROXIPRIN	OXYCODONE TEREPHTHALATE	5464088	C26H27NO8	481.501	\N	\N	3	9	3	134	35	0	722	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O.C1=CC(=CC=C1C(=O)O)C(=O)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;terephthalic acid
8132	SALAGEN	PILOCARPINE HYDROCHLORIDE	5909	C11H17ClN2O2	244.719	\N	\N	1	3	3	44.1	16	0	245	2	0	\N	\N	CCC1C(COC1=O)CC2=CN=CN2C.Cl	(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one;hydrochloride
8099	ROZEREM	RAMELTEON	208902	C16H21NO2	259.349	\N	2.7	1	2	4	38.3	19	0	331	1	0	\N	\N	CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3	N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e]benzofuran-8-yl]ethyl]propanamide
8046	RITODRINE HCL	RITODRINE HYDROCHLORIDE	31728	C17H22ClNO3	323.817	\N	\N	5	4	6	72.7	22	0	284	2	0	\N	\N	CC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O.Cl	4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl-ethyl]amino]ethyl]phenol;hydrochloride
8051	RIVASTIGMINE	RIVASTIGMINE	77991	C14H22N2O2	250.342	\N	2.3	0	3	5	32.8	18	0	269	1	0	\N	\N	CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C	[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methyl-carbamate
8070	ROFLUMILAST	ROFLUMILAST	449193	C17H14Cl2F2N2O3	403.207	\N	4.6	1	6	7	60.4	26	0	475	0	0	\N	\N	C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F	3-(cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridyl)-4-(difluoromethoxy)benzamide
8078	ROSIGLITAZONE	ROSIGLITAZONE MALEATE	5281055	C22H23N3O7S	473.5	\N	\N	3	10	9	171	33	0	588	0	1	\N	\N	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O	maleic acid;5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione
8086	ROSUVASTATIN CALCIUM	ROSUVASTATIN CALCIUM	5282455	C44H54CaF2N6O12S2	1001.141	\N	\N	4	20	18	304	67	0	761	4	0	\N	\N	CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Ca+2]	calcium;(E,3R,5S)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoate
8113	RUBY-FILL	RUBIDIUM CHLORIDE RB-82	71357	ClRb	117.368	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[Rb+]	rubidium-82(1+);chloride
8141	SAMSCA	TOLVAPTAN	216237	C26H25ClN2O3	448.947	\N	4.8	2	3	3	69.6	32	0	674	0	1	\N	\N	CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C	N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide
8127	SABRIL	VIGABATRIN	5665	C6H11NO2	129.159	\N	-2.2	2	3	4	63.3	9	0	112	0	1	\N	\N	C=CC(CCC(=O)O)N	4-aminohex-5-enoic acid
8103	RUBRATOPE-57	CYANOCOBALAMIN CO-57	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8104	RUBRATOPE-57 KIT	COBALT CHLORIDE CO-57	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8106	RUBRATOPE-57 KIT	CYANOCOBALAMIN CO-57	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8108	RUBRATOPE-60	CYANOCOBALAMIN CO-60	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8109	RUBRATOPE-60 KIT	COBALT CHLORIDE CO-60	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8111	RUBRATOPE-60 KIT	CYANOCOBALAMIN CO-60	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8123	RYZODEG 70/30	INSULIN ASPART	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8131	SAIZEN	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8152	SANTYL	COLLAGENASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8259	SIMBRINZA	BRINZOLAMIDE	68844	C12H21N3O5S3	383.496	\N	-0.3	2	9	7	164	23	0	598	1	0	\N	\N	CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC	(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide
8156	SARISOL	BUTABARBITAL SODIUM	23690439	C10H15N2NaO3	234.231	\N	\N	1	3	3	81.6	16	0	330	0	2	\N	\N	CCC(C)C1(C(=O)NC(=NC1=O)[O-])CC.[Na+]	sodium;5-ethyl-4,6-dioxo-5-sec-butyl-1H-pyrimidin-2-olate
8185	SEDAPAP	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
5396	MENRIUM 5-4	CHLORDIAZEPOXIDE	2712	C16H14ClN3O	299.758	\N	2.4	1	3	1	48.2	21	0	580	0	0	\N	\N	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine
8186	SEEBRI	GLYCOPYRROLATE	11693	C19H28BrNO3	398.341	\N	\N	1	4	5	46.5	24	0	424	0	2	\N	\N	C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-]	(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenyl-acetate;bromide
8212	SER-A-GEN	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
8213	SER-A-GEN	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
8163	SAXAGLIPTIN;METFORMIN HYDROCHLORIDE	SAXAGLIPTIN;METFORMIN HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8264	SINE-AID IB	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
8169	SCANLUX-300	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
8165	SCABENE	LINDANE	727	C6H6Cl6	290.814	\N	3.8	0	0	0	0	12	0	104	0	0	\N	\N	C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl	1,2,3,4,5,6-hexachlorocyclohexane
8167	SCANDONEST L	MEPIVACAINE HYDROCHLORIDE	66070	C15H23ClN2O	282.812	\N	\N	2	2	2	32.3	19	0	282	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl	N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide;hydrochloride
8171	SCLEROSOL	TALC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8246	SFROWASA	MESALAMINE	4075	C7H7NO3	153.137	\N	1.3	3	4	1	83.6	11	0	160	0	0	\N	\N	C1=CC(=C(C=C1N)C(=O)O)O	5-amino-2-hydroxy-benzoic acid
8159	SATRIC	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
8248	SHADE UVAGUARD	OCTINOXATE	5355130	C18H26O3	290.403	\N	5.3	0	3	10	35.5	21	0	304	0	1	\N	\N	CCCCC(CC)COC(=O)C=CC1=CC=C(C=C1)OC	2-ethylhexyl (E)-3-(4-methoxyphenyl)prop-2-enoate
8197	SEMPREX-D	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
8220	SEREVENT	SALMETEROL XINAFOATE	56801	C36H45NO7	603.756	\N	\N	6	8	17	140	44	0	629	0	1	\N	\N	C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O.C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O	2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol;1-hydroxynaphthalene-2-carboxylic acid
8180	SecreFlo	Porcine Secretin	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8181	SECREFLO	SECRETIN SYNTHETIC PORCINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8182	SECRETIN-FERRING	SECRETIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8162	SAXAGLIPTIN	SAXAGLIPTIN	11243969	C18H25N3O2	315.417	\N	0.7	2	4	2	90.4	23	0	609	4	2	\N	\N	C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N	(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
8172	SCOPOLAMINE	SCOPOLAMINE	3000322	C17H21NO4	303.358	\N	0.9	1	5	5	62.3	22	0	418	5	0	\N	\N	CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4	\N
8190	SELENOMETHIONINE SE 75	SELENOMETHIONINE SE-75	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8179	SECONAL SODIUM	SECOBARBITAL SODIUM	14148199	C12H17N2NaO3	260.269	\N	\N	1	4	5	64.2	18	0	370	0	2	\N	\N	CCCC(C)C1(C(=O)NC(=O)[N-]C1=O)CC=C.[Na+]	sodium;5-allyl-5-(1-methylbutyl)hexahydropyrimidin-3-ide-2,4,6-trione
8189	SELENIUM SULFIDE	SELENIUM SULFIDE	24011	SSe	111.031	\N	\N	0	1	0	32.1	2	0	2	0	0	\N	\N	S=[Se]	\N
8245	SEVOFLURANE	SEVOFLURANE	5206	C4H3F7O	200.056	\N	2.8	0	8	2	9.2	12	0	121	0	0	\N	\N	C(OC(C(F)(F)F)C(F)(F)F)F	1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane
8194	SEMILENTE	INSULIN ZINC SUSP PROMPT PURIFIED PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8195	SEMILENTE INSULIN	INSULIN ZINC SUSP PROMPT BEEF	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8206	SEPTRA	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8207	SEPTRA	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8201	SENSORCAINE	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8204	SEPTOCAINE	ARTICAINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8205	SEPTOCAINE	EPINEPHRINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8223	SEROPHENE	CLOMIPHENE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8224	SEROQUEL	QUETIAPINE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8225	SEROQUEL XR	QUETIAPINE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8226	SEROSTIM	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8227	SEROSTIM LQ	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8239	SERTRALINE HYDROCHLORIDE	SERTRALINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8242	SETHOTOPE	SELENOMETHIONINE SE-75	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8250	SIGNIFOR	PASIREOTIDE DIASPARTATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8253	SILDENAFIL CITRATE	SILDENAFIL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8258	SIMBRINZA	BRIMONIDINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8260	SIMPONI	GOLIMUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8261	SIMPONI ARIA	GOLIMUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8262	SIMULECT	BASILIXIMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8301	SODIUM BUTABARBITAL	BUTABARBITAL SODIUM	23690439	C10H15N2NaO3	234.231	\N	\N	1	3	3	81.6	16	0	330	0	2	\N	\N	CCC(C)C1(C(=O)NC(=NC1=O)[O-])CC.[Na+]	sodium;5-ethyl-4,6-dioxo-5-sec-butyl-1H-pyrimidin-2-olate
5071	LOPROX	CICLOPIROX	2749	C12H17NO2	207.273	\N	2	1	2	1	40.5	15	0	325	0	0	\N	\N	CC1=CC(=O)N(C(=C1)C2CCCCC2)O	6-cyclohexyl-1-hydroxy-4-methyl-pyridin-2-one
8288	SKLICE	IVERMECTIN	6321424	C48H74O14	875.106	\N	4.1	3	14	8	170	62	0	1680	20	0	\N	\N	CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C	\N
8349	SOLAGE	MEQUINOL	9015	C7H8O2	124.139	\N	1.3	1	2	1	29.5	9	0	75	0	0	\N	\N	COC1=CC=C(C=C1)O	4-methoxyphenol
8284	SKELAXIN	METAXALONE	15459	C12H15NO3	221.256	\N	2.2	1	3	3	47.6	16	0	247	0	1	\N	\N	CC1=CC(=CC(=C1)OCC2CNC(=O)O2)C	5-[(3,5-dimethylphenoxy)methyl]oxazolidin-2-one
8332	SODIUM PENTOBARBITAL	PENTOBARBITAL SODIUM	23676152	C11H17N2NaO3	248.258	\N	\N	1	3	4	81.6	17	0	344	0	2	\N	\N	CCCC(C)C1(C(=O)NC(=NC1=O)[O-])CC.[Na+]	sodium;5-ethyl-5-(1-methylbutyl)-4,6-dioxo-1H-pyrimidin-2-olate
8292	SLOW-K	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
8265	SINE-AID IB	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
8280	SITAGLIPTIN; METFORMIN HYDROCHLORIDE	SITAGLIPTIN	4369359	C16H15F6N5O	407.32	\N	0.7	1	10	4	77	28	0	566	1	0	\N	\N	C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N	(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
8275	SIRTURO	BEDAQUILINE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8297	SODIUM ACETATE IN PLASTIC CONTAINER	SODIUM ACETATE ANHYDROUS	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
8299	SODIUM BICARBONATE	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
8302	SODIUM CHLORIDE	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8279	SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE	SITAGLIPTIN PHOSPHATE;METFORMIN HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8319	SODIUM CHROMATE CR 51	SODIUM CHROMATE CR-51	3080662	CrNa2O4	160.92	\N	\N	0	4	0	80.3	7	0	62.2	0	0	\N	\N	[O-][Cr](=O)(=O)[O-].[Na+].[Na+]	disodium;dioxido(dioxo)chromium-51
8320	SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE	SODIUM FERRIC GLUCONATE COMPLEX	23693558	C6H11FeNaO7+3	273.982	\N	\N	5	7	5	141	15	3	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+].[Fe+3]	ferric;sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
8321	SODIUM FLUORIDE F 18	SODIUM FLUORIDE F-18	23690531	FNa	40.991	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[F-].[Na+]	sodium;fluorine-18(1-)
8322	SODIUM FLUORIDE F-18	SODIUM FLUORIDE F-18	23690531	FNa	40.991	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[F-].[Na+]	sodium;fluorine-18(1-)
8286	SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS	PERFLUOROPOLYMETHYLISOPROPYL ETHER	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8287	SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS	POLYTETRAFLUOROETHYLENE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8325	SODIUM IODIDE I 131	SODIUM IODIDE I-131	71368	INa	153.896	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[I-]	sodium;iodine-131(1-)
8326	SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
8293	SMOFLIPID 20%	FISH OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8294	SMOFLIPID 20%	MEDIUM CHAIN TRIGLYCERIDES	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8295	SMOFLIPID 20%	OLIVE OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8296	SMOFLIPID 20%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8327	SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
8328	SODIUM LACTATE IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
8329	SODIUM NITRITE	SODIUM NITRITE	23668193	NNaO2	68.995	\N	\N	0	3	0	52.5	4	0	13.5	0	0	\N	\N	N(=O)[O-].[Na+]	sodium;nitrite
8335	SODIUM PHENYLACETATE AND SODIUM BENZOATE	SODIUM PHENYLACETATE	23690424	C8H7NaO2	158.132	\N	\N	0	2	2	40.1	11	0	119	0	0	\N	\N	C1=CC=C(C=C1)CC(=O)[O-].[Na+]	sodium;2-phenylacetate
8337	SODIUM PHOSPHATE P 32	SODIUM PHOSPHATE P-32	71180	HNa2O4P	142.957	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[Na+].[Na+]	disodium;hydroxy-dioxido-oxo-$l^{5}-phosphane
8343	SODIUM SUCCINATE	SODIUM SUCCINATE	9020	C4H4Na2O4	162.052	\N	\N	0	4	1	80.3	10	0	81.6	0	0	\N	\N	C(CC(=O)[O-])C(=O)[O-].[Na+].[Na+]	disodium;butanedioate
8344	SODIUM SULAMYD	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
8290	SLO-BID	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8323	SODIUM HEPARIN	HEPARIN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8324	SODIUM IODIDE I 123	SODIUM IODIDE I-123	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8330	SODIUM NITROPRUSSIDE	SODIUM NITROPRUSSIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8333	SODIUM PERTECHNETATE TC 99M	TECHNETIUM TC-99M SODIUM PERTECHNETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8336	SODIUM PHENYLBUTYRATE	SODIUM PHENYLBUTYRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8338	SODIUM PHOSPHATES IN PLASTIC CONTAINER	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8340	SODIUM POLYPHOSPHATE-TIN KIT	TECHNETIUM TC-99M POLYPHOSPHATE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8341	SODIUM POLYSTYRENE SULFONATE	SODIUM POLYSTYRENE SULFONATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8346	SODIUM SULFATE;POTASSIUM SULFATE;MAGNESIUM SULFATE	SODIUM SULFATE;POTASSIUM SULFATE;MAGNESIUM SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8354	SOLIRIS	ECULIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8360	SOMA COMPOUND	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
8356	SOLTAMOX	TAMOXIFEN CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8357	SOLU-CORTEF	HYDROCORTISONE SODIUM SUCCINATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8358	SOLU-MEDROL	METHYLPREDNISOLONE SODIUM SUCCINATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8421	STALEVO 100	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
8359	SOMA	CARISOPRODOL	2576	C12H24N2O4	260.334	\N	1.9	2	4	9	90.6	18	0	281	0	1	\N	\N	CCCC(C)(COC(=O)N)COC(=O)NC(C)C	[2-(carbamoyloxymethyl)-2-methyl-pentyl] N-isopropylcarbamate
8372	SONAZINE	CHLORPROMAZINE HYDROCHLORIDE	6240	C17H20Cl2N2S	355.321	\N	\N	1	3	4	31.8	22	0	339	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl	3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine;hydrochloride
5945	NEOSAR	CYCLOPHOSPHAMIDE	2907	C7H15Cl2N2O2P	261.083	\N	0.6	1	4	5	41.6	14	0	212	0	1	\N	\N	C1CNP(=O)(OC1)N(CCCl)CCCl	N,N-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine
8366	SOMAVERT	PEGVISOMANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8222	SEROMYCIN	CYCLOSERINE	6234	C3H6N2O2	102.093	\N	-1.5	2	3	0	64.4	7	0	92.9	1	0	\N	\N	C1C(C(=O)NO1)N	(4R)-4-aminoisoxazolidin-3-one
8409	SPRINTEC	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
8393	SOY-DOME	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
8397	SPECTAMINE	IOFETAMINE HYDROCHLORIDE I-123	55305	C12H19ClIN	339.645	\N	\N	2	1	4	12	15	0	150	0	1	\N	\N	CC(C)NC(C)CC1=CC=C(C=C1)I.Cl	1-(4-iodophenyl)-N-isopropyl-propan-2-amine;hydrochloride
8374	SOOLANTRA	IVERMECTIN	6321424	C48H74O14	875.106	\N	4.1	3	14	8	170	62	0	1680	20	0	\N	\N	CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C	\N
8373	SONORX	SIMETHICONE-CELLULOSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8411	SPRITAM	LEVETIRACETAM	5284583	C8H14N2O2	170.212	\N	-0.3	1	2	3	63.4	12	0	203	1	0	\N	\N	CCC(C(=O)N)N1CCCC1=O	(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
8378	SORBITOL-MANNITOL	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
8441	STARLIX	NATEGLINIDE	5311309	C19H27NO3	317.429	\N	3.2	2	3	6	66.4	23	0	393	1	0	\N	\N	CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O	(2R)-2-[(4-isopropylcyclohexanecarbonyl)amino]-3-phenyl-propanoic acid
8410	SPRINTEC	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
8382	SORBITRATE	ISOSORBIDE DINITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8417	SSD	SILVER SULFADIAZINE	441244	C10H9AgN4O2S	357.136	\N	\N	1	6	3	95.3	18	0	327	0	0	\N	\N	C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ag+]	silver;(4-aminophenyl)sulfonyl-pyrimidin-2-yl-azanide
8375	SORAFENIB	SORAFENIB	216239	C21H16ClF3N4O3	464.829	\N	4.1	3	7	5	92.4	32	0	646	0	0	\N	\N	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide
8385	SORINE	SOTALOL HYDROCHLORIDE	66245	C12H21ClN2O3S	308.821	\N	\N	4	5	6	86.8	19	0	330	0	1	\N	\N	CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.Cl	N-[4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide;hydrochloride
8447	STAVUDINE	STAVUDINE	18283	C10H12N2O4	224.216	\N	-0.8	2	4	2	78.9	16	0	388	2	0	\N	\N	CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO	1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
8448	STAVUDINE; LAMIVUDINE	STAVUDINE	18283	C10H12N2O4	224.216	\N	-0.8	2	4	2	78.9	16	0	388	2	0	\N	\N	CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO	1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
8386	SOSOL	SULFISOXAZOLE	5344	C11H13N3O3S	267.303	\N	1	2	6	3	107	18	0	374	0	0	\N	\N	CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide
8392	SOXAZOLE	SULFISOXAZOLE	5344	C11H13N3O3S	267.303	\N	1	2	6	3	107	18	0	374	0	0	\N	\N	CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide
8394	SOYACAL 10%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8395	SOYACAL 20%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8401	SPIRIVA	TIOTROPIUM BROMIDE	5487426	C19H22BrNO4S2	472.412	\N	\N	1	7	5	116	27	0	564	4	0	\N	\N	C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-]	\N
8398	SPECTAZOLE	ECONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8461	STELARA	USTEKINUMAB	121750	C14H18Cl3N5O2	394.681	\N	2.8	2	3	6	98.5	24	0	503	0	0	\N	\N	CC1(N=C(N=C(N1OCCCOC2=CC(=C(C=C2Cl)Cl)Cl)N)N)C	6,6-dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,3,5-triazine-2,4-diamine
8413	SPRX-105	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8414	SPRX-3	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8416	SPS	SODIUM POLYSTYRENE SULFONATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8419	STADOL	BUTORPHANOL TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8420	STADOL PRESERVATIVE FREE	BUTORPHANOL TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8443	STATOBEX	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8444	STATOBEX-G	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8449	STAVUDINE; LAMIVUDINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8451	STAVUDINE; LAMIVUDINE W/NEVIRAPINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8454	STAVUDINE; LAMIVUDINE; EFAVIRENZ	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8457	STAVUDINE; LAMIVUDINE; NEVIRAPINE	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9440	UTIMOX	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
8490	STRIFON FORTE DSC	CHLORZOXAZONE	2733	C7H4ClNO2	169.564	\N	1.8	1	2	0	38.3	11	0	185	0	0	\N	\N	C1=CC2=C(C=C1Cl)NC(=O)O2	5-chloro-3H-1,3-benzoxazol-2-one
2935	DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM	DROSPIRENONE	68873	C24H30O3	366.501	\N	3.5	0	3	0	43.4	27	0	828	10	0	\N	\N	CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C	\N
9796	YASMIN	DROSPIRENONE	68873	C24H30O3	366.501	\N	3.5	0	3	0	43.4	27	0	828	10	0	\N	\N	CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C	\N
8472	STIE-CORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8492	STROMECTOL	IVERMECTIN	6321424	C48H74O14	875.106	\N	4.1	3	14	8	170	62	0	1680	20	0	\N	\N	CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C	\N
8500	SUCLEAR	MAGNESIUM SULFATE	24083	MgO4S	120.361	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Mg+2]	magnesium;sulfate
8537	SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE	PHENAZOPYRIDINE HYDROCHLORIDE	8691	C11H12ClN5	249.702	\N	\N	3	5	2	89.6	17	0	237	0	0	\N	\N	C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N.Cl	3-phenylazopyridine-2,6-diamine;hydrochloride
8501	SUCLEAR	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
8464	STERANE	PREDNISOLONE	5755	C21H28O5	360.45	\N	1.6	3	5	2	94.8	26	0	724	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
8480	STIVARGA	REGORAFENIB	11167602	C21H15ClF4N4O3	482.82	\N	4.2	3	8	5	92.4	33	0	686	0	0	\N	\N	CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F	4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluoro-phenoxy]-N-methyl-pyridine-2-carboxamide
8506	SUCLEAR	SODIUM SULFATE	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
8469	STERILE WATER	STERILE WATER FOR IRRIGATION	962	H2O	18.015	\N	-0.5	1	1	0	1	1	0	0	0	0	\N	\N	O	water
8483	STRENSIQ	ASFOTASE ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8468	STERILE WATER	STERILE WATER	962	H2O	18.015	\N	-0.5	1	1	0	1	1	0	0	0	0	\N	\N	O	water
8515	SULF-10	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
8524	SULFADIAZINE SODIUM	SULFADIAZINE SODIUM	15899898	C10H9N4NaO2S	272.258	\N	\N	1	6	3	95.3	18	0	332	0	0	\N	\N	C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Na+]	sodium;(4-aminophenyl)sulfonyl-pyrimidin-2-yl-azanide
8523	SULFADIAZINE	SULFADIAZINE	5215	C10H10N4O2S	250.276	\N	-0.1	2	6	3	106	17	0	327	0	0	\N	\N	C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-pyrimidin-2-yl-benzenesulfonamide
8489	STRIBILD	TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8560	SULFONAMIDES DUPLEX	SULFAMERAZINE	5325	C11H12N4O2S	264.303	\N	0.1	2	6	3	106	18	0	360	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide
8493	STRONTIUM CHLORIDE SR-89	STRONTIUM CHLORIDE SR-89	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8494	SUBLIMAZE PRESERVATIVE FREE	FENTANYL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8548	SULFATRIM	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8545	SULFANILAMIDE	SULFANILAMIDE	5333	C6H8N2O2S	172.202	\N	-0.6	2	4	1	94.6	11	0	211	0	0	\N	\N	C1=CC(=CC=C1N)S(=O)(=O)N	4-aminobenzenesulfonamide
8518	SULFABID	SULFAPHENAZOLE	5335	C15H14N4O2S	314.363	\N	1.5	2	5	4	98.4	22	0	451	0	0	\N	\N	C1=CC=C(C=C1)N2C(=CC=N2)NS(=O)(=O)C3=CC=C(C=C3)N	4-amino-N-(2-phenylpyrazol-3-yl)benzenesulfonamide
8546	SULFAPYRIDINE	SULFAPYRIDINE	5336	C11H11N3O2S	249.288	\N	0	2	5	3	93.5	17	0	331	0	0	\N	\N	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(2-pyridyl)benzenesulfonamide
8547	SULFASALAZINE	SULFASALAZINE	5353980	C18H14N4O5S	398.393	\N	2.3	3	9	6	146	28	0	804	0	0	\N	\N	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O	(3E)-6-oxo-3-[[4-(2-pyridylsulfamoyl)phenyl]hydrazono]cyclohexa-1,4-diene-1-carboxylic acid
8556	SULFINPYRAZONE	SULFINPYRAZONE	5342	C23H20N2O3S	404.484	\N	2.3	0	4	6	76.9	29	0	571	0	1	\N	\N	C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4	4-[2-(benzenesulfinyl)ethyl]-1,2-diphenyl-pyrazolidine-3,5-dione
8562	SULINDAC	SULINDAC	1548887	C20H17FO3S	356.411	\N	3.4	1	5	4	73.6	25	0	616	0	1	\N	\N	CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O	2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylene]inden-1-yl]acetic acid
8531	SULFAMETHOPRIM	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8517	SULFA-TRIPLE #2	TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)	60896	C33H36N12O6S3	792.909	\N	\N	6	18	9	319	54	0	1060	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-pyrimidin-2-yl-benzenesulfonamide
8467	STERILE UREA	UREA	1176	CH4N2O	60.056	\N	-1.4	2	1	0	69.1	4	0	29	0	0	\N	\N	C(=O)(N)N	urea
8508	SUCRAID	SACROSIDASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8509	SUCRALFATE	SUCRALFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8512	SUFENTA PRESERVATIVE FREE	SUFENTANIL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8513	SUFENTANIL CITRATE	SUFENTANIL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8616	SYNALGOS-DC	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
8606	SYMBICORT	BUDESONIDE	5281004	C25H34O6	430.541	\N	2.5	2	6	4	93.1	31	0	862	8	1	\N	\N	CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C	\N
8656	TAGAMET	CIMETIDINE	2756	C10H16N6S	252.34	\N	0.4	3	4	7	114	17	0	296	0	0	\N	\N	CC1=C(N=CN1)CSCCNC(=NC)NC#N	1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine
8627	SYNERCID	DALFOPRISTIN	6323289	C34H50N4O9S	690.853	\N	2.2	2	11	7	185	48	0	1340	5	0	\N	\N	CCN(CC)CCS(=O)(=O)C1CCN2C1C(=O)OC(C(C=CC(=O)NCC=CC(=CC(CC(=O)CC3=NC(=CO3)C2=O)O)C)C)C(C)C	\N
8586	SUPRANE	DESFLURANE	42113	C3H2F6O	168.038	\N	2.6	0	7	2	9.2	10	0	97.7	0	1	\N	\N	C(C(F)(F)F)(OC(F)F)F	2-(difluoromethoxy)-1,1,1,2-tetrafluoro-ethane
8601	SYEDA	DROSPIRENONE	68873	C24H30O3	366.501	\N	3.5	0	3	0	43.4	27	0	828	10	0	\N	\N	CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C	\N
9798	YAZ	DROSPIRENONE	68873	C24H30O3	366.501	\N	3.5	0	3	0	43.4	27	0	828	10	0	\N	\N	CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C	\N
8608	SYMBYAX	FLUOXETINE HYDROCHLORIDE	62857	C17H19ClF3NO	345.79	\N	\N	2	5	6	21.3	23	0	308	0	1	\N	\N	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl	N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride
8647	TAB-PROFEN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
8625	SYNERA	LIDOCAINE	3676	C14H22N2O	234.343	\N	2.3	1	2	5	32.3	17	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
2635	DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2677	DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
8648	TACARYL	METHDILAZINE	14677	C18H20N2S	296.432	\N	5.2	0	3	2	31.8	21	0	339	0	1	\N	\N	CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42	10-[(1-methylpyrrolidin-3-yl)methyl]phenothiazine
8609	SYMBYAX	OLANZAPINE	4585	C17H20N4S	312.435	\N	2.8	1	5	1	56.2	22	0	543	0	0	\N	\N	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
8640	SYNRIBO	OMACETAXINE MEPESUCCINATE	285033	C29H39NO9	545.629	\N	0.8	2	10	11	124	39	0	968	4	0	\N	\N	CC(C)(CCCC(CC(=O)OC)(C(=O)OC1C2C3=CC4=C(C=C3CCN5C2(CCC5)C=C1OC)OCO4)O)O	\N
8666	TALWIN	PENTAZOCINE LACTATE	656697	C22H33NO4	375.509	\N	\N	3	5	3	81	27	0	473	3	1	\N	\N	CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O.CC(C(=O)O)O	\N
8590	SUPREP BOWEL PREP KIT	POTASSIUM SULFATE	24507	K2O4S	174.253	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[K+].[K+]	dipotassium;sulfate
8637	SYNOVALYTE IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
8638	SYNOVALYTE IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8591	SUPREP BOWEL PREP KIT	SODIUM SULFATE	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
8566	SULMEPRIM PEDIATRIC	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8592	SURFAXIN	LUCINACTANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8570	SULSOXIN	SULFISOXAZOLE	5344	C11H13N3O3S	267.303	\N	1	2	6	3	107	18	0	374	0	0	\N	\N	CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide
8595	SURVANTA	BERACTANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8575	SUMATRIPTAN	SUMATRIPTAN	5358	C14H21N3O2S	295.401	\N	0.9	2	4	6	73.6	20	0	405	0	0	\N	\N	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C	1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide
8653	TACROLIMUS	TACROLIMUS	445643	C44H69NO12	804.031	\N	2.7	3	12	7	178	57	0	1480	14	0	\N	\N	CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC	\N
8626	SYNERA	TETRACAINE	5411	C15H24N2O2	264.369	\N	3.7	1	4	9	41.6	19	0	249	0	0	\N	\N	CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C	2-(dimethylamino)ethyl 4-(butylamino)benzoate
8597	SUSTAIRE	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8644	SYPRINE	TRIENTINE HYDROCHLORIDE	71433	C6H20Cl2N4	219.154	\N	\N	6	4	7	76.1	12	0	49.7	0	0	\N	\N	C(CNCCNCCN)N.Cl.Cl	N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;dihydrochloride
8603	SYLATRON	PEGINTERFERON ALFA-2B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8604	SYLVANT	SILTUXIMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8607	SYMBICORT	FORMOTEROL FUMARATE DIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8610	SYMLIN	PRAMLINTIDE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8612	SYNACORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8613	SYNAGIS	PALIVIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8618	SYNALGOS-DC	DIHYDROCODEINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8621	SYNALGOS-DC-A	DIHYDROCODEINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8641	SYNTHETIC CONJUGATED ESTROGENS A	ESTROGENS, CONJUGATED SYNTHETIC A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8652	TACLONEX	CALCIPOTRIENE HYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8661	TAGRISSO	OSIMERTINIB MESYLATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8663	TALACEN	PENTAZOCINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8664	TALC	TALC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8665	TALTZ	IXEKIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8667	TALWIN 50	PENTAZOCINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8669	TALWIN COMPOUND	PENTAZOCINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8671	TALWIN NX	PENTAZOCINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8674	TAMOXIFEN CITRATE	TAMOXIFEN CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8766	TENORETIC 100	ATENOLOL	2249	C14H22N2O3	266.341	\N	0.2	3	4	8	84.6	19	0	263	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide
8761	TENATHAN	BETHANIDINE SULFATE	2368	C10H15N3	177.251	\N	0.9	2	1	4	36.4	13	0	160	0	0	\N	\N	CNC(=NC)NCC1=CC=CC=C1	1-benzyl-2,3-dimethyl-guanidine
8763	TENCON	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
3894	HEMABATE	CARBOPROST TROMETHAMINE	5281074	C25H47NO8	489.65	\N	\N	8	9	15	185	34	0	527	5	0	\N	\N	CCCCCC(C)(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O.C(C(CO)(CO)N)O	2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyl-oct-1-enyl]cyclopentyl]hept-5-enoic acid
8681	TARACTAN	CHLORPROTHIXENE	667467	C18H18ClNS	315.859	\N	5.2	0	2	3	28.5	21	0	381	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl	(3Z)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethyl-propan-1-amine
8690	TATUM-T	COPPER	23978	Cu	63.546	\N	\N	0	0	0	0	1	0	0	0	0	\N	\N	[Cu]	copper
8773	TENUATE	DIETHYLPROPION HYDROCHLORIDE	91442	C13H20ClNO	241.759	\N	\N	1	2	5	20.3	16	0	193	0	1	\N	\N	CCN(CC)C(C)C(=O)C1=CC=CC=C1.Cl	2-(diethylamino)-1-phenyl-propan-1-one;hydrochloride
8732	TECZEM	ENALAPRIL MALEATE	5388961	C24H32N2O9	492.525	\N	\N	4	10	12	171	35	0	638	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O	(2S)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid;maleic acid
8764	TENEX	GUANFACINE HYDROCHLORIDE	71401	C9H10Cl3N3O	282.549	\N	\N	3	1	2	81.5	16	0	256	0	0	\N	\N	C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl.Cl	N-(diaminomethylene)-2-(2,6-dichlorophenyl)acetamide;hydrochloride
8688	TASIGNA	NILOTINIB HYDROCHLORIDE MONOHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8691	TAVIST	CLEMASTINE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8693	TAVIST ALLERGY/SINUS/HEADACHE	CLEMASTINE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8745	TELEPAQUE	IOPANOIC ACID	3735	C11H12I3NO2	570.935	\N	3.9	2	3	4	63.3	17	0	277	0	1	\N	\N	CCC(CC1=C(C(=C(C=C1I)I)N)I)C(=O)O	2-[(3-amino-2,4,6-triiodo-phenyl)methyl]butanoic acid
8695	TAVIST-1	CLEMASTINE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8679	TAPAZOLE	METHIMAZOLE	1349907	C4H6N2S	114.166	\N	-0.3	1	1	0	47.4	7	0	119	0	0	\N	\N	CN1C=CNC1=S	3-methyl-1H-imidazole-2-thione
8684	TARGINIQ	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
8760	TEN-K	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
8675	TAMSULOSIN HYDROCHLORIDE	TAMSULOSIN HYDROCHLORIDE	5362376	C20H29ClN2O5S	444.971	\N	\N	3	7	11	108	29	0	539	1	0	\N	\N	CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N.Cl	5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide;hydrochloride
8725	TECHNETIUM TC-99M MEBROFENIN	TECHNETIUM TC-99M MEBROFENIN KIT	11431716	C15H19BrN2O5Tc	486.136	\N	\N	3	6	7	107	24	0	443	0	0	\N	\N	CC1=CC(=C(C(=C1NC(=O)CN(CC(=O)O)CC(=O)O)C)Br)C.[Tc]	2-[[2-(3-bromo-2,4,6-trimethyl-anilino)-2-oxo-ethyl]-(carboxymethyl)amino]acetic acid;technetium-99
8756	TEMODAR	TEMOZOLOMIDE	5394	C6H6N6O2	194.154	\N	-1.1	1	5	1	106	14	0	315	0	0	\N	\N	CN1C(=O)N2C=NC(=C2N=N1)C(=O)N	3-methyl-4-oxo-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
8689	TASMAR	TOLCAPONE	4659569	C14H11NO5	273.244	\N	3.3	2	5	2	103	20	0	372	0	0	\N	\N	CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]	(3,4-dihydroxy-5-nitro-phenyl)-(p-tolyl)methanone
8705	TC 99M-LUNGAGGREGATE	TECHNETIUM TC-99M ALBUMIN AGGREGATED	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8706	TECENTRIQ	ATEZOLIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8707	TECFIDERA	DIMETHYL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8708	TECHNECOLL	TECHNETIUM TC-99M SULFUR COLLOID KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8709	TECHNELITE	TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8710	TECHNESCAN	TECHNETIUM TC-99M OXIDRONATE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8711	TECHNESCAN GLUCEPTATE	TECHNETIUM TC-99M GLUCEPTATE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8712	TECHNESCAN HIDA	TECHNETIUM TC-99M LIDOFENIN KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8713	TECHNESCAN MAA	TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8714	TECHNESCAN MAG3	TECHNETIUM TC-99M MERTIATIDE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8715	TECHNESCAN PYP KIT	TECHNETIUM TC-99M PYROPHOSPHATE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8716	TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT	TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8718	TECHNETIUM TC 99M GENERATOR	TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8719	TECHNETIUM TC 99M HSA	TECHNETIUM TC-99M ALBUMIN KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8720	TECHNETIUM TC 99M MAA	TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8721	TECHNETIUM TC 99M MPI MDP	TECHNETIUM TC-99M MEDRONATE KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8722	TECHNETIUM TC 99M SESTAMIBI	TECHNETIUM TC-99M SESTAMIBI KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8723	TECHNETIUM TC 99M SULFUR COLLOID	TECHNETIUM TC-99M SULFUR COLLOID	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8724	TECHNETIUM TC 99M TSC	TECHNETIUM TC-99M SULFUR COLLOID KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8727	TECHNETIUM TC-99M SESTAMIBI	TECHNETIUM TC-99M SESTAMIBI KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8739	TEKAMLO	ALISKIREN HEMIFUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8741	TEKTURNA	ALISKIREN HEMIFUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8742	TEKTURNA HCT	ALISKIREN HEMIFUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8746	TELMISARTAN	TELMISARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8748	TELMISARTAN AND AMLODIPINE	TELMISARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8750	TELMISARTAN AND HYDROCHLOROTHIAZIDE	TELMISARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8751	TELMISARTAN; HYDROCHLOROTHIAZIDE	TELMISARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8753	TEMARIL	TRIMEPRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8765	TENOFOVIR DISOPROXIL FUMARATE	TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8767	TENORETIC 100	CHLORTHALIDONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8769	TENORETIC 50	CHLORTHALIDONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8787	TERRAMYCIN	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
8864	THEROXIDIL	MINOXIDIL	4201	C9H15N5O	209.253	\N	1.2	3	3	1	88.9	15	0	329	0	0	\N	\N	C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O	3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine
8788	TERRAMYCIN	OXYTETRACYCLINE	54675779	C22H24N2O9	460.439	\N	-1.6	7	10	2	202	33	0	1000	6	0	\N	\N	CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O	(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
8832	THAM-E	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
8819	TETRACYN	PROCAINE HYDROCHLORIDE	5795	C13H21ClN2O2	272.773	\N	\N	2	4	7	55.6	18	0	222	0	0	\N	\N	CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.Cl	2-(diethylamino)ethyl 4-aminobenzoate;hydrochloride
8785	TERRA-CORTRIL	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8833	THAM-E	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8780	TERBINAFINE HYDROCHLORIDE	TERBINAFINE HYDROCHLORIDE	5282481	C21H26ClN	327.896	\N	\N	1	1	5	3.2	23	0	428	0	0	\N	\N	CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21.Cl	(E)-N,6,6-trimethyl-N-(1-naphthylmethyl)hept-2-en-4-yn-1-amine;hydrochloride
8809	TESTOSTERONE ENANTHATE	TESTOSTERONE ENANTHATE	9416	C26H40O3	400.603	\N	6.3	0	3	7	43.4	29	0	679	6	0	\N	\N	CCCCCCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C	[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate
8812	TESTOSTERONE PROPIONATE	TESTOSTERONE PROPIONATE	5995	C22H32O3	344.495	\N	4.4	0	3	3	43.4	25	0	621	6	0	\N	\N	CCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C	[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] propanoate
8815	TETRABENAZINE	TETRABENAZINE	6018	C19H27NO3	317.429	\N	2.9	0	4	4	38.8	23	0	425	0	2	\N	\N	CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC	3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one
8816	TETRACAINE HYDROCHLORIDE	TETRACAINE HYDROCHLORIDE	8695	C15H25ClN2O2	300.827	\N	\N	2	4	9	41.6	20	0	249	0	0	\N	\N	CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C.Cl	2-(dimethylamino)ethyl 4-(butylamino)benzoate;hydrochloride
8823	TETREX	TETRACYCLINE PHOSPHATE COMPLEX	54729668	C22H27N2O12P	542.434	\N	\N	9	13	2	259	37	0	1020	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.OP(=O)(O)O	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;phosphoric acid
8836	THEO-24	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8865	THIAMINE HYDROCHLORIDE	THIAMINE HYDROCHLORIDE	6202	C12H18Cl2N4OS	337.263	\N	\N	3	6	4	104	20	0	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-]	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol;chloride;hydrochloride
8866	THIOGUANINE	THIOGUANINE	2723601	C5H5N5S	167.19	\N	-0.1	3	2	0	111	11	0	225	0	0	\N	\N	C1=NC2=C(N1)C(=S)N=C(N2)N	2-amino-3,7-dihydropurine-6-thione
8869	THIORIDAZINE HYDROCHLORIDE	THIORIDAZINE HYDROCHLORIDE	66062	C21H27ClN2S2	407.031	\N	\N	1	4	4	57.1	26	0	432	0	1	\N	\N	CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC.Cl	10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine;hydrochloride
8870	THIORIDAZINE HYDROCHLORIDE INTENSOL	THIORIDAZINE HYDROCHLORIDE	66062	C21H27ClN2S2	407.031	\N	\N	1	4	4	57.1	26	0	432	0	1	\N	\N	CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC.Cl	10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine;hydrochloride
8868	THIOPLEX	THIOTEPA	5453	C6H12N3PS	189.217	\N	0.5	0	4	3	41.1	11	0	194	0	0	\N	\N	C1CN1P(=S)(N2CC2)N3CC3	tris(aziridin-1-yl)-thioxo-$l^{5}-phosphane
8872	THIOTEPA	THIOTEPA	5453	C6H12N3PS	189.217	\N	0.5	0	4	3	41.1	11	0	194	0	0	\N	\N	C1CN1P(=S)(N2CC2)N3CC3	tris(aziridin-1-yl)-thioxo-$l^{5}-phosphane
8874	THIOTHIXENE HYDROCHLORIDE	THIOTHIXENE HYDROCHLORIDE	941651	C23H29N3O2S2	443.624	\N	3.8	0	6	5	77.5	30	0	711	0	0	\N	\N	CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C	(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide
8875	THIOTHIXENE HYDROCHLORIDE INTENSOL	THIOTHIXENE HYDROCHLORIDE	941651	C23H29N3O2S2	443.624	\N	3.8	0	6	5	77.5	30	0	711	0	0	\N	\N	CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C	(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide
8873	THIOTHIXENE	THIOTHIXENE	941651	C23H29N3O2S2	443.624	\N	3.8	0	6	5	77.5	30	0	711	0	0	\N	\N	CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C	(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide
8867	THIOLA	TIOPRONIN	5483	C5H9NO3S	163.191	\N	-0.1	3	4	3	67.4	10	0	148	0	1	\N	\N	CC(C(=O)NCC(=O)O)S	2-(2-sulfanylpropanoylamino)acetic acid
8831	THAM	TROMETHAMINE	6503	C4H11NO3	121.136	\N	-2.9	4	4	3	86.7	8	0	54	0	0	\N	\N	C(C(CO)(CO)N)O	2-amino-2-(hydroxymethyl)propane-1,3-diol
8834	THAM-E	TROMETHAMINE	6503	C4H11NO3	121.136	\N	-2.9	4	4	3	86.7	8	0	54	0	0	\N	\N	C(C(CO)(CO)N)O	2-amino-2-(hydroxymethyl)propane-1,3-diol
8810	TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE	ESTRADIOL VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8814	TESULOID	TECHNETIUM TC-99M SULFUR COLLOID KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8824	TEVETEN	EPROSARTAN MESYLATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8825	TEVETEN HCT	EPROSARTAN MESYLATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8827	TEXACORT	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8828	THALITONE	CHLORTHALIDONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8829	THALLOUS CHLORIDE TL 201	THALLOUS CHLORIDE TL-201	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8982	TOTECT	DEXRAZOXANE HYDROCHLORIDE	6918223	C11H17ClN4O4	304.731	\N	\N	3	6	3	98.8	20	0	404	1	0	\N	\N	CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2.Cl	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione;hydrochloride
8895	TIAZAC	DILTIAZEM HYDROCHLORIDE	62920	C22H27ClN2O4S	450.978	\N	\N	1	6	7	84.4	30	0	565	2	0	\N	\N	CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;hydrochloride
8882	THYROGEN	THYROTROPIN ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8883	THYROGLOBULIN	THYROGLOBULIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8951	TOLAK	FLUOROURACIL	3385	C4H3FN2O2	130.078	\N	-0.9	2	3	0	58.2	9	0	199	0	0	\N	\N	C1=C(C(=O)NC(=O)N1)F	5-fluoro-1H-pyrimidine-2,4-dione
8907	TIMOLIDE 10-25	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
2682	DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2687	DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
8972	TOPROL-XL	METOPROLOL SUCCINATE	62937	C34H56N2O10	652.826	\N	\N	6	12	21	176	46	0	308	0	2	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.C(CC(=O)O)C(=O)O	1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol;succinic acid
8902	TILADE	NEDOCROMIL SODIUM	50295	C19H15NNa2O7	415.309	\N	\N	0	8	3	127	29	0	742	0	0	\N	\N	CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)[O-])C(=O)C=C(N2CC)C(=O)[O-].[Na+].[Na+]	disodium;9-ethyl-4,6-dioxo-10-propyl-pyrano[3,2-g]quinoline-2,8-dicarboxylate
8973	TORA	PHENTERMINE HYDROCHLORIDE	70969	C10H16ClN	185.695	\N	\N	2	1	2	26	12	0	112	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)N.Cl	2-methyl-1-phenyl-propan-2-amine;hydrochloride
8881	THYRO-BLOCK	POTASSIUM IODIDE	4875	IK	166.003	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[K+].[I-]	potassium;iodide
8892	THYTROPAR	THYROTROPIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8921	TIS-U-SOL	POTASSIUM PHOSPHATE, MONOBASIC	516951	H2KO4P	136.084	\N	\N	2	4	0	80.6	6	0	61.9	0	0	\N	\N	OP(=O)(O)[O-].[K+]	potassium;dihydrogen phosphate
8987	TPN	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
8922	TIS-U-SOL	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8923	TIS-U-SOL	SODIUM PHOSPHATE	24243	Na3O4P	163.939	\N	\N	0	4	0	86.2	8	0	36.8	0	0	\N	\N	[O-]P(=O)([O-])[O-].[Na+].[Na+].[Na+]	trisodium;phosphate
8975	TORECAN	THIETHYLPERAZINE MALATE	5440	C22H29N3S2	399.615	\N	5.4	0	5	6	60.3	27	0	455	0	0	\N	\N	CCSC1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)C	2-ethylsulfanyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine
8897	TICLID	TICLOPIDINE HYDROCHLORIDE	65335	C14H15Cl2NS	300.241	\N	\N	1	2	2	31.5	18	0	261	0	0	\N	\N	C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl	5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine;hydrochloride
8909	TIMOLOL	TIMOLOL	33624	C13H24N4O3S	316.42	\N	1.8	2	8	7	108	21	0	310	1	0	\N	\N	CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O	(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
8915	TINDAMAX	TINIDAZOLE	5479	C8H13N3O4S	247.269	\N	-0.4	0	5	4	106	16	0	345	0	0	\N	\N	CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C	1-(2-ethylsulfonylethyl)-2-methyl-5-nitro-imidazole
8931	TIZANIDINE HYDROCHLORIDE	TIZANIDINE HYDROCHLORIDE	114869	C9H9Cl2N5S	290.166	\N	\N	3	4	2	90.4	17	0	300	0	0	\N	\N	C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl.Cl	5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine;hydrochloride
8933	TOBI	TOBRAMYCIN	36294	C18H37N5O9	467.52	\N	-6.2	10	14	6	268	32	0	609	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
8962	TONOCARD	TOCAINIDE HYDROCHLORIDE	108173	C11H17ClN2O	228.72	\N	\N	3	2	2	55.1	15	0	196	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)C(C)N.Cl	2-amino-N-(2,6-dimethylphenyl)propanamide;hydrochloride
8952	TOLAZAMIDE	TOLAZAMIDE	5503	C14H21N3O3S	311.4	\N	1.5	2	4	3	86.9	21	0	431	0	0	\N	\N	CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2	1-(azepan-1-yl)-3-(p-tolylsulfonyl)urea
8953	TOLBUTAMIDE	TOLBUTAMIDE	5505	C12H18N2O3S	270.347	\N	2.3	2	3	5	83.6	18	0	354	0	0	\N	\N	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C	1-butyl-3-(p-tolylsulfonyl)urea
8963	TOPAMAX	TOPIRAMATE	5284627	C12H21NO8S	339.359	\N	-0.8	1	9	3	124	22	0	556	4	0	\N	\N	CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C	[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate
8970	TOPOTECAN	TOPOTECAN HYDROCHLORIDE	60699	C23H24ClN3O5	457.911	\N	\N	3	7	3	103	32	0	867	1	0	\N	\N	CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O.Cl	\N
8979	TORSEMIDE	TORSEMIDE	41781	C16H20N4O3S	348.421	\N	2.7	3	5	5	109	24	0	518	0	0	\N	\N	CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C	1-isopropyl-3-[[4-(3-methylanilino)-3-pyridyl]sulfonyl]urea
8932	TNKASE	TENECTEPLASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8950	TOFRANIL-PM	IMIPRAMINE PAMOATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8960	TOLTERODINE	TOLTERODINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8961	TOLTERODINE TARTRATE	TOLTERODINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8980	TOTACILLIN	AMPICILLIN/AMPICILLIN TRIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8983	TOUJEO SOLOSTAR	INSULIN GLARGINE RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8984	TOVALT ODT	ZOLPIDEM TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8985	TOVIAZ	FESOTERODINE FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
8989	TPN ELECTROLYTES IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
5368	MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER	CEFOXITIN SODIUM	23667300	C16H16N3NaO7S2	449.428	\N	\N	2	9	8	205	29	0	750	2	0	\N	\N	COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3.[Na+]	sodium;(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
8990	TPN ELECTROLYTES IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9010	TRANMEP	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
9012	TRANSDERM-NITRO	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
9016	TRASICOR	OXPRENOLOL HYDROCHLORIDE	71172	C15H24ClNO3	301.811	\N	\N	3	4	9	50.7	20	0	246	0	1	\N	\N	CC(C)NCC(COC1=CC=CC=C1OCC=C)O.Cl	1-(2-allyloxyphenoxy)-3-(isopropylamino)propan-2-ol;hydrochloride
8991	TPN ELECTROLYTES IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
9011	TRANSDERM SCOP	SCOPOLAMINE	3000322	C17H21NO4	303.358	\N	0.9	1	5	5	62.3	22	0	418	5	0	\N	\N	CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4	\N
8992	TPN ELECTROLYTES IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9037	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
8993	TPN ELECTROLYTES IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9015	TRANYLCYPROMINE SULFATE	TRANYLCYPROMINE SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9038	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9018	TRAVAMULSION 10%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9019	TRAVAMULSION 20%	SOYBEAN OIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9020	TRAVASE	SUTILAINS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9021	TRAVASOL 10% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9022	TRAVASOL 10% W/O ELECTROLYTES	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9023	TRAVASOL 2.75% IN DEXTROSE 10% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9024	TRAVASOL 2.75% IN DEXTROSE 10% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9025	TRAVASOL 2.75% IN DEXTROSE 15% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9026	TRAVASOL 2.75% IN DEXTROSE 15% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9027	TRAVASOL 2.75% IN DEXTROSE 20% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9028	TRAVASOL 2.75% IN DEXTROSE 20% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9029	TRAVASOL 2.75% IN DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9030	TRAVASOL 2.75% IN DEXTROSE 25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9031	TRAVASOL 2.75% IN DEXTROSE 5% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9032	TRAVASOL 2.75% IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9033	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9034	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9044	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8999	TRAMADOL HYDROCHLORIDE	TRAMADOL HYDROCHLORIDE	63013	C16H26ClNO2	299.839	\N	\N	2	3	4	32.7	20	0	282	2	0	\N	\N	CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O.Cl	(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol;hydrochloride
9039	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9040	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9001	TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN	TRAMADOL HYDROCHLORIDE	63013	C16H26ClNO2	299.839	\N	\N	2	3	4	32.7	20	0	282	2	0	\N	\N	CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O.Cl	(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol;hydrochloride
9006	TRANDOLAPRIL	TRANDOLAPRIL	5484727	C24H34N2O5	430.545	\N	2	2	6	10	95.9	31	0	634	5	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O	(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
9045	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9046	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9009	TRANEXAMIC ACID	TRANEXAMIC ACID	5526	C8H15NO2	157.213	\N	-2	2	3	2	63.3	11	0	139	0	0	\N	\N	C1CC(CCC1CN)C(=O)O	4-(aminomethyl)cyclohexanecarboxylic acid
9051	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9052	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9057	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9058	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9063	TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
406	AMBISOME	AMPHOTERICIN B	5280965	C47H73NO17	924.091	\N	0	12	18	3	320	65	0	1670	19	0	\N	\N	CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(1S,3R,4E,6E,8E,10E,12E,14E,16E,18S,19R,20R,21S,25R,27R,30R,31R,33S,35R,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxylic acid
9068	TRAVASOL 3.5% W/ ELECTROLYTES	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
4657	KENGREAL	CANGRELOR	9854012	C17H25Cl2F3N5O12P3S2	776.346	\N	-1	7	21	15	307	44	0	1140	4	0	\N	\N	CSCCNC1=NC(=NC2=C1N=CN2C3C(C(C(O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F	[dichloro-[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]methyl]phosphonic acid
9073	TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9074	TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9075	TRAVASOL 4.25% IN DEXTROSE 15% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9076	TRAVASOL 4.25% IN DEXTROSE 15% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9077	TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9078	TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9079	TRAVASOL 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9080	TRAVASOL 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9081	TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9082	TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9083	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9084	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9066	TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9089	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9090	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9071	TRAVASOL 3.5% W/ ELECTROLYTES	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9095	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9096	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9087	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9093	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9101	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9102	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9099	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9067	TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9107	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9108	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER	DEXTROSE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9072	TRAVASOL 3.5% W/ ELECTROLYTES	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9088	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9094	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9113	TRAVASOL 5.5% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9114	TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9100	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9106	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9119	TRAVASOL 5.5% W/ ELECTROLYTES	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9124	TRAVASOL 5.5% W/O ELECTROLYTES	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9125	TRAVASOL 8.5% IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9126	TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9131	TRAVASOL 8.5% W/ ELECTROLYTES	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9155	TREZIX	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
9136	TRAVASOL 8.5% W/O ELECTROLYTES	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1370	CAPOZIDE 25/25	CAPTOPRIL	44093	C9H15NO3S	217.283	\N	0.3	2	4	3	58.6	14	0	244	2	0	\N	\N	CC(CS)C(=O)N1CCCC1C(=O)O	(2S)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]pyrrolidine-2-carboxylic acid
1372	CAPOZIDE 50/15	CAPTOPRIL	44093	C9H15NO3S	217.283	\N	0.3	2	4	3	58.6	14	0	244	2	0	\N	\N	CC(CS)C(=O)N1CCCC1C(=O)O	(2S)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]pyrrolidine-2-carboxylic acid
9139	TRAVERT 10% IN PLASTIC CONTAINER	INVERT SUGAR	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9143	TRECATOR	ETHIONAMIDE	2761171	C8H10N2S	166.242	\N	1.1	1	2	2	71	11	0	147	0	0	\N	\N	CCC1=NC=CC(=C1)C(=S)N	2-ethylpyridine-4-carbothioamide
9171	TRI-LUMA	FLUOCINOLONE ACETONIDE	6215	C24H30F2O6	452.495	\N	2.5	2	8	2	93.1	32	0	960	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C	\N
9199	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9172	TRI-LUMA	HYDROQUINONE	785	C6H6O2	110.112	\N	0.6	2	2	0	40.5	8	0	54.9	0	0	\N	\N	C1=CC(=CC=C1O)O	benzene-1,4-diol
9132	TRAVASOL 8.5% W/ ELECTROLYTES	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9152	TREXIMET	NAPROXEN SODIUM	23681059	C14H13NaO3	252.245	\N	\N	0	3	3	49.4	18	0	282	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+]	sodium;(2S)-2-(6-methoxy-2-naphthyl)propanoate
9177	TRI-NORINYL 21-DAY	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
9239	TRILEPTAL	OXCARBAZEPINE	34312	C15H12N2O2	252.273	\N	1.7	1	2	0	63.4	19	0	382	0	0	\N	\N	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
9146	TRENTAL	PENTOXIFYLLINE	4740	C13H18N4O3	278.312	\N	0.3	0	4	5	75.5	20	0	426	0	0	\N	\N	CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C	3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione
9156	TREZIX	DIHYDROCODEINE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9205	TRIAVIL 2-10	PERPHENAZINE	4748	C21H26ClN3OS	403.969	\N	4.2	1	5	6	55.2	27	0	463	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
9198	TRIAMINIC-12	PHENYLPROPANOLAMINE HYDROCHLORIDE	9065	C9H14ClNO	187.667	\N	\N	3	2	2	46.2	12	0	110	0	2	\N	\N	CC(C(C1=CC=CC=C1)O)N.Cl	2-amino-1-phenyl-propan-1-ol;hydrochloride
9133	TRAVASOL 8.5% W/ ELECTROLYTES	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9134	TRAVASOL 8.5% W/ ELECTROLYTES	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9130	TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9153	TREXIMET	SUMATRIPTAN SUCCINATE	59772	C18H27N3O6S	413.489	\N	\N	4	8	9	148	28	0	498	0	0	\N	\N	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O	1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide;succinic acid
9147	TREPROSTINIL	TREPROSTINIL	6918140	C23H34O5	390.52	\N	4.5	3	5	10	87	28	0	495	5	0	\N	\N	CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O	2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid
9184	TRIACET	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
9196	TRIAMCINOLONE DIACETATE	TRIAMCINOLONE DIACETATE	6216	C25H31FO8	478.513	\N	1.9	2	9	6	127	34	0	1020	8	0	\N	\N	CC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)OC(=O)C)O	[2-[(8S,9R,10S,11S,13S,14S,16R,17S)-16-acetoxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
9200	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	TRIAMTERENE	5546	C12H11N7	253.269	\N	1	3	7	1	130	19	0	307	0	0	\N	\N	C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N	6-phenylpteridine-2,4,7-triamine
9218	TRICHLOREX	TRICHLORMETHIAZIDE	5560	C8H8Cl3N3O4S2	380.639	\N	0.6	3	7	2	135	20	0	571	0	1	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl	6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9223	TRICLOS	TRICLOFOS SODIUM	23677832	C2H3Cl3NaO4P	251.356	\N	\N	1	4	2	69.6	11	0	158	0	0	\N	\N	C(C(Cl)(Cl)Cl)OP(=O)(O)[O-].[Na+]	sodium;2,2,2-trichloroethyl hydrogen phosphate
9235	TRIFLURIDINE	TRIFLURIDINE	6256	C10H11F3N2O5	296.202	\N	-0.5	3	8	2	99.1	20	0	464	3	0	\N	\N	C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione
9230	TRIDIONE	TRIMETHADIONE	5576	C6H9NO3	143.142	\N	0.3	0	3	0	46.6	10	0	197	0	0	\N	\N	CC1(C(=O)N(C(=O)O1)C)C	3,5,5-trimethyloxazolidine-2,4-dione
9217	TRIBENZOR	OLMESARTAN MEDOXOMIL	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9224	TRICOR	FENOFIBRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9225	TRICOR (MICRONIZED)	FENOFIBRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9232	TRIFERIC	FERRIC PYROPHOSPHATE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9236	TRIGLIDE	FENOFIBRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9240	TRILIPIX	CHOLINE FENOFIBRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9293	TRIVAGIZOLE 3	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
9247	TRIMEPRAZINE TARTRATE	TRIMEPRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9332	TUZISTRA XR	CODEINE POLISTIREX	5284371	C18H21NO3	299.37	\N	1.1	1	4	1	41.9	22	0	509	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol
9317	TRUSOPT	DORZOLAMIDE HYDROCHLORIDE	6918132	C10H17ClN2O4S3	360.886	\N	\N	3	7	3	151	20	0	534	2	0	\N	\N	CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.Cl	(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride
9264	TRIPHASIL-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9324	TURGEX	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
9265	TRIPHASIL-21	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
9262	TRIOSTAT	LIOTHYRONINE SODIUM	23666110	C15H11I3NNaO4	672.959	\N	\N	2	5	5	95.6	24	0	408	1	0	\N	\N	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.[Na+]	sodium;(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoate
9243	TRILYTE	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
9261	TRINTELLIX	VORTIOXETINE HYDROBROMIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9244	TRILYTE	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
9697	VOSOL HC	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9260	TRINALIN	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
9245	TRILYTE	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
9246	TRILYTE	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9302	TROBICIN	SPECTINOMYCIN HYDROCHLORIDE	64740	C14H26Cl2N2O7	405.269	\N	\N	7	9	2	130	25	0	478	9	0	\N	\N	CC1CC(=O)C2(C(O1)OC3C(C(C(C(C3O2)NC)O)NC)O)O.Cl.Cl	\N
9248	TRIMETH/SULFA	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
9294	TRIVARIS	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
9254	TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE	TRIMETHOPRIM SULFATE	12254408	C14H20N4O7S	388.395	\N	\N	4	11	5	189	26	0	388	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N.OS(=O)(=O)O	sulfuric acid;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
9249	TRIMETH/SULFA	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
9255	TRIMIPRAMINE MALEATE	TRIMIPRAMINE MALEATE	5282318	C24H30N2O4	410.514	\N	\N	2	6	6	81.1	30	0	436	0	1	\N	\N	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C.C(=CC(=O)O)C(=O)O	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethyl-propan-1-amine;maleic acid
9242	TRILITRON	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
9306	TROPICACYL	TROPICAMIDE	5593	C17H20N2O2	284.359	\N	1.5	1	3	6	53.4	21	0	310	0	1	\N	\N	CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2	N-ethyl-3-hydroxy-2-phenyl-N-(4-pyridylmethyl)propanamide
9308	TROSPIUM CHLORIDE	TROSPIUM CHLORIDE	5284631	C25H30ClNO3	427.969	\N	\N	1	4	5	46.5	30	0	553	2	0	\N	\N	C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-]	[(1R,5S)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenyl-acetate;chloride
9322	TUBOCURARINE CHLORIDE	TUBOCURARINE CHLORIDE	6000	C37H41N2O6+	609.743	\N	6	2	7	2	80.6	45	1	990	2	0	\N	\N	CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)O)O3)[N+](CCC6=CC(=C5O)OC)(C)C)OC	\N
9287	TRISENOX	ARSENIC TRIOXIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9289	TRITEC	RANITIDINE BISMUTH CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9292	TRIUMEQ	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9300	TRIZIVIR	LAMIVUDINE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9304	TROPHAMINE	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9305	TROPHAMINE 10%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9311	TROVAN/ZITHROMAX COMPLIANCE PAK	AZITHROMYCIN DIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9315	TRULICITY	DULAGLUTIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9319	TRUVADA	TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9328	TUSSIGON	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9336	TWYNSTA	TELMISARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9339	TYCOLET	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9372	ULESFIA	BENZYL ALCOHOL	244	C7H8O	108.14	\N	1.1	1	1	1	20.2	8	0	55.4	0	0	\N	\N	C1=CC=C(C=C1)CO	phenylmethanol
9371	UCERIS	BUDESONIDE	5281004	C25H34O6	430.541	\N	2.5	2	6	4	93.1	31	0	862	8	1	\N	\N	CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C	\N
9421	UROLOGIC G IN PLASTIC CONTAINER	CITRIC ACID	311	C6H8O7	192.123	\N	-1.7	4	7	5	132	13	0	227	0	0	\N	\N	C(C(=O)O)C(CC(=O)O)(C(=O)O)O	citric acid
9428	UROVIST CYSTO	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
9431	UROVIST SODIUM 300	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
9452	VALIUM	DIAZEPAM	3016	C16H13ClN2O	284.743	\N	3	0	2	1	32.7	20	0	403	0	0	\N	\N	CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
9453	VALMID	ETHINAMATE	3284	C9H13NO2	167.208	\N	1.3	1	2	3	52.3	12	0	220	0	0	\N	\N	C#CC1(CCCCC1)OC(=O)N	(1-ethynylcyclohexyl) carbamate
9388	ULTRAVATE	HALOBETASOL PROPIONATE	6918178	C25H31ClF2O5	484.965	\N	3.7	1	7	5	80.7	33	0	964	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl	[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
9437	UTIBRON	INDACATEROL MALEATE	9827599	C28H32N2O7	508.571	\N	\N	6	8	8	156	37	0	708	1	0	\N	\N	CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC.C(=CC(=O)O)C(=O)O	5-[(1R)-2-[(5,6-diethylindan-2-yl)amino]-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one;maleic acid
9361	TYSABRI	NATALIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9341	TYKERB	LAPATINIB DITOSYLATE	9941095	C43H42ClFN4O10S3	925.455	\N	\N	4	15	13	240	62	0	1100	0	0	\N	\N	CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine;4-methylbenzenesulfonic acid
2692	DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2697	DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9354	TYLOX	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
9366	U-CORT	HYDROCORTISONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9368	U-GENCIN	GENTAMICIN SULFATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9357	TYLOX	OXYCODONE TEREPHTHALATE	5464088	C26H27NO8	481.501	\N	\N	3	9	3	134	35	0	722	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O.C1=CC(=CC=C1C(=O)O)C(=O)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;terephthalic acid
9412	UPTRAVI	SELEXIPAG	9913767	C26H32N4O4S	496.626	\N	3.8	1	7	12	110	35	0	730	0	0	\N	\N	CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3	2-[4-[(5,6-diphenylpyrazin-2-yl)-isopropyl-amino]butoxy]-N-methylsulfonyl-acetamide
9369	UCEPHAN	SODIUM BENZOATE	517055	C7H5NaO2	144.105	\N	\N	0	2	1	40.1	10	0	108	0	0	\N	\N	C1=CC=C(C=C1)C(=O)[O-].[Na+]	sodium;benzoate
9370	UCEPHAN	SODIUM PHENYLACETATE	23690424	C8H7NaO2	158.132	\N	\N	0	2	2	40.1	11	0	119	0	0	\N	\N	C1=CC=C(C=C1)CC(=O)[O-].[Na+]	sodium;2-phenylacetate
9377	ULTRA-TECHNEKOW FM	TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9378	ULTRACEF	CEFADROXIL/CEFADROXIL HEMIHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9363	TYZEKA	TELBIVUDINE	159269	C10H14N2O5	242.231	\N	-1.2	3	5	2	99.1	17	0	381	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O	1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
9398	UNI-DUR	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
9383	ULTRALENTE	INSULIN ZINC SUSP EXTENDED PURIFIED BEEF	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9380	ULTRACET	TRAMADOL HYDROCHLORIDE	63013	C16H26ClNO2	299.839	\N	\N	2	3	4	32.7	20	0	282	2	0	\N	\N	CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O.Cl	(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol;hydrochloride
9425	UROPLUS DS	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
9413	URACIL MUSTARD	URACIL MUSTARD	6194	C8H11Cl2N3O2	252.095	\N	0.5	2	3	5	61.4	15	0	288	0	0	\N	\N	C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl	5-[bis(2-chloroethyl)amino]-1H-pyrimidine-2,4-dione
9387	ULTRATAG	TECHNETIUM TC-99M RED BLOOD CELL KIT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9367	U-CORT	UREA	1176	CH4N2O	60.056	\N	-1.4	2	1	0	69.1	4	0	29	0	0	\N	\N	C(=O)(N)N	urea
9449	VALCYTE	VALGANCICLOVIR HYDROCHLORIDE	110632	C14H23ClN6O5	390.825	\N	\N	5	7	9	167	26	0	528	1	1	\N	\N	CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N.Cl	[2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxy-propyl] (2S)-2-amino-3-methyl-butanoate;hydrochloride
9395	ULTRESA	PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9407	UNITENSEN	CRYPTENAMINE ACETATES	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9408	UNITENSEN	CRYPTENAMINE TANNATES	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9410	UNITUXIN	DINUTUXIMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9417	UREX	METHENAMINE HIPPURATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9420	UROCIT-K	POTASSIUM CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9436	UTIBRON	GLYCOPYRROLATE 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9451	VALISONE	BETAMETHASONE VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9454	VALNAC	BETAMETHASONE VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9505	VASOCON-A	ANTAZOLINE PHOSPHATE	158798	C17H22N3O4P	363.354	\N	\N	4	6	5	105	25	0	364	0	0	\N	\N	C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3.OP(=O)(O)O	N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline;phosphoric acid
9459	VALSARTAN	VALSARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9461	VALSARTAN AND HYDROCHLOROTHIAZIDE	VALSARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9462	VALSARTAN; HYDROCHLOROTHIAZIDE	VALSARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9495	VASCOR	BEPRIDIL HYDROCHLORIDE	50088	C24H35ClN2O	403.007	\N	\N	1	3	10	15.7	28	0	382	0	1	\N	\N	CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3.Cl	N-benzyl-N-(3-isobutoxy-2-pyrrolidin-1-yl-propyl)aniline;hydrochloride
1374	CAPOZIDE 50/25	CAPTOPRIL	44093	C9H15NO3S	217.283	\N	0.3	2	4	3	58.6	14	0	244	2	0	\N	\N	CC(CS)C(=O)N1CCCC1C(=O)O	(2S)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]pyrrolidine-2-carboxylic acid
9562	VERSACLOZ	CLOZAPINE	2818	C18H19ClN4	326.828	\N	3.2	1	4	1	30.9	23	0	584	0	0	\N	\N	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine
9466	VALTROPIN	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9467	VALTURNA	ALISKIREN HEMIFUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9468	VALTURNA	VALSARTAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9527	VELIVET	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
9470	VANCENASE AQ	BECLOMETHASONE DIPROPIONATE MONOHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9509	VASOTEC	ENALAPRILAT	5462501	C18H24N2O5	348.399	\N	-0.7	3	6	8	107	25	0	490	3	0	\N	\N	CC(C(=O)N1CCCC1C(=O)O)NC(CCC2=CC=CC=C2)C(=O)O	(2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
9483	VANOS	FLUOCINONIDE	9642	C26H32F2O7	494.532	\N	3.2	1	9	4	99.1	35	0	1070	9	0	\N	\N	CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C	\N
9460	VALSARTAN AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9494	VASCEPA	ICOSAPENT ETHYL	9831415	C22H34O2	330.512	\N	6.3	0	2	15	26.3	24	0	425	0	0	\N	\N	CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC	ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
9497	VASCORAY	IOTHALAMATE SODIUM	23667529	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	426	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)C(=O)NC)I.[Na+]	sodium;3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoate
9520	VEINAMINE 8%	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9510	VASOXYL	METHOXAMINE HYDROCHLORIDE	6081	C11H18ClNO3	247.719	\N	\N	3	4	4	64.7	16	0	189	0	2	\N	\N	CC(C(C1=C(C=CC(=C1)OC)OC)O)N.Cl	2-amino-1-(2,5-dimethoxyphenyl)propan-1-ol;hydrochloride
9484	VANSIL	OXAMNIQUINE	4612	C14H21N3O3	279.34	\N	2.2	3	5	4	90.1	20	0	332	0	1	\N	\N	CC(C)NCC1CCC2=CC(=C(C=C2N1)[N+](=O)[O-])CO	[2-[(isopropylamino)methyl]-7-nitro-1,2,3,4-tetrahydroquinolin-6-yl]methanol
9511	VAZCULEP	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
9553	VERCYTE	PIPOBROMAN	4842	C10H16Br2N2O2	356.058	\N	0.4	0	2	4	40.6	16	0	227	0	0	\N	\N	C1CN(CCN1C(=O)CCBr)C(=O)CCBr	3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one
9522	VEINAMINE 8%	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
9482	VANOBID	CANDICIDIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9544	VENTAIRE	PROTOKYLOL HYDROCHLORIDE	8699	C18H22ClNO5	367.826	\N	\N	5	6	6	91.2	25	0	396	0	2	\N	\N	CC(CC1=CC2=C(C=C1)OCO2)NCC(C3=CC(=C(C=C3)O)O)O.Cl	4-[2-[[2-(1,3-benzodioxol-5-yl)-1-methyl-ethyl]amino]-1-hydroxy-ethyl]benzene-1,2-diol;hydrochloride
9501	VASOCIDIN	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
9456	VALPROATE SODIUM	VALPROATE SODIUM	16760703	C8H15NaO2	166.196	\N	\N	0	2	5	40.1	11	0	98.3	0	0	\N	\N	CCCC(CCC)C(=O)[O-].[Na+]	sodium;2-propylpentanoate
9457	VALPROIC ACID	VALPROIC ACID	3121	C8H16O2	144.214	\N	2.8	1	2	5	37.3	10	0	93.4	0	0	\N	\N	CCCC(CCC)C(=O)O	2-propylpentanoic acid
9491	VARENICLINE	VARENICLINE	5310966	C13H13N3	211.268	\N	0.8	1	3	0	37.8	16	0	254	2	0	\N	\N	C1C2CNCC1C3=CC4=NC=CN=C4C=C23	\N
9541	VENCLEXTA	VENETOCLAX	49846579	C45H50ClN7O7S	868.447	\N	8.2	3	11	12	183	61	0	1640	0	0	\N	\N	CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C	4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-cyclohexen-1-yl]methyl]piperazin-1-yl]-N-[3-nitro-4-(tetrahydropyran-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
9524	VELBAN	VINBLASTINE SULFATE	241902	C46H60N4O13S	909.061	\N	\N	5	16	10	237	64	0	1780	9	0	\N	\N	CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O	\N
9507	VASOSTRICT	VASOPRESSIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9512	VECTIBIX	PANITUMUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9519	VEINAMINE 8%	AMINO ACIDS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9525	VELCADE	BORTEZOMIB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9533	VELOSULIN	INSULIN PURIFIED PORK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9534	VELOSULIN BR	INSULIN RECOMBINANT HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9535	VELOSULIN BR HUMAN	INSULIN RECOMBINANT PURIFIED HUMAN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9538	VELTASSA	PATIROMER SORBITEX CALCIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9555	VEREGEN	SINECATECHINS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9558	VERILOID	ALKAVERVIR	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9559	VERLUMA	NOFETUMOMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9560	VERMIDOL	PIPERAZINE CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9605	VIEKIRA XR	DASABUVIR SODIUM	56640145	C26H26N3NaO5S	515.56	\N	\N	1	7	6	102	36	0	944	0	0	\N	\N	CC(C)(C)C1=C(C(=CC(=C1)N2C=CC(=O)[N-]C2=O)C3=CC4=C(C=C3)C=C(C=C4)NS(=O)(=O)C)OC.[Na+]	sodium;N-[6-[3-tert-butyl-5-(2,4-dioxopyrimidin-3-id-1-yl)-2-methoxy-phenyl]-2-naphthyl]methanesulfonamide
9566	VERTAVIS	VERATRUM VIRIDE ROOT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9585	VICKS FORMULA 44	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
9582	VIBRAMYCIN	DOXYCYCLINE	54671203	C22H24N2O8	444.44	\N	-0.7	6	9	2	182	32	0	956	6	0	\N	\N	CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
9681	VIVELLE	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
9665	VITAPED	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
9595	VICOPROFEN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
9617	VIMPAT	LACOSAMIDE	219078	C13H18N2O3	250.298	\N	0.3	2	3	6	67.4	18	0	275	1	0	\N	\N	CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1	(2R)-2-acetamido-N-benzyl-3-methoxy-propanamide
9637	VIRILON	METHYLTESTOSTERONE	6010	C20H30O2	302.458	\N	3.4	1	2	0	37.3	22	0	550	6	0	\N	\N	CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
9576	VIAGRA	SILDENAFIL CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9642	VISINE-A	NAPHAZOLINE HYDROCHLORIDE	11079	C14H15ClN2	246.738	\N	\N	2	1	2	24.4	17	0	272	0	0	\N	\N	C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl	2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride
9666	VITAPED	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
9641	VISINE L.R.	OXYMETAZOLINE HYDROCHLORIDE	66259	C16H25ClN2O	296.839	\N	\N	3	2	3	44.6	20	0	345	0	0	\N	\N	CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C.Cl	6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-phenol;hydrochloride
9607	VIEKIRA XR	PARITAPREVIR	45110509	C40H43N7O7S	765.886	\N	4.7	3	10	7	198	55	0	1600	5	0	\N	\N	CC1=NC=C(N=C1)C(=O)NC2CCCCCC=CC3CC3(NC(=O)C4CC(CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8	\N
9648	VISKAZIDE	PINDOLOL	4828	C14H20N2O2	248.326	\N	1.8	3	3	6	57.3	18	0	248	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=C1C=CN2)O	1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol
9669	VITAPED	PYRIDOXINE	1054	C8H11NO3	169.18	\N	-0.8	3	4	2	73.6	12	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol
9628	VIOXX	ROFECOXIB	5090	C17H14O4S	314.355	\N	2.3	0	4	3	68.8	22	0	556	0	0	\N	\N	CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3	3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one
9587	VICODIN	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9589	VICODIN ES	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9591	VICODIN HP	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9639	VISICOL	SODIUM PHOSPHATE, DIBASIC ANHYDROUS	24203	HNa2O4P	141.957	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[Na+].[Na+]	disodium;hydrogen phosphate
9593	VICOPRIN	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9594	VICOPROFEN	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9671	VITAPED	THIAMINE	1130	C12H17N4OS+	265.355	\N	1	2	5	4	104	18	1	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol
9569	VESPRIN	TRIFLUPROMAZINE	5568	C18H19F3N2S	352.419	\N	5.2	0	6	4	31.8	24	0	416	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F	N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine
9629	VIRA-A	VIDARABINE	21704	C10H13N5O4	267.245	\N	-1.1	4	8	2	140	19	0	335	4	0	\N	\N	C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O	(2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
9618	VINBLASTINE SULFATE	VINBLASTINE SULFATE	241902	C46H60N4O13S	909.061	\N	\N	5	16	10	237	64	0	1780	9	0	\N	\N	CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O	\N
9573	VI-DOM-A	VITAMIN A PALMITATE	5280531	C36H60O2	524.874	\N	13.6	0	2	21	26.3	38	0	803	0	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C	[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
9601	VIEKIRA PAK (COPACKAGED)	DASABUVIR SODIUM 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9655	VITAMIN A	VITAMIN A	445354	C20H30O	286.459	\N	5.7	1	1	5	20.2	21	0	496	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
9673	VITAPED	VITAMIN E	14985	C29H50O2	430.717	\N	10.7	1	2	12	29.5	31	0	503	3	0	\N	\N	CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O	(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
9614	VIMIZIM	ELOSULFASE ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9623	VINORELBINE TARTRATE	VINORELBINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9625	VIOKACE	PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9631	VIRAC REX	UNDECOYLIUM CHLORIDE IODINE COMPLEX	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9636	VIREAD	TENOFOVIR DISOPROXIL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9640	VISICOL	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9651	VISTARIL	HYDROXYZINE PAMOATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9654	VISUDYNE	VERTEPORFIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9675	VITRASE	HYALURONIDASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9677	VITRAVENE PRESERVATIVE FREE	FOMIVIRSEN SODIUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9679	VITUZ	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9714	WELLBUTRIN	BUPROPION HYDROCHLORIDE	62884	C13H19Cl2NO	276.201	\N	\N	2	2	4	29.1	17	0	247	0	1	\N	\N	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl	2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrochloride
9722	WIGRAINE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
9740	XALKORI	CRIZOTINIB	11626560	C21H22Cl2FN5O	450.339	\N	3.7	2	6	5	78	30	0	558	1	0	\N	\N	CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N	3-[(1R)-1-(2,6-dichloro-3-fluoro-phenyl)ethoxy]-5-[1-(4-piperidyl)pyrazol-4-yl]pyridin-2-amine
9690	VOLTAREN	DICLOFENAC SODIUM	5018304	C14H10Cl2NNaO2	318.129	\N	\N	1	3	4	52.2	20	0	310	0	0	\N	\N	C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+]	sodium;2-[2-(2,6-dichloroanilino)phenyl]acetate
9794	YAELA	DROSPIRENONE	68873	C24H30O3	366.501	\N	3.5	0	3	0	43.4	27	0	828	10	0	\N	\N	CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C	\N
9785	XYLOCAINE DENTAL WITH EPINEPHRINE	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
9689	VOLNEA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9708	VYTORIN	EZETIMIBE	150311	C24H21F2NO3	409.433	\N	4	2	5	6	60.8	30	0	567	3	0	\N	\N	C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O	(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxy-propyl]-4-(4-hydroxyphenyl)azetidin-2-one
9693	VORAXAZE	GLUCARPIDASE	21195079	Zn4+8	261.52	\N	\N	0	0	0	0	4	8	0	0	0	\N	\N	[Zn+2].[Zn+2].[Zn+2].[Zn+2]	zinc(2+)
9739	XALATAN	LATANOPROST	5311221	C26H40O5	432.601	\N	4.3	3	5	14	87	31	0	526	5	0	\N	\N	CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O	isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenyl-pentyl]cyclopentyl]hept-5-enoate
9780	XYLOCAINE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
9779	XYLOCAINE	LIDOCAINE	3676	C14H22N2O	234.343	\N	2.3	1	2	5	32.3	17	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
9765	XIIDRA	LIFITEGRAST	11965427	C29H24Cl2N2O7S	615.478	\N	4.7	2	7	7	142	41	0	1100	1	0	\N	\N	CS(=O)(=O)C1=CC=CC(=C1)CC(C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl	(2S)-2-[[2-(benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid
9700	VPRIV	VELAGLUCERASE ALFA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9710	VYVANSE	LISDEXAMFETAMINE DIMESYLATE	11597697	C17H33N3O7S2	455.585	\N	\N	5	9	8	207	29	0	344	2	0	\N	\N	CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O	(2S)-2,6-diamino-N-[(1S)-1-methyl-2-phenyl-ethyl]hexanamide;methanesulfonic acid
9729	WYAMINE SULFATE	MEPHENTERMINE SULFATE	5702236	C11H19NO4S	261.336	\N	\N	3	5	3	95	17	0	204	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)NC.OS(=O)(=O)O	N,2-dimethyl-1-phenyl-propan-2-amine;sulfuric acid
9703	VUSION	MICONAZOLE NITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9704	VUSION	PETROLATUM, WHITE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9728	WOMEN'S ROGAINE	MINOXIDIL	4201	C9H15N5O	209.253	\N	1.2	3	3	1	88.9	15	0	329	0	0	\N	\N	C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O	3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine
9711	WAMPOCAP	NIACIN	938	C6H5NO2	123.111	\N	0.4	1	3	1	50.2	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)O	nicotinic acid
9751	XENICAL	ORLISTAT	3034010	C29H53NO5	495.745	\N	10	1	5	23	81.7	35	0	579	4	0	\N	\N	CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O	[(1S)-1-[[(2S,3S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-formamido-4-methyl-pentanoate
9725	WILPO	PHENTERMINE HYDROCHLORIDE	70969	C10H16ClN	185.695	\N	\N	2	1	2	26	12	0	112	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)N.Cl	2-methyl-1-phenyl-propan-2-amine;hydrochloride
9727	WOLFINA	RAUWOLFIA SERPENTINA ROOT	441975	C21H24N2O3	352.434	\N	2.7	1	4	2	54.6	26	0	606	4	0	\N	\N	CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45	\N
9792	XYREM	SODIUM OXYBATE	23663870	C4H7NaO3	126.087	\N	\N	1	3	3	60.4	8	0	64.3	0	0	\N	\N	C(CC(=O)[O-])CO.[Na+]	sodium;4-hydroxybutanoate
9749	XENAZINE	TETRABENAZINE	6018	C19H27NO3	317.429	\N	2.9	0	4	4	38.8	23	0	425	0	2	\N	\N	CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC	3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one
9712	WARFARIN SODIUM	WARFARIN SODIUM	16204922	C19H15NaO4	330.315	\N	\N	0	4	4	66.4	24	0	508	0	1	\N	\N	CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)[O-].[Na+]	sodium;2-oxo-3-(3-oxo-1-phenyl-butyl)chromen-4-olate
9750	XENEISOL	XENON XE-133	66376	Xe	132.906	\N	\N	0	0	0	0	1	0	0	0	0	\N	\N	[Xe]	xenon-133
9778	XYLO-PFAN	XYLOSE	135191	C5H10O5	150.13	\N	-2.5	4	5	0	90.2	10	0	117	3	1	\N	\N	C1C(C(C(C(O1)O)O)O)O	(3R,4S,5R)-tetrahydropyran-2,3,4,5-tetrol
9721	WESTCORT	HYDROCORTISONE VALERATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9723	WIGRAINE	ERGOTAMINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9724	WIGRETTES	ERGOTAMINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9731	WYAMYCIN S	ERYTHROMYCIN STEARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9732	WYDASE	HYALURONIDASE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9737	X-TROZINE	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9738	X-TROZINE L.A.	PHENDIMETRAZINE TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9746	XELJANZ	TOFACITINIB CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9747	XELJANZ XR	TOFACITINIB CITRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9755	Xeomin	incobotulinumtoxinA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9757	XERESE	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9758	XGEVA	DENOSUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9759	XIAFLEX	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9764	XIGRIS	DROTRECOGIN ALFA (ACTIVATED)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9767	XOFIGO	RADIUM RA-223 DICHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9768	XOLAIR	OMALIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9771	XOPENEX HFA	LEVALBUTEROL TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9800	YERVOY	IPILIMUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9855	ZETONNA	CICLESONIDE	6918155	C32H44O7	540.697	\N	5.3	1	7	6	99.1	39	0	1100	9	0	\N	\N	CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6	\N
9881	ZIPSOR	DICLOFENAC POTASSIUM	23667642	C14H10Cl2KNO2	334.237	\N	\N	1	3	4	52.2	20	0	310	0	0	\N	\N	C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[K+]	potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate
9804	YTTERBIUM YB 169 DTPA	PENTETATE CALCIUM TRISODIUM YB-169	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9806	ZADITOR	KETOTIFEN FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9799	YAZ	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9882	ZIRGAN	GANCICLOVIR	3454	C9H13N5O4	255.234	\N	-1.7	4	5	5	135	18	0	346	0	0	\N	\N	C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N	2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-3H-purin-6-one
9810	ZALTRAP	ZIV-AFLIBERCEPT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9856	ZEVALIN	IBRITUMOMAB TIUXETAN	74890578	C24H35N5O11	569.568	\N	-7.1	7	14	19	237	40	0	862	1	1	\N	\N	CC(CN(CC(CC1=CC=C(C=C1)NC(=O)NC)N(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O	2-[[(2S)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid
9820	ZAROXOLYN	METOLAZONE	4170	C16H16ClN3O3S	365.832	\N	4.1	2	5	2	101	24	0	594	0	1	\N	\N	CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl	7-chloro-2-methyl-3-(o-tolyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide
9803	YOSPRALA	OMEPRAZOLE	4594	C17H19N3O3S	345.417	\N	2.2	1	6	5	96.3	24	0	453	0	1	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
9886	ZOFRAN	ONDANSETRON HYDROCHLORIDE	68647	C18H20ClN3O	329.828	\N	\N	1	2	2	39.8	23	0	440	0	1	\N	\N	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl	9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one;hydrochloride
9888	ZOFRAN ODT	ONDANSETRON	4595	C18H19N3O	293.37	\N	2.3	0	2	2	39.8	22	0	440	0	1	\N	\N	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
9878	ZIPAN-25	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
9813	ZANTAC	RANITIDINE HYDROCHLORIDE	3033332	C13H23ClN4O3S	350.862	\N	\N	3	7	9	112	22	0	347	0	0	\N	\N	CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C.Cl	(E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furyl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine;hydrochloride
9805	YUTOPAR	RITODRINE HYDROCHLORIDE	31728	C17H22ClNO3	323.817	\N	\N	5	4	6	72.7	22	0	284	2	0	\N	\N	CC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O.Cl	4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl-ethyl]amino]ethyl]phenol;hydrochloride
9821	ZARXIO	FILGRASTIM-SNDZ	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9835	ZELAPAR	SELEGILINE HYDROCHLORIDE	26758	C13H18ClN	223.744	\N	\N	1	1	4	3.2	15	0	195	1	0	\N	\N	CC(CC1=CC=CC=C1)N(C)CC#C.Cl	(2R)-N-methyl-1-phenyl-N-prop-2-ynyl-propan-2-amine;hydrochloride
9830	ZEGERID	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
9824	ZEBETA	BISOPROLOL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9849	ZERIT	STAVUDINE	18283	C10H12N2O4	224.216	\N	-0.8	2	4	2	78.9	16	0	388	2	0	\N	\N	CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO	1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
9877	ZIOPTAN	TAFLUPROST	9868491	C25H34F2O5	452.539	\N	4.5	2	7	13	76	32	0	614	4	0	\N	\N	CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC=C2)(F)F)O)O	isopropyl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxy-but-1-enyl]-3,5-dihydroxy-cyclopentyl]hept-5-enoate
9837	ZELNORM	TEGASEROD MALEATE	6918369	C20H27N5O5	417.466	\N	\N	5	8	10	159	30	0	551	0	0	\N	\N	CCCCCN=C(N)NNC=C1C=NC2=C1C=C(C=C2)OC.C(=CC(=O)O)C(=O)O	maleic acid;1-[[(Z)-(5-methoxyindol-3-ylidene)methyl]amino]-2-pentyl-guanidine
9828	ZEGERID	MAGNESIUM HYDROXIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9893	ZOLINZA	VORINOSTAT	5311	C14H20N2O3	264.325	\N	1.9	3	3	8	78.4	19	0	276	0	0	\N	\N	C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO	8-(hydroxyamino)-8-oxo-N-phenyl-octanamide
9809	ZALEPLON	ZALEPLON	5719	C17H15N5O	305.341	\N	1	0	4	3	74.3	23	0	487	0	0	\N	\N	CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C	N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamide
9873	ZINC SULFATE	ZINC SULFATE	24424	O4SZn	161.436	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Zn+2]	zinc;sulfate
9894	ZOLMITRIPTAN	ZOLMITRIPTAN	60857	C16H21N3O2	287.363	\N	2.2	2	3	5	57.4	21	0	375	1	0	\N	\N	CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3	(4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]oxazolidin-2-one
9904	ZONEGRAN	ZONISAMIDE	5734	C8H8N2O3S	212.223	\N	0.2	1	5	2	94.6	14	0	298	0	0	\N	\N	C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N	1,2-benzoxazol-3-ylmethanesulfonamide
9841	ZENAPAX	DACLIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9844	ZENPEP	PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9857	ZIAC	BISOPROLOL FUMARATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9862	ZIBA-RX	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9867	ZINBRYTA	DACLIZUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9868	ZINC BACITRACIN,NEOMYCIN SULFATE,POLYMYXIN B SULFATE & HYDROCORTISONE	BACITRACIN ZINC	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9869	ZINC BACITRACIN,NEOMYCIN SULFATE,POLYMYXIN B SULFATE & HYDROCORTISONE	HYDROCORTISONE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9872	ZINC CHLORIDE IN PLASTIC CONTAINER	ZINC CHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9876	ZINPLAVA	BEZLOTOXUMAB	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9890	ZOHYDRO ER	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9895	ZOLOFT	SERTRALINE HYDROCHLORIDE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9896	ZOLPIDEM TARTRATE	ZOLPIDEM TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9897	ZOLPIMIST	ZOLPIDEM TARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9898	ZOLYSE	CHYMOTRYPSIN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9899	ZOMACTON	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9907	ZORBTIVE	SOMATROPIN RECOMBINANT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1346	CAMPRAL	ACAMPROSATE CALCIUM	155434	C10H20CaN2O8S2	400.474	\N	\N	2	8	6	189	23	0	202	0	0	\N	\N	CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]	calcium;3-acetamidopropane-1-sulfonate
8183	SECTRAL	ACEBUTOLOL HYDROCHLORIDE	441307	C18H29ClN2O4	372.89	\N	\N	4	5	10	87.7	25	0	401	0	1	\N	\N	CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C.Cl	N-[3-acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]butanamide;hydrochloride
1907	CODEINE, ASPIRIN, APAP FORMULA NO. 2	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
9923	ZOVIRAX	ACYCLOVIR SODIUM	23665721	C8H10N5NaO3	247.19	\N	\N	2	7	4	122	17	0	237	0	0	\N	\N	C1=NC2=C(N1COCCO)N=C(N=C2[O-])N.[Na+]	sodium;2-amino-9-(2-hydroxyethoxymethyl)purin-6-olate
9922	ZOVIRAX	ACYCLOVIR	2022	C8H11N5O3	225.208	\N	-1.6	3	4	4	115	16	0	308	0	0	\N	\N	C1=NC2=C(N1COCCO)NC(=NC2=O)N	2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one
9943	ZYLOPRIM	ALLOPURINOL	2094	C5H4N4O	136.114	\N	-0.5	2	2	0	65.8	10	0	275	0	0	\N	\N	C1=C2C(=NC=NC2=O)NN1	1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one
9924	ZUBSOLV	BUPRENORPHINE HYDROCHLORIDE	3033050	C29H42ClNO4	504.108	\N	\N	3	5	5	62.2	35	0	869	7	0	\N	\N	CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O.Cl	\N
9929	ZUTRIPRO	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9931	ZYBAN	BUPROPION HYDROCHLORIDE	62884	C13H19Cl2NO	276.201	\N	\N	2	2	4	29.1	17	0	247	0	1	\N	\N	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl	2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrochloride
9935	ZYDONE	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1377	CAPTOPRIL	CAPTOPRIL	44093	C9H15NO3S	217.283	\N	0.3	2	4	3	58.6	14	0	244	2	0	\N	\N	CC(CS)C(=O)N1CCCC1C(=O)O	(2S)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]pyrrolidine-2-carboxylic acid
9939	ZYFREL	HYDROCODONE BITARTRATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
1378	CAPTOPRIL AND HYDROCHLOROTHIAZIDE	CAPTOPRIL	44093	C9H15NO3S	217.283	\N	0.3	2	4	3	58.6	14	0	244	2	0	\N	\N	CC(CS)C(=O)N1CCCC1C(=O)O	(2S)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]pyrrolidine-2-carboxylic acid
2960	DUOPA	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
9949	ZYRTEC	CETIRIZINE HYDROCHLORIDE	55182	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	0	1	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
9928	ZUTRIPRO	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
9947	ZYPREXA RELPREVV	OLANZAPINE PAMOATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9914	ZOVIA 1/35E-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9916	ZOVIA 1/35E-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9954	ZYTIGA	ABIRATERONE ACETATE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N
9918	ZOVIA 1/50E-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9915	ZOVIA 1/35E-21	ETHYNODIOL DIACETATE	9270	C24H32O4	384.516	\N	3.9	0	4	5	52.6	28	0	758	7	0	\N	\N	CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C	[(3S,8R,9S,10R,13S,14S,17R)-17-acetoxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
9944	ZYMAR	GATIFLOXACIN	5379	C19H22FN3O4	375.4	\N	-0.7	2	8	4	82.1	27	0	653	0	1	\N	\N	CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F	1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid
9933	ZYDELIG	IDELALISIB	11625818	C22H18FN7O	415.432	\N	3.7	2	7	5	99.2	31	0	685	1	0	\N	\N	CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5	5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one
9955	ZYVOX	LINEZOLID	441401	C16H20FN3O4	337.351	\N	0.7	1	6	4	71.1	24	0	472	1	0	\N	\N	CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F	N-[[(5S)-3-(3-fluoro-4-morpholino-phenyl)-2-oxo-oxazolidin-5-yl]methyl]acetamide
9926	ZUPLENZ	ONDANSETRON	4595	C18H19N3O	293.37	\N	2.3	0	2	2	39.8	22	0	440	0	1	\N	\N	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
9930	ZUTRIPRO	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
9936	ZYFLO	ZILEUTON	60490	C11H12N2O2S	236.289	\N	1.6	2	3	2	94.8	16	0	275	0	1	\N	\N	CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O	1-[1-(benzothiophen-2-yl)ethyl]-1-hydroxy-urea
6995	PLENAXIS	ABARELIX	16131215	C72H95ClN14O14	1416.086	\N	3.7	13	16	38	425	101	0	2770	10	0	\N	\N	CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)N(C)C(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C	(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-(2-naphthyl)propanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-(3-pyridyl)propanoyl]amino]-3-hydroxy-propanoyl]-methyl-amino]-3-(4-hydroxyphenyl)propanoyl]amino]-N-[(1S)-1-[[(1S)-1-[(2S)-2-[[(1R)-2-amino-1-methyl-2-oxo-ethyl]carbamoyl]pyrrolidine-1-carbonyl]-5-(isopropylamino)pentyl]carbamoyl]-3-methyl-butyl]butanediamide
7389	PRECOSE	ACARBOSE	41774	C25H43NO18	645.608	\N	-8.5	14	19	9	321	44	0	962	18	1	\N	\N	CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO	(3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]tetrahydropyran-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-6-(hydroxymethyl)tetrahydropyran-2,3,4-triol
49	ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
51	ACETAMINOPHEN, ASPIRIN AND CAFFEINE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
5086	LORTAB	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
3274	ESGIC-PLUS	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
54	ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
57	ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2674	DIAMOX	ACETAZOLAMIDE SODIUM	13290219	C4H5N4NaO3S2	244.219	\N	\N	2	7	2	127	14	0	302	0	0	\N	\N	CC(=O)NC1=NN=C(S1)S(=O)(=O)[NH-].[Na+]	sodium;(5-acetamido-1,3,4-thiadiazol-2-yl)sulfonylazanide
2673	DIAMOX	ACETAZOLAMIDE	1986	C4H6N4O3S2	222.237	\N	-0.3	2	7	2	152	13	0	297	0	0	\N	\N	CC(=O)NC1=NN=C(S1)S(=O)(=O)N	N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
74	ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
76	ACETIC ACID W/ HYDROCORTISONE	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
1151	BOROFAIR	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
2875	DOMEBORO	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
4089	HYDROCORTISONE AND ACETIC ACID	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
3001	DYMELOR	ACETOHEXAMIDE	1989	C15H20N2O4S	324.395	\N	2.4	2	4	4	101	22	0	498	0	0	\N	\N	CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2	1-(4-acetylphenyl)sulfonyl-3-cyclohexyl-urea
633	AMPHOTEC	AMPHOTERICIN B	5280965	C47H73NO17	924.091	\N	0	12	18	3	320	65	0	1670	19	0	\N	\N	CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(1S,3R,4E,6E,8E,10E,12E,14E,16E,18S,19R,20R,21S,25R,27R,30R,31R,33S,35R,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxylic acid
634	AMPHOTERICIN B	AMPHOTERICIN B	5280965	C47H73NO17	924.091	\N	0	12	18	3	320	65	0	1670	19	0	\N	\N	CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(1S,3R,4E,6E,8E,10E,12E,14E,16E,18S,19R,20R,21S,25R,27R,30R,31R,33S,35R,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxylic acid
3666	FUNGIZONE	AMPHOTERICIN B	5280965	C47H73NO17	924.091	\N	0	12	18	3	320	65	0	1670	19	0	\N	\N	CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(1S,3R,4E,6E,8E,10E,12E,14E,16E,18S,19R,20R,21S,25R,27R,30R,31R,33S,35R,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxylic acid
5605	MIRADON	ANISINDIONE	2197	C16H12O3	252.269	\N	2.9	0	3	2	43.4	19	0	344	0	0	\N	\N	COC1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O	2-(4-methoxyphenyl)indane-1,3-dione
9455	VALPIN 50	ANISOTROPINE METHYLBROMIDE	657201	C17H32BrNO2	362.352	\N	\N	0	3	7	26.3	21	0	318	2	0	\N	\N	CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-]	[(1R,5S)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] 2-propylpentanoate;bromide
3089	ELIQUIS	APIXABAN	10182969	C25H25N5O4	459.506	\N	2.2	1	5	5	111	34	0	777	0	0	\N	\N	COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N	1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidyl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide
725	APRACLONIDINE HYDROCHLORIDE	APRACLONIDINE HYDROCHLORIDE	51763	C9H11Cl3N4	281.565	\N	\N	4	2	2	62.4	16	0	247	0	0	\N	\N	C1CN=C(N1)NC2=C(C=C(C=C2Cl)N)Cl.Cl	2,6-dichloro-N1-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine;hydrochloride
3118	EMEND	APREPITANT	6918365	C23H21F7N4O3	534.435	\N	4.2	2	11	6	75.2	37	0	810	3	0	\N	\N	CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F	5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
8268	SINEMET CR	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
8424	STALEVO 125	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
8427	STALEVO 150	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
9017	TRASYLOL	APROTININ	16130295	C284H432N84O79S7	6511.509	\N	-25.4	93	97	111	2820	454	0	16700	57	0	\N	\N	CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C(=O)NC(C(=O)NCC(=O)N6CCCC6C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)N)C(C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)C)CCCCN)C(C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)NC(=O)C1CCCN1C(=O)C(CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)NC(C)C(=O)O)C(C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)C(C)CC	\N
765	ARGATROBAN IN DEXTROSE	ARGATROBAN	92722	C23H36N6O5S	508.638	\N	1.3	5	8	9	189	35	0	887	3	1	\N	\N	CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C	(2R,4R)-1-[(2S)-5-guanidino-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methyl-piperidine-2-carboxylic acid
766	ARGATROBAN IN SODIUM CHLORIDE	ARGATROBAN	92722	C23H36N6O5S	508.638	\N	1.3	5	8	9	189	35	0	887	3	1	\N	\N	CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C	(2R,4R)-1-[(2S)-5-guanidino-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methyl-piperidine-2-carboxylic acid
5174	M.V.I. ADULT	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
5187	M.V.I. ADULT (PHARMACY BULK PACKAGE)	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
5200	M.V.I. PEDIATRIC	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
5213	M.V.I.-12	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
5237	M.V.I.-12 (WITHOUT VITAMIN K)	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
5249	M.V.I.-12 LYOPHILIZED	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
5716	MVC PLUS	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
6706	PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
9661	VITAPED	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
798	ASENAPINE	ASENAPINE	3036780	C17H16ClNO	285.771	\N	3.8	0	2	0	12.5	20	0	363	2	0	\N	\N	CN1CC2C(C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24	\N
805	ASPIRIN AND DIPYRIDAMOLE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
1424	CARISOPRODOL AND ASPIRIN	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
1994	COMPOUND 65	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
3374	EXCEDRIN (MIGRAINE)	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
6777	PERCODAN	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
7728	PROPOXYPHENE COMPOUND-65	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
1274	BUTALBITAL, ASPIRIN AND CAFFEINE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
1277	BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
1281	BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
1426	CARISOPRODOL COMPOUND	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
1428	CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
1908	CODEINE, ASPIRIN, APAP FORMULA NO. 2	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
1911	CODEINE, ASPIRIN, APAP FORMULA NO. 3	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
1914	CODEINE, ASPIRIN, APAP FORMULA NO. 4	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
1920	CODOXY	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
2183	DARVON COMPOUND	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
2186	DARVON COMPOUND-65	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
2189	DARVON W/ ASA	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
2192	DARVON-N W/ ASA	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
2985	DURLAZA	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
7	ABACAVIR	ABACAVIR SULFATE	441384	C28H38N12O6S	670.75	\N	\N	8	16	8	287	47	0	496	4	0	\N	\N	C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.OS(=O)(=O)O	[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;sulfuric acid
9	ABACAVIR SULFATE	ABACAVIR SULFATE	441384	C28H38N12O6S	670.75	\N	\N	8	16	8	287	47	0	496	4	0	\N	\N	C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.OS(=O)(=O)O	[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;sulfuric acid
1233	BUCET	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
72	ACETIC ACID	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
73	ACETIC ACID 0.25% IN PLASTIC CONTAINER	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
3505	FIORINAL	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
3508	FIORINAL W/CODEINE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
4356	INVAGESIC	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
4359	INVAGESIC FORTE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
5345	MEASURIN	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
5411	MEPRO-ASPIRIN	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
5414	MEPROBAMATE AND ASPIRIN	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
5459	METHOCARBAMOL AND ASPIRIN	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
5539	MICRAININ	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
6092	NORGESIC	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
6095	NORGESIC FORTE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
6448	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
6451	ORPHENGESIC	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
6454	ORPHENGESIC FORTE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
6588	OXYCODONE AND ASPIRIN	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
6590	OXYCODONE AND ASPIRIN	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
6782	PERCODAN-DEMI	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
7378	PRAVIGARD PAC (COPACKAGED)	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
7725	PROPOXYPHENE COMPOUND 65	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
7735	PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
7814	Q-GESIC	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
8057	ROBAXISAL	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
8096	ROXIPRIN	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
8362	SOMA COMPOUND W/ CODEINE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
8668	TALWIN COMPOUND	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
9592	VICOPRIN	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
9802	YOSPRALA	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
8004	REYATAZ	ATAZANAVIR SULFATE	158550	C38H54N6O11S	802.941	\N	\N	7	13	18	254	56	0	1190	4	0	\N	\N	CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O	methyl N-[(1S)-1-[[(1S,2S)-1-benzyl-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[[4-(2-pyridyl)phenyl]methyl]amino]propyl]carbamoyl]-2,2-dimethyl-propyl]carbamate;sulfuric acid
824	ATENOLOL AND CHLORTHALIDONE	ATENOLOL	2249	C14H22N2O3	266.341	\N	0.2	3	4	8	84.6	19	0	263	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide
4980	LIPITOR	ATORVASTATIN CALCIUM	60822	C66H68CaF2N4O10	1155.363	\N	\N	6	12	22	229	83	0	817	4	0	\N	\N	CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2]	calcium;(3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoate
4993	LIPTRUZET	ATORVASTATIN CALCIUM	60822	C66H68CaF2N4O10	1155.363	\N	\N	6	12	22	229	83	0	817	4	0	\N	\N	CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2]	calcium;(3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoate
4782	LAMIVUDINE; ZIDOVUDINE; ABACAVIR	ABACAVIR	441300	C14H18N6O	286.339	\N	0.9	3	6	4	102	21	0	414	2	0	\N	\N	C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N	[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol
28	ACAMPROSATE CALCIUM	ACAMPROSATE CALCIUM	155434	C10H20CaN2O8S2	400.474	\N	\N	2	8	6	189	23	0	202	0	0	\N	\N	CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]	calcium;3-acetamidopropane-1-sulfonate
31	ACARBOSE	ACARBOSE	41774	C25H43NO18	645.608	\N	-8.5	14	19	9	321	44	0	962	18	1	\N	\N	CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO	(3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]tetrahydropyran-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-6-(hydroxymethyl)tetrahydropyran-2,3,4-triol
40	ACEBUTOLOL HYDROCHLORIDE	ACEBUTOLOL HYDROCHLORIDE	441307	C18H29ClN2O4	372.89	\N	\N	4	5	10	87.7	25	0	401	0	1	\N	\N	CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C.Cl	N-[3-acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]butanamide;hydrochloride
9338	TYCOLET	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2174	DARVOCET	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2176	DARVOCET A500	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2178	DARVOCET-N 100	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2180	DARVOCET-N 50	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
836	ATOVAQUONE AND PROGUANIL HYDROCHLORIDE	ATOVAQUONE	74989	C22H19ClO3	366.841	\N	5.2	1	3	2	54.4	26	0	595	0	0	\N	\N	C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O	3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxy-naphthalene-1,2-dione
5280	MALARONE	ATOVAQUONE	74989	C22H19ClO3	366.841	\N	5.2	1	3	2	54.4	26	0	595	0	0	\N	\N	C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O	3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxy-naphthalene-1,2-dione
5282	MALARONE PEDIATRIC	ATOVAQUONE	74989	C22H19ClO3	366.841	\N	5.2	1	3	2	54.4	26	0	595	0	0	\N	\N	C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O	3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxy-naphthalene-1,2-dione
5416	MEPRON	ATOVAQUONE	74989	C22H19ClO3	366.841	\N	5.2	1	3	2	54.4	26	0	595	0	0	\N	\N	C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O	3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxy-naphthalene-1,2-dione
839	ATRACURIUM BESYLATE PRESERVATIVE FREE	ATRACURIUM BESYLATE	47320	C65H82N2O18S2	1243.487	\N	\N	0	18	26	258	87	0	1560	0	4	\N	\N	C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]	benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
8995	TRACRIUM	ATRACURIUM BESYLATE	47320	C65H82N2O18S2	1243.487	\N	\N	0	18	26	258	87	0	1560	0	4	\N	\N	C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]	benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
8996	TRACRIUM PRESERVATIVE FREE	ATRACURIUM BESYLATE	47320	C65H82N2O18S2	1243.487	\N	\N	0	18	26	258	87	0	1560	0	4	\N	\N	C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]	benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
1944	COLONAID	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
5021	LO-TROL	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
5050	LOMOTIL	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
5053	LONOX	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
5116	LOW-QUEL	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
5402	MEPERIDINE AND ATROPINE SULFATE	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
5671	MOTOFEN	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
5673	MOTOFEN HALF-STRENGTH	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
2956	DUODOTE	ATROPINE	174174	C17H23NO3	289.375	\N	1.8	1	4	5	49.8	21	0	353	2	1	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3	[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenyl-propanoate
900	AVYCAZ	AVIBACTAM SODIUM	24944097	C7H10N3NaO6S	287.222	\N	\N	1	6	3	141	18	0	462	2	0	\N	\N	C1CC(N2CC1N(C2=O)OS(=O)(=O)[O-])C(=O)N.[Na+]	sodium;[(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl] sulfate
704	ANTHELIOS 40	AVOBENZONE	51040	C20H22O3	310.393	\N	4.8	0	3	6	43.4	23	0	405	0	0	\N	\N	CC(C)(C)C1=CC=C(C=C1)C(=O)CC(=O)C2=CC=C(C=C2)OC	1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione
708	ANTHELIOS SX	AVOBENZONE	51040	C20H22O3	310.393	\N	4.8	0	3	6	43.4	23	0	405	0	0	\N	\N	CC(C)(C)C1=CC=C(C=C1)C(=O)CC(=O)C2=CC=C(C=C2)OC	1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione
1363	CAPITAL SOLEIL 15	AVOBENZONE	51040	C20H22O3	310.393	\N	4.8	0	3	6	43.4	23	0	405	0	0	\N	\N	CC(C)(C)C1=CC=C(C=C1)C(=O)CC(=O)C2=CC=C(C=C2)OC	1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione
8247	SHADE UVAGUARD	AVOBENZONE	51040	C20H22O3	310.393	\N	4.8	0	3	6	43.4	23	0	405	0	0	\N	\N	CC(C)(C)C1=CC=C(C=C1)C(=O)CC(=O)C2=CC=C(C=C2)OC	1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione
9259	TRINALIN	AZATADINE MALEATE	5281066	C28H30N2O8	522.554	\N	\N	4	10	4	165	38	0	536	0	0	\N	\N	CN1CCC(=C2C3=CC=CC=C3CCC4=C2N=CC=C4)CC1.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O	maleic acid;11-(1-methyl-4-piperidylidene)-5,6-dihydrobenzo[1,2]cyclohepta[3,4-b]pyridine
3496	FINACEA	AZELAIC ACID	2266	C9H16O4	188.223	\N	1.6	2	4	8	74.6	13	0	147	0	0	\N	\N	C(CCCC(=O)O)CCCC(=O)O	nonanedioic acid
6403	OPTIVAR	AZELASTINE HYDROCHLORIDE	54360	C22H25Cl2N3O	418.362	\N	\N	1	3	3	35.9	28	0	558	0	1	\N	\N	CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl.Cl	4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;hydrochloride
9883	ZITHROMAX	AZITHROMYCIN	447043	C38H72N2O12	748.996	\N	4	5	14	7	180	52	0	1150	18	0	\N	\N	CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O	(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
9884	ZMAX	AZITHROMYCIN	447043	C38H72N2O12	748.996	\N	4	5	14	7	180	52	0	1150	18	0	\N	\N	CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O	(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
927	AZLIN	AZLOCILLIN SODIUM	23685176	C20H22N5NaO6S	483.475	\N	\N	3	7	5	176	33	0	851	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)[O-])C.[Na+]	sodium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-[(2-oxoimidazolidine-1-carbonyl)amino]-2-phenyl-acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
937	AZTREONAM	AZTREONAM	5742832	C13H17N5O8S2	435.426	\N	0.3	4	12	7	238	28	0	808	2	0	\N	\N	CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N	2-[(Z)-[1-(2-aminothiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-azetidin-3-yl]amino]-2-oxo-ethylidene]amino]oxy-2-methyl-propanoic acid
1451	CAYSTON	AZTREONAM	5742832	C13H17N5O8S2	435.426	\N	0.3	4	12	7	238	28	0	808	2	0	\N	\N	CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N	2-[(Z)-[1-(2-aminothiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-azetidin-3-yl]amino]-2-oxo-ethylidene]amino]oxy-2-methyl-propanoic acid
3747	GIAZO	BALSALAZIDE DISODIUM	6335412	C17H15N3O6	357.322	\N	1.2	4	8	7	145	26	0	687	0	0	\N	\N	C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O	(3Z)-3-[[4-(2-carboxyethylcarbamoyl)phenyl]hydrazono]-6-oxo-cyclohexa-1,4-diene-1-carboxylic acid
2943	DUAVEE	BAZEDOXIFENE ACETATE	154256	C32H38N2O5	530.665	\N	\N	3	6	7	95.2	39	0	654	0	0	\N	\N	CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O.CC(=O)O	acetic acid;1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-indol-5-ol
7818	QNASL	BECLOMETHASONE DIPROPIONATE	21700	C28H37ClO7	521.047	\N	3	1	7	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
7856	QVAR 40	BECLOMETHASONE DIPROPIONATE	21700	C28H37ClO7	521.047	\N	3	1	7	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
7857	QVAR 80	BECLOMETHASONE DIPROPIONATE	21700	C28H37ClO7	521.047	\N	3	1	7	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
9469	VANCENASE	BECLOMETHASONE DIPROPIONATE	21700	C28H37ClO7	521.047	\N	3	1	7	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
9471	VANCERIL	BECLOMETHASONE DIPROPIONATE	21700	C28H37ClO7	521.047	\N	3	1	7	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
9472	VANCERIL DOUBLE STRENGTH	BECLOMETHASONE DIPROPIONATE	21700	C28H37ClO7	521.047	\N	3	1	7	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
5096	LOTENSIN	BENAZEPRIL HYDROCHLORIDE	5362123	C24H29ClN2O5	460.955	\N	\N	3	6	10	95.9	32	0	619	2	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O.Cl	2-[(3S)-3-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid;hydrochloride
1018	BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	BENAZEPRIL HYDROCHLORIDE	5362123	C24H29ClN2O5	460.955	\N	\N	3	6	10	95.9	32	0	619	2	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O.Cl	2-[(3S)-3-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid;hydrochloride
9695	VOSOL	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
5010	LITHOSTAT	ACETOHYDROXAMIC ACID	1990	C2H5NO2	75.067	\N	-1.6	2	2	0	49.3	5	0	42.9	0	0	\N	\N	CC(=O)NO	ethanehydroxamic acid
8914	TINDAL	ACETOPHENAZINE MALEATE	5281082	C31H37N3O10S	643.708	\N	\N	5	14	11	222	45	0	659	0	0	\N	\N	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)CCO.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O	1-[10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazin-2-yl]ethanone;maleic acid
8135	SALPIX	ACETRIZOATE SODIUM	23665874	C9H5I3NNaO3	578.846	\N	\N	1	3	2	69.2	17	0	305	0	0	\N	\N	CC(=O)NC1=C(C=C(C(=C1I)C(=O)[O-])I)I.[Na+]	sodium;3-acetamido-2,4,6-triiodo-benzoate
5602	MIOCHOL	ACETYLCHOLINE CHLORIDE	6060	C7H16ClNO2	181.66	\N	\N	0	3	4	26.3	11	0	115	0	0	\N	\N	CC(=O)OCC[N+](C)(C)C.[Cl-]	2-acetoxyethyl(trimethyl)ammonium;chloride
5603	MIOCHOL-E	ACETYLCHOLINE CHLORIDE	6060	C7H16ClNO2	181.66	\N	\N	0	3	4	26.3	11	0	115	0	0	\N	\N	CC(=O)OCC[N+](C)(C)C.[Cl-]	2-acetoxyethyl(trimethyl)ammonium;chloride
1545	CETYLEV	ACETYLCYSTEINE	12035	C5H9NO3S	163.191	\N	0.4	3	4	3	67.4	10	0	148	1	0	\N	\N	CC(=O)NC(CS)C(=O)O	(2R)-2-acetamido-3-sulfanyl-propanoic acid
5702	MUCOMYST	ACETYLCYSTEINE	12035	C5H9NO3S	163.191	\N	0.4	3	4	3	67.4	10	0	148	1	0	\N	\N	CC(=O)NC(CS)C(=O)O	(2R)-2-acetamido-3-sulfanyl-propanoic acid
5703	MUCOMYST W/ ISOPROTERENOL	ACETYLCYSTEINE	12035	C5H9NO3S	163.191	\N	0.4	3	4	3	67.4	10	0	148	1	0	\N	\N	CC(=O)NC(CS)C(=O)O	(2R)-2-acetamido-3-sulfanyl-propanoic acid
5705	MUCOSIL-10	ACETYLCYSTEINE	12035	C5H9NO3S	163.191	\N	0.4	3	4	3	67.4	10	0	148	1	0	\N	\N	CC(=O)NC(CS)C(=O)O	(2R)-2-acetamido-3-sulfanyl-propanoic acid
8383	SORIATANE	ACITRETIN	5284513	C21H26O3	326.436	\N	6.1	1	3	6	46.5	24	0	539	0	0	\N	\N	CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC	(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid
9323	TUDORZA PRESSAIR	ACLIDINIUM BROMIDE	11519741	C26H30BrNO4S2	564.553	\N	\N	1	7	10	112	34	0	647	1	0	\N	\N	C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5.[Br-]	[(3R)-1-(3-phenoxypropyl)quinuclidin-1-ium-3-yl] 2-hydroxy-2,2-bis(2-thienyl)acetate;bromide
5097	LOTENSIN HCT	BENAZEPRIL HYDROCHLORIDE	5362123	C24H29ClN2O5	460.955	\N	\N	3	6	10	95.9	32	0	619	2	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O.Cl	2-[(3S)-3-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid;hydrochloride
5100	LOTREL	BENAZEPRIL HYDROCHLORIDE	5362123	C24H29ClN2O5	460.955	\N	\N	3	6	10	95.9	32	0	619	2	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O.Cl	2-[(3S)-3-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid;hydrochloride
1020	BENDAMUSTINE HYDROCHLORIDE	BENDAMUSTINE HYDROCHLORIDE	77082	C16H22Cl3N3O2	394.721	\N	\N	2	4	9	58.4	24	0	380	0	0	\N	\N	CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl	4-[5-[bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butanoic acid;hydrochloride
5850	NATURETIN-2.5	BENDROFLUMETHIAZIDE	2315	C15H14F3N3O4S2	421.409	\N	1.2	3	10	3	135	27	0	740	0	1	\N	\N	C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2	3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5851	NATURETIN-5	BENDROFLUMETHIAZIDE	2315	C15H14F3N3O4S2	421.409	\N	1.2	3	10	3	135	27	0	740	0	1	\N	\N	C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2	3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3198	EPIDUO	BENZOYL PEROXIDE	7187	C14H10O4	242.23	\N	3.5	0	4	5	52.6	18	0	258	0	0	\N	\N	C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2	benzoyl benzenecarboperoxoate
3257	ERYTHROMYCIN AND BENZOYL PEROXIDE	BENZOYL PEROXIDE	7187	C14H10O4	242.23	\N	3.5	0	4	5	52.6	18	0	258	0	0	\N	\N	C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2	benzoyl benzenecarboperoxoate
6369	ONEXTON	BENZOYL PEROXIDE	7187	C14H10O4	242.23	\N	3.5	0	4	5	52.6	18	0	258	0	0	\N	\N	C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2	benzoyl benzenecarboperoxoate
1049	BEPREVE	BEPOTASTINE BESILATE	164521	C27H31ClN2O6S	547.063	\N	\N	2	8	9	125	37	0	632	1	0	\N	\N	C1CN(CCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;4-[4-[(S)-(4-chlorophenyl)-(2-pyridyl)methoxy]-1-piperidyl]butanoic acid
1072	BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE	BETAMETHASONE ACETATE	443967	C24H31FO6	434.504	\N	2.8	2	7	4	101	31	0	910	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)O)C)O)F)C	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
1074	BETAMETHASONE DIPROPIONATE	BETAMETHASONE DIPROPIONATE	21800	C28H37FO7	504.595	\N	3.6	1	8	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
1885	CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE	BETAMETHASONE DIPROPIONATE	21800	C28H37FO7	504.595	\N	3.6	1	8	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
2830	DIPROLENE	BETAMETHASONE DIPROPIONATE	21800	C28H37FO7	504.595	\N	3.6	1	8	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
2831	DIPROLENE AF	BETAMETHASONE DIPROPIONATE	21800	C28H37FO7	504.595	\N	3.6	1	8	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
2832	DIPROSONE	BETAMETHASONE DIPROPIONATE	21800	C28H37FO7	504.595	\N	3.6	1	8	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
1289	BUTALIBITAL, ACETAMINOPHEN AND CAFFEINE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
132	ACYCLOVIR	ACYCLOVIR SODIUM	23665721	C8H10N5NaO3	247.19	\N	\N	2	7	4	122	17	0	237	0	0	\N	\N	C1=NC2=C(N1COCCO)N=C(N=C2[O-])N.[Na+]	sodium;2-amino-9-(2-hydroxyethoxymethyl)purin-6-olate
133	ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE	ACYCLOVIR SODIUM	23665721	C8H10N5NaO3	247.19	\N	\N	2	7	4	122	17	0	237	0	0	\N	\N	C1=NC2=C(N1COCCO)N=C(N=C2[O-])N.[Na+]	sodium;2-amino-9-(2-hydroxyethoxymethyl)purin-6-olate
8282	SITAVIG	ACYCLOVIR	2022	C8H11N5O3	225.208	\N	-1.6	3	4	4	115	16	0	308	0	0	\N	\N	C1=NC2=C(N1COCCO)NC(=NC2=O)N	2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one
9756	XERESE	ACYCLOVIR	2022	C8H11N5O3	225.208	\N	-1.6	3	4	4	115	16	0	308	0	0	\N	\N	C1=NC2=C(N1COCCO)NC(=NC2=O)N	2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one
140	ADAPALENE	ADAPALENE	60164	C28H28O3	412.529	\N	7.7	1	3	4	46.5	31	0	645	0	0	\N	\N	COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5	6-[3-(1-adamantyl)-4-methoxy-phenyl]naphthalene-2-carboxylic acid
141	ADAPALENE AND BENZOYL PEROXIDE	ADAPALENE	60164	C28H28O3	412.529	\N	7.7	1	3	4	46.5	31	0	645	0	0	\N	\N	COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5	6-[3-(1-adamantyl)-4-methoxy-phenyl]naphthalene-2-carboxylic acid
200	ADEFOVIR DIPIVOXIL	ADEFOVIR DIPIVOXIL	60871	C20H32N5O8P	501.477	\N	1.8	1	12	15	167	34	0	706	0	0	\N	\N	CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C	[2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate
3932	HEPSERA	ADEFOVIR DIPIVOXIL	60871	C20H32N5O8P	501.477	\N	1.8	1	12	15	167	34	0	706	0	0	\N	\N	CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C	[2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate
203	ADENOSCAN	ADENOSINE	60961	C10H13N5O4	267.245	\N	-1.1	4	8	2	140	19	0	335	4	0	\N	\N	C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O	(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
34	ACCUNEB	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
287	ALBUTEROL SULFATE	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
1503	CELESTONE	BETAMETHASONE	9782	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
4661	KERLEDEX	BETAXOLOL HYDROCHLORIDE	107952	C18H30ClNO3	343.892	\N	\N	3	4	11	50.7	23	0	286	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl	1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol;hydrochloride
4663	KERLONE	BETAXOLOL HYDROCHLORIDE	107952	C18H30ClNO3	343.892	\N	\N	3	4	11	50.7	23	0	286	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl	1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol;hydrochloride
204	ADENOSINE	ADENOSINE	60961	C10H13N5O4	267.245	\N	-1.1	4	8	2	140	19	0	335	4	0	\N	\N	C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O	(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
3761	GILOTRIF	AFATINIB DIMALEATE	15606394	C32H33ClFN5O11	718.088	\N	\N	6	16	12	238	50	0	821	1	0	\N	\N	CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O	(E)-N-[4-(3-chloro-4-fluoro-anilino)-7-[(3S)-tetrahydrofuran-3-yl]oxy-quinazolin-6-yl]-4-(dimethylamino)but-2-enamide;maleic acid
9310	TROVAN PRESERVATIVE FREE	ALATROFLOXACIN MESYLATE	5282517	C27H29F3N6O8S	654.618	\N	\N	5	15	7	221	45	0	1180	4	0	\N	\N	CC(C(=O)NC(C)C(=O)NC1C2C1CN(C2)C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F)N.CS(=O)(=O)O	7-[(1S,5R)-6-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid
285	ALBENZA	ALBENDAZOLE	2082	C12H15N3O2S	265.331	\N	2.9	2	4	5	92.3	18	0	291	0	0	\N	\N	CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC	methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
8677	TANZEUM	ALBIGLUTIDE	122173812	C148H223N39O46	3284.639	\N	-14	49	51	109	1380	233	0	7620	29	0	\N	\N	CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC6=CNC=N6)N	\N
288	ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
3178	ENSTILAR	BETAMETHASONE DIPROPIONATE	21800	C28H37FO7	504.595	\N	3.6	1	8	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
8221	SERNIVO	BETAMETHASONE DIPROPIONATE	21800	C28H37FO7	504.595	\N	3.6	1	8	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
8651	TACLONEX	BETAMETHASONE DIPROPIONATE	21800	C28H37FO7	504.595	\N	3.6	1	8	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
1117	BIMATOPROST	BIMATOPROST	5311027	C25H37NO4	415.574	\N	2.8	4	4	12	89.8	30	0	541	5	0	\N	\N	CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O	(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenyl-pent-1-enyl]cyclopentyl]-N-ethyl-hept-5-enamide
1292	BUTAPAP	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
7774	PROVENTIL	ALBUTEROL	2083	C13H21NO3	239.315	\N	0.3	4	4	5	72.7	17	0	227	0	1	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol
9546	VENTOLIN	ALBUTEROL	2083	C13H21NO3	239.315	\N	0.3	4	4	5	72.7	17	0	227	0	1	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol
4832	LASTACAFT	ALCAFTADINE	19371515	C19H21N3O	307.397	\N	1.7	0	3	1	38.1	23	0	479	0	0	\N	\N	CN1CCC(=C2C3=CC=CC=C3CCN4C2=NC=C4C=O)CC1	11-(1-methyl-4-piperidylidene)-5,6-dihydroimidazo[2,1-b][3]benzazepine-3-carbaldehyde
91	ACLOVATE	ALCLOMETASONE DIPROPIONATE	636374	C28H37ClO7	521.047	\N	3.2	1	7	8	107	36	0	1030	9	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3C2C(CC4=CC(=O)C=CC34C)Cl)O)C)C)OC(=O)CC	[2-[(7R,8S,9S,10R,11S,13S,14S,16R,17R)-7-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
293	ALCLOMETASONE DIPROPIONATE	ALCLOMETASONE DIPROPIONATE	636374	C28H37ClO7	521.047	\N	3.2	1	7	8	107	36	0	1030	9	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3C2C(CC4=CC(=O)C=CC34C)Cl)O)C)C)OC(=O)CC	[2-[(7R,8S,9S,10R,11S,13S,14S,16R,17R)-7-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
298	ALCOHOL 5% IN D5-W	ALCOHOL	702	C2H6O	46.069	\N	-0.1	1	1	0	20.2	3	0	2.8	0	0	\N	\N	CCO	ethanol
300	ALCOHOL 5% IN DEXTROSE 5%	ALCOHOL	702	C2H6O	46.069	\N	-0.1	1	1	0	20.2	3	0	2.8	0	0	\N	\N	CCO	ethanol
301	ALCOHOL 5% IN DEXTROSE 5% IN WATER	ALCOHOL	702	C2H6O	46.069	\N	-0.1	1	1	0	20.2	3	0	2.8	0	0	\N	\N	CCO	ethanol
874	AVAGARD	ALCOHOL	702	C2H6O	46.069	\N	-0.1	1	1	0	20.2	3	0	2.8	0	0	\N	\N	CCO	ethanol
331	ALFENTA	ALFENTANIL HYDROCHLORIDE	64761	C21H33ClN6O3	452.984	\N	\N	1	6	9	81	31	0	614	0	0	\N	\N	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC.Cl	N-[1-[2-(4-ethyl-5-oxo-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidyl]-N-phenyl-propanamide;hydrochloride
5129	LUMIGAN	BIMATOPROST	5311027	C25H37NO4	415.574	\N	2.8	4	4	12	89.8	30	0	541	5	0	\N	\N	CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O	(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenyl-pent-1-enyl]cyclopentyl]-N-ethyl-hept-5-enamide
4268	INFUVITE PEDIATRIC	BIOTIN	171548	C10H16N2O3S	244.309	\N	0.3	3	4	5	104	16	0	298	3	0	\N	\N	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
5163	M.V.C. 9+3	BIOTIN	171548	C10H16N2O3S	244.309	\N	0.3	3	4	5	104	16	0	298	3	0	\N	\N	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
5175	M.V.I. ADULT	BIOTIN	171548	C10H16N2O3S	244.309	\N	0.3	3	4	5	104	16	0	298	3	0	\N	\N	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
322	ALECENSA	ALECTINIB HYDROCHLORIDE	53239799	C30H35ClN4O2	519.086	\N	\N	2	5	3	72.4	37	0	867	0	0	\N	\N	CCC1=C(C=C2C(=C1)C(=O)C3=C(C2(C)C)NC4=C3C=CC(=C4)C#N)N5CCC(CC5)N6CCOCC6.Cl	9-ethyl-6,6-dimethyl-8-(4-morpholino-1-piperidyl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile;hydrochloride
323	ALENDRONATE SODIUM	ALENDRONATE SODIUM	16760285	C4H12NNaO7P2	271.077	\N	\N	5	8	5	164	15	0	293	0	1	\N	\N	C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.[Na+]	sodium;(4-amino-1-hydroxy-1-phosphono-butyl)-hydroxy-phosphinate
1118	BINOSTO	ALENDRONATE SODIUM	16760285	C4H12NNaO7P2	271.077	\N	\N	5	8	5	164	15	0	293	0	1	\N	\N	C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.[Na+]	sodium;(4-amino-1-hydroxy-1-phosphono-butyl)-hydroxy-phosphinate
3626	FOSAMAX	ALENDRONATE SODIUM	16760285	C4H12NNaO7P2	271.077	\N	\N	5	8	5	164	15	0	293	0	1	\N	\N	C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.[Na+]	sodium;(4-amino-1-hydroxy-1-phosphono-butyl)-hydroxy-phosphinate
3627	FOSAMAX PLUS D	ALENDRONATE SODIUM	16760285	C4H12NNaO7P2	271.077	\N	\N	5	8	5	164	15	0	293	0	1	\N	\N	C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.[Na+]	sodium;(4-amino-1-hydroxy-1-phosphono-butyl)-hydroxy-phosphinate
332	ALFENTANIL	ALFENTANIL HYDROCHLORIDE	64761	C21H33ClN6O3	452.984	\N	\N	1	6	9	81	31	0	614	0	0	\N	\N	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC.Cl	N-[1-[2-(4-ethyl-5-oxo-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidyl]-N-phenyl-propanamide;hydrochloride
9432	UROXATRAL	ALFUZOSIN HYDROCHLORIDE	71764	C19H28ClN5O4	425.914	\N	\N	3	8	8	112	29	0	511	0	1	\N	\N	CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl	N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]tetrahydrofuran-2-carboxamide;hydrochloride
6634	PANRETIN	ALITRETINOIN	449171	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
355	ALLOPURINOL SODIUM	ALLOPURINOL SODIUM	23662349	C5H3N4NaO	158.096	\N	\N	1	4	0	77.5	11	0	136	0	0	\N	\N	C1=NNC2=C1C(=NC=N2)[O-].[Na+]	sodium;1H-pyrazolo[3,4-d]pyrimidin-4-olate
361	ALOPRIM	ALLOPURINOL SODIUM	23662349	C5H3N4NaO	158.096	\N	\N	1	4	0	77.5	11	0	136	0	0	\N	\N	C1=NNC2=C1C(=NC=N2)[O-].[Na+]	sodium;1H-pyrazolo[3,4-d]pyrimidin-4-olate
5072	LOPURIN	ALLOPURINOL	2094	C5H4N4O	136.114	\N	-0.5	2	2	0	65.8	10	0	275	0	0	\N	\N	C1=C2C(=NC=NC2=O)NN1	1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one
5717	MVC PLUS	BIOTIN	171548	C10H16N2O3S	244.309	\N	0.3	3	4	5	104	16	0	298	3	0	\N	\N	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
5188	M.V.I. ADULT (PHARMACY BULK PACKAGE)	BIOTIN	171548	C10H16N2O3S	244.309	\N	0.3	3	4	5	104	16	0	298	3	0	\N	\N	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
5201	M.V.I. PEDIATRIC	BIOTIN	171548	C10H16N2O3S	244.309	\N	0.3	3	4	5	104	16	0	298	3	0	\N	\N	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
5214	M.V.I.-12	BIOTIN	171548	C10H16N2O3S	244.309	\N	0.3	3	4	5	104	16	0	298	3	0	\N	\N	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
5226	M.V.I.-12	BIOTIN	171548	C10H16N2O3S	244.309	\N	0.3	3	4	5	104	16	0	298	3	0	\N	\N	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
4636	KAZANO	ALOGLIPTIN BENZOATE	16088021	C25H27N5O4	461.522	\N	\N	2	7	4	131	34	0	726	1	0	\N	\N	CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N.C1=CC=C(C=C1)C(=O)O	2-[[6-[(3R)-3-amino-1-piperidyl]-3-methyl-2,4-dioxo-pyrimidin-1-yl]methyl]benzonitrile;benzoic acid
5965	NESINA	ALOGLIPTIN BENZOATE	16088021	C25H27N5O4	461.522	\N	\N	2	7	4	131	34	0	726	1	0	\N	\N	CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N.C1=CC=C(C=C1)C(=O)O	2-[[6-[(3R)-3-amino-1-piperidyl]-3-methyl-2,4-dioxo-pyrimidin-1-yl]methyl]benzonitrile;benzoic acid
363	ALOSETRON HYDROCHLORIDE	ALOSETRON HYDROCHLORIDE	60758	C17H19ClN4O	330.816	\N	\N	2	2	2	53.9	23	0	442	0	0	\N	\N	CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl	5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one;hydrochloride
5106	LOTRONEX	ALOSETRON HYDROCHLORIDE	60758	C17H19ClN4O	330.816	\N	\N	2	2	2	53.9	23	0	442	0	0	\N	\N	CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl	5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one;hydrochloride
4254	INFUVITE ADULT	ALPHA-TOCOPHEROL ACETATE	86472	C31H52O3	472.754	\N	10.8	0	3	14	35.5	34	0	602	3	0	\N	\N	CC1=C2C(=C(C(=C1C)OC(=O)C)C)CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C	[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-yl] acetate
6013	NIRAVAM	ALPRAZOLAM	2118	C17H13ClN4	308.769	\N	2.1	0	3	1	43.1	22	0	434	0	0	\N	\N	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4	8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
380	ALPROSTADIL	ALPROSTADIL	5280723	C20H34O5	354.487	\N	3.2	3	5	13	94.8	25	0	432	4	0	\N	\N	CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O	7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]heptanoic acid
1449	CAVERJECT	ALPROSTADIL	5280723	C20H34O5	354.487	\N	3.2	3	5	13	94.8	25	0	432	4	0	\N	\N	CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O	7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]heptanoic acid
3182	ENTEREG	ALVIMOPAN	5488548	C25H32N2O4	424.541	\N	1.7	3	5	8	89.9	31	0	606	3	0	\N	\N	CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O	2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidyl]propanoyl]amino]acetic acid
400	AMANTADINE HYDROCHLORIDE	AMANTADINE HYDROCHLORIDE	64150	C10H18ClN	187.711	\N	\N	2	1	0	26	12	0	144	0	0	\N	\N	C1C2CC3CC1CC(C2)(C3)N.Cl	adamantan-1-amine;hydrochloride
8605	SYMADINE	AMANTADINE HYDROCHLORIDE	64150	C10H18ClN	187.711	\N	\N	2	1	0	26	12	0	144	0	0	\N	\N	C1C2CC3CC1CC(C2)(C3)N.Cl	adamantan-1-amine;hydrochloride
5773	MYTELASE	AMBENONIUM CHLORIDE	8288	C28H42Cl4N4O2	608.47	\N	\N	2	4	14	58.2	38	0	614	0	0	\N	\N	CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl.[Cl-].[Cl-]	(2-chlorophenyl)methyl-[2-[[2-[2-[(2-chlorophenyl)methyl-diethyl-ammonio]ethylamino]-2-oxo-acetyl]amino]ethyl]-diethyl-ammonium;dichloride
4861	LETAIRIS	AMBRISENTAN	6918493	C22H22N2O4	378.428	\N	3.8	1	6	7	81.5	28	0	475	1	0	\N	\N	CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C	(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenyl-propanoic acid
2115	CYCLOCORT	AMCINONIDE	443958	C28H35FO7	502.579	\N	3.6	1	8	4	99.1	36	0	1090	8	0	\N	\N	CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CCC5=CC(=O)C=CC54C)F)O)C)OC6(O2)CCCC6	\N
1898	COACTIN	AMDINOCILLIN	36273	C15H23N3O3S	325.427	\N	2.1	1	5	3	98.5	22	0	500	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)N=CN3CCCCCC3)C(=O)O)C	(2S,5R,6R)-6-(azepan-1-ylmethyleneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
417	AMIFOSTINE	AMIFOSTINE	2141	C5H15N2O3PS	214.22	\N	-4.5	4	6	7	121	12	0	152	0	0	\N	\N	C(CN)CNCCSP(=O)(O)O	2-(3-aminopropylamino)ethylsulfanylphosphonic acid
3337	ETHYOL	AMIFOSTINE	2141	C5H15N2O3PS	214.22	\N	-4.5	4	6	7	121	12	0	152	0	0	\N	\N	C(CN)CNCCSP(=O)(O)O	2-(3-aminopropylamino)ethylsulfanylphosphonic acid
585	AMIODARONE HYDROCHLORIDE	AMIODARONE HYDROCHLORIDE	441325	C25H30ClI2NO3	681.778	\N	\N	1	4	11	42.7	32	0	547	0	0	\N	\N	CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I.Cl	(2-butylbenzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodo-phenyl]methanone;hydrochloride
5238	M.V.I.-12 (WITHOUT VITAMIN K)	BIOTIN	171548	C10H16N2O3S	244.309	\N	0.3	3	4	5	104	16	0	298	3	0	\N	\N	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
5250	M.V.I.-12 LYOPHILIZED	BIOTIN	171548	C10H16N2O3S	244.309	\N	0.3	3	4	5	104	16	0	298	3	0	\N	\N	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
6701	PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL	BISACODYL	2391	C22H19NO4	361.397	\N	3.8	0	5	7	65.5	27	0	457	0	0	\N	\N	CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3	[4-[(4-acetoxyphenyl)-(2-pyridyl)methyl]phenyl] acetate
9742	XANAX XR	ALPRAZOLAM	2118	C17H13ClN4	308.769	\N	2.1	0	3	1	43.1	22	0	434	0	0	\N	\N	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4	8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
1450	CAVERJECT IMPULSE	ALPROSTADIL	5280723	C20H34O5	354.487	\N	3.2	3	5	13	94.8	25	0	432	4	0	\N	\N	CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O	7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]heptanoic acid
3945	HEXALEN	ALTRETAMINE	2123	C9H18N6	210.285	\N	2.7	0	6	3	48.4	15	0	148	0	0	\N	\N	CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C	N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine
75	ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE	ALUMINUM ACETATE	8757	C6H9AlO6	204.114	\N	\N	0	6	0	120	13	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Al+3]	aluminum;triacetate
1152	BOROFAIR	ALUMINUM ACETATE	8757	C6H9AlO6	204.114	\N	\N	0	6	0	120	13	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Al+3]	aluminum;triacetate
2876	DOMEBORO	ALUMINUM ACETATE	8757	C6H9AlO6	204.114	\N	\N	0	6	0	120	13	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Al+3]	aluminum;triacetate
8611	SYMMETREL	AMANTADINE HYDROCHLORIDE	64150	C10H18ClN	187.711	\N	\N	2	1	0	26	12	0	144	0	0	\N	\N	C1C2CC3CC1CC(C2)(C3)N.Cl	adamantan-1-amine;hydrochloride
9662	VITAPED	BIOTIN	171548	C10H16N2O3S	244.309	\N	0.3	3	4	5	104	16	0	298	3	0	\N	\N	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
3890	HELIDAC	BISMUTH SUBSALICYLATE	16682734	C7H6BiO4	363.101	\N	\N	1	4	0	36.5	12	0	173	0	0	\N	\N	C1=CC=C2C(=C1)C(=O)O[Bi]O2.O	1,3,2$l^{2}-benzodioxabismin-4-one;hydrate
7596	PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
423	AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	AMILORIDE HYDROCHLORIDE	16230	C6H9Cl2N7O	266.086	\N	\N	5	5	1	159	16	0	279	0	0	\N	\N	C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.Cl	3,5-diamino-6-chloro-N-(diaminomethylene)pyrazine-2-carboxamide;hydrochloride
4046	HYDRO-RIDE	AMILORIDE HYDROCHLORIDE	16230	C6H9Cl2N7O	266.086	\N	\N	5	5	1	159	16	0	279	0	0	\N	\N	C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.Cl	3,5-diamino-6-chloro-N-(diaminomethylene)pyrazine-2-carboxamide;hydrochloride
5558	MIDAMOR	AMILORIDE HYDROCHLORIDE	16230	C6H9Cl2N7O	266.086	\N	\N	5	5	1	159	16	0	279	0	0	\N	\N	C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.Cl	3,5-diamino-6-chloro-N-(diaminomethylene)pyrazine-2-carboxamide;hydrochloride
5638	MODURETIC 5-50	AMILORIDE HYDROCHLORIDE	16230	C6H9Cl2N7O	266.086	\N	\N	5	5	1	159	16	0	279	0	0	\N	\N	C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.Cl	3,5-diamino-6-chloro-N-(diaminomethylene)pyrazine-2-carboxamide;hydrochloride
428	AMINOCAPROIC	AMINOCAPROIC ACID	564	C6H13NO2	131.175	\N	-3	2	3	5	63.3	9	0	83.1	0	0	\N	\N	C(CCC(=O)O)CCN	6-aminohexanoic acid
429	AMINOCAPROIC ACID	AMINOCAPROIC ACID	564	C6H13NO2	131.175	\N	-3	2	3	5	63.3	9	0	83.1	0	0	\N	\N	C(CCC(=O)O)CCN	6-aminohexanoic acid
1132	BLEOMYCIN SULFATE	BLEOMYCIN SULFATE	72466	C55H85N17O25S4	1512.619	\N	\N	21	35	36	770	101	0	2660	10	9	\N	\N	CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.OS(=O)(=O)[O-]	3-[[2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxo-propyl)amino]-3-oxo-propyl]-5-methyl-pyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2R,3S,4S,5R,6R)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methyl-pentanoyl]amino]-3-hydroxy-butanoyl]amino]ethyl]thiazol-4-yl]thiazole-4-carbonyl]amino]propyl-dimethyl-sulfonium;hydrogen sulfate
1168	BRETYLOL	BRETYLIUM TOSYLATE	6100	C18H24BrNO3S	414.358	\N	\N	0	3	3	65.6	24	0	349	0	0	\N	\N	CC[N+](C)(C)CC1=CC=CC=C1Br.CC1=CC=C(C=C1)S(=O)(=O)[O-]	(2-bromophenyl)methyl-ethyl-dimethyl-ammonium;4-methylbenzenesulfonate
2808	DIMETANE	BROMPHENIRAMINE MALEATE	5281067	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
2809	DIMETANE-DX	BROMPHENIRAMINE MALEATE	5281067	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
2812	DIMETANE-TEN	BROMPHENIRAMINE MALEATE	5281067	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
3066	EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE	BROMPHENIRAMINE MALEATE	5281067	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
430	AMINOCAPROIC ACID IN PLASTIC CONTAINER	AMINOCAPROIC ACID	564	C6H13NO2	131.175	\N	-3	2	3	5	63.3	9	0	83.1	0	0	\N	\N	C(CCC(=O)O)CCN	6-aminohexanoic acid
2141	CYTADREN	AMINOGLUTETHIMIDE	2145	C13H16N2O2	232.283	\N	1.2	2	3	2	72.2	17	0	321	0	1	\N	\N	CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N	3-(4-aminophenyl)-3-ethyl-piperidine-2,6-dione
4915	LEVULAN	AMINOLEVULINIC ACID HYDROCHLORIDE	123608	C5H10ClNO3	167.589	\N	\N	3	4	4	80.4	10	0	121	0	0	\N	\N	C(CC(=O)O)C(=O)CN.Cl	5-amino-4-oxo-pentanoic acid;hydrochloride
433	AMINOPHYLLINE	AMINOPHYLLINE	9433	C16H24N10O4	420.434	\N	\N	4	8	1	191	30	0	273	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N	1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine
434	AMINOPHYLLINE DYE FREE	AMINOPHYLLINE	9433	C16H24N10O4	420.434	\N	\N	4	8	1	191	30	0	273	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N	1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine
435	AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%	AMINOPHYLLINE	9433	C16H24N10O4	420.434	\N	\N	4	8	1	191	30	0	273	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N	1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine
436	AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	AMINOPHYLLINE	9433	C16H24N10O4	420.434	\N	\N	4	8	1	191	30	0	273	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N	1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine
6902	PHYLLOCONTIN	AMINOPHYLLINE	9433	C16H24N10O4	420.434	\N	\N	4	8	1	191	30	0	273	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N	1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine
8367	SOMOPHYLLIN	AMINOPHYLLINE	9433	C16H24N10O4	420.434	\N	\N	4	8	1	191	30	0	273	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N	1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine
5940	NEOPASALATE	AMINOSALICYLATE SODIUM	2724368	C7H6NNaO3	175.119	\N	\N	2	4	1	86.4	12	0	165	0	0	\N	\N	C1=CC(=C(C=C1N)O)C(=O)[O-].[Na+]	sodium;4-amino-2-hydroxy-benzoate
6615	P.A.S. SODIUM	AMINOSALICYLATE SODIUM	2724368	C7H6NNaO3	175.119	\N	\N	2	4	1	86.4	12	0	165	0	0	\N	\N	C1=CC(=C(C=C1N)O)C(=O)[O-].[Na+]	sodium;4-amino-2-hydroxy-benzoate
6650	PARASAL SODIUM	AMINOSALICYLATE SODIUM	2724368	C7H6NNaO3	175.119	\N	\N	2	4	1	86.4	12	0	165	0	0	\N	\N	C1=CC(=C(C=C1N)O)C(=O)[O-].[Na+]	sodium;4-amino-2-hydroxy-benzoate
8298	SODIUM AMINOSALICYLATE	AMINOSALICYLATE SODIUM	2724368	C7H6NNaO3	175.119	\N	\N	2	4	1	86.4	12	0	165	0	0	\N	\N	C1=CC(=C(C=C1N)O)C(=O)[O-].[Na+]	sodium;4-amino-2-hydroxy-benzoate
8331	SODIUM P.A.S.	AMINOSALICYLATE SODIUM	2724368	C7H6NNaO3	175.119	\N	\N	2	4	1	86.4	12	0	165	0	0	\N	\N	C1=CC(=C(C=C1N)O)C(=O)[O-].[Na+]	sodium;4-amino-2-hydroxy-benzoate
8733	TEEBACIN	AMINOSALICYLATE SODIUM	2724368	C7H6NNaO3	175.119	\N	\N	2	4	1	86.4	12	0	165	0	0	\N	\N	C1=CC(=C(C=C1N)O)C(=O)[O-].[Na+]	sodium;4-amino-2-hydroxy-benzoate
8005	REZIPAS	AMINOSALICYLIC ACID RESIN COMPLEX	4649	C7H7NO3	153.137	\N	1.3	3	4	1	83.6	11	0	160	0	0	\N	\N	C1=CC(=C(C=C1N)O)C(=O)O	4-amino-2-hydroxy-benzoic acid
5941	NEOPASALATE	AMINOSALICYLIC ACID	4649	C7H7NO3	153.137	\N	1.3	3	4	1	83.6	11	0	160	0	0	\N	\N	C1=CC(=C(C=C1N)O)C(=O)O	4-amino-2-hydroxy-benzoic acid
6666	PASER	AMINOSALICYLIC ACID	4649	C7H7NO3	153.137	\N	1.3	3	4	1	83.6	11	0	160	0	0	\N	\N	C1=CC(=C(C=C1N)O)C(=O)O	4-amino-2-hydroxy-benzoic acid
10	ABACAVIR SULFATE AND LAMIVUDINE	ABACAVIR SULFATE	441384	C28H38N12O6S	670.75	\N	\N	8	16	8	287	47	0	496	4	0	\N	\N	C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.OS(=O)(=O)O	[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;sulfuric acid
12	ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE	ABACAVIR SULFATE	441384	C28H38N12O6S	670.75	\N	\N	8	16	8	287	47	0	496	4	0	\N	\N	C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.OS(=O)(=O)O	[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;sulfuric acid
60	ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
341	ALLAY	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2624	DHC PLUS	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2870	DOLENE AP-65	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2926	DRIXORAL PLUS	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
2966	DURADYNE DHC	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
3127	EMPRACET W/ CODEINE PHOSPHATE #3	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
3129	EMPRACET W/ CODEINE PHOSPHATE #4	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
3271	ESGIC	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
42	ACEPHEN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
44	ACETAMINOPHEN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
45	ACETAMINOPHEN AND CODEINE PHOSPHATE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
47	ACETAMINOPHEN AND HYDROCODONE BITARTRATE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
9537	VELTANE	BROMPHENIRAMINE MALEATE	5281067	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
1235	BUCLADIN-S	BUCLIZINE HYDROCHLORIDE	6729	C28H33ClN2	433.036	\N	7.1	0	2	6	6.5	31	0	514	0	1	\N	\N	CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl	1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenyl-methyl]piperazine
7791	PULMICORT FLEXHALER	BUDESONIDE	5281004	C25H34O6	430.541	\N	2.5	2	6	4	93.1	31	0	862	8	1	\N	\N	CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C	\N
1243	BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	BUPIVACAINE HYDROCHLORIDE	64737	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
1245	BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	BUPIVACAINE HYDROCHLORIDE	64737	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
1247	BUPIVACAINE HYDROCHLORIDE KIT	BUPIVACAINE HYDROCHLORIDE	64737	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
1248	BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE	BUPIVACAINE HYDROCHLORIDE	64737	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
1249	BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE	BUPIVACAINE HYDROCHLORIDE	64737	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
2954	DUOCAINE	BUPIVACAINE HYDROCHLORIDE	64737	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
5303	MARCAINE	BUPIVACAINE HYDROCHLORIDE	64737	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
5304	MARCAINE HYDROCHLORIDE	BUPIVACAINE HYDROCHLORIDE	64737	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
5305	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	BUPIVACAINE HYDROCHLORIDE	64737	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
5306	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE	BUPIVACAINE HYDROCHLORIDE	64737	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
5308	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	BUPIVACAINE HYDROCHLORIDE	64737	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
8199	SENSORCAINE	BUPIVACAINE HYDROCHLORIDE	64737	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
8200	SENSORCAINE	BUPIVACAINE HYDROCHLORIDE	64737	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
1251	BUPRENEX	BUPRENORPHINE HYDROCHLORIDE	3033050	C29H42ClNO4	504.108	\N	\N	3	5	5	62.2	35	0	869	7	0	\N	\N	CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O.Cl	\N
7625	PROCALAMINE	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1252	BUPRENORPHINE HYDROCHLORIDE	BUPRENORPHINE HYDROCHLORIDE	3033050	C29H42ClNO4	504.108	\N	\N	3	5	5	62.2	35	0	869	7	0	\N	\N	CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O.Cl	\N
1295	BUTICAPS	BUTABARBITAL SODIUM	23690439	C10H15N2NaO3	234.231	\N	\N	1	3	3	81.6	16	0	330	0	2	\N	\N	CCC(C)C1(C(=O)NC(=NC1=O)[O-])CC.[Na+]	sodium;5-ethyl-4,6-dioxo-5-sec-butyl-1H-pyrimidin-2-olate
1296	BUTISOL SODIUM	BUTABARBITAL SODIUM	23690439	C10H15N2NaO3	234.231	\N	\N	1	3	3	81.6	16	0	330	0	2	\N	\N	CCC(C)C1(C(=O)NC(=NC1=O)[O-])CC.[Na+]	sodium;5-ethyl-4,6-dioxo-5-sec-butyl-1H-pyrimidin-2-olate
8157	SARISOL NO. 1	BUTABARBITAL SODIUM	23690439	C10H15N2NaO3	234.231	\N	\N	1	3	3	81.6	16	0	330	0	2	\N	\N	CCC(C)C1(C(=O)NC(=NC1=O)[O-])CC.[Na+]	sodium;5-ethyl-4,6-dioxo-5-sec-butyl-1H-pyrimidin-2-olate
8158	SARISOL NO. 2	BUTABARBITAL SODIUM	23690439	C10H15N2NaO3	234.231	\N	\N	1	3	3	81.6	16	0	330	0	2	\N	\N	CCC(C)C1(C(=O)NC(=NC1=O)[O-])CC.[Na+]	sodium;5-ethyl-4,6-dioxo-5-sec-butyl-1H-pyrimidin-2-olate
5355	MEDIGESIC PLUS	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
1271	BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
1275	BUTALBITAL, ASPIRIN AND CAFFEINE	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
1278	BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
1282	BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
1285	BUTALBITAL; ACETAMINOPHEN; CAFFEINE; CODEINE	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
1290	BUTALIBITAL, ACETAMINOPHEN AND CAFFEINE	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
1293	BUTAPAP	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
3272	ESGIC	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
3275	ESGIC-PLUS	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
3439	FEMCET	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
3499	FIORICET	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
3502	FIORICET W/ CODEINE	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
3506	FIORINAL	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
3509	FIORINAL W/CODEINE	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
4801	LANORINAL	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
6895	PHRENILIN	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
6897	PHRENILIN FORTE	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
6899	PHRENILIN WITH CAFFEINE AND CODEINE	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
9190	TRIAD	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
9202	TRIAPRIN	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
5398	MENTAX	BUTENAFINE HYDROCHLORIDE	443867	C23H28ClN	353.934	\N	\N	1	1	5	3.2	25	0	374	0	0	\N	\N	CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32.Cl	1-(4-tert-butylphenyl)-N-methyl-N-(1-naphthylmethyl)methanamine;hydrochloride
1986	COMETRIQ	CABOZANTINIB S-MALATE	25102846	C32H30FN3O10	635.601	\N	\N	5	12	11	194	46	0	924	1	0	\N	\N	COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F.C(C(C(=O)O)O)C(=O)O	N1-[4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N1'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;(2S)-2-hydroxybutanedioic acid
2184	DARVON COMPOUND	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
4357	INVAGESIC	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
61	ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
690	ANOQUAN	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
1272	BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
1276	BUTALBITAL, ASPIRIN AND CAFFEINE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
64	ACETASOL HC	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
271	AKRINOL	ACRISORCIN	24144	C25H28N2O2	388.511	\N	\N	3	4	5	79.4	29	0	354	0	0	\N	\N	CCCCCCC1=C(C=C(C=C1)O)O.C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)N	acridin-9-amine;4-hexylbenzene-1,3-diol
8196	SEMPREX-D	ACRIVASTINE	5284514	C22H24N2O2	348.446	\N	1.6	1	4	6	53.4	26	0	514	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC(=N3)C=CC(=O)O	(E)-3-[6-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]-2-pyridyl]prop-2-enoic acid
134	ACYCLOVIR SODIUM	ACYCLOVIR SODIUM	23665721	C8H10N5NaO3	247.19	\N	\N	2	7	4	122	17	0	237	0	0	\N	\N	C1=NC2=C(N1COCCO)N=C(N=C2[O-])N.[Na+]	sodium;2-amino-9-(2-hydroxyethoxymethyl)purin-6-olate
2783	DIFFERIN	ADAPALENE	60164	C28H28O3	412.529	\N	7.7	1	3	4	46.5	31	0	645	0	0	\N	\N	COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5	6-[3-(1-adamantyl)-4-methoxy-phenyl]naphthalene-2-carboxylic acid
3197	EPIDUO	ADAPALENE	60164	C28H28O3	412.529	\N	7.7	1	3	4	46.5	31	0	645	0	0	\N	\N	COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5	6-[3-(1-adamantyl)-4-methoxy-phenyl]naphthalene-2-carboxylic acid
3199	EPIDUO FORTE	ADAPALENE	60164	C28H28O3	412.529	\N	7.7	1	3	4	46.5	31	0	645	0	0	\N	\N	COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5	6-[3-(1-adamantyl)-4-methoxy-phenyl]naphthalene-2-carboxylic acid
202	ADENOCARD	ADENOSINE	60961	C10H13N5O4	267.245	\N	-1.1	4	8	2	140	19	0	335	4	0	\N	\N	C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O	(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
1978	COMBIVENT	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
1980	COMBIVENT RESPIMAT	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
2958	DUONEB	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
7599	PROAIR HFA	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
7600	PROAIR RESPICLICK	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
7775	PROVENTIL	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
1279	BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
1283	BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
1287	BUTALBITAL; ACETAMINOPHEN; CAFFEINE; CODEINE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
1291	BUTALIBITAL, ACETAMINOPHEN AND CAFFEINE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
1315	CAFERGOT	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
2187	DARVON COMPOUND-65	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
2625	DHC PLUS	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
3234	ERGOTAMINE TARTRATE AND CAFFEINE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
3276	ESGIC-PLUS	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
3440	FEMCET	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
3503	FIORICET W/ CODEINE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
3507	FIORINAL	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
3510	FIORINAL W/CODEINE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
4360	INVAGESIC FORTE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
6093	NORGESIC	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
6096	NORGESIC FORTE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
6449	ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
6452	ORPHENGESIC	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
6455	ORPHENGESIC FORTE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
7736	PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
15	ABACAVIR SULFATE; LAMIVUDINE	ABACAVIR SULFATE	441384	C28H38N12O6S	670.75	\N	\N	8	16	8	287	47	0	496	4	0	\N	\N	C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.OS(=O)(=O)O	[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;sulfuric acid
3218	EPZICOM	ABACAVIR SULFATE	441384	C28H38N12O6S	670.75	\N	\N	8	16	8	287	47	0	496	4	0	\N	\N	C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.OS(=O)(=O)O	[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;sulfuric acid
6825	PHENAPHEN W/ CODEINE NO. 3	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
334	ALFUZOSIN HYDROCHLORIDE	ALFUZOSIN HYDROCHLORIDE	71764	C19H28ClN5O4	425.914	\N	\N	3	8	8	112	29	0	511	0	1	\N	\N	CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl	N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]tetrahydrofuran-2-carboxamide;hydrochloride
358	ALMOTRIPTAN MALATE	ALMOTRIPTAN MALATE	123607	C21H31N3O7S	469.553	\N	\N	4	9	9	160	32	0	612	0	1	\N	\N	CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3.C(C(C(=O)O)O)C(=O)O	N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine;2-hydroxybutanedioic acid
902	AXERT	ALMOTRIPTAN MALATE	123607	C21H31N3O7S	469.553	\N	\N	4	9	9	160	32	0	612	0	1	\N	\N	CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3.C(C(C(=O)O)O)C(=O)O	N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine;2-hydroxybutanedioic acid
6510	OSENI	ALOGLIPTIN BENZOATE	16088021	C25H27N5O4	461.522	\N	\N	2	7	4	131	34	0	726	1	0	\N	\N	CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N.C1=CC=C(C=C1)C(=O)O	2-[[6-[(3R)-3-amino-1-piperidyl]-3-methyl-2,4-dioxo-pyrimidin-1-yl]methyl]benzonitrile;benzoic acid
8369	SOMOPHYLLIN-DF	AMINOPHYLLINE	9433	C16H24N10O4	420.434	\N	\N	4	8	1	191	30	0	273	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N	1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine
9316	TRUPHYLLINE	AMINOPHYLLINE	9433	C16H24N10O4	420.434	\N	\N	4	8	1	191	30	0	273	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N	1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine
2016	CORDARONE	AMIODARONE HYDROCHLORIDE	441325	C25H30ClI2NO3	681.778	\N	\N	1	4	11	42.7	32	0	547	0	0	\N	\N	CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I.Cl	(2-butylbenzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodo-phenyl]methanone;hydrochloride
5986	NEXTERONE	AMIODARONE HYDROCHLORIDE	441325	C25H30ClI2NO3	681.778	\N	\N	1	4	11	42.7	32	0	547	0	0	\N	\N	CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I.Cl	(2-butylbenzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodo-phenyl]methanone;hydrochloride
6616	PACERONE	AMIODARONE HYDROCHLORIDE	441325	C25H30ClI2NO3	681.778	\N	\N	1	4	11	42.7	32	0	547	0	0	\N	\N	CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I.Cl	(2-butylbenzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodo-phenyl]methanone;hydrochloride
3624	FORTICAL	CALCITONIN SALMON RECOMBINANT	16133812	C145H240N44O48S2	3431.895	\N	-16.6	52	55	99	1560	239	0	7970	34	0	\N	\N	CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CNC=N2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO	\N
1321	CALCIJEX	CALCITRIOL	5280453	C27H44O3	416.646	\N	5.1	3	3	6	60.7	30	0	688	6	0	\N	\N	CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-5-hydroxy-1,5-dimethyl-hexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
8064	ROCALTROL	CALCITRIOL	5280453	C27H44O3	416.646	\N	5.1	3	3	6	60.7	30	0	688	6	0	\N	\N	CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-5-hydroxy-1,5-dimethyl-hexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
9741	XANAX	ALPRAZOLAM	2118	C17H13ClN4	308.769	\N	2.1	0	3	1	43.1	22	0	434	0	0	\N	\N	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4	8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
3042	EDEX	ALPROSTADIL	5280723	C20H34O5	354.487	\N	3.2	3	5	13	94.8	25	0	432	4	0	\N	\N	CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O	7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]heptanoic acid
5713	MUSE	ALPROSTADIL	5280723	C20H34O5	354.487	\N	3.2	3	5	13	94.8	25	0	432	4	0	\N	\N	CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O	7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]heptanoic acid
7758	PROSTIN VR PEDIATRIC	ALPROSTADIL	5280723	C20H34O5	354.487	\N	3.2	3	5	13	94.8	25	0	432	4	0	\N	\N	CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O	7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]heptanoic acid
418	AMIKACIN SULFATE	AMIKACIN SULFATE	38351	C22H47N5O21S2	781.752	\N	\N	17	25	10	498	50	0	900	16	0	\N	\N	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N.OS(=O)(=O)O.OS(=O)(=O)O	(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-cyclohexyl]-2-hydroxy-butanamide;sulfuric acid
419	AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	AMIKACIN SULFATE	38351	C22H47N5O21S2	781.752	\N	\N	17	25	10	498	50	0	900	16	0	\N	\N	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N.OS(=O)(=O)O.OS(=O)(=O)O	(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-cyclohexyl]-2-hydroxy-butanamide;sulfuric acid
8617	SYNALGOS-DC	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
8620	SYNALGOS-DC-A	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
9191	TRIAD	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
7897	RAYALDEE	CALCIFEDIOL	5283731	C27H44O2	400.647	\N	6.2	2	2	6	40.5	29	0	655	5	0	\N	\N	CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-5-hydroxy-1,5-dimethyl-hexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
356	ALLZITAL	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
669	ANEXSIA	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
671	ANEXSIA 5/325	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
673	ANEXSIA 7.5/325	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
675	ANEXSIA 7.5/650	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
9513	VECTICAL	CALCITRIOL	5280453	C27H44O3	416.646	\N	5.1	3	3	6	60.7	30	0	688	6	0	\N	\N	CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-5-hydroxy-1,5-dimethyl-hexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
4718	LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
5855	NAVSTEL	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1782	CLINIMIX E 2.75/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1789	CLINIMIX E 2.75/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1796	CLINIMIX E 4.25/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1803	CLINIMIX E 4.25/20 SULFITE FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1810	CLINIMIX E 4.25/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1817	CLINIMIX E 4.25/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1824	CLINIMIX E 5/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1831	CLINIMIX E 5/15 SULFITE FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1838	CLINIMIX E 5/20 SULFITE FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1845	CLINIMIX E 5/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2242	DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2247	DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2252	DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2257	DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2262	DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2267	DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2272	DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2277	DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2282	DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2287	DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2297	DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2302	DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2447	DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2459	DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
6443	ORLEX	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
6444	ORLEX HC	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
9227	TRIDESILON	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
9696	VOSOL HC	ACETIC ACID, GLACIAL	176	C2H4O2	60.052	\N	-0.2	1	2	0	37.3	4	0	31	0	0	\N	\N	CC(=O)O	acetic acid
5706	MUCOSIL-20	ACETYLCYSTEINE	12035	C5H9NO3S	163.191	\N	0.4	3	4	3	67.4	10	0	148	1	0	\N	\N	CC(=O)NC(CS)C(=O)O	(2R)-2-acetamido-3-sulfanyl-propanoic acid
2476	DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2489	DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2507	DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2512	DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
9290	TRIUMEQ	ABACAVIR SULFATE	441384	C28H38N12O6S	670.75	\N	\N	8	16	8	287	47	0	496	4	0	\N	\N	C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.OS(=O)(=O)O	[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;sulfuric acid
9299	TRIZIVIR	ABACAVIR SULFATE	441384	C28H38N12O6S	670.75	\N	\N	8	16	8	287	47	0	496	4	0	\N	\N	C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.OS(=O)(=O)O	[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;sulfuric acid
9859	ZIAGEN	ABACAVIR SULFATE	441384	C28H38N12O6S	670.75	\N	\N	8	16	8	287	47	0	496	4	0	\N	\N	C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.OS(=O)(=O)O	[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;sulfuric acid
688	ANOQUAN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
986	BANCAP	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
988	BANCAP HC	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1265	BUTALBITAL AND ACETAMINOPHEN	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
1267	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE	ACETAMINOPHEN	1983	C8H9NO2	151.165	\N	0.5	2	2	1	49.3	11	0	139	0	0	\N	\N	CC(=O)NC1=CC=C(C=C1)O	N-(4-hydroxyphenyl)acetamide
420	AMIKIN	AMIKACIN SULFATE	38351	C22H47N5O21S2	781.752	\N	\N	17	25	10	498	50	0	900	16	0	\N	\N	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N.OS(=O)(=O)O.OS(=O)(=O)O	(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-cyclohexyl]-2-hydroxy-butanamide;sulfuric acid
421	AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	AMIKACIN SULFATE	38351	C22H47N5O21S2	781.752	\N	\N	17	25	10	498	50	0	900	16	0	\N	\N	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N.OS(=O)(=O)O.OS(=O)(=O)O	(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-cyclohexyl]-2-hydroxy-butanamide;sulfuric acid
2518	DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2633	DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2638	DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2643	DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2648	DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2653	DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2658	DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2663	DIALYTE W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2668	DIALYTE W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2675	DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2680	DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2685	DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2690	DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2695	DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2700	DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2705	DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2710	DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2715	DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2720	DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
7776	PROVENTIL-HFA	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
290	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
9547	VENTOLIN	ALBUTEROL SULFATE	39859	C26H44N2O10S	576.702	\N	\N	10	12	10	228	39	0	309	0	2	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O	4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;sulfuric acid
587	AMITID	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
589	AMITRIL	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
590	AMITRIPTYLINE HYDROCHLORIDE	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
1596	CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
3074	ELAVIL	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
3144	ENDEP	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
3343	ETRAFON 2-10	AMITRIPTYLINE HYDROCHLORIDE	11065	C20H24ClN	313.869	\N	\N	1	1	3	3.2	22	0	331	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
6593	OXYCODONE AND ASPIRIN (HALF-STRENGTH)	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
719	APHTHASOL	AMLEXANOX	2161	C16H14N2O4	298.298	\N	3.1	2	6	2	103	22	0	467	0	0	\N	\N	CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N	2-amino-7-isopropyl-5-oxo-chromeno[2,3-b]pyridine-3-carboxylic acid
593	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE	60496	C26H31ClN2O8S	567.05	\N	\N	3	10	11	163	38	0	830	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
687	ANISOTROPINE METHYLBROMIDE	ANISOTROPINE METHYLBROMIDE	657201	C17H32BrNO2	362.352	\N	\N	0	3	7	26.3	21	0	318	2	0	\N	\N	CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-]	[(1R,5S)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] 2-propylpentanoate;bromide
615	AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE	AMMONIUM CHLORIDE	25517	ClH4N	53.489	\N	\N	1	1	0	1	2	0	0	0	0	\N	\N	[NH4+].[Cl-]	ammonium;chloride
4715	LAC-HYDRIN	AMMONIUM LACTATE	62358	C3H9NO3	107.109	\N	\N	2	3	0	61.4	7	0	53.5	0	1	\N	\N	CC(C(=O)[O-])O.[NH4+]	ammonium;2-hydroxypropanoate
1344	CAMOQUIN HYDROCHLORIDE	AMODIAQUINE HYDROCHLORIDE	2165	C20H22ClN3O	355.866	\N	2.6	2	4	6	48.4	25	0	406	0	0	\N	\N	CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O	4-[(7-chloro-4-quinolyl)amino]-2-(diethylaminomethyl)phenol
799	ASENDIN	AMOXAPINE	2170	C17H16ClN3O	313.785	\N	2.6	1	3	1	36.9	22	0	424	0	0	\N	\N	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	8-chloro-6-piperazin-1-yl-benzo[b][1,4]benzoxazepine
625	AMOXICILLIN	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
629	AMOXIL	AMOXICILLIN	33613	C16H19N3O5S	365.404	\N	-2	4	7	4	158	25	0	590	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
5225	M.V.I.-12	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
1121	BIPHETAMINE 12.5	AMPHETAMINE RESIN COMPLEX	3007	C9H13N	135.21	\N	1.8	1	1	2	26	10	0	84.7	0	1	\N	\N	CC(CC1=CC=CC=C1)N	1-phenylpropan-2-amine
1123	BIPHETAMINE 20	AMPHETAMINE RESIN COMPLEX	3007	C9H13N	135.21	\N	1.8	1	1	2	26	10	0	84.7	0	1	\N	\N	CC(CC1=CC=CC=C1)N	1-phenylpropan-2-amine
1125	BIPHETAMINE 7.5	AMPHETAMINE RESIN COMPLEX	3007	C9H13N	135.21	\N	1.8	1	1	2	26	10	0	84.7	0	1	\N	\N	CC(CC1=CC=CC=C1)N	1-phenylpropan-2-amine
2995	DYANAVEL XR	AMPHETAMINE	3007	C9H13N	135.21	\N	1.8	1	1	2	26	10	0	84.7	0	1	\N	\N	CC(CC1=CC=CC=C1)N	1-phenylpropan-2-amine
19	ABELCET	AMPHOTERICIN B	5280965	C47H73NO17	924.091	\N	0	12	18	3	320	65	0	1670	19	0	\N	\N	CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(1S,3R,4E,6E,8E,10E,12E,14E,16E,18S,19R,20R,21S,25R,27R,30R,31R,33S,35R,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxylic acid
637	AMPICILLIN SODIUM	AMPICILLIN SODIUM	23663979	C16H18N3NaO4S	371.387	\N	\N	2	6	4	141	25	0	568	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C.[Na+]	sodium;(2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6355	OMNIPEN-N	AMPICILLIN SODIUM	23663979	C16H18N3NaO4S	371.387	\N	\N	2	6	4	141	25	0	568	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C.[Na+]	sodium;(2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6732	PENBRITIN-S	AMPICILLIN SODIUM	23663979	C16H18N3NaO4S	371.387	\N	\N	2	6	4	141	25	0	568	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C.[Na+]	sodium;(2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
7015	POLYCILLIN-N	AMPICILLIN SODIUM	23663979	C16H18N3NaO4S	371.387	\N	\N	2	6	4	141	25	0	568	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C.[Na+]	sodium;(2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
8981	TOTACILLIN-N	AMPICILLIN SODIUM	23663979	C16H18N3NaO4S	371.387	\N	\N	2	6	4	141	25	0	568	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C.[Na+]	sodium;(2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
9396	UNASYN	AMPICILLIN SODIUM	23663979	C16H18N3NaO4S	371.387	\N	\N	2	6	4	141	25	0	568	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C.[Na+]	sodium;(2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
256	AGENERASE	AMPRENAVIR	65016	C25H35N3O6S	505.63	\N	2.9	3	8	12	140	35	0	745	3	0	\N	\N	CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N	[(3S)-tetrahydrofuran-3-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate
655	ANASTROZOLE	ANASTROZOLE	2187	C17H19N5	293.374	\N	2.1	0	4	4	78.3	22	0	456	0	0	\N	\N	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	2-[3-(1-cyano-1-methyl-ethyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile
771	ARIMIDEX	ANASTROZOLE	2187	C17H19N5	293.374	\N	2.1	0	4	4	78.3	22	0	456	0	0	\N	\N	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	2-[3-(1-cyano-1-methyl-ethyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile
3226	ERAXIS	ANIDULAFUNGIN	166548	C58H73N7O17	1140.254	\N	2.3	14	17	14	377	82	0	2150	15	0	\N	\N	CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC=C(C=C7)O)O)O)C(C)O)C)O)O)O	\N
4853	LERITINE	ANILERIDINE HYDROCHLORIDE	31338	C22H30Cl2N2O2	425.394	\N	\N	3	4	7	55.6	28	0	431	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)CCC2=CC=C(C=C2)N)C3=CC=CC=C3.Cl.Cl	ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenyl-piperidine-4-carboxylate;dihydrochloride
4854	LERITINE	ANILERIDINE PHOSPHATE	16051989	C22H31N2O6P	450.472	\N	\N	4	8	7	133	31	0	481	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)CCC2=CC=C(C=C2)N)C3=CC=CC=C3.OP(=O)(O)O	ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenyl-piperidine-4-carboxylate;phosphoric acid
6779	PERCODAN	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
724	APOKYN	APOMORPHINE HYDROCHLORIDE	9410	C17H18ClNO2	303.786	\N	\N	3	3	0	43.7	21	0	374	1	0	\N	\N	CN1CCC2=CC=CC3=C2C1CC4=C3C(=C(C=C4)O)O.Cl	(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol;hydrochloride
4407	IOPIDINE	APRACLONIDINE HYDROCHLORIDE	51763	C9H11Cl3N4	281.565	\N	\N	4	2	2	62.4	16	0	247	0	0	\N	\N	C1CN=C(N1)NC2=C(C=C(C=C2Cl)N)Cl.Cl	2,6-dichloro-N1-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine;hydrochloride
6527	OTEZLA	APREMILAST	11561674	C22H24N2O7S	460.501	\N	1.8	1	7	8	128	32	0	825	1	0	\N	\N	CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC	N-[2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methylsulfonyl-ethyl]-1,3-dioxo-isoindolin-4-yl]acetamide
726	APREPITANT	APREPITANT	6918365	C23H21F7N4O3	534.435	\N	4.2	2	11	6	75.2	37	0	810	3	0	\N	\N	CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F	5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
3724	GENESA	ARBUTAMINE HYDROCHLORIDE	166551	C18H24ClNO4	353.843	\N	\N	6	5	8	93	24	0	320	1	0	\N	\N	C1=CC(=CC=C1CCCCNCC(C2=CC(=C(C=C2)O)O)O)O.Cl	4-[(1R)-1-hydroxy-2-[4-(4-hydroxyphenyl)butylamino]ethyl]benzene-1,2-diol;hydrochloride
6135	NORMIFLO	ARDEPARIN SODIUM	25244225	C12H17NO20S3-4	591.435	\N	-5.6	5	21	6	376	36	-4	1040	4	6	\N	\N	C(C1C(C(C(C(O1)O)NS(=O)(=O)[O-])O)OC2C(C(C(C(O2)C(=O)[O-])O)O)OS(=O)(=O)[O-])OS(=O)(=O)[O-]	(4S,6R)-6-[(2R,4R)-4,6-dihydroxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-3,4-dihydroxy-5-sulfonatooxy-tetrahydropyran-2-carboxylate
763	ARGATROBAN	ARGATROBAN	92722	C23H36N6O5S	508.638	\N	1.3	5	8	9	189	35	0	887	3	1	\N	\N	CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C	(2R,4R)-1-[(2S)-5-guanidino-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methyl-piperidine-2-carboxylic acid
764	ARGATROBAN IN 0.9% SODIUM CHLORIDE	ARGATROBAN	92722	C23H36N6O5S	508.638	\N	1.3	5	8	9	189	35	0	887	3	1	\N	\N	CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C	(2R,4R)-1-[(2S)-5-guanidino-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methyl-piperidine-2-carboxylic acid
7858	R-GENE 10	ARGININE HYDROCHLORIDE	66250	C6H15ClN4O2	210.662	\N	\N	5	4	5	128	13	0	176	1	0	\N	\N	C(CC(C(=O)O)N)CN=C(N)N.Cl	(2S)-2-amino-5-guanidino-pentanoic acid;hydrochloride
21	ABILIFY MAINTENA KIT	ARIPIPRAZOLE	60795	C23H27Cl2N3O2	448.388	\N	4.6	1	4	7	44.8	30	0	559	0	0	\N	\N	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
772	ARIPIPRAZOLE	ARIPIPRAZOLE	60795	C23H27Cl2N3O2	448.388	\N	4.6	1	4	7	44.8	30	0	559	0	0	\N	\N	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
6254	NUVIGIL	ARMODAFINIL	9690109	C15H15NO2S	273.35	\N	1.7	1	3	5	79.4	19	0	302	1	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	2-[(R)-benzhydrylsulfinyl]acetamide
1050	BEROCCA PN	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
4255	INFUVITE ADULT	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
4267	INFUVITE PEDIATRIC	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
4280	INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
5162	M.V.C. 9+3	ASCORBIC ACID	54670067	C6H8O6	176.124	\N	-1.6	4	6	2	107	12	0	232	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)O)O)O	(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
8153	SAPHRIS	ASENAPINE MALEATE	6917875	C21H20ClNO5	401.843	\N	\N	2	6	2	87.1	28	0	482	2	0	\N	\N	CN1CC2C(C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24.C(=CC(=O)O)C(=O)O	\N
55	ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
258	AGGRENOX	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
906	AXOTAL	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
920	AZDONE	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
998	BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN	ASPIRIN	2244	C9H8O4	180.159	\N	1.2	1	4	3	63.6	13	0	212	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)O	2-acetoxybenzoic acid
816	ATAZANAVIR SULFATE	ATAZANAVIR SULFATE	158550	C38H54N6O11S	802.941	\N	\N	7	13	18	254	56	0	1190	4	0	\N	\N	CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O	methyl N-[(1S)-1-[[(1S,2S)-1-benzyl-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[[4-(2-pyridyl)phenyl]methyl]amino]propyl]carbamoyl]-2,2-dimethyl-propyl]carbamate;sulfuric acid
817	ATAZANAVIR SULFATE AND RITONAVIR	ATAZANAVIR SULFATE	158550	C38H54N6O11S	802.941	\N	\N	7	13	18	254	56	0	1190	4	0	\N	\N	CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O	methyl N-[(1S)-1-[[(1S,2S)-1-benzyl-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[[4-(2-pyridyl)phenyl]methyl]amino]propyl]carbamoyl]-2,2-dimethyl-propyl]carbamate;sulfuric acid
819	ATAZANAVIR SULFATE; RITONAVIR	ATAZANAVIR SULFATE	158550	C38H54N6O11S	802.941	\N	\N	7	13	18	254	56	0	1190	4	0	\N	\N	CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O	methyl N-[(1S)-1-[[(1S,2S)-1-benzyl-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[[4-(2-pyridyl)phenyl]methyl]amino]propyl]carbamoyl]-2,2-dimethyl-propyl]carbamate;sulfuric acid
3368	EVOTAZ	ATAZANAVIR SULFATE	158550	C38H54N6O11S	802.941	\N	\N	7	13	18	254	56	0	1190	4	0	\N	\N	CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O	methyl N-[(1S)-1-[[(1S,2S)-1-benzyl-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[[4-(2-pyridyl)phenyl]methyl]amino]propyl]carbamoyl]-2,2-dimethyl-propyl]carbamate;sulfuric acid
8768	TENORETIC 50	ATENOLOL	2249	C14H22N2O3	266.341	\N	0.2	3	4	8	84.6	19	0	263	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide
8770	TENORMIN	ATENOLOL	2249	C14H22N2O3	266.341	\N	0.2	3	4	8	84.6	19	0	263	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide
833	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	54840	C17H22ClNO	291.819	\N	\N	2	2	6	21.3	20	0	237	1	0	\N	\N	CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2.Cl	(3R)-N-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine;hydrochloride
8482	STRATTERA	ATOMOXETINE HYDROCHLORIDE	54840	C17H22ClNO	291.819	\N	\N	2	2	6	21.3	20	0	237	1	0	\N	\N	CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2.Cl	(3R)-N-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine;hydrochloride
599	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	60822	C66H68CaF2N4O10	1155.363	\N	\N	6	12	22	229	83	0	817	4	0	\N	\N	CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2]	calcium;(3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoate
834	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	60822	C66H68CaF2N4O10	1155.363	\N	\N	6	12	22	229	83	0	817	4	0	\N	\N	CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2]	calcium;(3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoate
1313	CADUET	ATORVASTATIN CALCIUM	60822	C66H68CaF2N4O10	1155.363	\N	\N	6	12	22	229	83	0	817	4	0	\N	\N	CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2]	calcium;(3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoate
835	ATOVAQUONE	ATOVAQUONE	74989	C22H19ClO3	366.841	\N	5.2	1	3	2	54.4	26	0	595	0	0	\N	\N	C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O	3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxy-naphthalene-1,2-dione
847	ATROPINE	ATROPINE	174174	C17H23NO3	289.375	\N	1.8	1	4	5	49.8	21	0	353	2	1	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3	[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenyl-propanoate
838	ATRACURIUM BESYLATE	ATRACURIUM BESYLATE	47320	C65H82N2O18S2	1243.487	\N	\N	0	18	26	258	87	0	1560	0	4	\N	\N	C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]	benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
850	ATROPINE SULFATE	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
851	ATROPINE SULFATE ANSYR PLASTIC SYRINGE	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
2627	DI-ATRO	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
2823	DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
2825	DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
3162	ENLON-PLUS	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
5045	LOGEN	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
5048	LOMANATE	ATROPINE SULFATE	5927	C34H48N2O10S	676.822	\N	\N	4	12	10	183	47	0	434	0	6	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O	(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenyl-propanoate;sulfuric acid
846	ATROPEN	ATROPINE	174174	C17H23NO3	289.375	\N	1.8	1	4	5	49.8	21	0	353	2	1	\N	\N	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3	[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenyl-propanoate
8016	RIDAURA	AURANOFIN	24199313	C20H34AuO9PS	678.483	\N	\N	0	10	12	115	32	0	532	0	5	\N	\N	CCP(CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+]	gold(1+);3,4,5-triacetoxy-6-(acetoxymethyl)tetrahydropyran-2-thiolate;triethylphosphane
8463	STENDRA	AVANAFIL	9869929	C23H26ClN7O3	483.957	\N	2.6	3	9	9	125	34	0	642	1	0	\N	\N	COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCCC4CO)Cl	4-[(3-chloro-4-methoxy-phenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
700	ANTHELIOS 20	AVOBENZONE	51040	C20H22O3	310.393	\N	4.8	0	3	6	43.4	23	0	405	0	0	\N	\N	CC(C)(C)C1=CC=C(C=C1)C(=O)CC(=O)C2=CC=C(C=C2)OC	1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione
4296	INLYTA	AXITINIB	6450551	C22H18N4OS	386.473	\N	4.2	2	4	5	96	28	0	557	0	0	\N	\N	CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4	N-methyl-2-[[3-[(E)-2-(2-pyridyl)vinyl]-1H-indazol-6-yl]sulfanyl]benzamide
912	AZACITIDINE	AZACITIDINE	9444	C8H12N4O5	244.207	\N	-2.2	4	5	2	141	17	0	384	4	0	\N	\N	C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N	4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one
9598	VIDAZA	AZACITIDINE	9444	C8H12N4O5	244.207	\N	-2.2	4	5	2	141	17	0	384	4	0	\N	\N	C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N	4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one
6395	OPTIMINE	AZATADINE MALEATE	5281066	C28H30N2O8	522.554	\N	\N	4	10	4	165	38	0	536	0	0	\N	\N	CN1CCC(=C2C3=CC=CC=C3CCC4=C2N=CC=C4)CC1.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O	maleic acid;11-(1-methyl-4-piperidylidene)-5,6-dihydrobenzo[1,2]cyclohepta[3,4-b]pyridine
918	AZATHIOPRINE	AZATHIOPRINE SODIUM	2265	C9H7N7O2S	277.262	\N	0.1	1	7	2	143	19	0	354	0	0	\N	\N	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	6-(3-methyl-5-nitro-imidazol-4-yl)sulfanyl-7H-purine
919	AZATHIOPRINE SODIUM	AZATHIOPRINE SODIUM	2265	C9H7N7O2S	277.262	\N	0.1	1	7	2	143	19	0	354	0	0	\N	\N	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	6-(3-methyl-5-nitro-imidazol-4-yl)sulfanyl-7H-purine
4217	IMURAN	AZATHIOPRINE SODIUM	2265	C9H7N7O2S	277.262	\N	0.1	1	7	2	143	19	0	354	0	0	\N	\N	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	6-(3-methyl-5-nitro-imidazol-4-yl)sulfanyl-7H-purine
917	AZATHIOPRINE	AZATHIOPRINE	2265	C9H7N7O2S	277.262	\N	0.1	1	7	2	143	19	0	354	0	0	\N	\N	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	6-(3-methyl-5-nitro-imidazol-4-yl)sulfanyl-7H-purine
924	AZELEX	AZELAIC ACID	2266	C9H16O4	188.223	\N	1.6	2	4	8	74.6	13	0	147	0	0	\N	\N	C(CCCC(=O)O)CCCC(=O)O	nonanedioic acid
810	ASTEPRO	AZELASTINE HYDROCHLORIDE	54360	C22H25Cl2N3O	418.362	\N	\N	1	3	3	35.9	28	0	558	0	1	\N	\N	CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl.Cl	4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;hydrochloride
923	AZELASTINE HYDROCHLORIDE	AZELASTINE HYDROCHLORIDE	54360	C22H25Cl2N3O	418.362	\N	\N	1	3	3	35.9	28	0	558	0	1	\N	\N	CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl.Cl	4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;hydrochloride
3002	DYMISTA	AZELASTINE HYDROCHLORIDE	54360	C22H25Cl2N3O	418.362	\N	\N	1	3	3	35.9	28	0	558	0	1	\N	\N	CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl.Cl	4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;hydrochloride
916	AZASITE	AZITHROMYCIN	447043	C38H72N2O12	748.996	\N	4	5	14	7	180	52	0	1150	18	0	\N	\N	CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O	(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
926	AZITHROMYCIN	AZITHROMYCIN	447043	C38H72N2O12	748.996	\N	4	5	14	7	180	52	0	1150	18	0	\N	\N	CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O	(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
913	AZACTAM	AZTREONAM	5742832	C13H17N5O8S2	435.426	\N	0.3	4	12	7	238	28	0	808	2	0	\N	\N	CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N	2-[(Z)-[1-(2-aminothiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-azetidin-3-yl]amino]-2-oxo-ethylidene]amino]oxy-2-methyl-propanoic acid
914	AZACTAM IN PLASTIC CONTAINER	AZTREONAM	5742832	C13H17N5O8S2	435.426	\N	0.3	4	12	7	238	28	0	808	2	0	\N	\N	CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N	2-[(Z)-[1-(2-aminothiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-azetidin-3-yl]amino]-2-oxo-ethylidene]amino]oxy-2-methyl-propanoic acid
8400	SPECTROBID	BACAMPICILLIN HYDROCHLORIDE	441398	C21H28ClN3O7S	501.979	\N	\N	3	9	10	163	33	0	756	4	1	\N	\N	CCOC(=O)OC(C)OC(=O)C1C(SC2N1C(=O)C2NC(=O)C(C3=CC=CC=C3)N)(C)C.Cl	1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrochloride
3679	GABLOFEN	BACLOFEN	2284	C10H12ClNO2	213.661	\N	-1	2	3	4	63.3	14	0	191	0	1	\N	\N	C1=CC(=CC=C1C(CC(=O)O)CN)Cl	4-amino-3-(4-chlorophenyl)butanoic acid
4649	KEMSTRO	BACLOFEN	2284	C10H12ClNO2	213.661	\N	-1	2	3	4	63.3	14	0	191	0	1	\N	\N	C1=CC(=CC=C1C(CC(=O)O)CN)Cl	4-amino-3-(4-chlorophenyl)butanoic acid
4976	LIORESAL	BACLOFEN	2284	C10H12ClNO2	213.661	\N	-1	2	3	4	63.3	14	0	191	0	1	\N	\N	C1=CC(=CC=C1C(CC(=O)O)CN)Cl	4-amino-3-(4-chlorophenyl)butanoic acid
979	BALSALAZIDE DISODIUM	BALSALAZIDE DISODIUM	6335412	C17H15N3O6	357.322	\N	1.2	4	8	7	145	26	0	687	0	0	\N	\N	C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O	(3Z)-3-[[4-(2-carboxyethylcarbamoyl)phenyl]hydrazono]-6-oxo-cyclohexa-1,4-diene-1-carboxylic acid
1929	COLAZAL	BALSALAZIDE DISODIUM	6335412	C17H15N3O6	357.322	\N	1.2	4	8	7	145	26	0	687	0	0	\N	\N	C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O	(3Z)-3-[[4-(2-carboxyethylcarbamoyl)phenyl]hydrazono]-6-oxo-cyclohexa-1,4-diene-1-carboxylic acid
7902	READI-CAT 2	BARIUM SULFATE	24414	BaO4S	233.383	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Ba+2]	barium(2+);sulfate
7903	READI-CAT 2 SMOOTHIES	BARIUM SULFATE	24414	BaO4S	233.383	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Ba+2]	barium(2+);sulfate
1002	BECLOVENT	BECLOMETHASONE DIPROPIONATE	21700	C28H37ClO7	521.047	\N	3	1	7	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
1003	BECONASE	BECLOMETHASONE DIPROPIONATE	21700	C28H37ClO7	521.047	\N	3	1	7	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
1010	BELEODAQ	BELINOSTAT	6918638	C15H14N2O4S	318.347	\N	1.7	3	5	5	104	22	0	492	0	0	\N	\N	C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO	(E)-3-[3-(phenylsulfamoyl)phenyl]prop-2-enehydroxamic acid
601	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	BENAZEPRIL HYDROCHLORIDE	5362123	C24H29ClN2O5	460.955	\N	\N	3	6	10	95.9	32	0	619	2	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O.Cl	2-[(3S)-3-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid;hydrochloride
608	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	BENAZEPRIL HYDROCHLORIDE	5362123	C24H29ClN2O5	460.955	\N	\N	3	6	10	95.9	32	0	619	2	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O.Cl	2-[(3S)-3-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid;hydrochloride
612	AMLODIPINE MALEATE; BENAZEPRIL HYDROCHLORIDE	BENAZEPRIL HYDROCHLORIDE	5362123	C24H29ClN2O5	460.955	\N	\N	3	6	10	95.9	32	0	619	2	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O.Cl	2-[(3S)-3-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid;hydrochloride
1017	BENAZEPRIL HYDROCHLORIDE	BENAZEPRIL HYDROCHLORIDE	5362123	C24H29ClN2O5	460.955	\N	\N	3	6	10	95.9	32	0	619	2	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O.Cl	2-[(3S)-3-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid;hydrochloride
1090	BETOPTIC PILO	BETAXOLOL HYDROCHLORIDE	107952	C18H30ClNO3	343.892	\N	\N	3	4	11	50.7	23	0	286	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl	1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol;hydrochloride
1023	BENDEKA	BENDAMUSTINE HYDROCHLORIDE	77082	C16H22Cl3N3O2	394.721	\N	\N	2	4	9	58.4	24	0	380	0	0	\N	\N	CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl	4-[5-[bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butanoic acid;hydrochloride
9142	TREANDA	BENDAMUSTINE HYDROCHLORIDE	77082	C16H22Cl3N3O2	394.721	\N	\N	2	4	9	58.4	24	0	380	0	0	\N	\N	CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl	4-[5-[bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butanoic acid;hydrochloride
2057	CORZIDE	BENDROFLUMETHIAZIDE	2315	C15H14F3N3O4S2	421.409	\N	1.2	3	10	3	135	27	0	740	0	1	\N	\N	C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2	3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5786	NADOLOL AND BENDROFLUMETHIAZIDE	BENDROFLUMETHIAZIDE	2315	C15H14F3N3O4S2	421.409	\N	1.2	3	10	3	135	27	0	740	0	1	\N	\N	C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2	3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5849	NATURETIN-10	BENDROFLUMETHIAZIDE	2315	C15H14F3N3O4S2	421.409	\N	1.2	3	10	3	135	27	0	740	0	1	\N	\N	C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2	3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1031	BENOXINATE HYDROCHLORIDE	BENOXINATE HYDROCHLORIDE	6420040	C17H29ClN2O3	344.88	\N	\N	2	5	11	64.8	23	0	308	0	0	\N	\N	CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N.Cl	2-(diethylamino)ethyl 4-amino-3-butoxy-benzoate;hydrochloride
1650	CHYMEX	BENTIROMIDE	6957673	C23H20N2O5	404.422	\N	3.3	4	5	7	116	30	0	588	1	0	\N	\N	C1=CC=C(C=C1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC3=CC=C(C=C3)C(=O)O	4-[[(2S)-2-benzamido-3-(4-hydroxyphenyl)propanoyl]amino]benzoic acid
4561	IVY BLOCK	BENTOQUATAM	517273	Al2H2O6Si	180.058	\N	\N	1	6	0	78.5	9	0	52.4	0	0	\N	\N	O.O=[Al]O[Al]=O.O=[Si]=O	dioxosilane;oxo(oxoalumanyloxy)alumane;hydrate
1043	BENZONATATE	BENZONATATE	7699	C30H53NO11	603.75	\N	2.4	1	12	33	121	42	0	565	0	0	\N	\N	CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC	2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-(butylamino)benzoate
8800	TESSALON	BENZONATATE	7699	C30H53NO11	603.75	\N	2.4	1	12	33	121	42	0	565	0	0	\N	\N	CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC	2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-(butylamino)benzoate
273	AKTIPAK	BENZOYL PEROXIDE	7187	C14H10O4	242.23	\N	3.5	0	4	5	52.6	18	0	258	0	0	\N	\N	C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2	benzoyl benzenecarboperoxoate
1040	BENZAMYCIN	BENZOYL PEROXIDE	7187	C14H10O4	242.23	\N	3.5	0	4	5	52.6	18	0	258	0	0	\N	\N	C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2	benzoyl benzenecarboperoxoate
1741	CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE	BENZOYL PEROXIDE	7187	C14H10O4	242.23	\N	3.5	0	4	5	52.6	18	0	258	0	0	\N	\N	C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2	benzoyl benzenecarboperoxoate
2941	DUAC	BENZOYL PEROXIDE	7187	C14H10O4	242.23	\N	3.5	0	4	5	52.6	18	0	258	0	0	\N	\N	C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2	benzoyl benzenecarboperoxoate
3200	EPIDUO FORTE	BENZOYL PEROXIDE	7187	C14H10O4	242.23	\N	3.5	0	4	5	52.6	18	0	258	0	0	\N	\N	C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2	benzoyl benzenecarboperoxoate
2778	DIDREX	BENZPHETAMINE HYDROCHLORIDE	11558159	C17H22ClN	275.82	\N	\N	1	1	5	3.2	19	0	214	1	0	\N	\N	CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2.Cl	(2S)-N-benzyl-N-methyl-1-phenyl-propan-2-amine;hydrochloride
3120	EMETE-CON	BENZQUINAMIDE HYDROCHLORIDE	101584	C22H33ClN2O5	440.965	\N	\N	1	6	7	68.3	30	0	582	0	3	\N	\N	CCN(CC)C(=O)C1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C)OC)OC.Cl	[3-(diethylcarbamoyl)-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl] acetate;hydrochloride
1045	BENZTHIAZIDE	BENZTHIAZIDE	2343	C15H14ClN3O4S3	431.924	\N	1.7	2	7	5	161	26	0	739	0	0	\N	\N	C1=CC=C(C=C1)CSCC2=NS(=O)(=O)C3=CC(=C(C=C3N2)Cl)S(=O)(=O)N	3-(benzylsulfanylmethyl)-6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3638	FOVANE	BENZTHIAZIDE	2343	C15H14ClN3O4S3	431.924	\N	1.7	2	7	5	161	26	0	739	0	0	\N	\N	C1=CC=C(C=C1)CSCC2=NS(=O)(=O)C3=CC(=C(C=C3N2)Cl)S(=O)(=O)N	3-(benzylsulfanylmethyl)-6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9416	URESE	BENZTHIAZIDE	2343	C15H14ClN3O4S3	431.924	\N	1.7	2	7	5	161	26	0	739	0	0	\N	\N	C1=CC=C(C=C1)CSCC2=NS(=O)(=O)C3=CC(=C(C=C3N2)Cl)S(=O)(=O)N	3-(benzylsulfanylmethyl)-6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1046	BENZTROPINE MESYLATE	BENZTROPINE MESYLATE	238053	C22H29NO4S	403.537	\N	\N	1	5	4	75.2	28	0	433	0	2	\N	\N	CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O	3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane;methanesulfonic acid
1925	COGENTIN	BENZTROPINE MESYLATE	238053	C22H29NO4S	403.537	\N	\N	1	5	4	75.2	28	0	433	0	2	\N	\N	CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O	3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane;methanesulfonic acid
7385	PRE-PEN	BENZYLPENICILLOYL POLYLYSINE	119212	C22H31N3O6S	465.565	\N	-0.8	5	8	12	170	32	0	681	0	3	\N	\N	CC1(C(NC(S1)C(C(=O)NCCCCCC(=O)O)NC(=O)CC2=CC=CC=C2)C(=O)O)C	2-[2-(5-carboxypentylamino)-2-oxo-1-[(2-phenylacetyl)amino]ethyl]-5,5-dimethyl-thiazolidine-4-carboxylic acid
1092	BETOPTIC S	BETAXOLOL HYDROCHLORIDE	107952	C18H30ClNO3	343.892	\N	\N	3	4	11	50.7	23	0	286	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl	1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol;hydrochloride
1048	BEPADIN	BEPRIDIL HYDROCHLORIDE	50088	C24H35ClN2O	403.007	\N	\N	1	3	10	15.7	28	0	382	0	1	\N	\N	CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3.Cl	N-benzyl-N-(3-isobutoxy-2-pyrrolidin-1-yl-propyl)aniline;hydrochloride
1063	BESIVANCE	BESIFLOXACIN HYDROCHLORIDE	10224595	C19H22Cl2FN3O3	430.301	\N	\N	3	7	3	86.9	28	0	656	1	0	\N	\N	C1CCN(CC(C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F.Cl	7-[(3R)-3-aminoazepan-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-quinoline-3-carboxylic acid;hydrochloride
8352	SOLATENE	BETA CAROTENE	5280489	C40H56	536.888	\N	13.5	0	0	10	0	40	0	1120	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C)C)C	1,3,3-trimethyl-2-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohexene
2132	CYSTADANE	BETAINE HYDROCHLORIDE	11545	C5H12ClNO2	153.606	\N	\N	1	3	2	37.3	9	0	93.1	0	0	\N	\N	C[N+](C)(C)CC(=O)O.[Cl-]	carboxymethyl(trimethyl)ammonium;chloride
1505	CELESTONE SOLUSPAN	BETAMETHASONE ACETATE	443967	C24H31FO6	434.504	\N	2.8	2	7	4	101	31	0	910	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)O)C)O)F)C	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
9439	UTICORT	BETAMETHASONE BENZOATE	5282492	C29H33FO6	496.575	\N	3.9	2	7	5	101	36	0	1030	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)OC(=O)C5=CC=CC=C5)C)O)F)C	[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] benzoate
1325	CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE	BETAMETHASONE DIPROPIONATE	21800	C28H37FO7	504.595	\N	3.6	1	8	8	107	36	0	1050	8	0	\N	\N	CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
1073	BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE	BETAMETHASONE SODIUM PHOSPHATE	65478	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
1075	BETAMETHASONE SODIUM PHOSPHATE	BETAMETHASONE SODIUM PHOSPHATE	65478	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
1504	CELESTONE	BETAMETHASONE SODIUM PHOSPHATE	65478	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
1506	CELESTONE SOLUSPAN	BETAMETHASONE SODIUM PHOSPHATE	65478	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
1089	BETOPTIC	BETAXOLOL HYDROCHLORIDE	107952	C18H30ClNO3	343.892	\N	\N	3	4	11	50.7	23	0	286	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl	1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol;hydrochloride
3958	HISTALOG	BETAZOLE HYDROCHLORIDE	16051987	C5H10ClN3	147.606	\N	\N	3	2	2	54.7	9	0	64.7	0	0	\N	\N	C1=C(NN=C1)CCN.Cl	2-(1H-pyrazol-5-yl)ethanamine;hydrochloride
2993	DUVOID	BETHANECHOL CHLORIDE	11548	C7H17ClN2O2	196.675	\N	\N	1	3	4	52.3	12	0	140	0	1	\N	\N	CC(C[N+](C)(C)C)OC(=O)N.[Cl-]	2-carbamoyloxypropyl(trimethyl)ammonium;chloride
9415	URECHOLINE	BETHANECHOL CHLORIDE	11548	C7H17ClN2O2	196.675	\N	\N	1	3	4	52.3	12	0	140	0	1	\N	\N	CC(C[N+](C)(C)C)OC(=O)N.[Cl-]	2-carbamoyloxypropyl(trimethyl)ammonium;chloride
8685	TARGRETIN	BEXAROTENE	82146	C24H28O2	348.486	\N	7.6	1	2	3	37.3	26	0	551	0	0	\N	\N	CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C	4-[1-(1,1,4,4,7-pentamethyltetralin-6-yl)vinyl]benzoic acid
1104	BICALUTAMIDE	BICALUTAMIDE	2375	C18H14F4N2O4S	430.374	\N	2.3	2	9	5	116	29	0	750	0	1	\N	\N	CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O	N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methyl-propanamide
1440	CASODEX	BICALUTAMIDE	2375	C18H14F4N2O4S	430.374	\N	2.3	2	9	5	116	29	0	750	0	1	\N	\N	CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O	N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methyl-propanamide
4834	LATISSE	BIMATOPROST	5311027	C25H37NO4	415.574	\N	2.8	4	4	12	89.8	30	0	541	5	0	\N	\N	CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O	(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenyl-pent-1-enyl]cyclopentyl]-N-ethyl-hept-5-enamide
1051	BEROCCA PN	BIOTIN	171548	C10H16N2O3S	244.309	\N	0.3	3	4	5	104	16	0	298	3	0	\N	\N	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
4256	INFUVITE ADULT	BIOTIN	171548	C10H16N2O3S	244.309	\N	0.3	3	4	5	104	16	0	298	3	0	\N	\N	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
4281	INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)	BIOTIN	171548	C10H16N2O3S	244.309	\N	0.3	3	4	5	104	16	0	298	3	0	\N	\N	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
265	AKINETON	BIPERIDEN HYDROCHLORIDE	92151	C21H30ClNO	347.927	\N	\N	2	2	5	23.5	24	0	422	0	4	\N	\N	C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O.Cl	1-(5-bicyclo[2.2.1]hept-2-enyl)-1-phenyl-3-(1-piperidyl)propan-1-ol;hydrochloride
3862	HALFLYTELY	BISACODYL	2391	C22H19NO4	361.397	\N	3.8	0	5	7	65.5	27	0	457	0	0	\N	\N	CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3	[4-[(4-acetoxyphenyl)-(2-pyridyl)methyl]phenyl] acetate
7028	POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL	BISACODYL	2391	C22H19NO4	361.397	\N	3.8	0	5	7	65.5	27	0	457	0	0	\N	\N	CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3	[4-[(4-acetoxyphenyl)-(2-pyridyl)methyl]phenyl] acetate
8978	TORNALATE	BITOLTEROL MESYLATE	35329	C29H35NO8S	557.658	\N	\N	3	9	10	148	39	0	751	0	1	\N	\N	CC1=CC=C(C=C1)C(=O)OC2=C(C=C(C=C2)C(CNC(C)(C)C)O)OC(=O)C3=CC=C(C=C3)C.CS(=O)(=O)O	[4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(4-methylbenzoyl)oxy-phenyl] 4-methylbenzoate;methanesulfonic acid
680	ANGIOMAX	BIVALIRUDIN	16129704	C98H138N24O33	2180.317	\N	-7.1	28	35	67	902	155	0	4950	16	0	\N	\N	CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C5CCCN5C(=O)C(CC6=CC=CC=C6)N	\N
1130	BIVALIRUDIN	BIVALIRUDIN	16129704	C98H138N24O33	2180.317	\N	-7.1	28	35	67	902	155	0	4950	16	0	\N	\N	CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C5CCCN5C(=O)C(CC6=CC=CC=C6)N	\N
1131	BLENOXANE	BLEOMYCIN SULFATE	72466	C55H85N17O25S4	1512.619	\N	\N	21	35	36	770	101	0	2660	10	9	\N	\N	CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.OS(=O)(=O)[O-]	3-[[2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxo-propyl)amino]-3-oxo-propyl]-5-methyl-pyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2R,3S,4S,5R,6R)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methyl-pentanoyl]amino]-3-hydroxy-butanoyl]amino]ethyl]thiazol-4-yl]thiazole-4-carbonyl]amino]propyl-dimethyl-sulfonium;hydrogen sulfate
9597	VICTRELIS	BOCEPREVIR	10324367	C27H45N5O5	519.687	\N	3.1	4	5	10	151	37	0	959	4	1	\N	\N	CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C	(1R,2S,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxo-propyl]-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethyl-butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
8994	TRACLEER	BOSENTAN	104865	C27H29N5O6S	551.618	\N	3.8	2	11	11	154	39	0	839	0	0	\N	\N	CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC	4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide
1166	BRETYLIUM TOSYLATE IN DEXTROSE 5%	BRETYLIUM TOSYLATE	6100	C18H24BrNO3S	414.358	\N	\N	0	3	3	65.6	24	0	349	0	0	\N	\N	CC[N+](C)(C)CC1=CC=CC=C1Br.CC1=CC=C(C=C1)S(=O)(=O)[O-]	(2-bromophenyl)methyl-ethyl-dimethyl-ammonium;4-methylbenzenesulfonate
1167	BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER	BRETYLIUM TOSYLATE	6100	C18H24BrNO3S	414.358	\N	\N	0	3	3	65.6	24	0	349	0	0	\N	\N	CC[N+](C)(C)CC1=CC=CC=C1Br.CC1=CC=C(C=C1)S(=O)(=O)[O-]	(2-bromophenyl)methyl-ethyl-dimethyl-ammonium;4-methylbenzenesulfonate
8003	REXULTI	BREXPIPRAZOLE	11978813	C25H27N3O2S	433.57	\N	4.7	1	5	7	73	31	0	636	0	0	\N	\N	C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4	7-[4-[4-(benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one
1200	BROMFENAC SODIUM	BROMFENAC SODIUM	23693301	C15H11BrNNaO3	356.151	\N	\N	1	4	4	83.2	21	0	372	0	0	\N	\N	C1=CC(=C(C(=C1)CC(=O)[O-])N)C(=O)C2=CC=C(C=C2)Br.[Na+]	sodium;2-[2-amino-3-(4-bromobenzoyl)phenyl]acetate
1210	BROMSITE	BROMFENAC SODIUM	23693301	C15H11BrNNaO3	356.151	\N	\N	1	4	4	83.2	21	0	372	0	0	\N	\N	C1=CC(=C(C(=C1)CC(=O)[O-])N)C(=O)C2=CC=C(C=C2)Br.[Na+]	sodium;2-[2-amino-3-(4-bromobenzoyl)phenyl]acetate
7653	PROLENSA	BROMFENAC SODIUM	23693301	C15H11BrNNaO3	356.151	\N	\N	1	4	4	83.2	21	0	372	0	0	\N	\N	C1=CC(=C(C(=C1)CC(=O)[O-])N)C(=O)C2=CC=C(C=C2)Br.[Na+]	sodium;2-[2-amino-3-(4-bromobenzoyl)phenyl]acetate
9760	XIBROM	BROMFENAC SODIUM	23693301	C15H11BrNNaO3	356.151	\N	\N	1	4	4	83.2	21	0	372	0	0	\N	\N	C1=CC(=C(C(=C1)CC(=O)[O-])N)C(=O)C2=CC=C(C=C2)Br.[Na+]	sodium;2-[2-amino-3-(4-bromobenzoyl)phenyl]acetate
2122	CYCLOSET	BROMOCRIPTINE MESYLATE	31100	C33H44BrN5O8S	750.706	\N	\N	4	9	5	181	48	0	1320	6	0	\N	\N	CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O.CS(=O)(=O)O	\N
6658	PARLODEL	BROMOCRIPTINE MESYLATE	31100	C33H44BrN5O8S	750.706	\N	\N	4	9	5	181	48	0	1320	6	0	\N	\N	CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O.CS(=O)(=O)O	\N
407	AMBODRYL	BROMODIPHENHYDRAMINE HYDROCHLORIDE	15736	C17H21BrClNO	370.715	\N	\N	1	2	6	13.7	21	0	258	0	1	\N	\N	C[NH+](C)CCOC(C1=CC=CC=C1)C2=CC=C(C=C2)Br.[Cl-]	2-[(4-bromophenyl)-phenyl-methoxy]ethyl-dimethyl-ammonium;chloride
1194	BROMANYL	BROMODIPHENHYDRAMINE HYDROCHLORIDE	15736	C17H21BrClNO	370.715	\N	\N	1	2	6	13.7	21	0	258	0	1	\N	\N	C[NH+](C)CCOC(C1=CC=CC=C1)C2=CC=C(C=C2)Br.[Cl-]	2-[(4-bromophenyl)-phenyl-methoxy]ethyl-dimethyl-ammonium;chloride
1202	BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE	BROMODIPHENHYDRAMINE HYDROCHLORIDE	15736	C17H21BrClNO	370.715	\N	\N	1	2	6	13.7	21	0	258	0	1	\N	\N	C[NH+](C)CCOC(C1=CC=CC=C1)C2=CC=C(C=C2)Br.[Cl-]	2-[(4-bromophenyl)-phenyl-methoxy]ethyl-dimethyl-ammonium;chloride
1197	BROMFED-DM	BROMPHENIRAMINE MALEATE	5281067	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
1204	BROMPHENIRAMINE MALEATE	BROMPHENIRAMINE MALEATE	5281067	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
1205	BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE	BROMPHENIRAMINE MALEATE	5281067	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
7792	PULMICORT RESPULES	BUDESONIDE	5281004	C25H34O6	430.541	\N	2.5	2	6	4	93.1	31	0	862	8	1	\N	\N	CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C	\N
8010	RHINOCORT ALLERGY	BUDESONIDE	5281004	C25H34O6	430.541	\N	2.5	2	6	4	93.1	31	0	862	8	1	\N	\N	CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C	\N
1237	BUMETANIDE	BUMETANIDE	2471	C17H20N2O5S	364.416	\N	2.8	3	7	8	127	25	0	528	0	0	\N	\N	CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2	3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoic acid
1238	BUMEX	BUMETANIDE	2471	C17H20N2O5S	364.416	\N	2.8	3	7	8	127	25	0	528	0	0	\N	\N	CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2	3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoic acid
1242	BUPIVACAINE HYDROCHLORIDE	BUPIVACAINE HYDROCHLORIDE	64737	C18H29ClN2O	324.893	\N	\N	2	2	5	32.3	22	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride
2292	DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
3392	EXPAREL	BUPIVACAINE	2474	C18H28N2O	288.435	\N	3.4	1	2	5	32.3	21	0	321	0	1	\N	\N	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C	1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
1008	BELBUCA	BUPRENORPHINE HYDROCHLORIDE	3033050	C29H42ClNO4	504.108	\N	\N	3	5	5	62.2	35	0	869	7	0	\N	\N	CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O.Cl	\N
1253	BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE	BUPRENORPHINE HYDROCHLORIDE	3033050	C29H42ClNO4	504.108	\N	\N	3	5	5	62.2	35	0	869	7	0	\N	\N	CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O.Cl	\N
7612	PROBUPHINE	BUPRENORPHINE HYDROCHLORIDE	3033050	C29H42ClNO4	504.108	\N	\N	3	5	5	62.2	35	0	869	7	0	\N	\N	CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O.Cl	\N
8495	SUBOXONE	BUPRENORPHINE HYDROCHLORIDE	3033050	C29H42ClNO4	504.108	\N	\N	3	5	5	62.2	35	0	869	7	0	\N	\N	CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O.Cl	\N
8498	SUBUTEX	BUPRENORPHINE HYDROCHLORIDE	3033050	C29H42ClNO4	504.108	\N	\N	3	5	5	62.2	35	0	869	7	0	\N	\N	CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O.Cl	\N
722	APLENZIN	BUPROPION HYDROBROMIDE	11984562	C13H19BrClNO	320.655	\N	\N	2	2	4	29.1	17	0	247	0	1	\N	\N	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Br	2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrobromide
1256	BUPROPION HYDROCHLORIDE	BUPROPION HYDROCHLORIDE	62884	C13H19Cl2NO	276.201	\N	\N	2	2	4	29.1	17	0	247	0	1	\N	\N	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl	2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrochloride
2009	CONTRAVE	BUPROPION HYDROCHLORIDE	62884	C13H19Cl2NO	276.201	\N	\N	2	2	4	29.1	17	0	247	0	1	\N	\N	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl	2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrochloride
3617	FORFIVO XL	BUPROPION HYDROCHLORIDE	62884	C13H19Cl2NO	276.201	\N	\N	2	2	4	29.1	17	0	247	0	1	\N	\N	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl	2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrochloride
9715	WELLBUTRIN SR	BUPROPION HYDROCHLORIDE	62884	C13H19Cl2NO	276.201	\N	\N	2	2	4	29.1	17	0	247	0	1	\N	\N	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl	2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrochloride
9716	WELLBUTRIN XL	BUPROPION HYDROCHLORIDE	62884	C13H19Cl2NO	276.201	\N	\N	2	2	4	29.1	17	0	247	0	1	\N	\N	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl	2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrochloride
1258	BUSPIRONE HYDROCHLORIDE	BUSPIRONE HYDROCHLORIDE	36431	C21H32ClN5O2	421.97	\N	\N	1	6	6	69.6	29	0	529	0	0	\N	\N	C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4.Cl	8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;hydrochloride
1259	BUSULFAN	BUSULFAN	2478	C6H14O6S2	246.292	\N	-0.5	0	6	7	104	14	0	294	0	0	\N	\N	CS(=O)(=O)OCCCCOS(=O)(=O)C	4-methylsulfonyloxybutyl methanesulfonate
1260	BUSULFEX	BUSULFAN	2478	C6H14O6S2	246.292	\N	-0.5	0	6	7	104	14	0	294	0	0	\N	\N	CS(=O)(=O)OCCCCOS(=O)(=O)C	4-methylsulfonyloxybutyl methanesulfonate
5761	MYLERAN	BUSULFAN	2478	C6H14O6S2	246.292	\N	-0.5	0	6	7	104	14	0	294	0	0	\N	\N	CS(=O)(=O)OCCCCOS(=O)(=O)C	4-methylsulfonyloxybutyl methanesulfonate
1262	BUTABARBITAL	BUTABARBITAL SODIUM	23690439	C10H15N2NaO3	234.231	\N	\N	1	3	3	81.6	16	0	330	0	2	\N	\N	CCC(C)C1(C(=O)NC(=NC1=O)[O-])CC.[Na+]	sodium;5-ethyl-4,6-dioxo-5-sec-butyl-1H-pyrimidin-2-olate
1263	BUTABARBITAL SODIUM	BUTABARBITAL SODIUM	23690439	C10H15N2NaO3	234.231	\N	\N	1	3	3	81.6	16	0	330	0	2	\N	\N	CCC(C)C1(C(=O)NC(=NC1=O)[O-])CC.[Na+]	sodium;5-ethyl-4,6-dioxo-5-sec-butyl-1H-pyrimidin-2-olate
1264	BUTALAN	BUTABARBITAL SODIUM	23690439	C10H15N2NaO3	234.231	\N	\N	1	3	3	81.6	16	0	330	0	2	\N	\N	CCC(C)C1(C(=O)NC(=NC1=O)[O-])CC.[Na+]	sodium;5-ethyl-4,6-dioxo-5-sec-butyl-1H-pyrimidin-2-olate
357	ALLZITAL	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
907	AXOTAL	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
987	BANCAP	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
1268	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE	BUTALBITAL	2481	C11H16N2O3	224.26	\N	1.7	2	3	4	75.3	16	0	327	0	0	\N	\N	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C	5-allyl-5-isobutyl-hexahydropyrimidine-2,4,6-trione
5103	LOTRIMIN ULTRA	BUTENAFINE HYDROCHLORIDE	443867	C23H28ClN	353.934	\N	\N	1	1	5	3.2	25	0	374	0	0	\N	\N	CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32.Cl	1-(4-tert-butylphenyl)-N-methyl-N-(1-naphthylmethyl)methanamine;hydrochloride
5399	MENTAX-TC	BUTENAFINE HYDROCHLORIDE	443867	C23H28ClN	353.934	\N	\N	1	1	5	3.2	25	0	374	0	0	\N	\N	CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32.Cl	1-(4-tert-butylphenyl)-N-methyl-N-(1-naphthylmethyl)methanamine;hydrochloride
4585	JEVTANA KIT	CABAZITAXEL	9854073	C45H57NO14	835.944	\N	2.7	3	14	15	202	60	0	1690	11	0	\N	\N	CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC	\N
2894	DOSTINEX	CABERGOLINE	54746	C26H37N5O2	451.615	\N	3.4	2	4	8	71.7	33	0	713	3	0	\N	\N	CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C	(6aR,9R,10aR)-7-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
1311	CABOMETYX	CABOZANTINIB S-MALATE	25102846	C32H30FN3O10	635.601	\N	\N	5	12	11	194	46	0	924	1	0	\N	\N	COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F.C(C(C(=O)O)O)C(=O)O	N1-[4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N1'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;(2S)-2-hydroxybutanedioic acid
58	ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE	CAFFEINE	2519	C8H10N4O2	194.194	\N	-0.1	0	3	0	58.4	14	0	293	0	0	\N	\N	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione
1333	CALDEROL	CALCIFEDIOL	5283731	C27H44O2	400.647	\N	6.2	2	2	6	40.5	29	0	655	5	0	\N	\N	CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-5-hydroxy-1,5-dimethyl-hexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
1324	CALCIPOTRIENE	CALCIPOTRIENE	5288783	C27H40O3	412.614	\N	4.3	3	3	5	60.7	30	0	743	7	0	\N	\N	CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,1R,4S)-4-cyclopropyl-4-hydroxy-1-methyl-but-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
2896	DOVONEX	CALCIPOTRIENE	5288783	C27H40O3	412.614	\N	4.3	3	3	5	60.7	30	0	743	7	0	\N	\N	CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,1R,4S)-4-cyclopropyl-4-hydroxy-1-methyl-but-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
3179	ENSTILAR	CALCIPOTRIENE	5288783	C27H40O3	412.614	\N	4.3	3	3	5	60.7	30	0	743	7	0	\N	\N	CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,1R,4S)-4-cyclopropyl-4-hydroxy-1-methyl-but-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
8384	SORILUX	CALCIPOTRIENE	5288783	C27H40O3	412.614	\N	4.3	3	3	5	60.7	30	0	743	7	0	\N	\N	CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,1R,4S)-4-cyclopropyl-4-hydroxy-1-methyl-but-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
1328	CALCITRIOL	CALCITRIOL	5280453	C27H44O3	416.646	\N	5.1	3	3	6	60.7	30	0	688	6	0	\N	\N	CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-5-hydroxy-1,5-dimethyl-hexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
6873	PHOSLO GELCAPS	CALCIUM ACETATE	6116	C4H6CaO4	158.166	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Ca+2]	calcium;diacetate
6874	PHOSLYRA	CALCIUM ACETATE	6116	C4H6CaO4	158.166	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Ca+2]	calcium;diacetate
3417	FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE	CALCIUM CARBONATE	10112	CCaO3	100.086	\N	\N	0	3	0	63.2	5	0	18.8	0	0	\N	\N	C(=O)([O-])[O-].[Ca+2]	calcium;carbonate
538	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
551	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
561	AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1330	CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1410	CARDIOPLEGIC IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1775	CLINIMIX E 2.75/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
1332	CALCIUM GLUCEPTATE	CALCIUM GLUCEPTATE	62859	C14H26CaO16	490.424	\N	\N	12	16	10	323	31	0	202	8	2	\N	\N	C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.[Ca+2]	calcium;(3R,4S,5R,6R)-2,3,4,5,6,7-hexahydroxyheptanoate
4532	ISOPAQUE 440	CALCIUM METRIZOATE	10418946	C24H20CaI6N4O8	1293.949	\N	\N	2	8	4	179	43	0	443	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)N(C)C(=O)C)I.CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)N(C)C(=O)C)I.[Ca+2]	calcium;3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodo-benzoate
4368	INVOKAMET	CANAGLIFLOZIN	24812758	C24H25FO5S	444.517	\N	3.2	4	7	5	118	31	0	574	5	0	\N	\N	CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F	(2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methyl-phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
4370	INVOKAMET XR	CANAGLIFLOZIN	24812758	C24H25FO5S	444.517	\N	3.2	4	7	5	118	31	0	574	5	0	\N	\N	CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F	(2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methyl-phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
4372	INVOKANA	CANAGLIFLOZIN	24812758	C24H25FO5S	444.517	\N	3.2	4	7	5	118	31	0	574	5	0	\N	\N	CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F	(2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methyl-phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
1400	CARBOPLATIN	CARBOPLATIN	38904	C6H14N2O4Pt	373.272	\N	\N	4	6	0	76.6	13	0	169	0	0	\N	\N	C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]	ammonia;cyclobutane-1,1-dicarboxylic acid;platinum
9748	XELODA	CAPECITABINE	60953	C15H22FN3O6	359.354	\N	0.6	3	7	7	121	25	0	582	4	0	\N	\N	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O	pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl]-5-fluoro-2-oxo-pyrimidin-4-yl]carbamate
7855	QUTENZA	CAPSAICIN	1548943	C18H27NO3	305.418	\N	3.6	2	3	9	58.6	22	0	341	0	0	\N	\N	CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC	(E)-N-[(4-hydroxy-3-methoxy-phenyl)methyl]-8-methyl-non-6-enamide
1367	CAPOTEN	CAPTOPRIL	44093	C9H15NO3S	217.283	\N	0.3	2	4	3	58.6	14	0	244	2	0	\N	\N	CC(CS)C(=O)N1CCCC1C(=O)O	(2S)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]pyrrolidine-2-carboxylic acid
1368	CAPOZIDE 25/15	CAPTOPRIL	44093	C9H15NO3S	217.283	\N	0.3	2	4	3	58.6	14	0	244	2	0	\N	\N	CC(CS)C(=O)N1CCCC1C(=O)O	(2S)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]pyrrolidine-2-carboxylic acid
5604	MIOSTAT	CARBACHOL	5831	C6H15ClN2O2	182.648	\N	\N	1	3	4	52.3	11	0	117	0	0	\N	\N	C[N+](C)(C)CCOC(=O)N.[Cl-]	2-carbamoyloxyethyl(trimethyl)ammonium;chloride
1386	CARBATROL	CARBAMAZEPINE	2554	C15H12N2O	236.274	\N	2.5	1	1	0	46.3	18	0	326	0	0	\N	\N	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	benzo[b][1]benzazepine-11-carboxamide
3224	EQUETRO	CARBAMAZEPINE	2554	C15H12N2O	236.274	\N	2.5	1	1	0	46.3	18	0	326	0	0	\N	\N	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	benzo[b][1]benzazepine-11-carboxamide
8737	TEGRETOL	CARBAMAZEPINE	2554	C15H12N2O	236.274	\N	2.5	1	1	0	46.3	18	0	326	0	0	\N	\N	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	benzo[b][1]benzazepine-11-carboxamide
8738	TEGRETOL-XR	CARBAMAZEPINE	2554	C15H12N2O	236.274	\N	2.5	1	1	0	46.3	18	0	326	0	0	\N	\N	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	benzo[b][1]benzazepine-11-carboxamide
8784	TERIL	CARBAMAZEPINE	2554	C15H12N2O	236.274	\N	2.5	1	1	0	46.3	18	0	326	0	0	\N	\N	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	benzo[b][1]benzazepine-11-carboxamide
3742	GEOPEN	CARBENICILLIN DISODIUM	20933	C17H16N2Na2O6S	422.363	\N	\N	1	7	3	155	28	0	634	3	1	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)[O-])C(=O)[O-])C.[Na+].[Na+]	disodium;(2S,5R,6R)-6-[(2-carboxylato-2-phenyl-acetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
7805	PYOPEN	CARBENICILLIN DISODIUM	20933	C17H16N2Na2O6S	422.363	\N	\N	1	7	3	155	28	0	634	3	1	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)[O-])C(=O)[O-])C.[Na+].[Na+]	disodium;(2S,5R,6R)-6-[(2-carboxylato-2-phenyl-acetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
3739	GEOCILLIN	CARBENICILLIN INDANYL SODIUM	23676503	C26H25N2NaO6S	516.544	\N	\N	1	7	7	141	36	0	894	3	1	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)OC4=CC5=C(CCC5)C=C4)C(=O)[O-])C.[Na+]	sodium;(2S,5R,6R)-6-[(3-indan-5-yloxy-3-oxo-2-phenyl-propanoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
1387	CARBIDOPA	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
1388	CARBIDOPA AND LEVODOPA	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
1390	CARBIDOPA, LEVODOPA AND ENTACAPONE	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
1393	CARBILEV	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
5034	LODOSYN	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
8266	SINEMET	CARBIDOPA	34359	C10H14N2O4	226.232	\N	-2.2	5	6	4	116	16	0	261	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
4632	KARBINAL ER	CARBINOXAMINE MALEATE	5282409	C20H23ClN2O5	406.863	\N	\N	2	7	8	100	28	0	386	0	1	\N	\N	CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	2-[(4-chlorophenyl)-(2-pyridyl)methoxy]-N,N-dimethyl-ethanamine;maleic acid
9701	VRAYLAR	CARIPRAZINE HYDROCHLORIDE	25096873	C21H33Cl3N4O	463.872	\N	\N	2	3	5	38.8	29	0	491	0	0	\N	\N	CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl.Cl	3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethyl-urea;hydrochloride
1423	CARISOPRODOL	CARISOPRODOL	2576	C12H24N2O4	260.334	\N	1.9	2	4	9	90.6	18	0	281	0	1	\N	\N	CCCC(C)(COC(=O)N)COC(=O)NC(C)C	[2-(carbamoyloxymethyl)-2-methyl-pentyl] N-isopropylcarbamate
1425	CARISOPRODOL AND ASPIRIN	CARISOPRODOL	2576	C12H24N2O4	260.334	\N	1.9	2	4	9	90.6	18	0	281	0	1	\N	\N	CCCC(C)(COC(=O)N)COC(=O)NC(C)C	[2-(carbamoyloxymethyl)-2-methyl-pentyl] N-isopropylcarbamate
7651	PROKETAZINE	CARPHENAZINE MALEATE	6433356	C32H39N3O10S	657.735	\N	\N	5	14	12	222	46	0	674	0	0	\N	\N	CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)CCO.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O	1-[10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazin-2-yl]propan-1-one;maleic acid
8031	RIMADYL	CARPROFEN	2581	C15H12ClNO2	273.716	\N	4	2	2	2	53.1	19	0	362	0	1	\N	\N	CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O	2-(6-chloro-9H-carbazol-2-yl)propanoic acid
2022	COREG CR	CARVEDILOL PHOSPHATE	23649704	C24H31N2O9P	522.491	\N	\N	7	10	10	155	36	0	557	0	1	\N	\N	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O.O.OP(=O)(O)O	1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol;phosphoric acid;hydrate
1349	CANCIDAS	CASPOFUNGIN ACETATE	6850808	C56H96N10O19	1213.435	\N	\N	18	22	23	487	85	0	1930	14	2	\N	\N	CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O.CC(=O)O.CC(=O)O	\N
1441	CASPOFUNGIN ACETATE	CASPOFUNGIN ACETATE	6850808	C56H96N10O19	1213.435	\N	\N	18	22	23	487	85	0	1930	14	2	\N	\N	CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O.CC(=O)O.CC(=O)O	\N
1453	CECLOR	CEFACLOR	51039	C15H14ClN3O4S	367.804	\N	-1.8	3	6	4	138	24	0	606	3	0	\N	\N	C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl	(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
1454	CECLOR CD	CEFACLOR	51039	C15H14ClN3O4S	367.804	\N	-1.8	3	6	4	138	24	0	606	3	0	\N	\N	C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl	(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
657	ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER	CEFAZOLIN SODIUM	23675322	C14H13N8NaO4S3	476.48	\N	\N	1	12	7	238	30	0	746	2	0	\N	\N	CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
658	ANCEF IN PLASTIC CONTAINER	CEFAZOLIN SODIUM	23675322	C14H13N8NaO4S3	476.48	\N	\N	1	12	7	238	30	0	746	2	0	\N	\N	CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
659	ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	CEFAZOLIN SODIUM	23675322	C14H13N8NaO4S3	476.48	\N	\N	1	12	7	238	30	0	746	2	0	\N	\N	CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1461	CEFAZOLIN IN PLASTIC CONTAINER	CEFAZOLIN SODIUM	23675322	C14H13N8NaO4S3	476.48	\N	\N	1	12	7	238	30	0	746	2	0	\N	\N	CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1462	CEFAZOLIN SODIUM	CEFAZOLIN SODIUM	23675322	C14H13N8NaO4S3	476.48	\N	\N	1	12	7	238	30	0	746	2	0	\N	\N	CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1463	CEFDINIR	CEFDINIR	6915944	C14H13N5O5S2	395.408	\N	0	4	10	5	212	26	0	739	2	0	\N	\N	C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-hydroxyimino-acetyl]amino]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
6346	OMNICEF	CEFDINIR	6915944	C14H13N5O5S2	395.408	\N	0	4	10	5	212	26	0	739	2	0	\N	\N	C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-hydroxyimino-acetyl]amino]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
3863	HALFLYTELY	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
1465	CEFEPIME HYDROCHLORIDE	CEFEPIME HYDROCHLORIDE	9571075	C19H28Cl2N6O6S2	571.489	\N	\N	5	12	7	202	35	0	874	2	0	\N	\N	C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;chloride;hydrate;hydrochloride
8587	SUPRAX	CEFIXIME	5362065	C16H15N5O7S2	453.444	\N	-0.7	4	12	8	238	30	0	861	2	0	\N	\N	C=CC1=C(N2C(C(C2=O)NC(=O)C(=NOCC(=O)O)C3=CSC(=N3)N)SC1)C(=O)O	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
1471	CEFMAX	CEFMENOXIME HYDROCHLORIDE	11954009	C32H35ClN18O10S6	1059.558	\N	\N	7	28	16	539	67	0	890	4	0	\N	\N	CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.Cl	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrochloride
9826	ZEFAZONE	CEFMETAZOLE SODIUM	23666711	C15H16N7NaO5S3	493.507	\N	\N	1	12	9	242	31	0	824	2	0	\N	\N	CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)[O-].[Na+]	sodium;(6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
9827	ZEFAZONE IN PLASTIC CONTAINER	CEFMETAZOLE SODIUM	23666711	C15H16N7NaO5S3	493.507	\N	\N	1	12	9	242	31	0	824	2	0	\N	\N	CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)[O-].[Na+]	sodium;(6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
5661	MONOCID	CEFONICID SODIUM	43593	C18H16N6Na2O8S3	586.52	\N	\N	2	13	7	270	37	0	980	3	0	\N	\N	C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)O)C(=O)[O-])CSC4=NN=NN4CS(=O)(=O)[O-].[Na+].[Na+]	disodium;(6R,7R)-7-[[(2R)-2-hydroxy-2-phenyl-acetyl]amino]-8-oxo-3-[[1-(sulfonatomethyl)tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1473	CEFOBID IN PLASTIC CONTAINER	CEFOPERAZONE SODIUM	23663974	C25H26N9NaO8S2	667.648	\N	\N	3	13	9	274	45	0	1250	3	0	\N	\N	CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
7388	PRECEF	CEFORANIDE	43507	C20H21N7O6S2	519.551	\N	-3.2	4	12	10	244	35	0	905	2	0	\N	\N	C1C(=C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3CN)C(=O)O)CSC4=NN=NN4CC(=O)O	(6R,7R)-7-[[2-[2-(aminomethyl)phenyl]acetyl]amino]-3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
1476	CEFOTAXIME	CEFOTAXIME SODIUM	10695961	C16H16N5NaO7S2	477.442	\N	\N	2	12	8	230	31	0	839	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1477	CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER	CEFOTAXIME SODIUM	10695961	C16H16N5NaO7S2	477.442	\N	\N	2	12	8	230	31	0	839	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1478	CEFOTAXIME AND DEXTROSE 3.9% IN PLASTIC CONTAINER	CEFOTAXIME SODIUM	10695961	C16H16N5NaO7S2	477.442	\N	\N	2	12	8	230	31	0	839	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1479	CEFOTAXIME SODIUM	CEFOTAXIME SODIUM	10695961	C16H16N5NaO7S2	477.442	\N	\N	2	12	8	230	31	0	839	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1539	CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	CETIRIZINE HYDROCHLORIDE	55182	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	0	1	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
1523	CERADON	CEFOTIAM HYDROCHLORIDE	47896	C18H25Cl2N9O4S3	598.537	\N	\N	5	13	10	251	36	0	848	2	0	\N	\N	CN(C)CCN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)CC4=CSC(=N4)N)SC2)C(=O)O.Cl.Cl	(6R,7R)-7-[[2-(2-aminothiazol-4-yl)acetyl]amino]-3-[[1-[2-(dimethylamino)ethyl]tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;dihydrochloride
1483	CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER	CEFOXITIN SODIUM	23667300	C16H16N3NaO7S2	449.428	\N	\N	2	9	8	205	29	0	750	2	0	\N	\N	COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3.[Na+]	sodium;(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1484	CEFOXITIN IN PLASTIC CONTAINER	CEFOXITIN SODIUM	23667300	C16H16N3NaO7S2	449.428	\N	\N	2	9	8	205	29	0	750	2	0	\N	\N	COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3.[Na+]	sodium;(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1485	CEFPIRAMIDE SODIUM	CEFPIRAMIDE SODIUM	23663969	C25H23N8NaO7S2	634.618	\N	\N	4	13	9	262	43	0	1270	3	0	\N	\N	CC1=CC(=O)C(=CN1)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
985	BANAN	CEFPODOXIME PROXETIL	6526396	C21H27N5O9S2	557.593	\N	0.6	2	14	13	235	37	0	976	2	1	\N	\N	CC(C)OC(=O)OC(C)OC(=O)C1=C(CSC2N1C(=O)C2NC(=O)C(=NOC)C3=CSC(=N3)N)COC	1-isopropoxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
9486	VANTIN	CEFPODOXIME PROXETIL	6526396	C21H27N5O9S2	557.593	\N	0.6	2	14	13	235	37	0	976	2	1	\N	\N	CC(C)OC(=O)OC(C)OC(=O)C1=C(CSC2N1C(=O)C2NC(=O)C(=NOC)C3=CSC(=N3)N)COC	1-isopropoxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1487	CEFPROZIL	CEFPROZIL	5281006	C18H19N3O5S	389.426	\N	-1.4	4	7	5	158	27	0	699	3	0	\N	\N	CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O	(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
1500	CEFZIL	CEFPROZIL	5281006	C18H19N3O5S	389.426	\N	-1.4	4	7	5	158	27	0	699	3	0	\N	\N	CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O	(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
8734	TEFLARO	CEFTAROLINE FOSAMIL	9852981	C22H21N8O8PS4	684.672	\N	2.3	4	17	10	330	43	0	1210	2	0	\N	\N	CCON=C(C1=NSC(=N1)NP(=O)(O)O)C(=O)NC2C3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-]	(6R,7R)-7-[[(2Z)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl]sulfanyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1490	CEFTAZIDIME SODIUM IN PLASTIC CONTAINER	CEFTAZIDIME SODIUM	5488543	C22H21N6NaO7S2	568.555	\N	\N	2	12	7	248	38	0	1020	2	0	\N	\N	CC(C)(C(=O)[O-])ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxylato-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
3621	FORTAZ IN PLASTIC CONTAINER	CEFTAZIDIME SODIUM	5488543	C22H21N6NaO7S2	568.555	\N	\N	2	12	7	248	38	0	1020	2	0	\N	\N	CC(C)(C(=O)[O-])ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxylato-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
901	AVYCAZ	CEFTAZIDIME	5481173	C22H22N6O7S2	546.573	\N	0.4	3	12	8	245	37	0	1020	2	0	\N	\N	CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1488	CEFTAZIDIME	CEFTAZIDIME	5481173	C22H22N6O7S2	546.573	\N	0.4	3	12	8	245	37	0	1020	2	0	\N	\N	CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1469	CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER	CEFTIZOXIME SODIUM	23663938	C13H12N5NaO5S2	405.379	\N	\N	2	10	5	204	26	0	675	2	0	\N	\N	CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=CCS3)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1470	CEFIZOX IN PLASTIC CONTAINER	CEFTIZOXIME SODIUM	23663938	C13H12N5NaO5S2	405.379	\N	\N	2	10	5	204	26	0	675	2	0	\N	\N	CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=CCS3)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
9847	ZERBAXA	CEFTOLOZANE SULFATE	52918380	C23H32N12O12S3	764.761	\N	\N	9	20	12	439	50	0	1360	2	0	\N	\N	CC(C)(C(=O)O)ON=C(C1=NSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC(=C(N4C)N)NC(=O)NCCN)C(=O)O.OS(=O)(=O)[O-]	(6R,7R)-3-[[3-amino-4-(2-aminoethylcarbamoylamino)-2-methyl-pyrazol-1-ium-1-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrogen sulfate
1493	CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER	CEFTRIAXONE SODIUM	23679441	C18H17N8NaO7S3	576.553	\N	\N	3	13	8	291	37	0	1120	2	0	\N	\N	CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1494	CEFTRIAXONE IN PLASTIC CONTAINER	CEFTRIAXONE SODIUM	23679441	C18H17N8NaO7S3	576.553	\N	\N	3	13	8	291	37	0	1120	2	0	\N	\N	CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1491	CEFTIN	CEFUROXIME AXETIL	6321416	C20H22N4O10S	510.474	\N	0.9	2	12	12	214	35	0	968	2	1	\N	\N	CC(OC(=O)C)OC(=O)C1=C(CSC2N1C(=O)C2NC(=O)C(=NOC)C3=CC=CO3)COC(=O)N	1-acetoxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1497	CEFUROXIME AXETIL	CEFUROXIME AXETIL	6321416	C20H22N4O10S	510.474	\N	0.9	2	12	12	214	35	0	968	2	1	\N	\N	CC(OC(=O)C)OC(=O)C1=C(CSC2N1C(=O)C2NC(=O)C(=NOC)C3=CC=CO3)COC(=O)N	1-acetoxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1498	CEFUROXIME SODIUM	CEFUROXIME SODIUM	23670318	C16H15N4NaO8S	446.366	\N	\N	2	10	8	202	30	0	804	2	0	\N	\N	CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1499	CEFUROXIME SODIUM IN PLASTIC CONTAINER	CEFUROXIME SODIUM	23670318	C16H15N4NaO8S	446.366	\N	\N	2	10	8	202	30	0	804	2	0	\N	\N	CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
4643	KEFUROX	CEFUROXIME SODIUM	23670318	C16H15N4NaO8S	446.366	\N	\N	2	10	8	202	30	0	804	2	0	\N	\N	CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
4644	KEFUROX IN PLASTIC CONTAINER	CEFUROXIME SODIUM	23670318	C16H15N4NaO8S	446.366	\N	\N	2	10	8	202	30	0	804	2	0	\N	\N	CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1495	CEFUROXIME	CEFUROXIME	5479529	C16H16N4O8S	424.384	\N	-0.2	3	10	8	199	29	0	798	2	0	\N	\N	CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O	(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
1502	CELECOXIB	CELECOXIB	2662	C17H14F3N3O2S	381.373	\N	3.4	1	7	3	86.4	26	0	577	0	0	\N	\N	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
4642	KEFTAB	CEPHALEXIN HYDROCHLORIDE	62979	C16H20ClN3O5S	401.862	\N	\N	5	7	4	139	26	0	600	3	0	\N	\N	CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O.O.Cl	(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate;hydrochloride
1514	CEPHALEXIN	CEPHALEXIN	27447	C16H17N3O4S	347.389	\N	0.6	3	6	4	138	24	0	600	3	0	\N	\N	CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O	(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
4615	KAFOCIN	CEPHALOGLYCIN	19150	C18H19N3O6S	405.425	\N	-3	3	8	7	164	28	0	718	3	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O	(6R,7R)-3-(acetoxymethyl)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
1515	CEPHALOTHIN	CEPHALOTHIN SODIUM	23675321	C16H15N2NaO6S2	418.414	\N	\N	1	8	7	169	27	0	686	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1516	CEPHALOTHIN SODIUM	CEPHALOTHIN SODIUM	23675321	C16H15N2NaO6S2	418.414	\N	\N	1	8	7	169	27	0	686	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
695	ANSPOR	CEPHRADINE	38103	C16H19N3O4S	349.405	\N	0.4	3	6	4	138	24	0	697	3	0	\N	\N	CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O	(6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-yl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
1520	CEPHRADINE	CEPHRADINE	38103	C16H19N3O4S	349.405	\N	0.4	3	6	4	138	24	0	697	3	0	\N	\N	CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O	(6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-yl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
9530	VELOSEF '125'	CEPHRADINE	38103	C16H19N3O4S	349.405	\N	0.4	3	6	4	138	24	0	697	3	0	\N	\N	CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O	(6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-yl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
9531	VELOSEF '250'	CEPHRADINE	38103	C16H19N3O4S	349.405	\N	0.4	3	6	4	138	24	0	697	3	0	\N	\N	CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O	(6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-yl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
9532	VELOSEF '500'	CEPHRADINE	38103	C16H19N3O4S	349.405	\N	0.4	3	6	4	138	24	0	697	3	0	\N	\N	CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O	(6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-yl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
9360	TYMTRAN	CERULETIDE DIETHYLAMINE	16129675	C58H73N13O21S2	1352.412	\N	-3	17	22	38	585	94	0	2840	10	0	\N	\N	CC(C(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C5CCC(=O)N5)O	(3S)-4-[[(1S)-2-[[(1S,2R)-1-[[2-[[(1S)-2-[[(1S)-1-[[(1S)-2-[[(1S)-2-amino-1-benzyl-2-oxo-ethyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-2-hydroxy-propyl]amino]-2-oxo-1-[(4-sulfooxyphenyl)methyl]ethyl]amino]-3-[[(2S)-5-amino-5-oxo-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanoyl]amino]-4-oxo-butanoic acid
1537	CETIRIZINE HYDROCHLORIDE	CETIRIZINE HYDROCHLORIDE	55182	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	0	1	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
1538	CETIRIZINE HYDROCHLORIDE ALLERGY	CETIRIZINE HYDROCHLORIDE	55182	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	0	1	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
2872	DOLOBID	DIFLUNISAL	3059	C13H8F2O3	250.201	\N	4.4	2	5	2	57.5	18	0	311	0	0	\N	\N	C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O	5-(2,4-difluorophenyl)-2-hydroxy-benzoic acid
3227	ERBITUX	CETUXIMAB	85668777	C17H23NO2	273.376	\N	4	1	3	6	40.5	20	0	375	0	0	\N	\N	CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C	6-(3,3-dimethyl-2-methylene-indolin-1-yl)hexanoic acid
3370	EVOXAC	CEVIMELINE HYDROCHLORIDE	83898	C10H17NOS	199.312	\N	1.5	0	3	0	37.8	13	0	215	2	0	\N	\N	CC1OC2(CN3CCC2CC3)CS1	(2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine]
1550	CHENIX	CHENODIOL	10133	C24H40O4	392.58	\N	4.9	3	4	4	77.8	28	0	605	10	0	\N	\N	CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C	(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
1551	CHENODIOL	CHENODIOL	10133	C24H40O4	392.58	\N	4.9	3	4	4	77.8	28	0	605	10	0	\N	\N	CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C	(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
9373	ULO	CHLOPHEDIANOL HYDROCHLORIDE	83813	C17H21Cl2NO	326.261	\N	\N	2	2	5	23.5	21	0	291	0	1	\N	\N	CN(C)CCC(C1=CC=CC=C1)(C2=CC=CC=C2Cl)O.Cl	1-(2-chlorophenyl)-3-(dimethylamino)-1-phenyl-propan-1-ol;hydrochloride
1606	CHLOROMYCETIN PALMITATE	CHLORAMPHENICOL PALMITATE	443382	C27H42Cl2N2O6	561.541	\N	9	2	6	21	121	37	0	639	2	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OCC(C(C1=CC=C(C=C1)[N+](=O)[O-])O)NC(=O)C(Cl)Cl	[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] hexadecanoate
1582	CHLORAMPHENICOL SODIUM SUCCINATE	CHLORAMPHENICOL SODIUM SUCCINATE	656833	C15H15Cl2N2NaO8	445.181	\N	\N	2	8	9	162	28	0	541	2	0	\N	\N	C1=CC(=CC=C1C(C(COC(=O)CCC(=O)[O-])NC(=O)C(Cl)Cl)O)[N+](=O)[O-].[Na+]	sodium;4-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxo-butanoate
1603	CHLOROMYCETIN	CHLORAMPHENICOL SODIUM SUCCINATE	656833	C15H15Cl2N2NaO8	445.181	\N	\N	2	8	9	162	28	0	541	2	0	\N	\N	C1=CC(=CC=C1C(C(COC(=O)CCC(=O)[O-])NC(=O)C(Cl)Cl)O)[N+](=O)[O-].[Na+]	sodium;4-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxo-butanoate
5736	MYCHEL-S	CHLORAMPHENICOL SODIUM SUCCINATE	656833	C15H15Cl2N2NaO8	445.181	\N	\N	2	8	9	162	28	0	541	2	0	\N	\N	C1=CC(=CC=C1C(C(COC(=O)CCC(=O)[O-])NC(=O)C(Cl)Cl)O)[N+](=O)[O-].[Na+]	sodium;4-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxo-butanoate
1601	CHLOROFAIR	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
1602	CHLOROMYCETIN	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
1604	CHLOROMYCETIN HYDROCORTISONE	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
1607	CHLOROMYXIN	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
1610	CHLOROPTIC	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
1611	CHLOROPTIC S.O.P.	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
1597	CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE	CHLORDIAZEPOXIDE	2712	C16H14ClN3O	299.758	\N	2.4	1	3	1	48.2	21	0	580	0	0	\N	\N	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine
4925	LIBRITABS	CHLORDIAZEPOXIDE	2712	C16H14ClN3O	299.758	\N	2.4	1	3	1	48.2	21	0	580	0	0	\N	\N	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine
4965	LIMBITROL	CHLORDIAZEPOXIDE	2712	C16H14ClN3O	299.758	\N	2.4	1	3	1	48.2	21	0	580	0	0	\N	\N	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine
875	AVAGARD	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
1177	BRIAN CARE	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
1552	CHG SCRUB	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
1583	CHLORAPREP ONE-STEP	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
9002	TRANCOPAL	CHLORMEZANONE	2717	C11H12ClNO3S	273.731	\N	1.1	0	3	1	62.8	17	0	395	0	1	\N	\N	CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl	2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one
5963	NESACAINE	CHLOROPROCAINE HYDROCHLORIDE	441348	C13H20Cl2N2O2	307.215	\N	\N	2	4	7	55.6	19	0	259	0	0	\N	\N	CCN(CC)CCOC(=O)C1=C(C=C(C=C1)N)Cl.Cl	2-(diethylamino)ethyl 4-amino-2-chloro-benzoate;hydrochloride
5964	NESACAINE-MPF	CHLOROPROCAINE HYDROCHLORIDE	441348	C13H20Cl2N2O2	307.215	\N	\N	2	4	7	55.6	19	0	259	0	0	\N	\N	CCN(CC)CCOC(=O)C1=C(C=C(C=C1)N)Cl.Cl	2-(diethylamino)ethyl 4-amino-2-chloro-benzoate;hydrochloride
743	ARALEN HYDROCHLORIDE	CHLOROQUINE HYDROCHLORIDE	83820	C18H28Cl3N3	392.793	\N	\N	3	3	8	28.2	24	0	309	0	1	\N	\N	CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.Cl.Cl	N4-(7-chloro-4-quinolyl)-N1,N1-diethyl-pentane-1,4-diamine;dihydrochloride
744	ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE	CHLOROQUINE PHOSPHATE	64927	C18H32ClN3O8P2	515.865	\N	\N	7	11	8	184	32	0	359	0	1	\N	\N	CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O	N4-(7-chloro-4-quinolyl)-N1,N1-diethyl-pentane-1,4-diamine;phosphoric acid
307	ALDOCLOR-150	CHLOROTHIAZIDE	2720	C7H6ClN3O4S2	295.712	\N	-0.2	2	6	1	135	17	0	532	0	0	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2	6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
309	ALDOCLOR-250	CHLOROTHIAZIDE	2720	C7H6ClN3O4S2	295.712	\N	-0.2	2	6	1	135	17	0	532	0	0	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2	6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1616	CHLOROTHIAZIDE AND RESERPINE	CHLOROTHIAZIDE	2720	C7H6ClN3O4S2	295.712	\N	-0.2	2	6	1	135	17	0	532	0	0	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2	6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1619	CHLOROTHIAZIDE W/ RESERPINE	CHLOROTHIAZIDE	2720	C7H6ClN3O4S2	295.712	\N	-0.2	2	6	1	135	17	0	532	0	0	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2	6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
2850	DIUPRES-250	CHLOROTHIAZIDE	2720	C7H6ClN3O4S2	295.712	\N	-0.2	2	6	1	135	17	0	532	0	0	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2	6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
2852	DIUPRES-500	CHLOROTHIAZIDE	2720	C7H6ClN3O4S2	295.712	\N	-0.2	2	6	1	135	17	0	532	0	0	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2	6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
2854	DIURIL	CHLOROTHIAZIDE	2720	C7H6ClN3O4S2	295.712	\N	-0.2	2	6	1	135	17	0	532	0	0	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2	6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5471	METHYLDOPA AND CHLOROTHIAZIDE	CHLOROTHIAZIDE	2720	C7H6ClN3O4S2	295.712	\N	-0.2	2	6	1	135	17	0	532	0	0	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2	6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1623	CHLOROTRIANISENE	CHLOROTRIANISENE	11289	C23H21ClO3	380.868	\N	6.4	0	3	6	27.7	27	0	442	0	0	\N	\N	COC1=CC=C(C=C1)C(=C(C2=CC=C(C=C2)OC)Cl)C3=CC=C(C=C3)OC	1-[1-chloro-2,2-bis(4-methoxyphenyl)vinyl]-4-methoxy-benzene
223	ADVIL ALLERGY AND CONGESTION RELIEF	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
226	ADVIL ALLERGY SINUS	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
697	ANTAGONATE	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
2029	CORSYM	CHLORPHENIRAMINE POLISTIREX	2725	C16H19ClN2	274.792	\N	3.4	0	2	5	16.1	19	0	249	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine
4083	HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX	CHLORPHENIRAMINE POLISTIREX	2725	C16H19ClN2	274.792	\N	3.4	0	2	5	16.1	19	0	249	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine
9325	TUSSICAPS	CHLORPHENIRAMINE POLISTIREX	2725	C16H19ClN2	274.792	\N	3.4	0	2	5	16.1	19	0	249	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine
9329	TUSSIONEX PENNKINETIC	CHLORPHENIRAMINE POLISTIREX	2725	C16H19ClN2	274.792	\N	3.4	0	2	5	16.1	19	0	249	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine
9331	TUZISTRA XR	CHLORPHENIRAMINE POLISTIREX	2725	C16H19ClN2	274.792	\N	3.4	0	2	5	16.1	19	0	249	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine
1625	CHLORPROMAZINE HYDROCHLORIDE	CHLORPROMAZINE HYDROCHLORIDE	6240	C17H20Cl2N2S	355.321	\N	\N	1	3	4	31.8	22	0	339	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl	3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine;hydrochloride
1626	CHLORPROMAZINE HYDROCHLORIDE INTENSOL	CHLORPROMAZINE HYDROCHLORIDE	6240	C17H20Cl2N2S	355.321	\N	\N	1	3	4	31.8	22	0	339	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl	3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine;hydrochloride
7662	PROMAPAR	CHLORPROMAZINE HYDROCHLORIDE	6240	C17H20Cl2N2S	355.321	\N	\N	1	3	4	31.8	22	0	339	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl	3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine;hydrochloride
8877	THORAZINE	CHLORPROMAZINE HYDROCHLORIDE	6240	C17H20Cl2N2S	355.321	\N	\N	1	3	4	31.8	22	0	339	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl	3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine;hydrochloride
1629	CHLORZOXAZONE	CHLORZOXAZONE	2733	C7H4ClNO2	169.564	\N	1.8	1	2	0	38.3	11	0	185	0	0	\N	\N	C1=CC2=C(C=C1Cl)NC(=O)O2	5-chloro-3H-1,3-benzoxazol-2-one
6646	PARAFON FORTE DSC	CHLORZOXAZONE	2733	C7H4ClNO2	169.564	\N	1.8	1	2	0	38.3	11	0	185	0	0	\N	\N	C1=CC2=C(C=C1Cl)NC(=O)O2	5-chloro-3H-1,3-benzoxazol-2-one
3628	FOSAMAX PLUS D	CHOLECALCIFEROL	5280795	C27H44O	384.648	\N	7.9	1	1	6	20.2	28	0	610	5	0	\N	\N	CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-dimethylhexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
4257	INFUVITE ADULT	CHOLECALCIFEROL	5280795	C27H44O	384.648	\N	7.9	1	1	6	20.2	28	0	610	5	0	\N	\N	CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-dimethylhexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
1635	CHOLESTYRAMINE	CHOLESTYRAMINE	70695641	C21H30N+	296.478	\N	5.7	0	0	6	0	22	1	300	0	1	\N	\N	CCC1=CC=C(C=C1)C(C)CCC2=CC=C(C=C2)[N+](C)(C)C	[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethyl-ammonium
1636	CHOLESTYRAMINE LIGHT	CHOLESTYRAMINE	70695641	C21H30N+	296.478	\N	5.7	0	0	6	0	22	1	300	0	1	\N	\N	CCC1=CC=C(C=C1)C(C)CCC2=CC=C(C=C2)[N+](C)(C)C	[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethyl-ammonium
1643	CHOLYBAR	CHOLESTYRAMINE	70695641	C21H30N+	296.478	\N	5.7	0	0	6	0	22	1	300	0	1	\N	\N	CCC1=CC=C(C=C1)C(C)CCC2=CC=C(C=C2)[N+](C)(C)C	[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethyl-ammonium
1638	CHOLINE C-11	CHOLINE C-11	449688	C5H14NO+	103.173	\N	-0.4	1	1	2	20.2	7	1	46.5	0	0	\N	\N	C[N+](C)(C)CCO	2-hydroxyethyl-tri(methyl)ammonium
1647	CHROMIC CHLORIDE IN PLASTIC CONTAINER	CHROMIC CHLORIDE	6452300	Cl3Cr	158.346	\N	\N	0	3	0	0	4	0	0	0	0	\N	\N	[Cl-].[Cl-].[Cl-].[Cr+3]	chromic;trichloride
1651	CHYMODIACTIN	CHYMOPAPAIN	9001	C6H4Na2O8S2	314.19	\N	\N	2	8	0	172	18	0	413	0	0	\N	\N	C1=C(C=C(C(=C1S(=O)(=O)[O-])O)O)S(=O)(=O)[O-].[Na+].[Na+]	disodium;4,5-dihydroxybenzene-1,3-disulfonate
6743	PENLAC	CICLOPIROX	2749	C12H17NO2	207.273	\N	2	1	2	1	40.5	15	0	325	0	0	\N	\N	CC1=CC(=O)N(C(=C1)C2CCCCC2)O	6-cyclohexyl-1-hydroxy-4-methyl-pyridin-2-one
1656	CIDOFOVIR	CIDOFOVIR	60613	C8H14N3O6P	279.189	\N	-3.6	4	6	6	146	18	0	417	1	0	\N	\N	C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O	[(1S)-1-[(4-amino-2-oxo-pyrimidin-1-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid
9652	VISTIDE	CIDOFOVIR	60613	C8H14N3O6P	279.189	\N	-3.6	4	6	6	146	18	0	417	1	0	\N	\N	C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O	[(1S)-1-[(4-amino-2-oxo-pyrimidin-1-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid
4201	IMIPENEM AND CILASTATIN	CILASTATIN SODIUM	23663403	C16H25N2NaO5S	380.435	\N	\N	3	7	11	158	25	0	525	2	0	\N	\N	CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)[O-])C.[Na+]	sodium;(Z)-7-[(2R)-2-amino-2-carboxy-ethyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoate
1657	CILOSTAZOL	CILOSTAZOL	2754	C20H27N5O2	369.469	\N	3.1	1	5	7	81.9	27	0	485	0	0	\N	\N	C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4	6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one
1660	CIMETIDINE HYDROCHLORIDE	CIMETIDINE HYDROCHLORIDE	50963	C10H17ClN6S	288.798	\N	\N	4	4	7	114	18	0	296	0	0	\N	\N	CC1=C(N=CN1)CSCCNC(=NC)NC#N.Cl	1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine;hydrochloride
1661	CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	CIMETIDINE HYDROCHLORIDE	50963	C10H17ClN6S	288.798	\N	\N	4	4	7	114	18	0	296	0	0	\N	\N	CC1=C(N=CN1)CSCCNC(=NC)NC#N.Cl	1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine;hydrochloride
8658	TAGAMET HB	CIMETIDINE	2756	C10H16N6S	252.34	\N	0.4	3	4	7	114	17	0	296	0	0	\N	\N	CC1=C(N=CN1)CSCCNC(=NC)NC#N	1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine
8659	TAGAMET HB 200	CIMETIDINE	2756	C10H16N6S	252.34	\N	0.4	3	4	7	114	17	0	296	0	0	\N	\N	CC1=C(N=CN1)CSCCNC(=NC)NC#N	1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine
1664	CINACALCET HYDROCHLORIDE	CINACALCET HYDROCHLORIDE	156418	C22H23ClF3N	393.878	\N	\N	2	4	6	12	27	0	422	1	0	\N	\N	CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F.Cl	N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine;hydrochloride
8198	SENSIPAR	CINACALCET HYDROCHLORIDE	156418	C22H23ClF3N	393.878	\N	\N	2	4	6	12	27	0	422	1	0	\N	\N	CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F.Cl	N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine;hydrochloride
1667	CINOXACIN	CINOXACIN	2762	C12H10N2O5	262.221	\N	2.1	1	7	2	88.4	19	0	449	0	0	\N	\N	CCN1C2=CC3=C(C=C2C(=O)C(=N1)C(=O)O)OCO3	1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid
1658	CILOXAN	CIPROFLOXACIN HYDROCHLORIDE	62999	C17H19ClFN3O3	367.805	\N	\N	3	7	3	72.9	25	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.Cl	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid;hydrochloride
1671	CIPRO	CIPROFLOXACIN HYDROCHLORIDE	62999	C17H19ClFN3O3	367.805	\N	\N	3	7	3	72.9	25	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.Cl	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid;hydrochloride
1672	CIPRO HC	CIPROFLOXACIN HYDROCHLORIDE	62999	C17H19ClFN3O3	367.805	\N	\N	3	7	3	72.9	25	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.Cl	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid;hydrochloride
1675	CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	CIPROFLOXACIN	2764	C17H18FN3O3	331.347	\N	-1.1	2	7	3	72.9	24	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
1676	CIPRO XR	CIPROFLOXACIN	2764	C17H18FN3O3	331.347	\N	-1.1	2	7	3	72.9	24	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
1678	CIPRODEX	CIPROFLOXACIN	2764	C17H18FN3O3	331.347	\N	-1.1	2	7	3	72.9	24	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
1680	CIPROFLOXACIN	CIPROFLOXACIN	2764	C17H18FN3O3	331.347	\N	-1.1	2	7	3	72.9	24	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
1690	CISATRACURIUM BESYLATE PRESERVATIVE FREE	CISATRACURIUM BESYLATE	62886	C65H82N2O18S2	1243.487	\N	\N	0	18	26	258	87	0	1560	4	0	\N	\N	C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]	benzenesulfonate;5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
1507	CELEXA	CITALOPRAM HYDROBROMIDE	77995	C20H22BrFN2O	405.311	\N	\N	1	4	5	36.3	25	0	466	0	1	\N	\N	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.Br	1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile;hydrobromide
4868	LEUSTATIN	CLADRIBINE	20279	C10H12ClN5O3	285.688	\N	0.8	3	7	2	119	19	0	338	3	0	\N	\N	C1C(C(OC1N2C=NC3=C2N=C(N=C3N)Cl)CO)O	(2R,3S,5R)-5-(6-amino-2-chloro-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
1102	BIAXIN	CLARITHROMYCIN	84029	C38H69NO13	747.964	\N	3.2	4	14	8	183	52	0	1190	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
1103	BIAXIN XL	CLARITHROMYCIN	84029	C38H69NO13	747.964	\N	3.2	4	14	8	183	52	0	1190	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
1710	CLARITHROMYCIN	CLARITHROMYCIN	84029	C38H69NO13	747.964	\N	3.2	4	14	8	183	52	0	1190	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
858	AUGMENTIN '200'	CLAVULANATE POTASSIUM	23665591	C8H8KNO5	237.252	\N	\N	1	5	2	89.9	15	0	329	2	0	\N	\N	C1C2N(C1=O)C(C(=CCO)O2)C(=O)[O-].[K+]	potassium;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
860	AUGMENTIN '250'	CLAVULANATE POTASSIUM	23665591	C8H8KNO5	237.252	\N	\N	1	5	2	89.9	15	0	329	2	0	\N	\N	C1C2N(C1=O)C(C(=CCO)O2)C(=O)[O-].[K+]	potassium;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
862	AUGMENTIN '400'	CLAVULANATE POTASSIUM	23665591	C8H8KNO5	237.252	\N	\N	1	5	2	89.9	15	0	329	2	0	\N	\N	C1C2N(C1=O)C(C(=CCO)O2)C(=O)[O-].[K+]	potassium;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
864	AUGMENTIN '500'	CLAVULANATE POTASSIUM	23665591	C8H8KNO5	237.252	\N	\N	1	5	2	89.9	15	0	329	2	0	\N	\N	C1C2N(C1=O)C(C(=CCO)O2)C(=O)[O-].[K+]	potassium;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
866	AUGMENTIN '875'	CLAVULANATE POTASSIUM	23665591	C8H8KNO5	237.252	\N	\N	1	5	2	89.9	15	0	329	2	0	\N	\N	C1C2N(C1=O)C(C(=CCO)O2)C(=O)[O-].[K+]	potassium;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
868	AUGMENTIN ES-600	CLAVULANATE POTASSIUM	23665591	C8H8KNO5	237.252	\N	\N	1	5	2	89.9	15	0	329	2	0	\N	\N	C1C2N(C1=O)C(C(=CCO)O2)C(=O)[O-].[K+]	potassium;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
870	AUGMENTIN XR	CLAVULANATE POTASSIUM	23665591	C8H8KNO5	237.252	\N	\N	1	5	2	89.9	15	0	329	2	0	\N	\N	C1C2N(C1=O)C(C(=CCO)O2)C(=O)[O-].[K+]	potassium;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
4923	LIBRAX	CLIDINIUM BROMIDE	19004	C22H26BrNO3	432.358	\N	\N	1	4	5	46.5	27	0	482	0	1	\N	\N	C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O.[Br-]	(1-methylquinuclidin-1-ium-3-yl) 2-hydroxy-2,2-diphenyl-acetate;bromide
1728	CLEOCIN HYDROCHLORIDE	CLINDAMYCIN HYDROCHLORIDE	16051951	C18H34Cl2N2O5S	461.439	\N	\N	5	7	7	128	28	0	502	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl.Cl	(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide;hydrochloride
1726	CLEOCIN	CLINDAMYCIN PALMITATE HYDROCHLORIDE	16052038	C34H64Cl2N2O6S	699.854	\N	\N	4	8	23	134	45	0	810	9	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OC1C(C(C(OC1SC)C(C(C)Cl)NC(=O)C2CC(CN2C)CCC)O)O.Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] hexadecanoate;hydrochloride
1739	CLINDAMYCIN PALMITATE HYDROCHLORIDE	CLINDAMYCIN PALMITATE HYDROCHLORIDE	16052038	C34H64Cl2N2O6S	699.854	\N	\N	4	8	23	134	45	0	810	9	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OC1C(C(C(OC1SC)C(C(C)Cl)NC(=O)C2CC(CN2C)CCC)O)O.Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] hexadecanoate;hydrochloride
30	ACANYA	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
1039	BENZACLIN	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
4687	KLONOPIN	CLONAZEPAM	2802	C15H10ClN3O3	315.713	\N	2.4	1	4	1	87.3	22	0	491	0	0	\N	\N	C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl	5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
6262	NYSTAFORM	CLIOQUINOL	2788	C9H5ClINO	305.499	\N	3.5	1	2	0	33.1	13	0	193	0	0	\N	\N	C1=CC2=C(C(=C(C=C2Cl)I)O)N=C1	5-chloro-7-iodo-quinolin-8-ol
1863	CLOBETASOL PROPIONATE	CLOBETASOL PROPIONATE	32798	C25H32ClFO5	466.974	\N	3.8	1	6	5	80.7	32	0	929	8	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl	[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
1864	CLOBETASOL PROPIONATE (EMOLLIENT)	CLOBETASOL PROPIONATE	32798	C25H32ClFO5	466.974	\N	3.8	1	6	5	80.7	32	0	929	8	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl	[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
1865	CLOBEX	CLOBETASOL PROPIONATE	32798	C25H32ClFO5	466.974	\N	3.8	1	6	5	80.7	32	0	929	8	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl	[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
2026	CORMAX	CLOBETASOL PROPIONATE	32798	C25H32ClFO5	466.974	\N	3.8	1	6	5	80.7	32	0	929	8	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl	[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
3112	EMBELINE	CLOBETASOL PROPIONATE	32798	C25H32ClFO5	466.974	\N	3.8	1	6	5	80.7	32	0	929	8	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl	[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
3113	EMBELINE E	CLOBETASOL PROPIONATE	32798	C25H32ClFO5	466.974	\N	3.8	1	6	5	80.7	32	0	929	8	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl	[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
4791	LAMPRENE	CLOFAZIMINE	2794	C27H22Cl2N4	473.401	\N	7.1	1	4	4	40	33	0	829	0	0	\N	\N	CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl	N,5-bis(4-chlorophenyl)-3-isopropylimino-phenazin-2-amine
651	ANAFRANIL	CLOMIPRAMINE HYDROCHLORIDE	68539	C19H24Cl2N2	351.315	\N	\N	1	2	4	6.5	23	0	346	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl.Cl	3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine;hydrochloride
1872	CLOMIPRAMINE HYDROCHLORIDE	CLOMIPRAMINE HYDROCHLORIDE	68539	C19H24Cl2N2	351.315	\N	\N	1	2	4	6.5	23	0	346	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl.Cl	3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine;hydrochloride
1873	CLONAZEPAM	CLONAZEPAM	2802	C15H10ClN3O3	315.713	\N	2.4	1	4	1	87.3	22	0	491	0	0	\N	\N	C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl	5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
1877	CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONE	CLONIDINE HYDROCHLORIDE	20179	C9H10Cl3N3	266.55	\N	\N	3	1	2	36.4	15	0	222	0	0	\N	\N	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl	N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine;hydrochloride
1444	CATAPRES-TTS-1	CLONIDINE	2803	C9H9Cl2N3	230.092	\N	1.6	2	1	2	36.4	14	0	222	0	0	\N	\N	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl	N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
1445	CATAPRES-TTS-2	CLONIDINE	2803	C9H9Cl2N3	230.092	\N	1.6	2	1	2	36.4	14	0	222	0	0	\N	\N	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl	N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
1446	CATAPRES-TTS-3	CLONIDINE	2803	C9H9Cl2N3	230.092	\N	1.6	2	1	2	36.4	14	0	222	0	0	\N	\N	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl	N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
1878	CLOPIDOGREL BISULFATE	CLOPIDOGREL BISULFATE	115366	C16H18ClNO6S2	419.891	\N	\N	2	8	4	141	26	0	463	1	0	\N	\N	COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O	methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric acid
1881	CLORAZEPATE DIPOTASSIUM	CLORAZEPATE DIPOTASSIUM	2809	C16H11ClN2O3	314.725	\N	3.3	2	4	2	78.8	22	0	488	0	1	\N	\N	C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O	7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid
3717	GEN-XENE	CLORAZEPATE DIPOTASSIUM	2809	C16H11ClN2O3	314.725	\N	3.3	2	4	2	78.8	22	0	488	0	1	\N	\N	C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O	7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid
9014	TRANXENE SD	CLORAZEPATE DIPOTASSIUM	2809	C16H11ClN2O3	314.725	\N	3.3	2	4	2	78.8	22	0	488	0	1	\N	\N	C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O	7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid
1886	CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
3840	GYNE-LOTRIMIN	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
3841	GYNE-LOTRIMIN 3	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
1887	CLOXACILLIN SODIUM	CLOXACILLIN SODIUM	23675743	C19H19ClN3NaO6S	475.876	\N	\N	2	8	4	142	31	0	728	3	0	\N	\N	CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+]	sodium;(2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-isoxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate
1888	CLOXAPEN	CLOXACILLIN SODIUM	23675743	C19H19ClN3NaO6S	475.876	\N	\N	2	8	4	142	31	0	728	3	0	\N	\N	CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+]	sodium;(2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-isoxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate
8736	TEGOPEN	CLOXACILLIN SODIUM	23675743	C19H19ClN3NaO6S	475.876	\N	\N	2	8	4	142	31	0	728	3	0	\N	\N	CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+]	sodium;(2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-isoxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate
1890	CLOZARIL	CLOZAPINE	2818	C18H19ClN4	326.828	\N	3.2	1	4	1	30.9	23	0	584	0	0	\N	\N	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine
3369	EVOTAZ	COBICISTAT	25151504	C40H53N7O5S2	776.028	\N	5.7	3	10	20	195	54	0	1120	3	0	\N	\N	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5	thiazol-5-ylmethyl N-[(1R,4R)-1-benzyl-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-4-morpholino-butanoyl]amino]-5-phenyl-pentyl]carbamate
6639	PAPA-DEINE #3	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
56	ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
105	ACTIFED W/ CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
403	AMBENYL	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
1195	BROMANYL	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
677	ANGELIQ	DROSPIRENONE	68873	C24H30O3	366.501	\N	3.5	0	3	0	43.4	27	0	828	10	0	\N	\N	CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C	\N
6746	PENNTUSS	CODEINE POLISTIREX	5284371	C18H21NO3	299.37	\N	1.1	1	4	1	41.9	22	0	509	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol
1927	COL-PROBENECID	COLCHICINE	6167	C22H25NO6	399.443	\N	1	1	6	5	83.1	29	0	740	1	0	\N	\N	CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC	N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
1930	COLBENEMID	COLCHICINE	6167	C22H25NO6	399.443	\N	1	1	6	5	83.1	29	0	740	1	0	\N	\N	CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC	N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
1932	COLCHICINE	COLCHICINE	6167	C22H25NO6	399.443	\N	1	1	6	5	83.1	29	0	740	1	0	\N	\N	CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC	N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
1933	COLCRYS	COLCHICINE	6167	C22H25NO6	399.443	\N	1	1	6	5	83.1	29	0	740	1	0	\N	\N	CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC	N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
5618	MITIGARE	COLCHICINE	6167	C22H25NO6	399.443	\N	1	1	6	5	83.1	29	0	740	1	0	\N	\N	CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC	N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
9713	WELCHOL	COLESEVELAM HYDROCHLORIDE	160051	C31H67Cl3N4O	618.254	\N	\N	4	5	22	62.6	39	0	301	0	1	\N	\N	CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]	6-(allylamino)hexyl-trimethyl-ammonium;N-allyldecan-1-amine;2-(chloromethyl)oxirane;prop-2-en-1-amine;chloride;hydrochloride
1939	COLESTIPOL HYDROCHLORIDE	COLESTIPOL HYDROCHLORIDE	62816	C11H28ClN5O	281.829	\N	\N	5	6	11	101	18	0	117	0	1	\N	\N	C1C(O1)CCl.C(CNCCNCCNCCN)N	N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine;2-(chloromethyl)oxirane
3519	FLAVORED COLESTID	COLESTIPOL HYDROCHLORIDE	62816	C11H28ClN5O	281.829	\N	\N	5	6	11	101	18	0	117	0	1	\N	\N	C1C(O1)CCl.C(CNCCNCCNCCN)N	N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine;2-(chloromethyl)oxirane
3390	EXOSURF NEONATAL	COLFOSCERIL PALMITATE	452110	C40H80NO8P	734.053	\N	13.5	0	8	40	111	50	0	826	1	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC	[(2R)-2,3-di(hexadecanoyloxy)propyl] 2-(trimethylammonio)ethyl phosphate
1942	COLISTIMETHATE SODIUM	COLISTIMETHATE SODIUM	216258	C58H105N16Na5O28S5	1749.811	\N	\N	18	33	39	749	112	0	3430	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC(C(C)O)C(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCNCS(=O)(=O)[O-])CC(C)C)CC(C)C)CCNCS(=O)(=O)[O-])CCNCS(=O)(=O)[O-])C(C)O.[Na+].[Na+].[Na+].[Na+].[Na+]	pentasodium;[2-[17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-diisobutyl-3,6,9,12,15,18,23-heptaoxo-11,14-bis[2-(sulfonatomethylamino)ethyl]-1,4,7,10,13,16,19-heptazacyclotricos-2-yl]ethylamino]methanesulfonate
9488	VAPRISOL	CONIVAPTAN HYDROCHLORIDE	216322	C32H27ClN4O2	535.044	\N	\N	3	3	4	78.1	39	0	820	0	0	\N	\N	CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6.Cl	N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenyl-benzamide;hydrochloride
9489	VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER	CONIVAPTAN HYDROCHLORIDE	216322	C32H27ClN4O2	535.044	\N	\N	3	3	4	78.1	39	0	820	0	0	\N	\N	CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6.Cl	N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenyl-benzamide;hydrochloride
2081	CROLOM	CROMOLYN SODIUM	27503	C23H14Na2O11	512.334	\N	\N	1	11	6	172	36	0	824	0	0	\N	\N	C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)[O-])O)C(=O)C=C(O2)C(=O)[O-].[Na+].[Na+]	disodium;5-[3-(2-carboxylato-4-oxo-chromen-5-yl)oxy-2-hydroxy-propoxy]-4-oxo-chromene-2-carboxylate
2082	CROMOLYN SODIUM	CROMOLYN SODIUM	27503	C23H14Na2O11	512.334	\N	\N	1	11	6	172	36	0	824	0	0	\N	\N	C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)[O-])O)C(=O)C=C(O2)C(=O)[O-].[Na+].[Na+]	disodium;5-[3-(2-carboxylato-4-oxo-chromen-5-yl)oxy-2-hydroxy-propoxy]-4-oxo-chromene-2-carboxylate
2083	CROMOPTIC	CROMOLYN SODIUM	27503	C23H14Na2O11	512.334	\N	\N	1	11	6	172	36	0	824	0	0	\N	\N	C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)[O-])O)C(=O)C=C(O2)C(=O)[O-].[Na+].[Na+]	disodium;5-[3-(2-carboxylato-4-oxo-chromen-5-yl)oxy-2-hydroxy-propoxy]-4-oxo-chromene-2-carboxylate
1052	BEROCCA PN	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
2163	DANTROLENE SODIUM	DANTROLENE SODIUM	6604100	C14H9N4NaO5	336.239	\N	\N	0	6	3	127	24	0	536	0	0	\N	\N	C1C(=O)N=C(N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-].[Na+]	sodium;3-[(E)-[5-(4-nitrophenyl)-2-furyl]methyleneamino]-5-oxo-4H-imidazol-2-olate
2103	CYCLACILLIN	CYCLACILLIN	19003	C15H23N3O4S	341.426	\N	1.3	3	6	3	138	23	0	559	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C3(CCCCC3)N)C(=O)O)C	(2S,5R,6R)-6-[(1-aminocyclohexanecarbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
2111	CYCLAPEN-W	CYCLACILLIN	19003	C15H23N3O4S	341.426	\N	1.3	3	6	3	138	23	0	559	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C3(CCCCC3)N)C(=O)O)C	(2S,5R,6R)-6-[(1-aminocyclohexanecarbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
5310	MAREZINE	CYCLIZINE LACTATE	71473	C21H28N2O3	356.466	\N	\N	2	5	4	64	26	0	312	0	1	\N	\N	CC(C(=O)O)O.CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3	1-benzhydryl-4-methyl-piperazine;2-hydroxypropanoic acid
269	AKPENTOLATE	CYCLOPENTOLATE HYDROCHLORIDE	22162	C17H26ClNO3	327.849	\N	\N	2	4	7	49.8	22	0	331	0	1	\N	\N	CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O.Cl	2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenyl-acetate;hydrochloride
2116	CYCLOGYL	CYCLOPENTOLATE HYDROCHLORIDE	22162	C17H26ClNO3	327.849	\N	\N	2	4	7	49.8	22	0	331	0	1	\N	\N	CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O.Cl	2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenyl-acetate;hydrochloride
2117	CYCLOMYDRIL	CYCLOPENTOLATE HYDROCHLORIDE	22162	C17H26ClNO3	327.849	\N	\N	2	4	7	49.8	22	0	331	0	1	\N	\N	CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O.Cl	2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenyl-acetate;hydrochloride
2120	CYCLOPENTOLATE HYDROCHLORIDE	CYCLOPENTOLATE HYDROCHLORIDE	22162	C17H26ClNO3	327.849	\N	\N	2	4	7	49.8	22	0	331	0	1	\N	\N	CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O.Cl	2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenyl-acetate;hydrochloride
2148	CYTOXAN	CYCLOPHOSPHAMIDE	2907	C7H15Cl2N2O2P	261.083	\N	0.6	1	4	5	41.6	14	0	212	0	1	\N	\N	C1CNP(=O)(OC1)N(CCCl)CCCl	N,N-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine
2149	CYTOXAN (LYOPHILIZED)	CYCLOPHOSPHAMIDE	2907	C7H15Cl2N2O2P	261.083	\N	0.6	1	4	5	41.6	14	0	212	0	1	\N	\N	C1CNP(=O)(OC1)N(CCCl)CCCl	N,N-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine
686	ANHYDRON	CYCLOTHIAZIDE	2910	C14H16ClN3O4S2	389.869	\N	2	3	7	2	135	24	0	758	0	4	\N	\N	C1C2CC(C1C=C2)C3NC4=CC(=C(C=C4S(=O)(=O)N3)S(=O)(=O)N)Cl	3-(5-bicyclo[2.2.1]hept-2-enyl)-6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3557	FLUIDIL	CYCLOTHIAZIDE	2910	C14H16ClN3O4S2	389.869	\N	2	3	7	2	135	24	0	758	0	4	\N	\N	C1C2CC(C1C=C2)C3NC4=CC(=C(C=C4S(=O)(=O)N3)S(=O)(=O)N)Cl	3-(5-bicyclo[2.2.1]hept-2-enyl)-6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
6790	PERIACTIN	CYPROHEPTADINE HYDROCHLORIDE	13770	C21H22ClN	323.864	\N	\N	1	1	0	3.2	23	0	423	0	0	\N	\N	CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1.Cl	4-(dibenzo[1,2-a:1',2'-e][7]annulen-11-ylidene)-1-methyl-piperidine;hydrochloride
2135	CYSTEINE HYDROCHLORIDE	CYSTEINE HYDROCHLORIDE	25150	C3H8ClNO2S	157.612	\N	\N	4	4	2	64.3	8	0	75.3	0	1	\N	\N	C(C(C(=O)O)N)S.Cl	2-amino-3-sulfanyl-propanoic acid;hydrochloride
2142	CYTARABINE	CYTARABINE	6253	C9H13N3O5	243.219	\N	-2.1	4	5	2	129	17	0	383	4	0	\N	\N	C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O	4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one
2144	CYTOSAR-U	CYTARABINE	6253	C9H13N3O5	243.219	\N	-2.1	4	5	2	129	17	0	383	4	0	\N	\N	C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O	4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one
7363	PRADAXA	DABIGATRAN ETEXILATE MESYLATE	11434065	C35H45N7O8S	723.846	\N	\N	3	11	17	217	51	0	1100	0	0	\N	\N	CCCCCCOC(=O)N=C(C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)N.CS(=O)(=O)O	ethyl 3-[[2-[[4-[(Z)-N'-hexoxycarbonylcarbamimidoyl]anilino]methyl]-1-methyl-benzimidazole-5-carbonyl]-(2-pyridyl)amino]propanoate;methanesulfonic acid
8655	TAFINLAR	DABRAFENIB MESYLATE	44516822	C24H24F3N5O5S3	615.661	\N	\N	3	14	6	210	40	0	910	0	0	\N	\N	CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F.CS(=O)(=O)O	N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-thiazol-4-yl]-2-fluoro-phenyl]-2,6-difluoro-benzenesulfonamide;methanesulfonic acid
2939	DTIC-DOME	DACARBAZINE	5353562	C6H10N6O	182.187	\N	-0.3	2	4	3	95.4	13	0	302	0	0	\N	\N	CN(C)NN=C1C(=NC=N1)C(=O)N	(5E)-5-(dimethylaminohydrazono)imidazole-4-carboxamide
2154	DAKLINZA	DACLATASVIR DIHYDROCHLORIDE	25154713	C40H52Cl2N8O6	811.806	\N	\N	6	8	13	175	56	0	1190	4	0	\N	\N	CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC.Cl.Cl	methyl N-[(1S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carbonyl]-2-methyl-propyl]carbamate;dihydrochloride
2060	COSMEGEN	DACTINOMYCIN	457193	C62H86N12O16	1255.438	\N	3.8	5	18	8	356	90	0	3030	10	0	\N	\N	CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C	2-amino-N1,N9-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-phenoxazine-1,9-dicarboxamide
639	AMPYRA	DALFAMPRIDINE	1727	C5H6N2	94.117	\N	0.3	1	2	0	38.9	7	0	48	0	0	\N	\N	C1=CN=CC=C1N	pyridin-4-amine
2155	DALFAMPRIDINE	DALFAMPRIDINE	1727	C5H6N2	94.117	\N	0.3	1	2	0	38.9	7	0	48	0	0	\N	\N	C1=CN=CC=C1N	pyridin-4-amine
8630	SYNERCID	DALFOPRISTIN	6323289	C34H50N4O9S	690.853	\N	2.2	2	11	7	185	48	0	1340	5	0	\N	\N	CCN(CC)CCS(=O)(=O)C1CCN2C1C(=O)OC(C(C=CC(=O)NCC=CC(=CC(CC(=O)CC3=NC(=CO3)C2=O)O)C)C)C(C)C	\N
3639	FRAGMIN	DALTEPARIN SODIUM	59350241	C12H17NO20S3-4	591.435	\N	-5.6	5	21	6	376	36	-4	1040	0	10	\N	\N	C(C1C(C(C(C(O1)O)NS(=O)(=O)[O-])O)OC2C(C(C(C(O2)C(=O)[O-])O)O)OS(=O)(=O)[O-])OS(=O)(=O)[O-]	6-[4,6-dihydroxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-3,4-dihydroxy-5-sulfonatooxy-tetrahydropyran-2-carboxylate
2160	DANAZOL	DANAZOL	28417	C22H27NO2	337.463	\N	3.8	1	3	1	46.3	25	0	677	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5	\N
2161	DANOCRINE	DANAZOL	28417	C22H27NO2	337.463	\N	3.8	1	3	1	46.3	25	0	677	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5	\N
2162	DANTRIUM	DANTROLENE SODIUM	6604100	C14H9N4NaO5	336.239	\N	\N	0	6	3	127	24	0	536	0	0	\N	\N	C1C(=O)N=C(N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-].[Na+]	sodium;3-[(E)-[5-(4-nitrophenyl)-2-furyl]methyleneamino]-5-oxo-4H-imidazol-2-olate
3425	FARXIGA	DAPAGLIFLOZIN PROPANEDIOL	24906252	C24H35ClO9	502.985	\N	\N	7	9	7	141	34	0	493	6	0	\N	\N	CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl.CC(CO)O.O	(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol;(2S)-propane-1,2-diol;hydrate
2165	DAPSONE	DAPSONE	2955	C12H12N2O2S	248.3	\N	1	2	4	2	94.6	17	0	306	0	0	\N	\N	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	4-(4-aminophenyl)sulfonylaniline
2089	CUBICIN	DAPTOMYCIN	16129629	C72H101N17O26	1620.693	\N	-5.1	22	28	35	702	115	0	3480	10	3	\N	\N	CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C	\N
2090	CUBICIN RF	DAPTOMYCIN	16129629	C72H101N17O26	1620.693	\N	-5.1	22	28	35	702	115	0	3480	10	3	\N	\N	CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C	\N
7463	PREZCOBIX	DARUNAVIR ETHANOLATE	23725083	C29H43N3O8S	593.736	\N	\N	4	10	12	169	41	0	856	5	0	\N	\N	CCO.CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N	[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate;ethanol
7464	PREZISTA	DARUNAVIR ETHANOLATE	23725083	C29H43N3O8S	593.736	\N	\N	4	10	12	169	41	0	856	5	0	\N	\N	CCO.CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N	[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate;ethanol
2172	DARUNAVIR	DARUNAVIR	213039	C27H37N3O7S	547.667	\N	2.9	3	9	12	149	38	0	853	5	0	\N	\N	CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N	[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate
2195	DASATINIB	DASATINIB	3062316	C22H26ClN7O2S	488.007	\N	3.6	3	9	7	135	33	0	642	0	0	\N	\N	CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C	N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide
8415	SPRYCEL	DASATINIB	3062316	C22H26ClN7O2S	488.007	\N	3.6	3	9	7	135	33	0	642	0	0	\N	\N	CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C	N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide
1529	CERUBIDINE	DAUNORUBICIN HYDROCHLORIDE	62770	C27H30ClNO10	563.984	\N	\N	6	11	4	186	39	0	960	6	0	\N	\N	CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O.Cl	(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
2201	DAUNORUBICIN HYDROCHLORIDE	DAUNORUBICIN HYDROCHLORIDE	62770	C27H30ClNO10	563.984	\N	\N	6	11	4	186	39	0	960	6	0	\N	\N	CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O.Cl	(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
8623	SYNCURINE	DECAMETHONIUM BROMIDE	10921	C16H38Br2N2	418.302	\N	\N	0	2	11	0	20	0	164	0	0	\N	\N	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C.[Br-].[Br-]	trimethyl-[10-(trimethylammonio)decyl]ammonium;dibromide
2223	DEFERASIROX	DEFERASIROX	5493381	C21H15N3O4	373.368	\N	3.8	3	7	2	98.7	28	0	912	0	0	\N	\N	C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1	4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid
3386	EXJADE	DEFERASIROX	5493381	C21H15N3O4	373.368	\N	3.8	3	7	2	98.7	28	0	912	0	0	\N	\N	C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1	4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid
4565	JADENU	DEFERASIROX	5493381	C21H15N3O4	373.368	\N	3.8	3	7	2	98.7	28	0	912	0	0	\N	\N	C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1	4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid
3478	FERRIPROX	DEFERIPRONE	2972	C7H9NO2	139.154	\N	0.5	1	3	0	40.5	10	0	228	0	0	\N	\N	CC1=C(C(=O)C=CN1C)O	3-hydroxy-1,2-dimethyl-pyridin-4-one
2224	DEFEROXAMINE MESYLATE	DEFEROXAMINE MESYLATE	62881	C26H52N6O11S	656.793	\N	\N	7	12	23	269	44	0	832	0	0	\N	\N	CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O	N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxo-butanoyl]-hydroxy-amino]pentyl]-N'-(5-aminopentyl)-N'-hydroxy-butanediamide;methanesulfonic acid
2356	DESFERAL	DEFEROXAMINE MESYLATE	62881	C26H52N6O11S	656.793	\N	\N	7	12	23	269	44	0	832	0	0	\N	\N	CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O	N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxo-butanoyl]-hydroxy-amino]pentyl]-N'-(5-aminopentyl)-N'-hydroxy-butanediamide;methanesulfonic acid
3513	FIRMAGON	DEGARELIX ACETATE	16186010	C84H107ClN18O18	1692.338	\N	\N	18	20	41	550	121	0	3420	11	0	\N	\N	CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C.CC(=O)O	\N
7969	RESCRIPTOR	DELAVIRDINE MESYLATE	441386	C23H32N6O6S2	552.665	\N	\N	4	10	6	182	37	0	842	0	0	\N	\N	CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C.CS(=O)(=O)O	N-[2-[4-[3-(isopropylamino)-2-pyridyl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide;methanesulfonic acid
5252	M.V.I.-12 LYOPHILIZED	DEXPANTHENOL	131204	C9H19NO4	205.254	\N	-0.9	4	4	6	89.8	14	0	182	1	0	\N	\N	CC(C)(CO)C(C(=O)NCCCO)O	(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butanamide
4708	KYBELLA	DEOXYCHOLIC ACID	222528	C24H40O4	392.58	\N	4.9	3	4	4	77.8	28	0	605	10	0	\N	\N	CC(CCC(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C	(4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
3155	ENDURONYL	DESERPIDINE	8550	C32H38N2O8	578.662	\N	4.1	1	9	9	109	42	0	953	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-18-methoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
3157	ENDURONYL FORTE	DESERPIDINE	8550	C32H38N2O8	578.662	\N	4.1	1	9	9	109	42	0	953	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-18-methoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
2357	DESIPRAMINE HYDROCHLORIDE	DESIPRAMINE HYDROCHLORIDE	65327	C18H23ClN2	302.846	\N	\N	2	2	4	15.3	21	0	267	0	0	\N	\N	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methyl-propan-1-amine;hydrochloride
1456	CEDILANID-D	DESLANOSIDE	28620	C47H74O19	943.09	\N	-0.3	9	19	10	282	66	0	1760	26	0	\N	\N	CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CC(C5(C4(CCC5C6=CC(=O)OC6)O)C)O)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC9C(C(C(C(O9)CO)O)O)O)O)O	3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-3-[(2R,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-6-methyl-tetrahydropyran-2-yl]oxy-6-methyl-tetrahydropyran-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
1999	CONCENTRAID	DESMOPRESSIN ACETATE	9833407	C48H68N14O14S2	1129.276	\N	\N	14	17	19	526	78	0	2070	7	0	\N	\N	CC(=O)O.C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N	acetic acid;(2S)-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1R)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide
2208	DDAVP	DESMOPRESSIN ACETATE	9833407	C48H68N14O14S2	1129.276	\N	\N	14	17	19	526	78	0	2070	7	0	\N	\N	CC(=O)O.C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N	acetic acid;(2S)-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1R)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide
6233	NULYTELY-FLAVORED	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
1006	BEKYREE	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
2112	CYCLESSA	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
2366	DESOGESTREL AND ETHINYL ESTRADIOL	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
2368	DESOGESTREL; ETHINYL	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
2370	DESOGESTREL; ETHINYL ESTRADIOL	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
2374	DESOWEN	DESONIDE	5311066	C24H32O6	416.514	\N	2.7	2	6	2	93.1	30	0	873	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C	\N
9228	TRIDESILON	DESONIDE	5311066	C24H32O6	416.514	\N	2.7	2	6	2	93.1	30	0	873	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C	\N
9554	VERDESO	DESONIDE	5311066	C24H32O6	416.514	\N	2.7	2	6	2	93.1	30	0	873	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C	\N
2375	DESOXIMETASONE	DESOXIMETASONE	5311067	C22H29FO4	376.468	\N	2.3	2	5	2	74.6	27	0	757	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one
8965	TOPICORT	DESOXIMETASONE	5311067	C22H29FO4	376.468	\N	2.3	2	5	2	74.6	27	0	757	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one
8966	TOPICORT LP	DESOXIMETASONE	5311067	C22H29FO4	376.468	\N	2.3	2	5	2	74.6	27	0	757	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one
4677	KHEDEZLA	DESVENLAFAXINE	125017	C16H25NO2	263.381	\N	2.6	2	3	4	43.7	19	0	266	0	1	\N	\N	CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O	4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol
2218	DECADRON-LA	DEXAMETHASONE ACETATE	236702	C24H31FO6	434.504	\N	2.8	2	7	4	101	31	0	910	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)O)C)O)F)C	[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
246	AEROSEB-DEX	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
1679	CIPRODEX	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2214	DECADRON	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2220	DECASPRAY	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2392	DEXAMETHASONE INTENSOL	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2396	DEXASPORIN	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2836	DISOBROM	DEXBROMPHENIRAMINE MALEATE	6433334	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	1	0	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
2838	DISOMER	DEXBROMPHENIRAMINE MALEATE	6433334	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	1	0	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
2839	DISOPHROL	DEXBROMPHENIRAMINE MALEATE	6433334	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	1	0	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
2924	DRIXORAL	DEXBROMPHENIRAMINE MALEATE	6433334	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	1	0	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
2927	DRIXORAL PLUS	DEXBROMPHENIRAMINE MALEATE	6433334	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	1	0	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
7005	POLARAMINE	DEXCHLORPHENIRAMINE MALEATE	5281070	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	1	0	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
2404	DEXILANT	DEXLANSOPRAZOLE	9578005	C16H14F3N3O2S	369.362	\N	2.8	1	8	5	87.1	25	0	480	1	0	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
2405	DEXILANT SOLUTAB	DEXLANSOPRAZOLE	9578005	C16H14F3N3O2S	369.362	\N	2.8	1	8	5	87.1	25	0	480	1	0	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
2406	DEXLANSOPRAZOLE	DEXLANSOPRAZOLE	9578005	C16H14F3N3O2S	369.362	\N	2.8	1	8	5	87.1	25	0	480	1	0	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
2408	DEXMETHYLPHENIDATE HYDROCHLORIDE	DEXMETHYLPHENIDATE HYDROCHLORIDE	154100	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	2	0	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl (2R)-2-phenyl-2-[(2R)-2-piperidyl]acetate;hydrochloride
3598	FOCALIN	DEXMETHYLPHENIDATE HYDROCHLORIDE	154100	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	2	0	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl (2R)-2-phenyl-2-[(2R)-2-piperidyl]acetate;hydrochloride
3599	FOCALIN XR	DEXMETHYLPHENIDATE HYDROCHLORIDE	154100	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	2	0	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl (2R)-2-phenyl-2-[(2R)-2-piperidyl]acetate;hydrochloride
4284	INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)	DEXPANTHENOL	131204	C9H19NO4	205.254	\N	-0.9	4	4	6	89.8	14	0	182	1	0	\N	\N	CC(C)(CO)C(C(=O)NCCCO)O	(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butanamide
5203	M.V.I. PEDIATRIC	DEXPANTHENOL	131204	C9H19NO4	205.254	\N	-0.9	4	4	6	89.8	14	0	182	1	0	\N	\N	CC(C)(CO)C(C(=O)NCCCO)O	(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butanamide
5216	M.V.I.-12	DEXPANTHENOL	131204	C9H19NO4	205.254	\N	-0.9	4	4	6	89.8	14	0	182	1	0	\N	\N	CC(C)(CO)C(C(=O)NCCCO)O	(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butanamide
5228	M.V.I.-12	DEXPANTHENOL	131204	C9H19NO4	205.254	\N	-0.9	4	4	6	89.8	14	0	182	1	0	\N	\N	CC(C)(CO)C(C(=O)NCCCO)O	(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butanamide
5240	M.V.I.-12 (WITHOUT VITAMIN K)	DEXPANTHENOL	131204	C9H19NO4	205.254	\N	-0.9	4	4	6	89.8	14	0	182	1	0	\N	\N	CC(C)(CO)C(C(=O)NCCCO)O	(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butanamide
1122	BIPHETAMINE 12.5	DEXTROAMPHETAMINE RESIN COMPLEX	5826	C9H13N	135.21	\N	1.8	1	1	2	26	10	0	84.7	1	0	\N	\N	CC(CC1=CC=CC=C1)N	(2S)-1-phenylpropan-2-amine
1206	BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE	DEXTROMETHORPHAN HYDROBROMIDE	5464025	C18H26BrNO	352.316	\N	\N	1	2	1	12.5	21	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br	\N
3830	GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE	DEXTROMETHORPHAN HYDROBROMIDE	5464025	C18H26BrNO	352.316	\N	\N	1	2	1	12.5	21	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br	\N
2307	DELSYM	DEXTROMETHORPHAN POLISTIREX	5360696	C18H25NO	271.404	\N	3.4	0	2	1	12.5	20	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC	\N
2425	DEXTROMETHORPHAN POLISTIREX	DEXTROMETHORPHAN POLISTIREX	5360696	C18H25NO	271.404	\N	3.4	0	2	1	12.5	20	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC	\N
1642	CHOLOXIN	DEXTROTHYROXINE SODIUM	23677961	C15H12I4NNaO5	816.871	\N	\N	3	6	5	96.6	26	0	426	1	0	\N	\N	C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.O.[Na+]	sodium;(2R)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate;hydrate
682	ANGIOVIST 292	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
684	ANGIOVIST 370	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
9909	ZORVOLEX	DICLOFENAC	3033	C14H11Cl2NO2	296.147	\N	4.4	2	3	4	49.3	19	0	304	0	0	\N	\N	C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl	2-[2-(2,6-dichloroanilino)phenyl]acetic acid
685	ANGIOVIST 370	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
3700	GASTROGRAFIN	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
3703	GASTROVIST	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
4131	HYPAQUE SODIUM 20%	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
4133	HYPAQUE-76	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
4136	HYPAQUE-M,75%	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
4138	HYPAQUE-M,90%	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
5337	MD-60	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
5339	MD-76	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
2753	DIASTAT ACUDIAL	DIAZEPAM	3016	C16H13ClN2O	284.743	\N	3	0	2	1	32.7	20	0	403	0	0	\N	\N	CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
2757	DIAZEPAM	DIAZEPAM	3016	C16H13ClN2O	284.743	\N	3	0	2	1	32.7	20	0	403	0	0	\N	\N	CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
2758	DIAZEPAM INTENSOL	DIAZEPAM	3016	C16H13ClN2O	284.743	\N	3	0	2	1	32.7	20	0	403	0	0	\N	\N	CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
9458	VALRELEASE	DIAZEPAM	3016	C16H13ClN2O	284.743	\N	3	0	2	1	32.7	20	0	403	0	0	\N	\N	CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
3886	HEAVY SOLUTION NUPERCAINE	DIBUCAINE HYDROCHLORIDE	521951	C20H30ClN3O2	379.929	\N	\N	2	4	10	54.5	26	0	387	0	0	\N	\N	CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC.Cl	2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide;hydrochloride
2764	DICLOFENAC POTASSIUM	DICLOFENAC POTASSIUM	23667642	C14H10Cl2KNO2	334.237	\N	\N	1	3	4	52.2	20	0	310	0	0	\N	\N	C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[K+]	potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate
787	ARTHROTEC	DICLOFENAC SODIUM	5018304	C14H10Cl2NNaO2	318.129	\N	\N	1	3	4	52.2	20	0	310	0	0	\N	\N	C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+]	sodium;2-[2-(2,6-dichloroanilino)phenyl]acetate
2765	DICLOFENAC SODIUM	DICLOFENAC SODIUM	5018304	C14H10Cl2NNaO2	318.129	\N	\N	1	3	4	52.2	20	0	310	0	0	\N	\N	C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+]	sodium;2-[2-(2,6-dichloroanilino)phenyl]acetate
2766	DICLOFENAC SODIUM AND MISOPROSTOL	DICLOFENAC SODIUM	5018304	C14H10Cl2NNaO2	318.129	\N	\N	1	3	4	52.2	20	0	310	0	0	\N	\N	C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+]	sodium;2-[2-(2,6-dichloroanilino)phenyl]acetate
6744	PENNSAID	DICLOFENAC SODIUM	5018304	C14H10Cl2NNaO2	318.129	\N	\N	1	3	4	52.2	20	0	310	0	0	\N	\N	C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+]	sodium;2-[2-(2,6-dichloroanilino)phenyl]acetate
9691	VOLTAREN-XR	DICLOFENAC SODIUM	5018304	C14H10Cl2NNaO2	318.129	\N	\N	1	3	4	52.2	20	0	310	0	0	\N	\N	C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+]	sodium;2-[2-(2,6-dichloroanilino)phenyl]acetate
2772	DICUMAROL	DICUMAROL	54676038	C19H12O6	336.299	\N	2.6	2	6	2	93.1	25	0	605	0	0	\N	\N	C1=CC=C2C(=C1)C(=C(C(=O)O2)CC3=C(C4=CC=CC=C4OC3=O)O)O	4-hydroxy-3-[(4-hydroxy-2-oxo-chromen-3-yl)methyl]chromen-2-one
1034	BENTYL PRESERVATIVE FREE	DICYCLOMINE HYDROCHLORIDE	441344	C19H36ClNO2	345.952	\N	\N	1	3	8	29.5	23	0	326	0	0	\N	\N	CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2.Cl	2-(diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate;hydrochloride
2776	DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE)	DICYCLOMINE HYDROCHLORIDE	441344	C19H36ClNO2	345.952	\N	\N	1	3	8	29.5	23	0	326	0	0	\N	\N	CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2.Cl	2-(diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate;hydrochloride
9599	VIDEX	DIDANOSINE	50599	C10H12N4O3	236.231	\N	-1.2	2	4	2	88.7	17	0	348	2	0	\N	\N	C1CC(OC1CO)N2C=NC3=C2NC=NC3=O	9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purin-6-one
9600	VIDEX EC	DIDANOSINE	50599	C10H12N4O3	236.231	\N	-1.2	2	4	2	88.7	17	0	348	2	0	\N	\N	C1CC(OC1CO)N2C=NC3=C2NC=NC3=O	9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purin-6-one
2780	DIENESTROL	DIENESTROL	667476	C18H18O2	266.34	\N	5.4	2	2	3	40.5	20	0	318	0	0	\N	\N	CC=C(C1=CC=C(C=C1)O)C(=CC)C2=CC=C(C=C2)O	4-[(E,1E)-1-ethylidene-2-(4-hydroxyphenyl)but-2-enyl]phenol
3308	ESTRAGUARD	DIENESTROL	667476	C18H18O2	266.34	\N	5.4	2	2	3	40.5	20	0	318	0	0	\N	\N	CC=C(C1=CC=C(C=C1)O)C(=CC)C2=CC=C(C=C2)O	4-[(E,1E)-1-ethylidene-2-(4-hydroxyphenyl)but-2-enyl]phenol
3302	ESTRADIOL VALERATE AND DIENOGEST	DIENOGEST	68861	C20H25NO2	311.425	\N	1.8	1	3	1	61.1	23	0	679	4	0	\N	\N	CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2(CC#N)O	2-[(8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile
3306	ESTRADIOL VALERATE; ESTRADIOL VALERATE; DIENOGEST	DIENOGEST	68861	C20H25NO2	311.425	\N	1.8	1	3	1	61.1	23	0	679	4	0	\N	\N	CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2(CC#N)O	2-[(8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile
2781	DIETHYLPROPION HYDROCHLORIDE	DIETHYLPROPION HYDROCHLORIDE	91442	C13H20ClNO	241.759	\N	\N	1	2	5	20.3	16	0	193	0	1	\N	\N	CCN(CC)C(C)C(=O)C1=CC=CC=C1.Cl	2-(diethylamino)-1-phenyl-propan-1-one;hydrochloride
8774	TENUATE DOSPAN	DIETHYLPROPION HYDROCHLORIDE	91442	C13H20ClNO	241.759	\N	\N	1	2	5	20.3	16	0	193	0	1	\N	\N	CCN(CC)C(C)C(=O)C1=CC=CC=C1.Cl	2-(diethylamino)-1-phenyl-propan-1-one;hydrochloride
8775	TEPANIL	DIETHYLPROPION HYDROCHLORIDE	91442	C13H20ClNO	241.759	\N	\N	1	2	5	20.3	16	0	193	0	1	\N	\N	CCN(CC)C(C)C(=O)C1=CC=CC=C1.Cl	2-(diethylamino)-1-phenyl-propan-1-one;hydrochloride
8776	TEPANIL TEN-TAB	DIETHYLPROPION HYDROCHLORIDE	91442	C13H20ClNO	241.759	\N	\N	1	2	5	20.3	16	0	193	0	1	\N	\N	CCN(CC)C(C)C(=O)C1=CC=CC=C1.Cl	2-(diethylamino)-1-phenyl-propan-1-one;hydrochloride
8473	STILBESTROL	DIETHYLSTILBESTROL	448537	C18H20O2	268.356	\N	5.1	2	2	4	40.5	20	0	286	0	0	\N	\N	CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O	4-[(E)-1-ethyl-2-(4-hydroxyphenyl)but-1-enyl]phenol
8474	STILBETIN	DIETHYLSTILBESTROL	448537	C18H20O2	268.356	\N	5.1	2	2	4	40.5	20	0	286	0	0	\N	\N	CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O	4-[(E)-1-ethyl-2-(4-hydroxyphenyl)but-1-enyl]phenol
5672	MOTOFEN	DIFENOXIN HYDROCHLORIDE	34328	C28H28N2O2	424.544	\N	2.7	1	4	7	64.3	32	0	636	0	0	\N	\N	C1CN(CCC1(C2=CC=CC=C2)C(=O)O)CCC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4	1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylic acid
5674	MOTOFEN HALF-STRENGTH	DIFENOXIN HYDROCHLORIDE	34328	C28H28N2O2	424.544	\N	2.7	1	4	7	64.3	32	0	636	0	0	\N	\N	C1CN(CCC1(C2=CC=CC=C2)C(=O)O)CCC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4	1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylic acid
2785	DIFLORASONE DIACETATE	DIFLORASONE DIACETATE	71414	C26H32F2O7	494.532	\N	3	1	9	6	107	35	0	1050	9	0	\N	\N	CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)OC(=O)C)C)O)F)C)F	[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetoxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
3533	FLORONE	DIFLORASONE DIACETATE	71414	C26H32F2O7	494.532	\N	3	1	9	6	107	35	0	1050	9	0	\N	\N	CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)OC(=O)C)C)O)F)C)F	[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetoxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
3534	FLORONE E	DIFLORASONE DIACETATE	71414	C26H32F2O7	494.532	\N	3	1	9	6	107	35	0	1050	9	0	\N	\N	CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)OC(=O)C)C)O)F)C)F	[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetoxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
6692	PEG 3350 AND ELECTROLYTES	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
2150	D.H.E. 45	DIHYDROERGOTAMINE MESYLATE	71171	C34H41N5O8S	679.789	\N	\N	4	9	4	181	48	0	1260	7	0	\N	\N	CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O	\N
2793	DIHYDROERGOTAMINE MESYLATE	DIHYDROERGOTAMINE MESYLATE	71171	C34H41N5O8S	679.789	\N	\N	4	9	4	181	48	0	1260	7	0	\N	\N	CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O	\N
1416	CARDIZEM	DILTIAZEM HYDROCHLORIDE	62920	C22H27ClN2O4S	450.978	\N	\N	1	6	7	84.4	30	0	565	2	0	\N	\N	CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;hydrochloride
1417	CARDIZEM CD	DILTIAZEM HYDROCHLORIDE	62920	C22H27ClN2O4S	450.978	\N	\N	1	6	7	84.4	30	0	565	2	0	\N	\N	CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;hydrochloride
1418	CARDIZEM LA	DILTIAZEM HYDROCHLORIDE	62920	C22H27ClN2O4S	450.978	\N	\N	1	6	7	84.4	30	0	565	2	0	\N	\N	CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;hydrochloride
1419	CARDIZEM SR	DILTIAZEM HYDROCHLORIDE	62920	C22H27ClN2O4S	450.978	\N	\N	1	6	7	84.4	30	0	565	2	0	\N	\N	CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;hydrochloride
1437	CARTIA XT	DILTIAZEM HYDROCHLORIDE	62920	C22H27ClN2O4S	450.978	\N	\N	1	6	7	84.4	30	0	565	2	0	\N	\N	CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;hydrochloride
2794	DILACOR XR	DILTIAZEM HYDROCHLORIDE	62920	C22H27ClN2O4S	450.978	\N	\N	1	6	7	84.4	30	0	565	2	0	\N	\N	CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;hydrochloride
2804	DILT-CD	DILTIAZEM HYDROCHLORIDE	62920	C22H27ClN2O4S	450.978	\N	\N	1	6	7	84.4	30	0	565	2	0	\N	\N	CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;hydrochloride
8731	TECZEM	DILTIAZEM MALATE	168918	C26H32N2O9S	548.607	\N	\N	3	11	10	179	38	0	694	2	1	\N	\N	CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.C(C(C(=O)O)O)C(=O)O	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;2-hydroxybutanedioic acid
8894	TIAMATE	DILTIAZEM MALATE	168918	C26H32N2O9S	548.607	\N	\N	3	11	10	179	38	0	694	2	1	\N	\N	CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.C(C(C(=O)O)O)C(=O)O	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;2-hydroxybutanedioic acid
971	BAL	DIMERCAPROL	3080	C3H8OS2	124.216	\N	0.2	3	3	2	22.2	6	0	32	0	1	\N	\N	C(C(CS)S)O	2,3-bis(sulfanyl)propan-1-ol
4195	IMAGENT	DIMYRISTOYL LECITHIN	5459377	C36H72NO8P	677.945	\N	11.3	0	8	36	111	46	0	765	1	0	\N	\N	CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC	[(2R)-2,3-di(tetradecanoyloxy)propyl] 2-(trimethylammonio)ethyl phosphate
7757	PROSTIN F2 ALPHA	DINOPROST TROMETHAMINE	5282415	C24H45NO8	475.623	\N	\N	8	9	15	185	33	0	486	5	0	\N	\N	CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O.C(C(CO)(CO)N)O	2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid
7431	PREPIDIL	DINOPROSTONE	5280360	C20H32O5	352.471	\N	2.8	3	5	12	94.8	25	0	469	4	0	\N	\N	CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O	(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]hept-5-enoic acid
327	ALEVE PM	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
9692	VONTROL	DIPHENIDOL HYDROCHLORIDE	66266	C21H28ClNO	345.911	\N	\N	2	2	6	23.5	24	0	307	0	0	\N	\N	C1CCN(CC1)CCCC(C2=CC=CC=C2)(C3=CC=CC=C3)O.Cl	1,1-diphenyl-4-(1-piperidyl)butan-1-ol;hydrochloride
2628	DI-ATRO	DIPHENOXYLATE HYDROCHLORIDE	6432394	C30H33ClN2O2	489.056	\N	\N	1	4	9	53.3	35	0	666	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.Cl	ethyl 1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylate;hydrochloride
2826	DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE	DIPHENOXYLATE HYDROCHLORIDE	6432394	C30H33ClN2O2	489.056	\N	\N	1	4	9	53.3	35	0	666	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.Cl	ethyl 1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylate;hydrochloride
5022	LO-TROL	DIPHENOXYLATE HYDROCHLORIDE	6432394	C30H33ClN2O2	489.056	\N	\N	1	4	9	53.3	35	0	666	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.Cl	ethyl 1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylate;hydrochloride
5046	LOGEN	DIPHENOXYLATE HYDROCHLORIDE	6432394	C30H33ClN2O2	489.056	\N	\N	1	4	9	53.3	35	0	666	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.Cl	ethyl 1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylate;hydrochloride
5049	LOMANATE	DIPHENOXYLATE HYDROCHLORIDE	6432394	C30H33ClN2O2	489.056	\N	\N	1	4	9	53.3	35	0	666	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.Cl	ethyl 1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylate;hydrochloride
5051	LOMOTIL	DIPHENOXYLATE HYDROCHLORIDE	6432394	C30H33ClN2O2	489.056	\N	\N	1	4	9	53.3	35	0	666	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.Cl	ethyl 1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylate;hydrochloride
5054	LONOX	DIPHENOXYLATE HYDROCHLORIDE	6432394	C30H33ClN2O2	489.056	\N	\N	1	4	9	53.3	35	0	666	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.Cl	ethyl 1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylate;hydrochloride
3955	HISPRIL	DIPHENYLPYRALINE HYDROCHLORIDE	66063	C19H24ClNO	317.857	\N	\N	1	2	4	12.5	22	0	268	0	0	\N	\N	CN1CCC(CC1)OC(C2=CC=CC=C2)C3=CC=CC=C3.Cl	4-benzhydryloxy-1-methyl-piperidine;hydrochloride
270	AKPRO	DIPIVEFRIN HYDROCHLORIDE	71486	C19H30ClNO5	387.901	\N	\N	3	6	9	84.9	26	0	463	0	1	\N	\N	CC(C)(C)C(=O)OC1=C(C=C(C=C1)C(CNC)O)OC(=O)C(C)(C)C.Cl	[2-(2,2-dimethylpropanoyloxy)-4-[1-hydroxy-2-(methylamino)ethyl]phenyl] 2,2-dimethylpropanoate;hydrochloride
259	AGGRENOX	DIPYRIDAMOLE	3108	C24H40N8O4	504.636	\N	0.7	4	12	12	145	36	0	561	0	0	\N	\N	C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO	2-[[2-[bis(2-hydroxyethyl)amino]-4,8-bis(1-piperidyl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol
2833	DIPYRIDAMOLE	DIPYRIDAMOLE	3108	C24H40N8O4	504.636	\N	0.7	4	12	12	145	36	0	561	0	0	\N	\N	C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO	2-[[2-[bis(2-hydroxyethyl)amino]-4,8-bis(1-piperidyl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol
3005	DYNABAC	DIRITHROMYCIN	6473883	C42H78N2O14	835.086	\N	4.2	5	16	12	196	58	0	1300	20	0	\N	\N	CCC1C(C2C(C(C(CC(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)(C)O)C)NC(O2)COCCOC)C)(C)O	(1S,2R,4R,5R,6S,7S,8R,11R,12R,13R,15R,17S)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-11-ethyl-4,12-dihydroxy-7-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-15-(2-methoxyethoxymethyl)-2,4,6,8,12,17-hexamethyl-10,14-dioxa-16-azabicyclo[11.3.1]heptadecan-9-one
2841	DISOPYRAMIDE PHOSPHATE	DISOPYRAMIDE PHOSPHATE	30928	C21H32N3O5P	437.477	\N	\N	4	7	8	137	30	0	459	0	1	\N	\N	CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C.OP(=O)(O)O	4-(diisopropylamino)-2-phenyl-2-(2-pyridyl)butanamide;phosphoric acid
6161	NORPACE	DISOPYRAMIDE PHOSPHATE	30928	C21H32N3O5P	437.477	\N	\N	4	7	8	137	30	0	459	0	1	\N	\N	CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C.OP(=O)(O)O	4-(diisopropylamino)-2-phenyl-2-(2-pyridyl)butanamide;phosphoric acid
9334	TWINJECT 0.3	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
2332	DEPAKOTE	DIVALPROEX SODIUM	23663956	C16H31NaO4	310.41	\N	\N	1	4	10	77.4	21	0	192	0	0	\N	\N	CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+]	sodium;2-propylpentanoate;2-propylpentanoic acid
2861	DOBUTAMINE HYDROCHLORIDE	DOBUTAMINE HYDROCHLORIDE	65324	C18H24ClNO3	337.844	\N	\N	5	4	7	72.7	23	0	305	0	1	\N	\N	CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O.Cl	4-[2-[[3-(4-hydroxyphenyl)-1-methyl-propyl]amino]ethyl]benzene-1,2-diol;hydrochloride
2862	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%	DOBUTAMINE HYDROCHLORIDE	65324	C18H24ClNO3	337.844	\N	\N	5	4	7	72.7	23	0	305	0	1	\N	\N	CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O.Cl	4-[2-[[3-(4-hydroxyphenyl)-1-methyl-propyl]amino]ethyl]benzene-1,2-diol;hydrochloride
2863	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	DOBUTAMINE HYDROCHLORIDE	65324	C18H24ClNO3	337.844	\N	\N	5	4	7	72.7	23	0	305	0	1	\N	\N	CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O.Cl	4-[2-[[3-(4-hydroxyphenyl)-1-methyl-propyl]amino]ethyl]benzene-1,2-diol;hydrochloride
8697	TAXOTERE	DOCETAXEL	148124	C43H53NO14	807.89	\N	1.6	5	14	13	224	58	0	1660	11	0	\N	\N	CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	\N
2868	DOFETILIDE	DOFETILIDE	71329	C19H27N3O5S2	441.561	\N	1.8	2	8	11	122	29	0	672	0	0	\N	\N	CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C	N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methyl-amino]ethyl]phenyl]methanesulfonamide
8901	TIKOSYN	DOFETILIDE	71329	C19H27N3O5S2	441.561	\N	1.8	2	8	11	122	29	0	672	0	0	\N	\N	CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C	N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methyl-amino]ethyl]phenyl]methanesulfonamide
718	ANZEMET	DOLASETRON MESYLATE	60653	C20H24N2O6S	420.48	\N	\N	2	7	3	125	29	0	627	1	1	\N	\N	CS(=O)(=O)O.C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54	\N
8929	TIVICAY	DOLUTEGRAVIR SODIUM	46216142	C20H18F2N3NaO5	441.367	\N	\N	1	8	3	102	31	0	836	2	0	\N	\N	CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)[O-].[Na+]	sodium;(4R,12aS)-9-[(2,4-difluorophenyl)methylcarbamoyl]-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazin-7-olate
9291	TRIUMEQ	DOLUTEGRAVIR SODIUM	46216142	C20H18F2N3NaO5	441.367	\N	\N	1	8	3	102	31	0	836	2	0	\N	\N	CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)[O-].[Na+]	sodium;(4R,12aS)-9-[(2,4-difluorophenyl)methylcarbamoyl]-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazin-7-olate
2874	DOLUTEGRAVIR	DOLUTEGRAVIR	54726191	C20H19F2N3O5	419.385	\N	2.4	2	8	3	99.2	30	0	829	2	0	\N	\N	CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O	(4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazine-9-carboxamide
767	ARICEPT	DONEPEZIL HYDROCHLORIDE	5741	C24H30ClNO3	415.958	\N	\N	1	4	6	38.8	29	0	510	0	1	\N	\N	COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC.Cl	2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-one;hydrochloride
768	ARICEPT ODT	DONEPEZIL HYDROCHLORIDE	5741	C24H30ClNO3	415.958	\N	\N	1	4	6	38.8	29	0	510	0	1	\N	\N	COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC.Cl	2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-one;hydrochloride
5807	NAMZARIC	DONEPEZIL HYDROCHLORIDE	5741	C24H30ClNO3	415.958	\N	\N	1	4	6	38.8	29	0	510	0	1	\N	\N	COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC.Cl	2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-one;hydrochloride
2878	DOPAMINE HYDROCHLORIDE	DOPAMINE HYDROCHLORIDE	65340	C8H12ClNO2	189.639	\N	\N	4	3	2	66.5	12	0	119	0	0	\N	\N	C1=CC(=C(C=C1CCN)O)O.Cl	4-(2-aminoethyl)benzene-1,2-diol;hydrochloride
2879	DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%	DOPAMINE HYDROCHLORIDE	65340	C8H12ClNO2	189.639	\N	\N	4	3	2	66.5	12	0	119	0	0	\N	\N	C1=CC(=C(C=C1CCN)O)O.Cl	4-(2-aminoethyl)benzene-1,2-diol;hydrochloride
2880	DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER	DOPAMINE HYDROCHLORIDE	65340	C8H12ClNO2	189.639	\N	\N	4	3	2	66.5	12	0	119	0	0	\N	\N	C1=CC(=C(C=C1CCN)O)O.Cl	4-(2-aminoethyl)benzene-1,2-diol;hydrochloride
2881	DOPAMINE HYDROCHLORIDE IN DEXTROSE 5%	DOPAMINE HYDROCHLORIDE	65340	C8H12ClNO2	189.639	\N	\N	4	3	2	66.5	12	0	119	0	0	\N	\N	C1=CC(=C(C=C1CCN)O)O.Cl	4-(2-aminoethyl)benzene-1,2-diol;hydrochloride
2061	COSOPT	DORZOLAMIDE HYDROCHLORIDE	6918132	C10H17ClN2O4S3	360.886	\N	\N	3	7	3	151	20	0	534	2	0	\N	\N	CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.Cl	(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride
2063	COSOPT PF	DORZOLAMIDE HYDROCHLORIDE	6918132	C10H17ClN2O4S3	360.886	\N	\N	3	7	3	151	20	0	534	2	0	\N	\N	CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.Cl	(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride
2892	DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE	DORZOLAMIDE HYDROCHLORIDE	6918132	C10H17ClN2O4S3	360.886	\N	\N	3	7	3	151	20	0	534	2	0	\N	\N	CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.Cl	(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride
6240	NUROMAX	DOXACURIUM CHLORIDE	60168	C56H78Cl2N2O16	1106.138	\N	\N	0	18	29	163	76	0	1540	0	4	\N	\N	C[N+]1(CCC2=CC(=C(C(=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)OC)CCCOC(=O)CCC(=O)OCCC[N+]4(CCC5=CC(=C(C(=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)OC)C.[Cl-].[Cl-]	bis[3-[6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] butanedioate;dichloride
2018	CORDRAN N	FLURANDRENOLIDE	15209	C24H33FO6	436.52	\N	1.4	2	7	2	93.1	31	0	868	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)CCC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C	\N
1422	CARDURA XL	DOXAZOSIN MESYLATE	62978	C24H29N5O8S	547.583	\N	\N	2	12	4	175	38	0	770	0	1	\N	\N	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC.CS(=O)(=O)O	[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone;methanesulfonic acid
2900	DOXEPIN HYDROCHLORIDE	DOXEPIN HYDROCHLORIDE	6419921	C19H22ClNO	315.841	\N	\N	1	2	3	12.5	22	0	363	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31.Cl	(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
2901	DOXERCALCIFEROL	DOXERCALCIFEROL	5281107	C28H44O2	412.658	\N	6.3	2	2	5	40.5	30	0	712	7	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
3887	HECTOROL	DOXERCALCIFEROL	5281107	C28H44O2	412.658	\N	6.3	2	2	5	40.5	30	0	712	7	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
211	ADRIAMYCIN PFS	DOXORUBICIN HYDROCHLORIDE	443939	C27H30ClNO11	579.983	\N	\N	7	12	5	206	40	0	977	6	0	\N	\N	CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
2902	DOXIL (LIPOSOMAL)	DOXORUBICIN HYDROCHLORIDE	443939	C27H30ClNO11	579.983	\N	\N	7	12	5	206	40	0	977	6	0	\N	\N	CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
2903	DOXORUBICIN HYDROCHLORIDE	DOXORUBICIN HYDROCHLORIDE	443939	C27H30ClNO11	579.983	\N	\N	7	12	5	206	40	0	977	6	0	\N	\N	CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
9583	VIBRAMYCIN	DOXYCYCLINE CALCIUM	54671203	C22H24N2O8	444.44	\N	-0.7	6	9	2	182	32	0	956	6	0	\N	\N	CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
99	ACTICLATE	DOXYCYCLINE HYCLATE	54686183	C46H58Cl2N4O18	1025.88	\N	\N	16	20	4	385	70	0	958	12	0	\N	\N	CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
100	ACTICLATE CAP	DOXYCYCLINE HYCLATE	54686183	C46H58Cl2N4O18	1025.88	\N	\N	16	20	4	385	70	0	958	12	0	\N	\N	CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
841	ATRIDOX	DOXYCYCLINE HYCLATE	54686183	C46H58Cl2N4O18	1025.88	\N	\N	16	20	4	385	70	0	958	12	0	\N	\N	CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
7295	POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
5662	MONODOX	DOXYCYCLINE	54671203	C22H24N2O8	444.44	\N	-0.7	6	9	2	182	32	0	956	6	0	\N	\N	CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
6409	ORACEA	DOXYCYCLINE	54671203	C22H24N2O8	444.44	\N	-0.7	6	9	2	182	32	0	956	6	0	\N	\N	CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
9843	ZENAVOD	DOXYCYCLINE	54671203	C22H24N2O8	444.44	\N	-0.7	6	9	2	182	32	0	956	6	0	\N	\N	CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
2219	DECAPRYN	DOXYLAMINE SUCCINATE	11224	C21H28N2O5	388.464	\N	\N	2	7	9	100	28	0	369	0	1	\N	\N	CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O	N,N-dimethyl-2-[1-phenyl-1-(2-pyridyl)ethoxy]ethanamine;succinic acid
2762	DICLEGIS	DOXYLAMINE SUCCINATE	11224	C21H28N2O5	388.464	\N	\N	2	7	9	100	28	0	369	0	1	\N	\N	CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O	N,N-dimethyl-2-[1-phenyl-1-(2-pyridyl)ethoxy]ethanamine;succinic acid
2908	DOXY-SLEEP-AID	DOXYLAMINE SUCCINATE	11224	C21H28N2O5	388.464	\N	\N	2	7	9	100	28	0	369	0	1	\N	\N	CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O	N,N-dimethyl-2-[1-phenyl-1-(2-pyridyl)ethoxy]ethanamine;succinic acid
2914	DOXYLAMINE SUCCINATE	DOXYLAMINE SUCCINATE	11224	C21H28N2O5	388.464	\N	\N	2	7	9	100	28	0	369	0	1	\N	\N	CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O	N,N-dimethyl-2-[1-phenyl-1-(2-pyridyl)ethoxy]ethanamine;succinic acid
2915	DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE	DOXYLAMINE SUCCINATE	11224	C21H28N2O5	388.464	\N	\N	2	7	9	100	28	0	369	0	1	\N	\N	CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O	N,N-dimethyl-2-[1-phenyl-1-(2-pyridyl)ethoxy]ethanamine;succinic acid
9406	UNISOM	DOXYLAMINE SUCCINATE	11224	C21H28N2O5	388.464	\N	\N	2	7	9	100	28	0	369	0	1	\N	\N	CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O	N,N-dimethyl-2-[1-phenyl-1-(2-pyridyl)ethoxy]ethanamine;succinic acid
2929	DROLBAN	DROMOSTANOLONE PROPIONATE	224004	C23H36O3	360.538	\N	5.3	0	3	3	43.4	26	0	598	8	0	\N	\N	CCC(=O)OC1CCC2C1(CCC3C2CCC4C3(CC(C(=O)C4)C)C)C	[(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] propanoate
8624	SYNDROS	DRONABINOL	16078	C21H30O2	314.469	\N	7	1	2	4	29.5	23	0	439	2	0	\N	\N	CCCCCC1=CC2=C(C3C=C(CCC3C(O2)(C)C)C)C(=C1)O	(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol
2931	DRONEDARONE HYDROCHLORIDE	DRONEDARONE HYDROCHLORIDE	219025	C31H45ClN2O5S	593.22	\N	\N	2	7	18	97.2	40	0	800	0	0	\N	\N	CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC.Cl	N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]benzofuran-5-yl]methanesulfonamide;hydrochloride
2932	DROPERIDOL	DROPERIDOL	3168	C22H22FN3O2	379.435	\N	3.5	1	4	6	52.6	28	0	615	0	0	\N	\N	C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F	3-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one
3461	FENTANYL CITRATE AND DROPERIDOL	DROPERIDOL	3168	C22H22FN3O2	379.435	\N	3.5	1	4	6	52.6	28	0	615	0	0	\N	\N	C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F	3-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one
4218	INAPSINE	DROPERIDOL	3168	C22H22FN3O2	379.435	\N	3.5	1	4	6	52.6	28	0	615	0	0	\N	\N	C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F	3-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one
4300	INNOVAR	DROPERIDOL	3168	C22H22FN3O2	379.435	\N	3.5	1	4	6	52.6	28	0	615	0	0	\N	\N	C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F	3-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one
898	AVODART	DUTASTERIDE	6918296	C27H30F6N2O2	528.539	\N	5.4	2	8	2	58.2	37	0	964	7	0	\N	\N	CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C	(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
2803	DILOR-400	DYPHYLLINE	3182	C10H14N4O4	254.246	\N	-1.8	2	5	3	98.9	18	0	364	0	1	\N	\N	CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O	7-(2,3-dihydroxypropyl)-1,3-dimethyl-purine-2,6-dione
701	ANTHELIOS 20	ECAMSULE	6439900	C28H34O8S2	562.692	\N	3.1	2	8	6	160	38	0	1230	0	4	\N	\N	CC1(C2CCC1(C(=O)C2=CC3=CC=C(C=C3)C=C4C5CCC(C4=O)(C5(C)C)CS(=O)(=O)O)CS(=O)(=O)O)C	[(3E)-3-[[4-[(Z)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)norbornan-2-ylidene]methyl]phenyl]methylene]-7,7-dimethyl-2-oxo-norbornan-1-yl]methanesulfonic acid
705	ANTHELIOS 40	ECAMSULE	6439900	C28H34O8S2	562.692	\N	3.1	2	8	6	160	38	0	1230	0	4	\N	\N	CC1(C2CCC1(C(=O)C2=CC3=CC=C(C=C3)C=C4C5CCC(C4=O)(C5(C)C)CS(=O)(=O)O)CS(=O)(=O)O)C	[(3E)-3-[[4-[(Z)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)norbornan-2-ylidene]methyl]phenyl]methylene]-7,7-dimethyl-2-oxo-norbornan-1-yl]methanesulfonic acid
709	ANTHELIOS SX	ECAMSULE	6439900	C28H34O8S2	562.692	\N	3.1	2	8	6	160	38	0	1230	0	4	\N	\N	CC1(C2CCC1(C(=O)C2=CC3=CC=C(C=C3)C=C4C5CCC(C4=O)(C5(C)C)CS(=O)(=O)O)CS(=O)(=O)O)C	[(3E)-3-[[4-[(Z)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)norbornan-2-ylidene]methyl]phenyl]methylene]-7,7-dimethyl-2-oxo-norbornan-1-yl]methanesulfonic acid
1364	CAPITAL SOLEIL 15	ECAMSULE	6439900	C28H34O8S2	562.692	\N	3.1	2	8	6	160	38	0	1230	0	4	\N	\N	CC1(C2CCC1(C(=O)C2=CC3=CC=C(C=C3)C=C4C5CCC(C4=O)(C5(C)C)CS(=O)(=O)O)CS(=O)(=O)O)C	[(3E)-3-[[4-[(Z)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)norbornan-2-ylidene]methyl]phenyl]methylene]-7,7-dimethyl-2-oxo-norbornan-1-yl]methanesulfonic acid
1331	CALCIUM DISODIUM VERSENATE	EDETATE CALCIUM DISODIUM	6093170	C10H12CaN2Na2O8	374.27	\N	\N	0	10	7	167	23	0	293	0	0	\N	\N	C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Ca+2]	calcium;disodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate
8160	SAVAYSA	EDOXABAN TOSYLATE	44610678	C31H38ClN7O7S2	720.257	\N	\N	4	11	6	228	48	0	1090	3	0	\N	\N	CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C	N'-(5-chloro-2-pyridyl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide;4-methylbenzenesulfonic acid
3044	EDROPHONIUM CHLORIDE	EDROPHONIUM CHLORIDE	8307	C10H16ClNO	201.694	\N	\N	1	2	2	20.2	13	0	145	0	0	\N	\N	CC[N+](C)(C)C1=CC(=CC=C1)O.[Cl-]	ethyl-(3-hydroxyphenyl)-dimethyl-ammonium;chloride
3045	EDROPHONIUM CHLORIDE PRESERVATIVE FREE	EDROPHONIUM CHLORIDE	8307	C10H16ClNO	201.694	\N	\N	1	2	2	20.2	13	0	145	0	0	\N	\N	CC[N+](C)(C)C1=CC(=CC=C1)O.[Cl-]	ethyl-(3-hydroxyphenyl)-dimethyl-ammonium;chloride
3163	ENLON-PLUS	EDROPHONIUM CHLORIDE	8307	C10H16ClNO	201.694	\N	\N	1	2	2	20.2	13	0	145	0	0	\N	\N	CC[N+](C)(C)C1=CC(=CC=C1)O.[Cl-]	ethyl-(3-hydroxyphenyl)-dimethyl-ammonium;chloride
8771	TENSILON	EDROPHONIUM CHLORIDE	8307	C10H16ClNO	201.694	\N	\N	1	2	2	20.2	13	0	145	0	0	\N	\N	CC[N+](C)(C)C1=CC(=CC=C1)O.[Cl-]	ethyl-(3-hydroxyphenyl)-dimethyl-ammonium;chloride
3048	EFAVIRENZ 200MG SCORED TABLETS	EFAVIRENZ	64139	C14H9ClF3NO2	315.676	\N	4	1	5	1	38.3	21	0	519	1	0	\N	\N	C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
3051	EFAVIRENZ/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE	EFAVIRENZ	64139	C14H9ClF3NO2	315.676	\N	4	1	5	1	38.3	21	0	519	1	0	\N	\N	C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
3054	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	EFAVIRENZ	64139	C14H9ClF3NO2	315.676	\N	4	1	5	1	38.3	21	0	519	1	0	\N	\N	C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
3058	EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	EFAVIRENZ	64139	C14H9ClF3NO2	315.676	\N	4	1	5	1	38.3	21	0	519	1	0	\N	\N	C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
4785	LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ	EFAVIRENZ	64139	C14H9ClF3NO2	315.676	\N	4	1	5	1	38.3	21	0	519	1	0	\N	\N	C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
8598	SUSTIVA	EFAVIRENZ	64139	C14H9ClF3NO2	315.676	\N	4	1	5	1	38.3	21	0	519	1	0	\N	\N	C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
4586	JUBLIA	EFINACONAZOLE	489181	C18H22F2N4O	348.398	\N	2	1	6	5	54.2	25	0	470	2	0	\N	\N	CC(C(CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCC(=C)CC3	(2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylene-1-piperidyl)-1-(1,2,4-triazol-1-yl)butan-2-ol
6446	ORNIDYL	EFLORNITHINE HYDROCHLORIDE	57004	C6H13ClF2N2O2	218.629	\N	\N	4	6	5	89.3	13	0	166	0	1	\N	\N	C(CC(C(F)F)(C(=O)O)N)CN.Cl	2,5-diamino-2-(difluoromethyl)pentanoic acid;hydrochloride
7925	RELPAX	ELETRIPTAN HYDROBROMIDE	656631	C22H27BrN2O2S	463.434	\N	\N	2	3	6	61.6	28	0	582	1	0	\N	\N	CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4.Br	5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole;hydrobromide
7661	PROMACTA	ELTROMBOPAG OLAMINE	9915926	C29H36N6O6	564.643	\N	\N	7	11	7	204	41	0	974	0	0	\N	\N	CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)NN=C3C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C.C(CO)N.C(CO)N	2-aminoethanol;3-[(5E)-5-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]hydrazono]-6-oxo-cyclohexa-1,3-dien-1-yl]benzoic acid
3108	ELTROMBOPAG	ELTROMBOPAG	9846180	C25H22N4O4	442.475	\N	4.5	3	7	5	111	33	0	964	0	0	\N	\N	CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)NN=C3C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C	3-[(5E)-5-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]hydrazono]-6-oxo-cyclohexa-1,3-dien-1-yl]benzoic acid
9579	VIBERZI	ELUXADOLINE	11250029	C32H35N5O5	569.662	\N	0.9	4	7	11	165	42	0	917	2	0	\N	\N	CC1=CC(=CC(=C1CC(C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)C(C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N	5-[[[(2S)-2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)propanoyl]-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxy-benzoic acid
8487	STRIBILD	ELVITEGRAVIR	5277135	C23H23ClFNO5	447.887	\N	5.3	2	7	7	87.1	31	0	702	1	0	\N	\N	CC(C)C(CO)N1C=C(C(=O)C2=CC(=C(C=C21)OC)CC3=C(C(=CC=C3)Cl)F)C(=O)O	6-[(3-chloro-2-fluoro-phenyl)methyl]-1-[(1S)-1-(hydroxymethyl)-2-methyl-propyl]-7-methoxy-4-oxo-quinoline-3-carboxylic acid
9674	VITEKTA	ELVITEGRAVIR	5277135	C23H23ClFNO5	447.887	\N	5.3	2	7	7	87.1	31	0	702	1	0	\N	\N	CC(C)C(CO)N1C=C(C(=O)C2=CC(=C(C=C21)OC)CC3=C(C(=CC=C3)Cl)F)C(=O)O	6-[(3-chloro-2-fluoro-phenyl)methyl]-1-[(1S)-1-(hydroxymethyl)-2-methyl-propyl]-7-methoxy-4-oxo-quinoline-3-carboxylic acid
3800	GLYXAMBI	EMPAGLIFLOZIN	11949646	C23H27ClO7	450.912	\N	2	4	7	6	109	31	0	558	6	0	\N	\N	C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl	(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-tetrahydrofuran-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
4576	JARDIANCE	EMPAGLIFLOZIN	11949646	C23H27ClO7	450.912	\N	2	4	7	6	109	31	0	558	6	0	\N	\N	C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl	(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-tetrahydrofuran-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
2354	DESCOVY	EMTRICITABINE	60877	C8H10FN3O3S	247.244	\N	-0.6	2	5	2	113	16	0	374	2	0	\N	\N	C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F	4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
3132	EMTRICITABINE	EMTRICITABINE	60877	C8H10FN3O3S	247.244	\N	-0.6	2	5	2	113	16	0	374	2	0	\N	\N	C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F	4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
3133	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	EMTRICITABINE	60877	C8H10FN3O3S	247.244	\N	-0.6	2	5	2	113	16	0	374	2	0	\N	\N	C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F	4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
3136	EMTRIVA	EMTRICITABINE	60877	C8H10FN3O3S	247.244	\N	-0.6	2	5	2	113	16	0	374	2	0	\N	\N	C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F	4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
3140	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE	ENALAPRIL MALEATE	5388961	C24H32N2O9	492.525	\N	\N	4	10	12	171	35	0	638	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O	(2S)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid;maleic acid
3190	EPANED	ENALAPRIL MALEATE	5388961	C24H32N2O9	492.525	\N	\N	4	10	12	171	35	0	638	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O	(2S)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid;maleic acid
3191	EPANED KIT	ENALAPRIL MALEATE	5388961	C24H32N2O9	492.525	\N	\N	4	10	12	171	35	0	638	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O	(2S)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid;maleic acid
9498	VASERETIC	ENALAPRIL MALEATE	5388961	C24H32N2O9	492.525	\N	\N	4	10	12	171	35	0	638	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O	(2S)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid;maleic acid
3170	ENOXAPARIN SODIUM	ENOXAPARIN SODIUM	772	C26H42N2O37S5	1134.899	\N	-10.8	15	38	21	652	70	0	2410	0	20	\N	\N	CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O	6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)tetrahydropyran-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxy-tetrahydropyran-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxy-tetrahydropyran-3-yl]oxy-3,4-dihydroxy-5-sulfooxy-tetrahydropyran-2-carboxylic acid
3171	ENOXAPARIN SODIUM (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	772	C26H42N2O37S5	1134.899	\N	-10.8	15	38	21	652	70	0	2410	0	20	\N	\N	CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O	6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)tetrahydropyran-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxy-tetrahydropyran-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxy-tetrahydropyran-3-yl]oxy-3,4-dihydroxy-5-sulfooxy-tetrahydropyran-2-carboxylic acid
1998	COMTAN	ENTACAPONE	5281081	C14H15N3O5	305.29	\N	2.1	2	6	4	130	22	0	500	0	0	\N	\N	CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N	(E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide
3180	ENTACAPONE	ENTACAPONE	5281081	C14H15N3O5	305.29	\N	2.1	2	6	4	130	22	0	500	0	0	\N	\N	CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N	(E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide
8422	STALEVO 100	ENTACAPONE	5281081	C14H15N3O5	305.29	\N	2.1	2	6	4	130	22	0	500	0	0	\N	\N	CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N	(E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide
8425	STALEVO 125	ENTACAPONE	5281081	C14H15N3O5	305.29	\N	2.1	2	6	4	130	22	0	500	0	0	\N	\N	CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N	(E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide
992	BARACLUDE	ENTECAVIR	153941	C12H15N5O3	277.284	\N	-0.8	4	4	2	126	20	0	480	3	0	\N	\N	C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N	2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylene-cyclopentyl]-3H-purin-6-one
9773	XTANDI	ENZALUTAMIDE	15951529	C21H16F4N4O2S	464.439	\N	3.6	1	8	3	109	32	0	839	0	0	\N	\N	CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C	4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-imidazolidin-1-yl]-2-fluoro-N-methyl-benzamide
3078	ELESTAT	EPINASTINE HYDROCHLORIDE	157313	C16H16ClN3	285.775	\N	\N	2	1	0	41.6	20	0	378	0	1	\N	\N	C1C2C3=CC=CC=C3CC4=CC=CC=C4N2C(=N1)N.Cl	\N
3203	EPINASTINE HYDROCHLORIDE	EPINASTINE HYDROCHLORIDE	157313	C16H16ClN3	285.775	\N	\N	2	1	0	41.6	20	0	378	0	1	\N	\N	C1C2C3=CC=CC=C3CC4=CC=CC=C4N2C(=N1)N.Cl	\N
208	ADRENACLICK	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
209	ADRENALIN	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
368	ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
873	AUVI-Q	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
2976	DURANEST	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
3212	EPLERENONE	EPLERENONE	443872	C24H30O6	414.498	\N	1.4	0	6	2	82.2	30	0	907	8	0	\N	\N	CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC	\N
4336	INSPRA	EPLERENONE	443872	C24H30O6	414.498	\N	1.4	0	6	2	82.2	30	0	907	8	0	\N	\N	CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC	\N
3214	EPOPROSTENOL SODIUM	EPOPROSTENOL SODIUM	6364626	C20H31NaO5	374.453	\N	\N	2	5	10	89.8	26	0	491	5	0	\N	\N	CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)[O-])O2)O)O.[Na+]	sodium;(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate
3527	FLOLAN	EPOPROSTENOL SODIUM	6364626	C20H31NaO5	374.453	\N	\N	2	5	10	89.8	26	0	491	5	0	\N	\N	CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)[O-])O2)O)O.[Na+]	sodium;(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate
3217	EPTIFIBATIDE	EPTIFIBATIDE	448812	C35H49N11O9S2	831.965	\N	-2.4	10	12	10	377	57	0	1520	5	0	\N	\N	C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N	2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-(4-guanidinobutyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid
4344	INTEGRILIN	EPTIFIBATIDE	448812	C35H49N11O9S2	831.965	\N	-2.4	10	12	10	377	57	0	1520	5	0	\N	\N	C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N	2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-(4-guanidinobutyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid
1054	BEROCCA PN	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
2923	DRISDOL	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
340	ALKERGOT	ERGOLOID MESYLATES	71717894	C134H184N20O32S4	2715.294	\N	\N	16	36	19	724	190	0	4690	28	1	\N	\N	CCC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O	\N
5820	NAPROXEN AND ESOMEPRAZOLE MAGNESIUM	ESOMEPRAZOLE MAGNESIUM	130564	C34H36MgN6O6S2	713.123	\N	\N	0	14	10	163	49	0	453	0	2	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Mg+2]	magnesium;5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-ide
3854	HALAVEN	ERIBULIN MESYLATE	17755248	C41H63NO14S	826.008	\N	\N	3	15	4	209	57	0	1470	19	0	\N	\N	CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O.CS(=O)(=O)O	\N
3237	ERLOTINIB HYDROCHLORIDE	ERLOTINIB HYDROCHLORIDE	176871	C22H24ClN3O4	429.901	\N	\N	2	7	11	74.7	30	0	525	0	0	\N	\N	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl	N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride
8682	TARCEVA	ERLOTINIB HYDROCHLORIDE	176871	C22H24ClN3O4	429.901	\N	\N	2	7	11	74.7	30	0	525	0	0	\N	\N	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl	N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride
3259	ERYTHROMYCIN ESTOLATE	ERYTHROMYCIN ESTOLATE	441371	C52H97NO18S	1056.397	\N	\N	5	19	22	272	72	0	1550	18	0	\N	\N	CCCCCCCCCCCCOS(=O)(=O)O.CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CC)(C)O)C)C)O)(C)O	[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] propanoate;dodecyl hydrogen sulfate
4189	ILOSONE	ERYTHROMYCIN ESTOLATE	441371	C52H97NO18S	1056.397	\N	\N	5	19	22	272	72	0	1550	18	0	\N	\N	CCCCCCCCCCCCOS(=O)(=O)O.CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CC)(C)O)C)C)O)(C)O	[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] propanoate;dodecyl hydrogen sulfate
4190	ILOSONE SULFA	ERYTHROMYCIN ESTOLATE	441371	C52H97NO18S	1056.397	\N	\N	5	19	22	272	72	0	1550	18	0	\N	\N	CCCCCCCCCCCCOS(=O)(=O)O.CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CC)(C)O)C)C)O)(C)O	[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] propanoate;dodecyl hydrogen sulfate
3015	E-MYCIN E	ERYTHROMYCIN ETHYLSUCCINATE	443953	C43H75NO16	862.064	\N	3.4	4	17	14	226	60	0	1450	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O	O4-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] O1-ethyl butanedioate
3029	E.E.S.	ERYTHROMYCIN ETHYLSUCCINATE	443953	C43H75NO16	862.064	\N	3.4	4	17	14	226	60	0	1450	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O	O4-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] O1-ethyl butanedioate
4193	ILOTYCIN GLUCEPTATE	ERYTHROMYCIN GLUCEPTATE	16051953	C44H81NO21	960.118	\N	\N	12	22	13	353	66	0	1380	23	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O.C(C(C(C(C(C(C(=O)O)O)O)O)O)O)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;(2R,3R,4S,5R,6R)-2,3,4,5,6,7-hexahydroxyheptanoic acid
3256	ERYTHROMYCIN	ERYTHROMYCIN LACTOBIONATE	71469	C49H89NO25	1092.233	\N	\N	14	26	15	412	75	0	1580	27	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O.C(C1C(C(C(C(O1)OC(C(CO)O)C(C(C(=O)O)O)O)O)O)O)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;(2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hexanoic acid
3263	ERYTHROMYCIN LACTOBIONATE	ERYTHROMYCIN LACTOBIONATE	71469	C49H89NO25	1092.233	\N	\N	14	26	15	412	75	0	1580	27	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O.C(C1C(C(C(C(O1)OC(C(CO)O)C(C(C(=O)O)O)O)O)O)O)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;(2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hexanoic acid
6	A/T/S	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
5982	NEXIUM	ESOMEPRAZOLE MAGNESIUM	130564	C34H36MgN6O6S2	713.123	\N	\N	0	14	10	163	49	0	453	0	2	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Mg+2]	magnesium;5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-ide
750	ARANELLE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4916	LEXAPRO	ESCITALOPRAM OXALATE	146571	C22H23FN2O5	414.433	\N	\N	2	8	6	111	30	0	537	1	0	\N	\N	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O	(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile;oxalic acid
1170	BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER	ESMOLOL HYDROCHLORIDE	104769	C16H26ClNO4	331.837	\N	\N	3	5	10	67.8	22	0	288	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O.Cl	methyl 3-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]propanoate;hydrochloride
1171	BREVIBLOC IN PLASTIC CONTAINER	ESMOLOL HYDROCHLORIDE	104769	C16H26ClNO4	331.837	\N	\N	3	5	10	67.8	22	0	288	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O.Cl	methyl 3-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]propanoate;hydrochloride
3283	ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER	ESMOLOL HYDROCHLORIDE	104769	C16H26ClNO4	331.837	\N	\N	3	5	10	67.8	22	0	288	0	1	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O.Cl	methyl 3-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]propanoate;hydrochloride
3285	ESOMEPRAZOLE MAGNESIUM	ESOMEPRAZOLE MAGNESIUM	130564	C34H36MgN6O6S2	713.123	\N	\N	0	14	10	163	49	0	453	0	2	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Mg+2]	magnesium;5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-ide
800	ASHLYNA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3287	ESOMEPRAZOLE STRONTIUM	ESOMEPRAZOLE STRONTIUM	9568614	C17H19N3O3S	345.417	\N	2.2	1	6	5	96.3	24	0	453	1	0	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	6-methoxy-2-[(S)-(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
7752	PROSOM	ESTAZOLAM	3261	C16H11ClN4	294.742	\N	1.7	0	3	1	43.1	21	0	407	0	0	\N	\N	C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4	8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
3451	FEMTRACE	ESTRADIOL ACETATE	9818306	C20H26O3	314.425	\N	2.8	1	3	2	46.5	23	0	476	5	0	\N	\N	CC(=O)OC1=CC2=C(C=C1)C3CCC4(C(C3CC2)CCC4O)C	[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate
2339	DEPO-ESTRADIOL	ESTRADIOL CYPIONATE	9403	C26H36O3	396.571	\N	7.1	1	3	5	46.5	29	0	597	5	0	\N	\N	CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=C3C=CC(=C5)O	[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
2343	DEPO-TESTADIOL	ESTRADIOL CYPIONATE	9403	C26H36O3	396.571	\N	7.1	1	3	5	46.5	29	0	597	5	0	\N	\N	CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=C3C=CC(=C5)O	[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
398	AMABELZ	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
678	ANGELIQ	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3079	ELESTRIN	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3270	ESCLIM	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3293	ESTRACE	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
892	AVIANE-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3364	EVEX	ESTROGENS, ESTERIFIED	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3313	ESTROGENIC SUBSTANCE	ESTRONE	5870	C18H22O2	270.372	\N	3.1	1	2	0	37.3	20	0	418	4	0	\N	\N	CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one
3314	ESTRONE	ESTRONE	5870	C18H22O2	270.372	\N	3.1	1	2	0	37.3	20	0	418	4	0	\N	\N	CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one
8835	THEELIN	ESTRONE	5870	C18H22O2	270.372	\N	3.1	1	2	0	37.3	20	0	418	4	0	\N	\N	CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one
6307	OGEN	ESTROPIPATE	5284555	C22H32N2O5S	436.567	\N	\N	3	7	2	113	30	0	650	4	0	\N	\N	CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1	[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine
6308	OGEN .625	ESTROPIPATE	5284555	C22H32N2O5S	436.567	\N	\N	3	7	2	113	30	0	650	4	0	\N	\N	CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1	[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine
6309	OGEN 1.25	ESTROPIPATE	5284555	C22H32N2O5S	436.567	\N	\N	3	7	2	113	30	0	650	4	0	\N	\N	CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1	[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine
3321	ESZOPICLONE	ESZOPICLONE	969472	C17H17ClN6O3	388.812	\N	0.5	0	7	3	91.8	27	0	573	1	0	\N	\N	CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl	[(7S)-6-(5-chloro-2-pyridyl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate
5133	LUNESTA	ESZOPICLONE	969472	C17H17ClN6O3	388.812	\N	0.5	0	7	3	91.8	27	0	573	1	0	\N	\N	CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl	[(7S)-6-(5-chloro-2-pyridyl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate
3040	EDECRIN	ETHACRYNATE SODIUM	23668825	C13H11Cl2NaO4	325.117	\N	\N	0	4	6	66.4	20	0	375	0	0	\N	\N	CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)[O-])Cl)Cl.[Na+]	sodium;2-[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetate
3322	ETHACRYNATE SODIUM	ETHACRYNATE SODIUM	23668825	C13H11Cl2NaO4	325.117	\N	\N	0	4	6	66.4	20	0	375	0	0	\N	\N	CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)[O-])Cl)Cl.[Na+]	sodium;2-[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetate
3324	ETHAMBUTOL HYDROCHLORIDE	ETHAMBUTOL HYDROCHLORIDE	14052	C10H24N2O2	204.314	\N	-0.1	4	4	9	64.5	14	0	109	2	0	\N	\N	CCC(CO)NCCNC(CC)CO	(2S)-2-[2-[[(1S)-1-(hydroxymethyl)propyl]amino]ethylamino]butan-1-ol
5729	MYAMBUTOL	ETHAMBUTOL HYDROCHLORIDE	14052	C10H24N2O2	204.314	\N	-0.1	4	4	9	64.5	14	0	109	2	0	\N	\N	CCC(CO)NCCNC(CC)CO	(2S)-2-[2-[[(1S)-1-(hydroxymethyl)propyl]amino]ethylamino]butan-1-ol
3327	ETHCHLORVYNOL	ETHCHLORVYNOL	5281077	C7H9ClO	144.598	\N	1.5	1	1	3	20.2	9	0	154	0	1	\N	\N	CCC(C=CCl)(C#C)O	(E)-1-chloro-3-ethyl-pent-1-en-4-yn-3-ol
324	ALESSE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
385	ALTAVERA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
392	ALYACEN 1/35	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2969	DURAGESIC-12	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
9819	ZARONTIN	ETHOSUXIMIDE	3291	C7H11NO2	141.17	\N	0.4	1	2	1	46.2	10	0	188	0	1	\N	\N	CCC1(CC(=O)NC1=O)C	3-ethyl-3-methyl-pyrrolidine-2,5-dione
6717	PEGANONE	ETHOTOIN	3292	C11H12N2O2	204.229	\N	1	1	2	2	49.4	15	0	272	0	1	\N	\N	CCN1C(=O)C(NC1=O)C2=CC=CC=C2	3-ethyl-5-phenyl-imidazolidine-2,4-dione
1420	CARDRASE	ETHOXZOLAMIDE	3295	C9H10N2O3S2	258.31	\N	2	1	6	3	119	16	0	341	0	0	\N	\N	CCOC1=CC2=C(C=C1)N=C(S2)S(=O)(=O)N	6-ethoxy-1,3-benzothiazole-2-sulfonamide
2322	DEMULEN 1/35-28	ETHYNODIOL DIACETATE	9270	C24H32O4	384.516	\N	3.9	0	4	5	52.6	28	0	758	7	0	\N	\N	CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C	[(3S,8R,9S,10R,13S,14S,17R)-17-acetoxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
2977	DURANEST	ETIDOCAINE HYDROCHLORIDE	37497	C17H28N2O	276.424	\N	3.7	1	2	7	32.3	20	0	283	0	1	\N	\N	CCCN(CC)C(CC)C(=O)NC1=C(C=CC=C1C)C	N-(2,6-dimethylphenyl)-2-[ethyl(propyl)amino]butanamide
2978	DURANEST	ETIDOCAINE HYDROCHLORIDE	37497	C17H28N2O	276.424	\N	3.7	1	2	7	32.3	20	0	283	0	1	\N	\N	CCCN(CC)C(CC)C(=O)NC1=C(C=CC=C1C)C	N-(2,6-dimethylphenyl)-2-[ethyl(propyl)amino]butanamide
2779	DIDRONEL	ETIDRONATE DISODIUM	23894	C2H6Na2O7P2	249.99	\N	\N	3	7	2	141	13	0	206	0	0	\N	\N	CC(O)(P(=O)(O)[O-])P(=O)(O)[O-].[Na+].[Na+]	disodium;hydroxy-[1-hydroxy-1-[hydroxy(oxido)phosphoryl]ethyl]phosphinate
3338	ETIDRONATE DISODIUM	ETIDRONATE DISODIUM	23894	C2H6Na2O7P2	249.99	\N	\N	3	7	2	141	13	0	206	0	0	\N	\N	CC(O)(P(=O)(O)[O-])P(=O)(O)[O-].[Na+].[Na+]	disodium;hydroxy-[1-hydroxy-1-[hydroxy(oxido)phosphoryl]ethyl]phosphinate
3339	ETODOLAC	ETODOLAC	3308	C17H21NO3	287.359	\N	2.8	2	3	4	62.3	21	0	400	0	1	\N	\N	CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O	2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid
3341	ETOPOPHOS PRESERVATIVE FREE	ETOPOSIDE PHOSPHATE	6918092	C29H33O16P	668.541	\N	-0.7	4	16	7	207	46	0	1140	10	0	\N	\N	CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)OP(=O)(O)O)OC)O)O	[4-[(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-8-oxo-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,3]benzodioxol-9-yl]-2,6-dimethoxy-phenyl] dihydrogen phosphate
3342	ETOPOSIDE	ETOPOSIDE	36462	C29H32O13	588.562	\N	0.6	3	13	5	161	42	0	969	10	0	\N	\N	CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O	(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one
8969	TOPOSAR	ETOPOSIDE	36462	C29H32O13	588.562	\N	0.6	3	13	5	161	42	0	969	10	0	\N	\N	CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O	(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one
4345	INTELENCE	ETRAVIRINE	193962	C20H15BrN6O	435.285	\N	4.5	2	7	4	121	28	0	609	0	0	\N	\N	CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N	4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethyl-benzonitrile
8735	TEGISON	ETRETINATE	5282375	C23H30O3	354.49	\N	6.8	0	3	8	35.5	26	0	568	0	0	\N	\N	CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C(=C(C=C1C)OC)C)C	ethyl (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoate
3362	EVANS BLUE	EVANS BLUE	6321418	C34H24N6Na4O14S4	960.793	\N	\N	4	20	5	397	62	0	2000	0	0	\N	\N	CC1=C(C=CC(=C1)C2=CC(=C(C=C2)NN=C3C=CC4=C(C3=O)C(=C(C=C4S(=O)(=O)[O-])S(=O)(=O)[O-])N)C)NN=C5C=CC6=C(C5=O)C(=C(C=C6S(=O)(=O)[O-])S(=O)(=O)[O-])N.[Na+].[Na+].[Na+].[Na+]	tetrasodium;(6E)-4-amino-6-[[4-[4-[(2Z)-2-(8-amino-1-oxo-5,7-disulfonato-2-naphthylidene)hydrazino]-3-methyl-phenyl]-2-methyl-phenyl]hydrazono]-5-oxo-naphthalene-1,3-disulfonate
783	AROMASIN	EXEMESTANE	60198	C20H24O2	296.41	\N	3.1	0	2	0	34.1	22	0	653	5	0	\N	\N	CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C	(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione
3401	EZETIMIBE	EZETIMIBE	150311	C24H21F2NO3	409.433	\N	4	2	5	6	60.8	30	0	567	3	0	\N	\N	C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O	(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxy-propyl]-4-(4-hydroxyphenyl)azetidin-2-one
3402	EZETIMIBE; SIMVASTATIN	EZETIMIBE	150311	C24H21F2NO3	409.433	\N	4	2	5	6	60.8	30	0	567	3	0	\N	\N	C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O	(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxy-propyl]-4-(4-hydroxyphenyl)azetidin-2-one
9854	ZETIA	EZETIMIBE	150311	C24H21F2NO3	409.433	\N	4	2	5	6	60.8	30	0	567	3	0	\N	\N	C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O	(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxy-propyl]-4-(4-hydroxyphenyl)azetidin-2-one
3420	FAMVIR	FAMCICLOVIR	3324	C14H19N5O4	321.337	\N	0	1	8	9	122	23	0	404	0	0	\N	\N	CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C	[2-(acetoxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate
3414	FAMOTIDINE PRESERVATIVE FREE	FAMOTIDINE	5702160	C8H15N7O2S3	337.435	\N	-0.6	4	8	7	238	20	0	469	0	0	\N	\N	C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N	3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N'-sulfamoyl-propanamidine
3415	FAMOTIDINE PRESERVATIVE FREE (PHARMACY BULK)	FAMOTIDINE	5702160	C8H15N7O2S3	337.435	\N	-0.6	4	8	7	238	20	0	469	0	0	\N	\N	C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N	3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N'-sulfamoyl-propanamidine
3416	FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER	FAMOTIDINE	5702160	C8H15N7O2S3	337.435	\N	-0.6	4	8	7	238	20	0	469	0	0	\N	\N	C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N	3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N'-sulfamoyl-propanamidine
3418	FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE	FAMOTIDINE	5702160	C8H15N7O2S3	337.435	\N	-0.6	4	8	7	238	20	0	469	0	0	\N	\N	C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N	3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N'-sulfamoyl-propanamidine
6765	PEPCID	FAMOTIDINE	5702160	C8H15N7O2S3	337.435	\N	-0.6	4	8	7	238	20	0	469	0	0	\N	\N	C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N	3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N'-sulfamoyl-propanamidine
9374	ULORIC	FEBUXOSTAT	134018	C16H16N2O3S	316.375	\N	3.9	1	6	5	111	22	0	448	0	0	\N	\N	CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O	2-(3-cyano-4-isobutoxy-phenyl)-4-methyl-thiazole-5-carboxylic acid
3434	FELBATOL	FELBAMATE	3331	C11H14N2O4	238.243	\N	0.6	2	4	7	105	17	0	246	0	0	\N	\N	C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N	(3-carbamoyloxy-2-phenyl-propyl) carbamate
3436	FELODIPINE	FELODIPINE	3333	C18H19Cl2NO4	384.253	\N	3.9	1	5	6	64.6	25	0	614	0	1	\N	\N	CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C	O5-ethyl O3-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
2025	CORLOPAM	FENOLDOPAM MESYLATE	49659	C17H20ClNO6S	401.858	\N	\N	5	7	1	136	26	0	441	0	1	\N	\N	CS(=O)(=O)O.C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O	9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol;methanesulfonic acid
3456	FENOLDOPAM MESYLATE	FENOLDOPAM MESYLATE	49659	C17H20ClNO6S	401.858	\N	\N	5	7	1	136	26	0	441	0	1	\N	\N	CS(=O)(=O)O.C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O	9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol;methanesulfonic acid
344	ALLEGRA ALLERGY	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
345	ALLEGRA HIVES	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
346	ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
348	ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
1561	CHILDREN'S ALLEGRA ALLERGY	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
1562	CHILDREN'S ALLEGRA HIVES	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
1567	CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
1568	CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
8614	SYNALAR	FLUOCINOLONE ACETONIDE	6215	C24H30F2O6	452.495	\N	2.5	2	8	2	93.1	32	0	960	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C	\N
8615	SYNALAR-HP	FLUOCINOLONE ACETONIDE	6215	C24H30F2O6	452.495	\N	2.5	2	8	2	93.1	32	0	960	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C	\N
9774	XTORO	FINAFLOXACIN	11567473	C20H19FN4O4	398.394	\N	-0.7	2	9	3	106	29	0	806	2	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)C#N)N4CC5C(C4)OCCN5)F)C(=O)O	7-[(4aS,7aS)-3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxo-quinoline-3-carboxylic acid
7721	PROPECIA	FINASTERIDE	57363	C23H36N2O2	372.553	\N	3	2	2	2	58.2	27	0	678	7	0	\N	\N	CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C	(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
9418	URISPAS	FLAVOXATE HYDROCHLORIDE	441345	C24H26ClNO4	427.925	\N	\N	1	5	6	55.8	30	0	631	0	0	\N	\N	CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4.Cl	2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenyl-chromene-8-carboxylate;hydrochloride
8672	TAMBOCOR	FLECAINIDE ACETATE	41022	C19H24F6N2O5	474.4	\N	\N	3	12	7	96.9	32	0	531	0	1	\N	\N	CC(=O)O.C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F	acetic acid;N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide
199	ADDYI	FLIBANSERIN	6918248	C20H21F3N4O	390.41	\N	3.3	1	6	4	38.8	28	0	550	0	0	\N	\N	C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F	3-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1H-benzimidazol-2-one
646	AMYVID	FLORBETAPIR F-18	24822371	C20H25FN2O3	359.432	\N	3.5	1	6	12	52.6	26	0	376	0	0	\N	\N	CNC1=CC=C(C=C1)C=CC2=CN=C(C=C2)OCCOCCOCCF	4-[(E)-2-[6-[2-[2-(2-fluoranylethoxy)ethoxy]ethoxy]-3-pyridyl]vinyl]-N-methyl-aniline
3547	FLOXURIDINE	FLOXURIDINE	5790	C9H11FN2O5	246.194	\N	-1.2	3	6	2	99.1	17	0	386	3	0	\N	\N	C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O	5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione
3659	FUDR	FLOXURIDINE	5790	C9H11FN2O5	246.194	\N	-1.2	3	6	2	99.1	17	0	386	3	0	\N	\N	C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O	5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione
2787	DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER	FLUCONAZOLE	3365	C13H12F2N6O	306.277	\N	0.4	1	7	5	81.6	22	0	358	0	0	\N	\N	C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O	2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol
2788	DIFLUCAN IN SODIUM CHLORIDE 0.9%	FLUCONAZOLE	3365	C13H12F2N6O	306.277	\N	0.4	1	7	5	81.6	22	0	358	0	0	\N	\N	C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O	2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol
660	ANCOBON	FLUCYTOSINE	3366	C4H4FN3O	129.094	\N	-0.9	2	3	0	67.5	9	0	208	0	0	\N	\N	C1=NC(=O)NC(=C1F)N	6-amino-5-fluoro-1H-pyrimidin-2-one
3554	FLUDARABINE PHOSPHATE	FLUDARABINE PHOSPHATE	30751	C10H13FN5O7P	365.214	\N	-3.1	5	12	4	186	24	0	514	4	0	\N	\N	C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(N=C2N)F	[(2R,3S,4S,5R)-5-(6-amino-2-fluoro-purin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate
3559	FLUMAZENIL	FLUMAZENIL	3373	C15H14FN3O3	303.293	\N	1	0	5	3	64.4	22	0	461	0	0	\N	\N	CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C	ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
5031	LOCORTEN	FLUMETHASONE PIVALATE	443980	C27H36F2O6	494.576	\N	3.9	2	8	5	101	35	0	1030	9	0	\N	\N	CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C(C)(C)C)O)C)O)F)C)F	[2-[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] 2,2-dimethylpropanoate
240	AEROBID	FLUNISOLIDE	82153	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	910	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C	\N
248	AEROSPAN HFA	FLUNISOLIDE	82153	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	910	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C	\N
5836	NASALIDE	FLUNISOLIDE	82153	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	910	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C	\N
5837	NASAREL	FLUNISOLIDE	82153	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	910	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C	\N
3561	FLUOCET	FLUOCINOLONE ACETONIDE	6215	C24H30F2O6	452.495	\N	2.5	2	8	2	93.1	32	0	960	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C	\N
3562	FLUOCINOLONE ACETONIDE	FLUOCINOLONE ACETONIDE	6215	C24H30F2O6	452.495	\N	2.5	2	8	2	93.1	32	0	960	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C	\N
3565	FLUONID	FLUOCINOLONE ACETONIDE	6215	C24H30F2O6	452.495	\N	2.5	2	8	2	93.1	32	0	960	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C	\N
3572	FLUOTREX	FLUOCINOLONE ACETONIDE	6215	C24H30F2O6	452.495	\N	2.5	2	8	2	93.1	32	0	960	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C	\N
5896	NEO-SYNALAR	FLUOCINOLONE ACETONIDE	6215	C24H30F2O6	452.495	\N	2.5	2	8	2	93.1	32	0	960	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C	\N
3518	FLAREX	FLUOROMETHOLONE ACETATE	240767	C24H31FO5	418.505	\N	2.6	1	6	3	80.7	30	0	892	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)OC(=O)C	[(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11-hydroxy-6,10,13-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate
8945	TOBRASONE	FLUOROMETHOLONE ACETATE	240767	C24H31FO5	418.505	\N	2.6	1	6	3	80.7	30	0	892	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)OC(=O)C	[(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11-hydroxy-6,10,13-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate
3566	FLUOR-OP	FLUOROMETHOLONE	9878	C22H29FO4	376.468	\N	2	2	5	1	74.6	27	0	787	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O	(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
3590	FML	FLUOROMETHOLONE	9878	C22H29FO4	376.468	\N	2	2	5	1	74.6	27	0	787	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O	(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
212	ADRUCIL	FLUOROURACIL	3385	C4H3FN2O2	130.078	\N	-0.9	2	3	0	58.2	9	0	199	0	0	\N	\N	C1=C(C(=O)NC(=O)N1)F	5-fluoro-1H-pyrimidine-2,4-dione
1380	CARAC	FLUOROURACIL	3385	C4H3FN2O2	130.078	\N	-0.9	2	3	0	58.2	9	0	199	0	0	\N	\N	C1=C(C(=O)NC(=O)N1)F	5-fluoro-1H-pyrimidine-2,4-dione
3068	EFUDEX	FLUOROURACIL	3385	C4H3FN2O2	130.078	\N	-0.9	2	3	0	58.2	9	0	199	0	0	\N	\N	C1=C(C(=O)NC(=O)N1)F	5-fluoro-1H-pyrimidine-2,4-dione
3574	FLUOXETINE HYDROCHLORIDE	FLUOXETINE HYDROCHLORIDE	62857	C17H19ClF3NO	345.79	\N	\N	2	5	6	21.3	23	0	308	0	1	\N	\N	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl	N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride
6317	OLANZAPINE AND FLUOXETINE HYDROCHLORIDE	FLUOXETINE HYDROCHLORIDE	62857	C17H19ClF3NO	345.79	\N	\N	2	5	6	21.3	23	0	308	0	1	\N	\N	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl	N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride
7780	PROZAC	FLUOXETINE HYDROCHLORIDE	62857	C17H19ClF3NO	345.79	\N	\N	2	5	6	21.3	23	0	308	0	1	\N	\N	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl	N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride
666	ANDROID-F	FLUOXYMESTERONE	6446	C20H29FO3	336.447	\N	2.4	2	4	0	57.5	24	0	630	7	0	\N	\N	CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C)O)C)O)F	(8S,9R,10S,11S,13S,14S,17S)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
3575	FLUOXYMESTERONE	FLUOXYMESTERONE	6446	C20H29FO3	336.447	\N	2.4	2	4	0	57.5	24	0	630	7	0	\N	\N	CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C)O)C)O)F	(8S,9R,10S,11S,13S,14S,17S)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
3875	HALOTESTIN	FLUOXYMESTERONE	6446	C20H29FO3	336.447	\N	2.4	2	4	0	57.5	24	0	630	7	0	\N	\N	CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C)O)C)O)F	(8S,9R,10S,11S,13S,14S,17S)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
3576	FLUPHENAZINE	FLUPHENAZINE DECANOATE	3388	C32H44F3N3O2S	591.778	\N	9	0	9	16	61.3	41	0	765	0	0	\N	\N	CCCCCCCCCC(=O)OCCN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F	2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl decanoate
3577	FLUPHENAZINE DECANOATE	FLUPHENAZINE DECANOATE	3388	C32H44F3N3O2S	591.778	\N	9	0	9	16	61.3	41	0	765	0	0	\N	\N	CCCCCCCCCC(=O)OCCN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F	2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl decanoate
7658	PROLIXIN ENANTHATE	FLUPHENAZINE ENANTHATE	3389	C29H38F3N3O2S	549.697	\N	7.4	0	9	13	61.3	38	0	720	0	0	\N	\N	CCCCCCC(=O)OCCN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F	2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl heptanoate
3579	FLUPHENAZINE HYDROCHLORIDE	FLUPHENAZINE HYDROCHLORIDE	67356	C22H28Cl2F3N3OS	510.441	\N	\N	3	8	6	55.2	32	0	544	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO.Cl.Cl	2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride
6808	PERMITIL	FLUPHENAZINE HYDROCHLORIDE	67356	C22H28Cl2F3N3OS	510.441	\N	\N	3	8	6	55.2	32	0	544	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO.Cl.Cl	2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride
7656	PROLIXIN	FLUPHENAZINE HYDROCHLORIDE	67356	C22H28Cl2F3N3OS	510.441	\N	\N	3	8	6	55.2	32	0	544	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO.Cl.Cl	2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride
2017	CORDRAN	FLURANDRENOLIDE	15209	C24H33FO6	436.52	\N	1.4	2	7	2	93.1	31	0	868	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)CCC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C	\N
3581	FLURAZEPAM HYDROCHLORIDE	FLURAZEPAM HYDROCHLORIDE	3393	C21H23ClFN3O	387.883	\N	3	0	4	6	35.9	27	0	540	0	0	\N	\N	CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F	7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one
3583	FLURBIPROFEN SODIUM	FLURBIPROFEN SODIUM	23684814	C15H12FNaO2	266.247	\N	\N	0	3	3	40.1	19	0	292	0	1	\N	\N	CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)[O-].[Na+]	sodium;2-(3-fluoro-4-phenyl-phenyl)propanoate
3351	EULEXIN	FLUTAMIDE	3397	C11H11F3N2O3	276.215	\N	3.3	1	6	2	74.9	19	0	352	0	0	\N	\N	CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F	2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
3584	FLUTAMIDE	FLUTAMIDE	3397	C11H11F3N2O3	276.215	\N	3.3	1	6	2	74.9	19	0	352	0	0	\N	\N	CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F	2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
9685	VIZAMYL	FLUTEMETAMOL F-18	15950376	C14H11FN2OS	273.316	\N	3.8	2	5	2	73.4	19	0	320	0	0	\N	\N	CNC1=C(C=C(C=C1)C2=NC3=C(S2)C=C(C=C3)O)F	2-[3-fluoranyl-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol
782	ARNUITY ELLIPTA	FLUTICASONE FUROATE	9854489	C27H29F3O6S	538.578	\N	4.8	1	10	6	119	37	0	1080	9	0	\N	\N	CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
213	ADVAIR DISKUS 100/50	FLUTICASONE PROPIONATE	444036	C25H31F3O5S	500.573	\N	4	1	9	6	106	34	0	984	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
215	ADVAIR DISKUS 250/50	FLUTICASONE PROPIONATE	444036	C25H31F3O5S	500.573	\N	4	1	9	6	106	34	0	984	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
3588	FLUVOXAMINE MALEATE	FLUVOXAMINE MALEATE	9560989	C19H25F3N2O6	434.412	\N	\N	3	11	11	131	30	0	446	0	0	\N	\N	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O	maleic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
1055	BEROCCA PN	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
780	ARIXTRA	FONDAPARINUX SODIUM	636380	C31H43N3Na10O49S8	1728.035	\N	\N	9	52	20	901	101	0	3330	25	0	\N	\N	COC1C(C(C(C(O1)COS(=O)(=O)[O-])OC2C(C(C(C(O2)C(=O)[O-])OC3C(C(C(C(O3)COS(=O)(=O)[O-])OC4C(C(C(C(O4)C(=O)[O-])OC5C(C(C(C(O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]	decasodium;(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-5-sulfonatooxy-tetrahydropyran-3-yl]oxy-5-(sulfonatoamino)-4-sulfonatooxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-3-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-(sulfonatooxymethyl)tetrahydropyran-2-yl]oxy-4,5-dihydroxy-tetrahydropyran-2-carboxylate
3612	FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	636380	C31H43N3Na10O49S8	1728.035	\N	\N	9	52	20	901	101	0	3330	25	0	\N	\N	COC1C(C(C(C(O1)COS(=O)(=O)[O-])OC2C(C(C(C(O2)C(=O)[O-])OC3C(C(C(C(O3)COS(=O)(=O)[O-])OC4C(C(C(C(O4)C(=O)[O-])OC5C(C(C(C(O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]	decasodium;(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-5-sulfonatooxy-tetrahydropyran-3-yl]oxy-5-(sulfonatoamino)-4-sulfonatooxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-3-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-(sulfonatooxymethyl)tetrahydropyran-2-yl]oxy-4,5-dihydroxy-tetrahydropyran-2-carboxylate
3629	FOSAMPRENAVIR CALCIUM	FOSAMPRENAVIR CALCIUM	131535	C25H34CaN3O9PS	623.671	\N	\N	2	11	13	192	40	0	901	3	0	\N	\N	CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)([O-])[O-])S(=O)(=O)C3=CC=C(C=C3)N.[Ca+2]	calcium;[(1R,2S)-1-[[(4-aminophenyl)sulfonyl-isobutyl-amino]methyl]-3-phenyl-2-[[(3S)-tetrahydrofuran-3-yl]oxycarbonylamino]propyl] phosphate
4918	LEXIVA	FOSAMPRENAVIR CALCIUM	131535	C25H34CaN3O9PS	623.671	\N	\N	2	11	13	192	40	0	901	3	0	\N	\N	CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)([O-])[O-])S(=O)(=O)C3=CC=C(C=C3)N.[Ca+2]	calcium;[(1R,2S)-1-[[(4-aminophenyl)sulfonyl-isobutyl-amino]methyl]-3-phenyl-2-[[(3S)-tetrahydrofuran-3-yl]oxycarbonylamino]propyl] phosphate
1230	BSS PLUS	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
3633	FOSINOPRIL SODIUM	FOSINOPRIL SODIUM	23681451	C30H45NNaO7P	585.654	\N	\N	0	7	15	113	40	0	857	2	2	\N	\N	CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3.[Na+]	sodium;(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxy-propoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate
3634	FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE	FOSINOPRIL SODIUM	23681451	C30H45NNaO7P	585.654	\N	\N	0	7	15	113	40	0	857	2	2	\N	\N	CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3.[Na+]	sodium;(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxy-propoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate
3427	FASLODEX	FULVESTRANT	104741	C32H47F5O3S	606.777	\N	9.2	2	9	14	76.7	41	0	854	6	1	\N	\N	CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F	(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3967	HORIZANT	GABAPENTIN ENACARBIL	9883933	C16H27NO6	329.393	\N	3.1	2	6	9	102	23	0	428	0	1	\N	\N	CC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(=O)O	2-[1-[[1-(2-methylpropanoyloxy)ethoxycarbonylamino]methyl]cyclohexyl]acetic acid
3816	GRALISE	GABAPENTIN	3446	C9H17NO2	171.24	\N	-1.1	2	3	3	63.3	12	0	162	0	0	\N	\N	C1CCC(CC1)(CC(=O)O)CN	2-[1-(aminomethyl)cyclohexyl]acetic acid
5709	MULTIHANCE	GADOBENATE DIMEGLUMINE	6918204	C36H62GdN5O21	1058.156	\N	\N	14	26	29	440	63	0	860	8	1	\N	\N	CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O.C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)O.[Gd+3]	3-benzyloxy-2-[2-[carboxylatomethyl-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]ethyl-(carboxymethyl)amino]propanoate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
3680	GADAVIST	GADOBUTROL	6102852	C18H31GdN4O9	604.715	\N	\N	3	13	7	194	32	0	532	2	0	\N	\N	C1CN(CCN(CCN(CCN1CC(=O)[O-])CC(=O)[O-])C(CO)C(CO)O)CC(=O)[O-].[Gd+3]	2-[4,10-bis(carboxylatomethyl)-7-[(1R,2S)-2,3-dihydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
6357	OMNISCAN	GADODIAMIDE	153921	C16H26GdN5O8	573.661	\N	\N	2	11	13	188	30	0	527	0	0	\N	\N	CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]	2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxo-ethyl]amino]ethyl]amino]acetate;gadolinium(3+)
23	ABLAVAR	GADOFOSVESET TRISODIUM	23724913	C33H40GdN3Na3O15P	975.882	\N	\N	1	18	18	270	56	0	1130	0	1	\N	\N	C1CC(CCC1OP(=O)([O-])OCC(CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-])(C2=CC=CC=C2)C3=CC=CC=C3.O.[Na+].[Na+].[Na+].[Gd+3]	trisodium;2-[[2-[bis(carboxylatomethyl)amino]-3-[(4,4-diphenylcyclohexoxy)-oxido-phosphoryl]oxy-propyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+);hydrate
5277	MAGNEVIST	GADOPENTETATE DIMEGLUMINE	55466	C28H54GdN5O20	938.005	\N	\N	14	25	25	431	54	0	631	8	0	\N	\N	CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O.C(CN(CC(=O)O)CC(=O)[O-])N(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-].[Gd+3]	2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
7649	PROHANCE	GADOTERIDOL	60714	C17H29GdN4O7	558.69	\N	\N	1	11	5	154	29	0	471	0	1	\N	\N	CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3]	2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
7650	PROHANCE MULTIPACK	GADOTERIDOL	60714	C17H29GdN4O7	558.69	\N	\N	1	11	5	154	29	0	471	0	1	\N	\N	CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3]	2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
6394	OPTIMARK IN PLASTIC CONTAINER	GADOVERSETAMIDE	444013	C20H34GdN5O10	661.767	\N	\N	2	13	19	207	36	0	614	0	0	\N	\N	COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]	2-[bis[2-[carboxylatomethyl-[2-(2-methoxyethylamino)-2-oxo-ethyl]amino]ethyl]amino]acetate;gadolinium(3+)
7900	RAZADYNE ER	GALANTAMINE HYDROBROMIDE	121587	C17H22BrNO3	368.271	\N	\N	2	4	1	41.9	22	0	440	3	0	\N	\N	CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O.Br	\N
2147	CYTOVENE	GANCICLOVIR SODIUM	23700083	C9H12N5NaO4	277.216	\N	\N	3	8	5	142	19	0	273	0	0	\N	\N	C1=NC2=C(N1COC(CO)CO)N=C(N=C2[O-])N.[Na+]	sodium;2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]purin-6-olate
3687	GANCICLOVIR	GANCICLOVIR SODIUM	23700083	C9H12N5NaO4	277.216	\N	\N	3	8	5	142	19	0	273	0	0	\N	\N	C1=NC2=C(N1COC(CO)CO)N=C(N=C2[O-])N.[Na+]	sodium;2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]purin-6-olate
3688	GANCICLOVIR SODIUM	GANCICLOVIR SODIUM	23700083	C9H12N5NaO4	277.216	\N	\N	3	8	5	142	19	0	273	0	0	\N	\N	C1=NC2=C(N1COC(CO)CO)N=C(N=C2[O-])N.[Na+]	sodium;2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]purin-6-olate
2146	CYTOVENE	GANCICLOVIR	3454	C9H13N5O4	255.234	\N	-1.7	4	5	5	135	18	0	346	0	0	\N	\N	C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N	2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-3H-purin-6-one
9676	VITRASERT	GANCICLOVIR	3454	C9H13N5O4	255.234	\N	-1.7	4	5	5	135	18	0	346	0	0	\N	\N	C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N	2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-3H-purin-6-one
3704	GATIFLOXACIN	GATIFLOXACIN	5379	C19H22FN3O4	375.4	\N	-0.7	2	8	4	82.1	27	0	653	0	1	\N	\N	CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F	1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid
9945	ZYMAXID	GATIFLOXACIN	5379	C19H22FN3O4	375.4	\N	-0.7	2	8	4	82.1	27	0	653	0	1	\N	\N	CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F	1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid
4421	IRESSA	GEFITINIB	123631	C22H24ClFN4O3	446.907	\N	4.1	1	8	8	68.7	31	0	545	0	0	\N	\N	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	N-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine
3712	GEMCITABINE HYDROCHLORIDE	GEMCITABINE HYDROCHLORIDE	60749	C9H12ClF2N3O4	299.659	\N	\N	4	6	2	108	19	0	426	3	0	\N	\N	C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F.Cl	4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one;hydrochloride
3716	GEMZAR	GEMCITABINE HYDROCHLORIDE	60749	C9H12ClF2N3O4	299.659	\N	\N	4	6	2	108	19	0	426	3	0	\N	\N	C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F.Cl	4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one;hydrochloride
3713	GEMFIBROZIL	GEMFIBROZIL	3463	C15H22O3	250.338	\N	3.8	1	3	6	46.5	18	0	273	0	0	\N	\N	CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O	5-(2,5-dimethylphenoxy)-2,2-dimethyl-pentanoic acid
5060	LOPID	GEMFIBROZIL	3463	C15H22O3	250.338	\N	3.8	1	3	6	46.5	18	0	273	0	0	\N	\N	CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O	5-(2,5-dimethylphenoxy)-2,2-dimethyl-pentanoic acid
3407	FACTIVE	GEMIFLOXACIN MESYLATE	9588170	C19H24FN5O7S	485.487	\N	\N	3	13	5	184	33	0	817	0	1	\N	\N	CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F.CS(=O)(=O)O	7-[(4Z)-3-(aminomethyl)-4-methoxyimino-pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid
3714	GEMIFLOXACIN MESYLATE	GEMIFLOXACIN MESYLATE	9588170	C19H24FN5O7S	485.487	\N	\N	3	13	5	184	33	0	817	0	1	\N	\N	CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F.CS(=O)(=O)O	7-[(4Z)-3-(aminomethyl)-4-methoxyimino-pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid
3838	GVS	GENTIAN VIOLET	11057	C25H30ClN3	407.986	\N	\N	0	3	4	9.5	29	0	542	0	0	\N	\N	CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-]	[4-[bis[4-(dimethylamino)phenyl]methylene]cyclohexa-2,5-dien-1-ylidene]-dimethyl-ammonium;chloride
2012	COPAXONE	GLATIRAMER ACETATE	3081884	C25H45N5O13	623.657	\N	\N	12	18	13	374	43	0	519	4	0	\N	\N	CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N	acetic acid;(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid
3762	GLATOPA	GLATIRAMER ACETATE	3081884	C25H45N5O13	623.657	\N	\N	12	18	13	374	43	0	519	4	0	\N	\N	CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N	acetic acid;(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid
401	AMARYL	GLIMEPIRIDE	3476	C24H34N4O5S	490.619	\N	3.9	3	5	7	133	34	0	895	0	0	\N	\N	CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C	4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide
3766	GLIMEPIRIDE	GLIMEPIRIDE	3476	C24H34N4O5S	490.619	\N	3.9	3	5	7	133	34	0	895	0	0	\N	\N	CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C	4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide
3768	GLIPIZIDE AND METFORMIN HYDROCHLORIDE	GLIPIZIDE	3478	C21H27N5O4S	445.538	\N	1.9	3	6	7	139	31	0	697	0	0	\N	\N	CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide
3778	GLUCOTROL	GLIPIZIDE	3478	C21H27N5O4S	445.538	\N	1.9	3	6	7	139	31	0	697	0	0	\N	\N	CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide
3779	GLUCOTROL XL	GLIPIZIDE	3478	C21H27N5O4S	445.538	\N	1.9	3	6	7	139	31	0	697	0	0	\N	\N	CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide
5433	METAGLIP	GLIPIZIDE	3478	C21H27N5O4S	445.538	\N	1.9	3	6	7	139	31	0	697	0	0	\N	\N	CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide
3148	ENDOSOL EXTRA	GLUTATHIONE DISULFIDE	65359	C20H32N6O12S2	612.626	\N	-9.1	10	16	21	368	40	0	879	4	0	\N	\N	C(CC(=O)NC(CSSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)C(=O)NCC(=O)O)C(C(=O)O)N	(2S)-2-amino-5-[[(1R)-1-[[[(2R)-2-[[(4S)-4-amino-4-carboxy-butanoyl]amino]-3-(carboxymethylamino)-3-oxo-propyl]disulfanyl]methyl]-2-(carboxymethylamino)-2-oxo-ethyl]amino]-5-oxo-pentanoic acid
2887	DORIDEN	GLUTETHIMIDE	3487	C13H15NO2	217.268	\N	1.9	1	2	2	46.2	16	0	294	0	1	\N	\N	CCC1(CCC(=O)NC1=O)C2=CC=CC=C2	3-ethyl-3-phenyl-piperidine-2,6-dione
3780	GLUCOVANCE	GLYBURIDE	3488	C23H28ClN3O5S	494.003	\N	4.8	3	5	8	122	33	0	746	0	0	\N	\N	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide
3784	GLYBURIDE	GLYBURIDE	3488	C23H28ClN3O5S	494.003	\N	4.8	3	5	8	122	33	0	746	0	0	\N	\N	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide
1094	BEVESPI AEROSPHERE	GLYCOPYRROLATE	11693	C19H28BrNO3	398.341	\N	\N	1	4	5	46.5	24	0	424	0	2	\N	\N	C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-]	(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenyl-acetate;bromide
2097	CUVPOSA	GLYCOPYRROLATE	11693	C19H28BrNO3	398.341	\N	\N	1	4	5	46.5	24	0	424	0	2	\N	\N	C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-]	(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenyl-acetate;bromide
8061	ROBINUL	GLYCOPYRROLATE	11693	C19H28BrNO3	398.341	\N	\N	1	4	5	46.5	24	0	424	0	2	\N	\N	C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-]	(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenyl-acetate;bromide
5142	LUTREPULSE KIT	GONADORELIN ACETATE	11980076	C57H79N17O15	1242.363	\N	\N	17	17	31	512	89	0	2420	8	0	\N	\N	CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O	acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[2-[[(1S)-1-[[(1S)-1-[(2S)-2-[(2-amino-2-oxo-ethyl)carbamoyl]pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
3408	FACTREL	GONADORELIN HYDROCHLORIDE	23624131	C55H76ClN17O13	1218.769	\N	\N	17	15	31	475	86	0	2390	8	0	\N	\N	CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.Cl	(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[2-[[(1S)-1-[[(1S)-1-[(2S)-2-[(2-amino-2-oxo-ethyl)carbamoyl]pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide;hydrochloride
9891	ZOLADEX	GOSERELIN ACETATE	16052011	C61H88N18O16	1329.485	\N	\N	18	18	32	533	95	0	2590	9	0	\N	\N	CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O	acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-(tert-butoxymethyl)-2-[[(1S)-1-[[(1S)-4-guanidino-1-[(2S)-2-(ureidocarbamoyl)pyrrolidine-1-carbonyl]butyl]carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
5892	NEO-POLYCIN	GRAMICIDIN	16130140	C99H140N20O17	1882.332	\N	10.7	21	17	52	549	136	0	3980	14	0	\N	\N	CC(C)CC(C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CC(C)C)C(=O)NC(CC7=CNC8=CC=CC=C87)C(=O)NCCO)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)C)NC=O	\N
5913	NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN	GRAMICIDIN	16130140	C99H140N20O17	1882.332	\N	10.7	21	17	52	549	136	0	3980	14	0	\N	\N	CC(C)CC(C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CC(C)C)C(=O)NC(CC7=CNC8=CC=CC=C87)C(=O)NCCO)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)C)NC=O	\N
3817	GRANISETRON HYDROCHLORIDE	GRANISETRON HYDROCHLORIDE	65264	C18H25ClN4O	348.875	\N	\N	2	3	2	50.2	24	0	442	0	2	\N	\N	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl	1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide;hydrochloride
3818	GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE	GRANISETRON HYDROCHLORIDE	65264	C18H25ClN4O	348.875	\N	\N	2	3	2	50.2	24	0	442	0	2	\N	\N	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl	1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide;hydrochloride
3819	GRANISOL	GRANISETRON HYDROCHLORIDE	65264	C18H25ClN4O	348.875	\N	\N	2	3	2	50.2	24	0	442	0	2	\N	\N	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl	1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide;hydrochloride
8599	SUSTOL	GRANISETRON	5284566	C18H24N4O	312.417	\N	2.8	1	3	2	50.2	23	0	442	2	0	\N	\N	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C	1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide
9846	ZEPATIER	GRAZOPREVIR	44603531	C38H50N6O9S	766.911	\N	4.7	3	11	8	204	54	0	1580	7	0	\N	\N	CC(C)(C)C1C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCCC7CC7OC(=O)N1	\N
7895	RAXAR	GREPAFLOXACIN HYDROCHLORIDE	656829	C19H23ClFN3O3	395.859	\N	\N	3	7	3	72.9	27	0	636	0	1	\N	\N	CC1CN(CCN1)C2=C(C(=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)C)F.Cl	1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid;hydrochloride
3663	FULVICIN-U/F	GRISEOFULVIN, MICROCRYSTALLINE	441140	C17H17ClO6	352.767	\N	2.2	0	6	3	71.1	24	0	575	2	0	\N	\N	CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
3876	HALOTEX	HALOPROGIN	3561	C9H4Cl3IO	361.384	\N	4.6	0	1	2	9.2	14	0	247	0	0	\N	\N	C1=C(C(=CC(=C1Cl)Cl)Cl)OCC#CI	1,2,4-trichloro-5-(3-iodoprop-2-ynoxy)benzene
3822	GRIFULVIN V	GRISEOFULVIN, MICROSIZE	441140	C17H17ClO6	352.767	\N	2.2	0	6	3	71.1	24	0	575	2	0	\N	\N	CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
3660	FULVICIN P/G	GRISEOFULVIN, ULTRAMICROCRYSTALLINE	441140	C17H17ClO6	352.767	\N	2.2	0	6	3	71.1	24	0	575	2	0	\N	\N	CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
9381	ULTRAGRIS-165	GRISEOFULVIN, ULTRAMICROCRYSTALLINE	441140	C17H17ClO6	352.767	\N	2.2	0	6	3	71.1	24	0	575	2	0	\N	\N	CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
3823	GRIS-PEG	GRISEOFULVIN, ULTRAMICROSIZE	441140	C17H17ClO6	352.767	\N	2.2	0	6	3	71.1	24	0	575	2	0	\N	\N	CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
3827	GRISEOFULVIN, ULTRAMICROSIZE	GRISEOFULVIN, ULTRAMICROSIZE	441140	C17H17ClO6	352.767	\N	2.2	0	6	3	71.1	24	0	575	2	0	\N	\N	CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
3828	GRISEOFULVIN,ULTRAMICROSIZE	GRISEOFULVIN, ULTRAMICROSIZE	441140	C17H17ClO6	352.767	\N	2.2	0	6	3	71.1	24	0	575	2	0	\N	\N	CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
3831	GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE	GUAIFENESIN	3516	C10H14O4	198.218	\N	1.4	2	4	5	58.9	14	0	151	0	1	\N	\N	COC1=CC=CC=C1OCC(CO)O	3-(2-methoxyphenoxy)propane-1,2-diol
3832	GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE	GUAIFENESIN	3516	C10H14O4	198.218	\N	1.4	2	4	5	58.9	14	0	151	0	1	\N	\N	COC1=CC=CC=C1OCC(CO)O	3-(2-methoxyphenoxy)propane-1,2-diol
5701	MUCINEX DM	GUAIFENESIN	3516	C10H14O4	198.218	\N	1.4	2	4	5	58.9	14	0	151	0	1	\N	\N	COC1=CC=CC=C1OCC(CO)O	3-(2-methoxyphenoxy)propane-1,2-diol
9736	WYTENSIN	GUANABENZ ACETATE	5702062	C10H12Cl2N4O2	291.132	\N	\N	3	4	2	114	18	0	259	0	0	\N	\N	CC(=O)O.C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl	acetic acid;2-[(E)-(2,6-dichlorophenyl)methyleneamino]guanidine
4128	HYLOREL	GUANADREL SULFATE	68552	C20H40N6O8S	524.634	\N	\N	6	10	4	249	35	0	326	0	2	\N	\N	C1CCC2(CC1)OCC(O2)CN=C(N)N.C1CCC2(CC1)OCC(O2)CN=C(N)N.OS(=O)(=O)O	2-(1,4-dioxaspiro[4.5]decan-3-ylmethyl)guanidine;sulfuric acid
4430	ISMELIN	GUANETHIDINE MONOSULFATE	86471	C10H24N4O4S	296.386	\N	\N	4	6	3	151	19	0	248	0	0	\N	\N	C1CCCN(CCC1)CCN=C(N)N.OS(=O)(=O)O	2-[2-(azocan-1-yl)ethyl]guanidine;sulfuric acid
3836	GUANFACINE HYDROCHLORIDE	GUANFACINE HYDROCHLORIDE	71401	C9H10Cl3N3O	282.549	\N	\N	3	1	2	81.5	16	0	256	0	0	\N	\N	C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl.Cl	N-(diaminomethylene)-2-(2,6-dichlorophenyl)acetamide;hydrochloride
6676	PAXIPAM	HALAZEPAM	31640	C17H12ClF3N2O	352.741	\N	4	0	5	2	32.7	24	0	503	0	0	\N	\N	C1C(=O)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3)CC(F)(F)F	7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepin-2-one
3868	HALOG	HALCINONIDE	443943	C24H32ClFO5	454.963	\N	3.6	1	6	2	72.8	31	0	887	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)CCC5(C4(C(CC3(C2(O1)C(=O)CCl)C)O)F)C)C	\N
3869	HALOG-E	HALCINONIDE	443943	C24H32ClFO5	454.963	\N	3.6	1	6	2	72.8	31	0	887	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)CCC5(C4(C(CC3(C2(O1)C(=O)CCl)C)O)F)C)C	\N
3867	HALOBETASOL PROPIONATE	HALOBETASOL PROPIONATE	6918178	C25H31ClF2O5	484.965	\N	3.7	1	7	5	80.7	33	0	964	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl	[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
3857	HALDOL	HALOPERIDOL DECANOATE	52919	C31H41ClFNO3	530.121	\N	7.9	0	5	16	46.6	37	0	665	0	0	\N	\N	CCCCCCCCCC(=O)OC1(CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)Cl	[4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxo-butyl]-4-piperidyl] decanoate
3872	HALOPERIDOL DECANOATE	HALOPERIDOL DECANOATE	52919	C31H41ClFNO3	530.121	\N	7.9	0	5	16	46.6	37	0	665	0	0	\N	\N	CCCCCCCCCC(=O)OC1(CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)Cl	[4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxo-butyl]-4-piperidyl] decanoate
3858	HALDOL	HALOPERIDOL LACTATE	3559	C21H23ClFNO2	375.868	\N	3.2	1	4	6	40.5	26	0	451	0	0	\N	\N	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one
3871	HALOPERIDOL	HALOPERIDOL LACTATE	3559	C21H23ClFNO2	375.868	\N	3.2	1	4	6	40.5	26	0	451	0	0	\N	\N	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one
3873	HALOPERIDOL INTENSOL	HALOPERIDOL LACTATE	3559	C21H23ClFNO2	375.868	\N	3.2	1	4	6	40.5	26	0	451	0	0	\N	\N	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one
3870	HALOPERIDOL	HALOPERIDOL	3559	C21H23ClFNO2	375.868	\N	3.2	1	4	6	40.5	26	0	451	0	0	\N	\N	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one
9563	VERSAPEN	HETACILLIN	443387	C19H23N3O4S	389.47	\N	-0.6	2	6	3	115	27	0	688	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)N3C(=O)C(NC3(C)C)C4=CC=CC=C4)C(=O)O)C	(2S,5R,6R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenyl-imidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
2632	DIAL	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
5760	MYLAXEN	HEXAFLUORENIUM BROMIDE	9434	C36H42Br2N2	662.554	\N	\N	0	2	9	0	40	0	663	0	0	\N	\N	C[N+](C)(CCCCCC[N+](C)(C)C1C2=CC=CC=C2C3=CC=CC=C13)C4C5=CC=CC=C5C6=CC=CC=C46.[Br-].[Br-]	9H-fluoren-9-yl-[6-[9H-fluoren-9-yl(dimethyl)ammonio]hexyl]-dimethyl-ammonium;dibromide
8998	TRAL	HEXOCYCLIUM METHYLSULFATE	101587	C21H36N2O5S	428.588	\N	\N	1	6	4	98.3	29	0	453	0	1	\N	\N	C[N+]1(CCN(CC1)CC(C2CCCCC2)(C3=CC=CC=C3)O)C.COS(=O)(=O)[O-]	1-cyclohexyl-2-(4,4-dimethylpiperazin-4-ium-1-yl)-1-phenyl-ethanol;methyl sulfate
2110	CYCLAINE	HEXYLCAINE HYDROCHLORIDE	102426	C16H24ClNO2	297.823	\N	\N	2	3	6	38.3	20	0	268	0	1	\N	\N	CC(CNC1CCCCC1)OC(=O)C2=CC=CC=C2.Cl	[2-(cyclohexylamino)-1-methyl-ethyl] benzoate;hydrochloride
8584	SUPPRELIN	HISTRELIN ACETATE	25084151	C68H90N18O14	1383.58	\N	\N	16	17	34	487	100	0	2690	9	0	\N	\N	CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CN(C=N2)CC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8.CC(=O)O	acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[(1-benzylimidazol-4-yl)methyl]-2-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
8585	SUPPRELIN LA	HISTRELIN ACETATE	25084151	C68H90N18O14	1383.58	\N	\N	16	17	34	487	100	0	2690	9	0	\N	\N	CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CN(C=N2)CC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8.CC(=O)O	acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[(1-benzylimidazol-4-yl)methyl]-2-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
9485	VANTAS	HISTRELIN ACETATE	25084151	C68H90N18O14	1383.58	\N	\N	16	17	34	487	100	0	2690	9	0	\N	\N	CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CN(C=N2)CC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8.CC(=O)O	acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[(1-benzylimidazol-4-yl)methyl]-2-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
3964	HOMAPIN-5	HOMATROPINE METHYLBROMIDE	6646	C17H24BrNO3	370.287	\N	\N	1	4	4	46.5	22	0	374	0	3	\N	\N	C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-]	(8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenyl-acetate;bromide
3965	HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE	HOMATROPINE METHYLBROMIDE	6646	C17H24BrNO3	370.287	\N	\N	1	4	4	46.5	22	0	374	0	3	\N	\N	C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-]	(8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenyl-acetate;bromide
4006	HYCODAN	HOMATROPINE METHYLBROMIDE	6646	C17H24BrNO3	370.287	\N	\N	1	4	4	46.5	22	0	374	0	3	\N	\N	C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-]	(8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenyl-acetate;bromide
727	APRESAZIDE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
729	APRESOLINE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
313	ALDORIL 15	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
315	ALDORIL 25	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
317	ALDORIL D30	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
319	ALDORIL D50	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
424	AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
605	AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
731	APRESOLINE-ESIDRIX	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
814	ATACAND HCT	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5675	MOTRIN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4084	HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX	HYDROCODONE POLISTIREX	5284569	C18H21NO3	299.37	\N	2.2	0	4	1	38.8	22	0	509	4	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)CC4	(4R,4aR,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
9326	TUSSICAPS	HYDROCODONE POLISTIREX	5284569	C18H21NO3	299.37	\N	2.2	0	4	1	38.8	22	0	509	4	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)CC4	(4R,4aR,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
2848	DIUCARDIN	HYDROFLUMETHIAZIDE	3647	C8H8F3N3O4S2	331.284	\N	0.4	3	10	1	135	20	0	578	0	0	\N	\N	C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1	1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4101	HYDROFLUMETHIAZIDE AND RESERPINE	HYDROFLUMETHIAZIDE	3647	C8H8F3N3O4S2	331.284	\N	0.4	3	10	1	135	20	0	578	0	0	\N	\N	C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1	1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
8136	SALURON	HYDROFLUMETHIAZIDE	3647	C8H8F3N3O4S2	331.284	\N	0.4	3	10	1	135	20	0	578	0	0	\N	\N	C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1	1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
8137	SALUTENSIN	HYDROFLUMETHIAZIDE	3647	C8H8F3N3O4S2	331.284	\N	0.4	3	10	1	135	20	0	578	0	0	\N	\N	C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1	1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
2801	DILAUDID-HP	HYDROMORPHONE HYDROCHLORIDE	5284570	C17H19NO3	285.343	\N	1.8	1	4	0	49.8	21	0	494	4	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(=O)CC4	(4R,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
3372	EXALGO	HYDROMORPHONE HYDROCHLORIDE	5284570	C17H19NO3	285.343	\N	1.8	1	4	0	49.8	21	0	494	4	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(=O)CC4	(4R,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
4104	HYDROMORPHONE HYDROCHLORIDE	HYDROMORPHONE HYDROCHLORIDE	5284570	C17H19NO3	285.343	\N	1.8	1	4	0	49.8	21	0	494	4	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(=O)CC4	(4R,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6621	PALLADONE	HYDROMORPHONE HYDROCHLORIDE	5284570	C17H19NO3	285.343	\N	1.8	1	4	0	49.8	21	0	494	4	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(=O)CC4	(4R,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
376	ALPHAREDISOL	HYDROXOCOBALAMIN	5460373	C62H90CoN13O15P	1347.385	\N	\N	10	20	16	453	92	0	3150	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2]	cobaltous;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate
2102	CYANOKIT	HYDROXOCOBALAMIN	5460373	C62H90CoN13O15P	1347.385	\N	\N	10	20	16	453	92	0	3150	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2]	cobaltous;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate
6655	PAREMYD	HYDROXYAMPHETAMINE HYDROBROMIDE	9377	C9H14BrNO	232.121	\N	\N	3	2	2	46.2	12	0	108	0	1	\N	\N	CC(CC1=CC=C(C=C1)O)N.Br	4-(2-aminopropyl)phenol;hydrobromide
2228	DELALUTIN	HYDROXYPROGESTERONE CAPROATE	169870	C27H40O4	428.613	\N	5.7	0	4	7	60.4	31	0	797	6	0	\N	\N	CCCCCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)C	[(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate
5676	MOTRIN IB	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4121	HYDROXYSTILBAMIDINE ISETHIONATE	HYDROXYSTILBAMIDINE ISETHIONATE	5494031	C18H22N4O5S	406.457	\N	\N	6	8	4	202	28	0	808	0	0	\N	\N	C1=CC(=C(N)N)C=CC1=CC=C2C=CC(=CC2=O)C(=N)N.C(CS(=O)(=O)O)O	(4E)-4-[2-[4-(diaminomethylene)cyclohexa-2,5-dien-1-ylidene]ethylidene]-3-oxo-cyclohexa-1,5-diene-1-carboxamidine;2-hydroxyethanesulfonic acid
815	ATARAX	HYDROXYZINE HYDROCHLORIDE	3658	C21H27ClN2O2	374.909	\N	3.7	1	4	8	35.9	26	0	376	0	1	\N	\N	C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol
4124	HYDROXYZINE HYDROCHLORIDE	HYDROXYZINE HYDROCHLORIDE	3658	C21H27ClN2O2	374.909	\N	3.7	1	4	8	35.9	26	0	376	0	1	\N	\N	C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol
9650	VISTARIL	HYDROXYZINE HYDROCHLORIDE	3658	C21H27ClN2O2	374.909	\N	3.7	1	4	8	35.9	26	0	376	0	1	\N	\N	C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol
4148	IBANDRONATE SODIUM	IBANDRONATE SODIUM	23670359	C9H22NNaO7P2	341.212	\N	\N	4	8	9	141	20	0	377	0	1	\N	\N	CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+]	sodium;hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphono-propyl]phosphinate
224	ADVIL ALLERGY AND CONGESTION RELIEF	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
229	ADVIL COLD AND SINUS	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
231	ADVIL CONGESTION RELIEF	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
233	ADVIL LIQUI-GELS	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4173	IDAMYCIN PFS	IDARUBICIN HYDROCHLORIDE	636362	C26H28ClNO9	533.958	\N	\N	6	10	3	177	37	0	912	6	0	\N	\N	CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl	(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
4174	IDARUBICIN HYDROCHLORIDE	IDARUBICIN HYDROCHLORIDE	636362	C26H28ClNO9	533.958	\N	\N	6	10	3	177	37	0	912	6	0	\N	\N	CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl	(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
4175	IDARUBICIN HYDROCHLORIDE PFS	IDARUBICIN HYDROCHLORIDE	636362	C26H28ClNO9	533.958	\N	\N	6	10	3	177	37	0	912	6	0	\N	\N	CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl	(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
8481	STOXIL	IDOXURIDINE	5905	C9H11IN2O5	354.1	\N	-1	3	5	2	99.1	17	0	386	3	0	\N	\N	C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-iodo-pyrimidine-2,4-dione
4181	IFOSFAMIDE	IFOSFAMIDE	3690	C7H15Cl2N2O2P	261.083	\N	0.9	1	4	5	41.6	14	0	218	0	1	\N	\N	C1CN(P(=O)(OC1)NCCCl)CCCl	N,3-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine
4182	IFOSFAMIDE/MESNA KIT	IFOSFAMIDE	3690	C7H15Cl2N2O2P	261.083	\N	0.9	1	4	5	41.6	14	0	218	0	1	\N	\N	C1CN(P(=O)(OC1)NCCCl)CCCl	N,3-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine
9545	VENTAVIS	ILOPROST	5311181	C22H32O4	360.494	\N	2.8	3	4	8	77.8	26	0	606	5	1	\N	\N	CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O	(5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyl-oct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid
3763	GLEEVEC	IMATINIB MESYLATE	123596	C30H35N7O4S	589.715	\N	\N	3	10	7	149	42	0	799	0	0	\N	\N	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O	methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide
4198	IMATINIB MESYLATE	IMATINIB MESYLATE	123596	C30H35N7O4S	589.715	\N	\N	3	10	7	149	42	0	799	0	0	\N	\N	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O	methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide
4202	IMIPENEM AND CILASTATIN	IMIPENEM	104838	C12H17N3O4S	299.345	\N	-0.7	3	6	6	142	20	0	491	3	0	\N	\N	CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O	(5R,6S)-3-[2-(aminomethyleneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
7479	PRIMAXIN	IMIPENEM	104838	C12H17N3O4S	299.345	\N	-0.7	3	6	6	142	20	0	491	3	0	\N	\N	CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O	(5R,6S)-3-[2-(aminomethyleneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
4203	IMIPRAMINE HYDROCHLORIDE	IMIPRAMINE HYDROCHLORIDE	8228	C19H25ClN2	316.873	\N	\N	1	2	4	6.5	22	0	291	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine;hydrochloride
7435	PRESAMINE	IMIPRAMINE HYDROCHLORIDE	8228	C19H25ClN2	316.873	\N	\N	1	2	4	6.5	22	0	291	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine;hydrochloride
8949	TOFRANIL	IMIPRAMINE HYDROCHLORIDE	8228	C19H25ClN2	316.873	\N	\N	1	2	4	6.5	22	0	291	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine;hydrochloride
9932	ZYCLARA	IMIQUIMOD	57469	C14H16N4	240.31	\N	2.6	1	3	2	56.7	18	0	294	0	0	\N	\N	CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N	1-isobutylimidazo[4,5-c]quinolin-4-amine
640	AMRINONE LACTATE	INAMRINONE LACTATE	3698	C10H9N3O	187.202	\N	-0.2	2	3	1	68	14	0	301	0	0	\N	\N	C1=CN=CC=C1C2=CNC(=O)C(=C2)N	3-amino-5-(4-pyridyl)-1H-pyridin-2-one
4302	INOCOR	INAMRINONE LACTATE	3698	C10H9N3O	187.202	\N	-0.2	2	3	1	68	14	0	301	0	0	\N	\N	C1=CN=CC=C1C2=CNC(=O)C(=C2)N	3-amino-5-(4-pyridyl)-1H-pyridin-2-one
754	ARCAPTA NEOHALER	INDACATEROL MALEATE	9827599	C28H32N2O7	508.571	\N	\N	6	8	8	156	37	0	708	1	0	\N	\N	CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC.C(=CC(=O)O)C(=O)O	5-[(1R)-2-[(5,6-diethylindan-2-yl)amino]-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one;maleic acid
4223	INDAPAMIDE	INDAPAMIDE	3702	C16H16ClN3O3S	365.832	\N	2.9	2	5	3	101	24	0	580	0	1	\N	\N	CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N	4-chloro-N-(2-methylindolin-1-yl)-3-sulfamoyl-benzamide
2080	CRIXIVAN	INDINAVIR SULFATE	5462355	C36H49N5O8S	711.875	\N	\N	6	11	12	201	50	0	1030	5	0	\N	\N	CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5.OS(=O)(=O)O	(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxyindan-1-yl]amino]-5-oxo-pentyl]-N-tert-butyl-4-(3-pyridylmethyl)piperazine-2-carboxamide;sulfuric acid
4238	INDIUM IN 111 OXYQUINOLINE	INDIUM IN-111 OXYQUINOLINE	119117	C27H18InN3O3	543.364	\N	\N	0	6	0	108	34	0	138	0	0	\N	\N	C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.[In+3]	indium-111(3+);quinolin-8-olate
6285	OCTREOSCAN	INDIUM IN-111 PENTETREOTIDE KIT	3081912	C63H84InN13O19S2	1506.375	\N	\N	14	25	30	556	98	0	2570	0	10	\N	\N	[H+].CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C(=O)NC(CO)C(C)O)O.[In+3]	2-[2-[[2-[[2-[[10-(4-aminobutyl)-16-benzyl-7-(1-hydroxyethyl)-4-[[2-hydroxy-1-(hydroxymethyl)propyl]carbamoyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-benzyl-2-oxo-ethyl]amino]-2-oxo-ethyl]-(carboxylatomethyl)amino]ethyl-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;hydron;indium(3+)
4245	INDOMETHACIN SODIUM	INDOMETHACIN SODIUM	23675763	C19H15ClNNaO4	379.772	\N	\N	0	4	4	71.4	26	0	512	0	0	\N	\N	CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)[O-].[Na+]	sodium;2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetate
4240	INDOCIN	INDOMETHACIN	3715	C19H16ClNO4	357.79	\N	4.3	1	4	4	68.5	25	0	506	0	0	\N	\N	CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O	2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetic acid
4242	INDOCIN SR	INDOMETHACIN	3715	C19H16ClNO4	357.79	\N	4.3	1	4	4	68.5	25	0	506	0	0	\N	\N	CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O	2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetic acid
4244	INDOMETHACIN	INDOMETHACIN	3715	C19H16ClNO4	357.79	\N	4.3	1	4	4	68.5	25	0	506	0	0	\N	\N	CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O	2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetic acid
8124	RYZODEG 70/30	INSULIN DEGLUDEC	118984462	C274H411N65O81S6	6104.036	\N	-4.9	79	92	197	2510	426	0	15300	51	0	\N	\N	CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NC(CC(=O)N)C(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C(C)O)C(=O)N8CCCC8C(=O)NC(CCCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCC(=O)O)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CNC=N2)CO)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN	\N
4874	LEVEMIR	INSULIN DETEMIR RECOMBINANT	16137271	C267H402N64O76S6	5916.885	\N	-3.5	76	87	189	2400	413	0	14700	50	0	\N	\N	CCCCCCCCCCCCCC(=O)NCCCCC(C(=O)O)NC(=O)C1CCCN1C(=O)C(C(C)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CC=CC=C4)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C5CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C6CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N5)C(C)C)CC(C)C)CC7=CC=C(C=C7)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC8=CNC=N8)CO)NC(=O)C(CC(C)C)NC(=O)C(CC9=CNC=N9)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC1=CC=CC=C1)N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N6)C(C)CC)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN)CO)CC(C)C)CC1=CC=C(C=C1)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC1=CC=C(C=C1)O)C(=O)NC(CC(=O)N)C(=O)O	\N
4875	LEVEMIR FLEXPEN	INSULIN DETEMIR RECOMBINANT	16137271	C267H402N64O76S6	5916.885	\N	-3.5	76	87	189	2400	413	0	14700	50	0	\N	\N	CCCCCCCCCCCCCC(=O)NCCCCC(C(=O)O)NC(=O)C1CCCN1C(=O)C(C(C)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CC=CC=C4)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C5CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C6CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N5)C(C)C)CC(C)C)CC7=CC=C(C=C7)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC8=CNC=N8)CO)NC(=O)C(CC(C)C)NC(=O)C(CC9=CNC=N9)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC1=CC=CC=C1)N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N6)C(C)CC)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN)CO)CC(C)C)CC1=CC=C(C=C1)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC1=CC=C(C=C1)O)C(=O)NC(CC(=O)N)C(=O)O	\N
7956	RENOVUE-65	IODAMIDE MEGLUMINE	29182	C19H28I3N3O9	823.158	\N	\N	9	10	10	209	34	0	569	4	0	\N	\N	CC(=O)NCC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3-acetamido-5-(acetamidomethyl)-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
4873	LEVEMIR	INSULIN DETEMIR	16137271	C267H402N64O76S6	5916.885	\N	-3.5	76	87	189	2400	413	0	14700	50	0	\N	\N	CCCCCCCCCCCCCC(=O)NCCCCC(C(=O)O)NC(=O)C1CCCN1C(=O)C(C(C)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CC=CC=C4)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C5CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C6CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N5)C(C)C)CC(C)C)CC7=CC=C(C=C7)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC8=CNC=N8)CO)NC(=O)C(CC(C)C)NC(=O)C(CC9=CNC=N9)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC1=CC=CC=C1)N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N6)C(C)CC)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN)CO)CC(C)C)CC1=CC=C(C=C1)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC1=CC=C(C=C1)O)C(=O)NC(CC(=O)N)C(=O)O	\N
996	BASAGLAR	INSULIN GLARGINE	118984454	C267H404N72O78S6	6062.955	\N	-14.1	85	92	191	2590	423	0	15300	53	0	\N	\N	CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NCC(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C(C)O)C(=O)N8CCCC8C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CNC=N2)CO)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN	\N
9384	ULTRALENTE INSULIN	INSULIN ZINC SUSP EXTENDED BEEF	24839622	C257H383N65O77S6Zn	5873.009	\N	\N	76	89	179	2440	406	0	14800	51	3	\N	\N	CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NC(CC(=O)N)C(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C(C)O)C(=O)N8CCCC8C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2C=NC=N2)CO)NC(=O)C(CC(C)C)NC(=O)C(CC2C=NC=N2)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN.[Zn]	\N
4350	INTRON A	INTERFERON ALFA-2B	71306834	C16H17Cl3I2N3NaO5S	746.537	\N	\N	0	6	7	113	31	0	511	0	0	\N	\N	CCCN(CCOC1=C(C=C(C=C1Cl)Cl)Cl)C(=O)N2C=CN=C2.C(S(=O)(=O)[O-])(I)I.[Na+]	sodium;diiodomethanesulfonate;N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide
210	ADREVIEW	IOBENGUANE SULFATE I-123	135326	C8H10IN3	271.095	\N	1	2	1	2	64.4	12	0	166	0	0	\N	\N	C1=CC(=CC(=C1)I)CN=C(N)N	2-[(3-iodanylphenyl)methyl]guanidine
1640	CHOLOGRAFIN SODIUM	IODIPAMIDE SODIUM	17478	C20H12I6N2Na2O6	1183.73	\N	\N	2	6	7	139	36	0	703	0	0	\N	\N	C1=C(C(=C(C(=C1I)NC(=O)CCCCC(=O)NC2=C(C=C(C(=C2I)C(=O)[O-])I)I)I)C(=O)[O-])I.[Na+].[Na+]	disodium;3-[[6-(3-carboxylato-2,4,6-triiodo-anilino)-6-oxo-hexanoyl]amino]-2,4,6-triiodo-benzoate
9645	VISIPAQUE 270	IODIXANOL	3724	C35H44I6N6O15	1550.191	\N	-3.4	13	15	22	339	62	0	1330	0	4	\N	\N	CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I	5-[acetyl-[3-[N-acetyl-3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodo-anilino]-2-hydroxy-propyl]amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
1641	CHOLOVUE	IODOXAMATE MEGLUMINE	40120	C40H60I6N4O20	1678.355	\N	\N	16	22	31	396	70	0	1000	0	8	\N	\N	CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O.C1=C(C(=C(C(=C1I)NC(=O)CCOCCOCCOCCOCCC(=O)NC2=C(C=C(C(=C2I)C(=O)O)I)I)I)C(=O)O)I	3-[3-[2-[2-[2-[3-(3-carboxy-2,4,6-triiodo-anilino)-3-oxo-propoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodo-benzoic acid;6-(methylamino)hexane-1,2,3,4,5-pentol
2200	DATSCAN	IOFLUPANE I-123	3086674	C18H23FINO2	427.291	\N	4	0	4	6	29.5	23	0	414	4	0	\N	\N	COC(=O)C1C2CCC(N2CCCF)CC1C3=CC=C(C=C3)I	methyl (1S,3S,4S,5R)-8-(3-fluoropropyl)-3-(4-iodanylphenyl)-8-azabicyclo[3.2.1]octane-4-carboxylate
6348	OMNIPAQUE 180	IOHEXOL	3730	C19H26I3N3O9	821.142	\N	-3	8	9	12	200	34	0	653	0	3	\N	\N	CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I	5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
6349	OMNIPAQUE 210	IOHEXOL	3730	C19H26I3N3O9	821.142	\N	-3	8	9	12	200	34	0	653	0	3	\N	\N	CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I	5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
4399	IOPAMIDOL-200	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
4400	IOPAMIDOL-200 IN PLASTIC CONTAINER	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
4401	IOPAMIDOL-250	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
4402	IOPAMIDOL-250 IN PLASTIC CONTAINER	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
4403	IOPAMIDOL-300	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
4404	IOPAMIDOL-300 IN PLASTIC CONTAINER	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
4405	IOPAMIDOL-370	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
4406	IOPAMIDOL-370 IN PLASTIC CONTAINER	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
2883	DOPAR	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
9389	ULTRAVIST (PHARMACY BULK)	IOPROMIDE	3736	C18H24I3N3O8	791.116	\N	-2.1	6	8	11	169	32	0	647	0	2	\N	\N	CN(CC(CO)O)C(=O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)NC(=O)COC)I	N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N3-methyl-benzene-1,3-dicarboxamide
9390	ULTRAVIST 150	IOPROMIDE	3736	C18H24I3N3O8	791.116	\N	-2.1	6	8	11	169	32	0	647	0	2	\N	\N	CN(CC(CO)O)C(=O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)NC(=O)COC)I	N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N3-methyl-benzene-1,3-dicarboxamide
9391	ULTRAVIST 240	IOPROMIDE	3736	C18H24I3N3O8	791.116	\N	-2.1	6	8	11	169	32	0	647	0	2	\N	\N	CN(CC(CO)O)C(=O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)NC(=O)COC)I	N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N3-methyl-benzene-1,3-dicarboxamide
9392	ULTRAVIST 300	IOPROMIDE	3736	C18H24I3N3O8	791.116	\N	-2.1	6	8	11	169	32	0	647	0	2	\N	\N	CN(CC(CO)O)C(=O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)NC(=O)COC)I	N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N3-methyl-benzene-1,3-dicarboxamide
9393	ULTRAVIST 300 IN PLASTIC CONTAINER	IOPROMIDE	3736	C18H24I3N3O8	791.116	\N	-2.1	6	8	11	169	32	0	647	0	2	\N	\N	CN(CC(CO)O)C(=O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)NC(=O)COC)I	N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N3-methyl-benzene-1,3-dicarboxamide
9394	ULTRAVIST 370	IOPROMIDE	3736	C18H24I3N3O8	791.116	\N	-2.1	6	8	11	169	32	0	647	0	2	\N	\N	CN(CC(CO)O)C(=O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)NC(=O)COC)I	N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N3-methyl-benzene-1,3-dicarboxamide
2002	CONRAY	IOTHALAMATE MEGLUMINE	656642	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	555	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)C(=O)NC)I.CNCC(C(C(C(CO)O)O)O)O	3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
2003	CONRAY 30	IOTHALAMATE MEGLUMINE	656642	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	555	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)C(=O)NC)I.CNCC(C(C(C(CO)O)O)O)O	3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
2006	CONRAY 43	IOTHALAMATE MEGLUMINE	656642	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	555	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)C(=O)NC)I.CNCC(C(C(C(CO)O)O)O)O	3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
2137	CYSTO-CONRAY II	IOTHALAMATE MEGLUMINE	656642	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	555	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)C(=O)NC)I.CNCC(C(C(C(CO)O)O)O)O	3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
9496	VASCORAY	IOTHALAMATE MEGLUMINE	656642	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	555	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)C(=O)NC)I.CNCC(C(C(C(CO)O)O)O)O	3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
2005	CONRAY 400	IOTHALAMATE SODIUM	23667529	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	426	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)C(=O)NC)I.[Na+]	sodium;3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoate
6522	OSMOVIST 190	IOTROLAN	3738	C37H48I6N6O18	1626.242	\N	-4.2	16	18	24	400	67	0	1450	0	8	\N	\N	CN(C1=C(C(=C(C(=C1I)C(=O)NC(CO)C(CO)O)I)C(=O)NC(CO)C(CO)O)I)C(=O)CC(=O)N(C)C2=C(C(=C(C(=C2I)C(=O)NC(CO)C(CO)O)I)C(=O)NC(CO)C(CO)O)I	5-[[3-[3,5-bis[[2,3-dihydroxy-1-(hydroxymethyl)propyl]carbamoyl]-2,4,6-triiodo-N-methyl-anilino]-3-oxo-propanoyl]-methyl-amino]-N1,N3-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodo-benzene-1,3-dicarboxamide
6523	OSMOVIST 240	IOTROLAN	3738	C37H48I6N6O18	1626.242	\N	-4.2	16	18	24	400	67	0	1450	0	8	\N	\N	CN(C1=C(C(=C(C(=C1I)C(=O)NC(CO)C(CO)O)I)C(=O)NC(CO)C(CO)O)I)C(=O)CC(=O)N(C)C2=C(C(=C(C(=C2I)C(=O)NC(CO)C(CO)O)I)C(=O)NC(CO)C(CO)O)I	5-[[3-[3,5-bis[[2,3-dihydroxy-1-(hydroxymethyl)propyl]carbamoyl]-2,4,6-triiodo-N-methyl-anilino]-3-oxo-propanoyl]-methyl-amino]-N1,N3-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodo-benzene-1,3-dicarboxamide
6398	OPTIRAY 240	IOVERSOL	3741	C18H24I3N3O9	807.115	\N	-3	8	9	12	200	33	0	623	0	2	\N	\N	C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO	N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
6399	OPTIRAY 300	IOVERSOL	3741	C18H24I3N3O9	807.115	\N	-3	8	9	12	200	33	0	623	0	2	\N	\N	C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO	N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
4826	LARODOPA	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
3941	HEXABRIX	IOXAGLATE MEGLUMINE	3742	C24H21I6N5O8	1268.886	\N	2.8	6	8	10	194	43	0	1090	0	0	\N	\N	CC(=O)N(C)C1=C(C(=C(C(=C1I)C(=O)NCC(=O)NC2=C(C(=C(C(=C2I)C(=O)O)I)C(=O)NCCO)I)I)C(=O)NC)I	3-[[2-[[3-[acetyl(methyl)amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoyl]amino]acetyl]amino]-5-(2-hydroxyethylcarbamoyl)-2,4,6-triiodo-benzoic acid
3942	HEXABRIX	IOXAGLATE SODIUM	23688359	C24H20I6N5NaO8	1290.868	\N	\N	5	8	10	197	44	0	1100	0	0	\N	\N	CC(=O)N(C)C1=C(C(=C(C(=C1I)C(=O)NCC(=O)NC2=C(C(=C(C(=C2I)C(=O)[O-])I)C(=O)NCCO)I)I)C(=O)NC)I.[Na+]	sodium;3-[[2-[[3-[acetyl(methyl)amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoyl]amino]acetyl]amino]-5-(2-hydroxyethylcarbamoyl)-2,4,6-triiodo-benzoate
6570	OXILAN-350	IOXILAN	3743	C18H24I3N3O8	791.116	\N	-2.4	7	8	11	180	32	0	647	0	2	\N	\N	CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCCO)I	5-[acetyl(2,3-dihydroxypropyl)amino]-N3-(2,3-dihydroxypropyl)-N1-(2-hydroxyethyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
1114	BILIVIST	IPODATE SODIUM	23671932	C12H12I3N2NaO2	619.943	\N	\N	0	3	5	55.7	20	0	345	0	0	\N	\N	CN(C)C=NC1=C(C=C(C(=C1I)CCC(=O)[O-])I)I.[Na+]	sodium;3-[3-(dimethylaminomethyleneamino)-2,4,6-triiodo-phenyl]propanoate
6411	ORAGRAFIN SODIUM	IPODATE SODIUM	23671932	C12H12I3N2NaO2	619.943	\N	\N	0	3	5	55.7	20	0	345	0	0	\N	\N	CN(C)C=NC1=C(C=C(C(=C1I)CCC(=O)[O-])I)I.[Na+]	sodium;3-[3-(dimethylaminomethyleneamino)-2,4,6-triiodo-phenyl]propanoate
9543	VENOFER	IRON SUCROSE	11377634	C18H24Fe2O24	736.056	\N	\N	12	24	9	484	44	0	191	12	0	\N	\N	C(C(C(C(=O)[O-])O)O)(C(C(=O)[O-])O)O.C(C(C(C(=O)[O-])O)O)(C(C(=O)[O-])O)O.C(C(C(C(=O)[O-])O)O)(C(C(=O)[O-])O)O.[Fe+3].[Fe+3]	diferric;(2R,3S,4S,5S)-2,3,4,5-tetrahydroxyhexanedioate
2077	CRESEMBA	ISAVUCONAZONIUM SULFATE	72196309	C35H36F2N8O9S2	814.837	\N	\N	3	17	15	273	56	0	1290	2	1	\N	\N	CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=[N+](C=N3)C(C)OC(=O)N(C)C4=C(C=CC=N4)COC(=O)CNC)(C5=C(C=CC(=C5)F)F)O.OS(=O)(=O)[O-]	[2-[1-[1-[(2R,3R)-3-[4-(4-cyanophenyl)thiazol-2-yl]-2-(2,5-difluorophenyl)-2-hydroxy-butyl]-1,2,4-triazol-4-ium-4-yl]ethoxycarbonyl-methyl-amino]-3-pyridyl]methyl 2-(methylamino)acetate;hydrogen sulfate
1215	BRONKOMETER	ISOETHARINE MESYLATE	3762	C13H21NO3	239.315	\N	1.7	4	4	5	72.7	17	0	223	0	2	\N	\N	CCC(C(C1=CC(=C(C=C1)O)O)O)NC(C)C	4-[1-hydroxy-2-(isopropylamino)butyl]benzene-1,2-diol
4441	ISOFLURANE	ISOFLURANE	3763	C3H2ClF5O	184.49	\N	2.1	0	6	2	9.2	10	0	102	0	1	\N	\N	C(C(F)(F)F)(OC(F)F)Cl	2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane
6255	NYDRAZID	ISONIAZID	3767	C6H7N3O	137.142	\N	-0.7	2	3	1	68	10	0	120	0	0	\N	\N	C1=CN=CC=C1C(=O)NN	pyridine-4-carbohydrazide
8024	RIFATER	ISONIAZID	3767	C6H7N3O	137.142	\N	-0.7	2	3	1	68	10	0	120	0	0	\N	\N	C1=CN=CC=C1C(=O)NN	pyridine-4-carbohydrazide
8033	RIMIFON	ISONIAZID	3767	C6H7N3O	137.142	\N	-0.7	2	3	1	68	10	0	120	0	0	\N	\N	C1=CN=CC=C1C(=O)NN	pyridine-4-carbohydrazide
1592	CHLORAPREP TRIPLE SWABSTICK	ISOPROPYL ALCOHOL	3776	C3H8O	60.096	\N	0.3	1	1	0	20.2	4	0	10.8	0	0	\N	\N	CC(C)O	propan-2-ol
1594	CHLORAPREP WITH TINT	ISOPROPYL ALCOHOL	3776	C3H8O	60.096	\N	0.3	1	1	0	20.2	4	0	10.8	0	0	\N	\N	CC(C)O	propan-2-ol
7452	PREVANTICS SWAB	ISOPROPYL ALCOHOL	3776	C3H8O	60.096	\N	0.3	1	1	0	20.2	4	0	10.8	0	0	\N	\N	CC(C)O	propan-2-ol
7454	PREVANTICS SWABSTICK	ISOPROPYL ALCOHOL	3776	C3H8O	60.096	\N	0.3	1	1	0	20.2	4	0	10.8	0	0	\N	\N	CC(C)O	propan-2-ol
2952	DUO-MEDIHALER	ISOPROTERENOL HYDROCHLORIDE	5807	C11H18ClNO3	247.719	\N	\N	5	4	4	72.7	16	0	187	0	1	\N	\N	CC(C)NCC(C1=CC(=C(C=C1)O)O)O.Cl	4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol;hydrochloride
9487	VAPO-ISO	ISOPROTERENOL HYDROCHLORIDE	5807	C11H18ClNO3	247.719	\N	\N	5	4	4	72.7	16	0	187	0	1	\N	\N	CC(C)NCC(C1=CC(=C(C=C1)O)O)O.Cl	4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol;hydrochloride
5359	MEDIHALER-ISO	ISOPROTERENOL SULFATE	656677	C22H40N2O12S	556.624	\N	\N	12	14	8	230	37	0	268	0	2	\N	\N	CC(C)NCC(C1=CC(=C(C=C1)O)O)O.CC(C)NCC(C1=CC(=C(C=C1)O)O)O.O.O.OS(=O)(=O)O	4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol;sulfuric acid;dihydrate
4432	ISMOTIC	ISOSORBIDE	12597	C6H10O4	146.142	\N	-1.4	2	4	0	58.9	10	0	122	4	0	\N	\N	C1C(C2C(O1)C(CO2)O)O	(3S,3aR,6R,6aR)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diol
4545	ISOSULFAN BLUE	ISOSULFAN BLUE	50108	C27H31N2NaO6S2	566.663	\N	\N	0	7	7	137	38	0	1040	0	0	\N	\N	CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC)C=C2)C3=C(C=CC(=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+]	sodium;2-[[4-(diethylamino)phenyl]-(4-diethyliminiocyclohexa-2,5-dien-1-ylidene)methyl]benzene-1,4-disulfonate
26	ABSORICA	ISOTRETINOIN	5282379	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
39	ACCUTANE	ISOTRETINOIN	5282379	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
3007	DYNACIRC	ISRADIPINE	3784	C19H21N3O5	371.393	\N	4.3	1	8	6	104	27	0	685	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC	O5-isopropyl O3-methyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
4557	ITRACONAZOLE	ITRACONAZOLE	55283	C35H38Cl2N8O4	705.641	\N	5.7	0	9	11	101	49	0	1120	2	1	\N	\N	CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl	4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-sec-butyl-1,2,4-triazol-3-one
6440	ORKAMBI	IVACAFTOR	16220172	C24H28N2O3	392.499	\N	5.6	3	4	4	78.4	29	0	671	0	0	\N	\N	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	N-(2,4-ditert-butyl-5-hydroxy-phenyl)-4-oxo-1H-quinoline-3-carboxamide
4560	IVERMECTIN	IVERMECTIN	6321424	C48H74O14	875.106	\N	4.1	3	14	8	170	62	0	1680	20	0	\N	\N	CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C	\N
4562	IXEMPRA KIT	IXABEPILONE	6445540	C27H42N2O5S	506.702	\N	3.6	3	7	2	140	35	0	817	7	0	\N	\N	CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C	(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methylthiazol-4-yl)vinyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione
4624	KANAMYCIN	KANAMYCIN SULFATE	441374	C18H38N4O15S	582.575	\N	\N	13	19	6	366	38	0	720	15	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N.OS(=O)(=O)O	(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]tetrahydropyran-3,4,5-triol;sulfuric acid
4625	KANAMYCIN SULFATE	KANAMYCIN SULFATE	441374	C18H38N4O15S	582.575	\N	\N	13	19	6	366	38	0	720	15	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N.OS(=O)(=O)O	(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]tetrahydropyran-3,4,5-triol;sulfuric acid
4667	KETAMINE HCL	KETAMINE HYDROCHLORIDE	15851	C13H17Cl2NO	274.185	\N	\N	2	2	2	29.1	17	0	269	0	1	\N	\N	CNC1(CCCCC1=O)C2=CC=CC=C2Cl.Cl	2-(2-chlorophenyl)-2-(methylamino)cyclohexanone;hydrochloride
4668	KETAMINE HYDROCHLORIDE	KETAMINE HYDROCHLORIDE	15851	C13H17Cl2NO	274.185	\N	\N	2	2	2	29.1	17	0	269	0	1	\N	\N	CNC1(CCCCC1=O)C2=CC=CC=C2Cl.Cl	2-(2-chlorophenyl)-2-(methylamino)cyclohexanone;hydrochloride
3396	EXTINA	KETOCONAZOLE	456201	C26H28Cl2N4O4	531.434	\N	4.3	0	6	7	69.1	36	0	735	2	0	\N	\N	CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl	1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
4670	KETOCONAZOLE	KETOCONAZOLE	456201	C26H28Cl2N4O4	531.434	\N	4.3	0	6	7	69.1	36	0	735	2	0	\N	\N	CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl	1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
4674	KETOZOLE	KETOCONAZOLE	456201	C26H28Cl2N4O4	531.434	\N	4.3	0	6	7	69.1	36	0	735	2	0	\N	\N	CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl	1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
6041	NIZORAL A-D	KETOCONAZOLE	456201	C26H28Cl2N4O4	531.434	\N	4.3	0	6	7	69.1	36	0	735	2	0	\N	\N	CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl	1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
5981	NEXCEDE	KETOPROFEN	3825	C16H14O3	254.285	\N	3.1	1	3	4	54.4	19	0	331	0	1	\N	\N	CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O	2-(3-benzoylphenyl)propanoic acid
6505	ORUDIS	KETOPROFEN	3825	C16H14O3	254.285	\N	3.1	1	3	4	54.4	19	0	331	0	1	\N	\N	CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O	2-(3-benzoylphenyl)propanoic acid
6506	ORUDIS KT	KETOPROFEN	3825	C16H14O3	254.285	\N	3.1	1	3	4	54.4	19	0	331	0	1	\N	\N	CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O	2-(3-benzoylphenyl)propanoic acid
6507	ORUVAIL	KETOPROFEN	3825	C16H14O3	254.285	\N	3.1	1	3	4	54.4	19	0	331	0	1	\N	\N	CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O	2-(3-benzoylphenyl)propanoic acid
126	ACULAR	KETOROLAC TROMETHAMINE	84003	C19H24N2O6	376.409	\N	\N	5	7	6	146	27	0	430	0	1	\N	\N	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O	2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
127	ACULAR LS	KETOROLAC TROMETHAMINE	84003	C19H24N2O6	376.409	\N	\N	5	7	6	146	27	0	430	0	1	\N	\N	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O	2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
128	ACULAR PRESERVATIVE FREE	KETOROLAC TROMETHAMINE	84003	C19H24N2O6	376.409	\N	\N	5	7	6	146	27	0	430	0	1	\N	\N	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O	2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
6653	PARCOPA	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
9005	TRANDATE HCT	LABETALOL HYDROCHLORIDE	71412	C19H25ClN2O3	364.87	\N	\N	5	4	8	95.6	25	0	385	0	2	\N	\N	CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O.Cl	2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]ethyl]benzamide;hydrochloride
4716	LACOSAMIDE	LACOSAMIDE	219078	C13H18N2O3	250.298	\N	0.3	2	3	6	67.4	18	0	275	1	0	\N	\N	CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1	(2R)-2-acetamido-N-benzyl-3-methoxy-propanamide
7501	PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
7508	PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
7515	PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
7522	PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
7529	PRISMASOL BGK 2/0 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
87	ACILAC	LACTULOSE	11333	C12H22O11	342.297	\N	-4.3	8	11	5	190	23	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
1521	CEPHULAC	LACTULOSE	11333	C12H22O11	342.297	\N	-4.3	8	11	5	190	23	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
1630	CHOLAC	LACTULOSE	11333	C12H22O11	342.297	\N	-4.3	8	11	5	190	23	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
1649	CHRONULAC	LACTULOSE	11333	C12H22O11	342.297	\N	-4.3	8	11	5	190	23	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
2007	CONSTILAC	LACTULOSE	11333	C12H22O11	342.297	\N	-4.3	8	11	5	190	23	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
2008	CONSTULOSE	LACTULOSE	11333	C12H22O11	342.297	\N	-4.3	8	11	5	190	23	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
2962	DUPHALAC	LACTULOSE	11333	C12H22O11	342.297	\N	-4.3	8	11	5	190	23	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
3187	ENULOSE	LACTULOSE	11333	C12H22O11	342.297	\N	-4.3	8	11	5	190	23	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
3360	EVALOSE	LACTULOSE	11333	C12H22O11	342.297	\N	-4.3	8	11	5	190	23	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
4728	LAMICTAL	LAMOTRIGINE	3878	C9H7Cl2N5	256.09	\N	1.4	2	5	1	90.7	16	0	242	0	0	\N	\N	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
4729	LAMICTAL CD	LAMOTRIGINE	3878	C9H7Cl2N5	256.09	\N	1.4	2	5	1	90.7	16	0	242	0	0	\N	\N	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
8365	SOMATULINE DEPOT	LANREOTIDE ACETATE	71349	C54H69N11O10S2	1096.333	\N	2.5	13	14	17	406	77	0	2000	0	9	\N	\N	CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N	10-(4-aminobutyl)-19-[[2-amino-3-(2-naphthyl)propanoyl]amino]-N-(1-carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
4806	LANSOPRAZOLE	LANSOPRAZOLE	3883	C16H14F3N3O2S	369.362	\N	2.8	1	8	5	87.1	25	0	480	0	1	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
4809	LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN	LANSOPRAZOLE	3883	C16H14F3N3O2S	369.362	\N	2.8	1	8	5	87.1	25	0	480	0	1	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
7440	PREVACID 24 HR	LANSOPRAZOLE	3883	C16H14F3N3O2S	369.362	\N	2.8	1	8	5	87.1	25	0	480	0	1	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
7441	PREVACID IV	LANSOPRAZOLE	3883	C16H14F3N3O2S	369.362	\N	2.8	1	8	5	87.1	25	0	480	0	1	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
3637	FOSRENOL	LANTHANUM CARBONATE	168924	C3La2O9	457.835	\N	\N	0	9	0	190	14	0	18.8	0	0	\N	\N	C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].[La+3].[La+3]	lanthanum(3+);tricarbonate
4813	LAPATINIB	LAPATINIB	208908	C29H26ClFN4O4S	581.059	\N	5.1	2	9	11	115	40	0	898	0	0	\N	\N	CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine
9630	VIRAC REX	LAPYRIUM CHLORIDE	22659	C21H35ClN2O3	398.972	\N	\N	1	4	16	59.3	27	0	368	0	0	\N	\N	CCCCCCCCCCCC(=O)OCCNC(=O)C[N+]1=CC=CC=C1.[Cl-]	2-[(2-pyridin-1-ium-1-ylacetyl)amino]ethyl dodecanoate;chloride
3879	HARVONI	LEDIPASVIR	67505836	C49H54F2N8O6	889.018	\N	7.4	4	10	12	175	65	0	1820	6	0	\N	\N	CC(C)C(C(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)C9C1CCC(C1)N9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC	methyl N-[(1S)-1-[(6S)-6-[5-[9,9-difluoro-7-[2-[(1S,2S,4R)-3-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]-3-azabicyclo[2.2.1]heptan-2-yl]-3H-benzimidazol-5-yl]fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carbonyl]-2-methyl-propyl]carbamate
4850	LENVIMA	LENVATINIB MESYLATE	11237762	C22H23ClN4O7S	522.957	\N	\N	4	8	6	178	35	0	727	0	0	\N	\N	COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl.CS(=O)(=O)O	4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxy-quinoline-6-carboxamide;methanesulfonic acid
9927	ZURAMPIC	LESINURAD	53465279	C17H14BrN3O2S	404.282	\N	4.7	1	5	5	93.3	24	0	479	0	0	\N	\N	C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)O	2-[[5-bromo-4-(4-cyclopropyl-1-naphthyl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid
3437	FEMARA	LETROZOLE	3902	C17H11N5	285.31	\N	2.7	0	4	3	78.3	22	0	420	0	0	\N	\N	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile
4863	LEUCOVORIN CALCIUM	LEUCOVORIN CALCIUM	15150	C20H21CaN7O7	511.508	\N	\N	5	9	7	221	35	0	900	1	1	\N	\N	C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Ca+2]	calcium;(2S)-2-[[4-[(2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioate
4864	LEUCOVORIN CALCIUM PRESERVATIVE FREE	LEUCOVORIN CALCIUM	15150	C20H21CaN7O7	511.508	\N	\N	5	9	7	221	35	0	900	1	1	\N	\N	C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Ca+2]	calcium;(2S)-2-[[4-[(2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioate
9717	WELLCOVORIN	LEUCOVORIN CALCIUM	15150	C20H21CaN7O7	511.508	\N	\N	5	9	7	221	35	0	900	1	1	\N	\N	C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Ca+2]	calcium;(2S)-2-[[4-[(2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioate
8267	SINEMET	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
8269	SINEMET CR	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
1959	COLYTE	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
9770	XOPENEX	LEVALBUTEROL HYDROCHLORIDE	123601	C13H22ClNO3	275.773	\N	\N	5	4	5	72.7	18	0	227	1	0	\N	\N	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.Cl	4-[(1R)-2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol;hydrochloride
3229	ERGAMISOL	LEVAMISOLE HYDROCHLORIDE	27944	C11H13ClN2S	240.749	\N	\N	1	2	1	40.9	15	0	246	1	0	\N	\N	C1CSC2=NC(CN21)C3=CC=CC=C3.Cl	(6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole;hydrochloride
4880	LEVETIRACETAM IN SODIUM CHLORIDE	LEVETIRACETAM	5284583	C8H14N2O2	170.212	\N	-0.3	1	2	3	63.4	12	0	203	1	0	\N	\N	CCC(C(=O)N)N1CCCC1=O	(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
1085	BETAXON	LEVOBETAXOLOL HYDROCHLORIDE	60656	C18H30ClNO3	343.892	\N	\N	3	4	11	50.7	23	0	286	1	0	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl	(2S)-1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol;hydrochloride
1069	BETAGAN	LEVOBUNOLOL HYDROCHLORIDE	5284409	C17H26ClNO3	327.849	\N	\N	3	4	6	58.6	22	0	350	1	0	\N	\N	CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O.Cl	5-[(2S)-3-(tert-butylamino)-2-hydroxy-propoxy]tetralin-1-one;hydrochloride
4886	LEVOBUNOLOL HYDROCHLORIDE	LEVOBUNOLOL HYDROCHLORIDE	5284409	C17H26ClNO3	327.849	\N	\N	3	4	6	58.6	22	0	350	1	0	\N	\N	CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O.Cl	5-[(2S)-3-(tert-butylamino)-2-hydroxy-propoxy]tetralin-1-one;hydrochloride
5013	LIVOSTIN	LEVOCABASTINE HYDROCHLORIDE	54384	C26H30ClFN2O2	456.986	\N	\N	2	5	4	64.3	32	0	681	2	0	\N	\N	CC1CN(CCC1(C2=CC=CC=C2)C(=O)O)C3CCC(CC3)(C#N)C4=CC=C(C=C4)F.Cl	(3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-piperidine-4-carboxylic acid;hydrochloride
1434	CARNITOR	LEVOCARNITINE	10917	C7H15NO3	161.201	\N	-0.2	1	3	3	60.4	11	0	134	1	0	\N	\N	C[N+](C)(C)CC(CC(=O)[O-])O	(3R)-3-hydroxy-4-(trimethylammonio)butanoate
1435	CARNITOR SF	LEVOCARNITINE	10917	C7H15NO3	161.201	\N	-0.2	1	3	3	60.4	11	0	134	1	0	\N	\N	C[N+](C)(C)CC(CC(=O)[O-])O	(3R)-3-hydroxy-4-(trimethylammonio)butanoate
4888	LEVOCETIRIZINE DIHYDROCHLORIDE	LEVOCETIRIZINE DIHYDROCHLORIDE	9955977	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	1	0	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(R)-(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
9793	XYZAL	LEVOCETIRIZINE DIHYDROCHLORIDE	9955977	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	1	0	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(R)-(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
1394	CARBILEV	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
4871	LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER	LEVOFLOXACIN	149096	C18H20FN3O4	361.373	\N	-0.4	1	8	2	73.3	26	0	634	1	0	\N	\N	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	\N
4889	LEVOFLOXACIN	LEVOFLOXACIN	149096	C18H20FN3O4	361.373	\N	-0.4	1	8	2	73.3	26	0	634	1	0	\N	\N	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	\N
4890	LEVOFLOXACIN	LEVOFLOXACIN	149096	C18H20FN3O4	361.373	\N	-0.4	1	8	2	73.3	26	0	634	1	0	\N	\N	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	\N
4892	LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER	LEVOFLOXACIN	149096	C18H20FN3O4	361.373	\N	-0.4	1	8	2	73.3	26	0	634	1	0	\N	\N	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	\N
4893	LEVOFLOXACIN; DEXTROSE	LEVOFLOXACIN	149096	C18H20FN3O4	361.373	\N	-0.4	1	8	2	73.3	26	0	634	1	0	\N	\N	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	\N
4896	LEVOLEUCOVORIN	LEVOLEUCOVORIN	149436	C20H23N7O7	473.446	\N	-1.2	7	9	9	216	34	0	911	2	0	\N	\N	C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid
1101	BEYAZ	LEVOMEFOLATE CALCIUM	444412	C20H25N7O6	459.463	\N	-0.5	7	9	9	199	33	0	865	2	0	\N	\N	CN1C(CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[[(6S)-2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid
2937	DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM	LEVOMEFOLATE CALCIUM	444412	C20H25N7O6	459.463	\N	-0.5	7	9	9	199	33	0	865	2	0	\N	\N	CN1C(CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[[(6S)-2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid
6442	ORLAAM	LEVOMETHADYL ACETATE HYDROCHLORIDE	39371	C23H32ClNO2	389.964	\N	\N	1	3	9	29.5	27	0	404	2	0	\N	\N	CCC(C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C.Cl	[(1S,4S)-4-(dimethylamino)-1-ethyl-2,2-diphenyl-pentyl] acetate;hydrochloride
759	ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN	LEVONORDEFRIN	164739	C9H13NO3	183.207	\N	-0.8	4	4	2	86.7	13	0	165	2	0	\N	\N	CC(C(C1=CC(=C(C=C1)O)O)O)N	4-[(1R,2S)-2-amino-1-hydroxy-propyl]benzene-1,2-diol
1397	CARBOCAINE W/ NEO-COBEFRIN	LEVONORDEFRIN	164739	C9H13NO3	183.207	\N	-0.8	4	4	2	86.7	13	0	165	2	0	\N	\N	CC(C(C1=CC(=C(C=C1)O)O)O)N	4-[(1R,2S)-2-amino-1-hydroxy-propyl]benzene-1,2-diol
4434	ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN	LEVONORDEFRIN	164739	C9H13NO3	183.207	\N	-0.8	4	4	2	86.7	13	0	165	2	0	\N	\N	CC(C(C1=CC(=C(C=C1)O)O)O)N	4-[(1R,2S)-2-amino-1-hydroxy-propyl]benzene-1,2-diol
5408	MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN	LEVONORDEFRIN	164739	C9H13NO3	183.207	\N	-0.8	4	4	2	86.7	13	0	165	2	0	\N	\N	CC(C(C1=CC(=C(C=C1)O)O)O)N	4-[(1R,2S)-2-amino-1-hydroxy-propyl]benzene-1,2-diol
7007	POLOCAINE W/ LEVONORDEFRIN	LEVONORDEFRIN	164739	C9H13NO3	183.207	\N	-0.8	4	4	2	86.7	13	0	165	2	0	\N	\N	CC(C(C1=CC(=C(C=C1)O)O)O)N	4-[(1R,2S)-2-amino-1-hydroxy-propyl]benzene-1,2-diol
386	ALTAVERA	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
826	ATHENTIA NEXT	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
893	AVIANE-21	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
895	AVIANE-28	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
911	AYUNA	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
2206	DAYSEE	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6214	NOVRAD	LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS	28332	C32H37NO5S	547.71	\N	\N	1	6	10	92.3	39	0	688	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C.C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)O	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate;naphthalene-2-sulfonic acid
4912	LEVOTHROID	LEVOTHYROXINE SODIUM	23666112	C15H10I4NNaO4	798.856	\N	\N	2	5	5	95.6	25	0	426	1	0	\N	\N	C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+]	sodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate
4913	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	23666112	C15H10I4NNaO4	798.856	\N	\N	2	5	5	95.6	25	0	426	1	0	\N	\N	C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+]	sodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate
4914	LEVOXYL	LEVOTHYROXINE SODIUM	23666112	C15H10I4NNaO4	798.856	\N	\N	2	5	5	95.6	25	0	426	1	0	\N	\N	C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+]	sodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate
6213	NOVOTHYROX	LEVOTHYROXINE SODIUM	23666112	C15H10I4NNaO4	798.856	\N	\N	2	5	5	95.6	25	0	426	1	0	\N	\N	C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+]	sodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate
8642	SYNTHROID	LEVOTHYROXINE SODIUM	23666112	C15H10I4NNaO4	798.856	\N	\N	2	5	5	95.6	25	0	426	1	0	\N	\N	C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+]	sodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate
8918	TIROSINT	LEVOTHYROXINE SODIUM	23666112	C15H10I4NNaO4	798.856	\N	\N	2	5	5	95.6	25	0	426	1	0	\N	\N	C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+]	sodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate
272	AKTEN	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
367	ALPHACAINE HYDROCHLORIDE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
369	ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
668	ANESTACON	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
2217	DECADRON W/ XYLOCAINE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
3116	EMBOLEX	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4397	IONTOCAINE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4829	LARYNG-O-JET KIT	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4830	LARYNGOTRACHEAL ANESTHESIA KIT	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
3122	EMLA	LIDOCAINE	3676	C14H22N2O	234.343	\N	2.3	1	2	5	32.3	17	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
6418	ORAQIX	LIDOCAINE	3676	C14H22N2O	234.343	\N	2.3	1	2	5	32.3	17	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
3801	GLYXAMBI	LINAGLIPTIN	10096344	C25H28N8O2	472.553	\N	1.9	1	7	4	114	35	0	885	1	0	\N	\N	CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C	8-[(3R)-3-amino-1-piperidyl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
1964	COLYTE WITH FLAVOR PACKS	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
4971	LINCOMYCIN HYDROCHLORIDE	LINCOMYCIN HYDROCHLORIDE	64710	C18H35ClN2O6S	442.996	\N	\N	6	8	7	148	28	0	499	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O.Cl	(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide;hydrochloride
3684	GAMENE	LINDANE	727	C6H6Cl6	290.814	\N	3.8	0	0	0	0	12	0	104	0	0	\N	\N	C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl	1,2,3,4,5,6-hexachlorocyclohexane
4974	LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	LINEZOLID	441401	C16H20FN3O4	337.351	\N	0.7	1	6	4	71.1	24	0	472	1	0	\N	\N	CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F	N-[[(5S)-3-(3-fluoro-4-morpholino-phenyl)-2-oxo-oxazolidin-5-yl]methyl]acetamide
3354	EUTHROID-1	LIOTRIX (T4;T3)	71371	C30H21I7N2Na2O8	1471.815	\N	\N	4	10	8	191	49	0	811	2	0	\N	\N	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+].[Na+]	disodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate;(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoate
3355	EUTHROID-2	LIOTRIX (T4;T3)	71371	C30H21I7N2Na2O8	1471.815	\N	\N	4	10	8	191	49	0	811	2	0	\N	\N	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+].[Na+]	disodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate;(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoate
8164	SAXENDA	LIRAGLUTIDE RECOMBINANT	16153050	C172H265N43O51	3751.262	\N	-3.4	54	55	132	1510	266	0	8760	31	0	\N	\N	CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CNC=N6)N)C(=O)O	\N
9596	VICTOZA	LIRAGLUTIDE RECOMBINANT	16153050	C172H265N43O51	3751.262	\N	-3.4	54	55	132	1510	266	0	8760	31	0	\N	\N	CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CNC=N6)N)C(=O)O	\N
5000	LISDEXAMFETAMINE DIMESYLATE	LISDEXAMFETAMINE DIMESYLATE	11597697	C17H33N3O7S2	455.585	\N	\N	5	9	8	207	29	0	344	2	0	\N	\N	CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O	(2S)-2,6-diamino-N-[(1S)-1-methyl-2-phenyl-ethyl]hexanamide;methanesulfonic acid
5003	LISINOPRIL AND HYDROCHLOROTHIAZIDE	LISINOPRIL	5362119	C21H31N3O5	405.495	\N	-2.9	4	7	12	133	29	0	550	3	0	\N	\N	C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O	(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
7817	QBRELIS	LISINOPRIL	5362119	C21H31N3O5	405.495	\N	-2.9	4	7	12	133	29	0	550	3	0	\N	\N	C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O	(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
9852	ZESTORETIC	LISINOPRIL	5362119	C21H31N3O5	405.495	\N	-2.9	4	7	12	133	29	0	550	3	0	\N	\N	C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O	(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
3281	ESKALITH CR	LITHIUM CARBONATE	11125	CLi2O3	73.888	\N	\N	0	3	0	63.2	6	0	18.8	0	0	\N	\N	[Li+].[Li+].C(=O)([O-])[O-]	dilithium;carbonate
206	ADLYXIN	LIXISENATIDE	90472060	C215H347N61O65S	4858.563	\N	-30.8	70	77	170	2090	342	0	11800	42	0	\N	\N	CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC8=CNC=N8)N	\N
360	ALOMIDE	LODOXAMIDE TROMETHAMINE	11192129	C19H28ClN5O12	553.906	\N	\N	12	15	10	330	37	0	543	0	0	\N	\N	C1=C(C=C(C(=C1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N.C(C(CO)(CO)N)O.C(C(CO)(CO)N)O	2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-chloro-5-cyano-3-(oxaloamino)anilino]-2-oxo-acetic acid
5321	MAXAQUIN	LOMEFLOXACIN HYDROCHLORIDE	68624	C17H20ClF2N3O3	387.812	\N	\N	3	8	3	72.9	26	0	586	0	1	\N	\N	CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O.Cl	1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid;hydrochloride
3764	GLEOSTINE	LOMUSTINE	3950	C9H16ClN3O2	233.696	\N	2.8	1	3	3	61.8	15	0	219	0	0	\N	\N	C1CCC(CC1)NC(=O)N(CCCl)N=O	1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-urea
4209	IMODIUM	LOPERAMIDE HYDROCHLORIDE	71420	C29H34Cl2N2O2	513.503	\N	\N	2	3	7	43.8	35	0	623	0	0	\N	\N	CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl	4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide;hydrochloride
4210	IMODIUM A-D	LOPERAMIDE HYDROCHLORIDE	71420	C29H34Cl2N2O2	513.503	\N	\N	2	3	7	43.8	35	0	623	0	0	\N	\N	CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl	4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide;hydrochloride
4620	KALETRA	LOPINAVIR	92727	C37H48N4O5	628.814	\N	5.9	4	5	15	120	46	0	940	4	0	\N	\N	CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O	(2S)-N-[(1S,3S,4S)-1-benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-pentyl]-3-methyl-2-(2-oxohexahydropyrimidin-1-yl)butanamide
5073	LORABID	LORACARBEF	5284585	C16H16ClN3O4	349.771	\N	-1.7	3	5	4	113	24	0	600	3	0	\N	\N	C1CC(=C(N2C1C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl	(6R,7S)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
5078	LORAZ	LORAZEPAM	3958	C15H10Cl2N2O2	321.157	\N	2.4	2	3	1	61.7	21	0	443	0	1	\N	\N	C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl	7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one
5079	LORAZEPAM	LORAZEPAM	3958	C15H10Cl2N2O2	321.157	\N	2.4	2	3	1	61.7	21	0	443	0	1	\N	\N	C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl	7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one
5080	LORAZEPAM INTENSOL	LORAZEPAM	3958	C15H10Cl2N2O2	321.157	\N	2.4	2	3	1	61.7	21	0	443	0	1	\N	\N	C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl	7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one
5081	LORAZEPAM PRESERVATIVE FREE	LORAZEPAM	3958	C15H10Cl2N2O2	321.157	\N	2.4	2	3	1	61.7	21	0	443	0	1	\N	\N	C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl	7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one
1013	BELVIQ	LORCASERIN HYDROCHLORIDE	11673085	C11H15Cl2N	232.148	\N	\N	2	1	0	12	14	0	172	1	0	\N	\N	CC1CNCCC2=C1C=C(C=C2)Cl.Cl	(5R)-7-chloro-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;hydrochloride
1014	BELVIQ XR	LORCASERIN HYDROCHLORIDE	11673085	C11H15Cl2N	232.148	\N	\N	2	1	0	12	14	0	172	1	0	\N	\N	CC1CNCCC2=C1C=C(C=C2)Cl.Cl	(5R)-7-chloro-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;hydrochloride
381	ALREX	LOTEPREDNOL ETABONATE	444025	C24H31ClO7	466.955	\N	3.9	1	7	7	99.1	32	0	882	7	0	\N	\N	CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl	chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate
9941	ZYLET	LOTEPREDNOL ETABONATE	444025	C24H31ClO7	466.955	\N	3.9	1	7	7	99.1	32	0	882	7	0	\N	\N	CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl	chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate
1847	CLINIMIX E 5/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
5120	LOXITANE C	LOXAPINE HYDROCHLORIDE	71400	C18H19Cl2N3O	364.27	\N	\N	1	3	1	28.1	24	0	450	0	0	\N	\N	CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.Cl	8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine;hydrochloride
5119	LOXITANE	LOXAPINE SUCCINATE	71399	C22H24ClN3O5	445.9	\N	\N	2	7	4	103	31	0	542	0	0	\N	\N	CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O	8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine;succinic acid
588	AMITIZA	LUBIPROSTONE	157920	C20H32F2O5	390.468	\N	4	2	7	11	83.8	27	0	525	4	0	\N	\N	CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F	7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid
5147	LUZU	LULICONAZOLE	3003141	C14H9Cl2N3S2	354.267	\N	4	0	4	2	92.2	21	0	476	1	0	\N	\N	C1C(SC(=C(C#N)N2C=CN=C2)S1)C3=C(C=C(C=C3)Cl)Cl	(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-yl-acetonitrile
6441	ORKAMBI	LUMACAFTOR	16678941	C24H18F2N2O5	452.414	\N	4.4	2	8	5	97.8	33	0	776	0	0	\N	\N	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O	3-[6-[[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino]-3-methyl-2-pyridyl]benzoic acid
2750	DIAPID	LYPRESSIN	5772	C46H65N13O12S2	1056.225	\N	-3.9	13	16	19	476	73	0	1960	0	8	\N	\N	C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCCN)C(=O)NCC(=O)N	1-[19-amino-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[5-amino-1-[(2-amino-2-oxo-ethyl)carbamoyl]pentyl]pyrrolidine-2-carboxamide
4751	LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS	Lamivudine	60825	C8H11N3O3S	229.254	\N	-0.9	2	4	2	113	15	0	331	2	0	\N	\N	C1C(OC(S1)CO)N2C=CC(=NC2=O)N	4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
6391	OPSUMIT	MACITENTAN	16004692	C19H20Br2N6O4S	588.275	\N	3.7	2	10	11	137	32	0	642	0	0	\N	\N	CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br	5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-N-(propylsulfamoyl)pyrimidin-4-amine
5266	MAFENIDE ACETATE	MAFENIDE ACETATE	25590	C9H14N2O4S	246.281	\N	\N	3	6	2	132	16	0	255	0	0	\N	\N	CC(=O)O.C1=CC(=CC=C1CN)S(=O)(=O)N	acetic acid;4-(aminomethyl)benzenesulfonamide
8544	SULFAMYLON	MAFENIDE ACETATE	25590	C9H14N2O4S	246.281	\N	\N	3	6	2	132	16	0	255	0	0	\N	\N	CC(=O)O.C1=CC(=CC=C1CN)S(=O)(=O)N	acetic acid;4-(aminomethyl)benzenesulfonamide
452	AMINOSYN 3.5% M IN PLASTIC CONTAINER	MAGNESIUM ACETATE	8896	C4H6MgO4	142.393	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Mg+2]	magnesium;diacetate
501	AMINOSYN II 3.5% M IN PLASTIC CONTAINER	MAGNESIUM ACETATE	8896	C4H6MgO4	142.393	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Mg+2]	magnesium;diacetate
7933	RENACIDIN	MAGNESIUM CARBONATE	11029	CMgO3	84.313	\N	\N	0	3	0	63.2	5	0	18.8	0	0	\N	\N	C(=O)([O-])[O-].[Mg+2]	magnesium;carbonate
478	AMINOSYN II 10% W/ ELECTROLYTES	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
490	AMINOSYN II 3.5% M	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
496	AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
507	AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
8589	SUPREP BOWEL PREP KIT	MAGNESIUM SULFATE ANHYDROUS	24083	MgO4S	120.361	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Mg+2]	magnesium;sulfate
4608	KABIVEN IN PLASTIC CONTAINER	MAGNESIUM SULFATE	24083	MgO4S	120.361	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Mg+2]	magnesium;sulfate
5271	MAGNESIUM SULFATE	MAGNESIUM SULFATE	24083	MgO4S	120.361	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Mg+2]	magnesium;sulfate
5275	MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM SULFATE	24083	MgO4S	120.361	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Mg+2]	magnesium;sulfate
5276	MAGNESIUM SULFATE IN PLASTIC CONTAINER	MAGNESIUM SULFATE	24083	MgO4S	120.361	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Mg+2]	magnesium;sulfate
8799	TESLASCAN	MANGAFODIPIR TRISODIUM	160036	C22H27MnN4Na3O14P2	757.327	\N	\N	3	18	13	304	46	0	873	0	0	\N	\N	[H+].[H+].[H+].CC1=NC=C(C(=C1[O-])CN(CCN(CC2=C(C(=NC=C2COP(=O)([O-])[O-])C)[O-])CC(=O)[O-])CC(=O)[O-])COP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Mn+2]	manganous;trisodium;2-[2-[carboxylatomethyl-[[2-methyl-3-oxido-5-(phosphonatooxymethyl)-4-pyridyl]methyl]amino]ethyl-[[2-methyl-3-oxido-5-(phosphonatooxymethyl)-4-pyridyl]methyl]amino]acetate;hydron
5287	MANGANESE SULFATE	MANGANESE SULFATE	24580	MnO4S	150.994	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Mn+2]	manganous;sulfate
770	ARIDOL KIT	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
5289	MANNITOL 10% IN PLASTIC CONTAINER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
5290	MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
5291	MANNITOL 15%	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
5125	LUDIOMIL	MAPROTILINE HYDROCHLORIDE	71478	C20H24ClN	313.869	\N	\N	2	1	4	12	22	0	339	0	0	\N	\N	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24.Cl	\N
8193	SELZENTRY	MARAVIROC	3002977	C29H41F2N5O	513.678	\N	5.1	1	6	8	63	37	0	751	3	0	\N	\N	CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C	4,4-difluoro-N-[(1S)-3-[(1S,5R)-3-(3-isopropyl-5-methyl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenyl-propyl]cyclohexanecarboxamide
5714	MUSTARGEN	MECHLORETHAMINE HYDROCHLORIDE	5935	C5H12Cl3N	192.508	\N	\N	1	1	4	3.2	9	0	43.7	0	0	\N	\N	CN(CCCl)CCCl.Cl	2-chloro-N-(2-chloroethyl)-N-methyl-ethanamine;hydrochloride
713	ANTIVERT	MECLIZINE HYDROCHLORIDE	4034	C25H27ClN2	390.955	\N	5.8	0	2	5	6.5	28	0	448	0	1	\N	\N	CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl	1-[(4-chlorophenyl)-phenyl-methyl]-4-(m-tolylmethyl)piperazine
5347	MECLAN	MECLOCYCLINE SULFOSALICYLATE	54676538	C29H27ClN2O14S	695.045	\N	\N	9	15	4	302	47	0	1350	5	0	\N	\N	CN(C)C1C2C(C3C(=C)C4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O.C1=CC(=C(C=C1S(=O)(=O)O)C(=O)O)O	(4S,4aR,5S,5aR,12aR)-7-chloro-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;2-hydroxy-5-sulfo-benzoic acid
5350	MECLOFENAMATE SODIUM	MECLOFENAMATE SODIUM	4038	C14H10Cl2NNaO2	318.129	\N	\N	1	3	3	52.2	20	0	332	0	0	\N	\N	CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)[O-])Cl.[Na+]	sodium;2-(2,6-dichloro-3-methyl-anilino)benzoate
5351	MECLOMEN	MECLOFENAMATE SODIUM	4038	C14H10Cl2NNaO2	318.129	\N	\N	1	3	3	52.2	20	0	332	0	0	\N	\N	CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)[O-])Cl.[Na+]	sodium;2-(2,6-dichloro-3-methyl-anilino)benzoate
411	AMEN	MEDROXYPROGESTERONE ACETATE	6279	C24H34O4	386.532	\N	4.1	0	4	3	60.4	28	0	767	7	0	\N	\N	CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
2095	CURRETAB	MEDROXYPROGESTERONE ACETATE	6279	C24H34O4	386.532	\N	4.1	0	4	3	60.4	28	0	767	7	0	\N	\N	CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
3962	HMS	MEDRYSONE	247839	C22H32O3	344.495	\N	2.7	1	3	1	54.4	25	0	650	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)CC4)C)O)C)C(=O)C	(6S,8S,9S,10R,11S,13S,14S,17S)-17-acetyl-11-hydroxy-6,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
7037	PONSTEL	MEFENAMIC ACID	4044	C15H15NO2	241.29	\N	5.1	2	3	3	49.3	18	0	292	0	0	\N	\N	CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C	2-(2,3-dimethylanilino)benzoic acid
4815	LARIAM	MEFLOQUINE HYDROCHLORIDE	65329	C17H17ClF6N2O	414.776	\N	\N	3	9	2	45.2	27	0	483	2	0	\N	\N	C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O.Cl	(S)-[2,8-bis(trifluoromethyl)-4-quinolyl]-[(2R)-2-piperidyl]methanol;hydrochloride
5366	MEFLOQUINE HYDROCHLORIDE	MEFLOQUINE HYDROCHLORIDE	65329	C17H17ClF6N2O	414.776	\N	\N	3	9	2	45.2	27	0	483	2	0	\N	\N	C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O.Cl	(S)-[2,8-bis(trifluoromethyl)-4-quinolyl]-[(2R)-2-piperidyl]methanol;hydrochloride
5371	MEGACE	MEGESTROL ACETATE	11683	C24H32O4	384.516	\N	3.1	0	4	3	60.4	28	0	821	6	0	\N	\N	CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
5372	MEGACE ES	MEGESTROL ACETATE	11683	C24H32O4	384.516	\N	3.1	0	4	3	60.4	28	0	821	6	0	\N	\N	CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
5374	MEGESTROL ACETATE	MEGESTROL ACETATE	11683	C24H32O4	384.516	\N	3.1	0	4	3	60.4	28	0	821	6	0	\N	\N	CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
5629	MOBIC	MELOXICAM	54677470	C14H13N3O4S2	351.395	\N	3	2	7	2	136	23	0	628	0	0	\N	\N	CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O	4-hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-1,1-dioxo-1$l^{6},2-benzothiazine-3-carboxamide
339	ALKERAN	MELPHALAN HYDROCHLORIDE	9927978	C13H19Cl3N2O2	341.657	\N	\N	3	4	8	66.6	20	0	265	1	0	\N	\N	C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl.Cl	(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid;hydrochloride
5384	MEMANTINE HYDROCHLORIDE	MEMANTINE HYDROCHLORIDE	181458	C12H22ClN	215.765	\N	\N	2	1	0	26	14	0	240	0	2	\N	\N	CC12CC3CC(C1)(CC(C3)(C2)N)C.Cl	3,5-dimethyladamantan-1-amine;hydrochloride
4630	KAPPADIONE	MENADIOL SODIUM DIPHOSPHATE	8555	C11H8Na4O8P2	422.084	\N	\N	0	8	2	145	25	0	434	0	0	\N	\N	CC1=C(C2=CC=CC=C2C(=C1)OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]	tetrasodium;(2-methyl-4-phosphonatooxy-1-naphthyl) phosphate
8633	SYNKAYVITE	MENADIOL SODIUM DIPHOSPHATE	8555	C11H8Na4O8P2	422.084	\N	\N	0	8	2	145	25	0	434	0	0	\N	\N	CC1=C(C2=CC=CC=C2C(=C1)OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]	tetrasodium;(2-methyl-4-phosphonatooxy-1-naphthyl) phosphate
8133	SALONPAS	MENTHOL	1254	C10H20O	156.269	\N	3	1	1	1	20.2	11	0	120	0	3	\N	\N	CC1CCC(C(C1)O)C(C)C	2-isopropyl-5-methyl-cyclohexanol
1356	CANTIL	MEPENZOLATE BROMIDE	6461	C21H26BrNO3	420.347	\N	\N	1	4	5	46.5	26	0	432	0	1	\N	\N	C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C.[Br-]	(1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenyl-acetate;bromide
849	ATROPINE AND DEMEROL	MEPERIDINE HYDROCHLORIDE	5750	C15H22ClNO2	283.796	\N	\N	1	3	4	29.5	19	0	276	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2.Cl	ethyl 1-methyl-4-phenyl-piperidine-4-carboxylate;hydrochloride
5400	MEPERGAN	MEPERIDINE HYDROCHLORIDE	5750	C15H22ClNO2	283.796	\N	\N	1	3	4	29.5	19	0	276	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2.Cl	ethyl 1-methyl-4-phenyl-piperidine-4-carboxylate;hydrochloride
5403	MEPERIDINE AND ATROPINE SULFATE	MEPERIDINE HYDROCHLORIDE	5750	C15H22ClNO2	283.796	\N	\N	1	3	4	29.5	19	0	276	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2.Cl	ethyl 1-methyl-4-phenyl-piperidine-4-carboxylate;hydrochloride
758	ARESTOCAINE HYDROCHLORIDE	MEPIVACAINE HYDROCHLORIDE	66070	C15H23ClN2O	282.812	\N	\N	2	2	2	32.3	19	0	282	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl	N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide;hydrochloride
760	ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN	MEPIVACAINE HYDROCHLORIDE	66070	C15H23ClN2O	282.812	\N	\N	2	2	2	32.3	19	0	282	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl	N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide;hydrochloride
1398	CARBOCAINE W/ NEO-COBEFRIN	MEPIVACAINE HYDROCHLORIDE	66070	C15H23ClN2O	282.812	\N	\N	2	2	2	32.3	19	0	282	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl	N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide;hydrochloride
4433	ISOCAINE HYDROCHLORIDE	MEPIVACAINE HYDROCHLORIDE	66070	C15H23ClN2O	282.812	\N	\N	2	2	2	32.3	19	0	282	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl	N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide;hydrochloride
4435	ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN	MEPIVACAINE HYDROCHLORIDE	66070	C15H23ClN2O	282.812	\N	\N	2	2	2	32.3	19	0	282	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl	N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide;hydrochloride
1079	BETAPAR	MEPREDNISONE	5284587	C22H28O5	372.461	\N	1.9	2	5	2	91.7	27	0	795	7	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3C(=O)CC2(C1(C(=O)CO)O)C)C	(8S,9S,10R,13S,14S,16S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
984	BAMATE	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
3223	EQUANIL	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
5413	MEPROBAMATE	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
5415	MEPROBAMATE AND ASPIRIN	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
5417	MEPROSPAN	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
7798	PURIXAN	MERCAPTOPURINE	667490	C5H4N4S	152.175	\N	0	2	2	0	85.2	10	0	190	0	0	\N	\N	C1=NC2=C(N1)C(=S)N=CN2	3,7-dihydropurine-6-thione
5421	MEROPENEM	MEROPENEM	441130	C17H25N3O5S	383.463	\N	-2.4	3	7	5	136	26	0	679	6	0	\N	\N	CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O	(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
5422	MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER	MEROPENEM	441130	C17H25N3O5S	383.463	\N	-2.4	3	7	5	136	26	0	679	6	0	\N	\N	CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O	(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
792	ASACOL	MESALAMINE	4075	C7H7NO3	153.137	\N	1.3	3	4	1	83.6	11	0	160	0	0	\N	\N	C1=CC(=C(C=C1N)C(=O)O)O	5-amino-2-hydroxy-benzoic acid
793	ASACOL HD	MESALAMINE	4075	C7H7NO3	153.137	\N	1.3	3	4	1	83.6	11	0	160	0	0	\N	\N	C1=CC(=C(C=C1N)C(=O)O)O	5-amino-2-hydroxy-benzoic acid
8088	ROWASA	MESALAMINE	4075	C7H7NO3	153.137	\N	1.3	3	4	1	83.6	11	0	160	0	0	\N	\N	C1=CC(=C(C=C1N)C(=O)O)O	5-amino-2-hydroxy-benzoic acid
5428	MESNA	MESNA	23662354	C2H5NaO3S2	164.169	\N	\N	1	4	2	66.6	8	0	123	0	0	\N	\N	C(CS(=O)(=O)[O-])S.[Na+]	sodium;2-sulfanylethanesulfonate
5429	MESNEX	MESNA	23662354	C2H5NaO3S2	164.169	\N	\N	1	4	2	66.6	8	0	123	0	0	\N	\N	C(CS(=O)(=O)[O-])S.[Na+]	sodium;2-sulfanylethanesulfonate
8219	SERENTIL	MESORIDAZINE BESYLATE	36207	C27H32N2O4S3	544.743	\N	\N	1	8	5	131	36	0	686	0	2	\N	\N	CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)C.C1=CC=C(C=C1)S(=O)(=O)O	benzenesulfonic acid;10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfinyl-phenothiazine
3164	ENOVID	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
3166	ENOVID-E	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
3168	ENOVID-E 21	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6104	NORINYL	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
120	ACTOPLUS MET	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
122	ACTOPLUS MET XR	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
3769	GLIPIZIDE AND METFORMIN HYDROCHLORIDE	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
7779	PROVOCHOLINE	METHACHOLINE CHLORIDE	6114	C8H18ClNO2	195.687	\N	\N	0	3	4	26.3	12	0	138	0	1	\N	\N	CC(C[N+](C)(C)C)OC(=O)C.[Cl-]	2-acetoxypropyl(trimethyl)ammonium;chloride
2873	DOLOPHINE HYDROCHLORIDE	METHADONE HYDROCHLORIDE	14184	C21H28ClNO	345.911	\N	\N	1	2	7	20.3	24	0	346	0	1	\N	\N	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2.Cl	6-(dimethylamino)-4,4-diphenyl-heptan-3-one;hydrochloride
5449	METHADONE HYDROCHLORIDE INTENSOL	METHADONE HYDROCHLORIDE	14184	C21H28ClNO	345.911	\N	\N	1	2	7	20.3	24	0	346	0	1	\N	\N	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2.Cl	6-(dimethylamino)-4,4-diphenyl-heptan-3-one;hydrochloride
5450	METHADOSE	METHADONE HYDROCHLORIDE	14184	C21H28ClNO	345.911	\N	\N	1	2	7	20.3	24	0	346	0	1	\N	\N	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2.Cl	6-(dimethylamino)-4,4-diphenyl-heptan-3-one;hydrochloride
9720	WESTADONE	METHADONE HYDROCHLORIDE	14184	C21H28ClNO	345.911	\N	\N	1	2	7	20.3	24	0	346	0	1	\N	\N	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2.Cl	6-(dimethylamino)-4,4-diphenyl-heptan-3-one;hydrochloride
2376	DESOXYN	METHAMPHETAMINE HYDROCHLORIDE	10836	C10H15N	149.237	\N	2.1	1	1	3	12	11	0	95	1	0	\N	\N	CC(CC1=CC=CC=C1)NC	(2S)-N-methyl-1-phenyl-propan-2-amine
5452	METHAMPHETAMINE HYDROCHLORIDE	METHAMPHETAMINE HYDROCHLORIDE	10836	C10H15N	149.237	\N	2.1	1	1	3	12	11	0	95	1	0	\N	\N	CC(CC1=CC=CC=C1)NC	(2S)-N-methyl-1-phenyl-propan-2-amine
5454	METHDILAZINE HYDROCHLORIDE	METHDILAZINE HYDROCHLORIDE	14676	C18H21ClN2S	332.89	\N	\N	1	3	2	31.8	22	0	339	0	1	\N	\N	CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42.Cl	10-[(1-methylpyrrolidin-3-yl)methyl]phenothiazine;hydrochloride
8440	STAPHCILLIN	METHICILLIN SODIUM	23667627	C17H19N2NaO6S	402.397	\N	\N	1	7	5	133	27	0	606	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C3=C(C=CC=C3OC)OC)C(=O)[O-])C.[Na+]	sodium;(2S,5R,6R)-6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
9149	TREST	METHIXENE HYDROCHLORIDE	4167	C20H23NS	309.471	\N	4.9	0	2	2	28.5	22	0	349	0	1	\N	\N	CN1CCCC(C1)CC2C3=CC=CC=C3SC4=CC=CC=C24	1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine
3616	FORBAXIN	METHOCARBAMOL	4107	C11H15NO5	241.243	\N	0.6	2	5	7	91	17	0	236	0	1	\N	\N	COC1=CC=CC=C1OCC(COC(=O)N)O	[2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate
5458	METHOCARBAMOL	METHOCARBAMOL	4107	C11H15NO5	241.243	\N	0.6	2	5	7	91	17	0	236	0	1	\N	\N	COC1=CC=CC=C1OCC(COC(=O)N)O	[2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate
1176	BREVITAL SODIUM	METHOHEXITAL SODIUM	9034	C14H18N2O3	262.309	\N	2.3	1	3	3	66.5	19	0	497	0	2	\N	\N	CCC#CC(C)C1(C(=O)NC(=O)N(C1=O)C)CC=C	5-allyl-1-methyl-5-(1-methylpent-2-ynyl)hexahydropyrimidine-2,4,6-trione
22	ABITREXATE	METHOTREXATE SODIUM	126941	C20H22N8O5	454.447	\N	-1.8	5	12	9	211	33	0	704	1	0	\N	\N	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
3600	FOLEX	METHOTREXATE SODIUM	126941	C20H22N8O5	454.447	\N	-1.8	5	12	9	211	33	0	704	1	0	\N	\N	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
3601	FOLEX PFS	METHOTREXATE SODIUM	126941	C20H22N8O5	454.447	\N	-1.8	5	12	9	211	33	0	704	1	0	\N	\N	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
7880	RASUVO	METHOTREXATE	126941	C20H22N8O5	454.447	\N	-1.8	5	12	9	211	33	0	704	1	0	\N	\N	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
6573	OXSORALEN-ULTRA	METHOXSALEN	4114	C12H8O4	216.192	\N	1.9	0	4	1	48.7	16	0	325	0	0	\N	\N	COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2	9-methoxyfuro[3,2-g]chromen-7-one
9441	UVADEX	METHOXSALEN	4114	C12H8O4	216.192	\N	1.9	0	4	1	48.7	16	0	325	0	0	\N	\N	COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2	9-methoxyfuro[3,2-g]chromen-7-one
6627	PAMINE FORTE	METHSCOPOLAMINE BROMIDE	5459110	C18H24BrNO4	398.297	\N	\N	1	5	5	59.1	24	0	454	5	0	\N	\N	C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C.[Br-]	\N
2856	DIUTENSEN-R	METHYCLOTHIAZIDE	4121	C9H11Cl2N3O4S2	360.224	\N	1.4	2	7	2	126	20	0	571	0	1	\N	\N	CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl	6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3156	ENDURONYL	METHYCLOTHIAZIDE	4121	C9H11Cl2N3O4S2	360.224	\N	1.4	2	7	2	126	20	0	571	0	1	\N	\N	CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl	6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3158	ENDURONYL FORTE	METHYCLOTHIAZIDE	4121	C9H11Cl2N3O4S2	360.224	\N	1.4	2	7	2	126	20	0	571	0	1	\N	\N	CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl	6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3358	EUTRON	METHYCLOTHIAZIDE	4121	C9H11Cl2N3O4S2	360.224	\N	1.4	2	7	2	126	20	0	571	0	1	\N	\N	CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl	6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5518	METVIXIA	METHYL AMINOLEVULINATE HYDROCHLORIDE	157921	C6H12ClNO3	181.616	\N	\N	2	4	5	69.4	11	0	133	0	0	\N	\N	COC(=O)CCC(=O)CN.Cl	methyl 5-amino-4-oxo-pentanoate;hydrochloride
308	ALDOCLOR-150	METHYLDOPA	38853	C10H13NO4	211.217	\N	-1.9	4	5	3	104	15	0	246	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N	(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid
311	ALDOMET	METHYLDOPA	38853	C10H13NO4	211.217	\N	-1.9	4	5	3	104	15	0	246	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N	(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid
5475	METHYLDOPATE HCL	METHYLDOPATE HYDROCHLORIDE	17276	C12H18ClNO4	275.729	\N	\N	4	5	5	92.8	18	0	271	1	0	\N	\N	CCOC(=O)C(C)(CC1=CC(=C(C=C1)O)O)N.Cl	ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoate;hydrochloride
5476	METHYLDOPATE HYDROCHLORIDE	METHYLDOPATE HYDROCHLORIDE	17276	C12H18ClNO4	275.729	\N	\N	4	5	5	92.8	18	0	271	1	0	\N	\N	CCOC(=O)C(C)(CC1=CC(=C(C=C1)O)O)N.Cl	ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoate;hydrochloride
7773	PROVAYBLUE	METHYLENE BLUE	6099	C16H18ClN3S	319.851	\N	\N	0	4	1	43.9	21	0	483	0	0	\N	\N	CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-]	[7-(dimethylamino)phenothiazin-3-ylidene]-dimethyl-ammonium;chloride
5456	METHERGINE	METHYLERGONOVINE MALEATE	5281072	C24H29N3O6	455.511	\N	\N	5	7	6	143	33	0	668	3	0	\N	\N	CCC(CO)NC(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C.C(=CC(=O)O)C(=O)O	(6aR,9R)-N-[(1S)-1-(hydroxymethyl)propyl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;maleic acid
7924	RELISTOR	METHYLNALTREXONE BROMIDE	5361917	C21H26BrNO4	436.346	\N	\N	2	5	2	66.8	27	0	664	4	1	\N	\N	C[N+]1(CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6.[Br-]	(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-3-ium-7-one;bromide
733	APTENSIO XR	METHYLPHENIDATE HYDROCHLORIDE	9280	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	0	2	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl 2-phenyl-2-(2-piperidyl)acetate;hydrochloride
2000	CONCERTA	METHYLPHENIDATE HYDROCHLORIDE	9280	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	0	2	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl 2-phenyl-2-(2-piperidyl)acetate;hydrochloride
5432	METADATE ER	METHYLPHENIDATE HYDROCHLORIDE	9280	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	0	2	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl 2-phenyl-2-(2-piperidyl)acetate;hydrochloride
5478	METHYLIN	METHYLPHENIDATE HYDROCHLORIDE	9280	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	0	2	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl 2-phenyl-2-(2-piperidyl)acetate;hydrochloride
5479	METHYLIN ER	METHYLPHENIDATE HYDROCHLORIDE	9280	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	0	2	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl 2-phenyl-2-(2-piperidyl)acetate;hydrochloride
5480	METHYLPHENIDATE HYDROCHLORIDE	METHYLPHENIDATE HYDROCHLORIDE	9280	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	0	2	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl 2-phenyl-2-(2-piperidyl)acetate;hydrochloride
7839	QUILLIVANT XR	METHYLPHENIDATE HYDROCHLORIDE	9280	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	0	2	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl 2-phenyl-2-(2-piperidyl)acetate;hydrochloride
8043	RITALIN	METHYLPHENIDATE HYDROCHLORIDE	9280	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	0	2	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl 2-phenyl-2-(2-piperidyl)acetate;hydrochloride
2340	DEPO-MEDROL	METHYLPREDNISOLONE ACETATE	5877	C24H32O6	416.514	\N	2.7	2	6	4	101	30	0	858	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)C)O	[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
5362	MEDROL	METHYLPREDNISOLONE ACETATE	5877	C24H32O6	416.514	\N	2.7	2	6	4	101	30	0	858	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)C)O	[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
5363	MEDROL ACETATE	METHYLPREDNISOLONE ACETATE	5877	C24H32O6	416.514	\N	2.7	2	6	4	101	30	0	858	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)C)O	[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
5481	METHYLPREDNISOLONE	METHYLPREDNISOLONE	6741	C22H30O5	374.477	\N	1.9	3	5	2	94.8	27	0	754	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O	(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
663	ANDROID 10	METHYLTESTOSTERONE	6010	C20H30O2	302.458	\N	3.4	1	2	0	37.3	22	0	550	6	0	\N	\N	CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
6396	OPTIPRANOLOL	METIPRANOLOL HYDROCHLORIDE	31477	C17H27NO4	309.406	\N	2.7	2	5	8	67.8	22	0	348	0	1	\N	\N	CC1=CC(=C(C(=C1OC(=O)C)C)C)OCC(CNC(C)C)O	[4-[2-hydroxy-3-(isopropylamino)propoxy]-2,3,6-trimethyl-phenyl] acetate
1879	CLOPRA	METOCLOPRAMIDE HYDROCHLORIDE	23659	C14H23Cl2N3O2	336.257	\N	\N	3	4	7	67.6	21	0	300	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl.Cl	4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide;hydrochloride
1880	CLOPRA-""YELLOW""	METOCLOPRAMIDE HYDROCHLORIDE	23659	C14H23Cl2N3O2	336.257	\N	\N	3	4	7	67.6	21	0	300	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl.Cl	4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide;hydrochloride
5492	METOCLOPRAMIDE	METOCLOPRAMIDE HYDROCHLORIDE	23659	C14H23Cl2N3O2	336.257	\N	\N	3	4	7	67.6	21	0	300	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl.Cl	4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide;hydrochloride
5493	METOCLOPRAMIDE HCL	METOCLOPRAMIDE HYDROCHLORIDE	23659	C14H23Cl2N3O2	336.257	\N	\N	3	4	7	67.6	21	0	300	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl.Cl	4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide;hydrochloride
5494	METOCLOPRAMIDE HYDROCHLORIDE	METOCLOPRAMIDE HYDROCHLORIDE	23659	C14H23Cl2N3O2	336.257	\N	\N	3	4	7	67.6	21	0	300	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl.Cl	4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide;hydrochloride
5495	METOCLOPRAMIDE INTENSOL	METOCLOPRAMIDE HYDROCHLORIDE	23659	C14H23Cl2N3O2	336.257	\N	\N	3	4	7	67.6	21	0	300	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl.Cl	4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide;hydrochloride
5503	METOZOLV ODT	METOCLOPRAMIDE HYDROCHLORIDE	23659	C14H23Cl2N3O2	336.257	\N	\N	3	4	7	67.6	21	0	300	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl.Cl	4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide;hydrochloride
2849	DIULO	METOLAZONE	4170	C16H16ClN3O3S	365.832	\N	4.1	2	5	2	101	24	0	594	0	1	\N	\N	CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl	7-chloro-2-methyl-3-(o-tolyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide
5497	METOLAZONE	METOLAZONE	4170	C16H16ClN3O3S	365.832	\N	4.1	2	5	2	101	24	0	594	0	1	\N	\N	CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl	7-chloro-2-methyl-3-(o-tolyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide
5759	MYKROX	METOLAZONE	4170	C16H16ClN3O3S	365.832	\N	4.1	2	5	2	101	24	0	594	0	1	\N	\N	CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl	7-chloro-2-methyl-3-(o-tolyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide
2990	DUTOPROL	METOPROLOL SUCCINATE	62937	C34H56N2O10	652.826	\N	\N	6	12	21	176	46	0	308	0	2	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.C(CC(=O)O)C(=O)O	1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol;succinic acid
5499	METOPROLOL SUCCINATE	METOPROLOL SUCCINATE	62937	C34H56N2O10	652.826	\N	\N	6	12	21	176	46	0	308	0	2	\N	\N	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.C(CC(=O)O)C(=O)O	1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol;succinic acid
586	AMIPAQUE	METRIZAMIDE	443944	C18H22I3N3O8	789.1	\N	-0.4	6	8	5	169	32	0	719	4	1	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)NC2C(C(C(OC2O)CO)O)O)I)N(C)C(=O)C)I	3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodo-N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]benzamide
4535	ISOPAQUE 440	METRIZOATE SODIUM	23675747	C12H10I3N2NaO4	649.925	\N	\N	1	4	3	89.5	22	0	454	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)N(C)C(=O)C)I.[Na+]	sodium;3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodo-benzoate
3516	FLAGYL I.V.	METRONIDAZOLE HYDROCHLORIDE	68592	C6H10ClN3O3	207.614	\N	\N	2	4	2	83.9	13	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-].Cl	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol;hydrochloride
3515	FLAGYL ER	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
3517	FLAGYL I.V. RTU IN PLASTIC CONTAINER	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
3891	HELIDAC	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
5730	MYCAMINE	MICAFUNGIN SODIUM	23666118	C56H70N9NaO23S	1292.266	\N	\N	15	24	18	521	90	0	2580	15	0	\N	\N	CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)[O-])O)O)C(CC(=O)N)O)C)O)O)O.[Na+]	\N
5559	MIDAZOLAM HYDROCHLORIDE	MIDAZOLAM HYDROCHLORIDE	43032	C18H14Cl2FN3	362.229	\N	\N	1	3	1	30.2	24	0	471	0	0	\N	\N	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F.Cl	8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine;hydrochloride
5560	MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE	MIDAZOLAM HYDROCHLORIDE	43032	C18H14Cl2FN3	362.229	\N	\N	1	3	1	30.2	24	0	471	0	0	\N	\N	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F.Cl	8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine;hydrochloride
5564	MIDOZALAM HYDROCHLORIDE	MIDAZOLAM HYDROCHLORIDE	43032	C18H14Cl2FN3	362.229	\N	\N	1	3	1	30.2	24	0	471	0	0	\N	\N	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F.Cl	8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine;hydrochloride
9565	VERSED	MIDAZOLAM HYDROCHLORIDE	43032	C18H14Cl2FN3	362.229	\N	\N	1	3	1	30.2	24	0	471	0	0	\N	\N	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F.Cl	8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine;hydrochloride
6508	ORVATEN	MIDODRINE HYDROCHLORIDE	18340	C12H19ClN2O4	290.744	\N	\N	4	5	6	93.8	19	0	263	0	1	\N	\N	COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O.Cl	2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxy-ethyl]acetamide;hydrochloride
5565	MIFEPREX	MIFEPRISTONE	55245	C29H35NO2	429.604	\N	3.8	1	3	3	40.5	32	0	921	5	0	\N	\N	CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O	(8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
9822	ZAVESCA	MIGLUSTAT	51634	C10H21NO4	219.281	\N	-0.6	4	5	4	84.2	15	0	190	4	0	\N	\N	CCCCN1CC(C(C(C1CO)O)O)O	(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
5572	MILNACIPRAN HYDROCHLORIDE	MILNACIPRAN HYDROCHLORIDE	163701	C15H23ClN2O	282.812	\N	\N	2	2	5	46.3	19	0	295	2	0	\N	\N	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2.Cl	(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenyl-cyclopropanecarboxamide;hydrochloride
8161	SAVELLA	MILNACIPRAN HYDROCHLORIDE	163701	C15H23ClN2O	282.812	\N	\N	2	2	5	46.3	19	0	295	2	0	\N	\N	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2.Cl	(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenyl-cyclopropanecarboxamide;hydrochloride
5579	MILRINONE LACTATE	MILRINONE LACTATE	172293	C15H15N3O4	301.302	\N	\N	3	6	2	123	22	0	478	0	1	\N	\N	CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2.CC(C(=O)O)O	2-hydroxypropanoic acid;6-methyl-2-oxo-5-(4-pyridyl)-1H-pyridine-3-carbonitrile
5580	MILRINONE LACTATE IN DEXTROSE 5%	MILRINONE LACTATE	172293	C15H15N3O4	301.302	\N	\N	3	6	2	123	22	0	478	0	1	\N	\N	CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2.CC(C(=O)O)O	2-hydroxypropanoic acid;6-methyl-2-oxo-5-(4-pyridyl)-1H-pyridine-3-carbonitrile
757	ARESTIN	MINOCYCLINE HYDROCHLORIDE	54685925	C23H28ClN3O7	493.941	\N	\N	6	9	3	165	34	0	971	4	0	\N	\N	CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl	(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride
3006	DYNACIN	MINOCYCLINE HYDROCHLORIDE	54685925	C23H28ClN3O7	493.941	\N	\N	6	9	3	165	34	0	971	4	0	\N	\N	CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl	(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride
5595	MINOCYCLINE HYDROCHLORIDE	MINOCYCLINE HYDROCHLORIDE	54685925	C23H28ClN3O7	493.941	\N	\N	6	9	3	165	34	0	971	4	0	\N	\N	CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl	(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride
8355	SOLODYN	MINOCYCLINE HYDROCHLORIDE	54685925	C23H28ClN3O7	493.941	\N	\N	6	9	3	165	34	0	971	4	0	\N	\N	CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl	(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride
9766	XIMINO	MINOCYCLINE HYDROCHLORIDE	54685925	C23H28ClN3O7	493.941	\N	\N	6	9	3	165	34	0	971	4	0	\N	\N	CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl	(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride
788	ARTHROTEC	MISOPROSTOL	5282381	C22H38O5	382.541	\N	3.7	2	5	14	83.8	27	0	487	3	1	\N	\N	CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O	methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyl-oct-1-enyl]-5-oxo-cyclopentyl]heptanoate
5620	MITOSOL	MITOMYCIN	5746	C15H18N4O5	334.332	\N	-0.4	3	8	4	147	24	0	757	4	0	\N	\N	CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N	\N
5622	MITOZYTREX	MITOMYCIN	5746	C15H18N4O5	334.332	\N	-0.4	3	8	4	147	24	0	757	4	0	\N	\N	CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N	\N
5715	MUTAMYCIN	MITOMYCIN	5746	C15H18N4O5	334.332	\N	-0.4	3	8	4	147	24	0	757	4	0	\N	\N	CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N	\N
5157	LYSODREN	MITOTANE	4211	C14H10Cl4	320.034	\N	6.2	0	0	3	0	18	0	248	0	1	\N	\N	C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl	1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene
5621	MITOXANTRONE HYDROCHLORIDE	MITOXANTRONE HYDROCHLORIDE	51082	C22H30Cl2N4O6	517.404	\N	\N	10	10	12	163	34	0	571	0	0	\N	\N	C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO.Cl.Cl	1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;dihydrochloride
6188	NOVANTRONE	MITOXANTRONE HYDROCHLORIDE	51082	C22H30Cl2N4O6	517.404	\N	\N	10	10	12	163	34	0	571	0	0	\N	\N	C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO.Cl.Cl	1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;dihydrochloride
5623	MIVACRON	MIVACURIUM CHLORIDE	5281080	C58H80Cl2N2O14	1100.178	\N	\N	0	16	30	145	76	0	1550	2	2	\N	\N	C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C.[Cl-].[Cl-]	bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (E)-oct-4-enedioate;dichloride
5624	MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER	MIVACURIUM CHLORIDE	5281080	C58H80Cl2N2O14	1100.178	\N	\N	0	16	30	145	76	0	1550	2	2	\N	\N	C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C.[Cl-].[Cl-]	bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (E)-oct-4-enedioate;dichloride
5642	MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	MOEXIPRIL HYDROCHLORIDE	54889	C27H35ClN2O7	535.034	\N	\N	3	8	12	114	37	0	742	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC.Cl	(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
5644	MOEXIPRIL HYDROCHLORIDE AND HYDROCHOLROTHIAZIDE	MOEXIPRIL HYDROCHLORIDE	54889	C27H35ClN2O7	535.034	\N	\N	3	8	12	114	37	0	742	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC.Cl	(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
9405	UNIRETIC	MOEXIPRIL HYDROCHLORIDE	54889	C27H35ClN2O7	535.034	\N	\N	3	8	12	114	37	0	742	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC.Cl	(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
9411	UNIVASC	MOEXIPRIL HYDROCHLORIDE	54889	C27H35ClN2O7	535.034	\N	\N	3	8	12	114	37	0	742	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC.Cl	(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
5645	MOLINDONE HYDROCHLORIDE	MOLINDONE HYDROCHLORIDE	9883259	C16H25ClN2O2	312.838	\N	\N	2	3	3	45.3	21	0	354	0	1	\N	\N	CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C.Cl	3-ethyl-2-methyl-5-(morpholinomethyl)-1,5,6,7-tetrahydroindol-4-one;hydrochloride
802	ASMANEX HFA	MOMETASONE FUROATE	441336	C27H30Cl2O6	521.431	\N	3.9	1	6	5	93.8	35	0	1020	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C	[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
803	ASMANEX TWISTHALER	MOMETASONE FUROATE	441336	C27H30Cl2O6	521.431	\N	3.9	1	6	5	93.8	35	0	1020	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C	[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
2950	DULERA	MOMETASONE FUROATE	441336	C27H30Cl2O6	521.431	\N	3.9	1	6	5	93.8	35	0	1020	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C	[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
326	ALEVE	NAPROXEN SODIUM	23681059	C14H13NaO3	252.245	\N	\N	0	3	3	49.4	18	0	282	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+]	sodium;(2S)-2-(6-methoxy-2-naphthyl)propanoate
5667	MONTELUKAST SODIUM	MONTELUKAST SODIUM	23663996	C35H35ClNNaO3S	608.169	\N	\N	1	5	12	98.6	42	0	898	1	0	\N	\N	CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)[O-])O.[Na+]	sodium;2-[1-[[(1R)-1-[3-[(E)-2-(7-chloro-2-quinolyl)vinyl]phenyl]-3-[2-(1-hydroxy-1-methyl-ethyl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate
8271	SINGULAIR	MONTELUKAST SODIUM	23663996	C35H35ClNNaO3S	608.169	\N	\N	1	5	12	98.6	42	0	898	1	0	\N	\N	CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)[O-])O.[Na+]	sodium;2-[1-[[(1R)-1-[3-[(E)-2-(7-chloro-2-quinolyl)vinyl]phenyl]-3-[2-(1-hydroxy-1-methyl-ethyl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate
811	ASTRAMORPH PF	MORPHINE SULFATE	5288826	C17H19NO3	285.343	\N	0.8	2	4	0	52.9	21	0	494	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
2347	DEPODUR	MORPHINE SULFATE	5288826	C17H19NO3	285.343	\N	0.8	2	4	0	52.9	21	0	494	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
3110	EMBEDA	MORPHINE SULFATE	5288826	C17H19NO3	285.343	\N	0.8	2	4	0	52.9	21	0	494	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
888	AVELOX	MOXIFLOXACIN HYDROCHLORIDE	101526	C21H25ClFN3O4	437.896	\N	\N	3	8	4	82.1	30	0	727	2	0	\N	\N	COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl	7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid;hydrochloride
889	AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER	MOXIFLOXACIN HYDROCHLORIDE	101526	C21H25ClFN3O4	437.896	\N	\N	3	8	4	82.1	30	0	727	2	0	\N	\N	COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl	7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid;hydrochloride
5687	MOXEZA	MOXIFLOXACIN HYDROCHLORIDE	101526	C21H25ClFN3O4	437.896	\N	\N	3	8	4	82.1	30	0	727	2	0	\N	\N	COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl	7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid;hydrochloride
5689	MOXIFLOXACIN HYDROCHLORIDE	MOXIFLOXACIN HYDROCHLORIDE	101526	C21H25ClFN3O4	437.896	\N	\N	3	8	4	82.1	30	0	727	2	0	\N	\N	COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl	7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid;hydrochloride
9611	VIGAMOX	MOXIFLOXACIN HYDROCHLORIDE	101526	C21H25ClFN3O4	437.896	\N	\N	3	8	4	82.1	30	0	727	2	0	\N	\N	COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl	7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid;hydrochloride
5688	MOXIFLOXACIN	MOXIFLOXACIN	152946	C21H24FN3O4	401.438	\N	0.6	2	8	4	82.1	29	0	727	2	0	\N	\N	COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O	7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid
970	BACTROBAN	MUPIROCIN CALCIUM	6435927	C52H86CaO18	1039.32	\N	\N	6	18	32	298	71	0	689	16	0	\N	\N	CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)[O-])C)C(C)O.CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)[O-])C)C(C)O.[Ca+2]	calcium;9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methyl-propyl]oxiran-2-yl]methyl]tetrahydropyran-2-yl]-3-methyl-but-2-enoyl]oxynonanoate
5712	MUPIROCIN	MUPIROCIN CALCIUM	6435927	C52H86CaO18	1039.32	\N	\N	6	18	32	298	71	0	689	16	0	\N	\N	CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)[O-])C)C(C)O.CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)[O-])C)C(C)O.[Ca+2]	calcium;9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methyl-propyl]oxiran-2-yl]methyl]tetrahydropyran-2-yl]-3-methyl-but-2-enoyl]oxynonanoate
969	BACTROBAN	MUPIROCIN	446596	C26H44O9	500.629	\N	3	4	9	17	146	35	0	694	8	0	\N	\N	CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O	9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methyl-propyl]oxiran-2-yl]methyl]tetrahydropyran-2-yl]-3-methyl-but-2-enoyl]oxynonanoic acid
1512	CENTANY	MUPIROCIN	446596	C26H44O9	500.629	\N	3	4	9	17	146	35	0	694	8	0	\N	\N	CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O	9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methyl-propyl]oxiran-2-yl]methyl]tetrahydropyran-2-yl]-3-methyl-but-2-enoyl]oxynonanoic acid
1509	CELLCEPT	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	6441022	C23H32ClNO7	469.959	\N	\N	2	8	10	94.5	32	0	646	0	0	\N	\N	CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)OCCN3CCOCC3)OC.Cl	2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate;hydrochloride
5746	MYCOPHENOLATE MOFETIL	MYCOPHENOLATE MOFETIL	5281078	C23H31NO7	433.501	\N	3.2	1	8	10	94.5	31	0	646	0	0	\N	\N	CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)OCCN3CCOCC3)OC	2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate
5748	MYCOPHENOLIC ACID	MYCOPHENOLIC ACID	446541	C17H20O6	320.341	\N	3.2	2	6	6	93.1	23	0	486	0	0	\N	\N	CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)O)OC	(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoic acid
5784	NABUMETONE	NABUMETONE	4409	C15H16O2	228.291	\N	3.1	0	2	4	26.3	17	0	262	0	0	\N	\N	CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC	4-(6-methoxy-2-naphthyl)butan-2-one
2058	CORZIDE	NADOLOL	39147	C17H27NO4	309.406	\N	0.7	4	5	6	82	22	0	344	2	1	\N	\N	CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O	(2R,3S)-5-[3-(tert-butylamino)-2-hydroxy-propoxy]tetralin-2,3-diol
5785	NADOLOL	NADOLOL	39147	C17H27NO4	309.406	\N	0.7	4	5	6	82	22	0	344	2	1	\N	\N	CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O	(2R,3S)-5-[3-(tert-butylamino)-2-hydroxy-propoxy]tetralin-2,3-diol
8622	SYNAREL	NAFARELIN ACETATE	25079425	C68H89N17O16	1400.563	\N	\N	18	18	33	513	101	0	2760	9	0	\N	\N	CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8.CC(=O)O.O	acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-2-[[(1S)-1-[[(1S)-1-[(2S)-2-[(2-amino-2-oxo-ethyl)carbamoyl]pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-1-(2-naphthylmethyl)-2-oxo-ethyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide;hydrate
5789	NAFCILLIN SODIUM	NAFCILLIN SODIUM	23667630	C21H21N2NaO5S	436.458	\N	\N	1	6	5	124	30	0	705	3	0	\N	\N	CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+]	sodium;(2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
5797	NALLPEN	NAFCILLIN SODIUM	23667630	C21H21N2NaO5S	436.458	\N	\N	1	6	5	124	30	0	705	3	0	\N	\N	CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+]	sodium;(2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
5791	NAFTIN	NAFTIFINE HYDROCHLORIDE	5281098	C21H22ClN	323.864	\N	\N	1	1	5	3.2	23	0	342	0	0	\N	\N	CN(CC=CC1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32.Cl	(E)-N-methyl-N-(1-naphthylmethyl)-3-phenyl-prop-2-en-1-amine;hydrochloride
5794	NALBUPHINE HYDROCHLORIDE	NALBUPHINE HYDROCHLORIDE	5360733	C21H28ClNO4	393.908	\N	\N	4	5	2	73.2	27	0	597	5	0	\N	\N	C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O.Cl	(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol;hydrochloride
6222	NUBAIN	NALBUPHINE HYDROCHLORIDE	5360733	C21H28ClNO4	393.908	\N	\N	4	5	2	73.2	27	0	597	5	0	\N	\N	C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O.Cl	(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol;hydrochloride
5796	NALIDIXIC ACID	NALIDIXIC ACID	4421	C12H12N2O3	232.239	\N	1.4	1	5	2	70.5	17	0	378	0	0	\N	\N	CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O	1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
5868	NEGGRAM	NALIDIXIC ACID	4421	C12H12N2O3	232.239	\N	1.4	1	5	2	70.5	17	0	378	0	0	\N	\N	CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O	1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
7999	REVEX	NALMEFENE HYDROCHLORIDE	5388881	C21H26ClNO3	375.893	\N	\N	3	4	2	52.9	26	0	618	4	0	\N	\N	C=C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O.Cl	(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;hydrochloride
5678	MOVANTIK	NALOXEGOL OXALATE	56959086	C36H55NO15	741.828	\N	\N	4	16	25	201	52	0	971	5	0	\N	\N	COCCOCCOCCOCCOCCOCCOCCOC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC=C)O.C(=O)(C(=O)O)O	(4R,4aS,7S,7aR,12bS)-3-allyl-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;oxalic acid
1240	BUNAVAIL	NALOXONE HYDROCHLORIDE	5464092	C19H22ClNO4	363.838	\N	\N	3	5	2	70	25	0	594	4	0	\N	\N	C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.Cl	(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
1254	BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE	NALOXONE HYDROCHLORIDE	5464092	C19H22ClNO4	363.838	\N	\N	3	5	2	70	25	0	594	4	0	\N	\N	C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.Cl	(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
328	ALEVE PM	NAPROXEN SODIUM	23681059	C14H13NaO3	252.245	\N	\N	0	3	3	49.4	18	0	282	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+]	sodium;(2S)-2-(6-methoxy-2-naphthyl)propanoate
2010	CONTRAVE	NALTREXONE HYDROCHLORIDE	5485201	C20H24ClNO4	377.865	\N	\N	3	5	2	70	26	0	621	4	0	\N	\N	C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O.Cl	(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
3111	EMBEDA	NALTREXONE HYDROCHLORIDE	5485201	C20H24ClNO4	377.865	\N	\N	3	5	2	70	26	0	621	4	0	\N	\N	C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O.Cl	(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
8000	REVIA	NALTREXONE HYDROCHLORIDE	5485201	C20H24ClNO4	377.865	\N	\N	3	5	2	70	26	0	621	4	0	\N	\N	C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O.Cl	(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
9313	TROXYCA ER	NALTREXONE HYDROCHLORIDE	5485201	C20H24ClNO4	377.865	\N	\N	3	5	2	70	26	0	621	4	0	\N	\N	C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O.Cl	(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
9683	VIVITROL	NALTREXONE	5360515	C20H23NO4	341.407	\N	1.9	2	5	2	70	25	0	621	4	0	\N	\N	C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O	(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
2211	DECA-DURABOLIN	NANDROLONE DECANOATE	9677	C28H44O3	428.657	\N	7.3	0	3	10	43.4	31	0	680	6	0	\N	\N	CCCCCCCCCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C	[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] decanoate
5809	NANDROLONE DECANOATE	NANDROLONE DECANOATE	9677	C28H44O3	428.657	\N	7.3	0	3	10	43.4	31	0	680	6	0	\N	\N	CCCCCCCCCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C	[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] decanoate
2963	DURABOLIN	NANDROLONE PHENPROPIONATE	229455	C27H34O3	406.566	\N	5.1	0	3	5	43.4	30	0	703	6	0	\N	\N	CC12CCC3C(C1CCC2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CCC35	[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] 3-phenylpropanoate
5810	NANDROLONE PHENPROPIONATE	NANDROLONE PHENPROPIONATE	229455	C27H34O3	406.566	\N	5.1	0	3	5	43.4	30	0	703	6	0	\N	\N	CC12CCC3C(C1CCC2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CCC35	[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] 3-phenylpropanoate
5811	NAPHAZOLINE HYDROCHLORIDE	NAPHAZOLINE HYDROCHLORIDE	11079	C14H15ClN2	246.738	\N	\N	2	1	2	24.4	17	0	272	0	0	\N	\N	C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl	2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride
5812	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	NAPHAZOLINE HYDROCHLORIDE	11079	C14H15ClN2	246.738	\N	\N	2	1	2	24.4	17	0	272	0	0	\N	\N	C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl	2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride
5814	NAPHCON FORTE	NAPHAZOLINE HYDROCHLORIDE	11079	C14H15ClN2	246.738	\N	\N	2	1	2	24.4	17	0	272	0	0	\N	\N	C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl	2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride
5815	NAPHCON-A	NAPHAZOLINE HYDROCHLORIDE	11079	C14H15ClN2	246.738	\N	\N	2	1	2	24.4	17	0	272	0	0	\N	\N	C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl	2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride
6381	OPCON	NAPHAZOLINE HYDROCHLORIDE	11079	C14H15ClN2	246.738	\N	\N	2	1	2	24.4	17	0	272	0	0	\N	\N	C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl	2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride
6382	OPCON-A	NAPHAZOLINE HYDROCHLORIDE	11079	C14H15ClN2	246.738	\N	\N	2	1	2	24.4	17	0	272	0	0	\N	\N	C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl	2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride
9504	VASOCON	NAPHAZOLINE HYDROCHLORIDE	11079	C14H15ClN2	246.738	\N	\N	2	1	2	24.4	17	0	272	0	0	\N	\N	C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl	2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride
9506	VASOCON-A	NAPHAZOLINE HYDROCHLORIDE	11079	C14H15ClN2	246.738	\N	\N	2	1	2	24.4	17	0	272	0	0	\N	\N	C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl	2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride
5819	NAPROXEN	NAPROXEN	156391	C14H14O3	230.263	\N	3.3	1	3	3	46.5	17	0	277	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O	(2S)-2-(6-methoxy-2-naphthyl)propanoic acid
5821	NAPROXEN AND ESOMEPRAZOLE MAGNESIUM	NAPROXEN	156391	C14H14O3	230.263	\N	3.3	1	3	3	46.5	17	0	277	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O	(2S)-2-(6-methoxy-2-naphthyl)propanoic acid
7445	PREVACID NAPRAPAC 375 (COPACKAGED)	NAPROXEN	156391	C14H14O3	230.263	\N	3.3	1	3	3	46.5	17	0	277	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O	(2S)-2-(6-methoxy-2-naphthyl)propanoic acid
7447	PREVACID NAPRAPAC 500 (COPACKAGED)	NAPROXEN	156391	C14H14O3	230.263	\N	3.3	1	3	3	46.5	17	0	277	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O	(2S)-2-(6-methoxy-2-naphthyl)propanoic acid
9616	VIMOVO	NAPROXEN	156391	C14H14O3	230.263	\N	3.3	1	3	3	46.5	17	0	277	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O	(2S)-2-(6-methoxy-2-naphthyl)propanoic acid
5843	NATEGLINIDE	NATEGLINIDE	5311309	C19H27NO3	317.429	\N	3.2	2	3	6	66.4	23	0	393	1	0	\N	\N	CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O	(2R)-2-[(4-isopropylcyclohexanecarbonyl)amino]-3-phenyl-propanoic acid
1305	BYVALSON	NEBIVOLOL HYDROCHLORIDE	9933004	C22H26ClF2NO4	441.9	\N	\N	4	7	6	71	30	0	483	0	4	\N	\N	C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O.Cl	1-(6-fluorochroman-2-yl)-2-[[2-(6-fluorochroman-2-yl)-2-hydroxy-ethyl]amino]ethanol;hydrochloride
5864	NEBIVOLOL HYDROCHLORIDE	NEBIVOLOL HYDROCHLORIDE	9933004	C22H26ClF2NO4	441.9	\N	\N	4	7	6	71	30	0	483	0	4	\N	\N	C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O.Cl	1-(6-fluorochroman-2-yl)-2-[[2-(6-fluorochroman-2-yl)-2-hydroxy-ethyl]amino]ethanol;hydrochloride
5866	NEDOCROMIL SODIUM	NEDOCROMIL SODIUM	50295	C19H15NNa2O7	415.309	\N	\N	0	8	3	127	29	0	742	0	0	\N	\N	CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)[O-])C(=O)C=C(N2CC)C(=O)[O-].[Na+].[Na+]	disodium;9-ethyl-4,6-dioxo-10-propyl-pyrano[3,2-g]quinoline-2,8-dicarboxylate
8241	SERZONE	NEFAZODONE HYDROCHLORIDE	54911	C25H33Cl2N5O2	506.472	\N	\N	1	5	10	51.6	34	0	649	0	0	\N	\N	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl.Cl	2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one;hydrochloride
9632	VIRACEPT	NELFINAVIR MESYLATE	64142	C33H49N3O7S2	663.889	\N	\N	5	9	10	190	45	0	922	5	0	\N	\N	CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O)O	(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methyl-benzoyl)amino]-4-phenylsulfanyl-butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;methanesulfonic acid
947	BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
952	BACITRACIN-NEOMYCIN-POLYMYXIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
3815	GONITRO	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
1401	CARDENE	NICARDIPINE HYDROCHLORIDE	41114	C26H30ClN3O6	515.991	\N	\N	2	8	10	114	36	0	856	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC.Cl	O5-[2-[benzyl(methyl)amino]ethyl] O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
1402	CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER	NICARDIPINE HYDROCHLORIDE	41114	C26H30ClN3O6	515.991	\N	\N	2	8	10	114	36	0	856	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC.Cl	O5-[2-[benzyl(methyl)amino]ethyl] O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
1147	BLOXIVERZ	NEOSTIGMINE METHYLSULFATE	5824	C13H22N2O6S	334.387	\N	\N	0	6	3	104	22	0	337	0	0	\N	\N	CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.COS(=O)(=O)[O-]	[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-ammonium;methyl sulfate
5977	NEVANAC	NEPAFENAC	151075	C15H14N2O2	254.289	\N	1.9	2	3	4	86.2	19	0	337	0	0	\N	\N	C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)N)N	2-(2-amino-3-benzoyl-phenyl)acetamide
276	AKYNZEO	NETUPITANT	6451149	C30H32F6N4O	578.603	\N	6.8	0	10	5	39.7	41	0	865	0	0	\N	\N	CC1=CC=CC=C1C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN(CC4)C	2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[6-(4-methylpiperazin-1-yl)-4-(o-tolyl)-3-pyridyl]propanamide
4747	LAMIVUDINE, ZIDOVUDINE TABS 150MG/300MG CO-PACKAGED WITH NEVIRAPINE TABS 200MG	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
4750	Lamivudine, Zidovudine, Nevirapine Tabs 150mg/300mg/200mg	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
4758	Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
5989	NIASPAN	NIACIN	938	C6H5NO2	123.111	\N	0.4	1	3	1	50.2	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)O	nicotinic acid
5990	NIASPAN TITRATION STARTER PACK	NIACIN	938	C6H5NO2	123.111	\N	0.4	1	3	1	50.2	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)O	nicotinic acid
5994	NICOLAR	NIACIN	938	C6H5NO2	123.111	\N	0.4	1	3	1	50.2	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)O	nicotinic acid
4261	INFUVITE ADULT	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
5168	M.V.C. 9+3	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
5180	M.V.I. ADULT	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
5193	M.V.I. ADULT (PHARMACY BULK PACKAGE)	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
5206	M.V.I. PEDIATRIC	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
5219	M.V.I.-12	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
5231	M.V.I.-12	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
5243	M.V.I.-12 (WITHOUT VITAMIN K)	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
5255	M.V.I.-12 LYOPHILIZED	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
8986	TPN	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
5996	NICORETTE (MINT)	NICOTINE POLACRILEX	89594	C10H14N2	162.236	\N	1.2	0	2	1	16.1	12	0	147	1	0	\N	\N	CN1CCCC1C2=CN=CC=C2	3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
5998	NICOTINE POLACRILEX	NICOTINE POLACRILEX	89594	C10H14N2	162.236	\N	1.2	0	2	1	16.1	12	0	147	1	0	\N	\N	CN1CCCC1C2=CN=CC=C2	3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
8878	THRIVE	NICOTINE POLACRILEX	89594	C10H14N2	162.236	\N	1.2	0	2	1	16.1	12	0	147	1	0	\N	\N	CN1CCCC1C2=CN=CC=C2	3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
5997	NICOTINE	NICOTINE	89594	C10H14N2	162.236	\N	1.2	0	2	1	16.1	12	0	147	1	0	\N	\N	CN1CCCC1C2=CN=CC=C2	3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
5999	NICOTROL	NICOTINE	89594	C10H14N2	162.236	\N	1.2	0	2	1	16.1	12	0	147	1	0	\N	\N	CN1CCCC1C2=CN=CC=C2	3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
7755	PROSTEP	NICOTINE	89594	C10H14N2	162.236	\N	1.2	0	2	1	16.1	12	0	147	1	0	\N	\N	CN1CCCC1C2=CN=CC=C2	3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
139	ADALAT CC	NIFEDIPINE	4485	C17H18N2O6	346.339	\N	2.2	1	7	5	110	25	0	608	0	0	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
6000	NIFEDIPINE	NIFEDIPINE	4485	C17H18N2O6	346.339	\N	2.2	1	7	5	110	25	0	608	0	0	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
6005	NILUTAMIDE	NILUTAMIDE	4493	C12H10F3N3O4	317.224	\N	2	1	7	1	95.2	22	0	515	0	0	\N	\N	CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C	5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione
6008	NIMODIPINE	NIMODIPINE	4497	C21H26N2O7	418.446	\N	3.1	1	8	9	120	30	0	736	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC	O5-isopropyl O3-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
6009	NIMOTOP	NIMODIPINE	4497	C21H26N2O7	418.446	\N	3.1	1	8	9	120	30	0	736	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC	O5-isopropyl O3-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
6303	OFEV	NINTEDANIB ESYLATE	9809714	C33H39N5O7S	649.763	\N	\N	3	10	9	157	46	0	1050	0	0	\N	\N	CCS(=O)(=O)O.CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)NC(=C3C4=C(C=C(C=C4)C(=O)OC)NC3=O)C5=CC=CC=C5	ethanesulfonic acid;methyl (3Z)-3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenyl-methylene]-2-oxo-indoline-6-carboxylate
8514	SULAR	NISOLDIPINE	4499	C20H24N2O6	388.42	\N	3.3	1	7	7	110	28	0	704	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	O5-isobutyl O3-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
337	ALINIA	NITAZOXANIDE	41684	C12H9N3O5S	307.28	\N	2	1	7	4	142	21	0	428	0	0	\N	\N	CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]	[2-[(5-nitrothiazol-2-yl)carbamoyl]phenyl] acetate
6017	NITRIOUS OXIDE, USP	NITRIOUS OXIDE	948	N2O	44.013	\N	0.5	0	2	0	54.5	3	0	29.3	0	0	\N	\N	N#[N+][O-]	nitrous oxide
4559	IVADANTIN	NITROFURANTOIN SODIUM	9562058	C8H5N4NaO5	260.141	\N	\N	0	6	2	127	18	0	401	0	0	\N	\N	C1C(=O)N=C(N1N=CC2=CC=C(O2)[N+](=O)[O-])[O-].[Na+]	sodium;3-[(E)-(5-nitro-2-furyl)methyleneamino]-5-oxo-4H-imidazol-2-olate
5262	MACROBID	NITROFURANTOIN, MACROCRYSTALLINE	6604200	C8H6N4O5	238.159	\N	-0.5	1	6	2	121	17	0	390	0	0	\N	\N	C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]	1-[(E)-(5-nitro-2-furyl)methyleneamino]imidazolidine-2,4-dione
5263	MACRODANTIN	NITROFURANTOIN, MACROCRYSTALLINE	6604200	C8H6N4O5	238.159	\N	-0.5	1	6	2	121	17	0	390	0	0	\N	\N	C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]	1-[(E)-(5-nitro-2-furyl)methyleneamino]imidazolidine-2,4-dione
6022	NITROFURANTOIN	NITROFURANTOIN, MACROCRYSTALLINE	6604200	C8H6N4O5	238.159	\N	-0.5	1	6	2	121	17	0	390	0	0	\N	\N	C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]	1-[(E)-(5-nitro-2-furyl)methyleneamino]imidazolidine-2,4-dione
6024	NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)	NITROFURANTOIN, MACROCRYSTALLINE	6604200	C8H6N4O5	238.159	\N	-0.5	1	6	2	121	17	0	390	0	0	\N	\N	C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]	1-[(E)-(5-nitro-2-furyl)methyleneamino]imidazolidine-2,4-dione
6025	NITROFURANTOIN MACROCRYSTALLINE	NITROFURANTOIN, MACROCRYSTALLINE	6604200	C8H6N4O5	238.159	\N	-0.5	1	6	2	121	17	0	390	0	0	\N	\N	C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]	1-[(E)-(5-nitro-2-furyl)methyleneamino]imidazolidine-2,4-dione
3669	FURALAN	NITROFURANTOIN	6604200	C8H6N4O5	238.159	\N	-0.5	1	6	2	121	17	0	390	0	0	\N	\N	C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]	1-[(E)-(5-nitro-2-furyl)methyleneamino]imidazolidine-2,4-dione
6023	NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)	NITROFURANTOIN	6604200	C8H6N4O5	238.159	\N	-0.5	1	6	2	121	17	0	390	0	0	\N	\N	C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]	1-[(E)-(5-nitro-2-furyl)methyleneamino]imidazolidine-2,4-dione
110	ACTIN-N	NITROFURAZONE	5447130	C6H6N4O4	198.138	\N	0.2	2	5	2	126	14	0	261	0	0	\N	\N	C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N	[(E)-(5-nitro-2-furyl)methyleneamino]urea
1969	COLYTE-FLAVORED	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
8948	TODAY	NONOXYNOL-9	72385	C33H60O10	616.833	\N	4.6	1	10	35	103	43	0	520	0	0	\N	\N	CCCCCCCCCC1=CC=C(C=C1)OCCOCCOCCOCCOCCOCCOCCOCCOCCO	2-[2-[2-[2-[2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol
6464	ORTHO EVRA	NORELGESTROMIN	62930	C21H29NO2	327.468	\N	3.6	2	3	2	52.8	24	0	642	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=NO)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one oxime
9776	XULANE	NORELGESTROMIN	62930	C21H29NO2	327.468	\N	3.6	2	3	2	52.8	24	0	642	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=NO)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one oxime
116	ACTIVELLA	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
399	AMABELZ	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
909	AYGESTIN	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
1141	BLISOVI 24 FE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
1143	BLISOVI FE 1.5/30	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
393	ALYACEN 1/35	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
395	ALYACEN 7/7/7	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
396	ALYACEN 777	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
748	ARANELLE	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
749	ARANELLE	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
981	BALZIVA-21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
983	BALZIVA-28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
1175	BREVICON 28-DAY	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
1181	BRIELLYN	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
2105	CYCLAFEM 0.5/35	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
2107	CYCLAFEM 1/35	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6524	OSPHENA	OSPEMIFENE	3036505	C24H23ClO2	378.896	\N	6.5	1	2	8	29.5	27	0	441	0	0	\N	\N	C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=C(C=C3)OCCO)CCCl	2-[4-[(Z)-4-chloro-1,2-diphenyl-but-1-enyl]phenoxy]ethanol
3167	ENOVID-E	NORETHYNODREL	6231	C20H26O2	298.426	\N	2.1	1	2	1	37.3	22	0	606	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3CCC(=O)C4	(8R,9S,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3169	ENOVID-E 21	NORETHYNODREL	6231	C20H26O2	298.426	\N	2.1	1	2	1	37.3	22	0	606	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3CCC(=O)C4	(8R,9S,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
1553	CHIBROXIN	NORFLOXACIN	4539	C16H18FN3O3	319.336	\N	-1	2	7	3	72.9	23	0	519	0	0	\N	\N	CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O	1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
3289	ESTARYLLA	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
3087	ELINEST	NORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
5026	LO/OVRAL-28	NORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
284	ALBAMYCIN	NOVOBIOCIN SODIUM	23663939	C31H35N2NaO11	634.614	\N	\N	4	11	9	199	45	0	1160	4	0	\N	\N	CC1=C(C=CC2=C1OC(=O)C(=C2[O-])NC(=O)C3=CC(=C(C=C3)O)CC=C(C)C)OC4C(C(C(C(O4)(C)C)OC)OC(=O)N)O.[Na+]	sodium;7-[(2R,3R,4S,5R)-4-carbamoyloxy-3-hydroxy-5-methoxy-6,6-dimethyl-tetrahydropyran-2-yl]oxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxo-chromen-4-olate
995	BARSTATIN 100	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
1355	CANDEX	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
6669	PATANASE	OLOPATADINE HYDROCHLORIDE	5282402	C21H24ClNO3	373.877	\N	\N	2	4	5	49.8	26	0	488	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O.Cl	2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid;hydrochloride
6277	OCALIVA	OBETICHOLIC ACID	447715	C26H44O4	420.634	\N	5.7	3	4	5	77.8	30	0	649	11	0	\N	\N	CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCC(=O)O)C)C)O	(4R)-4-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
702	ANTHELIOS 20	OCTOCRYLENE	22571	C24H27NO2	361.485	\N	7.1	0	3	10	50.1	27	0	510	0	1	\N	\N	CCCCC(CC)COC(=O)C(=C(C1=CC=CC=C1)C2=CC=CC=C2)C#N	2-ethylhexyl 2-cyano-3,3-diphenyl-prop-2-enoate
706	ANTHELIOS 40	OCTOCRYLENE	22571	C24H27NO2	361.485	\N	7.1	0	3	10	50.1	27	0	510	0	1	\N	\N	CCCCC(CC)COC(=O)C(=C(C1=CC=CC=C1)C2=CC=CC=C2)C#N	2-ethylhexyl 2-cyano-3,3-diphenyl-prop-2-enoate
710	ANTHELIOS SX	OCTOCRYLENE	22571	C24H27NO2	361.485	\N	7.1	0	3	10	50.1	27	0	510	0	1	\N	\N	CCCCC(CC)COC(=O)C(=C(C1=CC=CC=C1)C2=CC=CC=C2)C#N	2-ethylhexyl 2-cyano-3,3-diphenyl-prop-2-enoate
6286	OCTREOTIDE ACETATE	OCTREOTIDE ACETATE	383414	C49H66N10O10S2	1019.247	\N	1	13	14	17	383	71	0	1740	0	10	\N	\N	CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O	10-(4-aminobutyl)-19-[(2-amino-3-phenyl-propanoyl)amino]-16-benzyl-7-(1-hydroxyethyl)-N-[2-hydroxy-1-(hydroxymethyl)propyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
3544	FLOXIN IN DEXTROSE 5%	OFLOXACIN	4583	C18H20FN3O4	361.373	\N	-0.4	1	8	2	73.3	26	0	634	0	1	\N	\N	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	\N
3545	FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER	OFLOXACIN	4583	C18H20FN3O4	361.373	\N	-0.4	1	8	2	73.3	26	0	634	0	1	\N	\N	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	\N
3546	FLOXIN OTIC	OFLOXACIN	4583	C18H20FN3O4	361.373	\N	-0.4	1	8	2	73.3	26	0	634	0	1	\N	\N	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	\N
6318	OLANZAPINE AND FLUOXETINE HYDROCHLORIDE	OLANZAPINE	4585	C17H20N4S	312.435	\N	2.8	1	5	1	56.2	22	0	543	0	0	\N	\N	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
9946	ZYPREXA	OLANZAPINE	4585	C17H20N4S	312.435	\N	2.8	1	5	1	56.2	22	0	543	0	0	\N	\N	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
9948	ZYPREXA ZYDIS	OLANZAPINE	4585	C17H20N4S	312.435	\N	2.8	1	5	1	56.2	22	0	543	0	0	\N	\N	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
8478	STIOLTO RESPIMAT	OLODATEROL HYDROCHLORIDE	11504295	C21H26N2O5	386.448	\N	1.8	4	6	7	100	28	0	521	1	0	\N	\N	CC(C)(CC1=CC=C(C=C1)OC)NCC(C2=CC(=CC3=C2OCC(=O)N3)O)O	6-hydroxy-8-[(1R)-1-hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethyl-ethyl]amino]ethyl]-4H-1,4-benzoxazin-3-one
8491	STRIVERDI RESPIMAT	OLODATEROL HYDROCHLORIDE	11504295	C21H26N2O5	386.448	\N	1.8	4	6	7	100	28	0	521	1	0	\N	\N	CC(C)(CC1=CC=C(C=C1)OC)NCC(C2=CC(=CC3=C2OCC(=O)N3)O)O	6-hydroxy-8-[(1R)-1-hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethyl-ethyl]amino]ethyl]-4H-1,4-benzoxazin-3-one
6668	PATADAY	OLOPATADINE HYDROCHLORIDE	5282402	C21H24ClNO3	373.877	\N	\N	2	4	5	49.8	26	0	488	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O.Cl	2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid;hydrochloride
2819	DIPENTUM	OLSALAZINE SODIUM	54727588	C14H8N2Na2O6	346.206	\N	\N	2	8	3	142	24	0	587	0	0	\N	\N	C1=CC(=C(C=C1NN=C2C=CC(=O)C(=C2)C(=O)O)C(=O)[O-])[O-].[Na+].[Na+]	disodium;5-[2-(3-carboxy-4-oxo-cyclohexa-2,5-dien-1-ylidene)hydrazino]-2-oxido-benzoate
8728	TECHNIVIE	OMBITASVIR	54767916	C50H67N7O8	894.127	\N	7.9	4	9	16	179	65	0	1540	6	0	\N	\N	CC(C)C(C(=O)N1CCCC1C(=O)NC2=CC=C(C=C2)C3CCC(N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC	methyl N-[(1S)-1-[(2S)-2-[[4-[(2S,5S)-1-(4-tert-butylphenyl)-5-[4-[[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidine-2-carbonyl]amino]phenyl]pyrrolidin-2-yl]phenyl]carbamoyl]pyrrolidine-1-carbonyl]-2-methyl-propyl]carbamate
6361	OMTRYG	OMEGA-3-ACID ETHYL ESTERS TYPE A	9831414	C46H70O4	687.062	\N	\N	0	4	31	52.6	50	0	916	0	0	\N	\N	CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC.CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC	ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
5109	LOVAZA	OMEGA-3-ACID ETHYL ESTERS	9831414	C46H70O4	687.062	\N	\N	0	4	31	52.6	50	0	916	0	0	\N	\N	CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC.CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC	ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
6335	OMEGA-3-ACID ETHYL ESTERS	OMEGA-3-ACID ETHYL ESTERS	9831414	C46H70O4	687.062	\N	\N	0	4	31	52.6	50	0	916	0	0	\N	\N	CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC.CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC	ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
3192	EPANOVA	OMEGA-3-CARBOXYLIC ACIDS	76322221	C181H286O18	2750.261	\N	\N	9	18	125	336	199	0	3350	0	0	\N	\N	CCCCCC=CCC=CCCCCCCCC(=O)O.CCCCCC=CCC=CCC=CCCCCC(=O)O.CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)O.CCC=CCC=CCC=CCCCCCCCC(=O)O.CCC=CCC=CCC=CCC=CCCCCCCC(=O)O.CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)O.CCC=CCC=CCC=CCC=CCC=CCCCCC(=O)O.CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O.CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)O	(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid;(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid;(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoic acid;(6Z,9Z,12Z,15Z,18Z)-henicosa-6,9,12,15,18-pentaenoic acid;(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid;(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoic acid;(9Z,12Z)-octadeca-9,12-dienoic acid;(6Z,9Z,12Z)-octadeca-6,9,12-trienoic acid;(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid
7472	PRILOSEC OTC	OMEPRAZOLE MAGNESIUM	4594	C17H19N3O3S	345.417	\N	2.2	1	6	5	96.3	24	0	453	0	1	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
5269	MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE	OMEPRAZOLE	4594	C17H19N3O3S	345.417	\N	2.2	1	6	5	96.3	24	0	453	0	1	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
6336	OMEPRAZOLE	OMEPRAZOLE	4594	C17H19N3O3S	345.417	\N	2.2	1	6	5	96.3	24	0	453	0	1	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
6339	OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN	OMEPRAZOLE	4594	C17H19N3O3S	345.417	\N	2.2	1	6	5	96.3	24	0	453	0	1	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
6340	OMEPRAZOLE AND SODIUM BICARBONATE	OMEPRAZOLE	4594	C17H19N3O3S	345.417	\N	2.2	1	6	5	96.3	24	0	453	0	1	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
6367	ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER	ONDANSETRON HYDROCHLORIDE	68647	C18H20ClN3O	329.828	\N	\N	1	2	2	39.8	23	0	440	0	1	\N	\N	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl	9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one;hydrochloride
6368	ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE	ONDANSETRON HYDROCHLORIDE	68647	C18H20ClN3O	329.828	\N	\N	1	2	2	39.8	23	0	440	0	1	\N	\N	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl	9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one;hydrochloride
9887	ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER	ONDANSETRON HYDROCHLORIDE	68647	C18H20ClN3O	329.828	\N	\N	1	2	2	39.8	23	0	440	0	1	\N	\N	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl	9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one;hydrochloride
9889	ZOFRAN PRESERVATIVE FREE	ONDANSETRON HYDROCHLORIDE	68647	C18H20ClN3O	329.828	\N	\N	1	2	2	39.8	23	0	440	0	1	\N	\N	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl	9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one;hydrochloride
8673	TAMIFLU	OSELTAMIVIR PHOSPHATE	78000	C16H31N2O8P	410.404	\N	\N	5	9	8	168	27	0	468	3	0	\N	\N	CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC.OP(=O)(O)O	ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohexene-1-carboxylate;phosphoric acid
6562	OXANDRIN	OXANDROLONE	5878	C19H30O3	306.446	\N	3.7	1	3	0	46.5	22	0	503	7	0	\N	\N	CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C	(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one
6563	OXANDROLONE	OXANDROLONE	5878	C19H30O3	306.446	\N	3.7	1	3	0	46.5	22	0	503	7	0	\N	\N	CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C	(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one
2203	DAYPRO	OXAPROZIN	4614	C18H15NO3	293.322	\N	4.2	1	4	5	63.3	22	0	361	0	0	\N	\N	C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3	3-(4,5-diphenyloxazol-2-yl)propanoic acid
8218	SERAX	OXAZEPAM	4616	C15H11ClN2O2	286.715	\N	2.2	2	3	1	61.7	20	0	407	0	1	\N	\N	C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O	7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
9823	ZAXOPAM	OXAZEPAM	4616	C15H11ClN2O2	286.715	\N	2.2	2	3	1	61.7	20	0	407	0	1	\N	\N	C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O	7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
6567	OXCARBAZEPINE	OXCARBAZEPINE	34312	C15H12N2O2	252.273	\N	1.7	1	2	0	63.4	19	0	382	0	0	\N	\N	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
6574	OXTELLAR XR	OXCARBAZEPINE	34312	C15H12N2O2	252.273	\N	1.7	1	2	0	63.4	19	0	382	0	0	\N	\N	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
1634	CHOLEDYL SA	OXTRIPHYLLINE	656652	C12H21N5O3	283.332	\N	\N	1	4	2	91.6	20	0	415	0	0	\N	\N	CN1C(=C2C(=NC=N2)N(C1=O)C)[O-].C[N+](C)(C)CCO	1,3-dimethyl-2-oxo-purin-6-olate;2-hydroxyethyl(trimethyl)ammonium
6575	OXTRIPHYLLINE	OXTRIPHYLLINE	656652	C12H21N5O3	283.332	\N	\N	1	4	2	91.6	20	0	415	0	0	\N	\N	CN1C(=C2C(=NC=N2)N(C1=O)C)[O-].C[N+](C)(C)CCO	1,3-dimethyl-2-oxo-purin-6-olate;2-hydroxyethyl(trimethyl)ammonium
6576	OXTRIPHYLLINE PEDIATRIC	OXTRIPHYLLINE	656652	C12H21N5O3	283.332	\N	\N	1	4	2	91.6	20	0	415	0	0	\N	\N	CN1C(=C2C(=NC=N2)N(C1=O)C)[O-].C[N+](C)(C)CCO	1,3-dimethyl-2-oxo-purin-6-olate;2-hydroxyethyl(trimethyl)ammonium
8249	SHADE UVAGUARD	OXYBENZONE	4632	C14H12O3	228.247	\N	3.6	1	3	3	46.5	17	0	258	0	0	\N	\N	COC1=CC(=C(C=C1)C(=O)C2=CC=CC=C2)O	(2-hydroxy-4-methoxy-phenyl)-phenyl-methanone
2846	DITROPAN	OXYBUTYNIN CHLORIDE	91505	C22H32ClNO3	393.952	\N	\N	2	4	8	49.8	27	0	490	0	1	\N	\N	CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl	4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenyl-acetate;hydrochloride
2847	DITROPAN XL	OXYBUTYNIN CHLORIDE	91505	C22H32ClNO3	393.952	\N	\N	2	4	8	49.8	27	0	490	0	1	\N	\N	CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl	4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenyl-acetate;hydrochloride
3710	GELNIQUE 3%	OXYBUTYNIN	4634	C22H31NO3	357.494	\N	4.2	1	4	8	49.8	26	0	490	0	1	\N	\N	CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O	4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenyl-acetate
1985	COMBUNOX	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6565	OXAYDO	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6581	OXYCET	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6622	PALONOSETRON	PALONOSETRON HYDROCHLORIDE	6918303	C19H25ClN2O	332.872	\N	\N	1	2	1	23.6	23	0	456	2	0	\N	\N	C1CC2CN(C(=O)C3=C2C(=CC=C3)C1)C4CN5CCC4CC5.Cl	(3aS)-2-[(3S)-quinuclidin-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one;hydrochloride
1922	CODOXY	OXYCODONE TEREPHTHALATE	5464088	C26H27NO8	481.501	\N	\N	3	9	3	134	35	0	722	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O.C1=CC(=CC=C1C(=O)O)C(=O)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;terephthalic acid
6784	PERCODAN-DEMI	OXYCODONE TEREPHTHALATE	5464088	C26H27NO8	481.501	\N	\N	3	9	3	134	35	0	722	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O.C1=CC(=CC=C1C(=O)O)C(=O)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;terephthalic acid
9772	XTAMPZA ER	OXYCODONE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
4701	KOVANAZE	OXYMETAZOLINE HYDROCHLORIDE	66259	C16H25ClN2O	296.839	\N	\N	3	2	3	44.6	20	0	345	0	0	\N	\N	CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C.Cl	6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-phenol;hydrochloride
6289	OCUCLEAR	OXYMETAZOLINE HYDROCHLORIDE	66259	C16H25ClN2O	296.839	\N	\N	3	2	3	44.6	20	0	345	0	0	\N	\N	CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C.Cl	6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-phenol;hydrochloride
650	ANADROL-50	OXYMETHOLONE	5281034	C21H32O3	332.484	\N	4.4	2	3	0	57.5	24	0	596	7	0	\N	\N	CC12CCC3C(C1CCC2(C)O)CCC4C3(CC(=CO)C(=O)C4)C	(2Z,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxymethylene)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6379	OPANA ER	OXYMORPHONE HYDROCHLORIDE	5284604	C17H19NO4	301.342	\N	0.8	2	5	0	70	22	0	539	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O	(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6605	OXYMORPHONE HYDROCHLORIDE	OXYMORPHONE HYDROCHLORIDE	5284604	C17H19NO4	301.342	\N	0.8	2	5	0	70	22	0	539	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O	(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
8676	TANDEARIL	OXYPHENBUTAZONE	4641	C19H20N2O3	324.38	\N	2.7	1	3	5	60.8	24	0	454	0	1	\N	\N	CCCCC1C(=O)N(N(C1=O)C2=CC=C(C=C2)O)C3=CC=CC=C3	4-butyl-1-(4-hydroxyphenyl)-2-phenyl-pyrazolidine-3,5-dione
2170	DARICON	OXYPHENCYCLIMINE HYDROCHLORIDE	66061	C20H29ClN2O3	380.913	\N	\N	2	4	6	62.1	26	0	481	0	1	\N	\N	CN1CCCN=C1COC(=O)C(C2CCCCC2)(C3=CC=CC=C3)O.Cl	(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)methyl 2-cyclohexyl-2-hydroxy-2-phenyl-acetate;hydrochloride
3085	ELIMITE	PERMETHRIN	40326	C21H20Cl2O3	391.288	\N	6.5	0	3	7	35.5	26	0	521	0	2	\N	\N	CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C	(3-phenoxyphenyl)methyl 3-(2,2-dichlorovinyl)-2,2-dimethyl-cyclopropanecarboxylate
6607	OXYTETRACYCLINE HYDROCHLORIDE	OXYTETRACYCLINE HYDROCHLORIDE	54680782	C22H25ClN2O9	496.897	\N	\N	8	10	2	202	34	0	1000	6	0	\N	\N	CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O.Cl	(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
6608	OXYTOCIN	OXYTOCIN	439302	C43H66N12O12S2	1007.193	\N	-2.6	12	15	17	450	69	0	1870	9	0	\N	\N	CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N	(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-16-[(4-hydroxyphenyl)methyl]-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1S)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide
6609	OXYTOCIN 10 USP UNITS IN DEXTROSE 5%	OXYTOCIN	439302	C43H66N12O12S2	1007.193	\N	-2.6	12	15	17	450	69	0	1870	9	0	\N	\N	CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N	(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-16-[(4-hydroxyphenyl)methyl]-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1S)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide
6610	OXYTOCIN 20 USP UNITS IN DEXTROSE 5%	OXYTOCIN	439302	C43H66N12O12S2	1007.193	\N	-2.6	12	15	17	450	69	0	1870	9	0	\N	\N	CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N	(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-16-[(4-hydroxyphenyl)methyl]-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1S)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide
6618	PACLITAXEL	PACLITAXEL	36314	C47H51NO14	853.918	\N	2.5	4	14	14	221	62	0	1790	11	0	\N	\N	CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	\N
8696	TAXOL	PACLITAXEL	36314	C47H51NO14	853.918	\N	2.5	4	14	14	221	62	0	1790	11	0	\N	\N	CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	\N
4364	INVEGA SUSTENNA	PALIPERIDONE PALMITATE	9852746	C39H57FN4O4	664.907	\N	10.1	0	8	20	88.2	48	0	1090	0	1	\N	\N	CCCCCCCCCCCCCCCC(=O)OC1CCCN2C1=NC(=C(C2=O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F)C	[3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-2-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-9-yl] hexadecanoate
4365	INVEGA TRINZA	PALIPERIDONE PALMITATE	9852746	C39H57FN4O4	664.907	\N	10.1	0	8	20	88.2	48	0	1090	0	1	\N	\N	CCCCCCCCCCCCCCCC(=O)OC1CCCN2C1=NC(=C(C2=O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F)C	[3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-2-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-9-yl] hexadecanoate
277	AKYNZEO	PALONOSETRON HYDROCHLORIDE	6918303	C19H25ClN2O	332.872	\N	\N	1	2	1	23.6	23	0	456	2	0	\N	\N	C1CC2CN(C(=O)C3=C2C(=CC=C3)C1)C4CN5CCC4CC5.Cl	(3aS)-2-[(3S)-quinuclidin-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one;hydrochloride
364	ALOXI	PALONOSETRON HYDROCHLORIDE	6918303	C19H25ClN2O	332.872	\N	\N	1	2	1	23.6	23	0	456	2	0	\N	\N	C1CC2CN(C(=O)C3=C2C(=CC=C3)C1)C4CN5CCC4CC5.Cl	(3aS)-2-[(3S)-quinuclidin-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one;hydrochloride
756	AREDIA	PAMIDRONATE DISODIUM	73351	C3H9NNa2O7P2	279.032	\N	\N	4	8	4	167	15	0	238	0	0	\N	\N	C(CN)C(O)(P(=O)(O)[O-])P(=O)(O)[O-].[Na+].[Na+]	disodium;[3-amino-1-hydroxy-1-[hydroxy(oxido)phosphoryl]propyl]-hydroxy-phosphinate
6629	PANCURONIUM BROMIDE	PANCURONIUM BROMIDE	27350	C35H60Br2N2O4	732.683	\N	\N	0	6	6	52.6	43	0	1000	10	0	\N	\N	CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-]	[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;dibromide
3426	FARYDAK	PANOBINOSTAT LACTATE	23725423	C24H29N3O5	439.512	\N	\N	6	6	8	135	32	0	533	0	1	\N	\N	CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO.CC(C(=O)O)O	2-hydroxypropanoic acid;(E)-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enehydroxamic acid
7764	PROTONIX	PANTOPRAZOLE SODIUM	15008962	C16H14F2N3NaO4S	405.352	\N	\N	0	10	7	90.8	27	0	497	0	1	\N	\N	COC1=C(C(=NC=C1)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC(F)F)OC.[Na+]	sodium;5-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]benzimidazol-1-ide
7765	PROTONIX IV	PANTOPRAZOLE SODIUM	15008962	C16H14F2N3NaO4S	405.352	\N	\N	0	10	7	90.8	27	0	497	0	1	\N	\N	COC1=C(C(=NC=C1)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC(F)F)OC.[Na+]	sodium;5-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]benzimidazol-1-ide
9667	VITAPED	PANTOTHENIC ACID	6613	C9H17NO5	219.237	\N	-1.1	4	5	6	107	15	0	239	1	0	\N	\N	CC(C)(CO)C(C(=O)NCCC(=O)O)O	3-[[(2R)-2,4-dihydroxy-3,3-dimethyl-butanoyl]amino]propanoic acid
3860	HALDRONE	PARAMETHASONE ACETATE	443928	C24H31FO6	434.504	\N	2.5	2	7	4	101	31	0	895	9	0	\N	\N	CC1CC2C3CC(C4=CC(=O)C=CC4(C3C(CC2(C1(C(=O)COC(=O)C)O)C)O)C)F	[2-[(6S,8S,9S,10R,11S,13S,14S,16R,17R)-6-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
3357	EUTONYL	PARGYLINE HYDROCHLORIDE	9373	C11H14ClN	195.69	\N	\N	1	1	3	3.2	13	0	159	0	0	\N	\N	CN(CC#C)CC1=CC=CC=C1.Cl	N-benzyl-N-methyl-prop-2-yn-1-amine;hydrochloride
3359	EUTRON	PARGYLINE HYDROCHLORIDE	9373	C11H14ClN	195.69	\N	\N	1	1	3	3.2	13	0	159	0	0	\N	\N	CN(CC#C)CC1=CC=CC=C1.Cl	N-benzyl-N-methyl-prop-2-yn-1-amine;hydrochloride
6657	PARICALCITOL	PARICALCITOL	5281104	C27H44O3	416.646	\N	5	3	3	5	60.7	30	0	676	7	0	\N	\N	CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C	(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,1R,4S)-5-hydroxy-1,4,5-trimethyl-hex-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
9839	ZEMPLAR	PARICALCITOL	5281104	C27H44O3	416.646	\N	5	3	3	5	60.7	30	0	676	7	0	\N	\N	CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C	(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,1R,4S)-5-hydroxy-1,4,5-trimethyl-hex-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
8729	TECHNIVIE	PARITAPREVIR	45110509	C40H43N7O7S	765.886	\N	4.7	3	10	7	198	55	0	1600	5	0	\N	\N	CC1=NC=C(N=C1)C(=O)NC2CCCCCC=CC3CC3(NC(=O)C4CC(CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8	\N
9603	VIEKIRA PAK (COPACKAGED)	PARITAPREVIR	45110509	C40H43N7O7S	765.886	\N	4.7	3	10	7	198	55	0	1600	5	0	\N	\N	CC1=NC=C(N=C1)C(=O)NC2CCCCCC=CC3CC3(NC(=O)C4CC(CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8	\N
6661	PAROMOMYCIN SULFATE	PAROMOMYCIN SULFATE	441375	C23H47N5O18S	713.706	\N	\N	15	23	9	430	47	0	952	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O	(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-6-hydroxy-cyclohexoxy]-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl]oxy-tetrahydropyran-3,4-diol;sulfuric acid
6664	PAROXETINE HYDROCHLORIDE	PAROXETINE HYDROCHLORIDE	62878	C19H21ClFNO3	365.829	\N	\N	2	5	4	39.7	25	0	402	2	0	\N	\N	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.Cl	(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrochloride
6674	PAXIL	PAROXETINE HYDROCHLORIDE	62878	C19H21ClFNO3	365.829	\N	\N	2	5	4	39.7	25	0	402	2	0	\N	\N	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.Cl	(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrochloride
6675	PAXIL CR	PAROXETINE HYDROCHLORIDE	62878	C19H21ClFNO3	365.829	\N	\N	2	5	4	39.7	25	0	402	2	0	\N	\N	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.Cl	(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrochloride
8251	SIGNIFOR LAR	PASIREOTIDE PAMOATE	11982961	C81H82N10O15	1435.602	\N	\N	13	17	22	396	106	0	2510	7	0	\N	\N	C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O	[(3S,6S,9S,12R,15S,18S,20R)-9-(4-aminobutyl)-3-benzyl-6-[(4-benzyloxyphenyl)methyl]-12-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-phenyl-1,4,7,10,13,16-hexazabicyclo[16.3.0]henicosan-20-yl] N-(2-aminoethyl)carbamate;4-[(3-carboxy-2-hydroxy-1-naphthyl)methyl]-3-hydroxy-naphthalene-2-carboxylic acid
9699	VOTRIENT	PAZOPANIB HYDROCHLORIDE	11525740	C21H24ClN7O2S	473.98	\N	\N	3	8	5	127	32	0	717	0	0	\N	\N	CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl	5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide;hydrochloride
336	ALIMTA	PEMETREXED DISODIUM	6918197	C20H19N5Na2O6	471.381	\N	\N	4	6	7	193	33	0	737	1	0	\N	\N	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+]	disodium;(2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate
6725	PEMETREXED	PEMETREXED DISODIUM	6918197	C20H19N5Na2O6	471.381	\N	\N	4	6	7	193	33	0	737	1	0	\N	\N	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+]	disodium;(2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate
3807	GOLYTELY	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
6724	PEMETREXED	PEMETREXED	446556	C20H21N5O6	427.417	\N	0.2	6	6	9	187	31	0	748	1	0	\N	\N	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid
280	ALAMAST	PEMIROLAST POTASSIUM	443866	C10H7KN6O	266.305	\N	\N	0	6	1	72.3	18	0	495	0	0	\N	\N	CC1=CC=CN2C1=NC=C(C2=O)C3=NN=N[N-]3.[K+]	potassium;9-methyl-3-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)pyrido[1,2-a]pyrimidin-4-one
2126	CYLERT	PEMOLINE	4723	C9H8N2O2	176.175	\N	0.9	1	2	1	64.7	13	0	244	0	1	\N	\N	C1=CC=C(C=C1)C2C(=O)N=C(O2)N	2-amino-5-phenyl-oxazol-4-one
2327	DENAVIR	PENCICLOVIR	4725	C10H15N5O3	253.262	\N	-1.6	4	4	5	126	18	0	344	0	0	\N	\N	C1=NC2=C(N1CCC(CO)CO)NC(=NC2=O)N	2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3H-purin-6-one
1105	BICILLIN	PENICILLIN G BENZATHINE	25137901	C48H56N6O8S2	909.13	\N	\N	4	10	13	263	64	0	696	6	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.C1=CC=C(C=C1)C[NH2+]CC[NH2+]CC2=CC=CC=C2	benzyl-[2-(benzylammonio)ethyl]ammonium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6735	PENICILLIN	PENICILLIN G POTASSIUM	23664709	C16H17KN2O4S	372.48	\N	\N	1	5	4	115	24	0	536	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6736	PENICILLIN G POTASSIUM	PENICILLIN G POTASSIUM	23664709	C16H17KN2O4S	372.48	\N	\N	1	5	4	115	24	0	536	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6737	PENICILLIN G POTASSIUM IN PLASTIC CONTAINER	PENICILLIN G POTASSIUM	23664709	C16H17KN2O4S	372.48	\N	\N	1	5	4	115	24	0	536	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6741	PENICILLIN-2	PENICILLIN G POTASSIUM	23664709	C16H17KN2O4S	372.48	\N	\N	1	5	4	115	24	0	536	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6755	PENTIDS '200'	PENICILLIN G POTASSIUM	23664709	C16H17KN2O4S	372.48	\N	\N	1	5	4	115	24	0	536	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6756	PENTIDS '250'	PENICILLIN G POTASSIUM	23664709	C16H17KN2O4S	372.48	\N	\N	1	5	4	115	24	0	536	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
1005	BEEPEN-VK	PENICILLIN V POTASSIUM	23676814	C16H17KN2O5S	388.479	\N	\N	1	6	5	124	25	0	553	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
4842	LEDERCILLIN VK	PENICILLIN V POTASSIUM	23676814	C16H17KN2O5S	388.479	\N	\N	1	6	5	124	25	0	553	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6730	PENAPAR-VK	PENICILLIN V POTASSIUM	23676814	C16H17KN2O5S	388.479	\N	\N	1	6	5	124	25	0	553	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6740	PENICILLIN V POTASSIUM	PENICILLIN V POTASSIUM	23676814	C16H17KN2O5S	388.479	\N	\N	1	6	5	124	25	0	553	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
9442	V-CILLIN	PENICILLIN V	6869	C16H18N2O5S	350.389	\N	2.1	2	6	5	121	24	0	547	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C	(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
5865	NEBUPENT	PENTAMIDINE ISETHIONATE	8813	C23H36N4O10S2	592.679	\N	\N	8	12	14	284	39	0	493	0	0	\N	\N	C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O	4-[5-(4-carbamimidoylphenoxy)pentoxy]benzamidine;2-hydroxyethanesulfonic acid
6747	PENTACARINAT	PENTAMIDINE ISETHIONATE	8813	C23H36N4O10S2	592.679	\N	\N	8	12	14	284	39	0	493	0	0	\N	\N	C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O	4-[5-(4-carbamimidoylphenoxy)pentoxy]benzamidine;2-hydroxyethanesulfonic acid
6749	PENTAM	PENTAMIDINE ISETHIONATE	8813	C23H36N4O10S2	592.679	\N	\N	8	12	14	284	39	0	493	0	0	\N	\N	C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O	4-[5-(4-carbamimidoylphenoxy)pentoxy]benzamidine;2-hydroxyethanesulfonic acid
6750	PENTAMIDINE ISETHIONATE	PENTAMIDINE ISETHIONATE	8813	C23H36N4O10S2	592.679	\N	\N	8	12	14	284	39	0	493	0	0	\N	\N	C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O	4-[5-(4-carbamimidoylphenoxy)pentoxy]benzamidine;2-hydroxyethanesulfonic acid
6753	PENTETATE ZINC TRISODIUM	PENTETATE ZINC TRISODIUM	164209	C14H18N3Na3O10Zn	522.658	\N	\N	0	13	11	210	31	0	454	0	0	\N	\N	C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Zn+2]	trisodium;zinc;2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate
5870	NEMBUTAL	PENTOBARBITAL SODIUM	23676152	C11H17N2NaO3	248.258	\N	\N	1	3	4	81.6	17	0	344	0	2	\N	\N	CCCC(C)C1(C(=O)NC(=NC1=O)[O-])CC.[Na+]	sodium;5-ethyl-5-(1-methylbutyl)-4,6-dioxo-1H-pyrimidin-2-olate
5871	NEMBUTAL SODIUM	PENTOBARBITAL SODIUM	23676152	C11H17N2NaO3	248.258	\N	\N	1	3	4	81.6	17	0	344	0	2	\N	\N	CCCC(C)C1(C(=O)NC(=NC1=O)[O-])CC.[Na+]	sodium;5-ethyl-5-(1-methylbutyl)-4,6-dioxo-1H-pyrimidin-2-olate
6759	PENTOBARBITAL SODIUM	PENTOBARBITAL SODIUM	23676152	C11H17N2NaO3	248.258	\N	\N	1	3	4	81.6	17	0	344	0	2	\N	\N	CCCC(C)C1(C(=O)NC(=NC1=O)[O-])CC.[Na+]	sodium;5-ethyl-5-(1-methylbutyl)-4,6-dioxo-1H-pyrimidin-2-olate
6011	NIPENT	PENTOSTATIN	439693	C11H16N4O4	268.273	\N	-2.1	4	6	2	112	19	0	356	4	0	\N	\N	C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O	(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol
6761	PENTOSTATIN	PENTOSTATIN	439693	C11H16N4O4	268.273	\N	-2.1	4	6	2	112	19	0	356	4	0	\N	\N	C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O	(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol
6764	PENTOXIL	PENTOXIFYLLINE	4740	C13H18N4O3	278.312	\N	0.3	0	4	5	75.5	20	0	426	0	0	\N	\N	CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C	3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione
7876	RAPIVAB	PERAMIVIR	154234	C15H28N4O4	328.413	\N	0	5	5	7	151	23	0	460	5	0	\N	\N	CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C	(1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethyl-butyl]-4-guanidino-2-hydroxy-cyclopentanecarboxylic acid
3676	FYCOMPA	PERAMPANEL	9924495	C23H15N3O	349.393	\N	3.4	0	3	3	57	27	0	664	0	0	\N	\N	C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4	2-[2-oxo-1-phenyl-5-(2-pyridyl)-3-pyridyl]benzonitrile
4197	IMAGENT	PERFLUBRON	9873	C8BrF17	498.965	\N	6.9	0	17	6	0	26	0	527	0	0	\N	\N	C(C(C(C(C(F)(F)Br)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F	1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-octane
6788	PERGOLIDE MESYLATE	PERGOLIDE MESYLATE	47812	C20H30N2O3S2	410.591	\N	\N	2	5	4	107	27	0	480	3	0	\N	\N	CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC.CS(=O)(=O)O	(6aR,9R,10aR)-9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline;methanesulfonic acid
7437	PRESTALIA	PERINDOPRIL ARGININE	12068809	C25H46N6O7	542.678	\N	\N	6	10	14	224	38	0	700	6	0	\N	\N	CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O.C(CC(C(=O)O)N)CN=C(N)N	(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonylbutyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid;(2S)-2-amino-5-guanidino-pentanoic acid
41	ACEON	PERINDOPRIL ERBUMINE	441313	C23H43N3O5	441.613	\N	\N	3	7	9	122	31	0	549	5	0	\N	\N	CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O.CC(C)(C)N	(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonylbutyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid;2-methylpropan-2-amine
6800	PERINDOPRIL ERBUMINE	PERINDOPRIL ERBUMINE	441313	C23H43N3O5	441.613	\N	\N	3	7	9	122	31	0	549	5	0	\N	\N	CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O.CC(C)(C)N	(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonylbutyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid;2-methylpropan-2-amine
3348	ETRAFON-A	PERPHENAZINE	4748	C21H26ClN3OS	403.969	\N	4.2	1	5	6	55.2	27	0	463	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
3350	ETRAFON-FORTE	PERPHENAZINE	4748	C21H26ClN3OS	403.969	\N	4.2	1	5	6	55.2	27	0	463	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
6849	PHENURONE	PHENACEMIDE	4753	C9H10N2O2	178.191	\N	0.9	2	2	2	72.2	13	0	198	0	0	\N	\N	C1=CC=C(C=C1)CC(=O)NC(=O)N	N-carbamoyl-2-phenyl-acetamide
931	AZO GANTRISIN	PHENAZOPYRIDINE HYDROCHLORIDE	8691	C11H12ClN5	249.702	\N	\N	3	5	2	89.6	17	0	237	0	0	\N	\N	C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N.Cl	3-phenylazopyridine-2,6-diamine;hydrochloride
5813	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	PHENIRAMINE MALEATE	5282139	C20H24N2O4	356.422	\N	\N	2	6	7	90.7	26	0	340	0	1	\N	\N	CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	N,N-dimethyl-3-phenyl-3-(2-pyridyl)propan-1-amine;maleic acid
5816	NAPHCON-A	PHENIRAMINE MALEATE	5282139	C20H24N2O4	356.422	\N	\N	2	6	7	90.7	26	0	340	0	1	\N	\N	CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	N,N-dimethyl-3-phenyl-3-(2-pyridyl)propan-1-amine;maleic acid
6383	OPCON-A	PHENIRAMINE MALEATE	5282139	C20H24N2O4	356.422	\N	\N	2	6	7	90.7	26	0	340	0	1	\N	\N	CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	N,N-dimethyl-3-phenyl-3-(2-pyridyl)propan-1-amine;maleic acid
9643	VISINE-A	PHENIRAMINE MALEATE	5282139	C20H24N2O4	356.422	\N	\N	2	6	7	90.7	26	0	340	0	1	\N	\N	CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	N,N-dimethyl-3-phenyl-3-(2-pyridyl)propan-1-amine;maleic acid
6844	PHENOXYBENZAMINE HYDROCHLORIDE	PHENOXYBENZAMINE HYDROCHLORIDE	5284441	C18H23Cl2NO	340.288	\N	\N	1	2	8	12.5	22	0	262	0	1	\N	\N	CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2.Cl	N-benzyl-N-(2-chloroethyl)-1-phenoxy-propan-2-amine;hydrochloride
6362	ONA-MAST	PHENTERMINE HYDROCHLORIDE	70969	C10H16ClN	185.695	\N	\N	2	1	2	26	12	0	112	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)N.Cl	2-methyl-1-phenyl-propan-2-amine;hydrochloride
6845	PHENTERMINE HYDROCHLORIDE	PHENTERMINE HYDROCHLORIDE	70969	C10H16ClN	185.695	\N	\N	2	1	2	26	12	0	112	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)N.Cl	2-methyl-1-phenyl-propan-2-amine;hydrochloride
8588	SUPRENZA	PHENTERMINE HYDROCHLORIDE	70969	C10H16ClN	185.695	\N	\N	2	1	2	26	12	0	112	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)N.Cl	2-methyl-1-phenyl-propan-2-amine;hydrochloride
4376	IONAMIN	PHENTERMINE RESIN COMPLEX	4771	C10H15N	149.237	\N	1.9	1	1	2	26	11	0	112	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)N	2-methyl-1-phenyl-propan-2-amine
6847	PHENTERMINE RESIN COMPLEX	PHENTERMINE RESIN COMPLEX	4771	C10H15N	149.237	\N	1.9	1	1	2	26	11	0	112	0	0	\N	\N	CC(C)(CC1=CC=CC=C1)N	2-methyl-1-phenyl-propan-2-amine
6421	ORAVERSE	PHENTOLAMINE MESYLATE	91430	C18H23N3O4S	377.459	\N	\N	3	6	4	111	26	0	456	0	0	\N	\N	CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O	3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methyl-anilino]phenol;methanesulfonic acid
6848	PHENTOLAMINE MESYLATE	PHENTOLAMINE MESYLATE	91430	C18H23N3O4S	377.459	\N	\N	3	6	4	111	26	0	456	0	0	\N	\N	CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O	3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methyl-anilino]phenol;methanesulfonic acid
1294	BUTAZOLIDIN	PHENYLBUTAZONE	4781	C19H20N2O2	308.381	\N	3.2	0	2	5	40.6	23	0	389	0	0	\N	\N	CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3	4-butyl-1,2-diphenyl-pyrazolidine-3,5-dione
6851	PHENYLBUTAZONE	PHENYLBUTAZONE	4781	C19H20N2O2	308.381	\N	3.2	0	2	5	40.6	23	0	389	0	0	\N	\N	CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3	4-butyl-1,2-diphenyl-pyrazolidine-3,5-dione
232	ADVIL CONGESTION RELIEF	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
2118	CYCLOMYDRIL	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
4161	IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
6344	OMIDRIA	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
6839	PHENERGAN VC W/ CODEINE	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
6852	PHENYLEPHRINE HYDROCHLORIDE	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
1935	COLD CAPSULE IV	PHENYLPROPANOLAMINE HYDROCHLORIDE	9065	C9H14ClNO	187.667	\N	\N	3	2	2	46.2	12	0	110	0	2	\N	\N	CC(C(C1=CC=CC=C1)O)N.Cl	2-amino-1-phenyl-propan-1-ol;hydrochloride
1937	COLD CAPSULE V	PHENYLPROPANOLAMINE HYDROCHLORIDE	9065	C9H14ClNO	187.667	\N	\N	3	2	2	46.2	12	0	110	0	2	\N	\N	CC(C(C1=CC=CC=C1)O)N.Cl	2-amino-1-phenyl-propan-1-ol;hydrochloride
3395	EXTENDED PHENYTOIN SODIUM	PHENYTOIN SODIUM	657302	C15H11N2NaO2	274.255	\N	\N	1	3	2	47.2	20	0	356	0	0	\N	\N	C1=CC=C(C=C1)C2(C(=O)[N-]C(=O)N2)C3=CC=CC=C3.[Na+]	sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione
6858	PHENYTOIN SODIUM	PHENYTOIN SODIUM	657302	C15H11N2NaO2	274.255	\N	\N	1	3	2	47.2	20	0	356	0	0	\N	\N	C1=CC=C(C=C1)C2(C(=O)[N-]C(=O)N2)C3=CC=CC=C3.[Na+]	sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione
2797	DILANTIN-125	PHENYTOIN	1775	C15H12N2O2	252.273	\N	2.5	2	2	2	58.2	19	0	350	0	0	\N	\N	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	5,5-diphenylimidazolidine-2,4-dione
2798	DILANTIN-30	PHENYTOIN	1775	C15H12N2O2	252.273	\N	2.5	2	2	2	58.2	19	0	350	0	0	\N	\N	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	5,5-diphenylimidazolidine-2,4-dione
3646	FREAMINE III 3% W/ ELECTROLYTES	PHOSPHORIC ACID	1004	H3O4P	97.994	\N	-2.1	3	4	0	77.8	5	0	49.8	0	0	\N	\N	OP(=O)(O)O	phosphoric acid
3653	FREAMINE III 8.5% W/ ELECTROLYTES	PHOSPHORIC ACID	1004	H3O4P	97.994	\N	-2.1	3	4	0	77.8	5	0	49.8	0	0	\N	\N	OP(=O)(O)O	phosphoric acid
4698	KONAKION	PHYTONADIONE	5284607	C31H46O2	450.707	\N	10.9	0	2	14	34.1	33	0	696	2	0	\N	\N	CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C	2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
5406	MEPHYTON	PHYTONADIONE	5284607	C31H46O2	450.707	\N	10.9	0	2	14	34.1	33	0	696	2	0	\N	\N	CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C	2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
6918	PHYTONADIONE	PHYTONADIONE	5284607	C31H46O2	450.707	\N	10.9	0	2	14	34.1	33	0	696	2	0	\N	\N	CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C	2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
9660	VITAMIN K1	PHYTONADIONE	5284607	C31H46O2	450.707	\N	10.9	0	2	14	34.1	33	0	696	2	0	\N	\N	CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C	2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
9668	VITAPED	PHYTONADIONE	5284607	C31H46O2	450.707	\N	10.9	0	2	14	34.1	33	0	696	2	0	\N	\N	CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C	2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
1091	BETOPTIC PILO	PILOCARPINE HYDROCHLORIDE	5909	C11H17ClN2O2	244.719	\N	\N	1	3	3	44.1	16	0	245	2	0	\N	\N	CCC1C(COC1=O)CC2=CN=CN2C.Cl	(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one;hydrochloride
6921	PILOPINE HS	PILOCARPINE HYDROCHLORIDE	5909	C11H17ClN2O2	244.719	\N	\N	1	3	3	44.1	16	0	245	2	0	\N	\N	CCC1C(COC1=O)CC2=CN=CN2C.Cl	(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one;hydrochloride
6296	OCUSERT PILO-40	PILOCARPINE	5910	C11H16N2O2	208.261	\N	1.1	0	3	3	44.1	15	0	245	2	0	\N	\N	CCC1C(COC1=O)CC2=CN=CN2C	(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one
6922	PIMOZIDE	PIMOZIDE	16362	C28H29F2N3O	461.557	\N	6.3	1	4	7	35.6	34	0	632	0	0	\N	\N	C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F	3-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidyl]-1H-benzimidazol-2-one
6926	PINDOLOL	PINDOLOL	4828	C14H20N2O2	248.326	\N	1.8	3	3	6	57.3	18	0	248	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=C1C=CN2)O	1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol
9649	VISKEN	PINDOLOL	4828	C14H20N2O2	248.326	\N	1.8	3	3	6	57.3	18	0	248	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=C1C=CN2)O	1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol
121	ACTOPLUS MET	PIOGLITAZONE HYDROCHLORIDE	60560	C19H21ClN2O3S	392.898	\N	\N	2	5	7	93.6	26	0	466	0	1	\N	\N	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl	5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione;hydrochloride
755	ARDUAN	PIPECURONIUM BROMIDE	65332	C35H62Br2N4O4	762.713	\N	\N	0	8	6	59.1	45	0	1060	10	0	\N	\N	CC(=O)OC1CC2CCC3C(C2(CC1N4CC[N+](CC4)(C)C)C)CCC5(C3CC(C5OC(=O)C)N6CC[N+](CC6)(C)C)C.[Br-].[Br-]	[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;dibromide
7837	QUIDE	PIPERACETAZINE	19675	C24H30N2O2S	410.576	\N	4	1	5	7	69.1	29	0	537	0	0	\N	\N	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCC(CC4)CCO	1-[10-[3-[4-(2-hydroxyethyl)-1-piperidyl]propyl]phenothiazin-2-yl]ethanone
6934	PIPERACILLIN AND TAZOBACTAM	PIPERACILLIN SODIUM	23666879	C23H26N5NaO7S	539.539	\N	\N	2	8	6	185	37	0	989	4	0	\N	\N	CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+]	sodium;(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6937	PIPRACIL	PIPERACILLIN SODIUM	23666879	C23H26N5NaO7S	539.539	\N	\N	2	8	6	185	37	0	989	4	0	\N	\N	CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+]	sodium;(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
9910	ZOSYN	PIPERACILLIN SODIUM	23666879	C23H26N5NaO7S	539.539	\N	\N	2	8	6	185	37	0	989	4	0	\N	\N	CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+]	sodium;(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
9912	ZOSYN IN PLASTIC CONTAINER	PIPERACILLIN SODIUM	23666879	C23H26N5NaO7S	539.539	\N	\N	2	8	6	185	37	0	989	4	0	\N	\N	CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+]	sodium;(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
3435	FELDENE	PIROXICAM	54676228	C15H13N3O4S	331.346	\N	3.1	2	6	2	108	23	0	611	0	0	\N	\N	CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3	4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1$l^{6},2-benzothiazine-3-carboxamide
5012	LIVALO	PITAVASTATIN CALCIUM	5282451	C50H46CaF2N2O8	880.999	\N	\N	4	12	14	187	63	0	626	4	0	\N	\N	C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.[Ca+2]	calcium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-hept-6-enoate
6943	PITAVASTATIN	PITAVASTATIN	5282452	C25H24FNO4	421.468	\N	3.5	3	6	8	90.6	31	0	631	2	0	\N	\N	C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)O)O)O)C4=CC=C(C=C4)F	(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-hept-6-enoic acid
5617	MITHRACIN	PLICAMYCIN	163659	C52H76O24	1085.156	\N	0.6	11	24	15	358	76	0	1940	25	0	\N	\N	CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O	(2S,3S)-2-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4-[(2S,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxo-pentyl]-6-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-8,9-dihydroxy-7-methyl-3,4-dihydro-2H-anthracen-1-one
2001	CONDYLOX	PODOFILOX	10607	C22H22O8	414.41	\N	2	1	8	4	92.7	30	0	629	4	0	\N	\N	COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O	(5R,5aR,8aR,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,3]benzodioxol-8-one
795	ASCLERA	POLIDOCANOL	656641	C30H62O10	582.816	\N	3.9	1	10	37	103	40	0	431	0	0	\N	\N	CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO	2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol
9492	VARITHENA	POLIDOCANOL	656641	C30H62O10	582.816	\N	3.9	1	10	37	103	40	0	431	0	0	\N	\N	CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO	2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol
1946	COLOVAGE	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
1962	COLYTE WITH FLAVOR PACKS	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
1967	COLYTE-FLAVORED	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
3790	GLYCOPREP	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
3802	GO-EVAC	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
249	AEROSPORIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
945	BACITRACIN ZINC AND POLYMYXIN B SULFATE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
2570	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2576	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.30% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
5592	MINIZIDE	POLYTHIAZIDE	4870	C11H13ClF3N3O4S3	439.867	\N	2.6	2	11	4	152	25	0	692	0	1	\N	\N	CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CSCC(F)(F)F	6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
7936	RENESE	POLYTHIAZIDE	4870	C11H13ClF3N3O4S3	439.867	\N	2.6	2	11	4	152	25	0	692	0	1	\N	\N	CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CSCC(F)(F)F	6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
7937	RENESE-R	POLYTHIAZIDE	4870	C11H13ClF3N3O4S3	439.867	\N	2.6	2	11	4	152	25	0	692	0	1	\N	\N	CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CSCC(F)(F)F	6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4171	ICLUSIG	PONATINIB HYDROCHLORIDE	46908927	C29H28ClF3N6O	569.029	\N	\N	2	8	6	65.8	40	0	910	0	0	\N	\N	CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5.Cl	3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide;hydrochloride
2579	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
454	AMINOSYN 3.5% M IN PLASTIC CONTAINER	POTASSIUM ACETATE	517044	C2H3KO2	98.142	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[K+]	potassium;acetate
502	AMINOSYN II 3.5% M IN PLASTIC CONTAINER	POTASSIUM ACETATE	517044	C2H3KO2	98.142	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[K+]	potassium;acetate
497	AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
508	AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
547	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
554	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
8890	THYROSAFE	POTASSIUM IODIDE	4875	IK	166.003	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[K+].[I-]	potassium;iodide
8891	THYROSHIELD	POTASSIUM IODIDE	4875	IK	166.003	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[K+].[I-]	potassium;iodide
480	AMINOSYN II 10% W/ ELECTROLYTES	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
509	AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
555	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
571	AMINOSYN II 7% W/ ELECTROLYTES	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
4387	IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, MONOBASIC	516951	H2KO4P	136.084	\N	\N	2	4	0	80.6	6	0	61.9	0	0	\N	\N	OP(=O)(O)[O-].[K+]	potassium;dihydrogen phosphate
8926	TIS-U-SOL IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, MONOBASIC	516951	H2KO4P	136.084	\N	\N	2	4	0	80.6	6	0	61.9	0	0	\N	\N	OP(=O)(O)[O-].[K+]	potassium;dihydrogen phosphate
3017	E-Z PREP	POVIDONE-IODINE	410087	C6H9I2NO	364.953	\N	\N	0	1	1	20.3	10	0	120	0	0	\N	\N	C=CN1CCCC1=O.II	molecular iodine;1-vinylpyrrolidin-2-one
3018	E-Z PREP 220	POVIDONE-IODINE	410087	C6H9I2NO	364.953	\N	\N	0	1	1	20.3	10	0	120	0	0	\N	\N	C=CN1CCCC1=O.II	molecular iodine;1-vinylpyrrolidin-2-one
3607	FOLOTYN	PRALATREXATE	148121	C23H23N7O5	477.481	\N	-0.9	5	11	10	207	35	0	809	1	1	\N	\N	C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic acid
7364	PRALATREXATE	PRALATREXATE	148121	C23H23N7O5	477.481	\N	-0.9	5	11	10	207	35	0	809	1	1	\N	\N	C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic acid
5609	MIRAPEX ER	PRAMIPEXOLE DIHYDROCHLORIDE	119569	C10H19Cl2N3S	284.243	\N	\N	4	4	3	79.2	16	0	188	1	0	\N	\N	CCCNC1CCC2=C(C1)SC(=N2)N.Cl.Cl	(6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride
7368	PRAMIPEXOLE DIHYDROCHLORIDE	PRAMIPEXOLE DIHYDROCHLORIDE	119569	C10H19Cl2N3S	284.243	\N	\N	4	4	3	79.2	16	0	188	1	0	\N	\N	CCCNC1CCC2=C(C1)SC(=N2)N.Cl.Cl	(6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride
3202	EPIFOAM	PRAMOXINE HYDROCHLORIDE	73957	C17H28ClNO3	329.865	\N	\N	1	4	9	30.9	22	0	248	0	0	\N	\N	CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2.Cl	4-[3-(4-butoxyphenoxy)propyl]morpholine;hydrochloride
4088	HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROCHLORIDE 1%	PRAMOXINE HYDROCHLORIDE	73957	C17H28ClNO3	329.865	\N	\N	1	4	9	30.9	22	0	248	0	0	\N	\N	CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2.Cl	4-[3-(4-butoxyphenoxy)propyl]morpholine;hydrochloride
7370	PRAMOSONE	PRAMOXINE HYDROCHLORIDE	73957	C17H28ClNO3	329.865	\N	\N	1	4	9	30.9	22	0	248	0	0	\N	\N	CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2.Cl	4-[3-(4-butoxyphenoxy)propyl]morpholine;hydrochloride
3064	EFFIENT	PRASUGREL HYDROCHLORIDE	10158453	C20H21ClFNO3S	409.9	\N	\N	1	6	6	74.8	27	0	555	0	1	\N	\N	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4.Cl	[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxo-ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate;hydrochloride
7376	PRAVACHOL	PRAVASTATIN SODIUM	16759173	C23H35NaO7	446.516	\N	\N	3	7	11	127	31	0	662	8	0	\N	\N	CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)[O-])O)O)O.[Na+]	sodium;(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-heptanoate
7377	PRAVASTATIN SODIUM	PRAVASTATIN SODIUM	16759173	C23H35NaO7	446.516	\N	\N	3	7	11	127	31	0	662	8	0	\N	\N	CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)[O-])O)O)O.[Na+]	sodium;(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-heptanoate
1513	CENTRAX	PRAZEPAM	4890	C19H17ClN2O	324.808	\N	3.6	0	2	3	32.7	23	0	482	0	0	\N	\N	C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4	7-chloro-1-(cyclopropylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one
5586	MINIPRESS	PRAZOSIN HYDROCHLORIDE	68546	C19H22ClN5O4	419.866	\N	\N	2	8	4	107	29	0	544	0	0	\N	\N	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC.Cl	[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone;hydrochloride
5587	MINIPRESS XL	PRAZOSIN HYDROCHLORIDE	68546	C19H22ClN5O4	419.866	\N	\N	2	8	4	107	29	0	544	0	0	\N	\N	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC.Cl	[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone;hydrochloride
2351	DERMATOP	PREDNICARBATE	6714002	C27H36O8	488.577	\N	4.2	1	8	9	116	35	0	982	7	0	\N	\N	CCC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)OC(=O)OCC	[2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
2352	DERMATOP E EMOLLIENT	PREDNICARBATE	6714002	C27H36O8	488.577	\N	4.2	1	8	9	116	35	0	982	7	0	\N	\N	CCC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)OC(=O)OCC	[2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
7398	PREDNICARBATE	PREDNICARBATE	6714002	C27H36O8	488.577	\N	4.2	1	8	9	116	35	0	982	7	0	\N	\N	CCC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)OC(=O)OCC	[2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
1135	BLEPHAMIDE	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
1137	BLEPHAMIDE S.O.P.	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
1535	CETAPRED	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
4250	INFLAMASE FORTE	PREDNISOLONE SODIUM PHOSPHATE	441409	C21H27Na2O8P	484.392	\N	\N	2	8	3	147	32	0	878	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]	disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
4251	INFLAMASE MILD	PREDNISOLONE SODIUM PHOSPHATE	441409	C21H27Na2O8P	484.392	\N	\N	2	8	3	147	32	0	878	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]	disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
5505	METRETON	PREDNISOLONE SODIUM PHOSPHATE	441409	C21H27Na2O8P	484.392	\N	\N	2	8	3	147	32	0	878	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]	disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
6416	ORAPRED	PREDNISOLONE SODIUM PHOSPHATE	441409	C21H27Na2O8P	484.392	\N	\N	2	8	3	147	32	0	878	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]	disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
6417	ORAPRED ODT	PREDNISOLONE SODIUM PHOSPHATE	441409	C21H27Na2O8P	484.392	\N	\N	2	8	3	147	32	0	878	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]	disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
6684	PEDIAPRED	PREDNISOLONE SODIUM PHOSPHATE	441409	C21H27Na2O8P	484.392	\N	\N	2	8	3	147	32	0	878	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]	disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
7395	PREDAIR FORTE	PREDNISOLONE SODIUM PHOSPHATE	441409	C21H27Na2O8P	484.392	\N	\N	2	8	3	147	32	0	878	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]	disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
7402	PREDNISOLONE SODIUM PHOSPHATE	PREDNISOLONE SODIUM PHOSPHATE	441409	C21H27Na2O8P	484.392	\N	\N	2	8	3	147	32	0	878	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]	disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
1025	BENEMID	PROBENECID	4911	C13H19NO4S	285.358	\N	3.2	1	5	7	83.1	19	0	374	0	0	\N	\N	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O	4-(dipropylsulfamoyl)benzoic acid
1613	CHLOROPTIC-P S.O.P.	PREDNISOLONE	5755	C21H28O5	360.45	\N	1.6	3	5	2	94.8	26	0	724	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
2308	DELTA-CORTEF	PREDNISOLONE	5755	C21H28O5	360.45	\N	1.6	3	5	2	94.8	26	0	724	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
3476	FERNISOLONE-P	PREDNISOLONE	5755	C21H28O5	360.45	\N	1.6	3	5	2	94.8	26	0	724	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
2033	CORTAN	PREDNISONE	5865	C21H26O5	358.434	\N	1.5	2	5	2	91.7	26	0	764	6	0	\N	\N	CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
2309	DELTA-DOME	PREDNISONE	5865	C21H26O5	358.434	\N	1.5	2	5	2	91.7	26	0	764	6	0	\N	\N	CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
2311	DELTASONE	PREDNISONE	5865	C21H26O5	358.434	\N	1.5	2	5	2	91.7	26	0	764	6	0	\N	\N	CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
3477	FERNISONE	PREDNISONE	5865	C21H26O5	358.434	\N	1.5	2	5	2	91.7	26	0	764	6	0	\N	\N	CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
4999	LIQUID PRED	PREDNISONE	5865	C21H26O5	358.434	\N	1.5	2	5	2	91.7	26	0	764	6	0	\N	\N	CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
1693	CITANEST	PRILOCAINE HYDROCHLORIDE	92163	C13H21ClN2O	256.774	\N	\N	3	2	5	41.1	17	0	218	0	1	\N	\N	CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl	N-(o-tolyl)-2-(propylamino)propanamide;hydrochloride
1695	CITANEST FORTE	PRILOCAINE HYDROCHLORIDE	92163	C13H21ClN2O	256.774	\N	\N	3	2	5	41.1	17	0	218	0	1	\N	\N	CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl	N-(o-tolyl)-2-(propylamino)propanamide;hydrochloride
1697	CITANEST FORTE DENTAL	PRILOCAINE HYDROCHLORIDE	92163	C13H21ClN2O	256.774	\N	\N	3	2	5	41.1	17	0	218	0	1	\N	\N	CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl	N-(o-tolyl)-2-(propylamino)propanamide;hydrochloride
1698	CITANEST PLAIN	PRILOCAINE HYDROCHLORIDE	92163	C13H21ClN2O	256.774	\N	\N	3	2	5	41.1	17	0	218	0	1	\N	\N	CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl	N-(o-tolyl)-2-(propylamino)propanamide;hydrochloride
1699	CITANEST PLAIN DENTAL	PRILOCAINE HYDROCHLORIDE	92163	C13H21ClN2O	256.774	\N	\N	3	2	5	41.1	17	0	218	0	1	\N	\N	CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl	N-(o-tolyl)-2-(propylamino)propanamide;hydrochloride
4931	LIDOCAINE AND PRILOCAINE	PRILOCAINE	4906	C13H20N2O	220.316	\N	2.1	2	2	5	41.1	16	0	218	0	1	\N	\N	CCCNC(C)C(=O)NC1=CC=CC=C1C	N-(o-tolyl)-2-(propylamino)propanamide
745	ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE	PRIMAQUINE PHOSPHATE	4908	C15H21N3O	259.353	\N	2.2	2	4	6	60.2	19	0	262	0	1	\N	\N	CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2	N4-(6-methoxy-8-quinolyl)pentane-1,4-diamine
5084	LORELCO	PROBUCOL	4912	C31H48O2S2	516.843	\N	11.3	2	4	8	91.1	35	0	583	0	0	\N	\N	CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C	2,6-ditert-butyl-4-[1-(3,5-ditert-butyl-4-hydroxy-phenyl)sulfanyl-1-methyl-ethyl]sulfanyl-phenol
7614	PROCAINAMIDE HYDROCHLORIDE	PROCAINAMIDE HYDROCHLORIDE	66068	C13H22ClN3O	271.789	\N	\N	3	3	6	58.4	18	0	221	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl	4-amino-N-[2-(diethylamino)ethyl]benzamide;hydrochloride
7626	PROCAN	PROCAINAMIDE HYDROCHLORIDE	66068	C13H22ClN3O	271.789	\N	\N	3	3	6	58.4	18	0	221	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl	4-amino-N-[2-(diethylamino)ethyl]benzamide;hydrochloride
83	ACHROMYCIN	PROCAINE HYDROCHLORIDE	5795	C13H21ClN2O2	272.773	\N	\N	2	4	7	55.6	18	0	222	0	0	\N	\N	CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.Cl	2-(diethylamino)ethyl 4-aminobenzoate;hydrochloride
6189	NOVOCAIN	PROCAINE HYDROCHLORIDE	5795	C13H21ClN2O2	272.773	\N	\N	2	4	7	55.6	18	0	222	0	0	\N	\N	CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.Cl	2-(diethylamino)ethyl 4-aminobenzoate;hydrochloride
7890	RAVOCAINE AND NOVOCAIN W/ LEVOPHED	PROCAINE HYDROCHLORIDE	5795	C13H21ClN2O2	272.773	\N	\N	2	4	7	55.6	18	0	222	0	0	\N	\N	CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.Cl	2-(diethylamino)ethyl 4-aminobenzoate;hydrochloride
7893	RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN	PROCAINE HYDROCHLORIDE	5795	C13H21ClN2O2	272.773	\N	\N	2	4	7	55.6	18	0	222	0	0	\N	\N	CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.Cl	2-(diethylamino)ethyl 4-aminobenzoate;hydrochloride
2773	DICURIN PROCAINE	PROCAINE MERETHOXYLLINE	72710718	C28H41HgN3O9	764.24	\N	\N	4	11	18	151	41	0	589	0	1	\N	\N	CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.COCCOC(CNC(=O)C1=CC=CC=C1OCC(=O)O)C[Hg+].[OH-]	[3-[[2-(carboxymethoxy)benzoyl]amino]-2-(2-methoxyethoxy)propyl]mercury(1+);2-(diethylamino)ethyl 4-aminobenzoate;hydroxide
1989	COMPAZINE	PROCHLORPERAZINE EDISYLATE	91499	C22H30ClN3O6S3	564.127	\N	\N	2	10	7	161	35	0	668	0	0	\N	\N	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl.C(CS(=O)(=O)O)S(=O)(=O)O	2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine;ethane-1,2-disulfonic acid
7635	PROCHLORPERAZINE EDISYLATE	PROCHLORPERAZINE EDISYLATE	91499	C22H30ClN3O6S3	564.127	\N	\N	2	10	7	161	35	0	668	0	0	\N	\N	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl.C(CS(=O)(=O)O)S(=O)(=O)O	2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine;ethane-1,2-disulfonic acid
7634	PROCHLORPERAZINE	PROCHLORPERAZINE MALEATE	4917	C20H24ClN3S	373.943	\N	4.9	0	4	4	35	25	0	429	0	0	\N	\N	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine
7636	PROCHLORPERAZINE MALEATE	PROCHLORPERAZINE MALEATE	4917	C20H24ClN3S	373.943	\N	4.9	0	4	4	35	25	0	429	0	0	\N	\N	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine
7637	PROCOMP	PROCHLORPERAZINE MALEATE	4917	C20H24ClN3S	373.943	\N	4.9	0	4	4	35	25	0	429	0	0	\N	\N	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine
1988	COMPAZINE	PROCHLORPERAZINE	4917	C20H24ClN3S	373.943	\N	4.9	0	4	4	35	25	0	429	0	0	\N	\N	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine
1997	COMPRO	PROCHLORPERAZINE	4917	C20H24ClN3S	373.943	\N	4.9	0	4	4	35	25	0	429	0	0	\N	\N	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine
2079	CRINONE	PROGESTERONE	5994	C21H30O2	314.469	\N	3.9	0	2	1	34.1	23	0	589	6	0	\N	\N	CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C	(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
3145	ENDOMETRIN	PROGESTERONE	5994	C21H30O2	314.469	\N	3.9	0	2	1	34.1	23	0	589	6	0	\N	\N	CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C	(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
7646	PROGESTERONE	PROGESTERONE	5994	C21H30O2	314.469	\N	3.9	0	2	1	34.1	23	0	589	6	0	\N	\N	CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C	(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
7712	PROMETRIUM	PROGESTERONE	5994	C21H30O2	314.469	\N	3.9	0	2	1	34.1	23	0	589	6	0	\N	\N	CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C	(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
837	ATOVAQUONE AND PROGUANIL HYDROCHLORIDE	PROGUANIL HYDROCHLORIDE	9570076	C11H17Cl2N5	290.192	\N	\N	4	1	4	88.8	18	0	292	0	0	\N	\N	CC(C)N=C(N)N=C(N)NC1=CC=C(C=C1)Cl.Cl	(1E)-1-[amino-(4-chloroanilino)methylene]-2-isopropyl-guanidine;hydrochloride
5281	MALARONE	PROGUANIL HYDROCHLORIDE	9570076	C11H17Cl2N5	290.192	\N	\N	4	1	4	88.8	18	0	292	0	0	\N	\N	CC(C)N=C(N)N=C(N)NC1=CC=C(C=C1)Cl.Cl	(1E)-1-[amino-(4-chloroanilino)methylene]-2-isopropyl-guanidine;hydrochloride
5283	MALARONE PEDIATRIC	PROGUANIL HYDROCHLORIDE	9570076	C11H17Cl2N5	290.192	\N	\N	4	1	4	88.8	18	0	292	0	0	\N	\N	CC(C)N=C(N)N=C(N)NC1=CC=C(C=C1)Cl.Cl	(1E)-1-[amino-(4-chloroanilino)methylene]-2-isopropyl-guanidine;hydrochloride
8396	SPARINE	PROMAZINE HYDROCHLORIDE	5887	C17H21ClN2S	320.879	\N	\N	1	3	4	31.8	21	0	285	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31.Cl	N,N-dimethyl-3-phenothiazin-10-yl-propan-1-amine;hydrochloride
6837	PHENERGAN VC	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
3101	ELLIOTTS B SOLUTION	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
8121	RYTHMOL	PROPAFENONE HYDROCHLORIDE	36708	C21H28ClNO3	377.909	\N	\N	3	4	11	58.6	26	0	368	0	1	\N	\N	CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O.Cl	1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one;hydrochloride
8122	RYTHMOL SR	PROPAFENONE HYDROCHLORIDE	36708	C21H28ClNO3	377.909	\N	\N	3	4	11	58.6	26	0	368	0	1	\N	\N	CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O.Cl	1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one;hydrochloride
6385	OPHTHAINE	PROPARACAINE HYDROCHLORIDE	517321	C16H27ClN2O3	330.853	\N	\N	2	5	10	64.8	22	0	295	0	0	\N	\N	CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N.Cl	2-(diethylamino)ethyl 3-amino-4-propoxy-benzoate;hydrochloride
6386	OPHTHETIC	PROPARACAINE HYDROCHLORIDE	517321	C16H27ClN2O3	330.853	\N	\N	2	5	10	64.8	22	0	295	0	0	\N	\N	CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N.Cl	2-(diethylamino)ethyl 3-amino-4-propoxy-benzoate;hydrochloride
6642	PARACAINE	PROPARACAINE HYDROCHLORIDE	517321	C16H27ClN2O3	330.853	\N	\N	2	5	10	64.8	22	0	295	0	0	\N	\N	CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N.Cl	2-(diethylamino)ethyl 3-amino-4-propoxy-benzoate;hydrochloride
2829	DIPRIVAN	PROPOFOL	4943	C12H18O	178.275	\N	3.8	1	1	2	20.2	13	0	135	0	0	\N	\N	CC(C)C1=C(C(=CC=C1)C(C)C)O	2,6-diisopropylphenol
7891	RAVOCAINE AND NOVOCAIN W/ LEVOPHED	PROPOXYCAINE HYDROCHLORIDE	11078	C16H27ClN2O3	330.853	\N	\N	2	5	10	64.8	22	0	295	0	0	\N	\N	CCCOC1=C(C=CC(=C1)N)C(=O)OCCN(CC)CC.Cl	2-(diethylamino)ethyl 4-amino-2-propoxy-benzoate;hydrochloride
7894	RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN	PROPOXYCAINE HYDROCHLORIDE	11078	C16H27ClN2O3	330.853	\N	\N	2	5	10	64.8	22	0	295	0	0	\N	\N	CCCOC1=C(C=CC(=C1)N)C(=O)OCCN(CC)CC.Cl	2-(diethylamino)ethyl 4-amino-2-propoxy-benzoate;hydrochloride
1996	COMPOUND 65	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
2175	DARVOCET	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
2179	DARVOCET-N 100	PROPOXYPHENE NAPSYLATE	28332	C32H37NO5S	547.71	\N	\N	1	6	10	92.3	39	0	688	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C.C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)O	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate;naphthalene-2-sulfonic acid
2181	DARVOCET-N 50	PROPOXYPHENE NAPSYLATE	28332	C32H37NO5S	547.71	\N	\N	1	6	10	92.3	39	0	688	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C.C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)O	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate;naphthalene-2-sulfonic acid
2191	DARVON-N	PROPOXYPHENE NAPSYLATE	28332	C32H37NO5S	547.71	\N	\N	1	6	10	92.3	39	0	688	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C.C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)O	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate;naphthalene-2-sulfonic acid
3151	ENDOSOL EXTRA	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
3895	HEMANGEOL	PROPRANOLOL HYDROCHLORIDE	62882	C16H22ClNO2	295.807	\N	\N	3	3	6	41.5	20	0	257	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl	1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol;hydrochloride
2815	DIONOSIL OILY	PROPYLIODONE	4949	C10H11I2NO3	447.011	\N	2.4	0	4	5	46.6	16	0	341	0	0	\N	\N	CCCOC(=O)CN1C=C(C(=O)C(=C1)I)I	propyl 2-(3,5-diiodo-4-oxo-1-pyridyl)acetate
8879	THYPINONE	PROTIRELIN	638678	C16H22N6O4	362.39	\N	-2.5	4	5	6	150	26	0	597	3	0	\N	\N	C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C(=O)N	(2S)-N-[(1S)-2-[(2S)-2-carbamoylpyrrolidin-1-yl]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
8880	THYREL TRH	PROTIRELIN	638678	C16H22N6O4	362.39	\N	-2.5	4	5	6	150	26	0	597	3	0	\N	\N	C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C(=O)N	(2S)-N-[(1S)-2-[(2S)-2-carbamoylpyrrolidin-1-yl]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
9680	VIVACTIL	PROTRIPTYLINE HYDROCHLORIDE	6603149	C19H22ClN	299.842	\N	\N	2	1	4	12	21	0	296	0	0	\N	\N	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13.Cl	3-(11H-dibenzo[1,2-a:1',2'-e][7]annulen-11-yl)-N-methyl-propan-1-amine;hydrochloride
92	ACTAHIST	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
103	ACTIFED	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
106	ACTIFED W/ CODEINE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
228	ADVIL ALLERGY SINUS	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
230	ADVIL COLD AND SINUS	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
330	ALEVE-D SINUS & COLD	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
347	ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
3804	GO-EVAC	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
1716	CLARITIN-D	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
1718	CLARITIN-D 24 HOUR	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
2400	DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
2837	DISOBROM	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
2840	DISOPHROL	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
3809	GOLYTELY	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
8025	RIFATER	PYRAZINAMIDE	1046	C5H5N3O	123.115	\N	-0.6	1	3	1	68.9	9	0	115	0	0	\N	\N	C1=CN=C(C=N1)C(=O)N	pyrazine-2-carboxamide
8015	RID MOUSSE	PYRETHRINS	71310221	C43H56O8	700.913	\N	\N	0	8	16	113	51	0	1390	3	3	\N	\N	CC1=C(C(=O)CC1OC(=O)C2C(C2(C)C)C=C(C)C)CC=CC=C.CC1=C(C(=O)CC1OC(=O)C2C(C2(C)C)C=C(C)C(=O)OC)CC=CC=C	[(1S)-2-methyl-4-oxo-3-[(2E)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;[2-methyl-4-oxo-3-[(2E)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1R)-3-[(E)-3-methoxy-2-methyl-3-oxo-prop-1-enyl]-2,2-dimethyl-cyclopropanecarboxylate
5430	MESTINON	PYRIDOSTIGMINE BROMIDE	7550	C9H13BrN2O2	261.119	\N	\N	0	3	2	33.4	14	0	183	0	0	\N	\N	C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-]	(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate;bromide
7808	PYRIDOSTIGMINE BROMIDE	PYRIDOSTIGMINE BROMIDE	7550	C9H13BrN2O2	261.119	\N	\N	0	3	2	33.4	14	0	183	0	0	\N	\N	C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-]	(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate;bromide
1057	BEROCCA PN	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
2916	DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
4287	INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)	PYRIDOXINE	1054	C8H11NO3	169.18	\N	-0.8	3	4	2	73.6	12	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol
7413	PREFRIN-A	PYRILAMINE MALEATE	5284451	C21H27N3O5	401.463	\N	\N	2	8	9	103	29	0	396	0	0	\N	\N	CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	maleic acid;N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-(2-pyridyl)ethane-1,2-diamine
7810	PYRILAMINE MALEATE	PYRILAMINE MALEATE	5284451	C21H27N3O5	401.463	\N	\N	2	8	9	103	29	0	396	0	0	\N	\N	CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	maleic acid;N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-(2-pyridyl)ethane-1,2-diamine
2168	DARAPRIM	PYRIMETHAMINE	4993	C12H13ClN4	248.714	\N	2.7	2	4	2	77.8	17	0	243	0	0	\N	\N	CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl	5-(4-chlorophenyl)-6-ethyl-pyrimidine-2,4-diamine
3422	FANSIDAR	PYRIMETHAMINE	4993	C12H13ClN4	248.714	\N	2.7	2	4	2	77.8	17	0	243	0	0	\N	\N	CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl	5-(4-chlorophenyl)-6-ethyl-pyrimidine-2,4-diamine
2885	DORAL	QUAZEPAM	4999	C17H11ClF4N2S	386.793	\N	4	0	6	2	47.7	25	0	539	0	0	\N	\N	C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F	7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine-2-thione
38	ACCURETIC	QUINAPRIL HYDROCHLORIDE	54891	C25H31ClN2O5	474.982	\N	\N	3	6	10	95.9	33	0	648	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O.Cl	(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
7843	QUINAPRIL HYDROCHLORIDE	QUINAPRIL HYDROCHLORIDE	54891	C25H31ClN2O5	474.982	\N	\N	3	6	10	95.9	33	0	648	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O.Cl	(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
3320	ESTROVIS	QUINESTROL	9046	C25H32O2	364.529	\N	5.3	1	2	3	29.5	27	0	613	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC5CCCC5	(8R,9S,13S,14S,17R)-3-(cyclopentoxy)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
4106	HYDROMOX R	QUINETHAZONE	6307	C10H12ClN3O3S	289.734	\N	1.2	3	5	2	110	18	0	436	0	1	\N	\N	CCC1NC2=CC(=C(C=C2C(=O)N1)S(=O)(=O)N)Cl	7-chloro-2-ethyl-4-oxo-2,3-dihydro-1H-quinazoline-6-sulfonamide
2982	DURAQUIN	QUINIDINE GLUCONATE	94328	C26H36N2O9	520.579	\N	\N	7	11	9	184	37	0	627	8	0	\N	\N	COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.C(C(C(C(C(C(=O)O)O)O)O)O)O	(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid
1414	CARDIOQUIN	QUINIDINE POLYGALACTURONATE	64641	C26H34N2O9	518.563	\N	\N	6	11	9	181	37	0	648	7	1	\N	\N	COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.C(=O)C(C(C(C(C(=O)O)O)O)O)O	(S)-(6-methoxy-4-quinolyl)-[(2R,5R)-5-vinylquinuclidin-2-yl]methanol;(2S,3R,4S,5R)-2,3,4,5-tetrahydroxy-6-oxo-hexanoic acid
6227	NUEDEXTA	QUINIDINE SULFATE	441074	C20H24N2O2	324.424	\N	2.9	1	4	4	45.6	24	0	457	4	0	\N	\N	COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O	(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol
7853	QUINORA	QUINIDINE SULFATE	441074	C20H24N2O2	324.424	\N	2.9	1	4	4	45.6	24	0	457	4	0	\N	\N	COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O	(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol
7823	QUALAQUIN	QUININE SULFATE	8549	C20H24N2O2	324.424	\N	2.9	1	4	4	45.6	24	0	457	3	1	\N	\N	COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O	(R)-(6-methoxy-4-quinolyl)-[(2S,5R)-5-vinylquinuclidin-2-yl]methanol
8628	SYNERCID	QUINUPRISTIN	5388937	C53H67N9O10S	1022.232	\N	4.2	4	14	10	257	73	0	2010	9	0	\N	\N	CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C	\N
8629	SYNERCID	QUINUPRISTIN	5388937	C53H67N9O10S	1022.232	\N	4.2	4	14	10	257	73	0	2010	9	0	\N	\N	CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C	\N
88	ACIPHEX	RABEPRAZOLE SODIUM	14720269	C18H20N3NaO3S	381.426	\N	\N	0	7	8	81.5	26	0	446	0	1	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCCCOC.[Na+]	sodium;2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]benzimidazol-1-ide
89	ACIPHEX SPRINKLE	RABEPRAZOLE SODIUM	14720269	C18H20N3NaO3S	381.426	\N	\N	0	7	8	81.5	26	0	446	0	1	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCCCOC.[Na+]	sodium;2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]benzimidazol-1-ide
7860	RABEPRAZOLE SODIUM	RABEPRAZOLE SODIUM	14720269	C18H20N3NaO3S	381.426	\N	\N	0	7	8	81.5	26	0	446	0	1	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCCCOC.[Na+]	sodium;2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]benzimidazol-1-ide
3365	EVISTA	RALOXIFENE HYDROCHLORIDE	54900	C28H28ClNO4S	510.045	\N	\N	3	6	7	98.2	35	0	655	0	0	\N	\N	C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O.Cl	[6-hydroxy-2-(4-hydroxyphenyl)benzothiophen-3-yl]-[4-[2-(1-piperidyl)ethoxy]phenyl]methanone;hydrochloride
7865	RALOXIFENE HYDROCHLORIDE	RALOXIFENE HYDROCHLORIDE	54900	C28H28ClNO4S	510.045	\N	\N	3	6	7	98.2	35	0	655	0	0	\N	\N	C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O.Cl	[6-hydroxy-2-(4-hydroxyphenyl)benzothiophen-3-yl]-[4-[2-(1-piperidyl)ethoxy]phenyl]methanone;hydrochloride
4427	ISENTRESS	RALTEGRAVIR POTASSIUM	23668479	C20H20FKN6O5	482.514	\N	\N	2	9	6	153	33	0	843	0	0	\N	\N	CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)[O-])C(=O)NCC3=CC=C(C=C3)F.[K+]	potassium;4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[1-methyl-1-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]ethyl]-6-oxo-pyrimidin-5-olate
7866	RALTEGRAVIR	RALTEGRAVIR	54671008	C20H21FN6O5	444.423	\N	1.1	3	9	6	150	32	0	836	0	0	\N	\N	CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F	N-[1-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxo-pyrimidin-2-yl]-1-methyl-ethyl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
7868	RAMIPRIL	RAMIPRIL	5362129	C23H32N2O5	416.518	\N	1.4	2	6	10	95.9	30	0	619	5	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O	(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid
7872	RANITIDINE HYDROCHLORIDE	RANITIDINE HYDROCHLORIDE	3033332	C13H23ClN4O3S	350.862	\N	\N	3	7	9	112	22	0	347	0	0	\N	\N	CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C.Cl	(E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furyl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine;hydrochloride
9814	ZANTAC 150	RANITIDINE HYDROCHLORIDE	3033332	C13H23ClN4O3S	350.862	\N	\N	3	7	9	112	22	0	347	0	0	\N	\N	CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C.Cl	(E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furyl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine;hydrochloride
9815	ZANTAC 25	RANITIDINE HYDROCHLORIDE	3033332	C13H23ClN4O3S	350.862	\N	\N	3	7	9	112	22	0	347	0	0	\N	\N	CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C.Cl	(E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furyl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine;hydrochloride
7869	RANEXA	RANOLAZINE	56959	C24H33N3O4	427.545	\N	2.7	2	6	9	74.3	31	0	531	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O	N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide
7873	RANOLAZINE	RANOLAZINE	56959	C24H33N3O4	427.545	\N	2.7	2	6	9	74.3	31	0	531	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O	N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide
7882	RAUDIXIN	RAUWOLFIA SERPENTINA ROOT	441975	C21H24N2O3	352.434	\N	2.7	1	4	2	54.6	26	0	606	4	0	\N	\N	CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45	\N
7883	RAUSERPIN	RAUWOLFIA SERPENTINA ROOT	441975	C21H24N2O3	352.434	\N	2.7	1	4	2	54.6	26	0	606	4	0	\N	\N	CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45	\N
4917	LEXISCAN	REGADENOSON	219024	C15H18N8O5	390.36	\N	-1.5	5	10	4	187	28	0	587	4	0	\N	\N	CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3C4C(C(C(O4)CO)O)O	1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-2-yl]-N-methyl-pyrazole-4-carboxamide
9376	ULTIVA	REMIFENTANIL HYDROCHLORIDE	60814	C20H29ClN2O5	412.911	\N	\N	1	6	9	76.2	28	0	523	0	0	\N	\N	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC.Cl	methyl 1-(3-methoxy-3-oxo-propyl)-4-(N-propanoylanilino)piperidine-4-carboxylate;hydrochloride
7372	PRANDIMET	REPAGLINIDE	65981	C27H36N2O4	452.595	\N	5.2	2	5	10	78.9	33	0	619	1	0	\N	\N	CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidyl)phenyl]butyl]amino]-2-oxo-ethyl]benzoic acid
7373	PRANDIN	REPAGLINIDE	65981	C27H36N2O4	452.595	\N	5.2	2	5	10	78.9	33	0	619	1	0	\N	\N	CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidyl)phenyl]butyl]amino]-2-oxo-ethyl]benzoic acid
7960	REPAGLINIDE	REPAGLINIDE	65981	C27H36N2O4	452.595	\N	5.2	2	5	10	78.9	33	0	619	1	0	\N	\N	CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidyl)phenyl]butyl]amino]-2-oxo-ethyl]benzoic acid
1665	CINNASIL	RESCINNAMINE	5280954	C35H42N2O9	634.726	\N	4.5	1	10	11	118	46	0	1080	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C=CC6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
1340	CAM-AP-ES	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
1617	CHLOROTHIAZIDE AND RESERPINE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
2013	COPEGUS	RIBAVIRIN	37542	C8H12N4O5	244.207	\N	-1.8	4	7	3	144	17	0	304	4	0	\N	\N	C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide
6720	PEGINTERFERON	RIBAVIRIN	37542	C8H12N4O5	244.207	\N	-1.8	4	7	3	144	17	0	304	4	0	\N	\N	C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide
6723	PEGINTRON/REBETOL COMBO PACK	RIBAVIRIN	37542	C8H12N4O5	244.207	\N	-1.8	4	7	3	144	17	0	304	4	0	\N	\N	C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide
7904	REBETOL	RIBAVIRIN	37542	C8H12N4O5	244.207	\N	-1.8	4	7	3	144	17	0	304	4	0	\N	\N	C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide
8013	RIBAVIRIN	RIBAVIRIN	37542	C8H12N4O5	244.207	\N	-1.8	4	7	3	144	17	0	304	4	0	\N	\N	C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide
9635	VIRAZOLE	RIBAVIRIN	37542	C8H12N4O5	244.207	\N	-1.8	4	7	3	144	17	0	304	4	0	\N	\N	C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide
1058	BEROCCA PN	RIBOFLAVIN 5'-PHOSPHATE SODIUM	23666409	C17H20N4NaO9P	478.33	\N	\N	5	10	7	204	32	0	856	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)[O-])O)O)O.[Na+]	sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentyl] hydrogen phosphate
5195	M.V.I. ADULT (PHARMACY BULK PACKAGE)	RIBOFLAVIN 5'-PHOSPHATE SODIUM	23666409	C17H20N4NaO9P	478.33	\N	\N	5	10	7	204	32	0	856	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)[O-])O)O)O.[Na+]	sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentyl] hydrogen phosphate
8047	RITODRINE HYDROCHLORIDE	RITODRINE HYDROCHLORIDE	31728	C17H22ClNO3	323.817	\N	\N	5	4	6	72.7	22	0	284	2	0	\N	\N	CC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O.Cl	4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl-ethyl]amino]ethyl]phenol;hydrochloride
4275	INFUVITE PEDIATRIC	RIBOFLAVIN	493570	C17H20N4O6	376.369	\N	-1.5	5	7	5	155	27	0	680	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O	7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione
4288	INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)	RIBOFLAVIN	493570	C17H20N4O6	376.369	\N	-1.5	5	7	5	155	27	0	680	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O	7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione
9670	VITAPED	RIBOFLAVIN	493570	C17H20N4O6	376.369	\N	-1.5	5	7	5	155	27	0	680	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O	7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione
8017	RIFABUTIN	RIFABUTIN	6323490	C46H62N4O11	847.019	\N	6.3	5	14	5	206	61	0	1870	9	0	\N	\N	CC1C=CC=C(C(=O)NC2=C3C(=NC4(N3)CCN(CC4)CC(C)C)C5=C6C(=C(C(=C5C2=O)O)C)OC(C6=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C	\N
8020	RIFAMATE	RIFAMPIN	5381226	C43H58N4O12	822.953	\N	4	6	15	5	217	59	0	1750	9	0	\N	\N	CC1C=CC=C(C(=O)NC2=C(C3=C(C(=C4C(=C3C(=O)C2=CNN5CCN(CC5)C)C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C	\N
8021	RIFAMPIN	RIFAMPIN	5381226	C43H58N4O12	822.953	\N	4	6	15	5	217	59	0	1750	9	0	\N	\N	CC1C=CC=C(C(=O)NC2=C(C3=C(C(=C4C(=C3C(=O)C2=CNN5CCN(CC5)C)C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C	\N
8023	RIFAMPIN AND ISONIAZID	RIFAMPIN	5381226	C43H58N4O12	822.953	\N	4	6	15	5	217	59	0	1750	9	0	\N	\N	CC1C=CC=C(C(=O)NC2=C(C3=C(C(=C4C(=C3C(=O)C2=CNN5CCN(CC5)C)C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C	\N
8026	RIFATER	RIFAMPIN	5381226	C43H58N4O12	822.953	\N	4	6	15	5	217	59	0	1750	9	0	\N	\N	CC1C=CC=C(C(=O)NC2=C(C3=C(C(=C4C(=C3C(=O)C2=CNN5CCN(CC5)C)C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C	\N
8030	RIMACTANE	RIFAMPIN	5381226	C43H58N4O12	822.953	\N	4	6	15	5	217	59	0	1750	9	0	\N	\N	CC1C=CC=C(C(=O)NC2=C(C3=C(C(=C4C(=C3C(=O)C2=CNN5CCN(CC5)C)C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C	\N
7466	PRIFTIN	RIFAPENTINE	6323497	C47H64N4O12	877.045	\N	5.8	6	15	6	217	63	0	1870	9	0	\N	\N	CC1C=CC=C(C(=O)NC2=C(C3=C(C(=C4C(=C3C(=O)C2=CNN5CCN(CC5)C6CCCC6)C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C	\N
9761	XIFAXAN	RIFAXIMIN	6436173	C43H51N3O11	785.891	\N	6.9	5	12	3	198	57	0	1590	9	0	\N	\N	CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C	\N
1992	COMPLERA	RILPIVIRINE HYDROCHLORIDE	11711114	C22H19ClN6	402.886	\N	\N	3	6	5	97.4	29	0	607	0	0	\N	\N	CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N.Cl	4-[[4-[4-[(E)-2-cyanovinyl]-2,6-dimethyl-anilino]pyrimidin-2-yl]amino]benzonitrile;hydrochloride
6300	ODEFSEY	RILPIVIRINE HYDROCHLORIDE	11711114	C22H19ClN6	402.886	\N	\N	3	6	5	97.4	29	0	607	0	0	\N	\N	CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N.Cl	4-[[4-[4-[(E)-2-cyanovinyl]-2,6-dimethyl-anilino]pyrimidin-2-yl]amino]benzonitrile;hydrochloride
8028	RILUTEK	RILUZOLE	5070	C8H5F3N2OS	234.196	\N	3.6	1	7	1	76.4	15	0	238	0	0	\N	\N	C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N	6-(trifluoromethoxy)-1,3-benzothiazol-2-amine
8029	RILUZOLE	RILUZOLE	5070	C8H5F3N2OS	234.196	\N	3.6	1	7	1	76.4	15	0	238	0	0	\N	\N	C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N	6-(trifluoromethoxy)-1,3-benzothiazol-2-amine
9571	VEXOL	RIMEXOLONE	5311412	C24H34O3	370.533	\N	3.5	1	3	2	54.4	27	0	749	8	0	\N	\N	CCC(=O)C1(C(CC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C)C	(8S,9S,10R,11S,13S,14S,16R,17S)-11-hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
117	ACTONEL	RISEDRONATE SODIUM	4194514	C7H10NNaO7P2	305.094	\N	\N	4	8	4	151	18	0	375	0	1	\N	\N	C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+]	sodium;hydroxy-[1-hydroxy-1-phosphono-2-(3-pyridyl)ethyl]phosphinate
119	ACTONEL WITH CALCIUM (COPACKAGED)	RISEDRONATE SODIUM	4194514	C7H10NNaO7P2	305.094	\N	\N	4	8	4	151	18	0	375	0	1	\N	\N	C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+]	sodium;hydroxy-[1-hydroxy-1-phosphono-2-(3-pyridyl)ethyl]phosphinate
822	ATELVIA	RISEDRONATE SODIUM	4194514	C7H10NNaO7P2	305.094	\N	\N	4	8	4	151	18	0	375	0	1	\N	\N	C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+]	sodium;hydroxy-[1-hydroxy-1-phosphono-2-(3-pyridyl)ethyl]phosphinate
8040	RISPERDAL	RISPERIDONE	5073	C23H27FN4O2	410.493	\N	2.7	0	6	4	61.9	30	0	731	0	0	\N	\N	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
8041	RISPERDAL CONSTA	RISPERIDONE	5073	C23H27FN4O2	410.493	\N	2.7	0	6	4	61.9	30	0	731	0	0	\N	\N	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
8042	RISPERIDONE	RISPERIDONE	5073	C23H27FN4O2	410.493	\N	2.7	0	6	4	61.9	30	0	731	0	0	\N	\N	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
818	ATAZANAVIR SULFATE AND RITONAVIR	RITONAVIR	392622	C37H48N6O5S2	720.948	\N	6	4	9	18	202	50	0	1040	4	0	\N	\N	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	thiazol-5-ylmethyl N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-5-phenyl-pentyl]carbamate
9743	XARELTO	RIVAROXABAN	9875401	C19H18ClN3O5S	435.879	\N	2.5	1	6	5	116	29	0	645	1	0	\N	\N	C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl	5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl]methyl]thiophene-2-carboxamide
5319	MAXALT	RIZATRIPTAN BENZOATE	77997	C22H25N5O2	391.475	\N	\N	2	5	6	87	29	0	412	0	0	\N	\N	CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O	benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine
5320	MAXALT-MLT	RIZATRIPTAN BENZOATE	77997	C22H25N5O2	391.475	\N	\N	2	5	6	87	29	0	412	0	0	\N	\N	CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O	benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine
8054	RIZATRIPTAN BENZOATE	RIZATRIPTAN BENZOATE	77997	C22H25N5O2	391.475	\N	\N	2	5	6	87	29	0	412	0	0	\N	\N	CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O	benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine
8069	ROCURONIUM BROMIDE	ROCURONIUM BROMIDE	441351	C32H53BrN2O4	609.69	\N	\N	1	6	6	59	39	0	898	10	0	\N	\N	CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-]	[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-16-(1-allylpyrrolidin-1-ium-1-yl)-3-hydroxy-10,13-dimethyl-2-morpholino-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate;bromide
9840	ZEMURON	ROCURONIUM BROMIDE	441351	C32H53BrN2O4	609.69	\N	\N	1	6	6	59	39	0	898	10	0	\N	\N	CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-]	[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-16-(1-allylpyrrolidin-1-ium-1-yl)-3-hydroxy-10,13-dimethyl-2-morpholino-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate;bromide
2157	DALIRESP	ROFLUMILAST	449193	C17H14Cl2F2N2O3	403.207	\N	4.6	1	6	7	60.4	26	0	475	0	0	\N	\N	C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F	3-(cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridyl)-4-(difluoromethoxy)benzamide
9493	VARUBI	ROLAPITANT HYDROCHLORIDE	16203739	C25H29ClF6N2O3	554.958	\N	\N	4	10	5	51.4	37	0	731	3	0	\N	\N	CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OCC2(CCC3(CCC(=O)N3)CN2)C4=CC=CC=C4.O.Cl	(5S,8S)-8-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-8-phenyl-1,9-diazaspiro[4.5]decan-2-one;hydrate;hydrochloride
4555	ISTODAX	ROMIDEPSIN	5352062	C24H36N4O6S2	540.694	\N	2.2	4	8	2	193	36	0	905	4	0	\N	\N	CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C	(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
6221	NPLATE	ROMIPLOSTIM	5329098	C15H14N2O	238.29	\N	2.5	2	1	1	44.9	18	0	377	0	0	\N	\N	CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C	(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]indolin-2-one
7968	REQUIP XL	ROPINIROLE HYDROCHLORIDE	68727	C16H25ClN2O	296.839	\N	\N	2	2	7	32.3	20	0	287	0	0	\N	\N	CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1.Cl	4-[2-(dipropylamino)ethyl]indolin-2-one;hydrochloride
8076	ROPINIROLE HYDROCHLORIDE	ROPINIROLE HYDROCHLORIDE	68727	C16H25ClN2O	296.839	\N	\N	2	2	7	32.3	20	0	287	0	0	\N	\N	CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1.Cl	4-[2-(dipropylamino)ethyl]indolin-2-one;hydrochloride
8077	ROPIVACAINE HYDROCHLORIDE	ROPIVACAINE HYDROCHLORIDE	175804	C17H27ClN2O	310.866	\N	\N	2	2	4	32.3	21	0	308	1	0	\N	\N	CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	(2S)-N-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide;hydrochloride
882	AVANDARYL	ROSIGLITAZONE MALEATE	5281055	C22H23N3O7S	473.5	\N	\N	3	10	9	171	33	0	588	0	1	\N	\N	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O	maleic acid;5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione
2078	CRESTOR	ROSUVASTATIN CALCIUM	5282455	C44H54CaF2N6O12S2	1001.141	\N	\N	4	20	18	304	67	0	761	4	0	\N	\N	CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Ca+2]	calcium;(E,3R,5S)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoate
8087	ROSUVASTATIN ZINC	ROSUVASTATIN ZINC	446157	C22H28FN3O6S	481.539	\N	1.6	3	10	10	149	33	0	767	2	0	\N	\N	CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	(E,3R,5S)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid
5971	NEUPRO	ROTIGOTINE	59227	C19H25NOS	315.475	\N	4.9	1	3	6	51.7	22	0	337	1	0	\N	\N	CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O	(2S)-2-[propyl-[2-(2-thienyl)ethyl]amino]tetralin-5-ol
8115	RUFINAMIDE	RUFINAMIDE	129228	C10H8F2N4O	238.198	\N	0.7	1	5	3	73.8	17	0	282	0	0	\N	\N	C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F	1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide
4566	JAKAFI	RUXOLITINIB PHOSPHATE	25127112	C17H21N6O4P	404.367	\N	\N	4	8	4	161	28	0	503	1	0	\N	\N	C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OP(=O)(O)O	(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile;phosphoric acid
214	ADVAIR DISKUS 100/50	SALMETEROL XINAFOATE	56801	C36H45NO7	603.756	\N	\N	6	8	17	140	44	0	629	0	1	\N	\N	C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O.C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O	2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol;1-hydroxynaphthalene-2-carboxylic acid
216	ADVAIR DISKUS 250/50	SALMETEROL XINAFOATE	56801	C36H45NO7	603.756	\N	\N	6	8	17	140	44	0	629	0	1	\N	\N	C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O.C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O	2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol;1-hydroxynaphthalene-2-carboxylic acid
218	ADVAIR DISKUS 500/50	SALMETEROL XINAFOATE	56801	C36H45NO7	603.756	\N	\N	6	8	17	140	44	0	629	0	1	\N	\N	C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O.C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O	2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol;1-hydroxynaphthalene-2-carboxylic acid
220	ADVAIR HFA	SALMETEROL XINAFOATE	56801	C36H45NO7	603.756	\N	\N	6	8	17	140	44	0	629	0	1	\N	\N	C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O.C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O	2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol;1-hydroxynaphthalene-2-carboxylic acid
7822	QUADRAMET	SAMARIUM SM-153 LEXIDRONAM PENTASODIUM	56841803	C6H16N2Na5O12P4Sm+	699.962	\N	\N	4	14	0	248	30	1	483	0	0	\N	\N	C(CN(CP(=O)(O)[O-])CP(=O)(O)[O-])N(CP(=O)(O)[O-])CP(=O)(O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Sm]	pentasodium;[2-[bis[[hydroxy(oxido)phosphoryl]methyl]amino]ethyl-[[hydroxy(oxido)phosphoryl]methyl]amino]methyl-hydroxy-phosphinate;samarium-153
4706	KUVAN	SAPROPTERIN DIHYDROCHLORIDE	636369	C9H17Cl2N5O3	314.167	\N	\N	8	5	2	132	19	0	405	3	0	\N	\N	CC(C(C1CNC2=C(N1)C(=O)N=C(N2)N)O)O.Cl.Cl	(6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-5,6,7,8-tetrahydro-1H-pteridin-4-one;dihydrochloride
4367	INVIRASE	SAQUINAVIR MESYLATE	60934	C39H54N6O8S	766.955	\N	\N	6	10	13	230	54	0	1230	6	0	\N	\N	CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O.CS(=O)(=O)O	(2S)-N-[(1S,2R)-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-1-benzyl-2-hydroxy-propyl]-2-(quinoline-2-carbonylamino)butanediamide;methanesulfonic acid
3625	FORTOVASE	SAQUINAVIR	441243	C38H50N6O5	670.855	\N	4.2	5	7	13	167	49	0	1140	6	0	\N	\N	CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O	(2S)-N-[(1S,2R)-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-1-benzyl-2-hydroxy-propyl]-2-(quinoline-2-carbonylamino)butanediamide
8155	SARENIN	SARALASIN ACETATE	11954381	C44H71N13O13	990.13	\N	\N	14	16	25	396	70	0	1700	7	0	\N	\N	CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)C)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)NC(C)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)CNC.CC(=O)O.O	acetic acid;(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-guanidino-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methyl-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methyl-butanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid;hydrate
4697	KOMBIGLYZE XR	SAXAGLIPTIN HYDROCHLORIDE	49800073	C18H26ClN3O2	351.875	\N	\N	3	4	2	90.4	24	0	609	4	2	\N	\N	C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N.Cl	(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;hydrochloride
8178	SECOBARBITAL SODIUM	SECOBARBITAL SODIUM	14148199	C12H17N2NaO3	260.269	\N	\N	1	4	5	64.2	18	0	370	0	2	\N	\N	CCCC(C)C1(C(=O)NC(=O)[N-]C1=O)CC=C.[Na+]	sodium;5-allyl-5-(1-methylbutyl)hexahydropyrimidin-3-ide-2,4,6-trione
3076	ELDEPRYL	SELEGILINE HYDROCHLORIDE	26758	C13H18ClN	223.744	\N	\N	1	1	4	3.2	15	0	195	1	0	\N	\N	CC(CC1=CC=CC=C1)N(C)CC#C.Cl	(2R)-N-methyl-1-phenyl-N-prop-2-ynyl-propan-2-amine;hydrochloride
3131	EMSAM	SELEGILINE	26757	C13H17N	187.286	\N	2.8	0	1	4	3.2	14	0	195	1	0	\N	\N	CC(CC1=CC=CC=C1)N(C)CC#C	(2R)-N-methyl-1-phenyl-N-prop-2-ynyl-propan-2-amine
8192	SELSUN	SELENIUM SULFIDE	24011	SSe	111.031	\N	\N	0	1	0	32.1	2	0	2	0	0	\N	\N	S=[Se]	\N
3743	GEREF	SERMORELIN ACETATE	16132412	C151H250N44O44S	3417.985	\N	\N	53	51	118	1510	240	0	7670	31	0	\N	\N	CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N.CC(=O)O	\N
7934	RENAGEL	SEVELAMER HYDROCHLORIDE	159247	C6H13Cl2NO	186.076	\N	\N	2	2	2	38.6	10	0	55.1	0	1	\N	\N	C=CCN.C1C(O1)CCl.Cl	2-(chloromethyl)oxirane;prop-2-en-1-amine;hydrochloride
8348	SOJOURN	SEVOFLURANE	5206	C4H3F7O	200.056	\N	2.8	0	8	2	9.2	12	0	121	0	0	\N	\N	C(OC(C(F)(F)F)C(F)(F)F)F	1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane
9375	ULTANE	SEVOFLURANE	5206	C4H3F7O	200.056	\N	2.8	0	8	2	9.2	12	0	121	0	0	\N	\N	C(OC(C(F)(F)F)C(F)(F)F)F	1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane
7874	RAPAFLO	SILODOSIN	5312125	C25H32F3N3O4	495.543	\N	3.6	3	9	13	97	35	0	654	1	0	\N	\N	CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F	1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]indoline-7-carboxamide
8255	SILODOSIN	SILODOSIN	5312125	C25H32F3N3O4	495.543	\N	3.6	3	9	13	97	35	0	654	1	0	\N	\N	CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F	1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]indoline-7-carboxamide
8252	SILDAFLO	SILVER SULFADIAZINE	441244	C10H9AgN4O2S	357.136	\N	\N	1	6	3	95.3	18	0	327	0	0	\N	\N	C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ag+]	silver;(4-aminophenyl)sulfonyl-pyrimidin-2-yl-azanide
8257	SILVADENE	SILVER SULFADIAZINE	441244	C10H9AgN4O2S	357.136	\N	\N	1	6	3	95.3	18	0	327	0	0	\N	\N	C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ag+]	silver;(4-aminophenyl)sulfonyl-pyrimidin-2-yl-azanide
8418	SSD AF	SILVER SULFADIAZINE	441244	C10H9AgN4O2S	357.136	\N	\N	1	6	3	95.3	18	0	327	0	0	\N	\N	C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ag+]	silver;(4-aminophenyl)sulfonyl-pyrimidin-2-yl-azanide
8863	THERMAZENE	SILVER SULFADIAZINE	441244	C10H9AgN4O2S	357.136	\N	\N	1	6	3	95.3	18	0	327	0	0	\N	\N	C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ag+]	silver;(4-aminophenyl)sulfonyl-pyrimidin-2-yl-azanide
6333	OLYSIO	SIMEPREVIR SODIUM	24873435	C38H47N5O7S2	749.942	\N	4.8	2	10	8	194	52	0	1490	5	0	\N	\N	CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC	\N
3403	EZETIMIBE; SIMVASTATIN	SIMVASTATIN	54454	C25H38O5	418.574	\N	4.7	1	5	7	72.8	30	0	706	7	0	\N	\N	CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C	[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
4598	JUVISYNC	SIMVASTATIN	54454	C25H38O5	418.574	\N	4.7	1	5	7	72.8	30	0	706	7	0	\N	\N	CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C	[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
4681	KINEVAC	SINCALIDE	9833444	C49H62N10O16S3	1143.269	\N	-2.6	13	19	33	486	78	0	2180	7	0	\N	\N	CSCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CC(=O)O)N	(3S)-3-amino-4-[[(1S)-2-[[(1S)-1-[[2-[[(1S)-2-[[(1S)-1-[[(1S)-2-[[(1S)-2-amino-1-benzyl-2-oxo-ethyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-2-oxo-1-[(4-sulfooxyphenyl)methyl]ethyl]amino]-4-oxo-butanoic acid
8274	SIROLIMUS	SIROLIMUS	5284616	C51H79NO13	914.187	\N	6	3	13	6	195	65	0	1760	15	0	\N	\N	CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC	\N
4572	JANUMET	SITAGLIPTIN PHOSPHATE	6451150	C16H18F6N5O5P	505.314	\N	\N	4	14	4	155	33	0	616	1	0	\N	\N	C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.OP(=O)(O)O	(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid
4574	JANUMET XR	SITAGLIPTIN PHOSPHATE	6451150	C16H18F6N5O5P	505.314	\N	\N	4	14	4	155	33	0	616	1	0	\N	\N	C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.OP(=O)(O)O	(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid
4575	JANUVIA	SITAGLIPTIN PHOSPHATE	6451150	C16H18F6N5O5P	505.314	\N	\N	4	14	4	155	33	0	616	1	0	\N	\N	C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.OP(=O)(O)O	(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid
975	BALANCED SALT	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
1828	CLINIMIX E 5/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
1835	CLINIMIX E 5/15 SULFITE FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
1842	CLINIMIX E 5/20 SULFITE FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
1856	CLINIMIX E 5/35 SULFITE FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
3656	FREAMINE III 8.5% W/ ELECTROLYTES	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4475	ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
5682	MOVIPREP	SODIUM ASCORBATE	23667548	C6H7NaO6	198.106	\N	\N	3	6	2	110	13	0	237	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)[O-])O)O.[Na+]	sodium;(2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-olate
6709	PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID	SODIUM ASCORBATE	23667548	C6H7NaO6	198.106	\N	\N	3	6	2	110	13	0	237	2	0	\N	\N	C(C(C1C(=C(C(=O)O1)O)[O-])O)O.[Na+]	sodium;(2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-olate
8334	SODIUM PHENYLACETATE AND SODIUM BENZOATE	SODIUM BENZOATE	517055	C7H5NaO2	144.105	\N	\N	0	2	1	40.1	10	0	108	0	0	\N	\N	C1=CC=C(C=C1)C(=O)[O-].[Na+]	sodium;benzoate
993	BAROS	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
4426	IRRIGATING SOLUTION G IN PLASTIC CONTAINER	SODIUM CARBONATE	10340	CNa2O3	105.988	\N	\N	0	3	0	63.2	6	0	18.8	0	0	\N	\N	C(=O)([O-])[O-].[Na+].[Na+]	disodium;carbonate
9423	UROLOGIC G IN PLASTIC CONTAINER	SODIUM CARBONATE	10340	CNa2O3	105.988	\N	\N	0	3	0	63.2	6	0	18.8	0	0	\N	\N	C(=O)([O-])[O-].[Na+].[Na+]	disodium;carbonate
455	AMINOSYN 3.5% M IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
468	AMINOSYN 7% W/ ELECTROLYTES	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
474	AMINOSYN 8.5% W/ ELECTROLYTES	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
481	AMINOSYN II 10% W/ ELECTROLYTES	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
492	AMINOSYN II 3.5% M	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
498	AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
503	AMINOSYN II 3.5% M IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
510	AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
556	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
566	AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
976	BALANCED SALT	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1231	BSS PLUS	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1787	CLINIMIX E 2.75/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1965	COLYTE WITH FLAVOR PACKS	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1648	CHROMITOPE SODIUM	SODIUM CHROMATE CR-51	3080662	CrNa2O4	160.92	\N	\N	0	4	0	80.3	7	0	62.2	0	0	\N	\N	[O-][Cr](=O)(=O)[O-].[Na+].[Na+]	disodium;dioxido(dioxo)chromium-51
6157	NORMOSOL-R IN PLASTIC CONTAINER	SODIUM GLUCONATE	23672301	C6H11NaO7	218.137	\N	\N	5	7	5	141	14	0	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+]	sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
6960	PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER	SODIUM GLUCONATE	23672301	C6H11NaO7	218.137	\N	\N	5	7	5	141	14	0	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+]	sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
4611	KABIVEN IN PLASTIC CONTAINER	SODIUM GLYCEROPHOSPHATE	14754	C3H7Na2O6P	216.036	\N	\N	2	6	3	113	12	0	117	0	1	\N	\N	C(C(COP(=O)([O-])[O-])O)O.[Na+].[Na+]	disodium;2,3-dihydroxypropyl phosphate
2251	DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2256	DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2261	DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2286	DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
3397	EXTRA-STRENGTH AIM	SODIUM MONOFLUOROPHOSPHATE	24266	FNa2O3P	143.949	\N	\N	0	4	0	63.2	7	0	49.8	0	0	\N	\N	[O-]P(=O)([O-])F.[Na+].[Na+]	disodium;fluoro-dioxido-oxo-$l^{5}-phosphane
620	AMMONUL	SODIUM PHENYLACETATE	23690424	C8H7NaO2	158.132	\N	\N	0	2	2	40.1	11	0	119	0	0	\N	\N	C1=CC=C(C=C1)CC(=O)[O-].[Na+]	sodium;2-phenylacetate
6878	PHOSPHOTOPE	SODIUM PHOSPHATE P-32	71180	HNa2O4P	142.957	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[Na+].[Na+]	disodium;hydroxy-dioxido-oxo-$l^{5}-phosphane
5659	MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	24203	HNa2O4P	141.957	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[Na+].[Na+]	disodium;hydrogen phosphate
4389	IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM PHOSPHATE, MONOBASIC ANHYDROUS	23672064	H2NaO4P	119.976	\N	\N	2	4	0	80.6	6	0	61.9	0	0	\N	\N	OP(=O)(O)[O-].[Na+]	sodium;dihydrogen phosphate
4394	IONOSOL T AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM PHOSPHATE, MONOBASIC ANHYDROUS	23672064	H2NaO4P	119.976	\N	\N	2	4	0	80.6	6	0	61.9	0	0	\N	\N	OP(=O)(O)[O-].[Na+]	sodium;dihydrogen phosphate
8339	SODIUM PHOSPHATES IN PLASTIC CONTAINER	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	23672064	H2NaO4P	119.976	\N	\N	2	4	0	80.6	6	0	61.9	0	0	\N	\N	OP(=O)(O)[O-].[Na+]	sodium;dihydrogen phosphate
1232	BSS PLUS	SODIUM PHOSPHATE	24243	Na3O4P	163.939	\N	\N	0	4	0	86.2	8	0	36.8	0	0	\N	\N	[O-]P(=O)([O-])[O-].[Na+].[Na+].[Na+]	trisodium;phosphate
3153	ENDOSOL EXTRA	SODIUM PHOSPHATE	24243	Na3O4P	163.939	\N	\N	0	4	0	86.2	8	0	36.8	0	0	\N	\N	[O-]P(=O)([O-])[O-].[Na+].[Na+].[Na+]	trisodium;phosphate
7434	PREPOPIK	SODIUM PICOSULFATE	68654	C18H13NNa2O8S2	481.401	\N	\N	0	9	5	163	31	0	633	0	0	\N	\N	C1=CC=NC(=C1)C(C2=CC=C(C=C2)OS(=O)(=O)[O-])C3=CC=C(C=C3)OS(=O)(=O)[O-].[Na+].[Na+]	disodium;[4-[2-pyridyl-(4-sulfonatooxyphenyl)methyl]phenyl] sulfate
1961	COLYTE	SODIUM SULFATE ANHYDROUS	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
1966	COLYTE WITH FLAVOR PACKS	SODIUM SULFATE ANHYDROUS	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
5684	MOVIPREP	SODIUM SULFATE	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
6282	OCL	SODIUM SULFATE	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
6711	PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID	SODIUM SULFATE	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
8388	SOTRADECOL	SODIUM TETRADECYL SULFATE	23665770	C14H29NaO4S	316.432	\N	\N	0	4	14	74.8	20	0	275	0	0	\N	\N	CCCCCCCCCCCCCCOS(=O)(=O)[O-].[Na+]	sodium;tetradecyl sulfate
6016	NITHIODOTE	SODIUM THIOSULFATE	24477	Na2O3S2	158.097	\N	\N	0	4	0	104	7	0	82.6	0	0	\N	\N	[O-]S(=O)(=S)[O-].[Na+].[Na+]	disodium;dioxido-oxo-thioxo-$l^{6}-sulfane
8347	SODIUM THIOSULFATE	SODIUM THIOSULFATE	24477	Na2O3S2	158.097	\N	\N	0	4	0	104	7	0	82.6	0	0	\N	\N	[O-]S(=O)(=S)[O-].[Na+].[Na+]	disodium;dioxido-oxo-thioxo-$l^{6}-sulfane
3193	EPCLUSA	SOFOSBUVIR	45375808	C22H29FN3O9P	529.458	\N	1	3	11	11	153	36	0	913	6	0	\N	\N	CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3	isopropyl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydrofuran-2-yl]methoxy-phenoxy-phosphoryl]amino]propanoate
8391	SOVALDI	SOFOSBUVIR	45375808	C22H29FN3O9P	529.458	\N	1	3	11	11	153	36	0	913	6	0	\N	\N	CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3	isopropyl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydrofuran-2-yl]methoxy-phenoxy-phosphoryl]amino]propanoate
8353	SOLIFENACIN SUCCINATE	SOLIFENACIN SUCCINATE	216457	C27H32N2O6	480.561	\N	\N	2	7	6	107	35	0	617	2	0	\N	\N	C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5.C(CC(=O)O)C(=O)O	[(3R)-quinuclidin-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate;succinic acid
9568	VESICARE	SOLIFENACIN SUCCINATE	216457	C27H32N2O6	480.561	\N	\N	2	7	6	107	35	0	617	2	0	\N	\N	C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5.C(CC(=O)O)C(=O)O	[(3R)-quinuclidin-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate;succinic acid
6302	ODOMZO	SONIDEGIB PHOSPHATE	45138699	C26H32F3N3O11P2	681.495	\N	\N	7	16	5	219	45	0	741	2	0	\N	\N	CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F.OP(=O)(O)O.OP(=O)(O)O	N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-3-pyridyl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide;phosphoric acid
5980	NEXAVAR	SORAFENIB TOSYLATE	406563	C28H24ClF3N4O6S	637.027	\N	\N	4	10	6	155	43	0	853	0	0	\N	\N	CC1=CC=C(C=C1)S(=O)(=O)O.CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide;4-methylbenzenesulfonic acid
8376	SORBITOL 3% IN PLASTIC CONTAINER	SORBITOL	5780	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol
8377	SORBITOL 3.3% IN PLASTIC CONTAINER	SORBITOL	5780	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol
8379	SORBITOL-MANNITOL	SORBITOL	5780	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol
8381	SORBITOL-MANNITOL IN PLASTIC CONTAINER	SORBITOL	5780	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol
1077	BETAPACE	SOTALOL HYDROCHLORIDE	66245	C12H21ClN2O3S	308.821	\N	\N	4	5	6	86.8	19	0	330	0	1	\N	\N	CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.Cl	N-[4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide;hydrochloride
1078	BETAPACE AF	SOTALOL HYDROCHLORIDE	66245	C12H21ClN2O3S	308.821	\N	\N	4	5	6	86.8	19	0	330	0	1	\N	\N	CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.Cl	N-[4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide;hydrochloride
8387	SOTALOL HYDROCHLORIDE	SOTALOL HYDROCHLORIDE	66245	C12H21ClN2O3S	308.821	\N	\N	4	5	6	86.8	19	0	330	0	1	\N	\N	CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.Cl	N-[4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide;hydrochloride
9808	ZAGAM	SPARFLOXACIN	60464	C19H22F2N4O3	392.407	\N	0.1	3	9	3	98.9	28	0	691	2	0	\N	\N	CC1CN(CC(N1)C)C2=C(C3=C(C(=C2F)N)C(=O)C(=CN3C4CC4)C(=O)O)F	5-amino-1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-quinoline-3-carboxylic acid
7949	RENORMAX	SPIRAPRIL HYDROCHLORIDE	6850814	C22H31ClN2O5S2	503.069	\N	\N	3	8	10	147	32	0	650	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3(CC2C(=O)O)SCCS3.Cl	(8S)-7-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid;hydrochloride
305	ALDACTONE	SPIRONOLACTONE	5833	C24H32O4S	416.576	\N	2.9	0	5	2	85.7	29	0	818	7	0	\N	\N	CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C	S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxo-spiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-tetrahydrofuran]-7-yl] ethanethioate
8838	THEOBID	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
9726	WINSTROL	STANOZOLOL	25249	C21H32N2O	328.5	\N	4.5	2	2	0	48.9	24	0	538	7	0	\N	\N	CC12CCC3C(C1CCC2(C)O)CCC4C3(CC5=C(C4)NN=C5)C	\N
4768	LAMIVUDINE; STAVUDINE; NEVIRAPINE	STAVUDINE	18283	C10H12N2O4	224.216	\N	-0.8	2	4	2	78.9	16	0	388	2	0	\N	\N	CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO	1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
8450	STAVUDINE; LAMIVUDINE W/NEVIRAPINE	STAVUDINE	18283	C10H12N2O4	224.216	\N	-0.8	2	4	2	78.9	16	0	388	2	0	\N	\N	CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO	1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
8453	STAVUDINE; LAMIVUDINE; EFAVIRENZ	STAVUDINE	18283	C10H12N2O4	224.216	\N	-0.8	2	4	2	78.9	16	0	388	2	0	\N	\N	CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO	1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
960	BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER	STERILE WATER FOR INJECTION	962	H2O	18.015	\N	-0.5	1	1	0	1	1	0	0	0	0	\N	\N	O	water
8470	STERILE WATER FOR INJECTION IN PLASTIC CONTAINER	STERILE WATER FOR INJECTION	962	H2O	18.015	\N	-0.5	1	1	0	1	1	0	0	0	0	\N	\N	O	water
8471	STERILE WATER IN PLASTIC CONTAINER	STERILE WATER FOR IRRIGATION	962	H2O	18.015	\N	-0.5	1	1	0	1	1	0	0	0	0	\N	\N	O	water
8484	STREPTOMYCIN SULFATE	STREPTOMYCIN SULFATE	19649	C21H39N7O12	581.58	\N	-8	12	15	9	336	40	0	940	15	0	\N	\N	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[(1S,2R,3R,4S,5R,6R)-2-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)tetrahydropyran-2-yl]oxy-4-formyl-4-hydroxy-5-methyl-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine
9812	ZANOSAR	STREPTOZOCIN	29327	C8H15N3O7	265.222	\N	-1.4	5	8	2	152	18	0	315	5	0	\N	\N	CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O	1-methyl-1-nitroso-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]urea
667	ANECTINE	SUCCINYLCHOLINE CHLORIDE	22475	C14H30Cl2N2O4	361.304	\N	\N	0	6	11	52.6	22	0	284	0	0	\N	\N	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]	trimethyl-[2-[4-oxo-4-[2-(trimethylammonio)ethoxy]butanoyl]oxyethyl]ammonium;dichloride
7830	QUELICIN	SUCCINYLCHOLINE CHLORIDE	22475	C14H30Cl2N2O4	361.304	\N	\N	0	6	11	52.6	22	0	284	0	0	\N	\N	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]	trimethyl-[2-[4-oxo-4-[2-(trimethylammonio)ethoxy]butanoyl]oxyethyl]ammonium;dichloride
7831	QUELICIN PRESERVATIVE FREE	SUCCINYLCHOLINE CHLORIDE	22475	C14H30Cl2N2O4	361.304	\N	\N	0	6	11	52.6	22	0	284	0	0	\N	\N	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]	trimethyl-[2-[4-oxo-4-[2-(trimethylammonio)ethoxy]butanoyl]oxyethyl]ammonium;dichloride
8499	SUCCINYLCHOLINE CHLORIDE	SUCCINYLCHOLINE CHLORIDE	22475	C14H30Cl2N2O4	361.304	\N	\N	0	6	11	52.6	22	0	284	0	0	\N	\N	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]	trimethyl-[2-[4-oxo-4-[2-(trimethylammonio)ethoxy]butanoyl]oxyethyl]ammonium;dichloride
8507	SUCOSTRIN	SUCCINYLCHOLINE CHLORIDE	22475	C14H30Cl2N2O4	361.304	\N	\N	0	6	11	52.6	22	0	284	0	0	\N	\N	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]	trimethyl-[2-[4-oxo-4-[2-(trimethylammonio)ethoxy]butanoyl]oxyethyl]ammonium;dichloride
9536	VELPHORO	SUCROFERRIC OXYHYDROXIDE	91663255	C12H29Fe5Na2O23	866.546	\N	\N	12	23	5	202	42	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)CO)O)O)O)O.O.O.O.[OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3]	pentaferric;disodium;(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol;oxygen(2-);hydroxide;trihydrate
1179	BRIDION	SUGAMMADEX SODIUM	6918584	C72H104Na8O48S8	2177.974	\N	\N	16	56	32	995	136	0	2790	40	0	\N	\N	C(CSCC1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(O2)C(C9O)O)CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])O)O)C(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]	\N
9397	UNASYN	SULBACTAM SODIUM	23663973	C8H10NNaO5S	255.22	\N	\N	0	5	1	103	16	0	452	2	0	\N	\N	CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)[O-])C.[Na+]	sodium;(2S,5R)-3,3-dimethyl-4,4,7-trioxo-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
1134	BLEPH-30	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
1136	BLEPHAMIDE	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
1138	BLEPHAMIDE S.O.P.	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
1536	CETAPRED	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
3593	FML-S	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
7948	RENOQUID	SULFACYTINE	5322	C12H14N4O3S	294.329	\N	0.1	2	4	4	113	20	0	527	0	0	\N	\N	CCN1C=CC(=NC1=O)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(1-ethyl-2-oxo-pyrimidin-4-yl)benzenesulfonamide
8563	SULLA	SULFAMETER	5326	C11H12N4O3S	280.302	\N	0.4	2	7	4	116	19	0	368	0	0	\N	\N	COC1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methoxypyrimidin-2-yl)benzenesulfonamide
5556	MICROSUL	SULFAMETHIZOLE	5328	C9H10N4O2S2	270.325	\N	0.5	2	7	3	135	17	0	349	0	0	\N	\N	CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide
8871	THIOSULFIL	SULFAMETHIZOLE	5328	C9H10N4O2S2	270.325	\N	0.5	2	7	3	135	17	0	349	0	0	\N	\N	CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide
930	AZO GANTANOL	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
963	BACTRIM	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
965	BACTRIM DS	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
967	BACTRIM PEDIATRIC	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
2070	COTRIM D.S.	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
3692	GANTANOL-DS	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8208	SEPTRA DS	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8210	SEPTRA GRAPE	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8530	SULFAMETHOPRIM	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8532	SULFAMETHOPRIM-DS	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8534	SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8535	SULFAMETHOXAZOLE AND TRIMETHOPRIM	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8839	THEOBID JR.	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
939	AZULFIDINE EN-TABS	SULFASALAZINE	5353980	C18H14N4O5S	398.393	\N	2.3	3	9	6	146	28	0	804	0	0	\N	\N	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O	(3E)-6-oxo-3-[[4-(2-pyridylsulfamoyl)phenyl]hydrazono]cyclohexa-1,4-diene-1-carboxylic acid
8126	S.A.S.-500	SULFASALAZINE	5353980	C18H14N4O5S	398.393	\N	2.3	3	9	6	146	28	0	804	0	0	\N	\N	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O	(3E)-6-oxo-3-[[4-(2-pyridylsulfamoyl)phenyl]hydrazono]cyclohexa-1,4-diene-1-carboxylic acid
716	ANTURANE	SULFINPYRAZONE	5342	C23H20N2O3S	404.484	\N	2.3	0	4	6	76.9	29	0	571	0	1	\N	\N	C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4	4-[2-(benzenesulfinyl)ethyl]-1,2-diphenyl-pyrazolidine-3,5-dione
3262	ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL	SULFISOXAZOLE ACETYL	6662	C13H15N3O4S	309.34	\N	1.3	1	6	3	115	21	0	482	0	0	\N	\N	CC1=C(ON=C1C)N(C(=O)C)S(=O)(=O)C2=CC=C(C=C2)N	N-(4-aminophenyl)sulfonyl-N-(3,4-dimethylisoxazol-5-yl)acetamide
3266	ERYZOLE	SULFISOXAZOLE ACETYL	6662	C13H15N3O4S	309.34	\N	1.3	1	6	3	115	21	0	482	0	0	\N	\N	CC1=C(ON=C1C)N(C(=O)C)S(=O)(=O)C2=CC=C(C=C2)N	N-(4-aminophenyl)sulfonyl-N-(3,4-dimethylisoxazol-5-yl)acetamide
3694	GANTRISIN	SULFISOXAZOLE ACETYL	6662	C13H15N3O4S	309.34	\N	1.3	1	6	3	115	21	0	482	0	0	\N	\N	CC1=C(ON=C1C)N(C(=O)C)S(=O)(=O)C2=CC=C(C=C2)N	N-(4-aminophenyl)sulfonyl-N-(3,4-dimethylisoxazol-5-yl)acetamide
3696	GANTRISIN PEDIATRIC	SULFISOXAZOLE ACETYL	6662	C13H15N3O4S	309.34	\N	1.3	1	6	3	115	21	0	482	0	0	\N	\N	CC1=C(ON=C1C)N(C(=O)C)S(=O)(=O)C2=CC=C(C=C2)N	N-(4-aminophenyl)sulfonyl-N-(3,4-dimethylisoxazol-5-yl)acetamide
4191	ILOSONE SULFA	SULFISOXAZOLE ACETYL	6662	C13H15N3O4S	309.34	\N	1.3	1	6	3	115	21	0	482	0	0	\N	\N	CC1=C(ON=C1C)N(C(=O)C)S(=O)(=O)C2=CC=C(C=C2)N	N-(4-aminophenyl)sulfonyl-N-(3,4-dimethylisoxazol-5-yl)acetamide
8558	SULFISOXAZOLE DIOLAMINE	SULFISOXAZOLE DIOLAMINE	5344	C11H13N3O3S	267.303	\N	1	2	6	3	107	18	0	374	0	0	\N	\N	CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide
3693	GANTRISIN	SULFISOXAZOLE	5344	C11H13N3O3S	267.303	\N	1	2	6	3	107	18	0	374	0	0	\N	\N	CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide
8528	SULFALAR	SULFISOXAZOLE	5344	C11H13N3O3S	267.303	\N	1	2	6	3	107	18	0	374	0	0	\N	\N	CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide
8557	SULFISOXAZOLE	SULFISOXAZOLE	5344	C11H13N3O3S	267.303	\N	1	2	6	3	107	18	0	374	0	0	\N	\N	CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide
1861	CLINORIL	SULINDAC	1548887	C20H17FO3S	356.411	\N	3.4	1	5	4	73.6	25	0	616	0	1	\N	\N	CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O	2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylene]inden-1-yl]acetic acid
382	ALSUMA	SUMATRIPTAN SUCCINATE	59772	C18H27N3O6S	413.489	\N	\N	4	8	9	148	28	0	498	0	0	\N	\N	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O	1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide;succinic acid
4207	IMITREX	SUMATRIPTAN SUCCINATE	59772	C18H27N3O6S	413.489	\N	\N	4	8	9	148	28	0	498	0	0	\N	\N	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O	1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide;succinic acid
4208	IMITREX STATDOSE	SUMATRIPTAN SUCCINATE	59772	C18H27N3O6S	413.489	\N	\N	4	8	9	148	28	0	498	0	0	\N	\N	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O	1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide;succinic acid
9825	ZECUITY	SUMATRIPTAN SUCCINATE	59772	C18H27N3O6S	413.489	\N	\N	4	8	9	148	28	0	498	0	0	\N	\N	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O	1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide;succinic acid
8840	THEOCHRON	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8303	SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8579	SUMATRIPTAN; NAPROXEN SODIUM	SUMATRIPTAN	5358	C14H21N3O2S	295.401	\N	0.9	2	4	6	73.6	20	0	405	0	0	\N	\N	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C	1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide
1012	BELSOMRA	SUVOREXANT	24965990	C23H23ClN6O2	450.927	\N	4.9	0	6	3	80.3	32	0	664	1	0	\N	\N	CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl	[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone
146	ADCIRCA	TADALAFIL	110635	C22H19N3O4	389.411	\N	2.3	1	4	1	74.9	29	0	702	2	0	\N	\N	CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36	(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-6,7,12,12a-tetrahydro-3H-pyrazino[1,2-b]$b-carboline-1,4-quinone
1652	CIALIS	TADALAFIL	110635	C22H19N3O4	389.411	\N	2.3	1	4	1	74.9	29	0	702	2	0	\N	\N	CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36	(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-6,7,12,12a-tetrahydro-3H-pyrazino[1,2-b]$b-carboline-1,4-quinone
8654	TADALAFIL	TADALAFIL	110635	C22H19N3O4	389.411	\N	2.3	1	4	1	74.9	29	0	702	2	0	\N	\N	CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36	(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-6,7,12,12a-tetrahydro-3H-pyrazino[1,2-b]$b-carboline-1,4-quinone
2988	DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE	TAMSULOSIN HYDROCHLORIDE	5362376	C20H29ClN2O5S	444.971	\N	\N	3	7	11	108	29	0	539	1	0	\N	\N	CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N.Cl	5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide;hydrochloride
3528	FLOMAX	TAMSULOSIN HYDROCHLORIDE	5362376	C20H29ClN2O5S	444.971	\N	\N	3	7	11	108	29	0	539	1	0	\N	\N	CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N.Cl	5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide;hydrochloride
4568	JALYN	TAMSULOSIN HYDROCHLORIDE	5362376	C20H29ClN2O5S	444.971	\N	\N	3	7	11	108	29	0	539	1	0	\N	\N	CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N.Cl	5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide;hydrochloride
6224	NUCYNTA	TAPENTADOL HYDROCHLORIDE	9838021	C14H24ClNO	257.802	\N	\N	2	2	5	23.5	17	0	193	2	0	\N	\N	CCC(C1=CC(=CC=C1)O)C(C)CN(C)C.Cl	3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methyl-propyl]phenol;hydrochloride
6225	NUCYNTA ER	TAPENTADOL HYDROCHLORIDE	9838021	C14H24ClNO	257.802	\N	\N	2	2	5	23.5	17	0	193	2	0	\N	\N	CCC(C1=CC(=CC=C1)O)C(C)CN(C)C.Cl	3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methyl-propyl]phenol;hydrochloride
8680	TAPENTADOL	TAPENTADOL	9838022	C14H23NO	221.344	\N	3.5	1	2	5	23.5	16	0	193	2	0	\N	\N	CCC(C1=CC(=CC=C1)O)C(C)CN(C)C	3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methyl-propyl]phenol
3937	HETLIOZ	TASIMELTEON	10220503	C15H19NO2	245.322	\N	2.2	1	2	4	38.3	18	0	318	2	0	\N	\N	CCC(=O)NCC1CC1C2=C3CCOC3=CC=C2	N-[[(1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl]methyl]propanamide
876	AVAGE	TAZAROTENE	5381	C21H21NO2S	351.464	\N	4.9	0	4	5	64.5	25	0	547	0	0	\N	\N	CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C	ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]pyridine-3-carboxylate
3405	FABIOR	TAZAROTENE	5381	C21H21NO2S	351.464	\N	4.9	0	4	5	64.5	25	0	547	0	0	\N	\N	CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C	ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]pyridine-3-carboxylate
8703	TAZORAC	TAZAROTENE	5381	C21H21NO2S	351.464	\N	4.9	0	4	5	64.5	25	0	547	0	0	\N	\N	CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C	ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]pyridine-3-carboxylate
9848	ZERBAXA	TAZOBACTAM SODIUM	23663400	C10H11N4NaO5S	322.271	\N	\N	0	7	3	134	21	0	579	3	0	\N	\N	CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)[O-])CN3C=CN=N3.[Na+]	sodium;(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
9911	ZOSYN	TAZOBACTAM SODIUM	23663400	C10H11N4NaO5S	322.271	\N	\N	0	7	3	134	21	0	579	3	0	\N	\N	CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)[O-])CN3C=CN=N3.[Na+]	sodium;(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
5695	MPI STANNOUS DIPHOSPHONATE	TECHNETIUM TC-99M ETIDRONATE KIT	123827	C2H8O7P2Tc	304.933	\N	\N	5	7	2	135	12	0	211	0	0	\N	\N	CC(O)(P(=O)(O)O)P(=O)(O)O.[Tc]	(1-hydroxy-1-phosphono-ethyl)phosphonic acid;technetium-99
8717	TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT	TECHNETIUM TC-99M ETIDRONATE KIT	123827	C2H8O7P2Tc	304.933	\N	\N	5	7	2	135	12	0	211	0	0	\N	\N	CC(O)(P(=O)(O)O)P(=O)(O)O.[Tc]	(1-hydroxy-1-phosphono-ethyl)phosphonic acid;technetium-99
1637	CHOLETEC	TECHNETIUM TC-99M MEBROFENIN KIT	11431716	C15H19BrN2O5Tc	486.136	\N	\N	3	6	7	107	24	0	443	0	0	\N	\N	CC1=CC(=C(C(=C1NC(=O)CN(CC(=O)O)CC(=O)O)C)Br)C.[Tc]	2-[[2-(3-bromo-2,4,6-trimethyl-anilino)-2-oxo-ethyl]-(carboxymethyl)amino]acetic acid;technetium-99
2921	DRAXIMAGE MDP-25	TECHNETIUM TC-99M MEDRONATE	157443	CH6O6P2Tc	274.907	\N	\N	4	6	2	115	10	0	152	0	0	\N	\N	C(P(=O)(O)O)P(=O)(O)O.[Tc]	phosphonomethylphosphonic acid;technetium-99
647	AN-DTPA	TECHNETIUM TC-99M PENTETATE KIT	3053	C14H23N3O10	393.349	\N	-8.5	5	13	16	196	27	0	481	0	0	\N	\N	C(CN(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O	2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid
2940	DTPA	TECHNETIUM TC-99M PENTETATE KIT	3053	C14H23N3O10	393.349	\N	-8.5	5	13	16	196	27	0	481	0	0	\N	\N	C(CN(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O	2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid
5692	MPI DTPA KIT - CHELATE	TECHNETIUM TC-99M PENTETATE KIT	3053	C14H23N3O10	393.349	\N	-8.5	5	13	16	196	27	0	481	0	0	\N	\N	C(CN(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O	2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid
8283	SIVEXTRO	TEDIZOLID PHOSPHATE	11476460	C17H16FN6O6P	450.323	\N	0.3	2	11	6	153	31	0	702	1	0	\N	\N	CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)COP(=O)(O)O)F	[(5R)-3-[3-fluoro-4-[6-(2-methyltetrazol-5-yl)-3-pyridyl]phenyl]-2-oxo-oxazolidin-5-yl]methyl dihydrogen phosphate
4220	INCIVEK	TELAPREVIR	3010818	C36H53N7O6	679.863	\N	4.2	4	8	14	180	49	0	1240	6	0	\N	\N	CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5	(3S,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethyl-butanoyl]-N-[(1S)-1-[2-(cyclopropylamino)-2-oxo-acetyl]butyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide
9578	VIBATIV	TELAVANCIN HYDROCHLORIDE	9812715	C80H107Cl3N11O27P	1792.11	\N	\N	24	31	30	598	122	0	3490	18	0	\N	\N	CCCCCCCCCCNCCNC1(CC(OC(C1O)C)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C(=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)CNCP(=O)(O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)C.Cl	\N
9577	VIBATIV	TELAVANCIN	3081362	C80H106Cl2N11O27P	1755.652	\N	-2.1	23	31	30	598	121	0	3490	18	0	\N	\N	CCCCCCCCCCNCCNC1(CC(OC(C1O)C)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C(=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)CNCP(=O)(O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)C	\N
4669	KETEK	TELITHROMYCIN	3002190	C43H65N5O10	812.018	\N	4.2	1	13	11	172	58	0	1440	13	0	\N	\N	CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C	(1R,2R,4R,6R,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-[4-(3-pyridyl)imidazol-1-yl]butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone
8754	TEMAZ	TEMAZEPAM	5391	C16H13ClN2O2	300.742	\N	2.2	1	3	1	52.9	21	0	434	0	1	\N	\N	CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3	7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
8755	TEMAZEPAM	TEMAZEPAM	5391	C16H13ClN2O2	300.742	\N	2.2	1	3	1	52.9	21	0	434	0	1	\N	\N	CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3	7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
8759	TEMOZOLOMIDE	TEMOZOLOMIDE	5394	C6H6N6O2	194.154	\N	-1.1	1	5	1	106	14	0	315	0	0	\N	\N	CN1C(=O)N2C=NC(=C2N=N1)C(=O)N	3-methyl-4-oxo-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
8977	TORISEL	TEMSIROLIMUS	6918289	C56H87NO16	1030.303	\N	5.6	4	16	11	242	73	0	2010	15	0	\N	\N	CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC	\N
9702	VUMON	TENIPOSIDE	452548	C32H32O13S	656.655	\N	1.2	3	14	6	189	46	0	1090	10	0	\N	\N	COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O	(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-(2-thienyl)-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one
8779	TERAZOSIN HYDROCHLORIDE	TERAZOSIN HYDROCHLORIDE	44383	C19H26ClN5O4	423.898	\N	\N	2	8	4	103	29	0	544	0	1	\N	\N	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.Cl	[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-tetrahydrofuran-2-yl-methanone;hydrochloride
4733	LAMISIL	TERBINAFINE HYDROCHLORIDE	5282481	C21H26ClN	327.896	\N	\N	1	1	5	3.2	23	0	428	0	0	\N	\N	CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21.Cl	(E)-N,6,6-trimethyl-N-(1-naphthylmethyl)hept-2-en-4-yn-1-amine;hydrochloride
4735	LAMISIL AT	TERBINAFINE HYDROCHLORIDE	5282481	C21H26ClN	327.896	\N	\N	1	1	5	3.2	23	0	428	0	0	\N	\N	CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21.Cl	(E)-N,6,6-trimethyl-N-(1-naphthylmethyl)hept-2-en-4-yn-1-amine;hydrochloride
4734	LAMISIL AT	TERBINAFINE	1549008	C21H25N	291.438	\N	5.6	0	1	5	3.2	22	0	428	0	0	\N	\N	CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21	(E)-N,6,6-trimethyl-N-(1-naphthylmethyl)hept-2-en-4-yn-1-amine
1164	BRETHINE	TERBUTALINE SULFATE	657301	C12H21NO7S	323.36	\N	\N	6	8	4	156	21	0	286	0	1	\N	\N	CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.OS(=O)(=O)O	5-[2-(tert-butylamino)-1-hydroxy-ethyl]benzene-1,3-diol;sulfuric acid
1178	BRICANYL	TERBUTALINE SULFATE	657301	C12H21NO7S	323.36	\N	\N	6	8	4	156	21	0	286	0	1	\N	\N	CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.OS(=O)(=O)O	5-[2-(tert-butylamino)-1-hydroxy-ethyl]benzene-1,3-diol;sulfuric acid
8781	TERBUTALINE SULFATE	TERBUTALINE SULFATE	657301	C12H21NO7S	323.36	\N	\N	6	8	4	156	21	0	286	0	1	\N	\N	CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.OS(=O)(=O)O	5-[2-(tert-butylamino)-1-hydroxy-ethyl]benzene-1,3-diol;sulfuric acid
8777	TERAZOL 3	TERCONAZOLE	441383	C26H31Cl2N5O3	532.466	\N	4.8	0	7	8	64.9	36	0	693	2	0	\N	\N	CC(C)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl	1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-isopropyl-piperazine
8778	TERAZOL 7	TERCONAZOLE	441383	C26H31Cl2N5O3	532.466	\N	4.8	0	7	8	64.9	36	0	693	2	0	\N	\N	CC(C)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl	1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-isopropyl-piperazine
854	AUBAGIO	TERIFLUNOMIDE	54684141	C12H9F3N2O2	270.211	\N	3.3	2	6	2	73.1	19	0	426	0	0	\N	\N	CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O	(Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide
1187	BRISTACYCLINE	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8841	THEOCLEAR L.A.-130	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8798	TESLAC	TESTOLACTONE	13769	C19H24O3	300.398	\N	3	0	3	0	43.4	22	0	602	5	0	\N	\N	CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C	(4aS,4bR,10aR,10bS,12aS)-10a,12a-dimethyl-4,4a,4b,5,6,10b,11,12-octahydro-3H-naphtho[2,1-f]chromene-2,8-dione
8806	TESTOSTERONE CYPIONATE	TESTOSTERONE CYPIONATE	441404	C27H40O3	412.614	\N	6.4	0	3	5	43.4	30	0	732	6	0	\N	\N	CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=CC(=O)CCC35C	[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
8808	TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE	TESTOSTERONE CYPIONATE	441404	C27H40O3	412.614	\N	6.4	0	3	5	43.4	30	0	732	6	0	\N	\N	CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=CC(=O)CCC35C	[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
8811	TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE	TESTOSTERONE ENANTHATE	9416	C26H40O3	400.603	\N	6.3	0	3	7	43.4	29	0	679	6	0	\N	\N	CCCCCCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C	[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate
887	AVEED	TESTOSTERONE UNDECANOATE	65157	C30H48O3	456.711	\N	8.5	0	3	11	43.4	33	0	739	6	0	\N	\N	CCCCCCCCCCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C	[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] undecanoate
661	ANDRODERM	TESTOSTERONE	6013	C19H28O2	288.431	\N	3.3	1	2	0	37.3	21	0	508	6	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
662	ANDROGEL	TESTOSTERONE	6013	C19H28O2	288.431	\N	3.3	1	2	0	37.3	21	0	508	6	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
4702	KOVANAZE	TETRACAINE HYDROCHLORIDE	8695	C15H25ClN2O2	300.827	\N	\N	2	4	9	41.6	20	0	249	0	0	\N	\N	CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C.Cl	2-(dimethylamino)ethyl 4-(butylamino)benzoate;hydrochloride
82	ACHROMYCIN	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
84	ACHROMYCIN	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
85	ACHROMYCIN	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
86	ACHROMYCIN V	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
113	ACTISITE	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8304	SODIUM CHLORIDE 0.9%	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7801	PYLERA	TETRACYCLINE	54675776	C22H24N2O8	444.44	\N	-2	6	9	2	182	32	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
9364	TYZINE	TETRAHYDROZOLINE HYDROCHLORIDE	10648	C13H17ClN2	236.743	\N	\N	2	1	1	24.4	16	0	259	0	1	\N	\N	C1CC(C2=CC=CC=C2C1)C3=NCCN3.Cl	2-tetralin-1-yl-4,5-dihydro-1H-imidazole;hydrochloride
8830	THALOMID	THALIDOMIDE	5426	C13H10N2O4	258.233	\N	0.3	1	4	1	83.6	19	0	449	0	1	\N	\N	C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O	2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione
8634	SYNOPHYLATE	THEOPHYLLINE SODIUM GLYCINATE	23663537	C9H12N5NaO4	277.216	\N	\N	2	6	1	135	19	0	314	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(C(=O)[O-])N.[Na+]	sodium;2-aminoacetate;1,3-dimethyl-7H-purine-2,6-dione
242	AEROLATE III	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
243	AEROLATE JR	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
244	AEROLATE SR	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
3091	ELIXICON	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
3092	ELIXOMIN	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
3093	ELIXOPHYLLIN	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
3094	ELIXOPHYLLIN SR	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
7836	QUIBRON-T/SR	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8291	SLO-PHYLLIN	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8368	SOMOPHYLLIN-CRT	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8370	SOMOPHYLLIN-T	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8645	T-PHYL	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8837	THEO-DUR	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
1071	BETALIN S	THIAMINE HYDROCHLORIDE	6202	C12H18Cl2N4OS	337.263	\N	\N	3	6	4	104	20	0	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-]	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol;chloride;hydrochloride
4264	INFUVITE ADULT	THIAMINE HYDROCHLORIDE	6202	C12H18Cl2N4OS	337.263	\N	\N	3	6	4	104	20	0	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-]	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol;chloride;hydrochloride
5183	M.V.I. ADULT	THIAMINE HYDROCHLORIDE	6202	C12H18Cl2N4OS	337.263	\N	\N	3	6	4	104	20	0	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-]	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol;chloride;hydrochloride
5196	M.V.I. ADULT (PHARMACY BULK PACKAGE)	THIAMINE HYDROCHLORIDE	6202	C12H18Cl2N4OS	337.263	\N	\N	3	6	4	104	20	0	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-]	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol;chloride;hydrochloride
5210	M.V.I. PEDIATRIC	THIAMINE HYDROCHLORIDE	6202	C12H18Cl2N4OS	337.263	\N	\N	3	6	4	104	20	0	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-]	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol;chloride;hydrochloride
5222	M.V.I.-12	THIAMINE HYDROCHLORIDE	6202	C12H18Cl2N4OS	337.263	\N	\N	3	6	4	104	20	0	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-]	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol;chloride;hydrochloride
5234	M.V.I.-12	THIAMINE HYDROCHLORIDE	6202	C12H18Cl2N4OS	337.263	\N	\N	3	6	4	104	20	0	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-]	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol;chloride;hydrochloride
5246	M.V.I.-12 (WITHOUT VITAMIN K)	THIAMINE HYDROCHLORIDE	6202	C12H18Cl2N4OS	337.263	\N	\N	3	6	4	104	20	0	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-]	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol;chloride;hydrochloride
5258	M.V.I.-12 LYOPHILIZED	THIAMINE	1130	C12H17N4OS+	265.355	\N	1	2	5	4	104	18	1	269	0	0	\N	\N	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO	2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol
8593	SURITAL	THIAMYLAL SODIUM	23677058	C12H17N2NaO2S	276.33	\N	\N	1	3	5	59.5	18	0	384	0	2	\N	\N	CCCC(C)C1(C(=O)NC(=NC1=O)[S-])CC=C.[Na+]	sodium;5-allyl-5-(1-methylbutyl)-4,6-dioxo-1H-pyrimidine-2-thiolate
8976	TORECAN	THIETHYLPERAZINE MALEATE	5282398	C30H37N3O8S2	631.759	\N	\N	4	13	10	210	43	0	574	0	0	\N	\N	CCSC1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)C.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O	2-ethylsulfanyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine;maleic acid
5380	MELLARIL	THIORIDAZINE HYDROCHLORIDE	66062	C21H27ClN2S2	407.031	\N	\N	1	4	4	57.1	26	0	432	0	1	\N	\N	CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC.Cl	10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine;hydrochloride
5853	NAVANE	THIOTHIXENE HYDROCHLORIDE	941651	C23H29N3O2S2	443.624	\N	3.8	0	6	5	77.5	30	0	711	0	0	\N	\N	CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C	(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide
5852	NAVANE	THIOTHIXENE	941651	C23H29N3O2S2	443.624	\N	3.8	0	6	5	77.5	30	0	711	0	0	\N	\N	CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C	(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide
8893	TIAGABINE HYDROCHLORIDE	TIAGABINE HYDROCHLORIDE	91274	C20H26ClNO2S2	412.003	\N	\N	2	5	6	97	26	0	474	1	0	\N	\N	CC1=C(SC=C1)C(=CCCN2CCCC(C2)C(=O)O)C3=C(C=CS3)C.Cl	(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-enyl]piperidine-3-carboxylic acid;hydrochloride
8896	TICAR	TICARCILLIN DISODIUM	470375	C15H14N2Na2O6S2	428.385	\N	\N	1	8	3	183	27	0	629	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CSC=C3)C(=O)[O-])C(=O)[O-])C.[Na+].[Na+]	disodium;(2S,5R,6R)-6-[[(2R)-2-carboxylato-2-(3-thienyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
8900	TIGECYCLINE	TIGECYCLINE	54686904	C29H39N5O8	585.658	\N	1.1	7	11	7	206	42	0	1240	4	0	\N	\N	CC(C)(C)NCC(=O)NC1=C(C2=C(CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C2O)O)O)C(=O)N)N(C)C)C(=C1)N(C)C)O	(4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
9340	TYGACIL	TIGECYCLINE	54686904	C29H39N5O8	585.658	\N	1.1	7	11	7	206	42	0	1240	4	0	\N	\N	CC(C)(C)NCC(=O)NC1=C(C2=C(CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C2O)O)O)C(=O)N)N(C)C)C(=C1)N(C)C)O	(4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
8285	SKELID	TILUDRONATE DISODIUM	60936	C7H7ClNa2O6P2S	362.564	\N	\N	2	7	4	146	19	0	320	0	0	\N	\N	C1=CC(=CC=C1SC(P(=O)(O)[O-])P(=O)(O)[O-])Cl.[Na+].[Na+]	disodium;[(4-chlorophenyl)sulfanyl-[hydroxy(oxido)phosphoryl]methyl]-hydroxy-phosphinate
1146	BLOCADREN	TIMOLOL MALEATE	5281056	C17H28N4O7S	432.492	\N	\N	4	12	9	183	29	0	429	1	0	\N	\N	CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O	(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;maleic acid
1185	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	TIMOLOL MALEATE	5281056	C17H28N4O7S	432.492	\N	\N	4	12	9	183	29	0	429	1	0	\N	\N	CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O	(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;maleic acid
1973	COMBIGAN	TIMOLOL MALEATE	5281056	C17H28N4O7S	432.492	\N	\N	4	12	9	183	29	0	429	1	0	\N	\N	CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O	(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;maleic acid
1088	BETIMOL	TIMOLOL	33624	C13H24N4O3S	316.42	\N	1.8	2	8	7	108	21	0	310	1	0	\N	\N	CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O	(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
8916	TINIDAZOLE	TINIDAZOLE	5479	C8H13N3O4S	247.269	\N	-0.4	0	5	4	106	16	0	345	0	0	\N	\N	CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C	1-(2-ethylsulfonylethyl)-2-methyl-5-nitro-imidazole
4298	INNOHEP	TINZAPARIN SODIUM	25244225	C12H17NO20S3-4	591.435	\N	-5.6	5	21	6	376	36	-4	1040	4	6	\N	\N	C(C1C(C(C(C(O1)O)NS(=O)(=O)[O-])O)OC2C(C(C(C(O2)C(=O)[O-])O)O)OS(=O)(=O)[O-])OS(=O)(=O)[O-]	(4S,6R)-6-[(2R,4R)-4,6-dihydroxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-3,4-dihydroxy-5-sulfonatooxy-tetrahydropyran-2-carboxylate
8917	TIOCONAZOLE	TIOCONAZOLE	5482	C16H13Cl3N2OS	387.703	\N	5.3	0	3	6	55.3	23	0	379	0	1	\N	\N	C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl	1-[2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole
9365	TZ-3	TIOCONAZOLE	5482	C16H13Cl3N2OS	387.703	\N	5.3	0	3	6	55.3	23	0	379	0	1	\N	\N	C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl	1-[2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole
9446	VAGISTAT-1	TIOCONAZOLE	5482	C16H13Cl3N2OS	387.703	\N	5.3	0	3	6	55.3	23	0	379	0	1	\N	\N	C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl	1-[2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole
8402	SPIRIVA RESPIMAT	TIOTROPIUM BROMIDE	5487426	C19H22BrNO4S2	472.412	\N	\N	1	7	5	116	27	0	564	4	0	\N	\N	C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-]	\N
5055	LONSURF	TIPIRACIL HYDROCHLORIDE	9903778	C9H12Cl2N4O2	279.121	\N	\N	4	3	2	85.3	17	0	404	0	0	\N	\N	C1CC(=N)N(C1)CC2=C(C(=O)NC(=O)N2)Cl.Cl	5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1H-pyrimidine-2,4-dione;hydrochloride
707	ANTHELIOS 40	TITANIUM DIOXIDE	26042	O2Ti	79.865	\N	\N	0	2	0	34.1	3	0	18.3	0	0	\N	\N	O=[Ti]=O	dioxotitanium
9811	ZANAFLEX	TIZANIDINE HYDROCHLORIDE	114869	C9H9Cl2N5S	290.166	\N	\N	3	4	2	90.4	17	0	300	0	0	\N	\N	C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl.Cl	5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine;hydrochloride
5863	NEBCIN	TOBRAMYCIN SULFATE	62005	C18H39N5O13S	565.592	\N	\N	12	18	6	351	37	0	691	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N.OS(=O)(=O)O	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol;sulfuric acid
275	AKTOB	TOBRAMYCIN	36294	C18H37N5O9	467.52	\N	-6.2	10	14	6	268	32	0	609	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
1087	BETHKIS	TOBRAMYCIN	36294	C18H37N5O9	467.52	\N	-6.2	10	14	6	268	32	0	609	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
4684	KITABIS PAK	TOBRAMYCIN	36294	C18H37N5O9	467.52	\N	-6.2	10	14	6	268	32	0	609	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
8934	TOBI PODHALER	TOBRAMYCIN	36294	C18H37N5O9	467.52	\N	-6.2	10	14	6	268	32	0	609	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
4290	INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)	TOCOPHEROL ACETATE	86472	C31H52O3	472.754	\N	10.8	0	3	14	35.5	34	0	602	3	0	\N	\N	CC1=C2C(=C(C(=C1C)OC(=O)C)C)CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C	[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-yl] acetate
8958	TOLINASE	TOLAZAMIDE	5503	C14H21N3O3S	311.4	\N	1.5	2	4	3	86.9	21	0	431	0	0	\N	\N	CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2	1-(azepan-1-yl)-3-(p-tolylsulfonyl)urea
8954	TOLCAPONE	TOLCAPONE	4659569	C14H11NO5	273.244	\N	3.3	2	5	2	103	20	0	372	0	0	\N	\N	CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]	(3,4-dihydroxy-5-nitro-phenyl)-(p-tolyl)methanone
8955	TOLECTIN	TOLMETIN SODIUM	23665411	C15H14NNaO3	279.271	\N	\N	0	3	4	62.1	20	0	353	0	0	\N	\N	CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)[O-].[Na+]	sodium;2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetate
7821	QSYMIA	TOPIRAMATE	5284627	C12H21NO8S	339.359	\N	-0.8	1	9	3	124	22	0	556	4	0	\N	\N	CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C	[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate
7829	QUDEXY XR	TOPIRAMATE	5284627	C12H21NO8S	339.359	\N	-0.8	1	9	3	124	22	0	556	4	0	\N	\N	CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C	[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate
8964	TOPAMAX SPRINKLE	TOPIRAMATE	5284627	C12H21NO8S	339.359	\N	-0.8	1	9	3	124	22	0	556	4	0	\N	\N	CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C	[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate
8971	TOPOTECAN HYDROCHLORIDE	TOPOTECAN HYDROCHLORIDE	60699	C23H24ClN3O5	457.911	\N	\N	3	7	3	103	32	0	867	1	0	\N	\N	CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O.Cl	\N
9801	YONDELIS	TRABECTEDIN	108150	C39H43N3O11S	761.843	\N	3.4	4	15	4	194	54	0	1450	7	0	\N	\N	CC1=C(C(=C2C3C4C5C6=C(C(N4C(C(N3C)CC2=C1)O)COC(=O)C7(CS5)C8=CC(=C(C=C8CCN7)O)OC)C9=C(C(=C6OC(=O)C)C)OCO9)O)OC	\N
8118	RYBIX ODT	TRAMADOL HYDROCHLORIDE	63013	C16H26ClNO2	299.839	\N	\N	2	3	4	32.7	20	0	282	2	0	\N	\N	CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O.Cl	(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol;hydrochloride
8125	RYZOLT	TRAMADOL HYDROCHLORIDE	63013	C16H26ClNO2	299.839	\N	\N	2	3	4	32.7	20	0	282	2	0	\N	\N	CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O.Cl	(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol;hydrochloride
9385	ULTRAM	TRAMADOL HYDROCHLORIDE	63013	C16H26ClNO2	299.839	\N	\N	2	3	4	32.7	20	0	282	2	0	\N	\N	CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O.Cl	(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol;hydrochloride
9386	ULTRAM ER	TRAMADOL HYDROCHLORIDE	63013	C16H26ClNO2	299.839	\N	\N	2	3	4	32.7	20	0	282	2	0	\N	\N	CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O.Cl	(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol;hydrochloride
5375	MEKINIST	TRAMETINIB DIMETHYL SULFOXIDE	11707110	C26H23FIN5O4	615.404	\N	3.4	2	6	5	102	37	0	1090	0	0	\N	\N	CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5	N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodo-anilino)-6,8-dimethyl-2,4,7-trioxo-pyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide
5317	MAVIK	TRANDOLAPRIL	5484727	C24H34N2O5	430.545	\N	2	2	6	10	95.9	31	0	634	5	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O	(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
8686	TARKA	TRANDOLAPRIL	5484727	C24H34N2O5	430.545	\N	2	2	6	10	95.9	31	0	634	5	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O	(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
9007	TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE	TRANDOLAPRIL	5484727	C24H34N2O5	430.545	\N	2	2	6	10	95.9	31	0	634	5	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O	(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
4563	IZBA	TRAVOPROST	5282226	C26H35F3O6	500.555	\N	4.1	3	9	13	96.2	35	0	693	5	0	\N	\N	CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O	isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate
9137	TRAVATAN	TRAVOPROST	5282226	C26H35F3O6	500.555	\N	4.1	3	9	13	96.2	35	0	693	5	0	\N	\N	CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O	isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate
9138	TRAVATAN Z	TRAVOPROST	5282226	C26H35F3O6	500.555	\N	4.1	3	9	13	96.2	35	0	693	5	0	\N	\N	CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O	isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate
9140	TRAVOPROST	TRAVOPROST	5282226	C26H35F3O6	500.555	\N	4.1	3	9	13	96.2	35	0	693	5	0	\N	\N	CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O	isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate
9141	TRAZODONE HYDROCHLORIDE	TRAZODONE HYDROCHLORIDE	62935	C19H23Cl2N5O	408.327	\N	\N	1	4	5	42.4	27	0	611	0	0	\N	\N	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl.Cl	2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride
9192	TRIALODINE	TRAZODONE HYDROCHLORIDE	62935	C19H23Cl2N5O	408.327	\N	\N	1	4	5	42.4	27	0	611	0	0	\N	\N	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl.Cl	2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride
6425	ORENITRAM	TREPROSTINIL DIOLAMINE	11179459	C27H45NO7	495.657	\N	\N	6	8	14	140	35	0	524	5	0	\N	\N	CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O.C(CO)NCCO	2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid;2-(2-hydroxyethylamino)ethanol
840	ATRALIN	TRETINOIN	444795	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
897	AVITA	TRETINOIN	444795	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
352	ALLERNAZE	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
775	ARISTOCORT	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
777	ARISTOCORT A	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
778	ARISTOGEL	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
928	AZMACORT	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
4652	KENALOG	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
4653	KENALOG IN ORABASE	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
4654	KENALOG-10	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
4655	KENALOG-40	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
4656	KENALOG-H	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
5742	MYCO-TRIACET II	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
5745	MYCOLOG-II	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
5757	MYKACET	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
5777	MYTREX F	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
5832	NASACORT	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
779	ARISTOSPAN	TRIAMCINOLONE HEXACETONIDE	21826	C30H41FO7	532.649	\N	4.8	1	8	6	99.1	38	0	1130	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)COC(=O)CC(C)(C)C)C)O)F)C)C	\N
774	ARISTOCORT	TRIAMCINOLONE	31307	C21H27FO6	394.439	\N	1.2	4	7	2	115	28	0	807	8	0	\N	\N	CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O	(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
4650	KENACORT	TRIAMCINOLONE	31307	C21H27FO6	394.439	\N	1.2	4	7	2	115	28	0	807	8	0	\N	\N	CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O	(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
9193	TRIAMCINOLONE	TRIAMCINOLONE	31307	C21H27FO6	394.439	\N	1.2	4	7	2	115	28	0	807	8	0	\N	\N	CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O	(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2997	DYAZIDE	TRIAMTERENE	5546	C12H11N7	253.269	\N	1	3	7	1	130	19	0	307	0	0	\N	\N	C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N	6-phenylpteridine-2,4,7-triamine
3010	DYRENIUM	TRIAMTERENE	5546	C12H11N7	253.269	\N	1	3	7	1	130	19	0	307	0	0	\N	\N	C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N	6-phenylpteridine-2,4,7-triamine
5333	MAXZIDE-25	TRIAMTERENE	5546	C12H11N7	253.269	\N	1	3	7	1	130	19	0	307	0	0	\N	\N	C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N	6-phenylpteridine-2,4,7-triamine
3855	HALCION	TRIAZOLAM	5556	C17H12Cl2N4	343.211	\N	2.4	0	3	1	43.1	23	0	472	0	0	\N	\N	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl	8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
9214	TRIAZOLAM	TRIAZOLAM	5556	C17H12Cl2N4	343.211	\N	2.4	0	3	1	43.1	23	0	472	0	0	\N	\N	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl	8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
5441	METATENSIN #2	TRICHLORMETHIAZIDE	5560	C8H8Cl3N3O4S2	380.639	\N	0.6	3	7	2	135	20	0	571	0	1	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl	6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5443	METATENSIN #4	TRICHLORMETHIAZIDE	5560	C8H8Cl3N3O4S2	380.639	\N	0.6	3	7	2	135	20	0	571	0	1	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl	6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5827	NAQUIVAL	TRICHLORMETHIAZIDE	5560	C8H8Cl3N3O4S2	380.639	\N	0.6	3	7	2	135	20	0	571	0	1	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl	6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9219	TRICHLORMAS	TRICHLORMETHIAZIDE	5560	C8H8Cl3N3O4S2	380.639	\N	0.6	3	7	2	135	20	0	571	0	1	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl	6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9220	TRICHLORMETHIAZIDE	TRICHLORMETHIAZIDE	5560	C8H8Cl3N3O4S2	380.639	\N	0.6	3	7	2	135	20	0	571	0	1	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl	6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1941	COLGATE TOTAL	TRICLOSAN	5564	C12H7Cl3O2	289.536	\N	5	1	2	2	29.5	17	0	252	0	0	\N	\N	C1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl	5-chloro-2-(2,4-dichlorophenoxy)phenol
6671	PATHILON	TRIDIHEXETHYL CHLORIDE	20298	C21H36ClNO	353.975	\N	\N	1	2	8	20.2	24	0	319	0	1	\N	\N	CC[N+](CC)(CC)CCC(C1CCCCC1)(C2=CC=CC=C2)O.[Cl-]	(3-cyclohexyl-3-hydroxy-3-phenyl-propyl)-triethyl-ammonium;chloride
8462	STELAZINE	TRIFLUOPERAZINE HYDROCHLORIDE	66064	C21H26Cl2F3N3S	480.415	\N	\N	2	7	4	35	30	0	510	0	0	\N	\N	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.Cl.Cl	10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine;dihydrochloride
9233	TRIFLUOPERAZINE HCL	TRIFLUOPERAZINE HYDROCHLORIDE	66064	C21H26Cl2F3N3S	480.415	\N	\N	2	7	4	35	30	0	510	0	0	\N	\N	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.Cl.Cl	10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine;dihydrochloride
9234	TRIFLUOPERAZINE HYDROCHLORIDE	TRIFLUOPERAZINE HYDROCHLORIDE	66064	C21H26Cl2F3N3S	480.415	\N	\N	2	7	4	35	30	0	510	0	0	\N	\N	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.Cl.Cl	10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine;dihydrochloride
9570	VESPRIN	TRIFLUPROMAZINE HYDROCHLORIDE	66069	C18H20ClF3N2S	388.877	\N	\N	1	6	4	31.8	25	0	416	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F.Cl	N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine;hydrochloride
5056	LONSURF	TRIFLURIDINE	6256	C10H11F3N2O5	296.202	\N	-0.5	3	8	2	99.1	20	0	464	3	0	\N	\N	C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione
9638	VIROPTIC	TRIFLURIDINE	6256	C10H11F3N2O5	296.202	\N	-0.5	3	8	2	99.1	20	0	464	3	0	\N	\N	C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione
5637	MODRASTANE	TRILOSTANE	656583	C20H27NO3	329.44	\N	2.9	2	4	0	76.8	24	0	692	8	0	\N	\N	CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C	\N
761	ARFONAD	TRIMETHAPHAN CAMSYLATE	441310	C32H40N2O5S2	596.801	\N	\N	0	5	5	107	41	0	905	0	5	\N	\N	CC1(C2CCC1(C(=O)C2)CS(=O)(=O)[O-])C.C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5	1,3-dibenzyl-4,6,7,8,8a,8b-hexahydro-3aH-thieno[5,6]thieno[1,2-b]imidazol-5-ium-2-one;(7,7-dimethyl-2-oxo-norbornan-1-yl)methanesulfonate
8899	TIGAN	TRIMETHOBENZAMIDE HYDROCHLORIDE	68385	C21H29ClN2O5	424.922	\N	\N	2	6	10	69.3	29	0	440	0	0	\N	\N	CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC.Cl	N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxy-benzamide;hydrochloride
966	BACTRIM DS	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
968	BACTRIM PEDIATRIC	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
2069	COTRIM	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
2071	COTRIM D.S.	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
5976	NEUTREXIN	TRIMETREXATE GLUCURONATE	54949	C25H33N5O10	563.564	\N	\N	8	15	11	253	40	0	648	4	0	\N	\N	CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC.C(=O)C(C(C(C(C(=O)O)O)O)O)O	5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine;(2S,3S,4S,5R)-2,3,4,5-tetrahydroxy-6-oxo-hexanoic acid
9288	TRISORALEN	TRIOXSALEN	5585	C14H12O3	228.247	\N	3	0	3	0	39.4	17	0	374	0	0	\N	\N	CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C	2,5,9-trimethylfuro[3,2-g]chromen-7-one
6679	PBZ	TRIPELENNAMINE HYDROCHLORIDE	9066	C16H22ClN3	291.823	\N	\N	1	3	6	19.4	20	0	236	0	0	\N	\N	CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2.Cl	N'-benzyl-N,N-dimethyl-N'-(2-pyridyl)ethane-1,2-diamine;hydrochloride
6680	PBZ-SR	TRIPELENNAMINE HYDROCHLORIDE	9066	C16H22ClN3	291.823	\N	\N	1	3	6	19.4	20	0	236	0	0	\N	\N	CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2.Cl	N'-benzyl-N,N-dimethyl-N'-(2-pyridyl)ethane-1,2-diamine;hydrochloride
102	ACTIDIL	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
104	ACTIFED	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
351	ALLERFED	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
2028	CORPHED	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
3957	HISTAFED	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
5755	MYIDYL	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
9187	TRIACIN-C	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
9269	TRIPHED	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
9275	TRIPROLIDINE AND PSEUDOEPHEDRINE	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
9144	TRELSTAR	TRIPTORELIN PAMOATE	25074470	C64H82N18O13	1311.473	\N	-0.3	17	15	33	490	95	0	2710	9	0	\N	\N	CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8	(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-2-[[(1S)-1-[[(1S)-1-[(2S)-2-[(2-amino-2-oxo-ethyl)carbamoyl]pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
4810	LANTRISUL	TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)	60896	C33H36N12O6S3	792.909	\N	\N	6	18	9	319	54	0	1060	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-pyrimidin-2-yl-benzenesulfonamide
8529	SULFALOID	TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)	60896	C33H36N12O6S3	792.909	\N	\N	6	18	9	319	54	0	1060	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-pyrimidin-2-yl-benzenesulfonamide
7416	PRELAY	TROGLITAZONE	5591	C24H27NO5S	441.542	\N	5.1	2	6	5	110	31	0	681	0	2	\N	\N	CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O	5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl)methoxy]phenyl]methyl]thiazolidine-2,4-dione
8678	TAO	TROLEANDOMYCIN	202225	C41H67NO15	813.979	\N	4.3	0	16	12	184	57	0	1430	18	0	\N	\N	CC1CC(C(C(O1)OC2C(CC3(CO3)C(=O)C(C(C(C(OC(=O)C(C(C2C)OC4CC(C(C(O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C	[(3R,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[(2S,3R,4S,6R)-3-acetoxy-4-(dimethylamino)-6-methyl-tetrahydropyran-2-yl]oxy-8-[(2R,4S,5S,6S)-5-acetoxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro[2.13]hexadecan-14-yl] acetate
5751	MYDRIAFAIR	TROPICAMIDE	5593	C17H20N2O2	284.359	\N	1.5	1	3	6	53.4	21	0	310	0	1	\N	\N	CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2	N-ethyl-3-hydroxy-2-phenyl-N-(4-pyridylmethyl)propanamide
9307	TROPICAMIDE	TROPICAMIDE	5593	C17H20N2O2	284.359	\N	1.5	1	3	6	53.4	21	0	310	0	1	\N	\N	CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2	N-ethyl-3-hydroxy-2-phenyl-N-(4-pyridylmethyl)propanamide
8142	SANCTURA	TROSPIUM CHLORIDE	5284631	C25H30ClNO3	427.969	\N	\N	1	4	5	46.5	30	0	553	2	0	\N	\N	C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-]	[(1R,5S)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenyl-acetate;chloride
8143	SANCTURA XR	TROSPIUM CHLORIDE	5284631	C25H30ClNO3	427.969	\N	\N	1	4	5	46.5	30	0	553	2	0	\N	\N	C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-]	[(1R,5S)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenyl-acetate;chloride
9309	TROVAN	TROVAFLOXACIN MESYLATE	62960	C21H19F3N4O6S	512.46	\N	\N	3	13	3	163	35	0	863	2	0	\N	\N	CS(=O)(=O)O.C1C2C(C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F	7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid
9312	TROVAN/ZITHROMAX COMPLIANCE PAK	TROVAFLOXACIN MESYLATE	62960	C21H19F3N4O6S	512.46	\N	\N	3	13	3	163	35	0	863	2	0	\N	\N	CS(=O)(=O)O.C1C2C(C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F	7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid
5385	MEMBRANEBLUE	TRYPAN BLUE	9562061	C34H24N6Na4O14S4	960.793	\N	\N	4	20	5	397	62	0	2030	0	0	\N	\N	CC1=C(C=CC(=C1)C2=CC(=C(C=C2)NN=C3C(=CC4=CC(=CC(=C4C3=O)N)S(=O)(=O)[O-])S(=O)(=O)[O-])C)NN=C5C(=CC6=CC(=CC(=C6C5=O)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+]	tetrasodium;(3Z)-5-amino-3-[[4-[4-[(2Z)-2-(8-amino-1-oxo-3,6-disulfonato-2-naphthylidene)hydrazino]-3-methyl-phenyl]-2-methyl-phenyl]hydrazono]-4-oxo-naphthalene-2,7-disulfonate
9644	VISIONBLUE	TRYPAN BLUE	9562061	C34H24N6Na4O14S4	960.793	\N	\N	4	20	5	397	62	0	2030	0	0	\N	\N	CC1=C(C=CC(=C1)C2=CC(=C(C=C2)NN=C3C(=CC4=CC(=CC(=C4C3=O)N)S(=O)(=O)[O-])S(=O)(=O)[O-])C)NN=C5C(=CC6=CC(=CC(=C6C5=O)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+]	tetrasodium;(3Z)-5-amino-3-[[4-[4-[(2Z)-2-(8-amino-1-oxo-3,6-disulfonato-2-naphthylidene)hydrazino]-3-methyl-phenyl]-2-methyl-phenyl]hydrazono]-4-oxo-naphthalene-2,7-disulfonate
1115	BILOPAQUE	TYROPANOATE SODIUM	541384	C15H17I3NNaO3	663.008	\N	\N	1	3	7	69.2	23	0	400	0	1	\N	\N	CCCC(=O)NC1=C(C=C(C(=C1I)CC(CC)C(=O)[O-])I)I.[Na+]	sodium;2-[[3-(butanoylamino)-2,4,6-triiodo-phenyl]methyl]butanoate
8988	TPN	TYROSINE	6057	C9H11NO3	181.191	\N	-2.3	3	4	3	83.6	13	0	176	1	0	\N	\N	C1=CC(=CC=C1CC(C(=O)O)N)O	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid
691	ANORO ELLIPTA	UMECLIDINIUM BROMIDE	11519069	C29H34BrNO2	508.5	\N	\N	1	3	8	29.5	33	0	543	0	0	\N	\N	C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5.[Br-]	[1-(2-benzyloxyethyl)quinuclidin-1-ium-4-yl]-diphenyl-methanol;bromide
4222	INCRUSE ELLIPTA	UMECLIDINIUM BROMIDE	11519069	C29H34BrNO2	508.5	\N	\N	1	3	8	29.5	33	0	543	0	0	\N	\N	C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5.[Br-]	[1-(2-benzyloxyethyl)quinuclidin-1-ium-4-yl]-diphenyl-methanol;bromide
7970	RESCULA	UNOPROSTONE ISOPROPYL	5282175	C25H44O5	424.622	\N	4.9	2	5	17	83.8	30	0	514	4	0	\N	\N	CCCCCCCC(=O)CCC1C(CC(C1CC=CCCCC(=O)OC(C)C)O)O	isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl]hept-5-enoate
7802	PYLORI-CHEK BREATH TEST	UREA C-13	636363	CH4N2O	61.048	\N	-1.4	2	1	0	69.1	4	0	29	0	0	\N	\N	C(=O)(N)N	diaminomethanone
7813	PYTEST KIT	UREA, C-14	11457650	CH4N2O	62.048	\N	-1.4	2	1	0	69.1	4	0	29	0	0	\N	\N	C(=O)(N)N	diaminomethanone
9414	UREAPHIL	UREA	1176	CH4N2O	60.056	\N	-1.4	2	1	0	69.1	4	0	29	0	0	\N	\N	C(=O)(N)N	urea
9653	VISTOGARD	URIDINE TRIACETATE	20058	C15H18N2O9	370.314	\N	-0.5	1	9	8	138	26	0	660	4	0	\N	\N	CC(=O)OCC1C(C(C(O1)N2C=CC(=O)NC2=O)OC(=O)C)OC(=O)C	[(2R,3R,4R,5R)-3,4-diacetoxy-5-(2,4-dioxopyrimidin-1-yl)tetrahydrofuran-2-yl]methyl acetate
9777	XURIDEN	URIDINE TRIACETATE	20058	C15H18N2O9	370.314	\N	-0.5	1	9	8	138	26	0	660	4	0	\N	\N	CC(=O)OCC1C(C(C(O1)N2C=CC(=O)NC2=O)OC(=O)C)OC(=O)C	[(2R,3R,4R,5R)-3,4-diacetoxy-5-(2,4-dioxopyrimidin-1-yl)tetrahydrofuran-2-yl]methyl acetate
1159	BRAVELLE	UROFOLLITROPIN	62819	C42H65N11O12S2	980.167	\N	-1.5	12	15	15	427	67	0	1790	0	10	\N	\N	CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)C(C)O	1-[19-amino-7-(2-amino-2-oxo-ethyl)-10-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-sec-butyl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide
108	ACTIGALL	URSODIOL	31401	C24H40O4	392.58	\N	4.9	3	4	4	77.8	28	0	605	10	0	\N	\N	CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C	(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
9433	URSO 250	URSODIOL	31401	C24H40O4	392.58	\N	4.9	3	4	4	77.8	28	0	605	10	0	\N	\N	CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C	(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
9434	URSO FORTE	URSODIOL	31401	C24H40O4	392.58	\N	4.9	3	4	4	77.8	28	0	605	10	0	\N	\N	CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C	(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
9447	VALACYCLOVIR HYDROCHLORIDE	VALACYCLOVIR HYDROCHLORIDE	60772	C13H21ClN6O4	360.799	\N	\N	4	6	8	147	24	0	483	1	0	\N	\N	CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N.Cl	2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methyl-butanoate;hydrochloride
9465	VALTREX	VALACYCLOVIR HYDROCHLORIDE	60772	C13H21ClN6O4	360.799	\N	\N	4	6	8	147	24	0	483	1	0	\N	\N	CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N.Cl	2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methyl-butanoate;hydrochloride
9450	VALGANCICLOVIR HYDROCHLORIDE	VALGANCICLOVIR HYDROCHLORIDE	110632	C14H23ClN6O5	390.825	\N	\N	5	7	9	167	26	0	528	1	1	\N	\N	CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N.Cl	[2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxy-propyl] (2S)-2-amino-3-methyl-butanoate;hydrochloride
2330	DEPACON	VALPROATE SODIUM	16760703	C8H15NaO2	166.196	\N	\N	0	2	5	40.1	11	0	98.3	0	0	\N	\N	CCCC(CCC)C(=O)[O-].[Na+]	sodium;2-propylpentanoate
2331	DEPAKENE	VALPROIC ACID	3121	C8H16O2	144.214	\N	2.8	1	2	5	37.3	10	0	93.4	0	0	\N	\N	CCCC(CCC)C(=O)O	2-propylpentanoic acid
8459	STAVZOR	VALPROIC ACID	3121	C8H16O2	144.214	\N	2.8	1	2	5	37.3	10	0	93.4	0	0	\N	\N	CCCC(CCC)C(=O)O	2-propylpentanoic acid
9464	VALSTAR PRESERVATIVE FREE	VALRUBICIN	454216	C34H36F3NO13	723.651	\N	4	5	16	11	215	51	0	1350	6	0	\N	\N	CCCCC(=O)OCC(=O)C1(CC(C2=C(C3=C(C(=C2C1)O)C(=O)C4=C(C3=O)C(=CC=C4)OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O	[2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]tetrahydropyran-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate
9473	VANCOCIN HYDROCHLORIDE	VANCOMYCIN HYDROCHLORIDE	6420023	C66H76Cl3N9O24	1485.723	\N	\N	20	26	13	531	102	0	2960	18	0	\N	\N	CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O.Cl	\N
9474	VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINER	VANCOMYCIN HYDROCHLORIDE	6420023	C66H76Cl3N9O24	1485.723	\N	\N	20	26	13	531	102	0	2960	18	0	\N	\N	CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O.Cl	\N
9475	VANCOLED	VANCOMYCIN HYDROCHLORIDE	6420023	C66H76Cl3N9O24	1485.723	\N	\N	20	26	13	531	102	0	2960	18	0	\N	\N	CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O.Cl	\N
9476	VANCOMYCIN HCL	VANCOMYCIN HYDROCHLORIDE	6420023	C66H76Cl3N9O24	1485.723	\N	\N	20	26	13	531	102	0	2960	18	0	\N	\N	CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O.Cl	\N
1376	CAPRELSA	VANDETANIB	3081361	C22H24BrFN4O2	475.362	\N	4.9	1	7	6	59.5	30	0	539	0	0	\N	\N	CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC	N-(4-bromo-2-fluoro-phenyl)-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazolin-4-amine
4881	LEVITRA	VARDENAFIL HYDROCHLORIDE	10142962	C23H33ClN6O4S	525.065	\N	\N	2	7	8	118	35	0	854	0	0	\N	\N	CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C.Cl	2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonyl-phenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one;hydrochloride
8460	STAXYN	VARDENAFIL HYDROCHLORIDE	10142962	C23H33ClN6O4S	525.065	\N	\N	2	7	8	118	35	0	854	0	0	\N	\N	CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C.Cl	2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonyl-phenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one;hydrochloride
6054	NORCURON	VECURONIUM BROMIDE	39764	C34H57BrN2O4	637.744	\N	\N	0	6	6	55.8	41	0	958	10	0	\N	\N	CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-]	[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-(1-piperidyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide
3194	EPCLUSA	VELPATASVIR	67683363	C49H54N8O8	883.019	\N	6.2	4	10	13	193	65	0	1690	6	0	\N	\N	CC1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)C8CC(CN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)COC	\N
9836	ZELBORAF	VEMURAFENIB	42611257	C23H18ClF2N3O3S	489.922	\N	5	2	7	7	100	33	0	790	0	0	\N	\N	CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F	N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl]propane-1-sulfonamide
3062	EFFEXOR	VENLAFAXINE HYDROCHLORIDE	62923	C17H28ClNO2	313.866	\N	\N	2	3	5	32.7	21	0	279	0	1	\N	\N	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O.Cl	1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol;hydrochloride
3063	EFFEXOR XR	VENLAFAXINE HYDROCHLORIDE	62923	C17H28ClNO2	313.866	\N	\N	2	3	5	32.7	21	0	279	0	1	\N	\N	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O.Cl	1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol;hydrochloride
9542	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	62923	C17H28ClNO2	313.866	\N	\N	2	3	5	32.7	21	0	279	0	1	\N	\N	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O.Cl	1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol;hydrochloride
1318	CALAN	VERAPAMIL HYDROCHLORIDE	62969	C27H39ClN2O4	491.069	\N	\N	1	6	13	64	34	0	606	0	1	\N	\N	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl	2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile;hydrochloride
1319	CALAN SR	VERAPAMIL HYDROCHLORIDE	62969	C27H39ClN2O4	491.069	\N	\N	1	6	13	64	34	0	606	0	1	\N	\N	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl	2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile;hydrochloride
2073	COVERA-HS	VERAPAMIL HYDROCHLORIDE	62969	C27H39ClN2O4	491.069	\N	\N	1	6	13	64	34	0	606	0	1	\N	\N	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl	2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile;hydrochloride
9612	VIIBRYD	VILAZODONE HYDROCHLORIDE	6918313	C26H28ClN5O2	477.993	\N	\N	3	5	7	102	34	0	729	0	0	\N	\N	C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N.Cl	5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide;hydrochloride
9613	VILAZODONE HYDROCHLORIDE	VILAZODONE HYDROCHLORIDE	6918313	C26H28ClN5O2	477.993	\N	\N	3	5	7	102	34	0	729	0	0	\N	\N	C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N.Cl	5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide;hydrochloride
5315	MARQIBO KIT	VINCRISTINE SULFATE	249332	C46H58N4O14S	923.044	\N	\N	5	16	10	254	65	0	1830	9	0	\N	\N	CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O	\N
6364	ONCOVIN	VINCRISTINE SULFATE	249332	C46H58N4O14S	923.044	\N	\N	5	16	10	254	65	0	1830	9	0	\N	\N	CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O	\N
9619	VINCASAR PFS	VINCRISTINE SULFATE	249332	C46H58N4O14S	923.044	\N	\N	5	16	10	254	65	0	1830	9	0	\N	\N	CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O	\N
9620	VINCREX	VINCRISTINE SULFATE	249332	C46H58N4O14S	923.044	\N	\N	5	16	10	254	65	0	1830	9	0	\N	\N	CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O	\N
9621	VINCRISTINE SULFATE	VINCRISTINE SULFATE	249332	C46H58N4O14S	923.044	\N	\N	5	16	10	254	65	0	1830	9	0	\N	\N	CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O	\N
3236	ERIVEDGE	VISMODEGIB	24776445	C19H14Cl2N2O3S	421.292	\N	3.8	1	4	4	84.5	27	0	625	0	0	\N	\N	CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl	2-chloro-N-[4-chloro-3-(2-pyridyl)phenyl]-4-methylsulfonyl-benzamide
250	AFAXIN	VITAMIN A PALMITATE	5280531	C36H60O2	524.874	\N	13.6	0	2	21	26.3	38	0	803	0	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C	[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
375	ALPHALIN	VITAMIN A PALMITATE	5280531	C36H60O2	524.874	\N	13.6	0	2	21	26.3	38	0	803	0	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C	[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
4278	INFUVITE PEDIATRIC	VITAMIN A	445354	C20H30O	286.459	\N	5.7	1	1	5	20.2	21	0	496	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
4291	INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)	VITAMIN A	445354	C20H30O	286.459	\N	5.7	1	1	5	20.2	21	0	496	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
5184	M.V.I. ADULT	VITAMIN A	445354	C20H30O	286.459	\N	5.7	1	1	5	20.2	21	0	496	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
5197	M.V.I. ADULT (PHARMACY BULK PACKAGE)	VITAMIN A	445354	C20H30O	286.459	\N	5.7	1	1	5	20.2	21	0	496	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
5211	M.V.I. PEDIATRIC	VITAMIN A	445354	C20H30O	286.459	\N	5.7	1	1	5	20.2	21	0	496	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
5223	M.V.I.-12	VITAMIN A	445354	C20H30O	286.459	\N	5.7	1	1	5	20.2	21	0	496	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
5235	M.V.I.-12	VITAMIN A	445354	C20H30O	286.459	\N	5.7	1	1	5	20.2	21	0	496	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
5247	M.V.I.-12 (WITHOUT VITAMIN K)	VITAMIN A	445354	C20H30O	286.459	\N	5.7	1	1	5	20.2	21	0	496	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
5726	MVC PLUS	VITAMIN A	445354	C20H30O	286.459	\N	5.7	1	1	5	20.2	21	0	496	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
1061	BEROCCA PN	VITAMIN E	14985	C29H50O2	430.717	\N	10.7	1	2	12	29.5	31	0	503	3	0	\N	\N	CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O	(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
5198	M.V.I. ADULT (PHARMACY BULK PACKAGE)	VITAMIN E	14985	C29H50O2	430.717	\N	10.7	1	2	12	29.5	31	0	503	3	0	\N	\N	CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O	(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
5212	M.V.I. PEDIATRIC	VITAMIN E	14985	C29H50O2	430.717	\N	10.7	1	2	12	29.5	31	0	503	3	0	\N	\N	CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O	(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
5224	M.V.I.-12	VITAMIN E	14985	C29H50O2	430.717	\N	10.7	1	2	12	29.5	31	0	503	3	0	\N	\N	CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O	(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
5236	M.V.I.-12	VITAMIN E	14985	C29H50O2	430.717	\N	10.7	1	2	12	29.5	31	0	503	3	0	\N	\N	CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O	(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
5248	M.V.I.-12 (WITHOUT VITAMIN K)	VITAMIN E	14985	C29H50O2	430.717	\N	10.7	1	2	12	29.5	31	0	503	3	0	\N	\N	CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O	(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
5260	M.V.I.-12 LYOPHILIZED	VITAMIN E	14985	C29H50O2	430.717	\N	10.7	1	2	12	29.5	31	0	503	3	0	\N	\N	CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O	(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
5727	MVC PLUS	VITAMIN E	14985	C29H50O2	430.717	\N	10.7	1	2	12	29.5	31	0	503	3	0	\N	\N	CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O	(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
9906	ZONTIVITY	VORAPAXAR SULFATE	10077129	C29H35FN2O8S	590.663	\N	\N	3	10	6	161	41	0	902	7	0	\N	\N	CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C.OS(=O)(=O)O	ethyl N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(E)-2-[5-(3-fluorophenyl)-2-pyridyl]vinyl]-1-methyl-3-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f]isobenzofuran-6-yl]carbamate;sulfuric acid
9572	VFEND	VORICONAZOLE	71616	C16H14F3N5O	349.317	\N	1.5	1	8	5	76.7	25	0	448	2	0	\N	\N	CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O	(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
9694	VORICONAZOLE	VORICONAZOLE	71616	C16H14F3N5O	349.317	\N	1.5	1	8	5	76.7	25	0	448	2	0	\N	\N	CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O	(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
828	ATHROMBIN-K	WARFARIN POTASSIUM	23706212	C19H15KO4	346.423	\N	\N	0	4	4	66.4	24	0	508	0	1	\N	\N	CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)[O-].[K+]	potassium;2-oxo-3-(3-oxo-1-phenyl-butyl)chromen-4-olate
4570	JANTOVEN	WARFARIN SODIUM	16204922	C19H15NaO4	330.315	\N	\N	0	4	4	66.4	24	0	508	0	1	\N	\N	CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)[O-].[Na+]	sodium;2-oxo-3-(3-oxo-1-phenyl-butyl)chromen-4-olate
6637	PANWARFIN	WARFARIN SODIUM	16204922	C19H15NaO4	330.315	\N	\N	0	4	4	66.4	24	0	508	0	1	\N	\N	CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)[O-].[Na+]	sodium;2-oxo-3-(3-oxo-1-phenyl-butyl)chromen-4-olate
9752	XENON XE 127	XENON XE-127	166973	Xe	126.905	\N	\N	0	0	0	0	1	0	0	0	0	\N	\N	[Xe]	xenon-127
9753	XENON XE 133	XENON XE-133	66376	Xe	132.906	\N	\N	0	0	0	0	1	0	0	0	0	\N	\N	[Xe]	xenon-133
9754	XENON XE 133-V.S.S.	XENON XE-133	66376	Xe	132.906	\N	\N	0	0	0	0	1	0	0	0	0	\N	\N	[Xe]	xenon-133
9791	XYLOSE	XYLOSE	135191	C5H10O5	150.13	\N	-2.5	4	5	0	90.2	10	0	117	3	1	\N	\N	C1C(C(C(C(O1)O)O)O)O	(3R,4S,5R)-tetrahydropyran-2,3,4,5-tetrol
9807	ZAFIRLUKAST	ZAFIRLUKAST	5717	C31H33N3O6S	575.68	\N	5.5	2	6	9	124	41	0	1010	0	0	\N	\N	CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC	cyclopentyl N-[3-[[2-methoxy-4-(o-tolylsulfonylcarbamoyl)phenyl]methyl]-1-methyl-indol-5-yl]carbamate
3960	HIVID	ZALCITABINE	24066	C9H13N3O3	211.221	\N	-1.3	2	3	2	88.2	15	0	327	2	0	\N	\N	C1CC(OC1CO)N2C=CC(=NC2=O)N	4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one
8371	SONATA	ZALEPLON	5719	C17H15N5O	305.341	\N	1	0	4	3	74.3	23	0	487	0	0	\N	\N	CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C	N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamide
7923	RELENZA	ZANAMIVIR	60855	C12H20N4O7	332.313	\N	-3.2	7	8	6	201	23	0	518	5	0	\N	\N	CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N	(2R,3R,4S)-3-acetamido-4-guanidino-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
14	ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
1983	COMBIVIR	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
2725	DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2730	DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2735	DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2740	DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
2745	DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4304	INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4309	INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4314	INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4319	INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4324	INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4328	INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4332	INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4442	ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4449	ISOLYTE E IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4455	ISOLYTE E W/ DEXTROSE 5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4492	ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4498	ISOLYTE R W/ DEXTROSE 5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4606	KABIVEN IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
4723	LACTATED RINGER'S IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
6793	PERIKABIVEN IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
6888	PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
6973	PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
6980	PLASMA-LYTE R IN PLASTIC CONTAINER	CALCIUM CHLORIDE	5284359	CaCl2	110.978	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Cl-].[Cl-].[Ca+2]	calcium;dichloride
9937	ZYFLO CR	ZILEUTON	60490	C11H12N2O2S	236.289	\N	1.6	2	3	2	94.8	16	0	275	0	1	\N	\N	CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O	1-[1-(benzothiophen-2-yl)ethyl]-1-hydroxy-urea
3683	GALZIN	ZINC ACETATE	11192	C4H6O4Zn	183.468	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Zn+2]	zinc;diacetate
9705	VUSION	ZINC OXIDE	14806	OZn	81.379	\N	\N	0	1	0	17.1	2	0	2	0	0	\N	\N	O=[Zn]	oxozinc
3740	GEODON	ZIPRASIDONE HYDROCHLORIDE	219099	C21H22Cl2N4OS	449.394	\N	\N	2	5	4	76.7	29	0	573	0	0	\N	\N	C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.Cl	5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one;hydrochloride
9880	ZIPRASIDONE HYDROCHLORIDE	ZIPRASIDONE HYDROCHLORIDE	219099	C21H22Cl2N4OS	449.394	\N	\N	2	5	4	76.7	29	0	573	0	0	\N	\N	C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.Cl	5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one;hydrochloride
3741	GEODON	ZIPRASIDONE MESYLATE	154068	C22H25ClN4O4S2	509.036	\N	\N	2	8	4	140	33	0	665	0	0	\N	\N	CS(=O)(=O)O.C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54	5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one;methanesulfonic acid
9892	ZOLEDRONIC ACID	ZOLEDRONIC ACID	68740	C5H10N2O7P2	272.09	\N	-4.3	5	8	4	153	16	0	327	0	0	\N	\N	C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O	(1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid
9900	ZOMETA	ZOLEDRONIC ACID	68740	C5H10N2O7P2	272.09	\N	-4.3	5	8	4	153	16	0	327	0	0	\N	\N	C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O	(1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid
9901	ZOMIG	ZOLMITRIPTAN	60857	C16H21N3O2	287.363	\N	2.2	2	3	5	57.4	21	0	375	1	0	\N	\N	CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3	(4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]oxazolidin-2-one
9902	ZOMIG-ZMT	ZOLMITRIPTAN	60857	C16H21N3O2	287.363	\N	2.2	2	3	5	57.4	21	0	375	1	0	\N	\N	CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3	(4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]oxazolidin-2-one
9905	ZONISAMIDE	ZONISAMIDE	5734	C8H8N2O3S	212.223	\N	0.2	1	5	2	94.6	14	0	298	0	0	\N	\N	C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N	1,2-benzoxazol-3-ylmethanesulfonamide
4711	KYPROLIS	CARFILZOMIB	11556711	C40H57N5O7	719.924	\N	4.7	4	8	20	159	52	0	1180	5	0	\N	\N	CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4	(2S)-N-[(1S)-1-benzyl-2-[[(1S)-3-methyl-1-[(2R)-2-methyloxirane-2-carbonyl]butyl]amino]-2-oxo-ethyl]-4-methyl-2-[[(2S)-2-[(2-morpholinoacetyl)amino]-4-phenyl-butanoyl]amino]pentanamide
8361	SOMA COMPOUND	CARISOPRODOL	2576	C12H24N2O4	260.334	\N	1.9	2	4	9	90.6	18	0	281	0	1	\N	\N	CCCC(C)(COC(=O)N)COC(=O)NC(C)C	[2-(carbamoyloxymethyl)-2-methyl-pentyl] N-isopropylcarbamate
1427	CARISOPRODOL COMPOUND	CARISOPRODOL	2576	C12H24N2O4	260.334	\N	1.9	2	4	9	90.6	18	0	281	0	1	\N	\N	CCCC(C)(COC(=O)N)COC(=O)NC(C)C	[2-(carbamoyloxymethyl)-2-methyl-pentyl] N-isopropylcarbamate
1429	CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE	CARISOPRODOL	2576	C12H24N2O4	260.334	\N	1.9	2	4	9	90.6	18	0	281	0	1	\N	\N	CCCC(C)(COC(=O)N)COC(=O)NC(C)C	[2-(carbamoyloxymethyl)-2-methyl-pentyl] N-isopropylcarbamate
7921	RELA	CARISOPRODOL	2576	C12H24N2O4	260.334	\N	1.9	2	4	9	90.6	18	0	281	0	1	\N	\N	CCCC(C)(COC(=O)N)COC(=O)NC(C)C	[2-(carbamoyloxymethyl)-2-methyl-pentyl] N-isopropylcarbamate
8363	SOMA COMPOUND W/ CODEINE	CARISOPRODOL	2576	C12H24N2O4	260.334	\N	1.9	2	4	9	90.6	18	0	281	0	1	\N	\N	CCCC(C)(COC(=O)N)COC(=O)NC(C)C	[2-(carbamoyloxymethyl)-2-methyl-pentyl] N-isopropylcarbamate
3765	GLIADEL	CARMUSTINE	2578	C5H9Cl2N3O2	214.046	\N	1.5	1	3	4	61.8	12	0	156	0	0	\N	\N	C(CCl)NC(=O)N(CCCl)N=O	1,3-bis(2-chloroethyl)-1-nitroso-urea
2021	COREG	CARVEDILOL	2585	C24H26N2O4	406.482	\N	4.2	3	5	10	75.7	30	0	508	0	1	\N	\N	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
1457	CEFACLOR	CEFACLOR	51039	C15H14ClN3O4S	367.804	\N	-1.8	3	6	4	138	24	0	606	3	0	\N	\N	C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl	(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
7870	RANICLOR	CEFACLOR	51039	C15H14ClN3O4S	367.804	\N	-1.8	3	6	4	138	24	0	606	3	0	\N	\N	C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl	(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
4645	KEFZOL	CEFAZOLIN SODIUM	23675322	C14H13N8NaO4S3	476.48	\N	\N	1	12	7	238	30	0	746	2	0	\N	\N	CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
8399	SPECTRACEF	CEFDITOREN PIVOXIL	6437877	C25H28N6O7S3	620.714	\N	4.7	2	14	12	257	41	0	1160	2	0	\N	\N	CC1=C(SC=N1)C=CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)OCOC(=O)C(C)(C)C	2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(Z)-2-(4-methylthiazol-5-yl)vinyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1464	CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER	CEFEPIME HYDROCHLORIDE	9571075	C19H28Cl2N6O6S2	571.489	\N	\N	5	12	7	202	35	0	874	2	0	\N	\N	C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;chloride;hydrate;hydrochloride
1466	CEFEPIME IN PLASTIC CONTAINER	CEFEPIME HYDROCHLORIDE	9571075	C19H28Cl2N6O6S2	571.489	\N	\N	5	12	7	202	35	0	874	2	0	\N	\N	C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;chloride;hydrate;hydrochloride
5325	MAXIPIME	CEFEPIME HYDROCHLORIDE	9571075	C19H28Cl2N6O6S2	571.489	\N	\N	5	12	7	202	35	0	874	2	0	\N	\N	C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;chloride;hydrate;hydrochloride
1701	CLAFORAN	CEFOTAXIME SODIUM	10695961	C16H16N5NaO7S2	477.442	\N	\N	2	12	8	230	31	0	839	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1702	CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER	CEFOTAXIME SODIUM	10695961	C16H16N5NaO7S2	477.442	\N	\N	2	12	8	230	31	0	839	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1703	CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	CEFOTAXIME SODIUM	10695961	C16H16N5NaO7S2	477.442	\N	\N	2	12	8	230	31	0	839	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1475	CEFOTAN IN PLASTIC CONTAINER	CEFOTETAN DISODIUM	53024	C17H15N7Na2O8S4	619.568	\N	\N	2	15	7	327	38	0	1080	2	0	\N	\N	CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)[O-])S4)OC)SC2)C(=O)[O-].[Na+].[Na+]	disodium;(6R,7S)-7-[[4-(2-amino-1-carboxylato-2-oxo-ethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1480	CEFOTETAN	CEFOTETAN DISODIUM	53024	C17H15N7Na2O8S4	619.568	\N	\N	2	15	7	327	38	0	1080	2	0	\N	\N	CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)[O-])S4)OC)SC2)C(=O)[O-].[Na+].[Na+]	disodium;(6R,7S)-7-[[4-(2-amino-1-carboxylato-2-oxo-ethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1481	CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER	CEFOTETAN DISODIUM	53024	C17H15N7Na2O8S4	619.568	\N	\N	2	15	7	327	38	0	1080	2	0	\N	\N	CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)[O-])S4)OC)SC2)C(=O)[O-].[Na+].[Na+]	disodium;(6R,7S)-7-[[4-(2-amino-1-carboxylato-2-oxo-ethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
5367	MEFOXIN	CEFOXITIN SODIUM	23667300	C16H16N3NaO7S2	449.428	\N	\N	2	9	8	205	29	0	750	2	0	\N	\N	COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3.[Na+]	sodium;(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
4967	LIMBITROL DS	CHLORDIAZEPOXIDE	2712	C16H14ClN3O	299.758	\N	2.4	1	3	1	48.2	21	0	580	0	0	\N	\N	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine
5369	MEFOXIN IN PLASTIC CONTAINER	CEFOXITIN SODIUM	23667300	C16H16N3NaO7S2	449.428	\N	\N	2	9	8	205	29	0	750	2	0	\N	\N	COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3.[Na+]	sodium;(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
5370	MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	CEFOXITIN SODIUM	23667300	C16H16N3NaO7S2	449.428	\N	\N	2	9	8	205	29	0	750	2	0	\N	\N	COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3.[Na+]	sodium;(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
3620	FORTAZ	CEFTAZIDIME	5481173	C22H22N6O7S2	546.573	\N	0.4	3	12	8	245	37	0	1020	2	0	\N	\N	CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1489	CEFTAZIDIME IN DEXTROSE CONTAINER	CEFTAZIDIME	5481173	C22H22N6O7S2	546.573	\N	0.4	3	12	8	245	37	0	1020	2	0	\N	\N	CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1522	CEPTAZ	CEFTAZIDIME	5481173	C22H22N6O7S2	546.573	\N	0.4	3	12	8	245	37	0	1020	2	0	\N	\N	CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
6748	PENTACEF	CEFTAZIDIME	5481173	C22H22N6O7S2	546.573	\N	0.4	3	12	8	245	37	0	1020	2	0	\N	\N	CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
8700	TAZICEF	CEFTAZIDIME	5481173	C22H22N6O7S2	546.573	\N	0.4	3	12	8	245	37	0	1020	2	0	\N	\N	CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
8701	TAZIDIME	CEFTAZIDIME	5481173	C22H22N6O7S2	546.573	\N	0.4	3	12	8	245	37	0	1020	2	0	\N	\N	CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
8702	TAZIDIME IN PLASTIC CONTAINER	CEFTAZIDIME	5481173	C22H22N6O7S2	546.573	\N	0.4	3	12	8	245	37	0	1020	2	0	\N	\N	CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]	(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
8065	ROCEPHIN	CEFTRIAXONE SODIUM	23679441	C18H17N8NaO7S3	576.553	\N	\N	3	13	8	291	37	0	1120	2	0	\N	\N	CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
8066	ROCEPHIN KIT	CEFTRIAXONE SODIUM	23679441	C18H17N8NaO7S3	576.553	\N	\N	3	13	8	291	37	0	1120	2	0	\N	\N	CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
8068	ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER	CEFTRIAXONE SODIUM	23679441	C18H17N8NaO7S3	576.553	\N	\N	3	13	8	291	37	0	1120	2	0	\N	\N	CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-].[Na+]	sodium;(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
9865	ZINACEF	CEFUROXIME SODIUM	23670318	C16H15N4NaO8S	446.366	\N	\N	2	10	8	202	30	0	804	2	0	\N	\N	CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
9866	ZINACEF IN PLASTIC CONTAINER	CEFUROXIME SODIUM	23670318	C16H15N4NaO8S	446.366	\N	\N	2	10	8	202	30	0	804	2	0	\N	\N	CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
4639	KEFLEX	CEPHALEXIN	27447	C16H17N3O4S	347.389	\N	0.6	3	6	4	138	24	0	600	3	0	\N	\N	CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O	(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
6632	PANIXINE DISPERDOSE	CEPHALEXIN	27447	C16H17N3O4S	347.389	\N	0.6	3	6	4	138	24	0	600	3	0	\N	\N	CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O	(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
1517	CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER	CEPHALOTHIN SODIUM	23675321	C16H15N2NaO6S2	418.414	\N	\N	1	8	7	169	27	0	686	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1518	CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER	CEPHALOTHIN SODIUM	23675321	C16H15N2NaO6S2	418.414	\N	\N	1	8	7	169	27	0	686	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
4640	KEFLIN	CEPHALOTHIN SODIUM	23675321	C16H15N2NaO6S2	418.414	\N	\N	1	8	7	169	27	0	686	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
4641	KEFLIN IN PLASTIC CONTAINER	CEPHALOTHIN SODIUM	23675321	C16H15N2NaO6S2	418.414	\N	\N	1	8	7	169	27	0	686	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
8187	SEFFIN	CEPHALOTHIN SODIUM	23675321	C16H15N2NaO6S2	418.414	\N	\N	1	8	7	169	27	0	686	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1519	CEPHAPIRIN SODIUM	CEPHAPIRIN SODIUM	23675312	C17H16N3NaO6S2	445.44	\N	\N	1	9	8	179	29	0	713	2	0	\N	\N	CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)[O-].[Na+]	sodium;(6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(4-pyridylsulfanyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
9529	VELOSEF	CEPHRADINE	38103	C16H19N3O4S	349.405	\N	0.4	3	6	4	138	24	0	697	3	0	\N	\N	CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O	(6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-yl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
9940	ZYKADIA	CERITINIB	57379345	C28H36ClN5O3S	558.138	\N	6.4	3	8	9	114	38	0	835	0	0	\N	\N	CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl	5-chloro-N2-[2-isopropoxy-5-methyl-4-(4-piperidyl)phenyl]-N4-(2-isopropylsulfonylphenyl)pyrimidine-2,4-diamine
9950	ZYRTEC ALLERGY	CETIRIZINE HYDROCHLORIDE	55182	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	0	1	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
9951	ZYRTEC HIVES RELIEF	CETIRIZINE HYDROCHLORIDE	55182	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	0	1	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
9952	ZYRTEC-D 12 HOUR	CETIRIZINE HYDROCHLORIDE	55182	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	0	1	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
1541	CETIRIZINE HYDROCHLORIDE HIVES	CETIRIZINE HYDROCHLORIDE	55182	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	0	1	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
1542	CETIRIZINE HYDROCHLORIDE HIVES RELIEF	CETIRIZINE HYDROCHLORIDE	55182	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	0	1	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
1563	CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY	CETIRIZINE HYDROCHLORIDE	55182	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	0	1	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
1564	CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF	CETIRIZINE HYDROCHLORIDE	55182	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	0	1	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
1573	CHILDREN'S ZYRTEC ALLERGY	CETIRIZINE HYDROCHLORIDE	55182	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	0	1	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
1574	CHILDREN'S ZYRTEC HIVES RELIEF	CETIRIZINE HYDROCHLORIDE	55182	C21H27Cl3N2O3	461.808	\N	\N	3	5	8	53	29	0	443	0	1	\N	\N	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl	2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
1544	CETROTIDE	CETRORELIX	25074887	C70H92ClN17O14	1431.061	\N	1.9	16	16	38	498	102	0	2840	10	0	\N	\N	CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCNC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C	(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-(2-naphthyl)propanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-(3-pyridyl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-ureido-pentanoyl]amino]-4-methyl-pentanoyl]amino]-5-guanidino-pentanoyl]-N-[(1R)-2-amino-1-methyl-2-oxo-ethyl]pyrrolidine-2-carboxamide
4865	LEUKERAN	CHLORAMBUCIL	2708	C14H19Cl2NO2	304.211	\N	1.7	1	3	9	40.5	19	0	250	0	0	\N	\N	C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl	4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid
6387	OPHTHOCHLOR	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
1612	CHLOROPTIC-P S.O.P.	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
3034	ECONOCHLOR	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
3071	ELASE-CHLOROMYCETIN	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
5735	MYCHEL	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
6388	OPHTHOCORT	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
6404	OPTOMYCIN	CHLORAMPHENICOL	5959	C11H12Cl2N2O5	323.126	\N	1.1	3	5	5	115	20	0	342	2	0	\N	\N	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
5150	LYGEN	CHLORDIAZEPOXIDE HYDROCHLORIDE	9916	C16H15Cl2N3O	336.216	\N	\N	2	3	1	48.2	22	0	580	0	0	\N	\N	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O.Cl	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine;hydrochloride
4	A-POXIDE	CHLORDIAZEPOXIDE HYDROCHLORIDE	9916	C16H15Cl2N3O	336.216	\N	\N	2	3	1	48.2	22	0	580	0	0	\N	\N	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O.Cl	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine;hydrochloride
4922	LIBRAX	CHLORDIAZEPOXIDE HYDROCHLORIDE	9916	C16H15Cl2N3O	336.216	\N	\N	2	3	1	48.2	22	0	580	0	0	\N	\N	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O.Cl	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine;hydrochloride
4926	LIBRIUM	CHLORDIAZEPOXIDE HYDROCHLORIDE	9916	C16H15Cl2N3O	336.216	\N	\N	2	3	1	48.2	22	0	580	0	0	\N	\N	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O.Cl	7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine;hydrochloride
2702	DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7438	PREVACARE R	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
1585	CHLORAPREP ONE-STEP FREPP	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
1587	CHLORAPREP ONE-STEP SEPP	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
1589	CHLORAPREP SINGLE SWABSTICK	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
1591	CHLORAPREP TRIPLE SWABSTICK	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
1593	CHLORAPREP WITH TINT	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
1599	CHLORHEXIDINE GLUCONATE	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
1655	CIDA-STAT	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
3004	DYNA-HEX	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
3019	E-Z SCRUB	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
3385	EXIDINE	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
3948	HIBICLENS	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
3949	HIBISTAT	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
5544	MICRODERM	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
6660	PAROEX	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
6791	PERIDEX	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
6801	PERIOCHIP	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
6802	PERIOGARD	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
6822	PHARMASEAL SCRUB CARE	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
7449	PREVANTICS MAXI SWABSTICK	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
7451	PREVANTICS SWAB	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
7453	PREVANTICS SWABSTICK	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
2707	DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
8466	STERI-STAT	CHLORHEXIDINE GLUCONATE	9552079	C22H30Cl2N10	505.452	\N	0.1	6	2	13	178	34	0	649	0	0	\N	\N	C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine
1621	CHLOROTHIAZIDE-RESERPINE	CHLOROTHIAZIDE	2720	C7H6ClN3O4S2	295.712	\N	-0.2	2	6	1	135	17	0	532	0	0	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2	6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
8650	TACE	CHLOROTRIANISENE	11289	C23H21ClO3	380.868	\N	6.4	0	3	6	27.7	27	0	442	0	0	\N	\N	COC1=CC=C(C=C1)C(=C(C2=CC=C(C=C2)OC)Cl)C3=CC=C(C=C3)OC	1-[1-chloro-2,2-bis(4-methoxyphenyl)vinyl]-4-methoxy-benzene
3065	EFIDAC 24 CHLORPHENIRAMINE MALEATE	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
6843	PHENETRON	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
8744	TELDRIN	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
9678	VITUZ	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
1555	CHILDREN'S ADVIL ALLERGY SINUS	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
1577	CHLOR-TRIMETON	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
1578	CHLOR-TRIMETON	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
1904	CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
1918	CODIMAL-L.A. 12	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
1934	COLD CAPSULE IV	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
1936	COLD CAPSULE V	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
4067	HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
4075	HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
4078	HYDROCODONE BITARTRATE,CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
7784	PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
7807	PYRIDAMAL 100	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
9197	TRIAMINIC-12	CHLORPHENIRAMINE MALEATE	5281068	C20H23ClN2O4	390.864	\N	\N	2	6	7	90.7	27	0	368	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
4081	HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX	CHLORPHENIRAMINE POLISTIREX	2725	C16H19ClN2	274.792	\N	3.4	0	2	5	16.1	19	0	249	0	1	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2	3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine
8876	THORAZINE	CHLORPROMAZINE	2726	C17H19ClN2S	318.863	\N	5.2	0	3	4	31.8	21	0	339	0	0	\N	\N	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl	3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine
2631	DIABINESE	CHLORPROPAMIDE	2727	C10H13ClN2O3S	276.735	\N	2.3	2	3	4	83.6	17	0	345	0	0	\N	\N	CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl	1-(4-chlorophenyl)sulfonyl-3-propyl-urea
4282	INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)	CHOLECALCIFEROL	5280795	C27H44O	384.648	\N	7.9	1	1	6	20.2	28	0	610	5	0	\N	\N	CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-dimethylhexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
5028	LOCHOLEST LIGHT	CHOLESTYRAMINE	70695641	C21H30N+	296.478	\N	5.7	0	0	6	0	22	1	300	0	1	\N	\N	CCC1=CC=C(C=C1)C(C)CCC2=CC=C(C=C2)[N+](C)(C)C	[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethyl-ammonium
7448	PREVALITE	CHOLESTYRAMINE	70695641	C21H30N+	296.478	\N	5.7	0	0	6	0	22	1	300	0	1	\N	\N	CCC1=CC=C(C=C1)C(C)CCC2=CC=C(C=C2)[N+](C)(C)C	[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethyl-ammonium
7833	QUESTRAN LIGHT	CHOLESTYRAMINE	70695641	C21H30N+	296.478	\N	5.7	0	0	6	0	22	1	300	0	1	\N	\N	CCC1=CC=C(C=C1)C(C)CCC2=CC=C(C=C2)[N+](C)(C)C	[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethyl-ammonium
1631	CHOLBAM	CHOLIC ACID	221493	C24H40O5	408.579	\N	3.6	4	5	4	98	29	0	637	11	0	\N	\N	CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C	(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
7478	PRIMAXIN	CILASTATIN SODIUM	23663403	C16H25N2NaO5S	380.435	\N	\N	3	7	11	158	25	0	525	2	0	\N	\N	CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)[O-])C.[Na+]	sodium;(Z)-7-[(2R)-2-amino-2-carboxy-ethyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoate
6997	PLETAL	CILOSTAZOL	2754	C20H27N5O2	369.469	\N	3.1	1	5	7	81.9	27	0	485	0	0	\N	\N	C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4	6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one
8657	TAGAMET	CIMETIDINE HYDROCHLORIDE	50963	C10H17ClN6S	288.798	\N	\N	4	4	7	114	18	0	296	0	0	\N	\N	CC1=C(N=CN1)CSCCNC(=NC)NC#N.Cl	1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine;hydrochloride
8660	TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	CIMETIDINE HYDROCHLORIDE	50963	C10H17ClN6S	288.798	\N	\N	4	4	7	114	18	0	296	0	0	\N	\N	CC1=C(N=CN1)CSCCNC(=NC)NC#N.Cl	1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine;hydrochloride
6540	OTOVEL	CIPROFLOXACIN HYDROCHLORIDE	62999	C17H19ClFN3O3	367.805	\N	\N	3	7	3	72.9	25	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.Cl	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid;hydrochloride
1677	CIPRO XR	CIPROFLOXACIN HYDROCHLORIDE	62999	C17H19ClFN3O3	367.805	\N	\N	3	7	3	72.9	25	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.Cl	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid;hydrochloride
1682	CIPROFLOXACIN EXTENDED RELEASE	CIPROFLOXACIN HYDROCHLORIDE	62999	C17H19ClFN3O3	367.805	\N	\N	3	7	3	72.9	25	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.Cl	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid;hydrochloride
1683	CIPROFLOXACIN HYDROCHLORIDE	CIPROFLOXACIN HYDROCHLORIDE	62999	C17H19ClFN3O3	367.805	\N	\N	3	7	3	72.9	25	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.Cl	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid;hydrochloride
1681	CIPROFLOXACIN EXTENDED RELEASE	CIPROFLOXACIN	2764	C17H18FN3O3	331.347	\N	-1.1	2	7	3	72.9	24	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
1684	CIPROFLOXACIN IN DEXTROSE 5%	CIPROFLOXACIN	2764	C17H18FN3O3	331.347	\N	-1.1	2	7	3	72.9	24	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
1685	CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER	CIPROFLOXACIN	2764	C17H18FN3O3	331.347	\N	-1.1	2	7	3	72.9	24	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
6531	OTIPRIO	CIPROFLOXACIN	2764	C17H18FN3O3	331.347	\N	-1.1	2	7	3	72.9	24	0	571	0	0	\N	\N	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
6006	NIMBEX	CISATRACURIUM BESYLATE	62886	C65H82N2O18S2	1243.487	\N	\N	0	18	26	258	87	0	1560	4	0	\N	\N	C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]	benzenesulfonate;5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
6007	NIMBEX PRESERVATIVE FREE	CISATRACURIUM BESYLATE	62886	C65H82N2O18S2	1243.487	\N	\N	0	18	26	258	87	0	1560	4	0	\N	\N	C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]	benzenesulfonate;5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
7460	PREVPAC	CLARITHROMYCIN	84029	C38H69NO13	747.964	\N	3.2	4	14	8	183	52	0	1190	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
4808	LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN	CLARITHROMYCIN	84029	C38H69NO13	747.964	\N	3.2	4	14	8	183	52	0	1190	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
6338	OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN	CLARITHROMYCIN	84029	C38H69NO13	747.964	\N	3.2	4	14	8	183	52	0	1190	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
8903	TIMENTIN	CLAVULANATE POTASSIUM	23665591	C8H8KNO5	237.252	\N	\N	1	5	2	89.9	15	0	329	2	0	\N	\N	C1C2N(C1=O)C(C(=CCO)O2)C(=O)[O-].[K+]	potassium;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
8905	TIMENTIN IN PLASTIC CONTAINER	CLAVULANATE POTASSIUM	23665591	C8H8KNO5	237.252	\N	\N	1	5	2	89.9	15	0	329	2	0	\N	\N	C1C2N(C1=O)C(C(=CCO)O2)C(=O)[O-].[K+]	potassium;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
1732	CLEVIPREX	CLEVIDIPINE	153994	C21H23Cl2NO6	456.316	\N	4.3	1	7	10	90.9	30	0	748	0	1	\N	\N	CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C	O5-(butanoyloxymethyl) O3-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
7826	QUARZAN	CLIDINIUM BROMIDE	19004	C22H26BrNO3	432.358	\N	\N	1	4	5	46.5	27	0	482	0	1	\N	\N	C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O.[Br-]	(1-methylquinuclidin-1-ium-3-yl) 2-hydroxy-2,2-diphenyl-acetate;bromide
1738	CLINDAMYCIN HYDROCHLORIDE	CLINDAMYCIN HYDROCHLORIDE	16051951	C18H34Cl2N2O5S	461.439	\N	\N	5	7	7	128	28	0	502	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl.Cl	(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide;hydrochloride
1729	CLEOCIN PHOSPHATE	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
1730	CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
1731	CLEOCIN T	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
1736	CLINDA-DERM	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
1737	CLINDAGEL	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
1740	CLINDAMYCIN PHOSPHATE	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
1742	CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
1743	CLINDAMYCIN PHOSPHATE AND TRETINOIN	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
1745	CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
1746	CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
1747	CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
1748	CLINDESSE	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
1749	CLINDETS	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
2942	DUAC	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
3366	EVOCLIN	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
6370	ONEXTON	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
9539	VELTIN	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
9860	ZIANA	CLINDAMYCIN PHOSPHATE	443385	C18H34ClN2O8PS	504.96	\N	-1.2	5	10	9	174	31	0	658	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
6331	OLUX	CLOBETASOL PROPIONATE	32798	C25H32ClFO5	466.974	\N	3.8	1	6	5	80.7	32	0	929	8	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl	[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
2864	DOBUTREX	DOBUTAMINE HYDROCHLORIDE	65324	C18H24ClNO3	337.844	\N	\N	5	4	7	72.7	23	0	305	0	1	\N	\N	CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O.Cl	4-[2-[[3-(4-hydroxyphenyl)-1-methyl-propyl]amino]ethyl]benzene-1,2-diol;hydrochloride
6332	OLUX E	CLOBETASOL PROPIONATE	32798	C25H32ClFO5	466.974	\N	3.8	1	6	5	80.7	32	0	929	8	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl	[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
8757	TEMOVATE	CLOBETASOL PROPIONATE	32798	C25H32ClFO5	466.974	\N	3.8	1	6	5	80.7	32	0	929	8	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl	[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
8758	TEMOVATE E	CLOBETASOL PROPIONATE	32798	C25H32ClFO5	466.974	\N	3.8	1	6	5	80.7	32	0	929	8	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl	[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
1869	CLOLAR	CLOFARABINE	119182	C10H11ClFN5O3	303.678	\N	0.9	3	8	2	119	20	0	370	4	0	\N	\N	C1=NC2=C(N1C3C(C(C(O3)CO)O)F)N=C(N=C2N)Cl	(2R,3R,4S,5R)-5-(6-amino-2-chloro-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol
4688	KLONOPIN RAPIDLY DISINTEGRATING	CLONAZEPAM	2802	C15H10ClN3O3	315.713	\N	2.4	1	4	1	87.3	22	0	491	0	0	\N	\N	C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl	5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
4579	JENLOGA	CLONIDINE HYDROCHLORIDE	20179	C9H10Cl3N3	266.55	\N	\N	3	1	2	36.4	15	0	222	0	0	\N	\N	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl	N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine;hydrochloride
1883	CLORPRES	CLONIDINE HYDROCHLORIDE	20179	C9H10Cl3N3	266.55	\N	\N	3	1	2	36.4	15	0	222	0	0	\N	\N	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl	N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine;hydrochloride
1977	COMBIPRES	CLONIDINE HYDROCHLORIDE	20179	C9H10Cl3N3	266.55	\N	\N	3	1	2	36.4	15	0	222	0	0	\N	\N	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl	N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine;hydrochloride
4631	KAPVAY	CLONIDINE HYDROCHLORIDE	20179	C9H10Cl3N3	266.55	\N	\N	3	1	2	36.4	15	0	222	0	0	\N	\N	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl	N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine;hydrochloride
6988	PLAVIX	CLOPIDOGREL BISULFATE	115366	C16H18ClNO6S2	419.891	\N	\N	2	8	4	141	26	0	463	1	0	\N	\N	COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O	methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric acid
9013	TRANXENE	CLORAZEPATE DIPOTASSIUM	2809	C16H11ClN2O3	314.725	\N	3.3	2	4	2	78.8	22	0	488	0	1	\N	\N	C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O	7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid
5731	MYCELEX	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
3842	GYNE-LOTRIMIN 3 COMBINATION PACK	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
3843	GYNE-LOTRIMIN COMBINATION PACK	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
3845	GYNIX	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
5101	LOTRIMIN	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
5102	LOTRIMIN AF	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
5105	LOTRISONE	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
5732	MYCELEX-7	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
5733	MYCELEX-7 COMBINATION PACK	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
5734	MYCELEX-G	CLOTRIMAZOLE	2812	C22H17ClN2	344.842	\N	5	0	1	4	17.8	25	0	396	0	0	\N	\N	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4	1-[(2-chlorophenyl)-diphenyl-methyl]imidazole
3735	GENVOYA	COBICISTAT	25151504	C40H53N7O5S2	776.028	\N	5.7	3	10	20	195	54	0	1120	3	0	\N	\N	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5	thiazol-5-ylmethyl N-[(1R,4R)-1-benzyl-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-4-morpholino-butanoyl]amino]-5-phenyl-pentyl]carbamate
7462	PREZCOBIX	COBICISTAT	25151504	C40H53N7O5S2	776.028	\N	5.7	3	10	20	195	54	0	1120	3	0	\N	\N	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5	thiazol-5-ylmethyl N-[(1R,4R)-1-benzyl-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-4-morpholino-butanoyl]amino]-5-phenyl-pentyl]carbamate
8486	STRIBILD	COBICISTAT	25151504	C40H53N7O5S2	776.028	\N	5.7	3	10	20	195	54	0	1120	3	0	\N	\N	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5	thiazol-5-ylmethyl N-[(1R,4R)-1-benzyl-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-4-morpholino-butanoyl]amino]-5-phenyl-pentyl]carbamate
9337	TYBOST	COBICISTAT	25151504	C40H53N7O5S2	776.028	\N	5.7	3	10	20	195	54	0	1120	3	0	\N	\N	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5	thiazol-5-ylmethyl N-[(1R,4R)-1-benzyl-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-4-morpholino-butanoyl]amino]-5-phenyl-pentyl]carbamate
3504	FIORICET W/ CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
9185	TRIACIN-C	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
1203	BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
1280	BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
1284	BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
1288	BUTALBITAL; ACETAMINOPHEN; CAFFEINE; CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
1362	CAPITAL AND CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
1430	CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
1905	CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
1909	CODEINE, ASPIRIN, APAP FORMULA NO. 2	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
1912	CODEINE, ASPIRIN, APAP FORMULA NO. 3	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
1915	CODEINE, ASPIRIN, APAP FORMULA NO. 4	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
1924	CODRIX	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
3128	EMPRACET W/ CODEINE PHOSPHATE #3	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
3130	EMPRACET W/ CODEINE PHOSPHATE #4	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
3511	FIORINAL W/CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
6641	PAPA-DEINE #4	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
6824	PHENAPHEN W/ CODEINE NO. 2	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
6826	PHENAPHEN W/ CODEINE NO. 3	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
6828	PHENAPHEN W/ CODEINE NO. 4	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
6830	PHENAPHEN-650 W/ CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
6838	PHENERGAN VC W/ CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
6841	PHENERGAN W/ CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
6863	PHERAZINE VC W/ CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
6866	PHERAZINE W/ CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
6901	PHRENILIN WITH CAFFEINE AND CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
7666	PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
7672	PROMETH VC W/ CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
7682	PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
7689	PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
7692	PROMETHAZINE HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
7696	PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
7702	PROMETHAZINE VC W/ CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
7705	PROMETHAZINE W/ CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
7709	PROMETHAZINE WITH CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
7772	PROVAL #3	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
8364	SOMA COMPOUND W/ CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
9278	TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W/ CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
9281	TRIPROLIDINE HCL, PSEUDOEPHEDRINE HCL AND CODEINE PHOSPHATE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
9344	TYLENOL W/ CODEINE	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
9346	TYLENOL W/ CODEINE NO. 1	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
9348	TYLENOL W/ CODEINE NO. 2	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
9350	TYLENOL W/ CODEINE NO. 3	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
9352	TYLENOL W/ CODEINE NO. 4	CODEINE PHOSPHATE	5359227	C18H24NO7P	397.364	\N	\N	4	8	1	120	27	0	558	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O.OP(=O)(O)O	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid
7605	PROBEN-C	COLCHICINE	6167	C22H25NO6	399.443	\N	1	1	6	5	83.1	29	0	740	1	0	\N	\N	CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC	N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
7608	PROBENECID AND COLCHICINE	COLCHICINE	6167	C22H25NO6	399.443	\N	1	1	6	5	83.1	29	0	740	1	0	\N	\N	CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC	N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
7610	PROBENECID W/ COLCHICINE	COLCHICINE	6167	C22H25NO6	399.443	\N	1	1	6	5	83.1	29	0	740	1	0	\N	\N	CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC	N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
2383	DEXACEN-4	DEXAMETHASONE SODIUM PHOSPHATE	16961	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
1951	COLY-MYCIN M	COLISTIMETHATE SODIUM	216258	C58H105N16Na5O28S5	1749.811	\N	\N	18	33	39	749	112	0	3430	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC(C(C)O)C(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCNCS(=O)(=O)[O-])CC(C)C)CC(C)C)CCNCS(=O)(=O)[O-])CCNCS(=O)(=O)[O-])C(C)O.[Na+].[Na+].[Na+].[Na+].[Na+]	pentasodium;[2-[17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-diisobutyl-3,6,9,12,15,18,23-heptaoxo-11,14-bis[2-(sulfonatomethylamino)ethyl]-1,4,7,10,13,16,19-heptazacyclotricos-2-yl]ethylamino]methanesulfonate
2088	CU-7	COPPER	23978	Cu	63.546	\N	\N	0	0	0	0	1	0	0	0	0	\N	\N	[Cu]	copper
3698	GASTROCROM	CROMOLYN SODIUM	27503	C23H14Na2O11	512.334	\N	\N	1	11	6	172	36	0	824	0	0	\N	\N	C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)[O-])O)C(=O)C=C(O2)C(=O)[O-].[Na+].[Na+]	disodium;5-[3-(2-carboxylato-4-oxo-chromen-5-yl)oxy-2-hydroxy-propoxy]-4-oxo-chromene-2-carboxylate
5835	NASALCROM	CROMOLYN SODIUM	27503	C23H14Na2O11	512.334	\N	\N	1	11	6	172	36	0	824	0	0	\N	\N	C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)[O-])O)C(=O)C=C(O2)C(=O)[O-].[Na+].[Na+]	disodium;5-[3-(2-carboxylato-4-oxo-chromen-5-yl)oxy-2-hydroxy-propoxy]-4-oxo-chromene-2-carboxylate
6392	OPTICROM	CROMOLYN SODIUM	27503	C23H14Na2O11	512.334	\N	\N	1	11	6	172	36	0	824	0	0	\N	\N	C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)[O-])O)C(=O)C=C(O2)C(=O)[O-].[Na+].[Na+]	disodium;5-[3-(2-carboxylato-4-oxo-chromen-5-yl)oxy-2-hydroxy-propoxy]-4-oxo-chromene-2-carboxylate
2336	DEPINAR	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
2769	DICOPAC KIT	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
1062	BERUBIGEN	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
1070	BETALIN 12	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
1337	CALOMIST	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
1901	COBAVITE	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
2098	CYANOCOBALAMIN	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
2099	CYANOCOBALAMIN CO 57 SCHILLING TEST KIT	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
8145	SANDIMMUNE	CYCLOSPORINE	5284373	C62H111N11O12	1202.635	\N	7.5	5	12	15	279	85	0	2330	12	0	\N	\N	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
4258	INFUVITE ADULT	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
4270	INFUVITE PEDIATRIC	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
4283	INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
5164	M.V.C. 9+3	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
5176	M.V.I. ADULT	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
5189	M.V.I. ADULT (PHARMACY BULK PACKAGE)	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
5202	M.V.I. PEDIATRIC	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
5215	M.V.I.-12	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
5227	M.V.I.-12	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
5239	M.V.I.-12 (WITHOUT VITAMIN K)	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
5251	M.V.I.-12 LYOPHILIZED	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
2858	DIVALPROEX SODIUM	DIVALPROEX SODIUM	23663956	C16H31NaO4	310.41	\N	\N	1	4	10	77.4	21	0	192	0	0	\N	\N	CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+]	sodium;2-propylpentanoate;2-propylpentanoic acid
5718	MVC PLUS	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
5838	NASCOBAL	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
7908	REDISOL	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
8101	RUBIVITE	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
8102	RUBRAMIN PC	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
8105	RUBRATOPE-57 KIT	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
8110	RUBRATOPE-60 KIT	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
8116	RUVITE	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
9574	VI-TWEL	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
9580	VIBISONE	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
9663	VITAPED	CYANOCOBALAMIN	5311498	C63H88CoN14O14P	1355.388	\N	\N	9	21	26	476	93	0	3220	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide
2114	CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	22576	C20H22ClN	311.853	\N	\N	1	1	3	3.2	22	0	365	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31.Cl	3-(dibenzo[1,2-a:1',2'-e][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
2123	CYCLOSPORINE	CYCLOSPORINE	5284373	C62H111N11O12	1202.635	\N	7.5	5	12	15	279	85	0	2330	12	0	\N	\N	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
3725	GENGRAF	CYCLOSPORINE	5284373	C62H111N11O12	1202.635	\N	7.5	5	12	15	279	85	0	2330	12	0	\N	\N	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
5944	NEORAL	CYCLOSPORINE	5284373	C62H111N11O12	1202.635	\N	7.5	5	12	15	279	85	0	2330	12	0	\N	\N	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
7988	RESTASIS	CYCLOSPORINE	5284373	C62H111N11O12	1202.635	\N	7.5	5	12	15	279	85	0	2330	12	0	\N	\N	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
6619	PAGITANE	CYCRIMINE HYDROCHLORIDE	101597	C19H30ClNO	323.905	\N	\N	2	2	5	23.5	22	0	301	0	1	\N	\N	C1CCN(CC1)CCC(C2CCCC2)(C3=CC=CC=C3)O.Cl	1-cyclopentyl-1-phenyl-3-(1-piperidyl)propan-1-ol;hydrochloride
2153	DACTINOMYCIN	DACTINOMYCIN	457193	C62H86N12O16	1255.438	\N	3.8	5	18	8	356	90	0	3030	10	0	\N	\N	CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C	2-amino-N1,N9-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-phenoxazine-1,9-dicarboxamide
8002	REVONTO	DANTROLENE SODIUM	6604100	C14H9N4NaO5	336.239	\N	\N	0	6	3	127	24	0	536	0	0	\N	\N	C1C(=O)N=C(N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-].[Na+]	sodium;3-[(E)-[5-(4-nitrophenyl)-2-furyl]methyleneamino]-5-oxo-4H-imidazol-2-olate
8117	RYANODEX	DANTROLENE SODIUM	6604100	C14H9N4NaO5	336.239	\N	\N	0	6	3	127	24	0	536	0	0	\N	\N	C1C(=O)N=C(N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-].[Na+]	sodium;3-[(E)-[5-(4-nitrophenyl)-2-furyl]methyleneamino]-5-oxo-4H-imidazol-2-olate
9762	XIGDUO XR	DAPAGLIFLOZIN PROPANEDIOL	24906252	C24H35ClO9	502.985	\N	\N	7	9	7	141	34	0	493	6	0	\N	\N	CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl.CC(CO)O.O	(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol;(2S)-propane-1,2-diol;hydrate
2166	DAPTOMYCIN	DAPTOMYCIN	16129629	C72H101N17O26	1620.693	\N	-5.1	22	28	35	702	115	0	3480	10	3	\N	\N	CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C	\N
2171	DARIFENACIN HYDROBROMIDE	DARIFENACIN HYDROBROMIDE	444030	C28H31BrN2O2	507.472	\N	\N	2	3	7	55.6	33	0	607	1	0	\N	\N	C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br	2-[(3S)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenyl-acetamide;hydrobromide
3987	HUMORSOL	DEMECARIUM BROMIDE	5965	C32H52Br2N4O4	716.6	\N	\N	0	6	17	59.1	42	0	686	0	0	\N	\N	CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC2=CC=CC(=C2)[N+](C)(C)C.[Br-].[Br-]	trimethyl-[3-[methyl-[10-[methyl-[3-(trimethylammonio)phenoxy]carbonyl-amino]decyl]carbamoyl]oxyphenyl]ammonium;dibromide
2314	DEMECLOCYCLINE HYDROCHLORIDE	DEMECLOCYCLINE HYDROCHLORIDE	54686764	C21H22Cl2N2O8	501.313	\N	\N	7	9	2	182	33	0	961	5	0	\N	\N	CN(C)C1C2CC3C(C4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O.Cl	(4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride
3878	HARMONYL	DESERPIDINE	8550	C32H38N2O8	578.662	\N	4.1	1	9	9	109	42	0	953	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-18-methoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
5468	METHYCLOTHIAZIDE AND DESERPIDINE	DESERPIDINE	8550	C32H38N2O8	578.662	\N	4.1	1	9	9	109	42	0	953	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-18-methoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
6427	ORETICYL 25	DESERPIDINE	8550	C32H38N2O8	578.662	\N	4.1	1	9	9	109	42	0	953	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-18-methoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
6429	ORETICYL 50	DESERPIDINE	8550	C32H38N2O8	578.662	\N	4.1	1	9	9	109	42	0	953	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-18-methoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
6431	ORETICYL FORTE	DESERPIDINE	8550	C32H38N2O8	578.662	\N	4.1	1	9	9	109	42	0	953	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-18-methoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
6165	NORPRAMIN	DESIPRAMINE HYDROCHLORIDE	65327	C18H23ClN2	302.846	\N	\N	2	2	4	15.3	21	0	267	0	0	\N	\N	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31.Cl	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methyl-propan-1-amine;hydrochloride
2216	DECADRON W/ XYLOCAINE	DEXAMETHASONE SODIUM PHOSPHATE	16961	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
2209	DDAVP (NEEDS NO REFRIGERATION)	DESMOPRESSIN ACETATE	9833407	C48H68N14O14S2	1129.276	\N	\N	14	17	19	526	78	0	2070	7	0	\N	\N	CC(=O)O.C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N	acetic acid;(2S)-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1R)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide
2361	DESMOPRESSIN ACETATE	DESMOPRESSIN ACETATE	9833407	C48H68N14O14S2	1129.276	\N	\N	14	17	19	526	78	0	2070	7	0	\N	\N	CC(=O)O.C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N	acetic acid;(2S)-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1R)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide
2362	DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION)	DESMOPRESSIN ACETATE	9833407	C48H68N14O14S2	1129.276	\N	\N	14	17	19	526	78	0	2070	7	0	\N	\N	CC(=O)O.C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N	acetic acid;(2S)-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1R)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide
2363	DESMOPRESSIN ACETATE PRESERVATIVE FREE	DESMOPRESSIN ACETATE	9833407	C48H68N14O14S2	1129.276	\N	\N	14	17	19	526	78	0	2070	7	0	\N	\N	CC(=O)O.C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N	acetic acid;(2S)-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1R)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide
5588	MINIRIN	DESMOPRESSIN ACETATE	9833407	C48H68N14O14S2	1129.276	\N	\N	14	17	19	526	78	0	2070	7	0	\N	\N	CC(=O)O.C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N	acetic acid;(2S)-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1R)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide
8476	STIMATE	DESMOPRESSIN ACETATE	9833407	C48H68N14O14S2	1129.276	\N	\N	14	17	19	526	78	0	2070	7	0	\N	\N	CC(=O)O.C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N	acetic acid;(2S)-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1R)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide
8477	STIMATE (NEEDS NO REFRIGERATION)	DESMOPRESSIN ACETATE	9833407	C48H68N14O14S2	1129.276	\N	\N	14	17	19	526	78	0	2070	7	0	\N	\N	CC(=O)O.C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N	acetic acid;(2S)-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1R)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide
2364	DESOGEN	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
3124	EMOQUETTE	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
3176	ENSKYCE	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
4428	ISIBLOOM	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
4678	KIMIDESS	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
5611	MIRCETTE	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
6923	PIMTREA	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
9626	VIORELE	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
9688	VOLNEA	DESOGESTREL	40973	C22H30O	310.481	\N	4.9	1	1	2	20.2	23	0	605	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
2391	DEXAMETHASONE ACETATE	DEXAMETHASONE ACETATE	236702	C24H31FO6	434.504	\N	2.8	2	7	4	101	31	0	910	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)O)C)O)F)C	[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
2215	DECADRON	DEXAMETHASONE SODIUM PHOSPHATE	16961	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
2712	DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2387	DEXACORT	DEXAMETHASONE SODIUM PHOSPHATE	16961	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
2388	DEXAIR	DEXAMETHASONE SODIUM PHOSPHATE	16961	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
2390	DEXAMETHASONE	DEXAMETHASONE SODIUM PHOSPHATE	16961	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
2393	DEXAMETHASONE SODIUM PHOSPHATE	DEXAMETHASONE SODIUM PHOSPHATE	16961	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
2394	DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE	DEXAMETHASONE SODIUM PHOSPHATE	16961	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
3944	HEXADROL	DEXAMETHASONE SODIUM PHOSPHATE	16961	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
5324	MAXIDEX	DEXAMETHASONE SODIUM PHOSPHATE	16961	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
5899	NEODECADRON	DEXAMETHASONE SODIUM PHOSPHATE	16961	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
5924	NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE	DEXAMETHASONE SODIUM PHOSPHATE	16961	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
5932	NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE	DEXAMETHASONE SODIUM PHOSPHATE	16961	C22H28FNa2O8P	516.41	\N	\N	2	9	3	147	34	0	962	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]	disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
2389	DEXAMETHASONE	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
3943	HEXADROL	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2409	DEXONE 0.5	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2410	DEXONE 0.75	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2411	DEXONE 1.5	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2412	DEXONE 4	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
5323	MAXIDEX	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
5326	MAXITROL	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
6614	OZURDEX	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
8935	TOBRADEX	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
7565	PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
8937	TOBRADEX ST	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
8940	TOBRAMYCIN AND DEXAMETHASONE	DEXAMETHASONE	5743	C22H29FO5	392.467	\N	1.9	3	6	2	94.8	28	0	805	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
7986	RESPORAL	DEXBROMPHENIRAMINE MALEATE	6433334	C20H23BrN2O4	435.318	\N	\N	2	6	7	90.7	27	0	368	1	0	\N	\N	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O	(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid
5177	M.V.I. ADULT	DEXPANTHENOL	131204	C9H19NO4	205.254	\N	-0.9	4	4	6	89.8	14	0	182	1	0	\N	\N	CC(C)(CO)C(C(=O)NCCCO)O	(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butanamide
5190	M.V.I. ADULT (PHARMACY BULK PACKAGE)	DEXPANTHENOL	131204	C9H19NO4	205.254	\N	-0.9	4	4	6	89.8	14	0	182	1	0	\N	\N	CC(C)(CO)C(C(=O)NCCCO)O	(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butanamide
9874	ZINECARD	DEXRAZOXANE HYDROCHLORIDE	6918223	C11H17ClN4O4	304.731	\N	\N	3	6	3	98.8	20	0	404	1	0	\N	\N	CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2.Cl	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione;hydrochloride
1124	BIPHETAMINE 20	DEXTROAMPHETAMINE RESIN COMPLEX	5826	C9H13N	135.21	\N	1.8	1	1	2	26	10	0	84.7	1	0	\N	\N	CC(CC1=CC=CC=C1)N	(2S)-1-phenylpropan-2-amine
1126	BIPHETAMINE 7.5	DEXTROAMPHETAMINE RESIN COMPLEX	5826	C9H13N	135.21	\N	1.8	1	1	2	26	10	0	84.7	1	0	\N	\N	CC(CC1=CC=CC=C1)N	(2S)-1-phenylpropan-2-amine
1198	BROMFED-DM	DEXTROMETHORPHAN HYDROBROMIDE	5464025	C18H26BrNO	352.316	\N	\N	1	2	1	12.5	21	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br	\N
6226	NUEDEXTA	DEXTROMETHORPHAN HYDROBROMIDE	5464025	C18H26BrNO	352.316	\N	\N	1	2	1	12.5	21	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br	\N
7675	PROMETH W/ DEXTROMETHORPHAN	DEXTROMETHORPHAN HYDROBROMIDE	5464025	C18H26BrNO	352.316	\N	\N	1	2	1	12.5	21	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br	\N
7679	PROMETHAZINE DM	DEXTROMETHORPHAN HYDROBROMIDE	5464025	C18H26BrNO	352.316	\N	\N	1	2	1	12.5	21	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br	\N
7684	PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE	DEXTROMETHORPHAN HYDROBROMIDE	5464025	C18H26BrNO	352.316	\N	\N	1	2	1	12.5	21	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br	\N
7698	PROMETHAZINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE	DEXTROMETHORPHAN HYDROBROMIDE	5464025	C18H26BrNO	352.316	\N	\N	1	2	1	12.5	21	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br	\N
7707	PROMETHAZINE W/ DEXTROMETHORPHAN	DEXTROMETHORPHAN HYDROBROMIDE	5464025	C18H26BrNO	352.316	\N	\N	1	2	1	12.5	21	0	370	3	0	\N	\N	CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br	\N
3699	GASTROGRAFIN	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
1408	CARDIOGRAFIN	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
2138	CYSTOGRAFIN	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
2139	CYSTOGRAFIN DILUTE	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
2754	DIATRIZOATE MEGLUMINE	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
2755	DIATRIZOATE-60	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
3702	GASTROVIST	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
4132	HYPAQUE-76	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
4134	HYPAQUE-CYSTO	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
4135	HYPAQUE-M,75%	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
4137	HYPAQUE-M,90%	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
5338	MD-76	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
5340	MD-76R	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
5342	MD-GASTROVIEW	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
7939	RENO-30	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
7940	RENO-60	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
7941	RENO-DIP	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
7942	RENOCAL-76	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
7944	RENOGRAFIN-60	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
7946	RENOGRAFIN-76	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
7952	RENOVIST	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
7954	RENOVIST II	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
8272	SINOGRAFIN	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
9429	UROVIST CYSTO PEDIATRIC	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
9430	UROVIST MEGLUMINE DIU/CT	DIATRIZOATE MEGLUMINE	8566	C18H26I3N3O9	809.131	\N	\N	9	10	9	209	33	0	525	4	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3,5-diacetamido-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
7945	RENOGRAFIN-60	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
7947	RENOGRAFIN-76	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
5341	MD-76R	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
5343	MD-GASTROVIEW	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
7953	RENOVIST	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
7955	RENOVIST II	DIATRIZOATE SODIUM	23672589	C11H8I3N2NaO4	635.898	\N	\N	2	4	3	98.3	21	0	396	0	0	\N	\N	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]	sodium;3,5-diacetamido-2,4,6-triiodo-benzoate
8351	SOLARAZE	DICLOFENAC SODIUM	5018304	C14H10Cl2NNaO2	318.129	\N	\N	1	3	4	52.2	20	0	310	0	0	\N	\N	C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+]	sodium;2-[2-(2,6-dichloroanilino)phenyl]acetate
2768	DICLOXACILLIN SODIUM	DICLOXACILLIN SODIUM	23675786	C19H18Cl2N3NaO6S	510.318	\N	\N	2	8	4	142	32	0	752	3	0	\N	\N	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+]	sodium;(2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-isoxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate
2998	DYCILL	DICLOXACILLIN SODIUM	23675786	C19H18Cl2N3NaO6S	510.318	\N	\N	2	8	4	142	32	0	752	3	0	\N	\N	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+]	sodium;(2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-isoxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate
3009	DYNAPEN	DICLOXACILLIN SODIUM	23675786	C19H18Cl2N3NaO6S	510.318	\N	\N	2	8	4	142	32	0	752	3	0	\N	\N	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+]	sodium;(2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-isoxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate
6672	PATHOCIL	DICLOXACILLIN SODIUM	23675786	C19H18Cl2N3NaO6S	510.318	\N	\N	2	8	4	142	32	0	752	3	0	\N	\N	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+]	sodium;(2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-isoxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate
5841	NATAZIA	DIENOGEST	68861	C20H25NO2	311.425	\N	1.8	1	3	1	61.1	23	0	679	4	0	\N	\N	CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2(CC#N)O	2-[(8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile
8475	STILPHOSTROL	DIETHYLSTILBESTROL DIPHOSPHATE	3032325	C18H22O8P2	428.314	\N	2.5	4	8	8	134	28	0	568	0	0	\N	\N	CCC(=C(CC)C1=CC=C(C=C1)OP(=O)(O)O)C2=CC=C(C=C2)OP(=O)(O)O	[4-[(E)-1-ethyl-2-(4-phosphonooxyphenyl)but-1-enyl]phenyl] dihydrogen phosphate
7788	PSORCON	DIFLORASONE DIACETATE	71414	C26H32F2O7	494.532	\N	3	1	9	6	107	35	0	1050	9	0	\N	\N	CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)OC(=O)C)C)O)F)C)F	[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetoxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
7789	PSORCON E	DIFLORASONE DIACETATE	71414	C26H32F2O7	494.532	\N	3	1	9	6	107	35	0	1050	9	0	\N	\N	CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)OC(=O)C)C)O)F)C)F	[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetoxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
2791	DIGOXIN	DIGOXIN	2724385	C41H64O14	780.949	\N	1.3	6	14	7	203	55	0	1450	21	0	\N	\N	CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O	3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
2792	DIGOXIN PEDIATRIC	DIGOXIN	2724385	C41H64O14	780.949	\N	1.3	6	14	7	203	55	0	1450	21	0	\N	\N	CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O	3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
4803	LANOXICAPS	DIGOXIN	2724385	C41H64O14	780.949	\N	1.3	6	14	7	203	55	0	1450	21	0	\N	\N	CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O	3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
4804	LANOXIN	DIGOXIN	2724385	C41H64O14	780.949	\N	1.3	6	14	7	203	55	0	1450	21	0	\N	\N	CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O	3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
4805	LANOXIN PEDIATRIC	DIGOXIN	2724385	C41H64O14	780.949	\N	1.3	6	14	7	203	55	0	1450	21	0	\N	\N	CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O	3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
8704	TAZTIA XT	DILTIAZEM HYDROCHLORIDE	62920	C22H27ClN2O4S	450.978	\N	\N	1	6	7	84.4	30	0	565	2	0	\N	\N	CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;hydrochloride
2805	DILTIAZEM HYDROCHLORIDE	DILTIAZEM HYDROCHLORIDE	62920	C22H27ClN2O4S	450.978	\N	\N	1	6	7	84.4	30	0	565	2	0	\N	\N	CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;hydrochloride
2806	DILTZAC	DILTIAZEM HYDROCHLORIDE	62920	C22H27ClN2O4S	450.978	\N	\N	1	6	7	84.4	30	0	565	2	0	\N	\N	CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;hydrochloride
7374	PRANTAL	DIPHEMANIL METHYLSULFATE	6126	C21H27NO4S	389.51	\N	\N	0	4	2	74.8	27	0	426	0	0	\N	\N	C[N+]1(CCC(=C(C2=CC=CC=C2)C3=CC=CC=C3)CC1)C.COS(=O)(=O)[O-]	4-benzhydrylidene-1,1-dimethyl-piperidin-1-ium;methyl sulfate
4038	HYDRAMINE	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
712	ANTITUSSIVE	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
1011	BELIX	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
1015	BENADRYL	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
1016	BENADRYL PRESERVATIVE FREE	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
1035	BENYLIN	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
1036	BENYLIN	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
2820	DIPHEN	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
2821	DIPHENHYDRAMINE HYDROCHLORIDE	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
2822	DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
8256	SILPHEN	DIPHENHYDRAMINE HYDROCHLORIDE	8980	C17H22ClNO	291.819	\N	\N	1	2	6	12.5	20	0	211	0	0	\N	\N	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	2-benzhydryloxy-N,N-dimethyl-ethanamine;hydrochloride
5117	LOW-QUEL	DIPHENOXYLATE HYDROCHLORIDE	6432394	C30H33ClN2O2	489.056	\N	\N	1	4	9	53.3	35	0	666	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.Cl	ethyl 1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylate;hydrochloride
6162	NORPACE CR	DISOPYRAMIDE PHOSPHATE	30928	C21H32N3O5P	437.477	\N	\N	4	7	8	137	30	0	459	0	1	\N	\N	CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C.OP(=O)(O)O	4-(diisopropylamino)-2-phenyl-2-(2-pyridyl)butanamide;phosphoric acid
2333	DEPAKOTE CP	DIVALPROEX SODIUM	23663956	C16H31NaO4	310.41	\N	\N	1	4	10	77.4	21	0	192	0	0	\N	\N	CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+]	sodium;2-propylpentanoate;2-propylpentanoic acid
2334	DEPAKOTE ER	DIVALPROEX SODIUM	23663956	C16H31NaO4	310.41	\N	\N	1	4	10	77.4	21	0	192	0	0	\N	\N	CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+]	sodium;2-propylpentanoate;2-propylpentanoic acid
2882	DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	DOPAMINE HYDROCHLORIDE	65340	C8H12ClNO2	189.639	\N	\N	4	3	2	66.5	12	0	119	0	0	\N	\N	C1=CC(=C(C=C1CCN)O)O.Cl	4-(2-aminoethyl)benzene-1,2-diol;hydrochloride
2884	DOPRAM	DOXAPRAM HYDROCHLORIDE	64647	C24H31ClN2O2	414.974	\N	\N	1	3	6	32.8	29	0	487	0	1	\N	\N	CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4.Cl	1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-pyrrolidin-2-one;hydrochloride
2898	DOXAPRAM HYDROCHLORIDE	DOXAPRAM HYDROCHLORIDE	64647	C24H31ClN2O2	414.974	\N	\N	1	3	6	32.8	29	0	487	0	1	\N	\N	CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4.Cl	1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-pyrrolidin-2-one;hydrochloride
8254	SILENOR	DOXEPIN HYDROCHLORIDE	6419921	C19H22ClNO	315.841	\N	\N	1	2	3	12.5	22	0	363	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31.Cl	(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
8270	SINEQUAN	DOXEPIN HYDROCHLORIDE	6419921	C19H22ClNO	315.841	\N	\N	1	2	3	12.5	22	0	363	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31.Cl	(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
9903	ZONALON	DOXEPIN HYDROCHLORIDE	6419921	C19H22ClNO	315.841	\N	\N	1	2	3	12.5	22	0	363	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31.Cl	(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride
2904	DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)	DOXORUBICIN HYDROCHLORIDE	443939	C27H30ClNO11	579.983	\N	\N	7	12	5	206	40	0	977	6	0	\N	\N	CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
8100	RUBEX	DOXORUBICIN HYDROCHLORIDE	443939	C27H30ClNO11	579.983	\N	\N	7	12	5	206	40	0	977	6	0	\N	\N	CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
2890	DORYX MPC	DOXYCYCLINE HYCLATE	54686183	C46H58Cl2N4O18	1025.88	\N	\N	16	20	4	385	70	0	958	12	0	\N	\N	CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
2905	DOXY 100	DOXYCYCLINE HYCLATE	54686183	C46H58Cl2N4O18	1025.88	\N	\N	16	20	4	385	70	0	958	12	0	\N	\N	CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
2906	DOXY 200	DOXYCYCLINE HYCLATE	54686183	C46H58Cl2N4O18	1025.88	\N	\N	16	20	4	385	70	0	958	12	0	\N	\N	CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
2907	DOXY-LEMMON	DOXYCYCLINE HYCLATE	54686183	C46H58Cl2N4O18	1025.88	\N	\N	16	20	4	385	70	0	958	12	0	\N	\N	CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
2910	DOXYCHEL HYCLATE	DOXYCYCLINE HYCLATE	54686183	C46H58Cl2N4O18	1025.88	\N	\N	16	20	4	385	70	0	958	12	0	\N	\N	CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
2912	DOXYCYCLINE	DOXYCYCLINE HYCLATE	54686183	C46H58Cl2N4O18	1025.88	\N	\N	16	20	4	385	70	0	958	12	0	\N	\N	CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
2913	DOXYCYCLINE HYCLATE	DOXYCYCLINE HYCLATE	54686183	C46H58Cl2N4O18	1025.88	\N	\N	16	20	4	385	70	0	958	12	0	\N	\N	CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
6803	PERIOSTAT	DOXYCYCLINE HYCLATE	54686183	C46H58Cl2N4O18	1025.88	\N	\N	16	20	4	385	70	0	958	12	0	\N	\N	CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
9581	VIBRA-TABS	DOXYCYCLINE HYCLATE	54686183	C46H58Cl2N4O18	1025.88	\N	\N	16	20	4	385	70	0	958	12	0	\N	\N	CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
9584	VIBRAMYCIN	DOXYCYCLINE HYCLATE	54686183	C46H58Cl2N4O18	1025.88	\N	\N	16	20	4	385	70	0	958	12	0	\N	\N	CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
2911	DOXYCYCLINE	DOXYCYCLINE	54671203	C22H24N2O8	444.44	\N	-0.7	6	9	2	182	32	0	956	6	0	\N	\N	CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
5707	MULTAQ	DRONEDARONE HYDROCHLORIDE	219025	C31H45ClN2O5S	593.22	\N	\N	2	7	18	97.2	40	0	800	0	0	\N	\N	CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC.Cl	N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]benzofuran-5-yl]methanesulfonamide;hydrochloride
6001	NIKKI	DROSPIRENONE	68873	C24H30O3	366.501	\N	3.5	0	3	0	43.4	27	0	828	10	0	\N	\N	CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C	\N
2986	DUTASTERIDE	DUTASTERIDE	6918296	C27H30F6N2O2	528.539	\N	5.4	2	8	2	58.2	37	0	964	7	0	\N	\N	CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C	(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
2987	DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE	DUTASTERIDE	6918296	C27H30F6N2O2	528.539	\N	5.4	2	8	2	58.2	37	0	964	7	0	\N	\N	CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C	(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
4567	JALYN	DUTASTERIDE	6918296	C27H30F6N2O2	528.539	\N	5.4	2	8	2	58.2	37	0	964	7	0	\N	\N	CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C	(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
8772	TENSILON PRESERVATIVE FREE	EDROPHONIUM CHLORIDE	8307	C10H16ClNO	201.694	\N	\N	1	2	2	20.2	13	0	145	0	0	\N	\N	CC[N+](C)(C)C1=CC(=CC=C1)O.[Cl-]	ethyl-(3-hydroxyphenyl)-dimethyl-ammonium;chloride
4779	LAMIVUDINE; ZIDOVUDINE	EFAVIRENZ	64139	C14H9ClF3NO2	315.676	\N	4	1	5	1	38.3	21	0	519	1	0	\N	\N	C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
8455	STAVUDINE; LAMIVUDINE; EFAVIRENZ	EFAVIRENZ	64139	C14H9ClF3NO2	315.676	\N	4	1	5	1	38.3	21	0	519	1	0	\N	\N	C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
9481	VANIQA	EFLORNITHINE HYDROCHLORIDE	57004	C6H13ClF2N2O2	218.629	\N	\N	4	6	5	89.3	13	0	166	0	1	\N	\N	C(CC(C(F)F)(C(=O)O)N)CN.Cl	2,5-diamino-2-(difluoromethyl)pentanoic acid;hydrochloride
9845	ZEPATIER	ELBASVIR	71661251	C49H55N9O7	882.035	\N	6.7	4	9	13	189	65	0	1680	5	0	\N	\N	CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC4=C(C=C3)N5C(OC6=C(C5=C4)C=CC(=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C(C)C)NC(=O)OC)C9=CC=CC=C9)NC(=O)OC	methyl N-[(1S)-1-[(2S)-2-[5-[(6S)-3-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-6-phenyl-6H-indolo[1,2-c][1,3]benzoxazin-10-yl]-1H-imidazol-2-yl]pyrrolidine-1-carbonyl]-2-methyl-propyl]carbamate
8631	SYNJARDY	EMPAGLIFLOZIN	11949646	C23H27ClO7	450.912	\N	2	4	7	6	109	31	0	558	6	0	\N	\N	C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl	(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-tetrahydrofuran-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
8488	STRIBILD	EMTRICITABINE	60877	C8H10FN3O3S	247.244	\N	-0.6	2	5	2	113	16	0	374	2	0	\N	\N	C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F	4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
3737	GENVOYA	EMTRICITABINE	60877	C8H10FN3O3S	247.244	\N	-0.6	2	5	2	113	16	0	374	2	0	\N	\N	C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F	4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
9318	TRUVADA	EMTRICITABINE	60877	C8H10FN3O3S	247.244	\N	-0.6	2	5	2	113	16	0	374	2	0	\N	\N	C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F	4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
4919	LEXXEL	ENALAPRIL MALEATE	5388961	C24H32N2O9	492.525	\N	\N	4	10	12	171	35	0	638	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O	(2S)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid;maleic acid
9508	VASOTEC	ENALAPRIL MALEATE	5388961	C24H32N2O9	492.525	\N	\N	4	10	12	171	35	0	638	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O	(2S)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid;maleic acid
5110	LOVENOX	ENOXAPARIN SODIUM	772	C26H42N2O37S5	1134.899	\N	-10.8	15	38	21	652	70	0	2410	0	20	\N	\N	CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O	6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)tetrahydropyran-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxy-tetrahydropyran-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxy-tetrahydropyran-3-yl]oxy-3,4-dihydroxy-5-sulfooxy-tetrahydropyran-2-carboxylic acid
5111	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	772	C26H42N2O37S5	1134.899	\N	-10.8	15	38	21	652	70	0	2410	0	20	\N	\N	CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O	6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)tetrahydropyran-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxy-tetrahydropyran-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxy-tetrahydropyran-3-yl]oxy-3,4-dihydroxy-5-sulfooxy-tetrahydropyran-2-carboxylic acid
8428	STALEVO 150	ENTACAPONE	5281081	C14H15N3O5	305.29	\N	2.1	2	6	4	130	22	0	500	0	0	\N	\N	CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N	(E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide
8431	STALEVO 200	ENTACAPONE	5281081	C14H15N3O5	305.29	\N	2.1	2	6	4	130	22	0	500	0	0	\N	\N	CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N	(E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide
8434	STALEVO 50	ENTACAPONE	5281081	C14H15N3O5	305.29	\N	2.1	2	6	4	130	22	0	500	0	0	\N	\N	CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N	(E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide
8437	STALEVO 75	ENTACAPONE	5281081	C14H15N3O5	305.29	\N	2.1	2	6	4	130	22	0	500	0	0	\N	\N	CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N	(E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide
3195	EPI E Z PEN JR	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
3204	EPINEPHRINE	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
3205	EPIPEN	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
3206	EPIPEN E Z PEN	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
3207	EPIPEN JR.	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
4396	IONTOCAINE	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
4949	LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
4952	LIDOCATON	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
4957	LIDOSITE TOPICAL SYSTEM KIT	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
6283	OCTOCAINE	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
8596	SUS-PHRINE SULFITE FREE	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
9333	TWINJECT 0.15	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
9789	XYLOCAINE W/ EPINEPHRINE	EPINEPHRINE	5816	C9H13NO3	183.207	\N	-1.4	4	4	3	72.7	13	0	154	1	0	\N	\N	CNCC(C1=CC(=C(C=C1)O)O)O	4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
3208	EPIRUBICIN HYDROCHLORIDE	EPIRUBICIN HYDROCHLORIDE	65348	C27H30ClNO11	579.983	\N	\N	7	12	5	206	40	0	977	6	0	\N	\N	CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl	(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
3096	ELLENCE	EPIRUBICIN HYDROCHLORIDE	65348	C27H30ClNO11	579.983	\N	\N	7	12	5	206	40	0	977	6	0	\N	\N	CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl	(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
9526	VELETRI	EPOPROSTENOL SODIUM	6364626	C20H31NaO5	374.453	\N	\N	2	5	10	89.8	26	0	491	5	0	\N	\N	CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)[O-])O2)O)O.[Na+]	sodium;(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate
5178	M.V.I. ADULT	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
5191	M.V.I. ADULT (PHARMACY BULK PACKAGE)	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
5204	M.V.I. PEDIATRIC	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
5217	M.V.I.-12	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
5229	M.V.I.-12	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
5241	M.V.I.-12 (WITHOUT VITAMIN K)	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
5253	M.V.I.-12 LYOPHILIZED	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
5720	MVC PLUS	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
9659	VITAMIN D	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
9664	VITAPED	ERGOCALCIFEROL	5280793	C28H44O	396.659	\N	7.4	1	1	5	20.2	29	0	678	6	0	\N	\N	CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol
1686	CIRCANOL	ERGOLOID MESYLATES	71717894	C134H184N20O32S4	2715.294	\N	\N	16	36	19	724	190	0	4690	28	1	\N	\N	CCC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O	\N
2210	DEAPRIL-ST	ERGOLOID MESYLATES	71717894	C134H184N20O32S4	2715.294	\N	\N	16	36	19	724	190	0	4690	28	1	\N	\N	CCC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O	\N
3231	ERGOLOID MESYLATES	ERGOLOID MESYLATES	71717894	C134H184N20O32S4	2715.294	\N	\N	16	36	19	724	190	0	4690	28	1	\N	\N	CCC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O	\N
3744	GERIMAL	ERGOLOID MESYLATES	71717894	C134H184N20O32S4	2715.294	\N	\N	16	36	19	724	190	0	4690	28	1	\N	\N	CCC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O	\N
4014	HYDERGINE	ERGOLOID MESYLATES	71717894	C134H184N20O32S4	2715.294	\N	\N	16	36	19	724	190	0	4690	28	1	\N	\N	CCC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O	\N
4015	HYDERGINE LC	ERGOLOID MESYLATES	71717894	C134H184N20O32S4	2715.294	\N	\N	16	36	19	724	190	0	4690	28	1	\N	\N	CCC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O	\N
4103	HYDROGENATED ERGOT ALKALOIDS	ERGOLOID MESYLATES	71717894	C134H184N20O32S4	2715.294	\N	\N	16	36	19	724	190	0	4690	28	1	\N	\N	CCC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O	\N
3030	E.E.S. 200	ERYTHROMYCIN ETHYLSUCCINATE	443953	C43H75NO16	862.064	\N	3.4	4	17	14	226	60	0	1450	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O	O4-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] O1-ethyl butanedioate
3031	E.E.S. 400	ERYTHROMYCIN ETHYLSUCCINATE	443953	C43H75NO16	862.064	\N	3.4	4	17	14	226	60	0	1450	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O	O4-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] O1-ethyl butanedioate
3250	ERYPED	ERYTHROMYCIN ETHYLSUCCINATE	443953	C43H75NO16	862.064	\N	3.4	4	17	14	226	60	0	1450	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O	O4-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] O1-ethyl butanedioate
3260	ERYTHROMYCIN ETHYLSUCCINATE	ERYTHROMYCIN ETHYLSUCCINATE	443953	C43H75NO16	862.064	\N	3.4	4	17	14	226	60	0	1450	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O	O4-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] O1-ethyl butanedioate
3261	ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL	ERYTHROMYCIN ETHYLSUCCINATE	443953	C43H75NO16	862.064	\N	3.4	4	17	14	226	60	0	1450	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O	O4-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] O1-ethyl butanedioate
3265	ERYZOLE	ERYTHROMYCIN ETHYLSUCCINATE	443953	C43H75NO16	862.064	\N	3.4	4	17	14	226	60	0	1450	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O	O4-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] O1-ethyl butanedioate
6682	PEDIAMYCIN	ERYTHROMYCIN ETHYLSUCCINATE	443953	C43H75NO16	862.064	\N	3.4	4	17	14	226	60	0	1450	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O	O4-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] O1-ethyl butanedioate
6683	PEDIAMYCIN 400	ERYTHROMYCIN ETHYLSUCCINATE	443953	C43H75NO16	862.064	\N	3.4	4	17	14	226	60	0	1450	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O	O4-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] O1-ethyl butanedioate
6687	PEDIAZOLE	ERYTHROMYCIN ETHYLSUCCINATE	443953	C43H75NO16	862.064	\N	3.4	4	17	14	226	60	0	1450	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O	O4-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] O1-ethyl butanedioate
9730	WYAMYCIN E	ERYTHROMYCIN ETHYLSUCCINATE	443953	C43H75NO16	862.064	\N	3.4	4	17	14	226	60	0	1450	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O	O4-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] O1-ethyl butanedioate
3253	ERYTHROCIN	ERYTHROMYCIN LACTOBIONATE	71469	C49H89NO25	1092.233	\N	\N	14	26	15	412	75	0	1580	27	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O.C(C1C(C(C(C(O1)OC(C(CO)O)C(C(C(=O)O)O)O)O)O)O)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;(2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hexanoic acid
267	AKNE-MYCIN	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
274	AKTIPAK	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
1041	BENZAMYCIN	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
1307	C-SOLVE-2	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3012	E-BASE	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3013	E-GLADES	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3014	E-MYCIN	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3016	E-SOLVE 2	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3241	ERY-TAB	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3242	ERYC	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3243	ERYC 125	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3244	ERYC SPRINKLES	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3245	ERYCETTE	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3246	ERYDERM	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3247	ERYGEL	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3248	ERYMAX	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3251	ERYTHRA-DERM	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3252	ERYTHRO-STATIN	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3255	ERYTHROMYCIN	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
3258	ERYTHROMYCIN AND BENZOYL PEROXIDE	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
4192	ILOTYCIN	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
6681	PCE	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
7859	R-P MYCIN	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
8060	ROBIMYCIN	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
8150	SANSAC	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
8442	STATICIN	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
8646	T-STAT	ERYTHROMYCIN	12560	C37H67NO13	733.937	\N	2.7	5	14	7	194	51	0	1180	18	0	\N	\N	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
5983	NEXIUM 24HR	ESOMEPRAZOLE MAGNESIUM	130564	C34H36MgN6O6S2	713.123	\N	\N	0	14	10	163	49	0	453	0	2	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Mg+2]	magnesium;5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-ide
9615	VIMOVO	ESOMEPRAZOLE MAGNESIUM	130564	C34H36MgN6O6S2	713.123	\N	\N	0	14	10	163	49	0	453	0	2	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Mg+2]	magnesium;5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-ide
5984	NEXIUM IV	ESOMEPRAZOLE SODIUM	10959536	C17H18N3NaO3S	367.399	\N	\N	0	7	5	81.5	25	0	459	0	1	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Na+]	sodium;5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-ide
5023	LO/OVRAL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5131	LUNELLE	ESTRADIOL CYPIONATE	9403	C26H36O3	396.571	\N	7.1	1	3	5	46.5	29	0	597	5	0	\N	\N	CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=C3C=CC(=C5)O	[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
3300	ESTRADIOL CYPIONATE	ESTRADIOL CYPIONATE	9403	C26H36O3	396.571	\N	7.1	1	3	5	46.5	29	0	597	5	0	\N	\N	CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=C3C=CC(=C5)O	[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
8807	TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE	ESTRADIOL CYPIONATE	9403	C26H36O3	396.571	\N	7.1	1	3	5	46.5	29	0	597	5	0	\N	\N	CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=C3C=CC(=C5)O	[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
115	ACTIVELLA	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
1734	CLIMARA PRO	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3294	ESTRADERM	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3295	ESTRADIOL	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3296	ESTRADIOL AND NORETHINDRONE ACETATE	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3298	ESTRADIOL AND NORGESTIMATE	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3311	ESTRING	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3312	ESTROGEL	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3361	EVAMIST	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3447	FEMPATCH	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
4297	INNOFEM	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
5591	MINIVELLE	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
7410	PREFEST	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
9444	VAGIFEM	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
9682	VIVELLE-DOT	ESTRADIOL	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
3117	EMCYT	ESTRAMUSTINE PHOSPHATE SODIUM	444000	C23H30Cl2NNa2O6P	564.347	\N	\N	0	6	7	102	35	0	735	5	0	\N	\N	CC12CCC3C(C1CCC2OP(=O)([O-])[O-])CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl.[Na+].[Na+]	disodium;[(8R,9S,13S,14S,17S)-3-[bis(2-chloroethyl)carbamoyloxy]-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] phosphate
3446	FEMOGEN	ESTROGENS, ESTERIFIED	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
5388	MENEST	ESTROGENS, ESTERIFIED	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
5393	MENRIUM 10-4	ESTROGENS, ESTERIFIED	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
5395	MENRIUM 5-2	ESTROGENS, ESTERIFIED	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
5397	MENRIUM 5-4	ESTROGENS, ESTERIFIED	5757	C18H24O2	272.388	\N	4	2	2	0	40.5	20	0	382	5	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
6310	OGEN 2.5	ESTROPIPATE	5284555	C22H32N2O5S	436.567	\N	\N	3	7	2	113	30	0	650	4	0	\N	\N	CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1	[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine
6311	OGEN 5	ESTROPIPATE	5284555	C22H32N2O5S	436.567	\N	\N	3	7	2	113	30	0	650	4	0	\N	\N	CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1	[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine
6475	ORTHO-EST	ESTROPIPATE	5284555	C22H32N2O5S	436.567	\N	\N	3	7	2	113	30	0	650	4	0	\N	\N	CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1	[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine
5527	MIBELAS 24 FE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
8174	SEASONALE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
8602	SYEDA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9920	ZOVIA 1/50E-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
394	ALYACEN 7/7/7	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
397	ALYACEN 777	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
894	AVIANE-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
980	BALZIVA-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
982	BALZIVA-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
1007	BEKYREE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
1142	BLISOVI FE 1.5/30	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
1144	BLISOVI FE 1/20	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
1172	BREVICON 21-DAY	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
1174	BREVICON 28-DAY	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
1180	BRIELLYN	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2085	CRYSELLE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2104	CYCLAFEM 0.5/35	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2106	CYCLAFEM 1/35	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2108	CYCLAFEM 7/7/7	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2113	CYCLESSA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2128	CYONANZ	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2198	DASETTA 7/7/7	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2205	DAYSEE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3082	ELIFEMME	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2319	DEMULEN 1/35-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2321	DEMULEN 1/35-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2323	DEMULEN 1/50-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2325	DEMULEN 1/50-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2367	DESOGESTREL AND ETHINYL ESTRADIOL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2369	DESOGESTREL; ETHINYL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2371	DESOGESTREL; ETHINYL ESTRADIOL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
2936	DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3086	ELINEST	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3125	EMOQUETTE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3172	ENPRESSE-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3174	ENPRESSE-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3177	ENSKYCE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3288	ESTARYLLA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3292	ESTINYL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3316	ESTROSTEP 21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3318	ESTROSTEP FE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3328	ETHINYL ESTRADIOL AND LEVONORGESTREL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3335	ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3429	FAYOSIM	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3441	FEMCON FE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3443	FEMHRT	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3445	FEMINONE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3674	FYAVOLV	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3719	GENCEPT 10/11-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3721	GENCEPT 10/11-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3748	GILDAGIA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3750	GILDESS 1.5/30	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3752	GILDESS 1/20	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3754	GILDESS 24 FE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3756	GILDESS FE 1.5/30	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
3758	GILDESS FE 1/20	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4429	ISIBLOOM	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4587	JUNEL 1.5/30	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4589	JUNEL 1/20	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4591	JUNEL FE 1.5/30	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4593	JUNEL FE 1/20	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4617	KAITLIB FE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4634	KARIVA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4646	KELNOR	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4679	KIMIDESS	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4704	KURVELO	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4818	LARIN 1/20	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4820	LARIN 24 FE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4822	LARIN FE 1.5/30	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4824	LARIN FE 1/20	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4851	LERIBANE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4857	LESSINA-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4859	LESSINA-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4882	LEVLITE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4898	LEVONEST	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4901	LEVONORGESTREL AND ETHINYL ESTRADIOL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4903	LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4907	LEVORA 0.15/30-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
4909	LEVORA 0.15/30-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5015	LO LOESTRIN FE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5018	LO MINASTRIN FE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5025	LO/OVRAL-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5035	LOESTRIN 21 1.5/30	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5037	LOESTRIN 21 1/20	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5039	LOESTRIN 24 FE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5043	LOESTRIN FE 1/20	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5089	LORYNA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5093	LOSEASONIQUE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5112	LOW-OGESTREL-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5114	LOW-OGESTREL-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5148	LYBREL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5312	MARLISSA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5545	MICROGESTIN 1.5/30	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5547	MICROGESTIN 1/20	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5549	MICROGESTIN FE 1.5/30	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5551	MICROGESTIN FE 1/20	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5570	MILI	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5584	MINASTRIN 24 FE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5612	MIRCETTE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5633	MODICON 21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5635	MODICON 28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5657	MONO-LINYAH	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5778	MYZILRA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5780	N.E.E. 1/35 21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
5782	N.E.E. 1/35 28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6002	NIKKI	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6046	NORCEPT-E 1/35 21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6048	NORCEPT-E 1/35 28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6055	NORDETTE-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6057	NORDETTE-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6063	NORETHIN 1/35E-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6065	NORETHIN 1/35E-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6073	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6075	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6077	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6081	NORETHINDRONE AND ETHINYL ESTRADIOL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6083	NORETHINDRONE AND ETHINYL ESTRADIOL (10/11)	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6085	NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6087	NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6098	NORGESTIMATE AND ETHINYL ESTRADIOL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6101	NORGESTIMATE; ETHINYL ESTRADIOL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6102	NORGESTREL AND ETHINYL ESTRADIOL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6106	NORINYL 1+35 21-DAY	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6108	NORINYL 1+35 28-DAY	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6121	NORLESTRIN 21 1/50	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6123	NORLESTRIN 21 2.5/50	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6125	NORLESTRIN 28 1/50	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6127	NORLESTRIN FE 1/50	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6130	NORLESTRIN FE 2.5/50	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6166	NORQUEST FE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6170	NORTREL 0.5/35-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6172	NORTREL 0.5/35-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6174	NORTREL 1/35-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
7383	PRE-OP	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
6176	NORTREL 1/35-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6178	NORTREL 7/7/7	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6251	NUVARING	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6256	NYLIA 1/35	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6258	NYLIA 7/7/7	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6314	OGESTREL 0.5/50-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6459	ORTHO CYCLEN-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6461	ORTHO CYCLEN-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6463	ORTHO EVRA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6465	ORTHO TRI-CYCLEN	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6467	ORTHO TRI-CYCLEN 21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6469	ORTHO TRI-CYCLEN 28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6471	ORTHO TRI-CYCLEN LO	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6474	ORTHO-CEPT	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6476	ORTHO-NOVUM 1/35-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6478	ORTHO-NOVUM 1/35-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6490	ORTHO-NOVUM 10/11-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6492	ORTHO-NOVUM 10/11-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6496	ORTHO-NOVUM 7/14-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6498	ORTHO-NOVUM 7/14-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6500	ORTHO-NOVUM 7/7/7-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6502	ORTHO-NOVUM 7/7/7-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6543	OVCON-35	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6545	OVCON-50	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6549	OVRAL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6551	OVRAL-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6924	PIMTREA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6938	PIRMELLA 1/35	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6940	PIRMELLA 7/7/7	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
7039	PORTIA-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
7041	PORTIA-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
7455	PREVEN EMERGENCY CONTRACEPTIVE KIT	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
7457	PREVIFEM	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
7824	QUARTETTE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
7827	QUASENSE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
8129	SAFYRAL	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
8176	SEASONIQUE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
8243	SETLAKIN	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
8698	TAYTULLA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9157	TRI LO SPRINTEC	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9159	TRI-ESTARYLLA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9161	TRI-LEGEST 21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9163	TRI-LEGEST FE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9165	TRI-LINYAH	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9167	TRI-LO-ESTARYLLA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9170	TRI-LO-LINYAH	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9174	TRI-MILI	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9176	TRI-NORINYL 21-DAY	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9178	TRI-NORINYL 28-DAY	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9180	TRI-PREVIFEM	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9182	TRI-SPRINTEC	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9266	TRIPHASIL-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9295	TRIVORA-21	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9297	TRIVORA-28	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9528	VELIVET	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9609	VIENVA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9627	VIORELE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9706	VYFEMLA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9718	WERA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9775	XULANE	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9795	YAELA	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
9797	YASMIN	ETHINYL ESTRADIOL	5991	C20H24O2	296.41	\N	3.7	2	2	1	40.5	22	0	505	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
6556	OVULEN-21	ETHYNODIOL DIACETATE	9270	C24H32O4	384.516	\N	3.9	0	4	5	52.6	28	0	758	7	0	\N	\N	CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C	[(3S,8R,9S,10R,13S,14S,17R)-17-acetoxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
2324	DEMULEN 1/50-21	ETHYNODIOL DIACETATE	9270	C24H32O4	384.516	\N	3.9	0	4	5	52.6	28	0	758	7	0	\N	\N	CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C	[(3S,8R,9S,10R,13S,14S,17R)-17-acetoxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
2326	DEMULEN 1/50-28	ETHYNODIOL DIACETATE	9270	C24H32O4	384.516	\N	3.9	0	4	5	52.6	28	0	758	7	0	\N	\N	CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C	[(3S,8R,9S,10R,13S,14S,17R)-17-acetoxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
4647	KELNOR	ETHYNODIOL DIACETATE	9270	C24H32O4	384.516	\N	3.9	0	4	5	52.6	28	0	758	7	0	\N	\N	CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C	[(3S,8R,9S,10R,13S,14S,17R)-17-acetoxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
6558	OVULEN-28	ETHYNODIOL DIACETATE	9270	C24H32O4	384.516	\N	3.9	0	4	5	52.6	28	0	758	7	0	\N	\N	CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C	[(3S,8R,9S,10R,13S,14S,17R)-17-acetoxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
9917	ZOVIA 1/35E-28	ETHYNODIOL DIACETATE	9270	C24H32O4	384.516	\N	3.9	0	4	5	52.6	28	0	758	7	0	\N	\N	CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C	[(3S,8R,9S,10R,13S,14S,17R)-17-acetoxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
9919	ZOVIA 1/50E-21	ETHYNODIOL DIACETATE	9270	C24H32O4	384.516	\N	3.9	0	4	5	52.6	28	0	758	7	0	\N	\N	CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C	[(3S,8R,9S,10R,13S,14S,17R)-17-acetoxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
9921	ZOVIA 1/50E-28	ETHYNODIOL DIACETATE	9270	C24H32O4	384.516	\N	3.9	0	4	5	52.6	28	0	758	7	0	\N	\N	CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C	[(3S,8R,9S,10R,13S,14S,17R)-17-acetoxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
5033	LODINE XL	ETODOLAC	3308	C17H21NO3	287.359	\N	2.8	2	3	4	62.3	21	0	400	0	1	\N	\N	CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O	2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid
4215	IMPLANON	ETONOGESTREL	6917715	C22H28O2	324.464	\N	3.3	1	2	2	37.3	24	0	677	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
6252	NUVARING	ETONOGESTREL	6917715	C22H28O2	324.464	\N	3.3	1	2	2	37.3	24	0	677	6	0	\N	\N	CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
9550	VEPESID	ETOPOSIDE	36462	C29H32O13	588.562	\N	0.6	3	13	5	161	42	0	969	10	0	\N	\N	CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O	(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one
253	AFINITOR DISPERZ	EVEROLIMUS	6442177	C53H83NO14	958.24	\N	5.9	3	14	9	205	68	0	1810	15	0	\N	\N	CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC	\N
9908	ZORTRESS	EVEROLIMUS	6442177	C53H83NO14	958.24	\N	5.9	3	14	9	205	68	0	1810	15	0	\N	\N	CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC	\N
1301	BYDUREON	EXENATIDE SYNTHETIC	45588096	C184H282N50O60S	4186.63	\N	-21	58	66	135	1780	295	0	10300	37	0	\N	\N	CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CNC=N9)N	\N
3537	FLOVENT DISKUS 100	FLUTICASONE PROPIONATE	444036	C25H31F3O5S	500.573	\N	4	1	9	6	106	34	0	984	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
1302	BYDUREON PEN	EXENATIDE SYNTHETIC	45588096	C184H282N50O60S	4186.63	\N	-21	58	66	135	1780	295	0	10300	37	0	\N	\N	CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CNC=N9)N	\N
1303	BYETTA	EXENATIDE SYNTHETIC	45588096	C184H282N50O60S	4186.63	\N	-21	58	66	135	1780	295	0	10300	37	0	\N	\N	CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CNC=N9)N	\N
6766	PEPCID AC	FAMOTIDINE	5702160	C8H15N7O2S3	337.435	\N	-0.6	4	8	7	238	20	0	469	0	0	\N	\N	C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N	3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N'-sulfamoyl-propanamidine
6768	PEPCID COMPLETE	FAMOTIDINE	5702160	C8H15N7O2S3	337.435	\N	-0.6	4	8	7	238	20	0	469	0	0	\N	\N	C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N	3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N'-sulfamoyl-propanamidine
6770	PEPCID PRESERVATIVE FREE	FAMOTIDINE	5702160	C8H15N7O2S3	337.435	\N	-0.6	4	8	7	238	20	0	469	0	0	\N	\N	C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N	3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N'-sulfamoyl-propanamidine
6771	PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER	FAMOTIDINE	5702160	C8H15N7O2S3	337.435	\N	-0.6	4	8	7	238	20	0	469	0	0	\N	\N	C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N	3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N'-sulfamoyl-propanamidine
6772	PEPCID RPD	FAMOTIDINE	5702160	C8H15N7O2S3	337.435	\N	-0.6	4	8	7	238	20	0	469	0	0	\N	\N	C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N	3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N'-sulfamoyl-propanamidine
2970	DURAGESIC-25	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
2971	DURAGESIC-50	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
2972	DURAGESIC-75	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
3458	FENTANYL	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
3464	FENTANYL-100	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
3465	FENTANYL-12	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
3466	FENTANYL-25	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
3467	FENTANYL-37	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
3468	FENTANYL-50	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
3469	FENTANYL-62	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
3470	FENTANYL-75	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
3471	FENTANYL-87	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
8497	SUBSYS	FENTANYL	3345	C22H28N2O	336.479	\N	4	0	2	6	23.6	25	0	391	0	0	\N	\N	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide
3488	FEXOFENADINE HYDROCHLORIDE	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
3489	FEXOFENADINE HYDROCHLORIDE ALLERGY	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
3490	FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
3492	FEXOFENADINE HYDROCHLORIDE HIVES	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
3493	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	FEXOFENADINE HYDROCHLORIDE	63002	C32H40ClNO4	538.125	\N	\N	4	5	10	81	38	0	678	0	1	\N	\N	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid;hydrochloride
3538	FLOVENT DISKUS 250	FLUTICASONE PROPIONATE	444036	C25H31F3O5S	500.573	\N	4	1	9	6	106	34	0	984	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
2784	DIFICID	FIDAXOMICIN	46174142	C52H74Cl2O18	1058.046	\N	6.4	7	18	15	267	72	0	1970	14	0	\N	\N	CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C	[(2R,3S,4S,5S,6R)-6-[[(3E,5E,8S,9Z,11S,12R,13E,15E,18S)-12-[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)tetrahydropyran-2-yl]oxy-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy]-4-hydroxy-5-methoxy-2-methyl-tetrahydropyran-3-yl] 3,5-dichloro-2-ethyl-4,6-dihydroxy-benzoate
2789	DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	FLUCONAZOLE	3365	C13H12F2N6O	306.277	\N	0.4	1	7	5	81.6	22	0	358	0	0	\N	\N	C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O	2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol
3548	FLUCONAZOLE	FLUCONAZOLE	3365	C13H12F2N6O	306.277	\N	0.4	1	7	5	81.6	22	0	358	0	0	\N	\N	C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O	2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol
3549	FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER	FLUCONAZOLE	3365	C13H12F2N6O	306.277	\N	0.4	1	7	5	81.6	22	0	358	0	0	\N	\N	C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O	2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol
3550	FLUCONAZOLE IN SODIUM CHLORIDE 0.9%	FLUCONAZOLE	3365	C13H12F2N6O	306.277	\N	0.4	1	7	5	81.6	22	0	358	0	0	\N	\N	C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O	2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol
3551	FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	FLUCONAZOLE	3365	C13H12F2N6O	306.277	\N	0.4	1	7	5	81.6	22	0	358	0	0	\N	\N	C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O	2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol
7995	RETISERT	FLUOCINOLONE ACETONIDE	6215	C24H30F2O6	452.495	\N	2.5	2	8	2	93.1	32	0	960	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C	\N
262	AK-FLUOR 25%	FLUORESCEIN SODIUM	9885981	C20H10Na2O5	376.275	\N	\N	0	5	0	81.6	27	0	522	0	0	\N	\N	C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)[O-])OC5=C3C=CC(=C5)[O-].[Na+].[Na+]	disodium;3-oxospiro[isobenzofuran-1,9'-xanthene]-3',6'-diolate
3567	FLUORESCITE	FLUORESCEIN SODIUM	9885981	C20H10Na2O5	376.275	\N	\N	0	5	0	81.6	27	0	522	0	0	\N	\N	C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)[O-])OC5=C3C=CC(=C5)[O-].[Na+].[Na+]	disodium;3-oxospiro[isobenzofuran-1,9'-xanthene]-3',6'-diolate
3665	FUNDUSCEIN-25	FLUORESCEIN SODIUM	9885981	C20H10Na2O5	376.275	\N	\N	0	5	0	81.6	27	0	522	0	0	\N	\N	C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)[O-])OC5=C3C=CC(=C5)[O-].[Na+].[Na+]	disodium;3-oxospiro[isobenzofuran-1,9'-xanthene]-3',6'-diolate
3591	FML FORTE	FLUOROMETHOLONE	9878	C22H29FO4	376.468	\N	2	2	5	1	74.6	27	0	787	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O	(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
3592	FML-S	FLUOROMETHOLONE	9878	C22H29FO4	376.468	\N	2	2	5	1	74.6	27	0	787	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O	(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
7781	PROZAC WEEKLY	FLUOXETINE HYDROCHLORIDE	62857	C17H19ClF3NO	345.79	\N	\N	2	5	6	21.3	23	0	308	0	1	\N	\N	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl	N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride
8154	SARAFEM	FLUOXETINE HYDROCHLORIDE	62857	C17H19ClF3NO	345.79	\N	\N	2	5	6	21.3	23	0	308	0	1	\N	\N	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl	N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride
8191	SELFEMRA	FLUOXETINE HYDROCHLORIDE	62857	C17H19ClF3NO	345.79	\N	\N	2	5	6	21.3	23	0	308	0	1	\N	\N	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl	N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride
2020	CORDRAN SP	FLURANDRENOLIDE	15209	C24H33FO6	436.52	\N	1.4	2	7	2	93.1	31	0	868	9	0	\N	\N	CC1(OC2CC3C4CC(C5=CC(=O)CCC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C	\N
6290	OCUFEN	FLURBIPROFEN SODIUM	23684814	C15H12FNaO2	266.247	\N	\N	0	3	3	40.1	19	0	292	0	1	\N	\N	CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)[O-].[Na+]	sodium;2-(3-fluoro-4-phenyl-phenyl)propanoate
3531	FLONASE SENSIMIST ALLERGY RELIEF	FLUTICASONE FUROATE	9854489	C27H29F3O6S	538.578	\N	4.8	1	10	6	119	37	0	1080	9	0	\N	\N	CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
217	ADVAIR DISKUS 500/50	FLUTICASONE PROPIONATE	444036	C25H31F3O5S	500.573	\N	4	1	9	6	106	34	0	984	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
219	ADVAIR HFA	FLUTICASONE PROPIONATE	444036	C25H31F3O5S	500.573	\N	4	1	9	6	106	34	0	984	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
3003	DYMISTA	FLUTICASONE PROPIONATE	444036	C25H31F3O5S	500.573	\N	4	1	9	6	106	34	0	984	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
3529	FLONASE	FLUTICASONE PROPIONATE	444036	C25H31F3O5S	500.573	\N	4	1	9	6	106	34	0	984	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
3530	FLONASE ALLERGY RELIEF	FLUTICASONE PROPIONATE	444036	C25H31F3O5S	500.573	\N	4	1	9	6	106	34	0	984	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
3536	FLOVENT	FLUTICASONE PROPIONATE	444036	C25H31F3O5S	500.573	\N	4	1	9	6	106	34	0	984	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
3539	FLOVENT DISKUS 50	FLUTICASONE PROPIONATE	444036	C25H31F3O5S	500.573	\N	4	1	9	6	106	34	0	984	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
3540	FLOVENT HFA	FLUTICASONE PROPIONATE	444036	C25H31F3O5S	500.573	\N	4	1	9	6	106	34	0	984	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
3586	FLUTICASONE PROPIONATE	FLUTICASONE PROPIONATE	444036	C25H31F3O5S	500.573	\N	4	1	9	6	106	34	0	984	9	0	\N	\N	CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF	[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
4856	LESCOL XL	FLUVASTATIN SODIUM	23663976	C24H25FNNaO4	433.455	\N	\N	2	5	8	85.5	31	0	596	2	0	\N	\N	CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+]	sodium;(E,3R,5S)-7-[3-(4-fluorophenyl)-1-isopropyl-indol-2-yl]-3,5-dihydroxy-hept-6-enoate
5145	LUVOX CR	FLUVOXAMINE MALEATE	9560989	C19H25F3N2O6	434.412	\N	\N	3	11	11	131	30	0	446	0	0	\N	\N	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O	maleic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
3602	FOLIC ACID	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
3603	FOLICET	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
3608	FOLVITE	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
3610	FOLVRON	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
4260	INFUVITE ADULT	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
4272	INFUVITE PEDIATRIC	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
4285	INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
5192	M.V.I. ADULT (PHARMACY BULK PACKAGE)	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
5205	M.V.I. PEDIATRIC	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
5218	M.V.I.-12	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
5230	M.V.I.-12	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
5242	M.V.I.-12 (WITHOUT VITAMIN K)	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
5254	M.V.I.-12 LYOPHILIZED	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
5721	MVC PLUS	FOLIC ACID	6037	C19H19N7O6	441.404	\N	-1.1	6	9	9	209	32	0	767	1	0	\N	\N	C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
3119	EMEND	FOSAPREPITANT DIMEGLUMINE	15527165	C37H56F7N6O16P	1004.844	\N	\N	15	26	19	350	67	0	1130	11	0	\N	\N	CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)N(N3)P(=O)(O)O)C4=CC=C(C=C4)F.CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O	[5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-3-oxo-1H-1,2,4-triazol-2-yl]phosphonic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
3630	FOSAPREPITANT DIMEGLUMINE	FOSAPREPITANT DIMEGLUMINE	15527165	C37H56F7N6O16P	1004.844	\N	\N	15	26	19	350	67	0	1130	11	0	\N	\N	CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)N(N3)P(=O)(O)O)C4=CC=C(C=C4)F.CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O	[5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-3-oxo-1H-1,2,4-triazol-2-yl]phosphonic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
5664	MONOPRIL	FOSINOPRIL SODIUM	23681451	C30H45NNaO7P	585.654	\N	\N	0	7	15	113	40	0	857	2	2	\N	\N	CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3.[Na+]	sodium;(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxy-propoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate
5665	MONOPRIL-HCT	FOSINOPRIL SODIUM	23681451	C30H45NNaO7P	585.654	\N	\N	0	7	15	113	40	0	857	2	2	\N	\N	CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3.[Na+]	sodium;(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxy-propoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate
6871	PHISOHEX	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
5710	MULTIHANCE MULTIPACK	GADOBENATE DIMEGLUMINE	6918204	C36H62GdN5O21	1058.156	\N	\N	14	26	29	440	63	0	860	8	1	\N	\N	CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O.C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)O.[Gd+3]	3-benzyloxy-2-[2-[carboxylatomethyl-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]ethyl-(carboxymethyl)amino]propanoate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
3689	GANIRELIX ACETATE	GANIRELIX ACETATE	16130957	C80H113ClN18O13	1570.347	\N	5.4	16	16	48	452	112	0	3030	10	0	\N	\N	CCNC(=NCCCCC(C(=O)NC(CC(C)C)C(=O)NC(CCCCN=C(NCC)NCC)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC	(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-(2-naphthyl)propanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-(3-pyridyl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-[bis(ethylamino)methyleneamino]hexanoyl]amino]-4-methyl-pentanoyl]amino]-6-[bis(ethylamino)methyleneamino]hexanoyl]-N-[(1R)-2-amino-1-methyl-2-oxo-ethyl]pyrrolidine-2-carboxamide
6929	PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE	GLIMEPIRIDE	3476	C24H34N4O5S	490.619	\N	3.9	3	5	7	133	34	0	895	0	0	\N	\N	CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C	4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide
8080	ROSIGLITAZONE MALEATE AND GLIMEPIRIDE	GLIMEPIRIDE	3476	C24H34N4O5S	490.619	\N	3.9	3	5	7	133	34	0	895	0	0	\N	\N	CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C	4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide
3785	GLYBURIDE (MICRONIZED)	GLYBURIDE	3488	C23H28ClN3O5S	494.003	\N	4.8	3	5	8	122	33	0	746	0	0	\N	\N	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide
3786	GLYBURIDE AND METFORMIN HYDROCHLORIDE	GLYBURIDE	3488	C23H28ClN3O5S	494.003	\N	4.8	3	5	8	122	33	0	746	0	0	\N	\N	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide
3798	GLYNASE	GLYBURIDE	3488	C23H28ClN3O5S	494.003	\N	4.8	3	5	8	122	33	0	746	0	0	\N	\N	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide
8062	ROBINUL FORTE	GLYCOPYRROLATE	11693	C19H28BrNO3	398.341	\N	\N	1	4	5	46.5	24	0	424	0	2	\N	\N	C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-]	(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenyl-acetate;bromide
5926	NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN	GRAMICIDIN	16130140	C99H140N20O17	1882.332	\N	10.7	21	17	52	549	136	0	3980	14	0	\N	\N	CC(C)CC(C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CC(C)C)C(=O)NC(CC7=CNC8=CC=CC=C87)C(=O)NCCO)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)C)NC=O	\N
5950	NEOSPORIN	GRAMICIDIN	16130140	C99H140N20O17	1882.332	\N	10.7	21	17	52	549	136	0	3980	14	0	\N	\N	CC(C)CC(C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CC(C)C)C(=O)NC(CC7=CNC8=CC=CC=C87)C(=O)NCCO)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)C)NC=O	\N
3824	GRISACTIN	GRISEOFULVIN, MICROCRYSTALLINE	441140	C17H17ClO6	352.767	\N	2.2	0	6	3	71.1	24	0	575	2	0	\N	\N	CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
3826	GRISEOFULVIN	GRISEOFULVIN, MICROSIZE	441140	C17H17ClO6	352.767	\N	2.2	0	6	3	71.1	24	0	575	2	0	\N	\N	CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
3661	FULVICIN P/G 165	GRISEOFULVIN, ULTRAMICROCRYSTALLINE	441140	C17H17ClO6	352.767	\N	2.2	0	6	3	71.1	24	0	575	2	0	\N	\N	CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
3662	FULVICIN P/G 330	GRISEOFULVIN, ULTRAMICROCRYSTALLINE	441140	C17H17ClO6	352.767	\N	2.2	0	6	3	71.1	24	0	575	2	0	\N	\N	CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
9382	ULTRAGRIS-330	GRISEOFULVIN, ULTRAMICROCRYSTALLINE	441140	C17H17ClO6	352.767	\N	2.2	0	6	3	71.1	24	0	575	2	0	\N	\N	CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
3874	HALOPERIDOL LACTATE	HALOPERIDOL LACTATE	3559	C21H23ClFNO2	375.868	\N	3.2	1	4	6	40.5	26	0	451	0	0	\N	\N	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one
3859	HALDOL SOLUTAB	HALOPERIDOL	3559	C21H23ClFNO2	375.868	\N	3.2	1	4	6	40.5	26	0	451	0	0	\N	\N	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one
9564	VERSAPEN-K	HETACILLIN POTASSIUM	23678597	C19H22KN3O4S	427.56	\N	\N	1	6	3	118	28	0	695	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)N3C(=O)C(NC3(C)C)C4=CC=CC=C4)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenyl-imidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
3020	E-Z SCRUB	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
3745	GERMA-MEDICA	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
3746	GERMA-MEDICA ""MG""	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
3940	HEXA-GERM	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
3946	HEXASCRUB	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
6870	PHISO-SCRUB	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
7384	PRE-OP II	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
8173	SCRUBTEAM SURGICAL SPONGEBRUSH	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
8202	SEPTI-SOFT	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
8203	SEPTISOL	HEXACHLOROPHENE	3598	C13H6Cl6O2	406.889	\N	7.5	2	2	2	40.5	21	0	328	0	0	\N	\N	C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol
4069	HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE	HOMATROPINE METHYLBROMIDE	6646	C17H24BrNO3	370.287	\N	\N	1	4	4	46.5	22	0	374	0	3	\N	\N	C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-]	(8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenyl-acetate;bromide
9327	TUSSIGON	HOMATROPINE METHYLBROMIDE	6646	C17H24BrNO3	370.287	\N	\N	1	4	4	46.5	22	0	374	0	3	\N	\N	C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-]	(8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenyl-acetate;bromide
730	APRESOLINE-ESIDRIX	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
1338	CAM-AP-ES	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
2919	DRALZINE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4018	HYDRALAZINE AND HYDROCHLOROTHIAZIDE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4020	HYDRALAZINE HYDROCHLORIDE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4021	HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4023	HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4025	HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4027	HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4029	HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE AND RESERPINE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4032	HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4035	HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4039	HYDRAP-ES	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4055	HYDROCHLOROTHIAZIDE W/ HYDRALAZINE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4059	HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4114	HYDROSERPINE PLUS (R-H-H)	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
7980	RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
7983	RESERPINE, HYDROCHLOROTHIAZIDE, AND HYDRALAZINE HYDROCHLORIDE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
8215	SER-AP-ES	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
8231	SERPASIL-APRESOLINE	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
9401	UNIPRES	HYDRALAZINE HYDROCHLORIDE	9351	C8H9ClN4	196.638	\N	\N	3	4	1	63.8	13	0	150	0	0	\N	\N	C1=CC=C2C(=C1)C=NN=C2NN.Cl	phthalazin-1-ylhydrazine;hydrochloride
4019	HYDRALAZINE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4022	HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4024	HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4040	HYDRAP-ES	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4047	HYDRO-RIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5641	MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9216	TRIBENZOR	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
877	AVALIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1019	BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1027	BENICAR HCT	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1129	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1339	CAM-AP-ES	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1352	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1354	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1369	CAPOZIDE 25/15	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1371	CAPOZIDE 25/25	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1373	CAPOZIDE 50/15	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1375	CAPOZIDE 50/25	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1379	CAPTOPRIL AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
2817	DIOVAN HCT	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
2989	DUTOPROL	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
2996	DYAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3141	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3277	ESIDRIX	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3279	ESIMIL	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3851	H.R.-50	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4026	HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4028	HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4030	HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE AND RESERPINE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4033	HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4036	HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4043	HYDRO-D	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4044	HYDRO-RESERP	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4049	HYDRO-SERP ""25""	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4051	HYDRO-SERP ""50""	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4053	HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4054	HYDROCHLOROTHIAZIDE INTENSOL	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4056	HYDROCHLOROTHIAZIDE W/ HYDRALAZINE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4057	HYDROCHLOROTHIAZIDE W/ RESERPINE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4060	HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4062	HYDROCHLOROTHIAZIDE; IRBESARTAN	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4110	HYDROPRES 25	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4112	HYDROPRES 50	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4115	HYDROSERPINE PLUS (R-H-H)	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4145	HYZAAR	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4226	INDERIDE LA 120/50	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4228	INDERIDE LA 160/50	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4230	INDERIDE LA 80/50	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4232	INDERIDE-40/25	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4234	INDERIDE-80/25	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4414	IRBESARTAN AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4416	IRBESARTAN HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4420	IRBESARTAN; HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5002	LISINOPRIL AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5091	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5098	LOTENSIN HCT	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5330	MAXZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5332	MAXZIDE-25	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5473	METHYLDOPA AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5501	METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5530	MICARDIS HCT	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4157	IBUPROFEN AND DIPHENHYDRAMINE CITRATE	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
5557	MICROZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5643	MOEXIPRIL HYDROCHLORIDE AND HYDROCHOLROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
6321	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
6324	OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
6328	OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
6428	ORETICYL 25	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
6430	ORETICYL 50	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
6432	ORETICYL FORTE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
7489	PRINZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
7741	PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
7743	PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
7844	QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
7846	QUINARETIC	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
7976	RESERPINE AND HYDROCHLOROTHIAZIDE-50	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
7981	RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
7984	RESERPINE, HYDROCHLOROTHIAZIDE, AND HYDRALAZINE HYDROCHLORIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
8216	SER-AP-ES	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
8233	SERPASIL-ESIDRIX #1	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
8235	SERPASIL-ESIDRIX #2	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
8404	SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
8406	SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
8743	TEKTURNA HCT	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
8749	TELMISARTAN AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
8752	TELMISARTAN; HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
8826	TEVETEN HCT	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9004	TRANDATE HCT	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9402	UNIPRES	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9404	UNIRETIC	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9463	VALSARTAN; HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9499	VASERETIC	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9647	VISKAZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9851	ZESTORETIC	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9858	ZIAC	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9863	ZIDE	HYDROCHLOROTHIAZIDE	3639	C7H8ClN3O4S2	297.728	\N	-0.1	3	7	1	135	17	0	494	0	0	\N	\N	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9330	TUSSIONEX PENNKINETIC	HYDROCODONE POLISTIREX	5284569	C18H21NO3	299.37	\N	2.2	0	4	1	38.8	22	0	509	4	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)CC4	(4R,4aR,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
8139	SALUTENSIN-DEMI	HYDROFLUMETHIAZIDE	3647	C8H8F3N3O4S2	331.284	\N	0.4	3	10	1	135	20	0	578	0	0	\N	\N	C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1	1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
4117	HYDROXOCOBALAMIN	HYDROXOCOBALAMIN	5460373	C62H90CoN13O15P	1347.385	\N	\N	10	20	16	453	92	0	3150	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2]	cobaltous;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate
4118	HYDROXOMIN	HYDROXOCOBALAMIN	5460373	C62H90CoN13O15P	1347.385	\N	\N	10	20	16	453	92	0	3150	14	0	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2]	cobaltous;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate
4120	HYDROXYPROGESTERONE CAPROATE	HYDROXYPROGESTERONE CAPROATE	169870	C27H40O4	428.613	\N	5.7	0	4	7	60.4	31	0	797	6	0	\N	\N	CCCCCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)C	[(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate
5278	MAKENA	HYDROXYPROGESTERONE CAPROATE	169870	C27H40O4	428.613	\N	5.7	0	4	7	60.4	31	0	797	6	0	\N	\N	CCCCCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)C	[(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate
5279	MAKENA PRESERVATIVE FREE	HYDROXYPROGESTERONE CAPROATE	169870	C27H40O4	428.613	\N	5.7	0	4	7	60.4	31	0	797	6	0	\N	\N	CCCCCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)C	[(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate
227	ADVIL ALLERGY SINUS	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4596	JUNIOR STRENGTH IBUPROFEN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
234	ADVIL MIGRAINE LIQUI-GELS	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
236	ADVIL PM	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
238	ADVIL PM	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
1558	CHILDREN'S ADVIL COLD	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
1560	CHILDREN'S ADVIL-FLAVORED	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
1566	CHILDREN'S ELIXSURE	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
1569	CHILDREN'S IBUPROFEN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
1570	CHILDREN'S MOTRIN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
1571	CHILDREN'S MOTRIN COLD	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4151	IBU	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4152	IBU-TAB	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4153	IBU-TAB 200	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4154	IBUPRIN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4155	IBUPROFEN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4159	IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4160	IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4162	IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4166	IBUPROHM	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4167	IBUPROHM COLD AND SINUS	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
4597	JUNIOR STRENGTH MOTRIN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
5563	MIDOL LIQUID GELS	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
5677	MOTRIN MIGRAINE PAIN	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
6685	PEDIATRIC ADVIL	IBUPROFEN	3672	C13H18O2	206.285	\N	3.5	1	2	4	37.3	15	0	203	0	1	\N	\N	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	2-(4-isobutylphenyl)propanoic acid
3512	FIRAZYR	ICATIBANT ACETATE	6918172	C61H93N19O15S	1364.593	\N	\N	16	20	30	589	96	0	2750	12	0	\N	\N	CC(=O)O.C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O	(2S)-2-[[(2S,3aS,7aS)-1-[(3R)-2-[(2S)-2-[[(2S)-2-[[2-[[(2S,4R)-1-[(2S)-1-[(2S)-2-[[(2R)-2-amino-5-guanidino-pentanoyl]amino]-5-guanidino-pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxy-pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-(2-thienyl)propanoyl]amino]-3-hydroxy-propanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carbonyl]amino]-5-guanidino-pentanoic acid;acetic acid
4170	IC-GREEN	INDOCYANINE GREEN	11967809	C43H47N2NaO6S2	774.967	\N	\N	0	7	12	137	54	0	1520	0	0	\N	\N	CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CCCCS(=O)(=O)[O-])C=CC=CC=CC=C4C(C5=C(N4CCCCS(=O)(=O)[O-])C=CC6=CC=CC=C65)(C)C)C.[Na+]	sodium;4-[(2E)-2-[(2E,4E,6E)-7-[1,1-dimethyl-3-(4-sulfonatobutyl)benzo[e]indol-3-ium-2-yl]hepta-2,4,6-trienylidene]-1,1-dimethyl-benzo[e]indol-3-yl]butane-1-sulfonate
4243	INDOCYANINE GREEN	INDOCYANINE GREEN	11967809	C43H47N2NaO6S2	774.967	\N	\N	0	7	12	137	54	0	1520	0	0	\N	\N	CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CCCCS(=O)(=O)[O-])C=CC=CC=CC=C4C(C5=C(N4CCCCS(=O)(=O)[O-])C=CC6=CC=CC=C65)(C)C)C.[Na+]	sodium;4-[(2E)-2-[(2E,4E,6E)-7-[1,1-dimethyl-3-(4-sulfonatobutyl)benzo[e]indol-3-ium-2-yl]hepta-2,4,6-trienylidene]-1,1-dimethyl-benzo[e]indol-3-yl]butane-1-sulfonate
8930	TIVORBEX	INDOMETHACIN	3715	C19H16ClNO4	357.79	\N	4.3	1	4	4	68.5	25	0	506	0	0	\N	\N	CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O	2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetic acid
9148	TRESIBA	INSULIN DEGLUDEC	118984462	C274H411N65O81S6	6104.036	\N	-4.9	79	92	197	2510	426	0	15300	51	0	\N	\N	CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NC(CC(=O)N)C(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C(C)O)C(=O)N8CCCC8C(=O)NC(CCCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCC(=O)O)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CNC=N2)CO)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN	\N
4876	LEVEMIR FLEXTOUCH	INSULIN DETEMIR RECOMBINANT	16137271	C267H402N64O76S6	5916.885	\N	-3.5	76	87	189	2400	413	0	14700	50	0	\N	\N	CCCCCCCCCCCCCC(=O)NCCCCC(C(=O)O)NC(=O)C1CCCN1C(=O)C(C(C)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CC=CC=C4)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C5CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C6CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N5)C(C)C)CC(C)C)CC7=CC=C(C=C7)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC8=CNC=N8)CO)NC(=O)C(CC(C)C)NC(=O)C(CC9=CNC=N9)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC1=CC=CC=C1)N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N6)C(C)CC)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN)CO)CC(C)C)CC1=CC=C(C=C1)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC1=CC=C(C=C1)O)C(=O)NC(CC(=O)N)C(=O)O	\N
4877	LEVEMIR INNOLET	INSULIN DETEMIR RECOMBINANT	16137271	C267H402N64O76S6	5916.885	\N	-3.5	76	87	189	2400	413	0	14700	50	0	\N	\N	CCCCCCCCCCCCCC(=O)NCCCCC(C(=O)O)NC(=O)C1CCCN1C(=O)C(C(C)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CC=CC=C4)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C5CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C6CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N5)C(C)C)CC(C)C)CC7=CC=C(C=C7)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC8=CNC=N8)CO)NC(=O)C(CC(C)C)NC(=O)C(CC9=CNC=N9)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC1=CC=CC=C1)N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N6)C(C)CC)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN)CO)CC(C)C)CC1=CC=C(C=C1)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC1=CC=C(C=C1)O)C(=O)NC(CC(=O)N)C(=O)O	\N
4878	LEVEMIR PENFILL	INSULIN DETEMIR RECOMBINANT	16137271	C267H402N64O76S6	5916.885	\N	-3.5	76	87	189	2400	413	0	14700	50	0	\N	\N	CCCCCCCCCCCCCC(=O)NCCCCC(C(=O)O)NC(=O)C1CCCN1C(=O)C(C(C)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CC=CC=C4)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C5CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C6CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N5)C(C)C)CC(C)C)CC7=CC=C(C=C7)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC8=CNC=N8)CO)NC(=O)C(CC(C)C)NC(=O)C(CC9=CNC=N9)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC1=CC=CC=C1)N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N6)C(C)CC)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN)CO)CC(C)C)CC1=CC=C(C=C1)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC1=CC=C(C=C1)O)C(=O)NC(CC(=O)N)C(=O)O	\N
4549	ISOVUE-300	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
7572	PRISMASOL BK 0/0 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2101	CYANOCOBALAMIN CO 57 SCHILLING TEST KIT	INTRINSIC FACTOR	24848138	C126H177Cl2Co3N28O28P2+2	2842.618	\N	\N	20	42	42	971	189	2	6440	15	12	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)N7)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5=NC4=C(C6=NC(=CC7=NC(=C(C8=NC5(C(C8CCC(=O)N)(C)CC(=O)N)C)C)C(C7CCC(=O)N)(C)CC(=O)N)C(C6CCC(=O)N)(C)C)C)CC(=O)N)C)O.[C-]#N.[C-]#N.Cl[Co]Cl.[Co+2].[Co+3]	cobaltous;cobalt-60(3+);dichlorocobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1S)-1-methyl-2-[3-[(2R,3R,5Z,7S,10Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-1,2,7,12,17,23-hexahydrocorrin-3-yl]propanoylamino]ethyl] hydrogen phosphate;[(2R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[(4Z,9Z,14Z)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydrocorrin-3-yl]propanoylamino]ethyl] phosphate;dicyanide
8107	RUBRATOPE-57 KIT	INTRINSIC FACTOR	24848138	C126H177Cl2Co3N28O28P2+2	2842.618	\N	\N	20	42	42	971	189	2	6440	15	12	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)N7)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5=NC4=C(C6=NC(=CC7=NC(=C(C8=NC5(C(C8CCC(=O)N)(C)CC(=O)N)C)C)C(C7CCC(=O)N)(C)CC(=O)N)C(C6CCC(=O)N)(C)C)C)CC(=O)N)C)O.[C-]#N.[C-]#N.Cl[Co]Cl.[Co+2].[Co+3]	cobaltous;cobalt-60(3+);dichlorocobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1S)-1-methyl-2-[3-[(2R,3R,5Z,7S,10Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-1,2,7,12,17,23-hexahydrocorrin-3-yl]propanoylamino]ethyl] hydrogen phosphate;[(2R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[(4Z,9Z,14Z)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydrocorrin-3-yl]propanoylamino]ethyl] phosphate;dicyanide
8112	RUBRATOPE-60 KIT	INTRINSIC FACTOR	24848138	C126H177Cl2Co3N28O28P2+2	2842.618	\N	\N	20	42	42	971	189	2	6440	15	12	\N	\N	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)N7)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5=NC4=C(C6=NC(=CC7=NC(=C(C8=NC5(C(C8CCC(=O)N)(C)CC(=O)N)C)C)C(C7CCC(=O)N)(C)CC(=O)N)C(C6CCC(=O)N)(C)C)C)CC(=O)N)C)O.[C-]#N.[C-]#N.Cl[Co]Cl.[Co+2].[Co+3]	cobaltous;cobalt-60(3+);dichlorocobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1S)-1-methyl-2-[3-[(2R,3R,5Z,7S,10Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-1,2,7,12,17,23-hexahydrocorrin-3-yl]propanoylamino]ethyl] hydrogen phosphate;[(2R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[(4Z,9Z,14Z)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydrocorrin-3-yl]propanoylamino]ethyl] phosphate;dicyanide
7957	RENOVUE-DIP	IODAMIDE MEGLUMINE	29182	C19H28I3N3O9	823.158	\N	\N	9	10	10	209	34	0	569	4	0	\N	\N	CC(=O)NCC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNCC(C(C(C(CO)O)O)O)O	3-acetamido-5-(acetamidomethyl)-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
1639	CHOLOGRAFIN MEGLUMINE	IODIPAMIDE MEGLUMINE	636408	C34H48I6N4O16	1530.197	\N	\N	16	18	21	359	60	0	848	8	0	\N	\N	CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O.C1=C(C(=C(C(=C1I)NC(=O)CCCCC(=O)NC2=C(C=C(C(=C2I)C(=O)O)I)I)I)C(=O)O)I	3-[[6-(3-carboxy-2,4,6-triiodo-anilino)-6-oxo-hexanoyl]amino]-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
8273	SINOGRAFIN	IODIPAMIDE MEGLUMINE	636408	C34H48I6N4O16	1530.197	\N	\N	16	18	21	359	60	0	848	8	0	\N	\N	CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O.C1=C(C(=C(C(=C1I)NC(=O)CCCCC(=O)NC2=C(C=C(C(=C2I)C(=O)O)I)I)I)C(=O)O)I	3-[[6-(3-carboxy-2,4,6-triiodo-anilino)-6-oxo-hexanoyl]amino]-2,4,6-triiodo-benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
9646	VISIPAQUE 320	IODIXANOL	3724	C35H44I6N6O15	1550.191	\N	-3.4	13	15	22	339	62	0	1330	0	4	\N	\N	CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I	5-[acetyl-[3-[N-acetyl-3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodo-anilino]-2-hydroxy-propyl]amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
6350	OMNIPAQUE 240	IOHEXOL	3730	C19H26I3N3O9	821.142	\N	-3	8	9	12	200	34	0	653	0	3	\N	\N	CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I	5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
6351	OMNIPAQUE 300	IOHEXOL	3730	C19H26I3N3O9	821.142	\N	-3	8	9	12	200	34	0	653	0	3	\N	\N	CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I	5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
6352	OMNIPAQUE 350	IOHEXOL	3730	C19H26I3N3O9	821.142	\N	-3	8	9	12	200	34	0	653	0	3	\N	\N	CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I	5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
6353	OMNIPAQUE 70	IOHEXOL	3730	C19H26I3N3O9	821.142	\N	-3	8	9	12	200	34	0	653	0	3	\N	\N	CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I	5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
6413	ORALTAG	IOHEXOL	3730	C19H26I3N3O9	821.142	\N	-3	8	9	12	200	34	0	653	0	3	\N	\N	CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I	5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
4546	ISOVUE-128	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
4547	ISOVUE-200	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
4548	ISOVUE-250	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
7536	PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER	LACTIC ACID	612	C3H6O3	90.078	\N	-0.7	2	3	1	57.5	6	0	59.1	0	1	\N	\N	CC(C(=O)O)O	2-hydroxypropanoic acid
4550	ISOVUE-370	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
4551	ISOVUE-M 200	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
4552	ISOVUE-M 300	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
8170	SCANLUX-370	IOPAMIDOL	65492	C17H22I3N3O8	777.089	\N	-2.4	8	8	10	188	31	0	583	1	0	\N	\N	CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
6400	OPTIRAY 320	IOVERSOL	3741	C18H24I3N3O9	807.115	\N	-3	8	9	12	200	33	0	623	0	2	\N	\N	C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO	N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
6401	OPTIRAY 350	IOVERSOL	3741	C18H24I3N3O9	807.115	\N	-3	8	9	12	200	33	0	623	0	2	\N	\N	C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO	N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
4439	ISOETHARINE HYDROCHLORIDE S/F	ISOETHARINE HYDROCHLORIDE	5791	C13H22ClNO3	275.773	\N	\N	5	4	5	72.7	18	0	223	0	2	\N	\N	CCC(C(C1=CC(=C(C=C1)O)O)O)NC(C)C.Cl	4-[1-hydroxy-2-(isopropylamino)butyl]benzene-1,2-diol;hydrochloride
8439	STANOZIDE	ISONIAZID	3767	C6H7N3O	137.142	\N	-0.7	2	3	1	68	10	0	120	0	0	\N	\N	C1=CN=CC=C1C(=O)NN	pyridine-4-carbohydrazide
6118	NORISODRINE	ISOPROTERENOL SULFATE	656677	C22H40N2O12S	556.624	\N	\N	12	14	8	230	37	0	268	0	2	\N	\N	CC(C)NCC(C1=CC(=C(C=C1)O)O)O.CC(C)NCC(C1=CC(=C(C=C1)O)O)O.O.O.OS(=O)(=O)O	4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol;sulfuric acid;dihydrate
621	AMNESTEEM	ISOTRETINOIN	5282379	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
5765	MYORISAN	ISOTRETINOIN	5282379	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
8389	SOTRET	ISOTRETINOIN	5282379	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
9842	ZENATANE	ISOTRETINOIN	5282379	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
3008	DYNACIRC CR	ISRADIPINE	3784	C19H21N3O5	371.393	\N	4.3	1	8	6	104	27	0	685	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC	O5-isopropyl O3-methyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
4553	ISRADIPINE	ISRADIPINE	3784	C19H21N3O5	371.393	\N	4.3	1	8	6	104	27	0	685	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC	O5-isopropyl O3-methyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
6374	ONMEL	ITRACONAZOLE	55283	C35H38Cl2N8O4	705.641	\N	5.7	0	9	11	101	49	0	1120	2	1	\N	\N	CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl	4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-sec-butyl-1,2,4-triazol-3-one
8408	SPORANOX	ITRACONAZOLE	55283	C35H38Cl2N8O4	705.641	\N	5.7	0	9	11	101	49	0	1120	2	1	\N	\N	CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl	4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-sec-butyl-1,2,4-triazol-3-one
4626	KANTREX	KANAMYCIN SULFATE	441374	C18H38N4O15S	582.575	\N	\N	13	19	6	366	38	0	720	15	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N.OS(=O)(=O)O	(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]tetrahydropyran-3,4,5-triol;sulfuric acid
4686	KLEBCIL	KANAMYCIN SULFATE	441374	C18H38N4O15S	582.575	\N	\N	13	19	6	366	38	0	720	15	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N.OS(=O)(=O)O	(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]tetrahydropyran-3,4,5-triol;sulfuric acid
9769	XOLEGEL	KETOCONAZOLE	456201	C26H28Cl2N4O4	531.434	\N	4.3	0	6	7	69.1	36	0	735	2	0	\N	\N	CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl	1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
130	ACUVAIL	KETOROLAC TROMETHAMINE	84003	C19H24N2O6	376.409	\N	\N	5	7	6	146	27	0	430	0	1	\N	\N	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O	2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
4672	KETOROLAC TROMETHAMINE	KETOROLAC TROMETHAMINE	84003	C19H24N2O6	376.409	\N	\N	5	7	6	146	27	0	430	0	1	\N	\N	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O	2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
6343	OMIDRIA	KETOROLAC TROMETHAMINE	84003	C19H24N2O6	376.409	\N	\N	5	7	6	146	27	0	430	0	1	\N	\N	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O	2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
8412	SPRIX	KETOROLAC TROMETHAMINE	84003	C19H24N2O6	376.409	\N	\N	5	7	6	146	27	0	430	0	1	\N	\N	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O	2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
8974	TORADOL	KETOROLAC TROMETHAMINE	84003	C19H24N2O6	376.409	\N	\N	5	7	6	146	27	0	430	0	1	\N	\N	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O	2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
9003	TRANDATE	LABETALOL HYDROCHLORIDE	71412	C19H25ClN2O3	364.87	\N	\N	5	4	8	95.6	25	0	385	0	2	\N	\N	CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O.Cl	2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]ethyl]benzamide;hydrochloride
3723	GENERLAC	LACTULOSE	11333	C12H22O11	342.297	\N	-4.3	8	11	5	190	23	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
3933	HEPTALAC	LACTULOSE	11333	C12H22O11	342.297	\N	-4.3	8	11	5	190	23	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
4727	LACTULOSE	LACTULOSE	11333	C12H22O11	342.297	\N	-4.3	8	11	5	190	23	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
7038	PORTALAC	LACTULOSE	11333	C12H22O11	342.297	\N	-4.3	8	11	5	190	23	0	395	9	0	\N	\N	C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
4730	LAMICTAL ODT	LAMOTRIGINE	3878	C9H7Cl2N5	256.09	\N	1.4	2	5	1	90.7	16	0	242	0	0	\N	\N	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
4731	LAMICTAL XR	LAMOTRIGINE	3878	C9H7Cl2N5	256.09	\N	1.4	2	5	1	90.7	16	0	242	0	0	\N	\N	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
4790	LAMOTRIGINE	LAMOTRIGINE	3878	C9H7Cl2N5	256.09	\N	1.4	2	5	1	90.7	16	0	242	0	0	\N	\N	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
7442	PREVACID NAPRAPAC 250 (COPACKAGED)	LANSOPRAZOLE	3883	C16H14F3N3O2S	369.362	\N	2.8	1	8	5	87.1	25	0	480	0	1	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
7444	PREVACID NAPRAPAC 375 (COPACKAGED)	LANSOPRAZOLE	3883	C16H14F3N3O2S	369.362	\N	2.8	1	8	5	87.1	25	0	480	0	1	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
7446	PREVACID NAPRAPAC 500 (COPACKAGED)	LANSOPRAZOLE	3883	C16H14F3N3O2S	369.362	\N	2.8	1	8	5	87.1	25	0	480	0	1	\N	\N	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
3084	ELIGARD	LEUPROLIDE ACETATE	657180	C61H88N16O14	1269.473	\N	\N	16	16	32	469	91	0	2420	9	0	\N	\N	CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O	acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
4867	LEUPROLIDE ACETATE	LEUPROLIDE ACETATE	657180	C61H88N16O14	1269.473	\N	\N	16	16	32	469	91	0	2420	9	0	\N	\N	CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O	acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
5135	LUPANETA PACK	LEUPROLIDE ACETATE	657180	C61H88N16O14	1269.473	\N	\N	16	16	32	469	91	0	2420	9	0	\N	\N	CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O	acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
5137	LUPRON	LEUPROLIDE ACETATE	657180	C61H88N16O14	1269.473	\N	\N	16	16	32	469	91	0	2420	9	0	\N	\N	CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O	acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
5138	LUPRON DEPOT	LEUPROLIDE ACETATE	657180	C61H88N16O14	1269.473	\N	\N	16	16	32	469	91	0	2420	9	0	\N	\N	CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O	acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
5139	LUPRON DEPOT-PED	LEUPROLIDE ACETATE	657180	C61H88N16O14	1269.473	\N	\N	16	16	32	469	91	0	2420	9	0	\N	\N	CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O	acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
9575	VIADUR	LEUPROLIDE ACETATE	657180	C61H88N16O14	1269.473	\N	\N	16	16	32	469	91	0	2420	9	0	\N	\N	CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O	acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
1392	CARBIDOPA, LEVODOPA AND ENTACAPONE	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
8423	STALEVO 100	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
8426	STALEVO 125	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
8429	STALEVO 150	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
8432	STALEVO 200	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
8435	STALEVO 50	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
8438	STALEVO 75	LEVODOPA	6047	C9H11NO4	197.19	\N	-2.7	4	5	3	104	14	0	209	1	0	\N	\N	C1=CC(=C(C=C1CC(C(=O)O)N)O)O	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
8130	SAFYRAL	LEVOMEFOLATE CALCIUM	444412	C20H25N7O6	459.463	\N	-0.5	7	9	9	199	33	0	865	2	0	\N	\N	CN1C(CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[[(6S)-2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid
7892	RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN	LEVONORDEFRIN	164739	C9H13NO3	183.207	\N	-0.8	4	4	2	86.7	13	0	165	2	0	\N	\N	CC(C(C1=CC(=C(C=C1)O)O)O)N	4-[(1R,2S)-2-amino-1-hydroxy-propyl]benzene-1,2-diol
8166	SCANDONEST L	LEVONORDEFRIN	164739	C9H13NO3	183.207	\N	-0.8	4	4	2	86.7	13	0	165	2	0	\N	\N	CC(C(C1=CC(=C(C=C1)O)O)O)N	4-[(1R,2S)-2-amino-1-hydroxy-propyl]benzene-1,2-diol
3175	ENPRESSE-28	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3329	ETHINYL ESTRADIOL AND LEVONORGESTREL	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3409	FALLBACK SOLO	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3411	FALMINA	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3430	FAYOSIM	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4353	INTROVALE	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4705	KURVELO	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4709	KYLEENA	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4858	LESSINA-21	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4860	LESSINA-28	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4883	LEVLITE	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4899	LEVONEST	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4900	LEVONORGESTREL	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4902	LEVONORGESTREL AND ETHINYL ESTRADIOL	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4904	LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4908	LEVORA 0.15/30-21	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4910	LEVORA 0.15/30-28	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
5149	LYBREL	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
5779	MYZILRA	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6056	NORDETTE-21	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6058	NORDETTE-28	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6164	NORPLANT SYSTEM IN PLASTIC CONTAINER	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6458	ORSYTHIA	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6947	PLAN B	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6948	PLAN B ONE-STEP	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
7040	PORTIA-21	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
7042	PORTIA-28	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
8175	SEASONALE	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
8177	SEASONIQUE	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
8244	SETLAKIN	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
8289	SKYLA	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
9267	TRIPHASIL-28	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
9296	TRIVORA-21	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
9298	TRIVORA-28	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
9610	VIENVA	LEVONORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4895	LEVOLET	LEVOTHYROXINE SODIUM	23666112	C15H10I4NNaO4	798.856	\N	\N	2	5	5	95.6	25	0	426	1	0	\N	\N	C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+]	sodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate
9409	UNITHROID	LEVOTHYROXINE SODIUM	23666112	C15H10I4NNaO4	798.856	\N	\N	2	5	5	95.6	25	0	426	1	0	\N	\N	C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+]	sodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate
4934	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4935	LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5%	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4936	LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4937	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4938	LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4939	LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4940	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
514	AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4941	LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4942	LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4944	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4945	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4946	LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4947	LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4948	LIDOCAINE HYDROCHLORIDE VISCOUS	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4950	LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4951	LIDOCAINE VISCOUS	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4953	LIDOCATON	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4954	LIDOCATON	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4956	LIDOPEN	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4958	LIDOSITE TOPICAL SYSTEM KIT	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4960	LIGNOSPAN FORTE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4962	LIGNOSPAN STANDARD	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
5123	LTA II KIT	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
6686	PEDIATRIC LTA KIT	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
9781	XYLOCAINE 1.5% W/ DEXTROSE 7.5%	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
9782	XYLOCAINE 4% PRESERVATIVE FREE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
9783	XYLOCAINE 5% W/ GLUCOSE 7.5%	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
9784	XYLOCAINE DENTAL	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
9786	XYLOCAINE DENTAL WITH EPINEPHRINE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
9787	XYLOCAINE PRESERVATIVE FREE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
9788	XYLOCAINE VISCOUS	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
9790	XYLOCAINE W/ EPINEPHRINE	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
9875	ZINGO	LIDOCAINE HYDROCHLORIDE	6314	C14H23ClN2O	270.801	\N	\N	2	2	5	32.3	18	0	228	0	0	\N	\N	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
4580	JENTADUETO	LINAGLIPTIN	10096344	C25H28N8O2	472.553	\N	1.9	1	7	4	114	35	0	885	1	0	\N	\N	CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C	8-[(3R)-3-amino-1-piperidyl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
4582	JENTADUETO XR	LINAGLIPTIN	10096344	C25H28N8O2	472.553	\N	1.9	1	7	4	114	35	0	885	1	0	\N	\N	CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C	8-[(3R)-3-amino-1-piperidyl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
8997	TRADJENTA	LINAGLIPTIN	10096344	C25H28N8O2	472.553	\N	1.9	1	7	4	114	35	0	885	1	0	\N	\N	CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C	8-[(3R)-3-amino-1-piperidyl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
4969	LINCOMYCIN	LINCOMYCIN HYDROCHLORIDE	64710	C18H35ClN2O6S	442.996	\N	\N	6	8	7	148	28	0	499	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O.Cl	(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide;hydrochloride
4970	LINCOMYCIN HCL	LINCOMYCIN HYDROCHLORIDE	64710	C18H35ClN2O6S	442.996	\N	\N	6	8	7	148	28	0	499	9	0	\N	\N	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O.Cl	(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide;hydrochloride
3353	EUTHROID-0.5	LIOTRIX (T4;T3)	71371	C30H21I7N2Na2O8	1471.815	\N	\N	4	10	8	191	49	0	811	2	0	\N	\N	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+].[Na+]	disodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate;(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoate
3356	EUTHROID-3	LIOTRIX (T4;T3)	71371	C30H21I7N2Na2O8	1471.815	\N	\N	4	10	8	191	49	0	811	2	0	\N	\N	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+].[Na+]	disodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate;(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoate
8884	THYROLAR-0.25	LIOTRIX (T4;T3)	71371	C30H21I7N2Na2O8	1471.815	\N	\N	4	10	8	191	49	0	811	2	0	\N	\N	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+].[Na+]	disodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate;(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoate
8885	THYROLAR-0.5	LIOTRIX (T4;T3)	71371	C30H21I7N2Na2O8	1471.815	\N	\N	4	10	8	191	49	0	811	2	0	\N	\N	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+].[Na+]	disodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate;(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoate
8886	THYROLAR-1	LIOTRIX (T4;T3)	71371	C30H21I7N2Na2O8	1471.815	\N	\N	4	10	8	191	49	0	811	2	0	\N	\N	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+].[Na+]	disodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate;(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoate
8887	THYROLAR-2	LIOTRIX (T4;T3)	71371	C30H21I7N2Na2O8	1471.815	\N	\N	4	10	8	191	49	0	811	2	0	\N	\N	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+].[Na+]	disodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate;(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoate
8888	THYROLAR-3	LIOTRIX (T4;T3)	71371	C30H21I7N2Na2O8	1471.815	\N	\N	4	10	8	191	49	0	811	2	0	\N	\N	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+].[Na+]	disodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate;(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoate
8889	THYROLAR-5	LIOTRIX (T4;T3)	71371	C30H21I7N2Na2O8	1471.815	\N	\N	4	10	8	191	49	0	811	2	0	\N	\N	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+].[Na+]	disodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate;(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoate
9853	ZESTRIL	LISINOPRIL	5362119	C21H31N3O5	405.495	\N	-2.9	4	7	12	133	29	0	550	3	0	\N	\N	C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O	(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
5004	LITHANE	LITHIUM CARBONATE	11125	CLi2O3	73.888	\N	\N	0	3	0	63.2	6	0	18.8	0	0	\N	\N	[Li+].[Li+].C(=O)([O-])[O-]	dilithium;carbonate
5005	LITHIUM CARBONATE	LITHIUM CARBONATE	11125	CLi2O3	73.888	\N	\N	0	3	0	63.2	6	0	18.8	0	0	\N	\N	[Li+].[Li+].C(=O)([O-])[O-]	dilithium;carbonate
5007	LITHOBID	LITHIUM CARBONATE	11125	CLi2O3	73.888	\N	\N	0	3	0	63.2	6	0	18.8	0	0	\N	\N	[Li+].[Li+].C(=O)([O-])[O-]	dilithium;carbonate
5008	LITHONATE	LITHIUM CARBONATE	11125	CLi2O3	73.888	\N	\N	0	3	0	63.2	6	0	18.8	0	0	\N	\N	[Li+].[Li+].C(=O)([O-])[O-]	dilithium;carbonate
5011	LITHOTABS	LITHIUM CARBONATE	11125	CLi2O3	73.888	\N	\N	0	3	0	63.2	6	0	18.8	0	0	\N	\N	[Li+].[Li+].C(=O)([O-])[O-]	dilithium;carbonate
4211	IMODIUM A-D EZ CHEWS	LOPERAMIDE HYDROCHLORIDE	71420	C29H34Cl2N2O2	513.503	\N	\N	2	3	7	43.8	35	0	623	0	0	\N	\N	CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl	4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide;hydrochloride
4212	IMODIUM MULTI-SYMPTOM RELIEF	LOPERAMIDE HYDROCHLORIDE	71420	C29H34Cl2N2O2	513.503	\N	\N	2	3	7	43.8	35	0	623	0	0	\N	\N	CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl	4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide;hydrochloride
5057	LOPERAMIDE HYDROCHLORIDE	LOPERAMIDE HYDROCHLORIDE	71420	C29H34Cl2N2O2	513.503	\N	\N	2	3	7	43.8	35	0	623	0	0	\N	\N	CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl	4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide;hydrochloride
5058	LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE	LOPERAMIDE HYDROCHLORIDE	71420	C29H34Cl2N2O2	513.503	\N	\N	2	3	7	43.8	35	0	623	0	0	\N	\N	CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl	4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide;hydrochloride
5519	MEVACOR	LOVASTATIN	53232	C24H36O5	404.547	\N	4.3	1	5	7	72.8	29	0	666	8	0	\N	\N	CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C	[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate
5108	LOVASTATIN	LOVASTATIN	53232	C24H36O5	404.547	\N	4.3	1	5	7	72.8	29	0	666	8	0	\N	\N	CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C	[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate
5121	LOXITANE IM	LOXAPINE HYDROCHLORIDE	71400	C18H19Cl2N3O	364.27	\N	\N	1	3	1	28.1	24	0	450	0	0	\N	\N	CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.Cl	8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine;hydrochloride
448	AMINOSYN 3.5% M	MAGNESIUM ACETATE	8896	C4H6MgO4	142.393	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Mg+2]	magnesium;diacetate
3645	FREAMINE III 3% W/ ELECTROLYTES	MAGNESIUM ACETATE	8896	C4H6MgO4	142.393	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Mg+2]	magnesium;diacetate
3652	FREAMINE III 8.5% W/ ELECTROLYTES	MAGNESIUM ACETATE	8896	C4H6MgO4	142.393	\N	\N	0	4	0	80.3	9	0	25.5	0	0	\N	\N	CC(=O)[O-].CC(=O)[O-].[Mg+2]	magnesium;diacetate
569	AMINOSYN II 7% W/ ELECTROLYTES	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1798	CLINIMIX E 4.25/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1805	CLINIMIX E 4.25/20 SULFITE FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1812	CLINIMIX E 4.25/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1819	CLINIMIX E 4.25/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2466	DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2640	DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2645	DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2650	DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2655	DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2660	DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2665	DIALYTE W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2670	DIALYTE W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4306	INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4450	ISOLYTE E IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4457	ISOLYTE E W/ DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
526	AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
532	AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
540	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
546	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
553	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
563	AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
575	AMINOSYN II 8.5% W/ ELECTROLYTES	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1228	BSS PLUS	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1791	CLINIMIX E 2.75/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1826	CLINIMIX E 5/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1833	CLINIMIX E 5/15 SULFITE FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1840	CLINIMIX E 5/20 SULFITE FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
1854	CLINIMIX E 5/35 SULFITE FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2244	DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2249	DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2254	DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2259	DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2264	DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2269	DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2274	DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2279	DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2284	DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2722	DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2727	DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2732	DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2737	DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2742	DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
2747	DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
3149	ENDOSOL EXTRA	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4311	INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4316	INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4321	INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4385	IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4444	ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4463	ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4468	ISOLYTE H W/ DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4483	ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4488	ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4494	ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4500	ISOLYTE R W/ DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4505	ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4510	ISOLYTE S IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4515	ISOLYTE S PH 7.4 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
4523	ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6139	NORMOCARB HF 35	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6148	NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6153	NORMOSOL-R IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6889	PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6908	PHYSIOSOL IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6913	PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6951	PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6956	PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6968	PLASMA-LYTE A IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6975	PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
6981	PLASMA-LYTE R IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7502	PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7509	PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7516	PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7523	PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7530	PRISMASOL BGK 2/0 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7537	PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7544	PRISMASOL BGK 4/0 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7579	PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7586	PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
7593	PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
8635	SYNOVALYTE IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9035	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9041	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9047	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9053	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9059	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9064	TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9069	TRAVASOL 3.5% W/ ELECTROLYTES	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9085	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9091	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9097	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9103	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9109	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9115	TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9120	TRAVASOL 5.5% W/ ELECTROLYTES	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9127	TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	MAGNESIUM CHLORIDE	5360315	Cl2Mg	95.205	\N	\N	0	2	0	0	3	0	0	0	0	\N	\N	[Mg+2].[Cl-].[Cl-]	magnesium;dichloride
9422	UROLOGIC G IN PLASTIC CONTAINER	MAGNESIUM OXIDE	14792	MgO	40.304	\N	\N	0	1	0	17.1	2	0	2	0	0	\N	\N	O=[Mg]	oxomagnesium
8919	TIS-U-SOL	MAGNESIUM SULFATE	24083	MgO4S	120.361	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Mg+2]	magnesium;sulfate
8924	TIS-U-SOL IN PLASTIC CONTAINER	MAGNESIUM SULFATE	24083	MgO4S	120.361	\N	\N	0	4	0	88.6	6	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Mg+2]	magnesium;sulfate
8380	SORBITOL-MANNITOL IN PLASTIC CONTAINER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
5292	MANNITOL 15% IN PLASTIC CONTAINER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
5293	MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
5294	MANNITOL 20%	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
5295	MANNITOL 20% IN PLASTIC CONTAINER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
5296	MANNITOL 25%	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
5297	MANNITOL 5%	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
5298	MANNITOL 5% IN PLASTIC CONTAINER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
5299	MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
6512	OSMITROL 10% IN WATER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
6513	OSMITROL 10% IN WATER IN PLASTIC CONTAINER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
6514	OSMITROL 15% IN WATER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
6515	OSMITROL 15% IN WATER IN PLASTIC CONTAINER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
6516	OSMITROL 20% IN WATER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
6517	OSMITROL 20% IN WATER IN PLASTIC CONTAINER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
6518	OSMITROL 5% IN WATER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
6519	OSMITROL 5% IN WATER IN PLASTIC CONTAINER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
7971	RESECTISOL	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
7972	RESECTISOL IN PLASTIC CONTAINER	MANNITOL	6251	C6H14O6	182.172	\N	-3.1	6	6	5	121	12	0	105	4	0	\N	\N	C(C(C(C(C(CO)O)O)O)O)O	(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
5302	MARAVIROC	MARAVIROC	3002977	C29H41F2N5O	513.678	\N	5.1	1	6	8	63	37	0	751	3	0	\N	\N	CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C	4,4-difluoro-N-[(1S)-3-[(1S,5R)-3-(3-isopropyl-5-methyl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenyl-propyl]cyclohexanecarboxamide
3137	EMVERM	MEBENDAZOLE	4030	C16H13N3O3	295.298	\N	2.8	2	4	4	84.1	22	0	423	0	0	\N	\N	COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3	methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate
9561	VERMOX	MEBENDAZOLE	4030	C16H13N3O3	295.298	\N	2.8	2	4	4	84.1	22	0	423	0	0	\N	\N	COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3	methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate
9448	VALCHLOR	MECHLORETHAMINE HYDROCHLORIDE	5935	C5H12Cl3N	192.508	\N	\N	1	1	4	3.2	9	0	43.7	0	0	\N	\N	CN(CCCl)CCCl.Cl	2-chloro-N-(2-chloroethyl)-N-methyl-ethanamine;hydrochloride
5348	MECLIZINE HYDROCHLORIDE	MECLIZINE HYDROCHLORIDE	4034	C25H27ClN2	390.955	\N	5.8	0	2	5	6.5	28	0	448	0	1	\N	\N	CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl	1-[(4-chlorophenyl)-phenyl-methyl]-4-(m-tolylmethyl)piperazine
2124	CYCRIN	MEDROXYPROGESTERONE ACETATE	6279	C24H34O4	386.532	\N	4.1	0	4	3	60.4	28	0	767	7	0	\N	\N	CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
5132	LUNELLE	MEDROXYPROGESTERONE ACETATE	6279	C24H34O4	386.532	\N	4.1	0	4	3	60.4	28	0	767	7	0	\N	\N	CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
5364	MEDROXYPROGESTERONE ACETATE	MEDROXYPROGESTERONE ACETATE	6279	C24H34O4	386.532	\N	4.1	0	4	3	60.4	28	0	767	7	0	\N	\N	CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
7423	PREMPHASE (PREMARIN;CYCRIN 14/14)	MEDROXYPROGESTERONE ACETATE	6279	C24H34O4	386.532	\N	4.1	0	4	3	60.4	28	0	767	7	0	\N	\N	CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
7425	PREMPHASE 14/14	MEDROXYPROGESTERONE ACETATE	6279	C24H34O4	386.532	\N	4.1	0	4	3	60.4	28	0	767	7	0	\N	\N	CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
7427	PREMPRO	MEDROXYPROGESTERONE ACETATE	6279	C24H34O4	386.532	\N	4.1	0	4	3	60.4	28	0	767	7	0	\N	\N	CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
7429	PREMPRO (PREMARIN;CYCRIN)	MEDROXYPROGESTERONE ACETATE	6279	C24H34O4	386.532	\N	4.1	0	4	3	60.4	28	0	767	7	0	\N	\N	CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
7777	PROVERA	MEDROXYPROGESTERONE ACETATE	6279	C24H34O4	386.532	\N	4.1	0	4	3	60.4	28	0	767	7	0	\N	\N	CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C	[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
9684	VIVLODEX	MELOXICAM	54677470	C14H13N3O4S2	351.395	\N	3	2	7	2	136	23	0	628	0	0	\N	\N	CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O	4-hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-1,1-dioxo-1$l^{6},2-benzothiazine-3-carboxamide
5805	NAMENDA	MEMANTINE HYDROCHLORIDE	181458	C12H22ClN	215.765	\N	\N	2	1	0	26	14	0	240	0	2	\N	\N	CC12CC3CC(C1)(CC(C3)(C2)N)C.Cl	3,5-dimethyladamantan-1-amine;hydrochloride
5806	NAMENDA XR	MEMANTINE HYDROCHLORIDE	181458	C12H22ClN	215.765	\N	\N	2	1	0	26	14	0	240	0	2	\N	\N	CC12CC3CC(C1)(CC(C3)(C2)N)C.Cl	3,5-dimethyladamantan-1-amine;hydrochloride
5808	NAMZARIC	MEMANTINE HYDROCHLORIDE	181458	C12H22ClN	215.765	\N	\N	2	1	0	26	14	0	240	0	2	\N	\N	CC12CC3CC(C1)(CC(C3)(C2)N)C.Cl	3,5-dimethyladamantan-1-amine;hydrochloride
5404	MEPERIDINE HYDROCHLORIDE	MEPERIDINE HYDROCHLORIDE	5750	C15H22ClNO2	283.796	\N	\N	1	3	4	29.5	19	0	276	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2.Cl	ethyl 1-methyl-4-phenyl-piperidine-4-carboxylate;hydrochloride
5405	MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE	MEPERIDINE HYDROCHLORIDE	5750	C15H22ClNO2	283.796	\N	\N	1	3	4	29.5	19	0	276	0	0	\N	\N	CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2.Cl	ethyl 1-methyl-4-phenyl-piperidine-4-carboxylate;hydrochloride
5407	MEPIVACAINE HYDROCHLORIDE	MEPIVACAINE HYDROCHLORIDE	66070	C15H23ClN2O	282.812	\N	\N	2	2	2	32.3	19	0	282	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl	N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide;hydrochloride
5409	MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN	MEPIVACAINE HYDROCHLORIDE	66070	C15H23ClN2O	282.812	\N	\N	2	2	2	32.3	19	0	282	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl	N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide;hydrochloride
7006	POLOCAINE	MEPIVACAINE HYDROCHLORIDE	66070	C15H23ClN2O	282.812	\N	\N	2	2	2	32.3	19	0	282	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl	N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide;hydrochloride
7008	POLOCAINE W/ LEVONORDEFRIN	MEPIVACAINE HYDROCHLORIDE	66070	C15H23ClN2O	282.812	\N	\N	2	2	2	32.3	19	0	282	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl	N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide;hydrochloride
7009	POLOCAINE-MPF	MEPIVACAINE HYDROCHLORIDE	66070	C15H23ClN2O	282.812	\N	\N	2	2	2	32.3	19	0	282	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl	N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide;hydrochloride
8168	SCANDONEST PLAIN	MEPIVACAINE HYDROCHLORIDE	66070	C15H23ClN2O	282.812	\N	\N	2	2	2	32.3	19	0	282	0	1	\N	\N	CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl	N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide;hydrochloride
5412	MEPRO-ASPIRIN	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
5576	MILPREM-200	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
5578	MILPREM-400	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
5583	MILTOWN	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
7003	PMB 400	MEPROBAMATE	4064	C9H18N2O4	218.253	\N	0.7	2	4	8	105	15	0	212	0	0	\N	\N	CCCC(C)(COC(=O)N)COC(=O)N	[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate
5423	MERREM	MEROPENEM	441130	C17H25N3O5S	383.463	\N	-2.4	3	7	5	136	26	0	679	6	0	\N	\N	CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O	(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
4180	IFEX/MESNEX KIT	MESNA	23662354	C2H5NaO3S2	164.169	\N	\N	1	4	2	66.6	8	0	123	0	0	\N	\N	C(CS(=O)(=O)[O-])S.[Na+]	sodium;2-sulfanylethanesulfonate
4183	IFOSFAMIDE/MESNA KIT	MESNA	23662354	C2H5NaO3S2	164.169	\N	\N	1	4	2	66.6	8	0	123	0	0	\N	\N	C(CS(=O)(=O)[O-])S.[Na+]	sodium;2-sulfanylethanesulfonate
6067	NORETHIN 1/50M-21	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6069	NORETHIN 1/50M-28	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6110	NORINYL 1+50 21-DAY	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6112	NORINYL 1+50 28-DAY	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6114	NORINYL 1+80 21-DAY	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6116	NORINYL 1+80 28-DAY	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6482	ORTHO-NOVUM 1/50 28	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6484	ORTHO-NOVUM 1/80 21	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6486	ORTHO-NOVUM 1/80 28	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6488	ORTHO-NOVUM 10-21	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6557	OVULEN-21	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
6559	OVULEN-28	MESTRANOL	6291	C21H26O2	310.437	\N	4	1	2	2	29.5	23	0	519	5	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
390	ALUPENT	METAPROTERENOL SULFATE	4086	C11H17NO3	211.261	\N	0.7	4	4	4	72.7	15	0	177	0	1	\N	\N	CC(C)NCC(C1=CC(=CC(=C1)O)O)O	5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol
5437	METAPROTERENOL SULFATE	METAPROTERENOL SULFATE	4086	C11H17NO3	211.261	\N	0.7	4	4	4	72.7	15	0	177	0	1	\N	\N	CC(C)NCC(C1=CC(=CC(=C1)O)O)O	5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol
7664	PROMETA	METAPROTERENOL SULFATE	4086	C11H17NO3	211.261	\N	0.7	4	4	4	72.7	15	0	177	0	1	\N	\N	CC(C)NCC(C1=CC(=CC(=C1)O)O)O	5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol
8632	SYNJARDY	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
3775	GLUCOPHAGE	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
3776	GLUCOPHAGE XR	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
3781	GLUCOVANCE	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
3782	GLUMETZA	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
3787	GLYBURIDE AND METFORMIN HYDROCHLORIDE	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
4371	INVOKAMET XR	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
4571	JANUMET	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
4573	JANUMET XR	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
4581	JENTADUETO	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
4583	JENTADUETO XR	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
4637	KAZANO	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
4696	KOMBIGLYZE XR	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
5434	METAGLIP	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
5445	METFORMIN HYDROCHLORIDE	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
5446	METFORMIN HYDROCHLORIDE AND  SITAGLIPTIN PHOSPHATE	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
7961	REPAGLINIDE AND METFORMIN HYDROCHLORIDE	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
8082	ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
8085	ROSIGLITAZONE MALEATE; METFORMIN HYDROCHLORIDE	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
8278	SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
8281	SITAGLIPTIN; METFORMIN HYDROCHLORIDE	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
9763	XIGDUO XR	METFORMIN HYDROCHLORIDE	14219	C4H12ClN5	165.625	\N	\N	4	1	2	91.5	10	0	132	0	0	\N	\N	CN(C)C(=N)N=C(N)N.Cl	3-(diaminomethylene)-1,1-dimethyl-guanidine;hydrochloride
990	BANTHINE	METHANTHELINE BROMIDE	5883	C21H26BrNO3	420.347	\N	\N	0	4	7	35.5	26	0	426	0	0	\N	\N	CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13.[Br-]	diethyl-methyl-[2-(9H-xanthene-9-carbonyloxy)ethyl]ammonium;bromide
8649	TACARYL	METHDILAZINE HYDROCHLORIDE	14676	C18H21ClN2S	332.89	\N	\N	1	3	2	31.8	22	0	339	0	1	\N	\N	CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42.Cl	10-[(1-methylpyrrolidin-3-yl)methyl]phenothiazine;hydrochloride
5460	METHOCARBAMOL AND ASPIRIN	METHOCARBAMOL	4107	C11H15NO5	241.243	\N	0.6	2	5	7	91	17	0	236	0	1	\N	\N	COC1=CC=CC=C1OCC(COC(=O)N)O	[2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate
8055	ROBAXIN	METHOCARBAMOL	4107	C11H15NO5	241.243	\N	0.6	2	5	7	91	17	0	236	0	1	\N	\N	COC1=CC=CC=C1OCC(COC(=O)N)O	[2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate
8056	ROBAXIN-750	METHOCARBAMOL	4107	C11H15NO5	241.243	\N	0.6	2	5	7	91	17	0	236	0	1	\N	\N	COC1=CC=CC=C1OCC(COC(=O)N)O	[2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate
8058	ROBAXISAL	METHOCARBAMOL	4107	C11H15NO5	241.243	\N	0.6	2	5	7	91	17	0	236	0	1	\N	\N	COC1=CC=CC=C1OCC(COC(=O)N)O	[2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate
5461	METHOTREXATE LPF	METHOTREXATE SODIUM	126941	C20H22N8O5	454.447	\N	-1.8	5	12	9	211	33	0	704	1	0	\N	\N	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
5462	METHOTREXATE PRESERVATIVE FREE	METHOTREXATE SODIUM	126941	C20H22N8O5	454.447	\N	-1.8	5	12	9	211	33	0	704	1	0	\N	\N	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
5463	METHOTREXATE SODIUM	METHOTREXATE SODIUM	126941	C20H22N8O5	454.447	\N	-1.8	5	12	9	211	33	0	704	1	0	\N	\N	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
5464	METHOTREXATE SODIUM PRESERVATIVE FREE	METHOTREXATE SODIUM	126941	C20H22N8O5	454.447	\N	-1.8	5	12	9	211	33	0	704	1	0	\N	\N	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
5521	MEXATE-AQ	METHOTREXATE SODIUM	126941	C20H22N8O5	454.447	\N	-1.8	5	12	9	211	33	0	704	1	0	\N	\N	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
5522	MEXATE-AQ PRESERVED	METHOTREXATE SODIUM	126941	C20H22N8O5	454.447	\N	-1.8	5	12	9	211	33	0	704	1	0	\N	\N	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
9151	TREXALL	METHOTREXATE SODIUM	126941	C20H22N8O5	454.447	\N	-1.8	5	12	9	211	33	0	704	1	0	\N	\N	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
6626	PAMINE	METHSCOPOLAMINE BROMIDE	5459110	C18H24BrNO4	398.297	\N	\N	1	5	5	59.1	24	0	454	5	0	\N	\N	C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C.[Br-]	\N
741	AQUATENSEN	METHYCLOTHIAZIDE	4121	C9H11Cl2N3O4S2	360.224	\N	1.4	2	7	2	126	20	0	571	0	1	\N	\N	CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl	6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
5469	METHYCLOTHIAZIDE AND DESERPIDINE	METHYCLOTHIAZIDE	4121	C9H11Cl2N3O4S2	360.224	\N	1.4	2	7	2	126	20	0	571	0	1	\N	\N	CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl	6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
310	ALDOCLOR-250	METHYLDOPA	38853	C10H13NO4	211.217	\N	-1.9	4	5	3	104	15	0	246	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N	(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid
314	ALDORIL 15	METHYLDOPA	38853	C10H13NO4	211.217	\N	-1.9	4	5	3	104	15	0	246	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N	(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid
316	ALDORIL 25	METHYLDOPA	38853	C10H13NO4	211.217	\N	-1.9	4	5	3	104	15	0	246	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N	(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid
318	ALDORIL D30	METHYLDOPA	38853	C10H13NO4	211.217	\N	-1.9	4	5	3	104	15	0	246	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N	(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid
320	ALDORIL D50	METHYLDOPA	38853	C10H13NO4	211.217	\N	-1.9	4	5	3	104	15	0	246	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N	(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid
5472	METHYLDOPA AND CHLOROTHIAZIDE	METHYLDOPA	38853	C10H13NO4	211.217	\N	-1.9	4	5	3	104	15	0	246	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N	(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid
5474	METHYLDOPA AND HYDROCHLOROTHIAZIDE	METHYLDOPA	38853	C10H13NO4	211.217	\N	-1.9	4	5	3	104	15	0	246	1	0	\N	\N	CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N	(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid
8044	RITALIN LA	METHYLPHENIDATE HYDROCHLORIDE	9280	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	0	2	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl 2-phenyl-2-(2-piperidyl)acetate;hydrochloride
8045	RITALIN-SR	METHYLPHENIDATE HYDROCHLORIDE	9280	C14H20ClNO2	269.769	\N	\N	2	3	4	38.3	18	0	249	0	2	\N	\N	COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl	methyl 2-phenyl-2-(2-piperidyl)acetate;hydrochloride
5885	NEO-MEDROL	METHYLPREDNISOLONE	6741	C22H30O5	374.477	\N	1.9	3	5	2	94.8	27	0	754	8	0	\N	\N	CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O	(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
664	ANDROID 25	METHYLTESTOSTERONE	6010	C20H30O2	302.458	\N	3.4	1	2	0	37.3	22	0	550	6	0	\N	\N	CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
665	ANDROID 5	METHYLTESTOSTERONE	6010	C20H30O2	302.458	\N	3.4	1	2	0	37.3	22	0	550	6	0	\N	\N	CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
5436	METANDREN	METHYLTESTOSTERONE	6010	C20H30O2	302.458	\N	3.4	1	2	0	37.3	22	0	550	6	0	\N	\N	CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
5485	METHYLTESTOSTERONE	METHYLTESTOSTERONE	6010	C20H30O2	302.458	\N	3.4	1	2	0	37.3	22	0	550	6	0	\N	\N	CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
6434	ORETON METHYL	METHYLTESTOSTERONE	6010	C20H30O2	302.458	\N	3.4	1	2	0	37.3	22	0	550	6	0	\N	\N	CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
8813	TESTRED	METHYLTESTOSTERONE	6010	C20H30O2	302.458	\N	3.4	1	2	0	37.3	22	0	550	6	0	\N	\N	CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
7911	REGLAN	METOCLOPRAMIDE HYDROCHLORIDE	23659	C14H23Cl2N3O2	336.257	\N	\N	3	4	7	67.6	21	0	300	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl.Cl	4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide;hydrochloride
7912	REGLAN ODT	METOCLOPRAMIDE HYDROCHLORIDE	23659	C14H23Cl2N3O2	336.257	\N	\N	3	4	7	67.6	21	0	300	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl.Cl	4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide;hydrochloride
5506	METRO I.V.	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
5507	METRO I.V. IN PLASTIC CONTAINER	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
5508	METROCREAM	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
5510	METROGEL	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
5511	METROGEL-VAGINAL	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
5512	METROLOTION	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
5513	METROMIDOL	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
5514	METRONIDAZOLE	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
5516	METRONIDAZOLE IN PLASTIC CONTAINER	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
7800	PYLERA	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
9480	VANDAZOLE	METRONIDAZOLE	4173	C6H9N3O3	171.156	\N	0	1	4	2	83.9	12	0	170	0	0	\N	\N	CC1=NC=C(N1CCO)[N+](=O)[O-]	2-(2-methyl-5-nitro-imidazol-1-yl)ethanol
5581	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	MILRINONE LACTATE	172293	C15H15N3O4	301.302	\N	\N	3	6	2	123	22	0	478	0	1	\N	\N	CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2.CC(C(=O)O)O	2-hydroxypropanoic acid;6-methyl-2-oxo-5-(4-pyridyl)-1H-pyridine-3-carbonitrile
5582	MILRINONE LACTATE IN PLASTIC CONTAINER	MILRINONE LACTATE	172293	C15H15N3O4	301.302	\N	\N	3	6	2	123	22	0	478	0	1	\N	\N	CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2.CC(C(=O)O)O	2-hydroxypropanoic acid;6-methyl-2-oxo-5-(4-pyridyl)-1H-pyridine-3-carbonitrile
5386	MEN'S ROGAINE	MINOXIDIL	4201	C9H15N5O	209.253	\N	1.2	3	3	1	88.9	15	0	329	0	0	\N	\N	C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O	3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine
5597	MINOXIDIL	MINOXIDIL	4201	C9H15N5O	209.253	\N	1.2	3	3	1	88.9	15	0	329	0	0	\N	\N	C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O	3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine
5598	MINOXIDIL (FOR MEN)	MINOXIDIL	4201	C9H15N5O	209.253	\N	1.2	3	3	1	88.9	15	0	329	0	0	\N	\N	C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O	3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine
5599	MINOXIDIL (FOR WOMEN)	MINOXIDIL	4201	C9H15N5O	209.253	\N	1.2	3	3	1	88.9	15	0	329	0	0	\N	\N	C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O	3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine
5600	MINOXIDIL EXTRA STRENGTH (FOR MEN)	MINOXIDIL	4201	C9H15N5O	209.253	\N	1.2	3	3	1	88.9	15	0	329	0	0	\N	\N	C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O	3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine
8071	ROGAINE (FOR MEN)	MINOXIDIL	4201	C9H15N5O	209.253	\N	1.2	3	3	1	88.9	15	0	329	0	0	\N	\N	C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O	3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine
8072	ROGAINE (FOR WOMEN)	MINOXIDIL	4201	C9H15N5O	209.253	\N	1.2	3	3	1	88.9	15	0	329	0	0	\N	\N	C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O	3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine
8073	ROGAINE EXTRA STRENGTH (FOR MEN)	MINOXIDIL	4201	C9H15N5O	209.253	\N	1.2	3	3	1	88.9	15	0	329	0	0	\N	\N	C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O	3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine
5625	MIVACURIUM CHLORIDE	MIVACURIUM CHLORIDE	5281080	C58H80Cl2N2O14	1100.178	\N	\N	0	16	30	145	76	0	1550	2	2	\N	\N	C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C.[Cl-].[Cl-]	bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (E)-oct-4-enedioate;dichloride
3105	ELOCON	MOMETASONE FUROATE	441336	C27H30Cl2O6	521.431	\N	3.9	1	6	5	93.8	35	0	1020	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C	[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
5646	MOMETASONE FUROATE	MOMETASONE FUROATE	441336	C27H30Cl2O6	521.431	\N	3.9	1	6	5	93.8	35	0	1020	8	0	\N	\N	CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C	[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
4253	INFUMORPH	MORPHINE SULFATE	5288826	C17H19NO3	285.343	\N	0.8	2	4	0	52.9	21	0	494	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
4614	KADIAN	MORPHINE SULFATE	5288826	C17H19NO3	285.343	\N	0.8	2	4	0	52.9	21	0	494	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
5669	MORPHABOND	MORPHINE SULFATE	5288826	C17H19NO3	285.343	\N	0.8	2	4	0	52.9	21	0	494	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
5670	MORPHINE SULFATE	MORPHINE SULFATE	5288826	C17H19NO3	285.343	\N	0.8	2	4	0	52.9	21	0	494	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
5696	MS CONTIN	MORPHINE SULFATE	5288826	C17H19NO3	285.343	\N	0.8	2	4	0	52.9	21	0	494	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
6414	ORAMORPH SR	MORPHINE SULFATE	5288826	C17H19NO3	285.343	\N	0.8	2	4	0	52.9	21	0	494	5	0	\N	\N	CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O	(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
5711	MUPIROCIN	MUPIROCIN	446596	C26H44O9	500.629	\N	3	4	9	17	146	35	0	694	8	0	\N	\N	CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O	9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methyl-propyl]oxiran-2-yl]methyl]tetrahydropyran-2-yl]-3-methyl-but-2-enoyl]oxynonanoic acid
5754	MYFORTIC	MYCOPHENOLIC ACID	446541	C17H20O6	320.341	\N	3.2	2	6	6	93.1	23	0	486	0	0	\N	\N	CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)O)OC	(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoic acid
5787	NADOLOL AND BENDROFLUMETHIAZIDE	NADOLOL	39147	C17H27NO4	309.406	\N	0.7	4	5	6	82	22	0	344	2	1	\N	\N	CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O	(2R,3S)-5-[3-(tert-butylamino)-2-hydroxy-propoxy]tetralin-2,3-diol
5798	NALLPEN IN PLASTIC CONTAINER	NAFCILLIN SODIUM	23667630	C21H21N2NaO5S	436.458	\N	\N	1	6	5	124	30	0	705	3	0	\N	\N	CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+]	sodium;(2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
9399	UNIPEN	NAFCILLIN SODIUM	23667630	C21H21N2NaO5S	436.458	\N	\N	1	6	5	124	30	0	705	3	0	\N	\N	CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+]	sodium;(2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
9400	UNIPEN IN PLASTIC CONTAINER	NAFCILLIN SODIUM	23667630	C21H21N2NaO5S	436.458	\N	\N	1	6	5	124	30	0	705	3	0	\N	\N	CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+]	sodium;(2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
3371	EVZIO	NALOXONE HYDROCHLORIDE	5464092	C19H22ClNO4	363.838	\N	\N	3	5	2	70	25	0	594	4	0	\N	\N	C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.Cl	(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
5800	NALOXONE HCL	NALOXONE HYDROCHLORIDE	5464092	C19H22ClNO4	363.838	\N	\N	3	5	2	70	25	0	594	4	0	\N	\N	C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.Cl	(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
5801	NALOXONE HYDROCHLORIDE	NALOXONE HYDROCHLORIDE	5464092	C19H22ClNO4	363.838	\N	\N	3	5	2	70	25	0	594	4	0	\N	\N	C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.Cl	(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
5802	NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE	NALOXONE HYDROCHLORIDE	5464092	C19H22ClNO4	363.838	\N	\N	3	5	2	70	25	0	594	4	0	\N	\N	C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.Cl	(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
5829	NARCAN	NALOXONE HYDROCHLORIDE	5464092	C19H22ClNO4	363.838	\N	\N	3	5	2	70	25	0	594	4	0	\N	\N	C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.Cl	(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
8496	SUBOXONE	NALOXONE HYDROCHLORIDE	5464092	C19H22ClNO4	363.838	\N	\N	3	5	2	70	25	0	594	4	0	\N	\N	C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.Cl	(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
8670	TALWIN NX	NALOXONE HYDROCHLORIDE	5464092	C19H22ClNO4	363.838	\N	\N	3	5	2	70	25	0	594	4	0	\N	\N	C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.Cl	(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
8683	TARGINIQ	NALOXONE HYDROCHLORIDE	5464092	C19H22ClNO4	363.838	\N	\N	3	5	2	70	25	0	594	4	0	\N	\N	C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.Cl	(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
9925	ZUBSOLV	NALOXONE HYDROCHLORIDE	5464092	C19H22ClNO4	363.838	\N	\N	3	5	2	70	25	0	594	4	0	\N	\N	C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.Cl	(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
329	ALEVE-D SINUS & COLD	NAPROXEN SODIUM	23681059	C14H13NaO3	252.245	\N	\N	0	3	3	49.4	18	0	282	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+]	sodium;(2S)-2-(6-methoxy-2-naphthyl)propanoate
654	ANAPROX DS	NAPROXEN SODIUM	23681059	C14H13NaO3	252.245	\N	\N	0	3	3	49.4	18	0	282	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+]	sodium;(2S)-2-(6-methoxy-2-naphthyl)propanoate
5823	NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE	NAPROXEN SODIUM	23681059	C14H13NaO3	252.245	\N	\N	0	3	3	49.4	18	0	282	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+]	sodium;(2S)-2-(6-methoxy-2-naphthyl)propanoate
8578	SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM	NAPROXEN SODIUM	23681059	C14H13NaO3	252.245	\N	\N	0	3	3	49.4	18	0	282	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+]	sodium;(2S)-2-(6-methoxy-2-naphthyl)propanoate
8580	SUMATRIPTAN; NAPROXEN SODIUM	NAPROXEN SODIUM	23681059	C14H13NaO3	252.245	\N	\N	0	3	3	49.4	18	0	282	1	0	\N	\N	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+]	sodium;(2S)-2-(6-methoxy-2-naphthyl)propanoate
956	BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
1955	COLY-MYCIN S	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
2015	COR-OTICIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
2019	CORDRAN N	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
2043	CORTISPORIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
2046	CORTISPORIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
2049	CORTISPORIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
2385	DEXACIDIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
2397	DEXASPORIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
4794	LANABIOTIC	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5327	MAXITROL	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5737	MYCIFRADIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5739	MYCITRACIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5774	MYTREX A	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5875	NEO-CORT-DOME	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5877	NEO-CORT-DOME	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5879	NEO-CORTEF	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5880	NEO-DELTA-CORTEF	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5882	NEO-FRADIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5883	NEO-HYDELTRASOL	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5886	NEO-MEDROL	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5888	NEO-MEDROL ACETATE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5890	NEO-POLYCIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5893	NEO-POLYCIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5895	NEO-RX	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5897	NEO-SYNALAR	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5898	NEOBIOTIC	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5900	NEODECADRON	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5903	NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5905	NEOMYCIN AND POLYMYXIN B SULFATE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5908	NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5911	NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5914	NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5917	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5921	NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5923	NEOMYCIN SULFATE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5925	NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5927	NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5930	NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5933	NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5935	NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5937	NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5948	NEOSPORIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5951	NEOSPORIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5953	NEOSPORIN	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5955	NEOSPORIN G.U. IRRIGANT	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
6529	OTICAIR	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
6533	OTOBIONE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
6538	OTOCORT	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
6690	PEDIOTIC	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
7010	POLY-PRED	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
8445	STATROL	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
9870	ZINC BACITRACIN,NEOMYCIN SULFATE,POLYMYXIN B SULFATE & HYDROCORTISONE	NEOMYCIN SULFATE	8378	C23H46N6O13	614.65	\N	-9	13	19	9	353	42	0	872	19	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
5966	NETROMYCIN	NETILMICIN SULFATE	62115	C42H92N10O34S5	1441.534	\N	\N	26	44	16	814	91	0	754	22	0	\N	\N	CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N.CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O	(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxy-cyclohexoxy]-5-methyl-4-(methylamino)tetrahydropyran-3,5-diol;sulfuric acid
4761	LAMIVUDINE/ZIDOVUDINE TABLETS CO-PACKAGED WITH NEVIRAPINE TABLETS	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
4763	LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
4769	LAMIVUDINE; STAVUDINE; NEVIRAPINE	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
4774	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
4789	LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
5978	NEVIRAPINE	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
5979	NEVIRAPINE TABLETS FOR ORAL SUSPENSION	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
8452	STAVUDINE; LAMIVUDINE W/NEVIRAPINE	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
8458	STAVUDINE; LAMIVUDINE; NEVIRAPINE	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
9633	VIRAMUNE	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
9634	VIRAMUNE XR	NEVIRAPINE	4463	C15H14N4O	266.304	\N	2	1	4	1	58.1	20	0	397	0	0	\N	\N	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one
4286	INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)	NIACINAMIDE	936	C6H6N2O	122.127	\N	-0.4	1	2	1	56	9	0	114	0	0	\N	\N	C1=CC(=CN=C1)C(=O)N	pyridine-3-carboxamide
1403	CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER	NICARDIPINE HYDROCHLORIDE	41114	C26H30ClN3O6	515.991	\N	\N	2	8	10	114	36	0	856	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC.Cl	O5-[2-[benzyl(methyl)amino]ethyl] O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
1404	CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER	NICARDIPINE HYDROCHLORIDE	41114	C26H30ClN3O6	515.991	\N	\N	2	8	10	114	36	0	856	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC.Cl	O5-[2-[benzyl(methyl)amino]ethyl] O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
1405	CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER	NICARDIPINE HYDROCHLORIDE	41114	C26H30ClN3O6	515.991	\N	\N	2	8	10	114	36	0	856	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC.Cl	O5-[2-[benzyl(methyl)amino]ethyl] O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
1406	CARDENE SR	NICARDIPINE HYDROCHLORIDE	41114	C26H30ClN3O6	515.991	\N	\N	2	8	10	114	36	0	856	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC.Cl	O5-[2-[benzyl(methyl)amino]ethyl] O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
5991	NICARDIPINE HYDROCHLORIDE	NICARDIPINE HYDROCHLORIDE	41114	C26H30ClN3O6	515.991	\N	\N	2	8	10	114	36	0	856	0	1	\N	\N	CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC.Cl	O5-[2-[benzyl(methyl)amino]ethyl] O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
6018	NITRO IV	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
6019	NITRO-BID	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
6020	NITRO-DUR	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
6028	NITROGLYCERIN	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
6029	NITROGLYCERIN IN DEXTROSE 5%	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
6030	NITROL	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
6031	NITROLINGUAL	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
6032	NITROLINGUAL PUMPSPRAY	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
6033	NITROMIST	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
6034	NITRONAL	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
6036	NITROSTAT	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
7907	RECTIV	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
9229	TRIDIL	NITROGLYCERIN	4510	C3H5N3O9	227.085	\N	1.6	0	9	5	165	15	0	219	0	0	\N	\N	C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]	2,3-dinitrooxypropyl nitrate
4817	LARIN 1.5/30	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
4819	LARIN 1/20	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
1145	BLISOVI FE 1/20	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
3297	ESTRADIOL AND NORETHINDRONE ACETATE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
3317	ESTROSTEP 21	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
3319	ESTROSTEP FE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
3444	FEMHRT	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
3675	FYAVOLV	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
3751	GILDESS 1.5/30	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
3753	GILDESS 1/20	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
3755	GILDESS 24 FE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
3757	GILDESS FE 1.5/30	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
3759	GILDESS FE 1/20	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
4588	JUNEL 1.5/30	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
4590	JUNEL 1/20	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
4592	JUNEL FE 1.5/30	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
4594	JUNEL FE 1/20	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
4821	LARIN 24 FE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
4823	LARIN FE 1.5/30	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
4825	LARIN FE 1/20	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
4852	LERIBANE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5019	LO MINASTRIN FE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5036	LOESTRIN 21 1.5/30	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5038	LOESTRIN 21 1/20	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5040	LOESTRIN 24 FE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5042	LOESTRIN FE 1.5/30	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5044	LOESTRIN FE 1/20	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5136	LUPANETA PACK	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5546	MICROGESTIN 1.5/30	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5548	MICROGESTIN 1/20	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5550	MICROGESTIN FE 1.5/30	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5552	MICROGESTIN FE 1/20	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5585	MINASTRIN 24 FE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6074	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6076	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6122	NORLESTRIN 21 1/50	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6124	NORLESTRIN 21 2.5/50	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6126	NORLESTRIN 28 1/50	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6129	NORLESTRIN FE 1/50	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6132	NORLESTRIN FE 2.5/50	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6133	NORLUTATE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
8699	TAYTULLA	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
9162	TRI-LEGEST 21	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
9164	TRI-LEGEST FE	NORETHINDRONE ACETATE	5832	C22H28O3	340.463	\N	3.5	0	3	3	43.4	25	0	695	6	0	\N	\N	CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C	[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
3722	GENCEPT 10/11-28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6084	NORETHINDRONE AND ETHINYL ESTRADIOL (10/11)	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6869	PHILITH	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6939	PIRMELLA 1/35	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6941	PIRMELLA 7/7/7	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
2109	CYCLAFEM 7/7/7	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
2129	CYONANZ	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
2197	DASETTA 1/35	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
2199	DASETTA 7/7/7	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3238	ERRIN	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3749	GILDAGIA	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3885	HEATHER	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4219	INCASSIA	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
4618	KAITLIB FE	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
5634	MODICON 21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
5636	MODICON 28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
5781	N.E.E. 1/35 21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
5783	N.E.E. 1/35 28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6047	NORCEPT-E 1/35 21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6049	NORCEPT-E 1/35 28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6064	NORETHIN 1/35E-21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6066	NORETHIN 1/35E-28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6068	NORETHIN 1/50M-21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6070	NORETHIN 1/50M-28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6071	NORETHINDRONE	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6086	NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6088	NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6090	NORETHINDRONE AND MESTRANOL	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6105	NORINYL	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6107	NORINYL 1+35 21-DAY	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6109	NORINYL 1+35 28-DAY	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6111	NORINYL 1+50 21-DAY	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6113	NORINYL 1+50 28-DAY	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6115	NORINYL 1+80 21-DAY	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6117	NORINYL 1+80 28-DAY	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6134	NORLUTIN	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6168	NORQUEST FE	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6171	NORTREL 0.5/35-21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6173	NORTREL 0.5/35-28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6175	NORTREL 1/35-21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6177	NORTREL 1/35-28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6179	NORTREL 7/7/7	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6257	NYLIA 1/35	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6259	NYLIA 7/7/7	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6477	ORTHO-NOVUM 1/35-21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6479	ORTHO-NOVUM 1/35-28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6481	ORTHO-NOVUM 1/50 21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6483	ORTHO-NOVUM 1/50 28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6485	ORTHO-NOVUM 1/80 21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6487	ORTHO-NOVUM 1/80 28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6491	ORTHO-NOVUM 10/11-21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6493	ORTHO-NOVUM 10/11-28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6495	ORTHO-NOVUM 2-21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6497	ORTHO-NOVUM 7/14-21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6499	ORTHO-NOVUM 7/14-28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6501	ORTHO-NOVUM 7/7/7-21	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6503	ORTHO-NOVUM 7/7/7-28	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6544	OVCON-35	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6546	OVCON-50	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
9179	TRI-NORINYL 28-DAY	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
9707	VYFEMLA	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
9719	WERA	NORETHINDRONE	6230	C20H26O2	298.426	\N	3	1	2	1	37.3	22	0	594	6	0	\N	\N	CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
3299	ESTRADIOL AND NORGESTIMATE	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5571	MILI	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5658	MONO-LINYAH	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6462	ORTHO CYCLEN-28	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6466	ORTHO TRI-CYCLEN	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6468	ORTHO TRI-CYCLEN 21	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6470	ORTHO TRI-CYCLEN 28	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
6472	ORTHO TRI-CYCLEN LO	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
7458	PREVIFEM	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
9160	TRI-ESTARYLLA	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
9158	TRI LO SPRINTEC	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
9166	TRI-LINYAH	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
9168	TRI-LO-ESTARYLLA	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
9169	TRI-LO-LINYAH	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
9175	TRI-MILI	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
9181	TRI-PREVIFEM	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
9183	TRI-SPRINTEC	NORGESTIMATE	6540478	C23H31NO3	369.505	\N	4.1	1	4	4	58.9	27	0	744	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
5115	LOW-OGESTREL-28	NORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6313	OGESTREL 0.5/50-21	NORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6315	OGESTREL 0.5/50-28	NORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6553	OVRETTE	NORGESTREL	13109	C21H28O2	312.453	\N	3.3	1	2	2	37.3	23	0	609	6	0	\N	\N	CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
6004	NILSTAT	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
4700	KOROSTATIN	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
5741	MYCO-TRIACET II	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
5744	MYCOLOG-II	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
5749	MYCOSTATIN	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
5756	MYKACET	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
5758	MYKINAC	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
5776	MYTREX F	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
6263	NYSTAFORM	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
6264	NYSTATIN	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
6265	NYSTATIN AND TRIAMCINOLONE ACETONIDE	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
6267	NYSTATIN TRIAMCINOLONE ACETONIDE	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
6269	NYSTATIN-TRIAMCINOLONE ACETONIDE	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
6271	NYSTEX	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
6272	NYSTOP	NYSTATIN	6433272	C47H75NO17	926.107	\N	-0.2	12	18	3	320	65	0	1620	10	9	\N	\N	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O	(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
6287	OCTREOTIDE ACETATE (PRESERVATIVE FREE)	OCTREOTIDE ACETATE	383414	C49H66N10O10S2	1019.247	\N	1	13	14	17	383	71	0	1740	0	10	\N	\N	CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O	10-(4-aminobutyl)-19-[(2-amino-3-phenyl-propanoyl)amino]-16-benzyl-7-(1-hydroxyethyl)-N-[2-hydroxy-1-(hydroxymethyl)propyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
7060	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6288	OCTREOTIDE ACETATE PRESERVATIVE FREE	OCTREOTIDE ACETATE	383414	C49H66N10O10S2	1019.247	\N	1	13	14	17	383	71	0	1740	0	10	\N	\N	CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O	10-(4-aminobutyl)-19-[(2-amino-3-phenyl-propanoyl)amino]-16-benzyl-7-(1-hydroxyethyl)-N-[2-hydroxy-1-(hydroxymethyl)propyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
8146	SANDOSTATIN	OCTREOTIDE ACETATE	383414	C49H66N10O10S2	1019.247	\N	1	13	14	17	383	71	0	1740	0	10	\N	\N	CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O	10-(4-aminobutyl)-19-[(2-amino-3-phenyl-propanoyl)amino]-16-benzyl-7-(1-hydroxyethyl)-N-[2-hydroxy-1-(hydroxymethyl)propyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
8147	SANDOSTATIN LAR	OCTREOTIDE ACETATE	383414	C49H66N10O10S2	1019.247	\N	1	13	14	17	383	71	0	1740	0	10	\N	\N	CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O	10-(4-aminobutyl)-19-[(2-amino-3-phenyl-propanoyl)amino]-16-benzyl-7-(1-hydroxyethyl)-N-[2-hydroxy-1-(hydroxymethyl)propyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
6670	PATANOL	OLOPATADINE HYDROCHLORIDE	5282402	C21H24ClNO3	373.877	\N	\N	2	4	5	49.8	26	0	488	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O.Cl	2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid;hydrochloride
6677	PAZEO	OLOPATADINE HYDROCHLORIDE	5282402	C21H24ClNO3	373.877	\N	\N	2	4	5	49.8	26	0	488	0	0	\N	\N	CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O.Cl	2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid;hydrochloride
9602	VIEKIRA PAK (COPACKAGED)	OMBITASVIR	54767916	C50H67N7O8	894.127	\N	7.9	4	9	16	179	65	0	1540	6	0	\N	\N	CC(C)C(C(=O)N1CCCC1C(=O)NC2=CC=C(C=C2)C3CCC(N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC	methyl N-[(1S)-1-[(2S)-2-[[4-[(2S,5S)-1-(4-tert-butylphenyl)-5-[4-[[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidine-2-carbonyl]amino]phenyl]pyrrolidin-2-yl]phenyl]carbamoyl]pyrrolidine-1-carbonyl]-2-methyl-propyl]carbamate
9606	VIEKIRA XR	OMBITASVIR	54767916	C50H67N7O8	894.127	\N	7.9	4	9	16	179	65	0	1540	6	0	\N	\N	CC(C)C(C(=O)N1CCCC1C(=O)NC2=CC=C(C=C2)C3CCC(N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC	methyl N-[(1S)-1-[(2S)-2-[[4-[(2S,5S)-1-(4-tert-butylphenyl)-5-[4-[[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidine-2-carbonyl]amino]phenyl]pyrrolidin-2-yl]phenyl]carbamoyl]pyrrolidine-1-carbonyl]-2-methyl-propyl]carbamate
9829	ZEGERID	OMEPRAZOLE	4594	C17H19N3O3S	345.417	\N	2.2	1	6	5	96.3	24	0	453	0	1	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
9831	ZEGERID	OMEPRAZOLE	4594	C17H19N3O3S	345.417	\N	2.2	1	6	5	96.3	24	0	453	0	1	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
9833	ZEGERID OTC	OMEPRAZOLE	4594	C17H19N3O3S	345.417	\N	2.2	1	6	5	96.3	24	0	453	0	1	\N	\N	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
6423	ORBACTIV	ORITAVANCIN DIPHOSPHATE	53297457	C86H103Cl3N10O34P2	1989.104	\N	\N	26	37	19	717	135	0	3750	22	0	\N	\N	CC1C(C(CC(O1)OC2C3C(=O)NC(C4=CC(=CC(=C4C5=C(C=CC(=C5)C(C(=O)N3)NC(=O)C6C7=CC(=C(C(=C7)OC8=C(C=C(C=C8)C(C(C(=O)NC(C(=O)N6)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)OC9C(C(C(C(O9)CO)O)O)OC1CC(C(C(O1)C)O)(C)NCC1=CC=C(C=C1)C1=CC=C(C=C1)Cl)OC1=C(C=C2C=C1)Cl)O)O)O)C(=O)O)(C)N)O.OP(=O)(O)O.OP(=O)(O)O	\N
962	BACTOCILL IN PLASTIC CONTAINER	OXACILLIN SODIUM	23667631	C19H18N3NaO5S	423.419	\N	\N	1	7	4	141	29	0	687	3	0	\N	\N	CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+]	sodium;(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-isoxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6560	OXACILLIN SODIUM	OXACILLIN SODIUM	23667631	C19H18N3NaO5S	423.419	\N	\N	1	7	4	141	29	0	687	3	0	\N	\N	CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+]	sodium;(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-isoxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
7753	PROSTAPHLIN	OXACILLIN SODIUM	23667631	C19H18N3NaO5S	423.419	\N	\N	1	7	4	141	29	0	687	3	0	\N	\N	CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+]	sodium;(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-isoxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6613	OXYTROL FOR WOMEN	OXYBUTYNIN	4634	C22H31NO3	357.494	\N	4.2	1	4	8	49.8	26	0	490	0	1	\N	\N	CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O	4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenyl-acetate
6583	OXYCODONE 2.5/APAP 500	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6585	OXYCODONE 5/APAP 500	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6587	OXYCODONE AND ACETAMINOPHEN	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6589	OXYCODONE AND ASPIRIN	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6591	OXYCODONE AND ASPIRIN	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6594	OXYCODONE AND ASPIRIN (HALF-STRENGTH)	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6596	OXYCODONE HYDROCHLORIDE	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6598	OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6600	OXYCODONE HYDROCHLORIDE AND IBUPROFEN	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6602	OXYCONTIN	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6776	PERCOCET	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6778	PERCODAN	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6780	PERCODAN	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6783	PERCODAN-DEMI	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
8092	ROXICET 5/500	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
8093	ROXICODONE	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
8095	ROXILOX	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
8097	ROXIPRIN	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
9314	TROXYCA ER	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
9356	TYLOX	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
9359	TYLOX-325	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
9745	XARTEMIS XR	OXYCODONE HYDROCHLORIDE	5284603	C18H21NO4	315.369	\N	1.2	1	5	1	59	23	0	553	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
6595	OXYCODONE AND ASPIRIN (HALF-STRENGTH)	OXYCODONE TEREPHTHALATE	5464088	C26H27NO8	481.501	\N	\N	3	9	3	134	35	0	722	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O.C1=CC(=CC=C1C(=O)O)C(=O)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;terephthalic acid
6781	PERCODAN	OXYCODONE TEREPHTHALATE	5464088	C26H27NO8	481.501	\N	\N	3	9	3	134	35	0	722	4	0	\N	\N	CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O.C1=CC(=CC=C1C(=O)O)C(=O)O	(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;terephthalic acid
8790	TERRAMYCIN	OXYTETRACYCLINE CALCIUM	54675779	C22H24N2O9	460.439	\N	-1.6	7	10	2	202	33	0	1000	6	0	\N	\N	CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O	(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
8786	TERRA-CORTRIL	OXYTETRACYCLINE HYDROCHLORIDE	54680782	C22H25ClN2O9	496.897	\N	\N	8	10	2	202	34	0	1000	6	0	\N	\N	CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O.Cl	(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8791	TERRAMYCIN	OXYTETRACYCLINE HYDROCHLORIDE	54680782	C22H25ClN2O9	496.897	\N	\N	8	10	2	202	34	0	1000	6	0	\N	\N	CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O.Cl	(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8792	TERRAMYCIN W/ POLYMYXIN	OXYTETRACYCLINE HYDROCHLORIDE	54680782	C22H25ClN2O9	496.897	\N	\N	8	10	2	202	34	0	1000	6	0	\N	\N	CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O.Cl	(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8794	TERRAMYCIN W/ POLYMYXIN B SULFATE	OXYTETRACYCLINE HYDROCHLORIDE	54680782	C22H25ClN2O9	496.897	\N	\N	8	10	2	202	34	0	1000	6	0	\N	\N	CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O.Cl	(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8796	TERRAMYCIN-POLYMYXIN	OXYTETRACYCLINE HYDROCHLORIDE	54680782	C22H25ClN2O9	496.897	\N	\N	8	10	2	202	34	0	1000	6	0	\N	\N	CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O.Cl	(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
7063	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
8789	TERRAMYCIN	OXYTETRACYCLINE	54675779	C22H24N2O9	460.439	\N	-1.6	7	10	2	202	33	0	1000	6	0	\N	\N	CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O	(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
6611	OXYTOCIN 5 USP UNITS IN DEXTROSE 5%	OXYTOCIN	439302	C43H66N12O12S2	1007.193	\N	-2.6	12	15	17	450	69	0	1870	9	0	\N	\N	CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N	(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-16-[(4-hydroxyphenyl)methyl]-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1S)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide
6944	PITOCIN	OXYTOCIN	439302	C43H66N12O12S2	1007.193	\N	-2.6	12	15	17	450	69	0	1870	9	0	\N	\N	CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N	(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-16-[(4-hydroxyphenyl)methyl]-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1S)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide
8643	SYNTOCINON	OXYTOCIN	439302	C43H66N12O12S2	1007.193	\N	-2.6	12	15	17	450	69	0	1870	9	0	\N	\N	CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N	(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-16-[(4-hydroxyphenyl)methyl]-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1S)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide
6623	PALONOSETRON HYDROCHLORIDE	PALONOSETRON HYDROCHLORIDE	6918303	C19H25ClN2O	332.872	\N	\N	1	2	1	23.6	23	0	456	2	0	\N	\N	C1CC2CN(C(=O)C3=C2C(=CC=C3)C1)C4CN5CCC4CC5.Cl	(3aS)-2-[(3S)-quinuclidin-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one;hydrochloride
6625	PAMIDRONATE DISODIUM	PAMIDRONATE DISODIUM	73351	C3H9NNa2O7P2	279.032	\N	\N	4	8	4	167	15	0	238	0	0	\N	\N	C(CN)C(O)(P(=O)(O)[O-])P(=O)(O)[O-].[Na+].[Na+]	disodium;[3-amino-1-hydroxy-1-[hydroxy(oxido)phosphoryl]propyl]-hydroxy-phosphinate
6673	PAVULON	PANCURONIUM BROMIDE	27350	C35H60Br2N2O4	732.683	\N	\N	0	6	6	52.6	43	0	1000	10	0	\N	\N	CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-]	[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;dibromide
6727	PEMETREXED DISODIUM	PEMETREXED DISODIUM	6918197	C20H19N5Na2O6	471.381	\N	\N	4	6	7	193	33	0	737	1	0	\N	\N	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+]	disodium;(2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate
1106	BICILLIN C-R	PENICILLIN G BENZATHINE	25137901	C48H56N6O8S2	909.13	\N	\N	4	10	13	263	64	0	696	6	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.C1=CC=C(C=C1)C[NH2+]CC[NH2+]CC2=CC=CC=C2	benzyl-[2-(benzylammonio)ethyl]ammonium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
1108	BICILLIN C-R 900/300	PENICILLIN G BENZATHINE	25137901	C48H56N6O8S2	909.13	\N	\N	4	10	13	263	64	0	696	6	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.C1=CC=C(C=C1)C[NH2+]CC[NH2+]CC2=CC=CC=C2	benzyl-[2-(benzylammonio)ethyl]ammonium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
1110	BICILLIN L-A	PENICILLIN G BENZATHINE	25137901	C48H56N6O8S2	909.13	\N	\N	4	10	13	263	64	0	696	6	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.C1=CC=C(C=C1)C[NH2+]CC[NH2+]CC2=CC=CC=C2	benzyl-[2-(benzylammonio)ethyl]ammonium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6805	PERMAPEN	PENICILLIN G BENZATHINE	25137901	C48H56N6O8S2	909.13	\N	\N	4	10	13	263	64	0	696	6	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.C1=CC=C(C=C1)C[NH2+]CC[NH2+]CC2=CC=CC=C2	benzyl-[2-(benzylammonio)ethyl]ammonium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6757	PENTIDS '400'	PENICILLIN G POTASSIUM	23664709	C16H17KN2O4S	372.48	\N	\N	1	5	4	115	24	0	536	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6758	PENTIDS '800'	PENICILLIN G POTASSIUM	23664709	C16H17KN2O4S	372.48	\N	\N	1	5	4	115	24	0	536	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6817	PFIZERPEN	PENICILLIN G POTASSIUM	23664709	C16H17KN2O4S	372.48	\N	\N	1	5	4	115	24	0	536	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6818	PFIZERPEN G	PENICILLIN G POTASSIUM	23664709	C16H17KN2O4S	372.48	\N	\N	1	5	4	115	24	0	536	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6742	PENICILLIN-VK	PENICILLIN V POTASSIUM	23676814	C16H17KN2O5S	388.479	\N	\N	1	6	5	124	25	0	553	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6819	PFIZERPEN VK	PENICILLIN V POTASSIUM	23676814	C16H17KN2O5S	388.479	\N	\N	1	6	5	124	25	0	553	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
9438	UTICILLIN VK	PENICILLIN V POTASSIUM	23676814	C16H17KN2O5S	388.479	\N	\N	1	6	5	124	25	0	553	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
9443	V-CILLIN K	PENICILLIN V POTASSIUM	23676814	C16H17KN2O5S	388.479	\N	\N	1	6	5	124	25	0	553	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
7066	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
9515	VEETIDS	PENICILLIN V POTASSIUM	23676814	C16H17KN2O5S	388.479	\N	\N	1	6	5	124	25	0	553	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
9516	VEETIDS '125'	PENICILLIN V POTASSIUM	23676814	C16H17KN2O5S	388.479	\N	\N	1	6	5	124	25	0	553	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
9517	VEETIDS '250'	PENICILLIN V POTASSIUM	23676814	C16H17KN2O5S	388.479	\N	\N	1	6	5	124	25	0	553	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
9518	VEETIDS '500'	PENICILLIN V POTASSIUM	23676814	C16H17KN2O5S	388.479	\N	\N	1	6	5	124	25	0	553	3	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+]	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
6038	NIX	PERMETHRIN	40326	C21H20Cl2O3	391.288	\N	6.5	0	3	7	35.5	26	0	521	0	2	\N	\N	CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C	(3-phenoxyphenyl)methyl 3-(2,2-dichlorovinyl)-2,2-dimethyl-cyclopropanecarboxylate
6807	PERMETHRIN	PERMETHRIN	40326	C21H20Cl2O3	391.288	\N	6.5	0	3	7	35.5	26	0	521	0	2	\N	\N	CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C	(3-phenoxyphenyl)methyl 3-(2,2-dichlorovinyl)-2,2-dimethyl-cyclopropanecarboxylate
6811	PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE	PERPHENAZINE	4748	C21H26ClN3OS	403.969	\N	4.2	1	5	6	55.2	27	0	463	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
9207	TRIAVIL 2-25	PERPHENAZINE	4748	C21H26ClN3OS	403.969	\N	4.2	1	5	6	55.2	27	0	463	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
9209	TRIAVIL 4-10	PERPHENAZINE	4748	C21H26ClN3OS	403.969	\N	4.2	1	5	6	55.2	27	0	463	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
9211	TRIAVIL 4-25	PERPHENAZINE	4748	C21H26ClN3OS	403.969	\N	4.2	1	5	6	55.2	27	0	463	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
9213	TRIAVIL 4-50	PERPHENAZINE	4748	C21H26ClN3OS	403.969	\N	4.2	1	5	6	55.2	27	0	463	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
9238	TRILAFON	PERPHENAZINE	4748	C21H26ClN3OS	403.969	\N	4.2	1	5	6	55.2	27	0	463	0	0	\N	\N	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
6853	PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
6861	PHERAZINE VC	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
6864	PHERAZINE VC W/ CODEINE	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
7412	PREFRIN-A	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
7667	PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
7670	PROMETH VC PLAIN	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
7673	PROMETH VC W/ CODEINE	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
7686	PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
7690	PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
7693	PROMETHAZINE HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
7700	PROMETHAZINE VC PLAIN	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
7703	PROMETHAZINE VC W/ CODEINE	PHENYLEPHRINE HYDROCHLORIDE	5284443	C9H14ClNO2	203.666	\N	\N	4	3	3	52.5	13	0	130	1	0	\N	\N	CNCC(C1=CC(=CC=C1)O)O.Cl	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
123	ACTOPLUS MET XR	PIOGLITAZONE HYDROCHLORIDE	60560	C19H21ClN2O3S	392.898	\N	\N	2	5	7	93.6	26	0	466	0	1	\N	\N	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl	5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione;hydrochloride
124	ACTOS	PIOGLITAZONE HYDROCHLORIDE	60560	C19H21ClN2O3S	392.898	\N	\N	2	5	7	93.6	26	0	466	0	1	\N	\N	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl	5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione;hydrochloride
2946	DUETACT	PIOGLITAZONE HYDROCHLORIDE	60560	C19H21ClN2O3S	392.898	\N	\N	2	5	7	93.6	26	0	466	0	1	\N	\N	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl	5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione;hydrochloride
6511	OSENI	PIOGLITAZONE HYDROCHLORIDE	60560	C19H21ClN2O3S	392.898	\N	\N	2	5	7	93.6	26	0	466	0	1	\N	\N	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl	5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione;hydrochloride
6927	PIOGLITAZONE	PIOGLITAZONE HYDROCHLORIDE	60560	C19H21ClN2O3S	392.898	\N	\N	2	5	7	93.6	26	0	466	0	1	\N	\N	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl	5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione;hydrochloride
6928	PIOGLITAZONE HYDROCHLORIDE	PIOGLITAZONE HYDROCHLORIDE	60560	C19H21ClN2O3S	392.898	\N	\N	2	5	7	93.6	26	0	466	0	1	\N	\N	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl	5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione;hydrochloride
6930	PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE	PIOGLITAZONE HYDROCHLORIDE	60560	C19H21ClN2O3S	392.898	\N	\N	2	5	7	93.6	26	0	466	0	1	\N	\N	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl	5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione;hydrochloride
6932	PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE	PIOGLITAZONE HYDROCHLORIDE	60560	C19H21ClN2O3S	392.898	\N	\N	2	5	7	93.6	26	0	466	0	1	\N	\N	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl	5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione;hydrochloride
6697	PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
6702	PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
6712	PEG-LYTE	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
7018	POLYETHYLENE GLYCOL 3350	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
7019	POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
7024	POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL	POLYETHYLENE GLYCOL 3350	174	C2H6O2	62.068	\N	-1.4	2	2	1	40.5	4	0	6	0	0	\N	\N	C(CO)O	ethylene glycol
5894	NEO-POLYCIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5904	NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
948	BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
950	BACITRACIN ZINC-POLYMYXIN B SULFATE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
953	BACITRACIN-NEOMYCIN-POLYMYXIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
957	BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
1608	CHLOROMYXIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
2044	CORTISPORIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
2047	CORTISPORIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
7069	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7072	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2050	CORTISPORIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
2386	DEXACIDIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
2398	DEXASPORIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
4795	LANABIOTIC	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
4797	LANABIOTIC	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5328	MAXITROL	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5740	MYCITRACIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5906	NEOMYCIN AND POLYMYXIN B SULFATE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5909	NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5912	NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5915	NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5918	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5922	NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
7073	POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
5928	NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5931	NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5936	NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5949	NEOSPORIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5952	NEOSPORIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5954	NEOSPORIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
5956	NEOSPORIN G.U. IRRIGANT	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
6293	OCUMYCIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
6390	OPHTHOCORT	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
6530	OTICAIR	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
6534	OTOBIONE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
6536	OTOBIOTIC	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
6539	OTOCORT	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
7076	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7079	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6691	PEDIOTIC	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
7011	POLY-PRED	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
7013	POLY-RX	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
7030	POLYMYCIN B SULFATE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
7031	POLYMYXIN B SULFATE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
7033	POLYSPORIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
7034	POLYTRIM	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
7804	PYOCIDIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
8446	STATROL	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
8793	TERRAMYCIN W/ POLYMYXIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
8795	TERRAMYCIN W/ POLYMYXIN B SULFATE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
8797	TERRAMYCIN-POLYMYXIN	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
9253	TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
7082	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7085	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
9871	ZINC BACITRACIN,NEOMYCIN SULFATE,POLYMYXIN B SULFATE & HYDROCORTISONE	POLYMYXIN B SULFATE	5702105	C56H100N16O17S	1301.571	\N	\N	20	22	29	574	90	0	2240	0	13	\N	\N	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O	N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid
6215	NOXAFIL	POSACONAZOLE	468595	C37H42F2N8O4	700.792	\N	4.6	1	11	12	112	51	0	1170	4	0	\N	\N	CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F	4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(1S,2S)-1-ethyl-2-hydroxy-propyl]-1,2,4-triazol-3-one
6145	NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM ACETATE	517044	C2H3KO2	98.142	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[K+]	potassium;acetate
6966	PLASMA-LYTE 56 IN PLASTIC CONTAINER	POTASSIUM ACETATE	517044	C2H3KO2	98.142	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[K+]	potassium;acetate
9521	VEINAMINE 8%	POTASSIUM ACETATE	517044	C2H3KO2	98.142	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[K+]	potassium;acetate
534	AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
541	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2461	DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2509	DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4464	ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4469	ISOLYTE H W/ DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4473	ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4478	ISOLYTE M W/ DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7182	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7240	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7300	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7316	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6279	OCL	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6708	PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6713	PEG-LYTE	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6796	PERIKABIVEN IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6884	PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6890	PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6909	PHYSIOSOL IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6914	PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6952	PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6957	PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6969	PLASMA-LYTE A IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6976	PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6982	PLASMA-LYTE R IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7027	POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7046	POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7048	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7051	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7054	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7057	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7201	POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
564	AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
570	AMINOSYN II 7% W/ ELECTROLYTES	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
576	AMINOSYN II 8.5% W/ ELECTROLYTES	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
1229	BSS PLUS	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
1721	CLENZ-LYTE	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
1968	COLYTE-FLAVORED	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2467	DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2472	DEXTROSE 5% AND ELECTROLYTE NO. 75 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2478	DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2482	DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2486	DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2488	DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2491	DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2514	DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2520	DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2531	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.075%	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2534	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2537	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2540	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2543	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2546	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K)	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2549	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2552	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K)	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2555	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2558	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2561	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2564	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K)	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2567	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6234	NULYTELY-FLAVORED	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2582	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2585	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2588	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2591	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2594	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2597	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.075%	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2600	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2603	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2606	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2609	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2612	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
2615	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
3024	E-Z-EM PREP LYTE	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
3100	ELLIOTTS B SOLUTION	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
3655	FREAMINE III 8.5% W/ ELECTROLYTES	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
3808	GOLYTELY	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
3864	HALFLYTELY	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4386	IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4391	IONOSOL T AND DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4445	ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4484	ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4489	ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4495	ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4501	ISOLYTE R W/ DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4506	ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4511	ISOLYTE S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4516	ISOLYTE S PH 7.4 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4524	ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4601	K+10	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4602	K+8	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4603	K-LEASE	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4604	K-TAB	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4609	KABIVEN IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4628	KAON CL	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4629	KAON CL-10	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4690	KLOR-CON M10	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4691	KLOR-CON M15	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4692	KLOR-CON M20	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4720	LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
4724	LACTATED RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
5542	MICRO-K 10	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
5543	MICRO-K LS	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
6154	NORMOSOL-R IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7088	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7091	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7094	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7097	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7100	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7103	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7104	POTASSIUM CHLORIDE 0.075% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7107	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7110	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7113	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7116	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7119	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7122	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7125	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7128	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7131	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7134	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7135	POTASSIUM CHLORIDE 0.11% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7137	POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7140	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7143	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7146	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7149	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7152	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7155	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7158	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7161	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7164	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7167	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7168	POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7170	POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7173	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7176	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7179	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7185	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7188	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7191	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7194	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7197	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7200	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7203	POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7205	POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7208	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7211	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7214	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7217	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7220	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7223	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7226	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7229	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7232	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7235	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7236	POTASSIUM CHLORIDE 0.3% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7244	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7247	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7250	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7253	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7255	POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7258	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7262	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7265	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7268	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7271	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7275	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7279	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7282	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7285	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7288	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7291	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7293	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7296	POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7304	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7307	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7310	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7313	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7317	POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7320	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7324	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7327	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7330	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7333	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7336	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7337	POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7338	POTASSIUM CHLORIDE 40MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7342	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7346	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7349	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7352	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7355	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7357	POTASSIUM CHLORIDE IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7496	PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7503	PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7510	PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7517	PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7524	PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7531	PRISMASOL BGK 2/0 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7538	PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7545	PRISMASOL BGK 4/0 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7552	PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7559	PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7566	PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7573	PRISMASOL BK 0/0 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7580	PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7587	PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7594	PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
7623	PROCALAMINE	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
8305	SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
8307	SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
8309	SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
8311	SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
8502	SUCLEAR	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
8636	SYNOVALYTE IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
8920	TIS-U-SOL	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
8925	TIS-U-SOL IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	4873	ClK	74.548	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Cl-].[K+]	potassium;chloride
548	AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
1820	CLINIMIX E 4.25/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9065	TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9070	TRAVASOL 3.5% W/ ELECTROLYTES	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9086	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9092	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
565	AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
577	AMINOSYN II 8.5% W/ ELECTROLYTES	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
1785	CLINIMIX E 2.75/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
1792	CLINIMIX E 2.75/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
1827	CLINIMIX E 5/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
1834	CLINIMIX E 5/15 SULFITE FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
1841	CLINIMIX E 5/20 SULFITE FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
1848	CLINIMIX E 5/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
1855	CLINIMIX E 5/35 SULFITE FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9036	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9042	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9048	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9054	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9060	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9098	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9104	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9110	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9116	TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9121	TRAVASOL 5.5% W/ ELECTROLYTES	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
9128	TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, DIBASIC	24450	HK2O4P	174.174	\N	\N	1	4	0	83.4	7	0	46.5	0	0	\N	\N	OP(=O)([O-])[O-].[K+].[K+]	dipotassium;hydrogen phosphate
2473	DEXTROSE 5% AND ELECTROLYTE NO. 75 IN PLASTIC CONTAINER	POTASSIUM PHOSPHATE, MONOBASIC	516951	H2KO4P	136.084	\N	\N	2	4	0	80.6	6	0	61.9	0	0	\N	\N	OP(=O)(O)[O-].[K+]	potassium;dihydrogen phosphate
5273	MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE	POTASSIUM SULFATE	24507	K2O4S	174.253	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[K+].[K+]	dipotassium;sulfate
8503	SUCLEAR	POTASSIUM SULFATE	24507	K2O4S	174.253	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[K+].[K+]	dipotassium;sulfate
3021	E-Z SCRUB 201	POVIDONE-IODINE	410087	C6H9I2NO	364.953	\N	\N	0	1	1	20.3	10	0	120	0	0	\N	\N	C=CN1CCCC1=O.II	molecular iodine;1-vinylpyrrolidin-2-one
3022	E-Z SCRUB 241	POVIDONE-IODINE	410087	C6H9I2NO	364.953	\N	\N	0	1	1	20.3	10	0	120	0	0	\N	\N	C=CN1CCCC1=O.II	molecular iodine;1-vinylpyrrolidin-2-one
7379	PRAVIGARD PAC (COPACKAGED)	PRAVASTATIN SODIUM	16759173	C23H35NaO7	446.516	\N	\N	3	7	11	127	31	0	662	8	0	\N	\N	CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)[O-])O)O)O.[Na+]	sodium;(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-heptanoate
7532	PRISMASOL BGK 2/0 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
5593	MINIZIDE	PRAZOSIN HYDROCHLORIDE	68546	C19H22ClN5O4	419.866	\N	\N	2	8	4	107	29	0	544	0	0	\N	\N	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC.Cl	[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone;hydrochloride
7382	PRAZOSIN HYDROCHLORIDE	PRAZOSIN HYDROCHLORIDE	68546	C19H22ClN5O4	419.866	\N	\N	2	8	4	107	29	0	544	0	0	\N	\N	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC.Cl	[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone;hydrochloride
3035	ECONOPRED	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
5487	METICORTELONE	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
5489	METIMYD	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
6356	OMNIPRED	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
7390	PRED FORTE	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
7391	PRED MILD	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
7396	PREDAMIDE	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
7401	PREDNISOLONE ACETATE	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
7406	PREDSULFAIR	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
7408	PREDSULFAIR II	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
8465	STERANE	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
8568	SULPHRIN	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
9500	VASOCIDIN	PREDNISOLONE ACETATE	5834	C23H30O6	402.487	\N	2.4	2	6	4	101	29	0	827	7	0	\N	\N	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O	[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
7394	PREDAIR	PREDNISOLONE SODIUM PHOSPHATE	441409	C21H27Na2O8P	484.392	\N	\N	2	8	3	147	32	0	878	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]	disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
8521	SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE	PREDNISOLONE SODIUM PHOSPHATE	441409	C21H27Na2O8P	484.392	\N	\N	2	8	3	147	32	0	878	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]	disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
8571	SULSTER	PREDNISOLONE SODIUM PHOSPHATE	441409	C21H27Na2O8P	484.392	\N	\N	2	8	3	147	32	0	878	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]	disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
9502	VASOCIDIN	PREDNISOLONE SODIUM PHOSPHATE	441409	C21H27Na2O8P	484.392	\N	\N	2	8	3	147	32	0	878	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=CC34C)O.[Na+].[Na+]	disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
7400	PREDNISOLONE	PREDNISOLONE	5755	C21H28O5	360.45	\N	1.6	3	5	2	94.8	26	0	724	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
7417	PRELONE	PREDNISOLONE	5755	C21H28O5	360.45	\N	1.6	3	5	2	94.8	26	0	724	7	0	\N	\N	CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
5488	METICORTEN	PREDNISONE	5865	C21H26O5	358.434	\N	1.5	2	5	2	91.7	26	0	764	6	0	\N	\N	CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
6420	ORASONE	PREDNISONE	5865	C21H26O5	358.434	\N	1.5	2	5	2	91.7	26	0	764	6	0	\N	\N	CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
7404	PREDNISONE	PREDNISONE	5865	C21H26O5	358.434	\N	1.5	2	5	2	91.7	26	0	764	6	0	\N	\N	CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
7405	PREDNISONE INTENSOL	PREDNISONE	5865	C21H26O5	358.434	\N	1.5	2	5	2	91.7	26	0	764	6	0	\N	\N	CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
7898	RAYOS	PREDNISONE	5865	C21H26O5	358.434	\N	1.5	2	5	2	91.7	26	0	764	6	0	\N	\N	CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
8240	SERVISONE	PREDNISONE	5865	C21H26O5	358.434	\N	1.5	2	5	2	91.7	26	0	764	6	0	\N	\N	CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
7607	PROBENECID	PROBENECID	4911	C13H19NO4S	285.358	\N	3.2	1	5	7	83.1	19	0	374	0	0	\N	\N	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O	4-(dipropylsulfamoyl)benzoic acid
7487	PRINCIPEN W/ PROBENECID	PROBENECID	4911	C13H19NO4S	285.358	\N	3.2	1	5	7	83.1	19	0	374	0	0	\N	\N	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O	4-(dipropylsulfamoyl)benzoic acid
7609	PROBENECID AND COLCHICINE	PROBENECID	4911	C13H19NO4S	285.358	\N	3.2	1	5	7	83.1	19	0	374	0	0	\N	\N	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O	4-(dipropylsulfamoyl)benzoic acid
7611	PROBENECID W/ COLCHICINE	PROBENECID	4911	C13H19NO4S	285.358	\N	3.2	1	5	7	83.1	19	0	374	0	0	\N	\N	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O	4-(dipropylsulfamoyl)benzoic acid
7627	PROCAN SR	PROCAINAMIDE HYDROCHLORIDE	66068	C13H22ClN3O	271.789	\N	\N	3	3	6	58.4	18	0	221	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl	4-amino-N-[2-(diethylamino)ethyl]benzamide;hydrochloride
7628	PROCANBID	PROCAINAMIDE HYDROCHLORIDE	66068	C13H22ClN3O	271.789	\N	\N	3	3	6	58.4	18	0	221	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl	4-amino-N-[2-(diethylamino)ethyl]benzamide;hydrochloride
7629	PROCAPAN	PROCAINAMIDE HYDROCHLORIDE	66068	C13H22ClN3O	271.789	\N	\N	3	3	6	58.4	18	0	221	0	0	\N	\N	CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl	4-amino-N-[2-(diethylamino)ethyl]benzamide;hydrochloride
6840	PHENERGAN VC W/ CODEINE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
6842	PHENERGAN W/ CODEINE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
6854	PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
6860	PHERAZINE DM	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
6862	PHERAZINE VC	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
6865	PHERAZINE VC W/ CODEINE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
6867	PHERAZINE W/ CODEINE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7665	PROMETH FORTIS	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7668	PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7669	PROMETH PLAIN	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7671	PROMETH VC PLAIN	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7674	PROMETH VC W/ CODEINE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7676	PROMETH W/ DEXTROMETHORPHAN	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7677	PROMETHACON	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7678	PROMETHAZINE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7680	PROMETHAZINE DM	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7681	PROMETHAZINE HYDROCHLORIDE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7683	PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7685	PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7687	PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7688	PROMETHAZINE HYDROCHLORIDE PLAIN	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7691	PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7694	PROMETHAZINE HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7695	PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7697	PROMETHAZINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7699	PROMETHAZINE PLAIN	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7701	PROMETHAZINE VC PLAIN	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7704	PROMETHAZINE VC W/ CODEINE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7706	PROMETHAZINE W/ CODEINE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7708	PROMETHAZINE W/ DEXTROMETHORPHAN	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7710	PROMETHAZINE WITH CODEINE	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
7711	PROMETHEGAN	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
9879	ZIPAN-50	PROMETHAZINE HYDROCHLORIDE	6014	C17H21ClN2S	320.879	\N	\N	1	3	3	31.8	21	0	298	0	1	\N	\N	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl	N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride
2182	DARVON	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
2185	DARVON COMPOUND	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
2188	DARVON COMPOUND-65	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
2190	DARVON W/ ASA	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
2869	DOLENE	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
2871	DOLENE AP-65	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
7727	PROPOXYPHENE COMPOUND 65	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
7730	PROPOXYPHENE COMPOUND-65	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
7731	PROPOXYPHENE HYDROCHLORIDE	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
7732	PROPOXYPHENE HYDROCHLORIDE 65	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
7734	PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
7737	PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
9734	WYGESIC	PROPOXYPHENE HYDROCHLORIDE	10100	C22H29NO2	339.479	\N	4.2	0	3	9	29.5	25	0	397	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate
7783	PSEUDOEPHEDRINE HYDROCHLORIDE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
2193	DARVON-N W/ ASA	PROPOXYPHENE NAPSYLATE	28332	C32H37NO5S	547.71	\N	\N	1	6	10	92.3	39	0	688	2	0	\N	\N	CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C.C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)O	[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate;naphthalene-2-sulfonic acid
4225	INDERAL LA	PROPRANOLOL HYDROCHLORIDE	62882	C16H22ClNO2	295.807	\N	\N	3	3	6	41.5	20	0	257	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl	1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol;hydrochloride
4227	INDERIDE LA 120/50	PROPRANOLOL HYDROCHLORIDE	62882	C16H22ClNO2	295.807	\N	\N	3	3	6	41.5	20	0	257	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl	1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol;hydrochloride
4229	INDERIDE LA 160/50	PROPRANOLOL HYDROCHLORIDE	62882	C16H22ClNO2	295.807	\N	\N	3	3	6	41.5	20	0	257	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl	1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol;hydrochloride
4231	INDERIDE LA 80/50	PROPRANOLOL HYDROCHLORIDE	62882	C16H22ClNO2	295.807	\N	\N	3	3	6	41.5	20	0	257	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl	1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol;hydrochloride
4233	INDERIDE-40/25	PROPRANOLOL HYDROCHLORIDE	62882	C16H22ClNO2	295.807	\N	\N	3	3	6	41.5	20	0	257	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl	1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol;hydrochloride
4235	INDERIDE-80/25	PROPRANOLOL HYDROCHLORIDE	62882	C16H22ClNO2	295.807	\N	\N	3	3	6	41.5	20	0	257	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl	1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol;hydrochloride
4299	INNOPRAN XL	PROPRANOLOL HYDROCHLORIDE	62882	C16H22ClNO2	295.807	\N	\N	3	3	6	41.5	20	0	257	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl	1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol;hydrochloride
7742	PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE	PROPRANOLOL HYDROCHLORIDE	62882	C16H22ClNO2	295.807	\N	\N	3	3	6	41.5	20	0	257	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl	1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol;hydrochloride
7744	PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	PROPRANOLOL HYDROCHLORIDE	62882	C16H22ClNO2	295.807	\N	\N	3	3	6	41.5	20	0	257	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl	1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol;hydrochloride
7745	PROPRANOLOL HYDROCHLORIDE INTENSOL	PROPRANOLOL HYDROCHLORIDE	62882	C16H22ClNO2	295.807	\N	\N	3	3	6	41.5	20	0	257	0	1	\N	\N	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl	1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol;hydrochloride
4168	IBUPROHM COLD AND SINUS	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
349	ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
350	ALLERFED	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
1037	BENYLIN	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
1199	BROMFED-DM	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
1207	BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
1557	CHILDREN'S ADVIL ALLERGY SINUS	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
1559	CHILDREN'S ADVIL COLD	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
1572	CHILDREN'S MOTRIN COLD	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
1919	CODIMAL-L.A. 12	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
3067	EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
3487	FEXOFENADINE HCL; PSEUDOEPHEDRINE HCL	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
3491	FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
3494	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
3956	HISTAFED	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
4077	HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
4080	HYDROCODONE BITARTRATE,CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
5752	MYFED	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
5824	NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
7785	PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
7786	PSEUDOEPHEDRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
8007	REZIRA	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
8510	SUDAFED 12 HOUR	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
8511	SUDAFED 24 HOUR	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
8694	TAVIST ALLERGY/SINUS/HEADACHE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
9186	TRIACIN-C	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
9241	TRILITRON	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
9268	TRIPHED	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
9274	TRIPROLIDINE AND PSEUDOEPHEDRINE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
9276	TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
9279	TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W/ CODEINE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
9282	TRIPROLIDINE HCL, PSEUDOEPHEDRINE HCL AND CODEINE PHOSPHATE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
9285	TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
9953	ZYRTEC-D 12 HOUR	PSEUDOEPHEDRINE HYDROCHLORIDE	9581	C10H16ClNO	201.694	\N	\N	3	2	3	32.3	13	0	121	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.Cl	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;hydrochloride
2928	DRIXORAL PLUS	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
5076	LORATADINE AND PSEUDOEPHEDRINE SULFATE	PSEUDOEPHEDRINE SULFATE	62945	C10H17NO5S	263.308	\N	\N	4	6	3	115	17	0	202	2	0	\N	\N	CC(C(C1=CC=CC=C1)O)NC.OS(=O)(=O)O	(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol;sulfuric acid
3939	HEXA-BETALIN	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
5169	M.V.C. 9+3	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
5181	M.V.I. ADULT	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
5194	M.V.I. ADULT (PHARMACY BULK PACKAGE)	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
5208	M.V.I. PEDIATRIC	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
5220	M.V.I.-12	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
5232	M.V.I.-12	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
5244	M.V.I.-12 (WITHOUT VITAMIN K)	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
5723	MVC PLUS	PYRIDOXINE HYDROCHLORIDE	6019	C8H12ClNO3	205.638	\N	\N	4	4	2	73.6	13	0	142	0	0	\N	\N	CC1=NC=C(C(=C1O)CO)CO.Cl	4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol;hydrochloride
7845	QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	QUINAPRIL HYDROCHLORIDE	54891	C25H31ClN2O5	474.982	\N	\N	3	6	10	95.9	33	0	648	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O.Cl	(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
7847	QUINARETIC	QUINAPRIL HYDROCHLORIDE	54891	C25H31ClN2O5	474.982	\N	\N	3	6	10	95.9	33	0	648	3	0	\N	\N	CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O.Cl	(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
7841	QUINAGLUTE	QUINIDINE GLUCONATE	94328	C26H36N2O9	520.579	\N	\N	7	11	9	184	37	0	627	8	0	\N	\N	COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.C(C(C(C(C(C(=O)O)O)O)O)O)O	(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid
7842	QUINALAN	QUINIDINE GLUCONATE	94328	C26H36N2O9	520.579	\N	\N	7	11	9	184	37	0	627	8	0	\N	\N	COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.C(C(C(C(C(C(=O)O)O)O)O)O)O	(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid
7525	PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
7848	QUINATIME	QUINIDINE GLUCONATE	94328	C26H36N2O9	520.579	\N	\N	7	11	9	184	37	0	627	8	0	\N	\N	COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.C(C(C(C(C(C(=O)O)O)O)O)O)O	(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid
7850	QUINIDINE GLUCONATE	QUINIDINE GLUCONATE	94328	C26H36N2O9	520.579	\N	\N	7	11	9	184	37	0	627	8	0	\N	\N	COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.C(C(C(C(C(C(=O)O)O)O)O)O)O	(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid
7851	QUINIDINE SULFATE	QUINIDINE SULFATE	441074	C20H24N2O2	324.424	\N	2.9	1	4	4	45.6	24	0	457	4	0	\N	\N	COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O	(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol
9816	ZANTAC 300	RANITIDINE HYDROCHLORIDE	3033332	C13H23ClN4O3S	350.862	\N	\N	3	7	9	112	22	0	347	0	0	\N	\N	CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C.Cl	(E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furyl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine;hydrochloride
9817	ZANTAC 75	RANITIDINE HYDROCHLORIDE	3033332	C13H23ClN4O3S	350.862	\N	\N	3	7	9	112	22	0	347	0	0	\N	\N	CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C.Cl	(E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furyl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine;hydrochloride
9818	ZANTAC IN PLASTIC CONTAINER	RANITIDINE HYDROCHLORIDE	3033332	C13H23ClN4O3S	350.862	\N	\N	3	7	9	112	22	0	347	0	0	\N	\N	CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C.Cl	(E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furyl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine;hydrochloride
7877	RAPLON	RAPACURONIUM BROMIDE	5311398	C37H61BrN2O4	677.809	\N	\N	0	6	9	55.8	44	0	1030	10	0	\N	\N	CCC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)OC(=O)C)N5CCCCC5)C)C)[N+]6(CCCCC6)CC=C.[Br-]	[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-acetoxy-16-(1-allylpiperidin-1-ium-1-yl)-10,13-dimethyl-2-(1-piperidyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] propanoate;bromide
7885	RAUVAL	RAUWOLFIA SERPENTINA ROOT	441975	C21H24N2O3	352.434	\N	2.7	1	4	2	54.6	26	0	606	4	0	\N	\N	CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45	\N
7887	RAUWOLFIA SERPENTINA	RAUWOLFIA SERPENTINA ROOT	441975	C21H24N2O3	352.434	\N	2.7	1	4	2	54.6	26	0	606	4	0	\N	\N	CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45	\N
7962	REPAGLINIDE AND METFORMIN HYDROCHLORIDE	REPAGLINIDE	65981	C27H36N2O4	452.595	\N	5.2	2	5	10	78.9	33	0	619	1	0	\N	\N	CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidyl)phenyl]butyl]amino]-2-oxo-ethyl]benzoic acid
1620	CHLOROTHIAZIDE W/ RESERPINE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
1622	CHLOROTHIAZIDE-RESERPINE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
2851	DIUPRES-250	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
2853	DIUPRES-500	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
2857	DIUTENSEN-R	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
2918	DRALSERP	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
3852	H.R.-50	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
3954	HISERPIA	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
4034	HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
4037	HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
4041	HYDRAP-ES	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
4045	HYDRO-RESERP	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
4050	HYDRO-SERP ""25""	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
4052	HYDRO-SERP ""50""	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
4058	HYDROCHLOROTHIAZIDE W/ RESERPINE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
4061	HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
4102	HYDROFLUMETHIAZIDE AND RESERPINE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
4107	HYDROMOX R	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
4111	HYDROPRES 25	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
4113	HYDROPRES 50	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
4116	HYDROSERPINE PLUS (R-H-H)	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
5440	METATENSIN #2	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
5442	METATENSIN #4	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
5826	NAQUIVAL	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
7916	REGROTON	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
7973	RESERPINE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
7975	RESERPINE AND HYDROCHLOROTHIAZIDE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
7977	RESERPINE AND HYDROCHLOROTHIAZIDE-50	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
7979	RESERPINE AND HYDROFLUMETHIAZIDE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
7982	RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
7985	RESERPINE, HYDROCHLOROTHIAZIDE, AND HYDRALAZINE HYDROCHLORIDE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
8138	SALUTENSIN	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
8140	SALUTENSIN-DEMI	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
8148	SANDRIL	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
8214	SER-A-GEN	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
8217	SER-AP-ES	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
8228	SERPALAN	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
8229	SERPANRAY	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
8230	SERPASIL	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
8232	SERPASIL-APRESOLINE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
8234	SERPASIL-ESIDRIX #1	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
8236	SERPASIL-ESIDRIX #2	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
8237	SERPATE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
8238	SERPIVITE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
9221	TRICHLORMETHIAZIDE W/ RESERPINE	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
9403	UNIPRES	RESERPINE	5770	C33H40N2O9	608.688	\N	4	1	10	10	118	44	0	1000	6	0	\N	\N	COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
6881	PHOTREXA VISCOUS IN DEXTRAN 20%	RIBOFLAVIN 5'-PHOSPHATE SODIUM	23666409	C17H20N4NaO9P	478.33	\N	\N	5	10	7	204	32	0	856	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)[O-])O)O)O.[Na+]	sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentyl] hydrogen phosphate
5209	M.V.I. PEDIATRIC	RIBOFLAVIN 5'-PHOSPHATE SODIUM	23666409	C17H20N4NaO9P	478.33	\N	\N	5	10	7	204	32	0	856	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)[O-])O)O)O.[Na+]	sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentyl] hydrogen phosphate
5221	M.V.I.-12	RIBOFLAVIN 5'-PHOSPHATE SODIUM	23666409	C17H20N4NaO9P	478.33	\N	\N	5	10	7	204	32	0	856	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)[O-])O)O)O.[Na+]	sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentyl] hydrogen phosphate
5245	M.V.I.-12 (WITHOUT VITAMIN K)	RIBOFLAVIN 5'-PHOSPHATE SODIUM	23666409	C17H20N4NaO9P	478.33	\N	\N	5	10	7	204	32	0	856	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)[O-])O)O)O.[Na+]	sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentyl] hydrogen phosphate
5257	M.V.I.-12 LYOPHILIZED	RIBOFLAVIN 5'-PHOSPHATE SODIUM	23666409	C17H20N4NaO9P	478.33	\N	\N	5	10	7	204	32	0	856	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)[O-])O)O)O.[Na+]	sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentyl] hydrogen phosphate
5724	MVC PLUS	RIBOFLAVIN 5'-PHOSPHATE SODIUM	23666409	C17H20N4NaO9P	478.33	\N	\N	5	10	7	204	32	0	856	3	0	\N	\N	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)[O-])O)O)O.[Na+]	sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentyl] hydrogen phosphate
8039	RISEDRONATE SODIUM	RISEDRONATE SODIUM	4194514	C7H10NNaO7P2	305.094	\N	\N	4	8	4	151	18	0	375	0	1	\N	\N	C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+]	sodium;hydroxy-[1-hydroxy-1-phosphono-2-(3-pyridyl)ethyl]phosphinate
8048	RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	RITODRINE HYDROCHLORIDE	31728	C17H22ClNO3	323.817	\N	\N	5	4	6	72.7	22	0	284	2	0	\N	\N	CC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O.Cl	4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl-ethyl]amino]ethyl]phenol;hydrochloride
820	ATAZANAVIR SULFATE; RITONAVIR	RITONAVIR	392622	C37H48N6O5S2	720.948	\N	6	4	9	18	202	50	0	1040	4	0	\N	\N	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	thiazol-5-ylmethyl N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-5-phenyl-pentyl]carbamate
4621	KALETRA	RITONAVIR	392622	C37H48N6O5S2	720.948	\N	6	4	9	18	202	50	0	1040	4	0	\N	\N	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	thiazol-5-ylmethyl N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-5-phenyl-pentyl]carbamate
5063	LOPINAVIR; RITONAVIR	RITONAVIR	392622	C37H48N6O5S2	720.948	\N	6	4	9	18	202	50	0	1040	4	0	\N	\N	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	thiazol-5-ylmethyl N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-5-phenyl-pentyl]carbamate
6182	NORVIR	RITONAVIR	392622	C37H48N6O5S2	720.948	\N	6	4	9	18	202	50	0	1040	4	0	\N	\N	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	thiazol-5-ylmethyl N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-5-phenyl-pentyl]carbamate
8049	RITONAVIR	RITONAVIR	392622	C37H48N6O5S2	720.948	\N	6	4	9	18	202	50	0	1040	4	0	\N	\N	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	thiazol-5-ylmethyl N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-5-phenyl-pentyl]carbamate
8730	TECHNIVIE	RITONAVIR	392622	C37H48N6O5S2	720.948	\N	6	4	9	18	202	50	0	1040	4	0	\N	\N	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	thiazol-5-ylmethyl N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-5-phenyl-pentyl]carbamate
9604	VIEKIRA PAK (COPACKAGED)	RITONAVIR	392622	C37H48N6O5S2	720.948	\N	6	4	9	18	202	50	0	1040	4	0	\N	\N	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	thiazol-5-ylmethyl N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-5-phenyl-pentyl]carbamate
9608	VIEKIRA XR	RITONAVIR	392622	C37H48N6O5S2	720.948	\N	6	4	9	18	202	50	0	1040	4	0	\N	\N	CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	thiazol-5-ylmethyl N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-5-phenyl-pentyl]carbamate
8342	SODIUM ROSE BENGAL I 131	ROSE BENGAL SODIUM I-131	49799974	C20H2Cl4I4Na2O5	1033.635	\N	\N	0	5	0	81.6	35	0	780	0	0	\N	\N	C1=C2C(=C(C(=C1I)[O-])I)OC3=C(C(=C(C=C3C24C5=C(C(=C(C(=C5Cl)Cl)Cl)Cl)C(=O)O4)I)[O-])I.[Na+].[Na+]	disodium;4,5,6,7-tetrachloro-2',4',5',7'-tetrakis(iodanyl)-3-oxo-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diolate
8059	ROBENGATOPE	ROSE BENGAL SODIUM I-131	49799974	C20H2Cl4I4Na2O5	1033.635	\N	\N	0	5	0	81.6	35	0	780	0	0	\N	\N	C1=C2C(=C(C(=C1I)[O-])I)OC3=C(C(=C(C=C3C24C5=C(C(=C(C(=C5Cl)Cl)Cl)Cl)C(=O)O4)I)[O-])I.[Na+].[Na+]	disodium;4,5,6,7-tetrachloro-2',4',5',7'-tetrakis(iodanyl)-3-oxo-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diolate
883	AVANDIA	ROSIGLITAZONE MALEATE	5281055	C22H23N3O7S	473.5	\N	\N	3	10	9	171	33	0	588	0	1	\N	\N	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O	maleic acid;5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione
8079	ROSIGLITAZONE MALEATE	ROSIGLITAZONE MALEATE	5281055	C22H23N3O7S	473.5	\N	\N	3	10	9	171	33	0	588	0	1	\N	\N	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O	maleic acid;5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione
8081	ROSIGLITAZONE MALEATE AND GLIMEPIRIDE	ROSIGLITAZONE MALEATE	5281055	C22H23N3O7S	473.5	\N	\N	3	10	9	171	33	0	588	0	1	\N	\N	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O	maleic acid;5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione
8083	ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE	ROSIGLITAZONE MALEATE	5281055	C22H23N3O7S	473.5	\N	\N	3	10	9	171	33	0	588	0	1	\N	\N	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O	maleic acid;5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione
8084	ROSIGLITAZONE MALEATE; METFORMIN HYDROCHLORIDE	ROSIGLITAZONE MALEATE	5281055	C22H23N3O7S	473.5	\N	\N	3	10	9	171	33	0	588	0	1	\N	\N	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O	maleic acid;5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione
8188	SELEGILINE HYDROCHLORIDE	SELEGILINE HYDROCHLORIDE	26758	C13H18ClN	223.744	\N	\N	1	1	4	3.2	15	0	195	1	0	\N	\N	CC(CC1=CC=CC=C1)N(C)CC#C.Cl	(2R)-N-methyl-1-phenyl-N-prop-2-ynyl-propan-2-amine;hydrochloride
97	ACTHAR GEL-SYNTHETIC	SERACTIDE ACETATE	118984407	C209H314N56O61S	4619.202	\N	\N	65	71	148	1900	327	0	11200	36	0	\N	\N	CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C6CCCN6C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CNC=N1)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)N.CC(=O)O.O	\N
8263	SIMVASTATIN	SIMVASTATIN	54454	C25H38O5	418.574	\N	4.7	1	5	7	72.8	30	0	706	7	0	\N	\N	CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C	[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
9709	VYTORIN	SIMVASTATIN	54454	C25H38O5	418.574	\N	4.7	1	5	7	72.8	30	0	706	7	0	\N	\N	CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C	[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
9885	ZOCOR	SIMVASTATIN	54454	C25H38O5	418.574	\N	4.7	1	5	7	72.8	30	0	706	7	0	\N	\N	CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C	[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
4599	JUVISYNC	SITAGLIPTIN PHOSPHATE	6451150	C16H18F6N5O5P	505.314	\N	\N	4	14	4	155	33	0	616	1	0	\N	\N	C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.OP(=O)(O)O	(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid
5447	METFORMIN HYDROCHLORIDE AND  SITAGLIPTIN PHOSPHATE	SITAGLIPTIN PHOSPHATE	6451150	C16H18F6N5O5P	505.314	\N	\N	4	14	4	155	33	0	616	1	0	\N	\N	C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.OP(=O)(O)O	(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid
8276	SITAGLIPTIN PHOSPHATE	SITAGLIPTIN PHOSPHATE	6451150	C16H18F6N5O5P	505.314	\N	\N	4	14	4	155	33	0	616	1	0	\N	\N	C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.OP(=O)(O)O	(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid
8277	SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE	SITAGLIPTIN PHOSPHATE	6451150	C16H18F6N5O5P	505.314	\N	\N	4	14	4	155	33	0	616	1	0	\N	\N	C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.OP(=O)(O)O	(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid
2510	DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9043	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9105	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9111	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4480	ISOLYTE M W/ DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4486	ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4491	ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4496	ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4502	ISOLYTE R W/ DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4507	ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4512	ISOLYTE S IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
4518	ISOLYTE S PH 7.4 IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
6155	NORMOSOL-R IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
6958	PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
6970	PLASMA-LYTE A IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
6977	PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
6983	PLASMA-LYTE R IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
7624	PROCALAMINE	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9049	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9055	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9061	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9117	TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9122	TRAVASOL 5.5% W/ ELECTROLYTES	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9129	TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
9523	VEINAMINE 8%	SODIUM ACETATE	517045	C2H3NaO2	82.034	\N	\N	0	2	0	40.1	5	0	34.6	0	0	\N	\N	CC(=O)[O-].[Na+]	sodium;acetate
7026	POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
3865	HALFLYTELY	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
5860	NAVSTEL	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
6140	NORMOCARB HF 35	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
6235	NULYTELY-FLAVORED	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
6341	OMEPRAZOLE AND SODIUM BICARBONATE	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
6694	PEG 3350 AND ELECTROLYTES	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
6699	PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
6891	PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
7504	PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
7511	PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
7518	PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
7539	PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
7546	PRISMASOL BGK 4/0 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
7553	PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
7560	PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
7567	PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
7574	PRISMASOL BK 0/0 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
7581	PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
7588	PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
7595	PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
8300	SODIUM BICARBONATE IN PLASTIC CONTAINER	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
8504	SUCLEAR	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
9832	ZEGERID	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
9834	ZEGERID OTC	SODIUM BICARBONATE	516892	CHNaO3	84.006	\N	\N	1	3	0	60.4	5	0	33.9	0	0	\N	\N	C(=O)(O)[O-].[Na+]	sodium;hydrogen carbonate
572	AMINOSYN II 7% W/ ELECTROLYTES	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2255	DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2444	DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2521	DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2523	DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2525	DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2527	DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2529	DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2532	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.075%	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2535	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2538	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2577	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.30% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2580	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2583	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2586	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2589	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2592	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2595	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4497	ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4503	ISOLYTE R W/ DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7049	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7070	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7074	POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7077	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7080	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7083	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7086	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7089	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7092	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7095	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7098	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7101	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7105	POTASSIUM CHLORIDE 0.075% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7108	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7126	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7129	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7132	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7136	POTASSIUM CHLORIDE 0.11% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7138	POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7141	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7144	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7147	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7150	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7153	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7156	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7159	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7162	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7186	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7189	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7192	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7195	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7198	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7202	POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7204	POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7206	POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7209	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7212	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7215	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7245	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7248	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7251	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7254	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7259	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7263	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7266	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7269	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7272	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7276	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7280	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7305	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7308	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7311	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7314	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7321	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7325	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7328	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7331	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7334	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9050	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1829	CLINIMIX E 5/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1836	CLINIMIX E 5/15 SULFITE FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1843	CLINIMIX E 5/20 SULFITE FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1850	CLINIMIX E 5/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1857	CLINIMIX E 5/35 SULFITE FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
1970	COLYTE-FLAVORED	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2250	DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2260	DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2265	DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2270	DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2275	DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2280	DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2285	DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2290	DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2295	DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2300	DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2305	DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2429	DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2431	DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2433	DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2435	DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2446	DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2450	DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2456	DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2462	DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2469	DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2474	DEXTROSE 5% AND ELECTROLYTE NO. 75 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2479	DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2492	DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2494	DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2496	DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2498	DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2500	DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2502	DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2504	DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2506	DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2541	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2544	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2547	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K)	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2550	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2553	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K)	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2556	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2559	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2562	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2565	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K)	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2568	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2571	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2598	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.075%	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2601	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2604	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2607	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2610	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2613	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2616	DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2637	DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2667	DIALYTE W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2672	DIALYTE W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2678	DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2698	DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2703	DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2708	DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2713	DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2723	DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2728	DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2733	DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2738	DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2743	DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
2748	DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
3102	ELLIOTTS B SOLUTION	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
3810	GOLYTELY	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
3866	HALFLYTELY	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4312	INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4317	INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4322	INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4326	INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4330	INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4334	INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4393	IONOSOL T AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4447	ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4508	ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4513	ISOLYTE S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4519	ISOLYTE S PH 7.4 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4725	LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
4891	LEVOFLOXACIN	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
5861	NAVSTEL	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6141	NORMOCARB HF 35	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6146	NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6151	NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6156	NORMOSOL-R IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6236	NULYTELY-FLAVORED	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6700	PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6705	PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6710	PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6959	PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6964	PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6967	PLASMA-LYTE 56 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6971	PLASMA-LYTE A IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6978	PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6984	PLASMA-LYTE R IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7052	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7055	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7058	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7061	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7064	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7067	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7111	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7114	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7117	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7120	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7123	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7165	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7169	POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7171	POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7174	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7177	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7180	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7218	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7221	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7224	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7227	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7230	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7233	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7237	POTASSIUM CHLORIDE 0.3% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7283	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7286	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7289	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7294	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7339	POTASSIUM CHLORIDE 40MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7343	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7347	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7350	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7353	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7526	PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7533	PRISMASOL BGK 2/0 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7540	PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7547	PRISMASOL BGK 4/0 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7582	PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
7589	PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8306	SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8308	SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8310	SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8312	SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8313	SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8314	SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8315	SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8316	SODIUM CHLORIDE 3% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8317	SODIUM CHLORIDE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8318	SODIUM CHLORIDE IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8505	SUCLEAR	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
8927	TIS-U-SOL IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9056	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9062	TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9112	TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9118	TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9123	TRAVASOL 5.5% W/ ELECTROLYTES	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
9135	TRAVASOL 8.5% W/ ELECTROLYTES	SODIUM CHLORIDE	5234	ClNa	58.44	\N	\N	0	1	0	0	2	0	2	0	0	\N	\N	[Na+].[Cl-]	sodium;chloride
6955	PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM GLUCONATE	23672301	C6H11NaO7	218.137	\N	\N	5	7	5	141	14	0	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+]	sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
6972	PLASMA-LYTE A IN PLASTIC CONTAINER	SODIUM GLUCONATE	23672301	C6H11NaO7	218.137	\N	\N	5	7	5	141	14	0	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+]	sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
8639	SYNOVALYTE IN PLASTIC CONTAINER	SODIUM GLUCONATE	23672301	C6H11NaO7	218.137	\N	\N	5	7	5	141	14	0	176	4	0	\N	\N	C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+]	sodium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
2281	DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2475	DEXTROSE 5% AND ELECTROLYTE NO. 75 IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2480	DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2694	DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2699	DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2704	DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2724	DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2729	DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
4313	INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
4318	INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
4323	INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2291	DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2296	DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2301	DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2306	DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2709	DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2714	DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2734	DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2739	DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2744	DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
2749	DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
4327	INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
4331	INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
4335	INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
4388	IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
4726	LACTATED RINGER'S IN PLASTIC CONTAINER	SODIUM LACTATE	23666456	C3H5NaO3	112.06	\N	\N	1	3	1	60.4	7	0	63.2	0	1	\N	\N	CC(C(=O)[O-])O.[Na+]	sodium;2-hydroxypropanoate
6893	PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER	SODIUM PHOSPHATE	24243	Na3O4P	163.939	\N	\N	0	4	0	86.2	8	0	36.8	0	0	\N	\N	[O-]P(=O)([O-])[O-].[Na+].[Na+].[Na+]	trisodium;phosphate
8928	TIS-U-SOL IN PLASTIC CONTAINER	SODIUM PHOSPHATE	24243	Na3O4P	163.939	\N	\N	0	4	0	86.2	8	0	36.8	0	0	\N	\N	[O-]P(=O)([O-])[O-].[Na+].[Na+].[Na+]	trisodium;phosphate
1971	COLYTE-FLAVORED	SODIUM SULFATE ANHYDROUS	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
3806	GO-EVAC	SODIUM SULFATE ANHYDROUS	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
3811	GOLYTELY	SODIUM SULFATE ANHYDROUS	24436	Na2O4S	142.036	\N	\N	0	4	0	88.6	7	0	62.2	0	0	\N	\N	[O-]S(=O)(=O)[O-].[Na+].[Na+]	disodium;sulfate
8390	SOTYLIZE	SOTALOL HYDROCHLORIDE	66245	C12H21ClN2O3S	308.821	\N	\N	4	5	6	86.8	19	0	330	0	1	\N	\N	CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.Cl	N-[4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide;hydrochloride
8403	SPIRONOLACTONE	SPIRONOLACTONE	5833	C24H32O4S	416.576	\N	2.9	0	5	2	85.7	29	0	818	7	0	\N	\N	CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C	S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxo-spiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-tetrahydrofuran]-7-yl] ethanethioate
8405	SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE	SPIRONOLACTONE	5833	C24H32O4S	416.576	\N	2.9	0	5	2	85.7	29	0	818	7	0	\N	\N	CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C	S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxo-spiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-tetrahydrofuran]-7-yl] ethanethioate
8407	SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE	SPIRONOLACTONE	5833	C24H32O4S	416.576	\N	2.9	0	5	2	85.7	29	0	818	7	0	\N	\N	CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C	S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxo-spiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-tetrahydrofuran]-7-yl] ethanethioate
8456	STAVUDINE; LAMIVUDINE; NEVIRAPINE	STAVUDINE	18283	C10H12N2O4	224.216	\N	-0.8	2	4	2	78.9	16	0	388	2	0	\N	\N	CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO	1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
9850	ZERIT XR	STAVUDINE	18283	C10H12N2O4	224.216	\N	-0.8	2	4	2	78.9	16	0	388	2	0	\N	\N	CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO	1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
4744	LAMIVUDINE, NEVIRAPINE, AND STAVUDINE	STAVUDINE	18283	C10H12N2O4	224.216	\N	-0.8	2	4	2	78.9	16	0	388	2	0	\N	\N	CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO	1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
4541	ISOPTO CETAPRED	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
4685	KLARON	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
6297	OCUSULF-10	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
6298	OCUSULF-30	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
7407	PREDSULFAIR	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
7409	PREDSULFAIR II	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
8345	SODIUM SULFACETAMIDE	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
8516	SULF-15	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
8519	SULFACEL-15	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
8520	SULFACETAMIDE SODIUM	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
8522	SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
8525	SULFAIR 10	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
8526	SULFAIR FORTE	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
8527	SULFAIR-15	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
8569	SULPHRIN	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
8572	SULSTER	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
8573	SULTEN-10	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
9503	VASOCIDIN	SULFACETAMIDE SODIUM	4022878	C8H9N2NaO3S	236.221	\N	\N	1	5	2	86.6	15	0	304	0	0	\N	\N	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	sodium;acetyl-(4-aminophenyl)sulfonyl-azanide
8559	SULFONAMIDES DUPLEX	SULFADIAZINE	5215	C10H10N4O2S	250.276	\N	-0.1	2	6	3	106	17	0	327	0	0	\N	\N	C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-pyrimidin-2-yl-benzenesulfonamide
8538	SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8540	SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8542	SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8550	SULFATRIM PEDIATRIC	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8552	SULFATRIM-DS	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8554	SULFATRIM-SS	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8564	SULMEPRIM	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
9419	UROBAK	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
9424	UROPLUS DS	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
9426	UROPLUS SS	SULFAMETHOXAZOLE	5329	C10H11N3O3S	253.276	\N	0.9	2	6	3	107	17	0	346	0	0	\N	\N	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
8576	SUMATRIPTAN SUCCINATE	SUMATRIPTAN SUCCINATE	59772	C18H27N3O6S	413.489	\N	\N	4	8	9	148	28	0	498	0	0	\N	\N	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O	1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide;succinic acid
8577	SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM	SUMATRIPTAN SUCCINATE	59772	C18H27N3O6S	413.489	\N	\N	4	8	9	148	28	0	498	0	0	\N	\N	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O	1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide;succinic acid
8581	SUMAVEL DOSEPRO	SUMATRIPTAN SUCCINATE	59772	C18H27N3O6S	413.489	\N	\N	4	8	9	148	28	0	498	0	0	\N	\N	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O	1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide;succinic acid
9838	ZEMBRACE SYMTOUCH	SUMATRIPTAN SUCCINATE	59772	C18H27N3O6S	413.489	\N	\N	4	8	9	148	28	0	498	0	0	\N	\N	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O	1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide;succinic acid
8583	SUNITINIB MALATE	SUNITINIB MALATE	6456015	C26H33FN4O7	532.569	\N	\N	6	9	10	172	38	0	765	1	0	\N	\N	CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C.C(C(C(=O)O)O)C(=O)O	N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acid
8600	SUTENT	SUNITINIB MALATE	6456015	C26H33FN4O7	532.569	\N	\N	6	9	10	172	38	0	765	1	0	\N	\N	CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C.C(C(C(=O)O)O)C(=O)O	N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acid
9913	ZOSYN IN PLASTIC CONTAINER	TAZOBACTAM SODIUM	23663400	C10H11N4NaO5S	322.271	\N	\N	0	7	3	134	21	0	579	3	0	\N	\N	CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)[O-])CN3C=CN=N3.[Na+]	sodium;(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
8726	TECHNETIUM TC-99M PENTETATE KIT	TECHNETIUM TC-99M PENTETATE KIT	3053	C14H23N3O10	393.349	\N	-8.5	5	13	16	196	27	0	481	0	0	\N	\N	C(CN(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O	2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid
3705	GATTEX KIT	TEDUGLUTIDE RECOMBINANT	70683012	C164H252N44O55S	3752.133	\N	-15.2	55	60	126	1650	264	0	9030	38	0	\N	\N	CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC5=CNC=N5)N	\N
8782	TERCONAZOLE	TERCONAZOLE	441383	C26H31Cl2N5O3	532.466	\N	4.8	0	7	8	64.9	36	0	693	2	0	\N	\N	CC(C)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl	1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-isopropyl-piperazine
8967	TOPICYCLINE	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
3069	EGRIFTA	TESAMORELIN ACETATE	44147413	C223H370N72O69S	5195.908	\N	\N	84	78	187	2400	365	0	12800	44	0	\N	\N	CCC=CCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(C(C)CC)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N.CC(=O)O	\N
905	AXIRON	TESTOSTERONE	6013	C19H28O2	288.431	\N	3.3	1	2	0	37.3	21	0	508	6	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
3623	FORTESTA	TESTOSTERONE	6013	C19H28O2	288.431	\N	3.3	1	2	0	37.3	21	0	508	6	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
5844	NATESTO	TESTOSTERONE	6013	C19H28O2	288.431	\N	3.3	1	2	0	37.3	21	0	508	6	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
8485	STRIANT	TESTOSTERONE	6013	C19H28O2	288.431	\N	3.3	1	2	0	37.3	21	0	508	6	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
8801	TESTIM	TESTOSTERONE	6013	C19H28O2	288.431	\N	3.3	1	2	0	37.3	21	0	508	6	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
8802	TESTODERM	TESTOSTERONE	6013	C19H28O2	288.431	\N	3.3	1	2	0	37.3	21	0	508	6	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
8803	TESTODERM TTS	TESTOSTERONE	6013	C19H28O2	288.431	\N	3.3	1	2	0	37.3	21	0	508	6	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
8804	TESTOPEL	TESTOSTERONE	6013	C19H28O2	288.431	\N	3.3	1	2	0	37.3	21	0	508	6	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
8805	TESTOSTERONE	TESTOSTERONE	6013	C19H28O2	288.431	\N	3.3	1	2	0	37.3	21	0	508	6	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
9686	VOGELXO	TESTOSTERONE	6013	C19H28O2	288.431	\N	3.3	1	2	0	37.3	21	0	508	6	0	\N	\N	CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
2119	CYCLOPAR	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
3892	HELIDAC	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
6633	PANMYCIN	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
7991	RETET	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8063	ROBITET	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8582	SUMYCIN	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8817	TETRACHEL	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8818	TETRACYCLINE HYDROCHLORIDE	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8820	TETRACYN	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8821	TETRACYN	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8822	TETRAMED	TETRACYCLINE HYDROCHLORIDE	54704426	C22H25ClN2O8	480.898	\N	\N	7	9	2	182	33	0	971	5	0	\N	\N	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
8842	THEOCLEAR L.A.-260	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8843	THEOCLEAR-100	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8844	THEOCLEAR-200	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8845	THEOCLEAR-80	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8846	THEOLAIR	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8847	THEOLAIR-SR	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8848	THEOLIXIR	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8849	THEOPHYL	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8850	THEOPHYL-225	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8851	THEOPHYL-SR	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8852	THEOPHYLLINE	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8853	THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8854	THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8855	THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8856	THEOPHYLLINE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8857	THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8858	THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8859	THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8860	THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8861	THEOPHYLLINE-SR	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
8862	THEOVENT	THEOPHYLLINE	2153	C7H8N4O2	180.167	\N	0	1	3	0	69.3	13	0	267	0	0	\N	\N	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione
5381	MELLARIL-S	THIORIDAZINE	5452	C21H26N2S2	370.573	\N	5.9	0	4	4	57.1	25	0	432	0	1	\N	\N	CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC	10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine
8904	TIMENTIN	TICARCILLIN DISODIUM	470375	C15H14N2Na2O6S2	428.385	\N	\N	1	8	3	183	27	0	629	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CSC=C3)C(=O)[O-])C(=O)[O-])C.[Na+].[Na+]	disodium;(2S,5R,6R)-6-[[(2R)-2-carboxylato-2-(3-thienyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
8906	TIMENTIN IN PLASTIC CONTAINER	TICARCILLIN DISODIUM	470375	C15H14N2Na2O6S2	428.385	\N	\N	1	8	3	183	27	0	629	4	0	\N	\N	CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CSC=C3)C(=O)[O-])C(=O)[O-])C.[Na+].[Na+]	disodium;(2S,5R,6R)-6-[[(2R)-2-carboxylato-2-(3-thienyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
8898	TICLOPIDINE HYDROCHLORIDE	TICLOPIDINE HYDROCHLORIDE	65335	C14H15Cl2NS	300.241	\N	\N	1	2	2	31.5	18	0	261	0	0	\N	\N	C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl	5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine;hydrochloride
2064	COSOPT PF	TIMOLOL MALEATE	5281056	C17H28N4O7S	432.492	\N	\N	4	12	9	183	29	0	429	1	0	\N	\N	CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O	(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;maleic acid
2893	DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE	TIMOLOL MALEATE	5281056	C17H28N4O7S	432.492	\N	\N	4	12	9	183	29	0	429	1	0	\N	\N	CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O	(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;maleic acid
8911	TIMOPTIC	TIMOLOL MALEATE	5281056	C17H28N4O7S	432.492	\N	\N	4	12	9	183	29	0	429	1	0	\N	\N	CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O	(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;maleic acid
8908	TIMOLIDE 10-25	TIMOLOL MALEATE	5281056	C17H28N4O7S	432.492	\N	\N	4	12	9	183	29	0	429	1	0	\N	\N	CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O	(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;maleic acid
8910	TIMOLOL MALEATE	TIMOLOL MALEATE	5281056	C17H28N4O7S	432.492	\N	\N	4	12	9	183	29	0	429	1	0	\N	\N	CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O	(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;maleic acid
8912	TIMOPTIC IN OCUDOSE	TIMOLOL MALEATE	5281056	C17H28N4O7S	432.492	\N	\N	4	12	9	183	29	0	429	1	0	\N	\N	CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O	(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;maleic acid
8913	TIMOPTIC-XE	TIMOLOL MALEATE	5281056	C17H28N4O7S	432.492	\N	\N	4	12	9	183	29	0	429	1	0	\N	\N	CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O	(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;maleic acid
8479	STIOLTO RESPIMAT	TIOTROPIUM BROMIDE	5487426	C19H22BrNO4S2	472.412	\N	\N	1	7	5	116	27	0	564	4	0	\N	\N	C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-]	\N
8350	SOLAGE	TRETINOIN	444795	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
735	APTIVUS	TIPRANAVIR	54682461	C31H33F3N2O5S	602.669	\N	7	2	10	11	114	42	0	1050	2	0	\N	\N	CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4	N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide
8942	TOBRAMYCIN SULFATE	TOBRAMYCIN SULFATE	62005	C18H39N5O13S	565.592	\N	\N	12	18	6	351	37	0	691	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N.OS(=O)(=O)O	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol;sulfuric acid
8943	TOBRAMYCIN SULFATE (PHARMACY BULK)	TOBRAMYCIN SULFATE	62005	C18H39N5O13S	565.592	\N	\N	12	18	6	351	37	0	691	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N.OS(=O)(=O)O	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol;sulfuric acid
8944	TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	TOBRAMYCIN SULFATE	62005	C18H39N5O13S	565.592	\N	\N	12	18	6	351	37	0	691	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N.OS(=O)(=O)O	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol;sulfuric acid
8936	TOBRADEX	TOBRAMYCIN	36294	C18H37N5O9	467.52	\N	-6.2	10	14	6	268	32	0	609	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
8938	TOBRADEX ST	TOBRAMYCIN	36294	C18H37N5O9	467.52	\N	-6.2	10	14	6	268	32	0	609	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
8939	TOBRAMYCIN	TOBRAMYCIN	36294	C18H37N5O9	467.52	\N	-6.2	10	14	6	268	32	0	609	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
8941	TOBRAMYCIN AND DEXAMETHASONE	TOBRAMYCIN	36294	C18H37N5O9	467.52	\N	-6.2	10	14	6	268	32	0	609	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
8946	TOBRASONE	TOBRAMYCIN	36294	C18H37N5O9	467.52	\N	-6.2	10	14	6	268	32	0	609	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
8947	TOBREX	TOBRAMYCIN	36294	C18H37N5O9	467.52	\N	-6.2	10	14	6	268	32	0	609	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
9942	ZYLET	TOBRAMYCIN	36294	C18H37N5O9	467.52	\N	-6.2	10	14	6	268	32	0	609	14	0	\N	\N	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
6439	ORINASE DIAGNOSTIC	TOLBUTAMIDE SODIUM	23690448	C12H17N2NaO3S	292.329	\N	\N	1	4	5	72.6	19	0	360	0	0	\N	\N	CCCCNC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)C.[Na+]	sodium;butylcarbamoyl(p-tolylsulfonyl)azanide
8956	TOLECTIN 600	TOLMETIN SODIUM	23665411	C15H14NNaO3	279.271	\N	\N	0	3	4	62.1	20	0	353	0	0	\N	\N	CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)[O-].[Na+]	sodium;2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetate
8957	TOLECTIN DS	TOLMETIN SODIUM	23665411	C15H14NNaO3	279.271	\N	\N	0	3	4	62.1	20	0	353	0	0	\N	\N	CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)[O-].[Na+]	sodium;2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetate
8959	TOLMETIN SODIUM	TOLMETIN SODIUM	23665411	C15H14NNaO3	279.271	\N	\N	0	3	4	62.1	20	0	353	0	0	\N	\N	CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)[O-].[Na+]	sodium;2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetate
8968	TOPIRAMATE	TOPIRAMATE	5284627	C12H21NO8S	339.359	\N	-0.8	1	9	3	124	22	0	556	4	0	\N	\N	CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C	[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate
9303	TROKENDI XR	TOPIRAMATE	5284627	C12H21NO8S	339.359	\N	-0.8	1	9	3	124	22	0	556	4	0	\N	\N	CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C	[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate
7929	REMODULIN	TREPROSTINIL	6918140	C23H34O5	390.52	\N	4.5	3	5	10	87	28	0	495	5	0	\N	\N	CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O	2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid
9362	TYVASO	TREPROSTINIL	6918140	C23H34O5	390.52	\N	4.5	3	5	10	87	28	0	495	5	0	\N	\N	CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O	2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid
7951	RENOVA	TRETINOIN	444795	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
7992	RETIN-A	TRETINOIN	444795	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
7993	RETIN-A MICRO	TRETINOIN	444795	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
7994	RETIN-A-MICRO	TRETINOIN	444795	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
9150	TRETINOIN	TRETINOIN	444795	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
9173	TRI-LUMA	TRETINOIN	444795	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
9540	VELTIN	TRETINOIN	444795	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
9567	VESANOID	TRETINOIN	444795	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
9861	ZIANA	TRETINOIN	444795	C20H28O2	300.442	\N	6.3	1	2	5	37.3	22	0	567	0	0	\N	\N	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
5833	NASACORT ALLERGY 24 HOUR	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
5834	NASACORT HFA	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
6268	NYSTATIN TRIAMCINOLONE ACETONIDE	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
6270	NYSTATIN-TRIAMCINOLONE ACETONIDE	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
6412	ORALONE	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
9188	TRIACORT	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
9194	TRIAMCINOLONE ACETONIDE	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
9195	TRIAMCINOLONE ACETONIDE IN ABSORBASE	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
9203	TRIATEX	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
9226	TRIDERM	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
9231	TRIESENCE	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
9320	TRYMEX	TRIAMCINOLONE ACETONIDE	6436	C24H31FO6	434.504	\N	2.5	2	7	2	93.1	31	0	925	8	0	\N	\N	CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C	\N
9222	TRICHLORMETHIAZIDE W/ RESERPINE	TRICHLORMETHIAZIDE	5560	C8H8Cl3N3O4S2	380.639	\N	0.6	3	7	2	135	20	0	571	0	1	\N	\N	C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl	6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
9145	TREMIN	TRIHEXYPHENIDYL HYDROCHLORIDE	66007	C20H32ClNO	337.932	\N	\N	2	2	5	23.5	23	0	314	0	1	\N	\N	C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O.Cl	1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol;hydrochloride
9237	TRIHEXYPHENIDYL HYDROCHLORIDE	TRIHEXYPHENIDYL HYDROCHLORIDE	66007	C20H32ClNO	337.932	\N	\N	2	2	5	23.5	23	0	314	0	1	\N	\N	C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O.Cl	1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol;hydrochloride
9250	TRIMETHOBENZAMIDE HYDROCHLORIDE	TRIMETHOBENZAMIDE HYDROCHLORIDE	68385	C21H29ClN2O5	424.922	\N	\N	2	6	10	69.3	29	0	440	0	0	\N	\N	CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC.Cl	N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxy-benzamide;hydrochloride
9251	TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE	TRIMETHOBENZAMIDE HYDROCHLORIDE	68385	C21H29ClN2O5	424.922	\N	\N	2	6	10	69.3	29	0	440	0	0	\N	\N	CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC.Cl	N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxy-benzamide;hydrochloride
8209	SEPTRA DS	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8211	SEPTRA GRAPE	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8533	SULFAMETHOPRIM-DS	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8536	SULFAMETHOXAZOLE AND TRIMETHOPRIM	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8539	SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8541	SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8543	SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8549	SULFATRIM	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8551	SULFATRIM PEDIATRIC	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8553	SULFATRIM-DS	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8555	SULFATRIM-SS	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8565	SULMEPRIM	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8567	SULMEPRIM PEDIATRIC	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
9252	TRIMETHOPRIM	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
9257	TRIMPEX	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
9258	TRIMPEX 200	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
9427	UROPLUS SS	TRIMETHOPRIM	5578	C14H18N4O3	290.323	\N	0.9	2	7	5	106	21	0	307	0	0	\N	\N	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
8594	SURMONTIL	TRIMIPRAMINE MALEATE	5282318	C24H30N2O4	410.514	\N	\N	2	6	6	81.1	30	0	436	0	1	\N	\N	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C.C(=CC(=O)O)C(=O)O	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethyl-propan-1-amine;maleic acid
9263	TRIPELENNAMINE HYDROCHLORIDE	TRIPELENNAMINE HYDROCHLORIDE	9066	C16H22ClN3	291.823	\N	\N	1	3	6	19.4	20	0	236	0	0	\N	\N	CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2.Cl	N'-benzyl-N,N-dimethyl-N'-(2-pyridyl)ethane-1,2-diamine;hydrochloride
3844	GYNE-SULF	TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)	60896	C33H36N12O6S3	792.909	\N	\N	6	18	9	319	54	0	1060	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-pyrimidin-2-yl-benzenesulfonamide
8574	SULTRIN	TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)	60896	C33H36N12O6S3	792.909	\N	\N	6	18	9	319	54	0	1060	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-pyrimidin-2-yl-benzenesulfonamide
9270	TRIPLE SULFA	TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)	60896	C33H36N12O6S3	792.909	\N	\N	6	18	9	319	54	0	1060	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-pyrimidin-2-yl-benzenesulfonamide
9321	TRYSUL	TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)	60896	C33H36N12O6S3	792.909	\N	\N	6	18	9	319	54	0	1060	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-pyrimidin-2-yl-benzenesulfonamide
9445	VAGILIA	TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)	60896	C33H36N12O6S3	792.909	\N	\N	6	18	9	319	54	0	1060	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-pyrimidin-2-yl-benzenesulfonamide
9277	TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
9280	TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W/ CODEINE	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
9283	TRIPROLIDINE HCL, PSEUDOEPHEDRINE HCL AND CODEINE PHOSPHATE	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
9284	TRIPROLIDINE HYDROCHLORIDE	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
9286	TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	TRIPROLIDINE HYDROCHLORIDE	5702129	C19H23ClN2	314.857	\N	\N	1	2	4	16.1	22	0	336	0	0	\N	\N	CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.Cl	2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine;hydrochloride
9271	TRIPLE SULFA	TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)	60896	C33H36N12O6S3	792.909	\N	\N	6	18	9	319	54	0	1060	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-pyrimidin-2-yl-benzenesulfonamide
9272	TRIPLE SULFAS	TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)	60896	C33H36N12O6S3	792.909	\N	\N	6	18	9	319	54	0	1060	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-pyrimidin-2-yl-benzenesulfonamide
8561	SULFOSE	TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)	60896	C33H36N12O6S3	792.909	\N	\N	6	18	9	319	54	0	1060	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-pyrimidin-2-yl-benzenesulfonamide
8783	TERFONYL	TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)	60896	C33H36N12O6S3	792.909	\N	\N	6	18	9	319	54	0	1060	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-pyrimidin-2-yl-benzenesulfonamide
9273	TRIPLE SULFOID	TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)	60896	C33H36N12O6S3	792.909	\N	\N	6	18	9	319	54	0	1060	0	0	\N	\N	CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide;4-amino-N-pyrimidin-2-yl-benzenesulfonamide
3483	FERTINEX	UROFOLLITROPIN	62819	C42H65N11O12S2	980.167	\N	-1.5	12	15	15	427	67	0	1790	0	10	\N	\N	CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)C(C)O	1-[19-amino-7-(2-amino-2-oxo-ethyl)-10-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-sec-butyl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide
5509	METRODIN	UROFOLLITROPIN	62819	C42H65N11O12S2	980.167	\N	-1.5	12	15	15	427	67	0	1790	0	10	\N	\N	CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)C(C)O	1-[19-amino-7-(2-amino-2-oxo-ethyl)-10-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-sec-butyl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide
9435	URSODIOL	URSODIOL	31401	C24H40O4	392.58	\N	4.9	3	4	4	77.8	28	0	605	10	0	\N	\N	CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C	(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
9477	VANCOMYCIN HYDROCHLORIDE	VANCOMYCIN HYDROCHLORIDE	6420023	C66H76Cl3N9O24	1485.723	\N	\N	20	26	13	531	102	0	2960	18	0	\N	\N	CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O.Cl	\N
9478	VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER	VANCOMYCIN HYDROCHLORIDE	6420023	C66H76Cl3N9O24	1485.723	\N	\N	20	26	13	531	102	0	2960	18	0	\N	\N	CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O.Cl	\N
9479	VANCOR	VANCOMYCIN HYDROCHLORIDE	6420023	C66H76Cl3N9O24	1485.723	\N	\N	20	26	13	531	102	0	2960	18	0	\N	\N	CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O.Cl	\N
9490	VARDENAFIL HYDROCHLORIDE	VARDENAFIL HYDROCHLORIDE	10142962	C23H33ClN6O4S	525.065	\N	\N	2	7	8	118	35	0	854	0	0	\N	\N	CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C.Cl	2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonyl-phenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one;hydrochloride
6945	PITRESSIN TANNATE	VASOPRESSIN TANNATE	8230	C46H65N15O12S2	1084.239	\N	-4.8	14	16	19	515	75	0	2070	0	8	\N	\N	C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N	1-[19-amino-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxo-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide
9514	VECURONIUM BROMIDE	VECURONIUM BROMIDE	39764	C34H57BrN2O4	637.744	\N	\N	0	6	6	55.8	41	0	958	10	0	\N	\N	CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-]	[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-(1-piperidyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide
4537	ISOPTIN	VERAPAMIL HYDROCHLORIDE	62969	C27H39ClN2O4	491.069	\N	\N	1	6	13	64	34	0	606	0	1	\N	\N	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl	2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile;hydrochloride
8687	TARKA	VERAPAMIL HYDROCHLORIDE	62969	C27H39ClN2O4	491.069	\N	\N	1	6	13	64	34	0	606	0	1	\N	\N	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl	2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile;hydrochloride
9008	TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	62969	C27H39ClN2O4	491.069	\N	\N	1	6	13	64	34	0	606	0	1	\N	\N	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl	2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile;hydrochloride
9551	VERAPAMIL HCL	VERAPAMIL HYDROCHLORIDE	62969	C27H39ClN2O4	491.069	\N	\N	1	6	13	64	34	0	606	0	1	\N	\N	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl	2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile;hydrochloride
9552	VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	62969	C27H39ClN2O4	491.069	\N	\N	1	6	13	64	34	0	606	0	1	\N	\N	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl	2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile;hydrochloride
9556	VERELAN	VERAPAMIL HYDROCHLORIDE	62969	C27H39ClN2O4	491.069	\N	\N	1	6	13	64	34	0	606	0	1	\N	\N	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl	2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile;hydrochloride
9557	VERELAN PM	VERAPAMIL HYDROCHLORIDE	62969	C27H39ClN2O4	491.069	\N	\N	1	6	13	64	34	0	606	0	1	\N	\N	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl	2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile;hydrochloride
9622	VINCRISTINE SULFATE PFS	VINCRISTINE SULFATE	249332	C46H58N4O14S	923.044	\N	\N	5	16	10	254	65	0	1830	9	0	\N	\N	CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O	\N
9624	VIOCIN SULFATE	VIOMYCIN SULFATE	5282488	C25H45N13O14S	783.772	\N	\N	17	17	10	476	53	0	1360	7	0	\N	\N	C1C(NC(=NC1O)N)C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CO)CO)NC(=O)CC(CCCN)N.OS(=O)(=O)O	(3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4S,6R)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-6-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide;sulfuric acid
739	AQUASOL A	VITAMIN A PALMITATE	5280531	C36H60O2	524.874	\N	13.6	0	2	21	26.3	38	0	803	0	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C	[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
1060	BEROCCA PN	VITAMIN A PALMITATE	5280531	C36H60O2	524.874	\N	13.6	0	2	21	26.3	38	0	803	0	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C	[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
9656	VITAMIN A	VITAMIN A PALMITATE	5280531	C36H60O2	524.874	\N	13.6	0	2	21	26.3	38	0	803	0	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C	[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
9657	VITAMIN A PALMITATE	VITAMIN A PALMITATE	5280531	C36H60O2	524.874	\N	13.6	0	2	21	26.3	38	0	803	0	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C	[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
9658	VITAMIN A SOLUBILIZED	VITAMIN A PALMITATE	5280531	C36H60O2	524.874	\N	13.6	0	2	21	26.3	38	0	803	0	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C	[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
9672	VITAPED	VITAMIN A PALMITATE	5280531	C36H60O2	524.874	\N	13.6	0	2	21	26.3	38	0	803	0	0	\N	\N	CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C	[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
4266	INFUVITE ADULT	VITAMIN K	5280483	C31H46O2	450.707	\N	10.9	0	2	14	34.1	33	0	696	0	2	\N	\N	CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C	2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
4279	INFUVITE PEDIATRIC	VITAMIN K	5280483	C31H46O2	450.707	\N	10.9	0	2	14	34.1	33	0	696	0	2	\N	\N	CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C	2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
4292	INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)	VITAMIN K	5280483	C31H46O2	450.707	\N	10.9	0	2	14	34.1	33	0	696	0	2	\N	\N	CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C	2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
4740	LAMIVUDINE AND ZIDOVUDINE	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
4746	LAMIVUDINE, ZIDOVUDINE TABS 150MG/300MG CO-PACKAGED WITH NEVIRAPINE TABS 200MG	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
4749	Lamivudine, Zidovudine, Nevirapine Tabs 150mg/300mg/200mg	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
4757	Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
4760	LAMIVUDINE/ZIDOVUDINE TABLETS CO-PACKAGED WITH NEVIRAPINE TABLETS	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
4764	LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
4776	LAMIVUDINE; ZIDOVUDINE	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
4778	LAMIVUDINE; ZIDOVUDINE	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
4781	LAMIVUDINE; ZIDOVUDINE; ABACAVIR	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
4784	LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
4788	LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
7996	RETROVIR	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
9301	TRIZIVIR	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
9864	ZIDOVUDINE	ZIDOVUDINE	35370	C10H13N5O4	267.245	\N	0	2	6	3	93.2	19	0	484	3	0	\N	\N	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
\.


--
-- Name: drugs_id_seq; Type: SEQUENCE SET; Schema: public; Owner: -
--

SELECT pg_catalog.setval('drugs_id_seq', 9955, true);


--
-- Name: drugs_pkey; Type: CONSTRAINT; Schema: public; Owner: -
--

ALTER TABLE ONLY drugs
    ADD CONSTRAINT drugs_pkey PRIMARY KEY (id);


--
-- Name: public; Type: ACL; Schema: -; Owner: -
--

REVOKE ALL ON SCHEMA public FROM PUBLIC;
REVOKE ALL ON SCHEMA public FROM postgres;
GRANT ALL ON SCHEMA public TO postgres;
GRANT ALL ON SCHEMA public TO PUBLIC;


--
-- PostgreSQL database dump complete
--

